data_1a5e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1a5e _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.177 0.513 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.517 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.4 m0 -72.31 -11.46 60.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.484 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -74.86 -58.5 3.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.441 -0.787 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.522 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.2 -49.43 77.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -43.89 -67.9 0.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.835 -0.541 . . . . 0.0 110.737 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.506 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -46.24 -51.21 14.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.33 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 52' ' ' MET . . . -46.59 -54.18 9.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.667 . . . . 0.0 110.334 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.14 -20.11 65.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.409 -0.807 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.447 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 26.4 mtm180 -99.38 22.2 10.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 111.364 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.513 ' CA ' ' HG3' ' A' ' 53' ' ' MET . . . 54.38 52.61 43.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 14.7 mmt180 -124.97 89.93 3.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.2 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 81.2 t -74.36 -40.51 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.443 -0.786 . . . . 0.0 110.041 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -34.7 76.75 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.385 -0.822 . . . . 0.0 110.729 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 1.6 tp10 -61.07 -50.71 72.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG21 ' CB ' ' A' ' 19' ' ' ALA . 20.6 t -71.55 -48.54 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.903 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.524 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -41.18 -42.1 1.97 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 -179.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.72 -50.33 13.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.49 -0.756 . . . . 0.0 109.09 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -61.56 -60.19 4.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.502 -0.749 . . . . 0.0 110.049 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.56 ' HG ' ' CD2' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -42.95 -46.27 5.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.75 -0.594 . . . . 0.0 110.83 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -75.53 -14.85 60.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 110.318 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.36 -8.39 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.843 . . . . 0.0 110.769 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.58 16.95 3.28 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.119 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 32' ' ' LEU . . . -56.81 135.65 55.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.892 -1.357 . . . . 0.0 110.292 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.0 tp -83.19 116.71 65.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.669 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HA ' HD22 ' A' ' 16' ' ' LEU . 43.6 Cg_endo -73.1 -36.72 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.488 1.257 . . . . 0.0 110.944 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -91.94 24.09 3.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.306 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.32 148.32 64.03 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.381 -0.824 . . . . 0.0 110.444 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.67 93.4 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.782 1.412 . . . . 0.0 110.258 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -65.43 158.89 25.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.65 -0.656 . . . . 0.0 110.356 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.9 3.51 55.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 110.65 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 11.6 m-85 -114.3 23.12 13.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 74' ' ' ASP . . . 47.18 31.22 6.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HD3' ' HG2' ' A' ' 50' ' ' GLN . 15.1 mtt-85 -114.18 -161.09 0.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.684 -0.892 . . . . 0.0 110.427 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.472 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.98 179.13 0.82 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.955 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 47.5 Cg_endo -71.21 -26.42 21.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.935 1.492 . . . . 0.0 110.126 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 52' ' ' MET . 4.4 mt -109.31 -37.57 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.376 -0.828 . . . . 0.0 109.826 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.415 ' HG2' ' HD3' ' A' ' 46' ' ' ARG . 2.0 tt0 -49.4 -22.04 1.05 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.079 -1.013 . . . . 0.0 110.05 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -104.43 -10.28 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.454 -0.779 . . . . 0.0 110.585 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.481 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -65.08 161.54 18.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.159 -0.963 . . . . 0.0 110.557 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.513 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.54 105.82 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.552 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -62.62 -10.53 12.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.469 -0.769 . . . . 0.0 110.881 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -90.33 28.38 7.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.461 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -161.39 81.24 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -1.123 . . . . 0.0 110.07 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.11 -24.45 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -52.47 -49.86 63.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 56' ' ' SER . 2.7 t -56.66 -65.15 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.267 -0.896 . . . . 0.0 110.086 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' VAL . . . -40.53 -42.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.606 -0.683 . . . . 0.0 110.008 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -46.37 84.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.458 -0.776 . . . . 0.0 109.055 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -53.05 -55.2 25.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 48' ' ' PRO . 2.5 mp -66.54 -43.89 83.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.853 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.483 HD21 HG11 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -64.24 -55.07 24.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.462 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.5 tp -49.18 -34.36 14.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.849 0.833 . . . . 0.0 108.912 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.56 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 2.7 m-70 -83.14 -35.02 25.9 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.4 58.62 0.18 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.644 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.439 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . . . -78.05 -156.57 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 72' ' ' CYS . 1.8 mt-10 -114.92 64.42 1.61 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.454 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . 40.9 Cg_endo -67.19 -13.95 41.42 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.786 1.413 . . . . 0.0 110.409 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.409 ' O ' ' HD2' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -107.26 -57.6 2.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -48.32 150.27 1.32 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 110.751 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HB1' ' CD ' ' A' ' 80' ' ' ARG . . . -136.54 -139.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.737 . . . . 0.0 109.757 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' LEU . 2.8 t0 -116.32 126.78 27.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.19 -8.89 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.143 1.076 . . . . 0.0 110.142 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.33 -46.87 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.581 HG21 ' CH2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -116.3 -0.52 12.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.1 mt 46.92 23.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.911 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.9 m -61.54 94.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.18 -0.95 . . . . 0.0 108.8 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.547 ' NH2' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -66.49 143.56 98.25 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.567 -0.708 . . . . 0.0 109.2 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 39.1 Cg_endo -66.56 -9.6 24.86 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.784 1.413 . . . . 0.0 110.142 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.454 HG13 ' CB ' ' A' ' 114' ' ' PRO . 42.7 t -70.56 -25.12 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.537 ' NE2' ' OD1' ' A' ' 108' ' ' ASP . 5.9 m80 -72.78 -41.8 64.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.212 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.552 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 15.9 m-20 -47.47 -42.88 23.64 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.277 0.561 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -66.28 -65.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.959 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -59.58 -48.57 81.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -0.899 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.437 ' O ' HD21 ' A' ' 121' ' ' LEU . 5.4 tmm_? -51.51 -35.69 41.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.987 -1.071 . . . . 0.0 109.872 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.482 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 2.3 tp10 -88.85 4.07 49.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.09 -1.006 . . . . 0.0 110.218 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 69.56 28.38 72.37 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.8 OUTLIER -106.21 120.12 41.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.448 -1.031 . . . . 0.0 110.046 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.47 -41.27 9.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 0.0 110.01 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 1.2 m-20 -52.58 -25.35 10.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.905 . . . . 0.0 110.471 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 5.6 m -74.85 -45.95 39.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.191 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.531 ' CD1' ' CG1' ' A' ' 126' ' ' VAL . 0.4 OUTLIER -57.96 -54.97 40.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.37 -50.68 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.394 -0.816 . . . . 0.0 109.379 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.483 HG11 HD21 ' A' ' 64' ' ' LEU . 85.3 t -51.07 -55.99 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.748 -0.595 . . . . 0.0 110.162 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.454 ' HG ' ' CB ' ' A' ' 70' ' ' PRO . 7.6 mp -49.73 -53.51 24.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -61.62 -31.14 71.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.0 109.977 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -71.05 -11.96 61.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.935 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB1' ' CD2' ' A' ' 64' ' ' LEU . . . -140.63 66.32 1.38 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.185 -0.947 . . . . 0.0 111.004 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.87 97.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 70' ' ' PRO . . . -160.41 108.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -1.147 . . . . 0.0 110.445 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.7 ttt85 -64.75 128.46 35.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.325 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.21 19.72 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.388 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -124.48 58.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 110.077 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.547 HG22 ' NH2' ' A' ' 80' ' ' ARG . 5.2 p -117.4 -175.39 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.345 -0.847 . . . . 0.0 109.731 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.02 127.96 23.64 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.56 -0.712 . . . . 0.0 110.235 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.537 ' OD1' ' NE2' ' A' ' 83' ' ' HIS . 1.7 m-20 -51.31 150.64 3.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 109.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.19 -35.76 2.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.463 -0.773 . . . . 0.0 111.034 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.581 ' CH2' HG21 ' A' ' 77' ' ' THR . 13.4 m-90 -59.57 -79.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.18 29.36 0.02 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.427 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -107.42 -165.04 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -1.21 . . . . 0.0 110.975 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.402 HD21 HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -147.03 160.51 39.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 39.5 Cg_endo -67.66 -33.64 27.46 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.433 1.228 . . . . 0.0 110.645 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 5.4 p -78.33 -37.81 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.0 110.082 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.99 -43.64 91.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.51 -0.744 . . . . 0.0 109.978 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mt -52.27 -39.29 60.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 123' ' ' HIS . . . -69.12 -34.08 74.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.532 -0.73 . . . . 0.0 110.008 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.0 -20.08 64.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.427 ' OE2' ' NH2' ' A' ' 112' ' ' ARG . 29.2 tt0 -86.25 -57.98 2.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.706 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 6.7 mp -57.07 -81.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.008 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.3 40.41 0.02 OUTLIER Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . 21.5 m-70 -115.09 43.39 2.0 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.43 -1.041 . . . . 0.0 109.759 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -45.65 -37.19 5.45 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -62.33 -37.46 85.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.62 -0.675 . . . . 0.0 109.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.557 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -80.93 -36.19 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 118' ' ' ALA . . . -68.34 -32.93 73.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.544 -0.722 . . . . 0.0 109.602 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -59.3 -66.27 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.406 -0.809 . . . . 0.0 109.741 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -52.13 -25.51 9.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.36 -0.838 . . . . 0.0 109.352 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.488 HD12 ' HB1' ' A' ' 86' ' ' ALA . 8.7 mt -73.88 -58.82 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 110.427 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -24.06 0.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.84 -51.04 9.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.955 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.15 -13.19 53.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.0 110.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 110.715 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.829 0.347 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.537 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.9 m0 -79.78 -9.97 59.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -74.92 -50.75 15.73 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.164 -0.96 . . . . 0.0 109.354 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.46 -47.78 66.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.368 -0.833 . . . . 0.0 109.799 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -50.89 -49.81 58.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.456 -0.777 . . . . 0.0 110.411 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.89 -55.71 30.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 52' ' ' MET . . . -48.21 -44.25 32.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.315 -0.866 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.33 -32.09 54.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 111.034 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 1.1 ttt-85 -90.99 32.25 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.264 -0.898 . . . . 0.0 111.196 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.38 71.17 0.62 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -137.49 50.4 1.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.386 -1.067 . . . . 0.0 110.061 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' A' ' 59' ' ' VAL . 70.7 t -45.96 -37.41 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.459 -0.776 . . . . 0.0 110.282 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.83 -46.6 62.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.38 -44.89 89.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.315 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.426 HG13 HD13 ' A' ' 32' ' ' LEU . 23.7 t -66.02 -46.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.886 . . . . 0.0 109.958 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.487 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -51.27 -46.04 62.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.07 -39.8 65.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.496 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.3 -56.31 11.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.498 -0.751 . . . . 0.0 110.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD13 ' CD2' ' A' ' 62' ' ' LEU . 14.3 mt -50.1 -50.38 48.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 110.16 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.22 -13.62 60.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.361 -0.837 . . . . 0.0 110.742 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 -11.53 36.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.977 -1.077 . . . . 0.0 111.006 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.55 37.0 0.7 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -66.84 162.36 21.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -1.125 . . . . 0.0 109.905 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.482 ' O ' ' CD2' ' A' ' 16' ' ' LEU . 5.5 tp -92.18 115.23 64.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 0.0 109.663 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.39 -28.58 39.06 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.461 1.243 . . . . 0.0 110.195 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.414 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 28.6 m120 -129.74 66.49 1.47 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 109.753 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.33 108.52 22.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 47.5 Cg_endo -71.63 94.31 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.622 1.327 . . . . 0.0 110.061 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -94.02 -174.81 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.812 . . . . 0.0 110.644 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.46 5.59 41.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 110.914 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.9 -5.56 53.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.83 22.84 12.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -115.03 134.74 54.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -1.064 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.598 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -60.37 169.16 1.86 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 39.6 Cg_endo -66.35 -23.23 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.542 1.285 . . . . 0.0 111.296 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.42 HG13 ' CB ' ' A' ' 68' ' ' ALA . 6.1 mt -107.99 -36.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.973 -1.079 . . . . 0.0 109.065 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HG3' ' OD2' ' A' ' 84' ' ' ASP . 2.7 tt0 -52.18 -19.85 2.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.734 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.37 2.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.497 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -76.91 165.16 25.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.999 -1.063 . . . . 0.0 110.147 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.404 ' N ' ' O ' ' A' ' 20' ' ' ALA . 3.3 tpp -61.1 96.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.218 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.56 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -55.82 -13.64 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.038 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -90.5 8.94 79.01 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.18 88.84 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.204 -1.174 . . . . 0.0 109.856 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . . . -59.22 -24.34 63.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -52.15 -49.96 62.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' A' ' 25' ' ' VAL . 40.6 t -56.72 -56.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 110.109 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -41.7 -57.56 2.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.606 -0.684 . . . . 0.0 110.64 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -47.02 -48.87 21.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.37 -0.831 . . . . 0.0 110.232 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.7 OUTLIER -49.62 -70.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.523 -0.735 . . . . 0.0 109.854 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' CG ' HD12 ' A' ' 16' ' ' LEU . 3.8 mt -59.96 -48.73 80.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.641 0.734 . . . . 0.0 110.024 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.491 ' CD2' ' HG3' ' A' ' 70' ' ' PRO . 3.4 tm? -50.96 -69.53 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.692 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 62' ' ' LEU . 1.4 pp -53.01 -24.88 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 110.027 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.59 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.35 -55.36 5.46 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.481 -0.762 . . . . 0.0 109.319 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.02 44.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.563 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 63' ' ' LEU . . . -76.05 -158.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.019 -1.283 . . . . 0.0 109.117 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.55 74.63 3.21 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.357 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.491 ' HG3' ' CD2' ' A' ' 64' ' ' LEU . 55.8 Cg_endo -78.69 10.15 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.955 1.502 . . . . 0.0 110.351 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.487 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -139.53 -60.92 0.55 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.43 152.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.624 -0.672 . . . . 0.0 110.316 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB1' ' HG2' ' A' ' 80' ' ' ARG . . . -143.14 -161.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.316 -0.865 . . . . 0.0 110.512 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.6 140.17 25.18 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 110.267 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 1.32 9.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.453 1.239 . . . . 0.0 110.564 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.0 -39.39 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 109.631 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.523 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -128.98 2.07 5.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.49 -0.756 . . . . 0.0 110.279 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.3 mt 47.76 21.73 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.941 . . . . 0.0 111.684 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -59.08 102.81 0.14 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.926 -1.109 . . . . 0.0 109.115 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.487 ' CZ ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -77.89 159.1 76.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.757 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 42.2 Cg_endo -68.13 -13.92 39.36 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.154 1.607 . . . . 0.0 110.267 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.2 -28.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.569 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.487 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.3 m80 -70.74 -44.07 67.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.56 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.11 -47.05 45.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.732 -0.605 . . . . 0.0 110.982 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -62.2 -66.23 0.57 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.562 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.551 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -54.32 -43.4 71.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.449 -0.782 . . . . 0.0 110.592 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -46.38 -41.95 14.33 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.514 -0.741 . . . . 0.0 110.559 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.59 -2.27 45.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.195 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 75.99 47.25 11.69 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -115.87 95.2 5.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.304 -1.115 . . . . 0.0 111.18 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.424 HD23 ' CD2' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.3 -36.33 79.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.534 179.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 1.7 m-20 -50.46 -58.59 5.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 0.0 109.357 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 92.4 m -52.77 -44.48 66.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.491 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 5.9 tp -54.89 -53.22 58.3 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.32 -40.16 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.409 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.8 t -62.75 -40.41 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.38 -61.48 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.42 -17.66 3.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -39.01 66.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.382 -0.824 . . . . 0.0 110.963 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.455 ' CB ' HD12 ' A' ' 64' ' ' LEU . . . -118.98 70.83 0.83 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 111.457 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.65 90.78 0.01 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -143.94 82.5 1.72 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -1.167 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.16 143.81 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.51 -0.744 . . . . 0.0 110.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 mp -129.74 0.53 4.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.654 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.68 56.65 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.245 -0.909 . . . . 0.0 110.296 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.459 HG13 ' CG ' ' A' ' 80' ' ' ARG . 1.7 p -114.99 -164.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -147.37 140.33 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.518 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 110' ' ' TRP . 45.2 t0 -68.73 63.75 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 57.06 -77.17 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.4 m-90 -45.94 -70.7 0.09 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.728 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.36 -34.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -43.73 144.79 0.76 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.651 -0.911 . . . . 0.0 110.855 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.405 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -114.67 167.03 10.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.371 -0.831 . . . . 0.0 110.464 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.45 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 40.9 Cg_endo -68.61 -34.76 18.64 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.884 1.465 . . . . 0.0 110.563 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -80.77 -23.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.767 . . . . 0.0 110.337 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.78 -44.69 40.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.638 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.414 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 4.5 pp -63.0 -21.42 66.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.637 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.39 -49.91 13.88 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -31.02 28.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.159 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -86.69 -51.29 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.77 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.524 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -178.46 39.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 39.0 m-70 -120.05 49.19 1.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.383 -1.069 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -53.91 11.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.728 -0.608 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.13 -34.98 24.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.488 -0.758 . . . . 0.0 109.722 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -83.41 -35.73 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.151 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.33 94.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.513 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -55.23 20.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.383 -0.823 . . . . 0.0 109.446 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.424 ' CD2' HD23 ' A' ' 91' ' ' LEU . 20.5 t80 -55.19 -40.52 70.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.346 -0.846 . . . . 0.0 109.539 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HG ' ' CD2' ' A' ' 94' ' ' LEU . 12.1 mt -64.52 -50.48 67.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 109.312 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -53.23 -27.64 23.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 0.0 110.328 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.3 -42.8 20.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.48 -11.01 50.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.416 -0.802 . . . . 0.0 110.729 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.42 ' O ' ' HB ' ' A' ' 18' ' ' THR . 9.4 t70 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.914 0.387 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.445 ' HA ' ' CG2' ' A' ' 18' ' ' THR . 42.2 m0 -76.51 -8.27 56.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.211 -0.931 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.438 HD12 HD22 ' A' ' 63' ' ' LEU . 1.2 tp -79.41 -50.89 10.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.31 -0.869 . . . . 0.0 109.036 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.49 46.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -63.96 -40.66 96.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.934 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . . . -63.35 -45.5 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 108.894 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 59' ' ' VAL . . . -62.68 -54.3 41.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.95 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 51' ' ' VAL . . . -54.82 -22.03 13.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.548 -0.72 . . . . 0.0 110.979 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.94 27.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.943 . . . . 0.0 110.581 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.05 34.12 4.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 1.2 tpt180 -118.69 105.76 11.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.474 -1.015 . . . . 0.0 110.527 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.477 HG23 HG21 ' A' ' 59' ' ' VAL . 71.6 t -72.46 -56.93 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.299 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -48.92 -26.89 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.533 -0.729 . . . . 0.0 110.909 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 3.0 mm-40 -71.52 -44.73 64.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 108.84 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.447 ' CG1' HD22 ' A' ' 62' ' ' LEU . 22.7 t -75.75 -52.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -0.807 . . . . 0.0 109.103 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HD2' ' HB2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -43.57 -50.43 7.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.599 -0.688 . . . . 0.0 110.406 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -73.02 -48.84 32.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.597 -0.689 . . . . 0.0 109.99 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 13.5 mt -55.27 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 111.251 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.498 ' HB2' HD22 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -45.64 -49.42 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.0 111.537 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -68.98 -9.1 50.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 110.804 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -102.03 -23.2 14.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.937 -1.102 . . . . 0.0 111.261 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 162.5 -28.62 0.26 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.635 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' A' ' 31' ' ' LEU . . . -41.87 141.03 0.9 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.286 -1.126 . . . . 0.0 110.464 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 154.81 13.25 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.2 -38.9 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.818 1.431 . . . . 0.0 109.844 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 68' ' ' ALA . 7.9 m120 -122.63 -65.54 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.58 -0.7 . . . . 0.0 109.817 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.59 154.19 0.1 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.586 -0.696 . . . . 0.0 110.275 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.17 177.27 8.04 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.7 1.368 . . . . 0.0 110.171 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.7 155.62 47.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 110.077 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.42 16.14 18.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.5 23.18 34.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -110.14 174.5 5.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.498 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.8 mmp_? -86.49 165.45 33.06 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.0 Cg_endo -68.69 -12.6 35.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.773 1.407 . . . . 0.0 110.374 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 49' ' ' ILE . 5.9 mt -109.37 -36.67 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 108.731 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.46 -21.72 38.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.871 -1.143 . . . . 0.0 108.979 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 14.6 p -114.87 31.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.443 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.53 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -96.89 33.65 1.85 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 109.798 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.8 tmm? 72.5 -14.5 0.56 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.781 -0.574 . . . . 0.0 111.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.53 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 50.28 25.25 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.983 -1.073 . . . . 0.0 110.075 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -126.33 15.75 6.77 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.431 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -156.22 93.41 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 109.866 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.37 -22.74 33.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.347 -0.845 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.421 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -58.33 -39.57 79.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.458 -0.776 . . . . 0.0 110.16 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 20' ' ' ALA . 11.0 t -53.98 -65.17 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -52.72 -33.63 48.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HA ' HG12 ' A' ' 96' ' ' VAL . 19.4 tt0 -47.23 -42.15 19.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 32' ' ' LEU . 1.7 tp -82.7 -41.47 19.27 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -63.83 -62.87 1.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.629 -0.669 . . . . 0.0 109.739 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -48.54 -43.73 35.77 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.355 -0.841 . . . . 0.0 109.756 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.95 -43.16 91.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.183 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CG ' HD23 ' A' ' 32' ' ' LEU . 3.5 m80 -81.06 0.03 37.78 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.729 -0.607 . . . . 0.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.11 60.13 1.98 Allowed Glycine 0 N--CA 1.48 1.609 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 63' ' ' LEU . . . -66.83 -148.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.252 . . . . 0.0 109.014 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -115.17 52.75 0.76 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.867 . . . . 0.0 109.662 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' CD ' ' C ' ' A' ' 68' ' ' ALA . 48.6 Cg_endo -70.77 -31.32 16.24 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.461 1.243 . . . . 0.0 109.628 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.403 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.6 OUTLIER -82.85 -75.46 0.31 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.563 -0.711 . . . . 0.0 109.139 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.13 164.43 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.566 -0.709 . . . . 0.0 110.534 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.03 -126.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.027 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.2 m-20 -110.31 132.79 21.32 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.783 -1.198 . . . . 0.0 109.932 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.92 -9.91 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.313 1.165 . . . . 0.0 110.655 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.72 -74.63 0.42 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.377 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.449 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -100.3 9.11 43.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 110.473 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.3 mt 51.09 39.75 24.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -0.896 . . . . 0.0 110.318 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.19 96.21 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 110.019 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.58 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -73.19 148.58 88.83 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 110.636 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.58 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.7 Cg_endo -67.99 -14.49 41.25 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.699 1.368 . . . . 0.0 109.129 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 94.3 t -64.36 -31.51 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 26.1 m80 -67.74 -41.23 83.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.497 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 4.0 m-20 -52.35 -51.16 60.35 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.211 0.529 . . . . 0.0 110.58 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -53.52 -64.98 0.65 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.442 -0.787 . . . . 0.0 109.452 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.531 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -58.7 -27.9 65.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -49.61 68.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.15 -0.969 . . . . 0.0 110.591 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.84 4.5 53.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 110.321 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.521 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 71.89 36.33 61.29 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -102.53 83.25 2.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.358 -1.083 . . . . 0.0 110.87 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.436 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.88 -39.06 80.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.431 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . 1.2 m-20 -47.67 -37.43 12.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.502 -0.749 . . . . 0.0 110.006 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.7 m -64.3 -46.59 82.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.437 ' HG ' ' CB ' ' A' ' 85' ' ' ALA . 1.2 mp -63.3 -45.11 92.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 110.138 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 55.6 t -48.79 -44.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 61' ' ' GLU . 10.9 t -67.02 -45.4 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.689 . . . . 0.0 109.147 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -53.09 -43.34 66.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.448 -0.782 . . . . 0.0 109.859 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -83.49 -33.48 25.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.074 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.43 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 5.6 ttt85 -66.09 -11.22 47.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.556 -0.715 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.1 -67.71 0.66 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.082 -1.012 . . . . 0.0 111.071 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.57 107.1 0.23 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -167.29 117.07 0.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.452 -1.028 . . . . 0.0 110.271 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.8 113.88 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 1.1 mp -106.41 25.68 10.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 110.225 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 134' ' ' ALA . 1.6 p30 -128.79 47.71 2.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.365 -0.834 . . . . 0.0 110.59 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.441 HG12 ' CG ' ' A' ' 80' ' ' ARG . 1.6 p -112.14 -169.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.857 . . . . 0.0 109.961 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.422 ' N ' HG11 ' A' ' 106' ' ' VAL . 19.3 ptt180 -140.64 146.74 38.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.96 66.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 110.117 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.78 -84.9 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.611 -0.681 . . . . 0.0 110.67 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.506 ' N ' ' O ' ' A' ' 108' ' ' ASP . 23.9 p90 -122.94 15.16 9.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.98 -81.0 1.35 Allowed Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.79 -164.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.228 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 41.8 mt -95.79 163.42 21.27 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.75 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.3 Cg_endo -65.6 -19.14 60.26 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.88 1.463 . . . . 0.0 110.379 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.445 ' HA ' HD11 ' A' ' 130' ' ' LEU . 14.3 p -79.36 -36.59 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.824 . . . . 0.0 110.152 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.95 -39.66 87.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.854 . . . . 0.0 110.353 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 tt -69.04 -35.74 76.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.951 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.07 -55.96 26.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.531 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -60.52 -41.97 95.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.803 . . . . 0.0 110.473 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.18 -37.89 67.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 109.984 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.463 ' CB ' ' CD2' ' A' ' 123' ' ' HIS . 11.7 mt -86.47 -2.32 58.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 110.416 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.44 33.64 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 71.9 m-70 -102.77 46.18 0.93 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.89 -1.359 . . . . 0.0 109.56 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -45.82 -37.97 6.71 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.29 0.566 . . . . 0.0 110.346 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.15 -42.95 87.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.725 . . . . 0.0 109.195 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 13.6 t -76.09 -37.79 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.72 85.43 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -56.51 -61.34 2.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.905 . . . . 0.0 109.625 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -57.63 -24.92 59.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 109.454 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 115' ' ' VAL . 11.3 mt -75.73 -52.87 9.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.79 . . . . 0.0 109.545 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -23.28 2.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.814 . . . . 0.0 110.169 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.24 -57.43 3.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.981 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.45 -1.65 34.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 111.013 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.55 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.412 ' O ' ' OG1' ' A' ' 18' ' ' THR . 20.5 t70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.832 0.349 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.446 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 31.1 m0 -40.19 -30.55 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.619 . . . . 0.0 111.012 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' CB ' ' A' ' 36' ' ' ALA . 9.8 mt -75.68 -54.57 6.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.512 -0.742 . . . . 0.0 109.144 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.41 69.43 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.783 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -73.9 -59.31 2.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.755 -0.591 . . . . 0.0 110.633 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.414 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -49.67 -54.43 18.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB3' HG13 ' A' ' 59' ' ' VAL . . . -47.73 -50.22 25.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -36.8 82.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.184 -0.947 . . . . 0.0 109.952 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.84 15.1 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.81 72.05 0.6 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 93.0 mtt180 -136.74 67.95 1.44 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.517 -0.99 . . . . 0.0 109.739 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.497 HG11 ' HD3' ' A' ' 29' ' ' ARG . 50.4 t -57.27 -62.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.451 -0.78 . . . . 0.0 110.058 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 25' ' ' VAL . 9.3 mt-10 -39.73 -36.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.75 -0.594 . . . . 0.0 110.943 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -72.34 -50.11 29.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.554 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.432 ' CG1' HD11 ' A' ' 62' ' ' LEU . 43.6 t -62.58 -38.87 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.181 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -55.2 -38.44 68.4 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.855 -1.153 . . . . 0.0 108.434 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.88 12.11 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.93 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 4.2 mt -56.35 -65.86 0.53 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 110.339 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 13.5 mt -43.42 -51.04 6.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.296 -0.877 . . . . 0.0 109.68 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 43.0 mt-10 -69.79 -15.25 63.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.61 -5.46 58.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.0 110.732 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.05 2.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -75.91 165.44 24.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.547 -0.972 . . . . 0.0 110.253 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.43 137.92 51.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 110.344 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.14 -40.8 0.58 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.888 1.467 . . . . 0.0 110.323 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 25.6 m120 -101.71 -83.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.653 -0.654 . . . . 0.0 110.087 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 57.41 69.66 1.56 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 45.4 Cg_endo -71.44 101.97 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.048 1.552 . . . . 0.0 111.708 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 3.9 p30 -178.75 -156.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.52 -0.737 . . . . 0.0 109.706 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 1.1 t 61.72 85.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.42 -0.8 . . . . 0.0 109.747 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.597 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.1 m-85 65.89 8.37 5.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 109.836 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.13 23.57 52.71 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.555 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 16.2 mmt-85 -99.62 35.49 1.98 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.07 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.498 ' CB ' ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 53.23 -178.34 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 47' ' ' ARG . 55.7 Cg_endo -82.58 -29.27 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.426 1.224 . . . . 0.0 111.337 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.494 HG13 ' CB ' ' A' ' 68' ' ' ALA . 6.4 mt -107.47 -35.53 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.498 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 20.4 tt0 -60.51 -11.72 7.79 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.019 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 12.9 p -105.79 3.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.873 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -73.11 166.28 23.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.967 -1.083 . . . . 0.0 109.024 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.3 ttm -63.87 -6.74 6.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.355 -0.841 . . . . 0.0 111.204 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.466 ' HE2' ' CB ' ' A' ' 84' ' ' ASP . 8.5 mmt 56.1 17.22 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.885 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.47 -0.65 24.82 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.533 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -139.32 88.74 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -1.027 . . . . 0.0 109.873 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -53.35 -24.55 12.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.314 -0.867 . . . . 0.0 110.651 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -48.23 70.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 108.84 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 56' ' ' SER . 67.3 t -52.4 -49.5 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -51.71 -53.51 38.54 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -49.23 -47.11 46.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.715 -0.615 . . . . 0.0 110.04 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -56.26 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 110.176 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.516 HD22 HD13 ' A' ' 32' ' ' LEU . 69.1 mt -53.67 -49.85 67.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.481 -0.762 . . . . 0.0 110.396 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.519 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -50.7 -69.19 0.12 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.427 -0.796 . . . . 0.0 111.045 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -51.26 -22.32 2.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.412 -0.805 . . . . 0.0 109.697 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -83.87 -49.11 9.34 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.646 -0.659 . . . . 0.0 109.596 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 154.51 39.07 0.02 OUTLIER Glycine 0 N--CA 1.478 1.46 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.744 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 49' ' ' ILE . . . -71.09 -173.94 0.9 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.557 -1.555 . . . . 0.0 108.593 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 3.6 mt-10 -113.72 64.71 1.17 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.072 -1.017 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 46.3 Cg_endo -70.77 -10.31 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.093 1.575 . . . . 0.0 109.857 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.469 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 10.2 t-20 -107.89 -29.06 9.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -0.774 . . . . 0.0 109.688 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 158.71 16.94 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.652 -0.655 . . . . 0.0 110.099 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB1' ' CD ' ' A' ' 80' ' ' ARG . . . -137.24 -145.92 0.21 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.409 -0.807 . . . . 0.0 110.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.9 143.05 26.1 Favored Pre-proline 0 C--N 1.306 -1.304 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.31 -12.22 23.0 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.82 1.432 . . . . 0.0 110.019 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.86 -71.22 0.46 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.573 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -103.04 -2.53 27.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 111.017 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 mt 63.58 20.92 12.5 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.224 -0.923 . . . . 0.0 111.282 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.7 m -65.51 97.03 0.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.572 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 11.9 mmt85 -69.62 164.21 52.44 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.148 -0.97 . . . . 0.0 109.217 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.509 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -67.18 -21.46 48.39 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.879 1.463 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 103' ' ' ARG . 13.4 t -59.99 -27.26 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.567 0.699 . . . . 0.0 109.491 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.511 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.1 m80 -80.47 -32.09 37.23 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.466 ' CB ' ' HE2' ' A' ' 54' ' ' MET . 5.0 m-20 -61.07 -43.03 99.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' CB ' HG23 ' A' ' 93' ' ' THR . . . -60.32 -64.41 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.368 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.591 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -59.59 -35.32 74.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.516 -0.74 . . . . 0.0 110.107 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -45.41 -55.88 5.6 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.249 -0.907 . . . . 0.0 110.717 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.64 5.02 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.4 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 72.74 27.72 68.56 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 1.6 t80 -94.99 103.75 15.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.304 -1.115 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.96 -43.69 34.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.862 -0.524 . . . . 0.0 110.807 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.532 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.1 m-20 -44.39 -34.89 2.16 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.547 0.689 . . . . 0.0 109.748 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.44 HG23 ' CB ' ' A' ' 85' ' ' ALA . 95.2 m -66.37 -39.89 89.41 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.338 0.589 . . . . 0.0 109.901 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 91' ' ' LEU . 1.0 OUTLIER -64.02 -58.28 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 40.0 t -38.21 -53.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.732 -0.605 . . . . 0.0 110.208 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 64' ' ' LEU . 24.7 t -55.74 -56.34 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.783 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.443 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -44.35 -44.35 8.17 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.351 -0.843 . . . . 0.0 110.509 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -82.4 -26.87 32.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.1 ttt85 -65.05 -10.3 28.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.697 -0.627 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.11 -68.7 0.58 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 111.153 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.12 107.85 0.25 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 97' ' ' LEU . . . -152.39 -155.61 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.572 -0.958 . . . . 0.0 109.629 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.468 ' O ' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -162.63 105.92 1.1 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.9 OUTLIER -98.9 68.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.585 -0.697 . . . . 0.0 110.812 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -175.34 42.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.498 HG13 ' HG3' ' A' ' 80' ' ' ARG . 1.4 p -107.16 -175.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 109' ' ' ALA . 2.5 mtp85 -125.8 133.83 51.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -67.05 64.23 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.752 -0.592 . . . . 0.0 110.197 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . 57.87 -80.85 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.449 -0.782 . . . . 0.0 110.947 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.573 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.2 m-90 -45.68 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.0 110.266 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.24 73.05 0.06 OUTLIER Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -134.34 -164.02 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.395 -1.062 . . . . 0.0 109.884 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.481 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -153.07 166.48 15.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.6 Cg_endo -70.33 -54.9 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.875 1.46 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.478 ' HA ' HD11 ' A' ' 130' ' ' LEU . 4.2 p -62.16 -26.03 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.626 -0.671 . . . . 0.0 110.482 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.473 ' N ' HG11 ' A' ' 115' ' ' VAL . 12.7 t0 -62.38 -30.24 71.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.449 -0.782 . . . . 0.0 110.494 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -44.31 18.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 109.666 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . . . -52.84 -47.03 68.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 127' ' ' ALA . 64.5 mm-40 -63.98 -35.0 79.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.024 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.48 -25.07 50.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.772 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.61 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 42.6 mt -101.7 2.57 38.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.44 43.51 24.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 20.4 m-70 -106.63 55.52 0.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.086 -1.244 . . . . 0.0 110.154 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 12.4 mmt180 -41.05 -57.31 2.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.843 -0.536 . . . . 0.0 110.418 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -43.59 -43.98 5.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.555 HG13 ' CB ' ' A' ' 86' ' ' ALA . 1.4 t -86.9 -50.96 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.353 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 119' ' ' GLU . . . -49.94 -50.69 45.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -62.24 -66.12 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.445 ' CD2' HD23 ' A' ' 91' ' ' LEU . 56.6 t80 -47.66 -40.58 20.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.717 . . . . 0.0 109.844 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 134' ' ' ALA . 10.0 mt -60.24 -54.12 49.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.659 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -45.28 -36.72 4.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.565 -0.709 . . . . 0.0 110.656 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.82 62.3 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.408 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -83.56 -1.22 53.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.714 -0.616 . . . . 0.0 110.602 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 110.283 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 18' ' ' THR . 16.6 p30 . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.937 0.398 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.473 ' HB3' HD11 ' A' ' 31' ' ' LEU . 42.3 m0 -45.49 -43.6 11.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.593 -0.692 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.445 HD11 ' CD2' ' A' ' 32' ' ' LEU . 12.4 mt -58.1 -58.61 7.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.0 109.158 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.4 -51.64 66.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.729 -0.607 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -51.51 -66.14 0.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.342 -0.849 . . . . 0.0 110.845 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' ARG . . . -58.47 -52.2 66.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.98 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' CB ' HG12 ' A' ' 59' ' ' VAL . . . -50.4 -58.31 6.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.358 -0.839 . . . . 0.0 110.399 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -52.58 -24.55 8.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.798 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.2 7.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.43 47.81 61.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 10.6 mtt180 -118.62 73.03 0.9 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.443 -1.034 . . . . 0.0 109.896 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG13 ' CB ' ' A' ' 58' ' ' ARG . 49.2 t -60.59 -60.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.334 -0.854 . . . . 0.0 111.125 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -47.63 -35.19 8.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 110.969 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -70.29 -39.41 74.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.277 -0.889 . . . . 0.0 109.584 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.435 ' CG1' HD22 ' A' ' 62' ' ' LEU . 39.1 t -76.13 -49.84 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.187 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -42.32 -46.51 4.61 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.446 -0.784 . . . . 0.0 110.039 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -72.39 -51.86 18.58 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.852 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 15' ' ' TRP . 60.4 mt -51.99 -66.88 0.31 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.542 -0.724 . . . . 0.0 110.964 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.516 HD12 ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -41.51 -59.24 1.66 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.707 -0.621 . . . . 0.0 111.282 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -13.44 61.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.822 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -85.04 -6.93 59.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.97 -1.082 . . . . 0.0 110.86 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.51 -10.29 6.45 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.535 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 32' ' ' LEU . . . -50.92 143.6 9.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.274 . . . . 0.0 110.264 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 37' ' ' LEU . 5.8 mp -59.82 153.77 51.57 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.395 -0.816 . . . . 0.0 109.957 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.02 -56.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.679 1.357 . . . . 0.0 110.932 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -96.96 -66.97 0.87 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.11 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.34 101.55 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.17 122.41 9.47 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.579 1.305 . . . . 0.0 110.705 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -103.87 -166.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.592 -0.693 . . . . 0.0 109.739 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.1 38.5 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.287 -0.883 . . . . 0.0 110.519 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 18.9 m-85 -122.49 13.75 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.82 49.78 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HD3' ' HB3' ' A' ' 44' ' ' TYR . 2.9 ptm180 -159.73 131.67 6.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -1.143 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.605 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.86 -173.66 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.668 -0.645 . . . . 0.0 110.169 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.5 Cg_endo -64.44 -173.7 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.196 1.103 . . . . 0.0 111.467 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 3.2 mt 62.97 -64.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.6 tt0 -48.08 -25.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.001 -1.062 . . . . 0.0 109.344 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 12.5 p -120.7 34.18 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.611 -0.681 . . . . 0.0 109.556 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.51 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -94.11 38.25 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.0 110.068 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.434 ' CB ' ' O ' ' A' ' 52' ' ' MET . 7.5 tmm? 66.98 -10.62 0.3 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.509 -0.745 . . . . 0.0 110.751 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.51 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 48.56 27.76 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.989 -1.069 . . . . 0.0 110.127 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.454 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -133.05 13.76 4.95 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m -144.13 78.13 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -1.044 . . . . 0.0 109.941 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . . . -50.63 -29.53 11.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 110.006 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.41 ' CB ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -56.91 -31.53 65.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.618 -0.677 . . . . 0.0 109.464 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.473 HG12 ' CB ' ' A' ' 20' ' ' ALA . 53.1 t -58.59 -65.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.082 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -50.76 -39.21 51.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 110.22 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.479 ' HA ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -51.44 -36.91 46.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.189 -0.945 . . . . 0.0 110.038 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 29' ' ' ARG . 6.9 tp -89.97 -43.8 10.31 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.455 -0.778 . . . . 0.0 109.158 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' CD2' HD11 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -63.7 -55.59 22.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.19 -47.36 85.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.335 -0.853 . . . . 0.0 109.7 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -52.54 -28.35 20.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.213 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.516 ' CG ' HD12 ' A' ' 32' ' ' LEU . 1.1 m-70 -93.36 -41.36 9.88 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.551 -0.718 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.34 47.49 0.04 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.593 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 49' ' ' ILE . . . -67.01 -149.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.008 -1.29 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.473 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 3.1 pt-20 -116.71 56.71 1.59 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.981 . . . . 0.0 110.872 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 40.1 Cg_endo -68.28 -15.04 41.86 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.635 1.334 . . . . 0.0 109.886 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -110.27 -77.9 0.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.528 -0.733 . . . . 0.0 110.095 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -43.0 145.04 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 110.95 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.72 -143.0 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 11.3 m-20 -112.58 134.44 21.64 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 109.978 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.54 -19.91 36.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.489 1.257 . . . . 0.0 110.062 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.54 -76.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 108.915 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 69.6 p -122.36 36.15 4.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.931 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.7 mt 48.17 34.13 4.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.498 -0.751 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.0 101.67 0.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.44 ' CZ ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -85.36 173.18 7.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.47 -11.62 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.07 1.563 . . . . 0.0 110.14 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.91 -30.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 26.6 m80 -73.1 -47.03 47.92 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 20.6 m-20 -47.28 -47.0 25.24 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.894 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.16 -59.98 4.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.827 . . . . 0.0 109.669 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.584 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -61.07 -51.52 68.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.399 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.443 ' HD3' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -41.88 -30.54 0.26 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.522 -0.736 . . . . 0.0 111.058 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.12 -18.89 15.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 110.391 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.84 23.81 34.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.454 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -97.0 85.02 3.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -1.067 . . . . 0.0 111.018 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -58.89 -38.39 78.74 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -50.67 -36.99 38.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.3 m -62.96 -47.96 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.404 HD12 HG12 ' A' ' 126' ' ' VAL . 1.4 mp -60.84 -43.61 98.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.488 -0.758 . . . . 0.0 109.68 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.71 -47.67 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.366 -0.834 . . . . 0.0 109.183 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.536 HG13 HD11 ' A' ' 64' ' ' LEU . 45.2 t -60.02 -48.12 89.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 1.7 mp -54.98 -40.96 70.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -82.9 -33.11 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.084 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -65.69 -12.2 51.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -0.775 . . . . 0.0 110.439 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.84 -82.15 0.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.715 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.71 56.04 0.13 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . . . -105.7 122.62 46.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -1.132 . . . . 0.0 110.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -54.87 162.13 1.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 109.849 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.59 36.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.301 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -150.64 40.63 0.75 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 111.34 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' A' ' 80' ' ' ARG . 5.1 p -97.87 -176.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HG3' ' C ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -130.2 146.93 51.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.341 -0.849 . . . . 0.0 109.681 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 110' ' ' TRP . 15.1 p-10 -74.53 50.36 0.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 109.851 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 61.66 -60.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.694 -0.628 . . . . 0.0 110.795 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.555 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.41 -54.94 14.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.62 -25.4 0.75 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -60.87 -174.15 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.228 -1.16 . . . . 0.0 110.697 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.451 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -138.55 175.46 3.32 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 46.5 Cg_endo -73.48 -47.61 0.29 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.539 1.284 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 130' ' ' LEU . 9.2 p -54.46 -33.0 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 0.0 109.1 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -37.72 69.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.639 -0.663 . . . . 0.0 109.321 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -30.78 67.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.217 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 127' ' ' ALA . . . -69.38 -53.41 19.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.49 ' N ' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -65.37 -16.13 63.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.431 -0.793 . . . . 0.0 110.06 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -38.4 36.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.502 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 5.1 mt -92.23 1.46 57.2 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 110.955 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.06 12.87 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.617 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 80.3 m-70 -95.78 46.69 1.09 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.974 -1.309 . . . . 0.0 109.318 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -43.79 -38.1 3.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.747 -0.595 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.419 ' HB2' HD13 ' A' ' 91' ' ' LEU . 15.9 p-10 -64.23 -40.8 96.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.371 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -82.94 -40.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.49 ' HB3' ' N ' ' A' ' 119' ' ' GLU . . . -57.51 -53.89 53.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.082 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 mtt-85 -52.99 -59.75 4.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 110.264 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -59.32 -39.88 84.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 126' ' ' VAL . 12.6 mt -60.06 -30.66 69.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -67.6 -36.74 81.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.875 . . . . 0.0 109.634 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.13 -35.88 36.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.448 -0.782 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.08 23.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.0 110.119 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 0.0 110.091 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.083 0.468 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.491 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 16.2 m0 -69.88 -5.5 26.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.454 HD21 HG12 ' A' ' 28' ' ' VAL . 30.7 mt -76.62 -54.33 6.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.981 -1.074 . . . . 0.0 109.689 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -66.16 -33.04 74.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.73 -0.606 . . . . 0.0 110.513 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -71.84 -59.99 2.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 15' ' ' TRP . . . -55.86 -47.73 76.79 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.887 -1.133 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -47.95 -62.89 1.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.449 -0.782 . . . . 0.0 110.186 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -51.34 -24.25 4.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.233 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -90.27 28.86 1.34 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.521 -0.737 . . . . 0.0 111.028 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.29 43.48 9.77 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.483 ' HD2' ' HB3' ' A' ' 22' ' ' ARG . 1.7 mtt180 -122.91 96.66 5.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.435 -1.038 . . . . 0.0 109.661 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 60.1 t -82.05 -55.48 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.07 -33.22 1.4 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.668 -0.645 . . . . 0.0 111.685 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.572 ' O ' ' HB3' ' A' ' 31' ' ' LEU . 1.3 mt-10 -67.77 -65.87 0.64 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.896 -1.127 . . . . 0.0 108.621 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 32' ' ' LEU . 6.7 t -58.01 -44.47 87.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.517 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.5 tpt85 -47.51 -48.93 27.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.947 -1.096 . . . . 0.0 110.31 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.37 -51.28 5.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -58.28 -40.64 82.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HB2' HG11 ' A' ' 28' ' ' VAL . 6.6 tt -67.92 -47.69 68.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.338 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -59.93 -15.14 19.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.0 110.407 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.33 -62.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.71 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.14 28.1 0.08 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -70.17 167.37 17.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 110.469 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' O ' ' CD1' ' A' ' 16' ' ' LEU . 4.0 mm? -98.23 134.22 22.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.846 . . . . 0.0 110.975 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 44.6 Cg_endo -71.6 -22.95 23.68 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.587 1.309 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -129.81 53.92 1.88 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.578 -0.701 . . . . 0.0 109.279 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.06 145.91 44.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.612 -0.68 . . . . 0.0 111.051 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.44 136.9 29.63 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.95 1.5 . . . . 0.0 109.92 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 8.7 m-80 -100.71 -161.8 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -0.889 . . . . 0.0 110.562 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.24 13.34 16.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.488 -0.757 . . . . 0.0 110.246 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -149.1 27.12 0.86 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 110.137 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.86 56.29 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.501 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -115.27 96.48 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.534 -0.98 . . . . 0.0 110.138 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 29.0 mmt-85 -52.27 171.89 0.19 Allowed Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.332 -0.855 . . . . 0.0 110.45 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.47 ' O ' ' HB ' ' A' ' 49' ' ' ILE . 38.9 Cg_endo -65.89 166.68 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.566 1.298 . . . . 0.0 110.215 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 52' ' ' MET . 1.2 mt 64.21 -64.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.808 -0.557 . . . . 0.0 109.625 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' PRO . 17.7 tt0 -45.55 -27.61 0.78 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.861 -1.149 . . . . 0.0 109.35 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.501 ' HB ' ' CG ' ' A' ' 46' ' ' ARG . 9.9 p -117.35 43.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.313 -0.867 . . . . 0.0 110.541 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -104.08 33.65 3.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 109.173 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.456 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 9.7 ttp 70.76 -6.62 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.883 -0.511 . . . . 0.0 110.318 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.554 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.92 25.78 0.11 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.0 110.736 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.28 19.16 4.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.02 75.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.455 -1.026 . . . . 0.0 109.697 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.492 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -45.03 -27.48 0.56 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.895 . . . . 0.0 109.756 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -49.84 20.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.654 -0.654 . . . . 0.0 109.503 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG2' HG23 ' A' ' 25' ' ' VAL . 62.9 t -56.61 -64.29 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -0.758 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 61' ' ' GLU . . . -44.54 -52.16 8.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.432 -0.792 . . . . 0.0 109.827 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.456 ' O ' HD21 ' A' ' 65' ' ' LEU . 7.0 tm-20 -41.75 -53.38 3.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.517 HD21 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -59.57 -53.44 58.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.671 -0.643 . . . . 0.0 109.992 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -65.31 -50.9 63.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.588 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -48.88 -59.4 3.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.797 . . . . 0.0 110.424 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 1.2 pp -57.67 -23.32 50.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.077 -1.015 . . . . 0.0 108.776 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.538 ' CD2' ' CD2' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -86.76 -3.12 59.01 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.639 -0.663 . . . . 0.0 109.915 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 84.92 46.91 5.5 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' CB ' HG13 ' A' ' 49' ' ' ILE . . . -64.26 -146.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -1.164 . . . . 0.0 109.301 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 2.0 tp10 -120.72 64.36 11.58 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.04 -35.23 4.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.916 1.482 . . . . 0.0 110.468 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 3.5 m-80 -85.28 -69.3 0.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.294 -0.879 . . . . 0.0 110.242 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.453 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.3 t -48.71 144.02 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -0.757 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.92 -152.83 0.53 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.512 -0.743 . . . . 0.0 109.815 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.65 149.51 37.53 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.205 -0.934 . . . . 0.0 109.823 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.88 -21.42 24.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.645 1.339 . . . . 0.0 109.098 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.09 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.72 -0.613 . . . . 0.0 109.593 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 27.2 p -133.48 40.98 3.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.445 -0.784 . . . . 0.0 109.079 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mt 41.82 42.8 2.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.729 -0.607 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 m -78.7 103.5 8.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.579 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -76.4 155.13 83.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 109.388 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 39.5 Cg_endo -64.57 -15.67 51.16 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.422 1.222 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 114' ' ' PRO . 11.1 t -61.07 -33.29 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 87' ' ' ARG . 7.4 m80 -71.72 -35.36 70.16 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.554 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -54.84 -46.89 74.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -57.99 -58.09 9.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.458 -0.776 . . . . 0.0 109.384 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HB1' HD13 ' A' ' 130' ' ' LEU . . . -69.67 -15.83 63.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.7 tpt180 -80.81 -22.73 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.52 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -112.32 -12.93 13.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 110.134 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' CE1' ' A' ' 123' ' ' HIS . . . 80.99 61.02 2.18 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.492 ' CE1' ' HB1' ' A' ' 57' ' ' ALA . 1.2 t80 -135.97 86.08 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -1.069 . . . . 0.0 110.335 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.452 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.2 OUTLIER -60.36 -40.52 91.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 111.047 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -45.7 -37.14 5.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.83 . . . . 0.0 109.851 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.412 HG22 ' CE ' ' A' ' 52' ' ' MET . 8.5 m -73.8 -42.81 60.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.498 -0.751 . . . . 0.0 109.417 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.49 -45.51 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.662 0.744 . . . . 0.0 109.203 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 92' ' ' ASP . 6.5 t -60.31 -50.34 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -48.26 -44.32 33.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.512 -0.743 . . . . 0.0 110.141 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -84.94 -36.91 21.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.258 -0.901 . . . . 0.0 110.58 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -59.52 -15.12 15.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.2 -81.64 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.662 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.33 106.15 0.27 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . . . -159.06 120.87 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.372 -1.075 . . . . 0.0 110.378 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.543 ' HD3' ' NH1' ' A' ' 80' ' ' ARG . 41.6 ttt85 -74.71 102.08 4.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.513 -0.742 . . . . 0.0 110.073 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 1.2 mp -98.31 56.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.25 -0.906 . . . . 0.0 110.396 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -162.36 50.79 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.874 -1.141 . . . . 0.0 110.7 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG1' ' HD2' ' A' ' 80' ' ' ARG . 2.5 p -111.61 -169.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.929 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.41 ' HG2' HD22 ' A' ' 113' ' ' LEU . 20.0 mtt180 -127.95 138.25 52.56 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.529 -0.732 . . . . 0.0 109.967 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.4 m-20 -75.34 57.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 110.264 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 57.65 -69.56 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.704 -0.623 . . . . 0.0 111.376 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.566 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.03 -50.49 36.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.328 -0.858 . . . . 0.0 110.425 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.48 -21.33 0.83 Allowed Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -49.27 168.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.416 -1.049 . . . . 0.0 110.778 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 30.9 mt -131.68 167.75 20.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -69.6 -42.19 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.7 1.368 . . . . 0.0 109.699 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 116' ' ' ASP . 5.7 p -71.25 -25.73 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 110.203 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t70 -67.68 -58.19 5.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.57 -60.03 2.41 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.445 -0.784 . . . . 0.0 110.653 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 86' ' ' ALA . . . -47.22 -53.1 14.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -31.25 64.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -26.91 46.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.049 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.52 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 12.4 mt -92.66 -0.72 57.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.72 23.95 40.52 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.52 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 15.6 m170 -95.33 49.34 1.19 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.268 -1.136 . . . . 0.0 109.704 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' HIS . 10.7 mmm-85 -43.16 -33.71 0.96 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.527 -0.733 . . . . 0.0 109.616 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -46.4 79.7 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 123' ' ' HIS . 2.4 t -82.81 -34.85 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.478 -0.763 . . . . 0.0 109.544 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.1 -51.36 61.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 108.961 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -64.65 -52.5 57.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.655 -0.653 . . . . 0.0 109.482 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.471 ' C ' ' CD1' ' A' ' 129' ' ' TYR . 7.7 t80 -50.76 -40.08 53.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.41 -0.807 . . . . 0.0 109.136 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.478 HD13 ' HB1' ' A' ' 86' ' ' ALA . 24.0 mt -65.57 -53.51 40.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.695 -0.628 . . . . 0.0 109.587 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -21.32 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.123 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.26 -54.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 110.566 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.94 56.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.755 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.5 p30 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.738 0.304 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.447 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 24.6 m0 -52.05 -52.2 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.996 -1.065 . . . . 0.0 110.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -51.01 -27.49 7.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.26 -0.9 . . . . 0.0 109.899 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.68 -44.04 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 0.0 109.492 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -65.86 -44.55 85.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.65 -45.86 88.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.537 ' HB3' HG13 ' A' ' 59' ' ' VAL . . . -58.61 -44.54 89.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.909 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.63 -30.03 71.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.555 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -97.61 22.38 9.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.432 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.39 60.64 6.59 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 67.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -1.085 . . . . 0.0 110.464 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 64.0 t -52.53 -58.92 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -43.12 -41.62 3.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.713 -0.617 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HG3' HD13 ' A' ' 31' ' ' LEU . 3.3 tp10 -66.4 -46.55 76.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 62' ' ' LEU . 22.1 t -70.24 -41.03 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.325 -0.86 . . . . 0.0 110.893 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 24.9 mmm-85 -51.0 -46.01 61.37 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.186 -0.946 . . . . 0.0 109.93 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.43 -43.45 32.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 0.0 109.956 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD13 ' HG3' ' A' ' 27' ' ' GLU . 1.4 mt -57.78 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 62' ' ' LEU . 12.4 mt -53.25 -44.49 68.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 0.0 110.048 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.19 -16.04 63.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.862 . . . . 0.0 109.917 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.21 -9.79 55.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 110.311 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 22.95 3.53 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -62.04 134.96 57.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -1.221 . . . . 0.0 109.906 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 tp -83.3 116.87 66.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.425 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -71.74 -41.74 2.05 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.671 1.353 . . . . 0.0 110.489 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.83 48.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.02 118.57 67.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.72 94.99 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.618 1.325 . . . . 0.0 110.524 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -78.44 179.29 7.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 110.005 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -90.93 23.11 3.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.441 ' CD1' ' HD2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -113.66 -19.05 11.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.73 37.11 93.02 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 47' ' ' ARG . 32.6 mtt-85 -124.34 31.62 5.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -1.12 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 12.7 mmt-85 49.32 177.31 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.522 -0.736 . . . . 0.0 110.585 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 51.6 Cg_endo -79.71 -19.64 9.76 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.357 1.188 . . . . 0.0 109.92 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CG ' ' A' ' 52' ' ' MET . 7.0 mt -109.06 -42.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.688 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -50.73 -22.91 2.33 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.881 -1.137 . . . . 0.0 110.295 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.8 5.31 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.605 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.494 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.94 146.49 24.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.844 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 106.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.333 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.514 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 13.5 mmt -59.67 -8.46 2.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.814 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -82.0 11.56 47.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 m -144.95 88.65 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.216 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.68 -29.68 70.24 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.16 -0.963 . . . . 0.0 109.546 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -29.75 10.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.681 -0.637 . . . . 0.0 109.821 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 20' ' ' ALA . 11.2 t -74.85 -55.3 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.144 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.454 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -50.22 -47.77 54.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.382 -0.824 . . . . 0.0 109.5 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -51.36 -66.31 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.481 0.658 . . . . 0.0 109.943 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.4 mt -68.25 -49.54 59.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 110.858 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 1.8 tt -44.9 -67.37 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.439 -0.788 . . . . 0.0 110.858 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -23.5 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -79.19 -43.35 24.07 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.409 -0.807 . . . . 0.0 109.534 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.96 36.05 0.06 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -68.89 -171.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.657 -1.496 . . . . 0.0 109.257 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -111.18 73.07 0.91 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.5 -7.84 22.21 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.959 1.505 . . . . 0.0 110.64 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.34 -57.17 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.63 161.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 111.566 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.08 -143.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.512 -0.743 . . . . 0.0 109.966 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' LEU . 31.3 t0 -114.37 134.57 22.26 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 109.416 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD2' ' OD1' ' A' ' 74' ' ' ASP . 48.8 Cg_endo -72.71 -3.06 12.84 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.29 1.153 . . . . 0.0 111.011 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.37 -41.3 9.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.0 110.256 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.508 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -131.15 5.98 4.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.09 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.8 mt 48.48 42.63 18.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -0.838 . . . . 0.0 111.008 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 m -75.65 93.32 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 110.401 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.495 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -70.72 168.77 17.63 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 108.777 179.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.495 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -75.62 -0.87 10.66 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.096 1.051 . . . . 0.0 110.289 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 104' ' ' LEU . 11.4 t -76.31 -34.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -68.08 -36.34 79.67 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.251 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 1.8 m-20 -55.46 -56.12 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.695 -0.628 . . . . 0.0 110.474 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' N ' ' SD ' ' A' ' 54' ' ' MET . . . -55.12 -62.06 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.355 -0.84 . . . . 0.0 109.985 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -56.59 -49.3 75.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 111.108 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -32.35 12.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.081 -1.012 . . . . 0.0 111.045 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -94.3 -4.28 49.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.497 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 81.8 25.51 52.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.521 ' CE1' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -98.76 143.7 28.81 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.328 -1.101 . . . . 0.0 110.63 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.429 ' HA ' HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -117.04 -39.36 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -52.83 -36.66 58.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.5 m -60.53 -49.66 76.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.667 -0.646 . . . . 0.0 109.635 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' A' ' 91' ' ' LEU . 1.8 mp -57.65 -45.23 85.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 109.685 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.0 t -55.89 -43.29 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.343 -0.848 . . . . 0.0 108.922 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 64' ' ' LEU . 46.2 t -61.13 -45.27 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.42 0.629 . . . . 0.0 109.479 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.415 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 96.0 mt -57.43 -46.89 83.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.513 -0.742 . . . . 0.0 110.313 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -77.77 -25.94 49.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.498 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -67.04 -13.52 62.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 110.11 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.22 -74.24 0.59 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.19 105.83 0.21 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.18 -165.0 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -1.084 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.86 102.59 3.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.489 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.485 ' CD2' HG12 ' A' ' 82' ' ' VAL . 1.7 mp -93.26 11.31 28.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.843 . . . . 0.0 109.444 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.34 31.06 4.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.407 HG22 ' CZ ' ' A' ' 80' ' ' ARG . 4.1 p -104.01 -176.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 110.055 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.7 ptt-85 -139.21 145.4 39.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.581 -0.7 . . . . 0.0 109.568 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -70.55 63.11 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.124 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 60.04 -65.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.697 -0.627 . . . . 0.0 111.007 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.1 m-90 -57.47 -74.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 110.873 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.76 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -49.69 124.26 9.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -1.12 . . . . 0.0 110.634 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.4 mt -85.97 164.79 37.67 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -20.3 46.04 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.719 1.378 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 7.4 p -83.65 -37.88 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.382 -0.824 . . . . 0.0 109.832 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.408 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.3 OUTLIER -70.96 -38.13 72.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.852 . . . . 0.0 109.898 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.36 -41.54 89.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.126 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.6 -59.42 5.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.619 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -30.9 35.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.314 -0.866 . . . . 0.0 110.433 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -24.75 56.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.534 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -90.28 -3.65 57.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 110.607 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.35 14.72 46.85 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 44.2 m-70 -98.42 48.95 0.99 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.91 -1.347 . . . . 0.0 109.478 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -30.17 2.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.687 -0.633 . . . . 0.0 110.229 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -65.41 -41.88 93.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 4.7 t -81.6 -38.32 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.42 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.86 97.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -57.96 -67.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.429 -0.795 . . . . 0.0 109.494 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -50.59 -40.89 53.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 134' ' ' ALA . 13.8 mt -57.02 -50.3 73.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.401 ' CA ' HG22 ' A' ' 115' ' ' VAL . 4.7 ttp180 -56.23 -22.13 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.753 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.02 -66.39 0.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.083 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.97 -7.31 53.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 111.105 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.144 -0.973 . . . . 0.0 110.355 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.77 0.319 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 38.2 m0 -74.42 -24.5 59.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.257 -0.902 . . . . 0.0 109.877 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.56 -35.54 79.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 110.151 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.88 -50.56 12.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.457 -0.777 . . . . 0.0 109.184 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -51.36 -51.56 53.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.333 -0.854 . . . . 0.0 109.669 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.477 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . . . -58.64 -37.93 76.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.16 -61.02 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.48 ' CA ' ' O ' ' A' ' 51' ' ' VAL . . . -46.46 -29.1 1.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.702 -0.624 . . . . 0.0 111.105 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 21.2 mtm-85 -91.9 32.43 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.451 -0.78 . . . . 0.0 111.04 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.39 36.2 3.01 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 3.0 mpt_? -108.5 94.74 5.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -1.12 . . . . 0.0 109.609 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.442 HG21 ' CG2' ' A' ' 59' ' ' VAL . 89.8 t -74.46 -59.73 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.646 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -43.15 -30.75 0.49 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 111.668 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.477 ' OE1' ' HB3' ' A' ' 19' ' ' ALA . 1.5 mt-10 -68.0 -52.46 35.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 32' ' ' LEU . 6.1 t -68.49 -41.22 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.578 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.574 ' CD ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.02 -50.42 27.77 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.439 -0.788 . . . . 0.0 109.616 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.82 -49.1 66.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.643 -0.661 . . . . 0.0 109.84 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' ALA . 4.1 mt -58.78 -60.25 4.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 63' ' ' LEU . 11.7 mt -44.41 -49.25 9.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.595 -0.691 . . . . 0.0 109.95 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.08 -14.29 61.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.471 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -94.63 -3.42 49.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.992 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.35 33.05 1.26 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.684 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -79.36 140.22 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.296 . . . . 0.0 108.761 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 3.0 tp -79.72 123.34 84.01 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.083 -1.01 . . . . 0.0 111.058 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 42.2 Cg_endo -70.72 -21.33 29.18 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.827 1.435 . . . . 0.0 109.84 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.78 52.65 1.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.067 -1.02 . . . . 0.0 110.03 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . . . -86.32 154.99 57.38 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.843 . . . . 0.0 110.131 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -79.04 132.04 10.27 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.868 1.457 . . . . 0.0 109.858 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -97.95 -171.84 2.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.38 -0.825 . . . . 0.0 110.822 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 m -113.47 2.78 15.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.79 . . . . 0.0 110.271 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.488 ' CB ' ' HD3' ' A' ' 46' ' ' ARG . 72.5 m-85 -118.24 20.06 13.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.595 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.91 22.69 35.45 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.488 ' HD3' ' CB ' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -109.5 -169.64 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -1.201 . . . . 0.0 109.896 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 23.7 mmt180 -106.02 165.9 12.21 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.379 -0.826 . . . . 0.0 109.72 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.2 Cg_endo -62.85 -12.79 30.86 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.665 1.35 . . . . 0.0 109.885 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.8 mt -110.96 -35.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.431 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 4.1 tt0 -59.17 -15.9 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.48 ' O ' ' CA ' ' A' ' 21' ' ' ALA . 7.7 p -118.12 38.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.358 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.523 ' CE ' ' HB1' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.96 29.96 4.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.755 -1.216 . . . . 0.0 109.578 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 7.5 tmm? 74.21 -8.78 1.38 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.792 -0.567 . . . . 0.0 110.46 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 45.11 24.22 0.12 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.596 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -130.05 18.01 5.35 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 57' ' ' ALA . 1.1 t -149.54 64.58 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.486 -1.008 . . . . 0.0 110.586 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -38.33 -32.76 0.08 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.568 -0.707 . . . . 0.0 110.087 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 56' ' ' SER . 3.9 mmt85 -49.74 -41.13 43.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.591 -0.693 . . . . 0.0 109.201 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ALA . 40.8 t -62.22 -61.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.578 -0.701 . . . . 0.0 109.492 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.523 ' HB1' ' CE ' ' A' ' 52' ' ' MET . . . -35.55 -52.84 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.481 -0.762 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.33 -55.39 15.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.006 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.574 HD13 ' CD ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -43.45 -65.8 0.45 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.641 -0.662 . . . . 0.0 110.506 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CD2' HD13 ' A' ' 32' ' ' LEU . 74.2 mt -66.78 -49.88 64.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.526 -0.734 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.505 HD21 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -41.82 -72.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.629 -0.669 . . . . 0.0 110.648 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 1.3 pp -52.46 -23.64 6.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -79.04 -31.55 44.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.649 -0.657 . . . . 0.0 109.545 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 124.76 41.1 0.39 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.497 ' HB3' HG13 ' A' ' 49' ' ' ILE . . . -63.51 -156.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.07 -1.253 . . . . 0.0 109.745 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.492 ' HG2' ' CB ' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -118.87 59.08 4.05 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.426 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.495 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 51.9 Cg_endo -69.89 -22.09 31.97 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 124.149 1.605 . . . . 0.0 110.178 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.31 -52.32 3.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.731 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.492 ' CB ' ' HG2' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -60.51 133.27 55.93 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.545 0.688 . . . . 0.0 110.649 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.554 ' HB3' ' HA ' ' A' ' 80' ' ' ARG . . . -123.81 -177.27 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.35 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.48 138.48 36.07 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.192 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.0 -29.26 18.21 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 124.089 1.573 . . . . 0.0 110.539 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.15 -61.03 1.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.481 ' CG2' ' CZ2' ' A' ' 110' ' ' TRP . 13.2 p -137.66 41.56 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.691 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 1.7 mt 37.56 56.21 1.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.311 0.577 . . . . 0.0 111.401 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 58.3 m -77.54 104.4 8.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.596 -0.69 . . . . 0.0 110.048 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.554 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -79.37 142.92 59.05 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.495 ' HG2' ' O ' ' A' ' 70' ' ' PRO . 42.9 Cg_endo -66.92 -10.65 29.2 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.804 1.423 . . . . 0.0 109.654 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG23 HD22 ' A' ' 104' ' ' LEU . 6.0 t -70.46 -36.84 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.911 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.477 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 16.4 m80 -57.37 -40.47 78.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HB3' ' CG ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -50.01 -58.69 4.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.999 -0.438 . . . . 0.0 111.314 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB1' HG23 ' A' ' 93' ' ' THR . . . -46.41 -55.11 7.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.617 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.534 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -67.21 -35.76 80.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 0.0 110.767 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HD2' ' C ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -46.27 -39.46 10.03 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 111.286 -178.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -105.37 -3.63 22.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 110.46 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.43 35.45 23.05 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.596 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 1.0 OUTLIER -105.83 83.55 1.94 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.393 -1.063 . . . . 0.0 110.336 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.438 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -56.97 -46.35 82.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 111.575 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -42.93 -37.95 2.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.39 -0.819 . . . . 0.0 110.338 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' HB1' ' A' ' 85' ' ' ALA . 52.4 m -62.63 -44.32 96.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.579 -0.701 . . . . 0.0 109.327 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.501 HD12 HG11 ' A' ' 126' ' ' VAL . 1.4 mp -61.51 -55.94 25.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 0.0 109.769 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 94' ' ' LEU . 39.1 t -38.97 -45.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.731 -0.606 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.505 ' CG1' HD21 ' A' ' 64' ' ' LEU . 11.9 t -63.42 -53.75 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.664 0.745 . . . . 0.0 109.013 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 mt -47.99 -58.95 3.75 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.456 0.646 . . . . 0.0 110.266 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.99 -28.34 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -72.73 -3.86 27.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.353 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -146.56 53.81 1.12 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.965 -1.084 . . . . 0.0 111.438 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . 56.84 107.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.11 86.59 0.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -1.049 . . . . 0.0 109.68 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -51.14 116.9 2.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 110.683 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.436 HD22 HG23 ' A' ' 82' ' ' VAL . 1.3 mp -101.22 -16.21 17.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 26.1 t0 -85.1 55.13 3.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 80' ' ' ARG . 1.9 p -110.49 -170.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.161 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.415 ' N ' HG11 ' A' ' 106' ' ' VAL . 1.9 mtt180 -137.04 135.69 37.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.213 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.9 m-20 -73.82 58.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.51 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 54.27 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.376 -0.828 . . . . 0.0 110.555 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.54 ' CE3' ' N ' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -37.32 -63.38 0.44 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.412 0.625 . . . . 0.0 110.7 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.32 -34.74 0.23 Allowed Glycine 0 N--CA 1.478 1.471 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -48.42 141.94 6.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -1.11 . . . . 0.0 109.976 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -109.89 170.49 5.29 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.408 -0.808 . . . . 0.0 109.742 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 42.4 Cg_endo -70.44 -40.25 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.856 1.45 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.3 p -70.51 -34.15 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.588 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.73 -51.67 25.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.513 -0.742 . . . . 0.0 109.812 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 117' ' ' LEU . 14.2 tp -51.78 -32.33 30.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.267 -0.896 . . . . 0.0 109.746 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 86' ' ' ALA . . . -73.7 -46.58 45.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.876 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -30.29 69.68 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -67.69 -41.48 83.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.545 -0.722 . . . . 0.0 110.091 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.525 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -83.32 -4.31 58.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 111.022 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.3 25.78 17.91 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.306 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 74.7 m-70 -98.27 47.11 1.0 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.069 -1.254 . . . . 0.0 109.39 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.48 -38.01 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.672 -0.643 . . . . 0.0 109.739 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.424 ' CG ' HD13 ' A' ' 91' ' ' LEU . 11.2 t70 -55.19 -47.03 75.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 94' ' ' LEU . 3.2 t -79.65 -46.28 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 108.88 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.29 -43.72 61.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.607 -0.683 . . . . 0.0 110.369 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -68.16 -54.81 15.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 110.058 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -58.8 -39.59 81.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.171 -0.956 . . . . 0.0 109.143 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 86' ' ' ALA . 10.7 mt -62.21 -35.0 77.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.529 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -65.13 -27.28 68.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.93 28.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.418 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -89.51 -16.05 31.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.287 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 0.0 110.452 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.244 0.545 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 15' ' ' TRP . 40.2 m0 -73.01 -31.82 64.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.058 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -53.06 -33.49 52.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 0.0 110.795 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.9 -48.49 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -51.8 37.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -65.89 -40.54 91.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' CB ' HG12 ' A' ' 59' ' ' VAL . . . -56.81 -52.36 65.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.203 -0.936 . . . . 0.0 109.62 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.491 ' HA ' ' N ' ' A' ' 53' ' ' MET . . . -57.3 -29.39 63.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.38 23.16 4.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.0 110.765 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.72 61.42 6.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.54 53.89 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.396 -1.061 . . . . 0.0 110.01 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 98.0 t -42.36 -59.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.848 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -45.98 -38.57 7.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.773 . . . . 0.0 110.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.93 -36.32 72.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.979 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 ' CB ' ' A' ' 19' ' ' ALA . 5.2 t -79.6 -41.4 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 3.0 mmm180 -51.59 -41.91 61.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.874 . . . . 0.0 109.363 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.52 ' O ' ' HB1' ' A' ' 34' ' ' ALA . . . -80.39 -56.07 4.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.673 -0.642 . . . . 0.0 109.461 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.8 mt -45.0 -60.16 2.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.554 -0.717 . . . . 0.0 110.597 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.483 ' CD2' ' CD2' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -51.83 -51.88 53.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.5 -0.75 . . . . 0.0 110.258 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.98 -9.29 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 110.428 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 30' ' ' ALA . . . -92.05 -13.56 30.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.07 -1.019 . . . . 0.0 110.895 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.02 -20.59 1.59 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.462 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -47.73 136.93 10.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.282 -1.128 . . . . 0.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.13 155.75 89.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.975 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.59 -54.8 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.737 1.388 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -98.63 21.22 11.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 39' ' ' ASN . . . -39.53 100.22 0.21 Allowed Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.71 -0.619 . . . . 0.0 110.689 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.63 146.8 44.35 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.875 1.46 . . . . 0.0 110.963 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -139.28 174.47 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.618 -0.676 . . . . 0.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.07 50.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.926 . . . . 0.0 110.574 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -3.47 5.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.17 23.51 25.31 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -138.64 106.15 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -1.051 . . . . 0.0 110.46 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.517 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -58.11 -177.2 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' GLN . 41.1 Cg_endo -66.52 175.68 4.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.319 1.168 . . . . 0.0 111.263 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.7 mt 61.92 -64.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.919 -0.488 . . . . 0.0 110.045 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' PRO . 50.2 tt0 -44.16 -26.91 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 47' ' ' ARG . 7.3 p -123.56 36.57 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.641 -0.662 . . . . 0.0 109.891 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.522 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -94.24 38.32 1.09 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.772 -1.205 . . . . 0.0 110.653 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.491 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 6.1 tmm? 71.15 -14.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.52 -0.737 . . . . 0.0 110.672 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.522 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.43 27.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.71 13.47 5.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.47 82.91 1.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -1.013 . . . . 0.0 109.734 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -50.66 -25.24 4.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.0 110.394 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -53.56 -41.09 66.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.279 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 52' ' ' MET . 24.1 t -55.57 -58.47 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.233 -0.917 . . . . 0.0 109.566 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.67 -52.78 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.675 . . . . 0.0 109.708 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.497 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -45.23 -42.75 9.72 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' A' ' 63' ' ' LEU . 2.9 tp -73.83 -61.33 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.588 -0.695 . . . . 0.0 110.087 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.526 ' N ' ' HG ' ' A' ' 62' ' ' LEU . 5.3 mt -64.7 -55.87 17.3 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 110.993 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -46.68 -61.75 1.69 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.447 -0.783 . . . . 0.0 111.118 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' CD2' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -57.55 -23.58 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.935 -1.103 . . . . 0.0 109.655 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CD2' ' CD2' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -81.98 -38.88 24.45 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.457 -0.777 . . . . 0.0 109.969 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.01 46.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB3' HG13 ' A' ' 49' ' ' ILE . . . -75.98 -151.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.008 -1.289 . . . . 0.0 109.583 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -117.14 53.51 1.3 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.003 . . . . 0.0 110.718 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.2 Cg_endo -66.85 -15.32 46.83 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.444 1.234 . . . . 0.0 109.877 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.473 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 4.1 m-20 -107.93 -72.56 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 171.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.33 -152.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.276 -0.89 . . . . 0.0 110.114 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -98.59 131.77 25.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.25 -27.55 34.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.337 1.177 . . . . 0.0 110.729 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.1 -64.43 0.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.508 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 27.5 p -130.29 36.31 3.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 4.3 mt 43.29 37.91 1.48 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.639 -0.663 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.9 OUTLIER -70.05 99.51 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.514 ' NH1' ' O ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -76.43 165.4 53.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.494 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 47.1 Cg_endo -69.8 -23.2 30.86 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.655 1.345 . . . . 0.0 109.536 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.8 t -55.89 -29.29 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.676 -0.64 . . . . 0.0 109.968 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 12.2 m80 -74.15 -50.16 20.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.509 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -45.24 -43.96 10.81 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -64.46 -67.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -54.14 -45.68 72.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.776 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -48.56 -33.33 9.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.277 -0.89 . . . . 0.0 110.627 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.28 -11.97 20.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 110.342 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.487 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 83.78 33.84 20.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.435 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -104.99 92.28 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -1.052 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -67.66 -32.55 73.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 110.063 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -52.26 -50.06 62.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.873 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 m -56.95 -36.28 70.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 1.2 mp -60.84 -44.12 97.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.503 -0.748 . . . . 0.0 109.701 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 16.5 t -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.6 t -55.51 -46.01 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.411 -0.806 . . . . 0.0 109.571 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.404 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -54.94 -69.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 110.057 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.12 -22.25 50.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.369 -0.832 . . . . 0.0 110.158 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -72.04 -16.54 62.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.25 72.68 1.35 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.338 -0.851 . . . . 0.0 110.596 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.52 101.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -161.93 79.28 0.54 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -1.087 . . . . 0.0 110.411 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.514 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 1.2 ttp180 -56.89 119.64 6.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.121 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 12.0 mt -99.13 15.49 25.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.059 . . . . 0.0 109.544 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.65 43.29 1.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.822 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.445 HG13 ' CG ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -103.19 -169.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -142.0 140.69 32.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.652 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 110' ' ' TRP . 10.8 t0 -73.46 54.81 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.02 -75.59 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.616 -0.677 . . . . 0.0 111.483 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -46.73 -39.15 11.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.294 -0.879 . . . . 0.0 110.37 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.23 -28.74 2.21 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -56.23 128.87 37.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -1.065 . . . . 0.0 110.569 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -93.09 171.64 7.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.63 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.465 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 41.7 Cg_endo -69.46 -38.64 8.16 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.488 1.257 . . . . 0.0 110.048 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.55 -31.03 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.276 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.36 -26.06 66.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.548 -0.72 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.02 -55.05 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.39 -0.819 . . . . 0.0 110.551 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 127' ' ' ALA . . . -47.97 -40.92 23.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 110.285 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -47.66 81.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.526 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -60.91 -54.13 48.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 109.627 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 1.9 mm? -55.16 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.0 110.427 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.19 41.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 49.4 m-70 -122.23 63.32 0.94 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.388 -1.066 . . . . 0.0 109.546 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -45.3 46.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.488 ' O ' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -52.83 -46.16 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.867 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -74.83 -42.01 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.408 ' CB ' ' HB2' ' A' ' 118' ' ' ALA . . . -59.77 -47.72 84.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 109.64 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -52.93 -67.45 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.86 -30.4 33.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.919 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 5.8 mt -70.75 -53.58 15.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.596 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -55.23 -29.79 58.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.182 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.86 -54.23 4.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.664 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.87 -9.14 58.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.327 -0.858 . . . . 0.0 110.781 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.164 -0.96 . . . . 0.0 110.693 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.026 0.441 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.469 ' HB3' HD23 ' A' ' 31' ' ' LEU . 16.3 m0 -57.03 -17.22 9.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 110.457 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -69.85 -56.03 8.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.481 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -71.81 -42.96 66.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -47.81 -62.51 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.166 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . . . -52.0 -42.96 63.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.816 . . . . 0.0 109.936 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.487 ' HB3' ' CB ' ' A' ' 52' ' ' MET . . . -57.63 -52.15 66.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.679 -0.638 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 51' ' ' VAL . . . -50.38 -25.63 4.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.451 -0.781 . . . . 0.0 110.607 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . 37.6 mtt180 -103.74 28.93 6.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.656 -0.652 . . . . 0.0 109.849 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.76 41.89 10.43 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 28' ' ' VAL . 11.7 mtt180 -99.85 54.93 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -1.081 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 58' ' ' ARG . 99.3 t -38.9 -53.61 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.769 -0.582 . . . . 0.0 111.07 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -49.81 -56.29 10.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.755 . . . . 0.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 tp10 -54.45 -39.0 67.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.383 -0.823 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' CG1' HD22 ' A' ' 62' ' ' LEU . 14.0 t -71.74 -56.0 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.707 -0.621 . . . . 0.0 110.279 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -39.41 -52.48 2.08 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.428 -0.795 . . . . 0.0 110.668 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -73.82 -50.75 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.76 . . . . 0.0 109.907 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 15' ' ' TRP . 14.0 mt -47.37 -57.05 5.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.59 -0.694 . . . . 0.0 110.728 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.604 ' CD1' ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -49.86 -50.36 45.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 109.491 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -70.53 -17.38 62.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.714 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -81.83 -6.35 59.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.067 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.06 16.68 6.1 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.565 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -58.15 160.87 4.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.074 -1.25 . . . . 0.0 109.975 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.417 HD21 ' CA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -101.39 113.26 65.85 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 111.269 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.41 -5.17 16.62 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.753 1.396 . . . . 0.0 110.421 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -131.59 40.06 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 110.075 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.417 ' CA ' HD21 ' A' ' 37' ' ' LEU . . . -84.18 133.85 44.51 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.268 -0.895 . . . . 0.0 110.546 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.3 89.65 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.726 1.382 . . . . 0.0 110.375 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.76 166.18 5.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -85.41 21.71 1.7 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -119.38 15.35 12.99 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.16 24.15 20.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.4 -170.33 1.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.447 -1.031 . . . . 0.0 110.256 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.499 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.3 mmt180 -103.45 167.51 10.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.673 . . . . 0.0 109.547 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.517 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 42.6 Cg_endo -67.26 -12.0 34.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.582 1.306 . . . . 0.0 110.414 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.1 mt -107.2 -42.76 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 108.637 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -49.44 -20.95 0.79 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.383 -0.823 . . . . 0.0 110.472 179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 10.8 p -115.91 35.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 110.477 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -96.4 34.57 1.6 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 109.729 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 10.0 ttp 67.67 -6.69 0.65 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 110.821 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.551 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.66 27.19 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.235 -0.916 . . . . 0.0 110.41 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.464 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.35 11.65 7.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.442 ' HB3' HG21 ' A' ' 59' ' ' VAL . 1.8 m -148.91 93.22 2.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.482 -1.011 . . . . 0.0 109.615 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.42 -34.15 70.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.468 -0.77 . . . . 0.0 109.872 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.447 ' HB3' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -52.15 -42.04 63.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 110.093 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 20' ' ' ALA . 91.0 t -48.15 -53.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -62.79 -43.69 98.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.565 -0.709 . . . . 0.0 109.315 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 4.0 tt0 -46.8 -31.73 3.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.248 -0.908 . . . . 0.0 110.276 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.537 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 7.5 tp -89.87 -49.66 6.49 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -56.65 -55.41 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.451 0.643 . . . . 0.0 109.387 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -61.23 -45.76 93.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.671 -0.643 . . . . 0.0 109.756 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 2.4 tp -53.04 -32.97 49.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -0.874 . . . . 0.0 108.719 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CG ' ' CD1' ' A' ' 32' ' ' LEU . 2.0 m80 -92.6 -1.04 57.21 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.426 0.631 . . . . 0.0 110.355 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.0 63.48 1.97 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' HD21 ' A' ' 63' ' ' LEU . . . -72.26 -149.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -1.067 . . . . 0.0 109.228 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mt-10 -114.88 57.22 0.97 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HB3' HD13 ' A' ' 64' ' ' LEU . 53.6 Cg_endo -72.17 -0.89 9.26 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.315 1.166 . . . . 0.0 110.585 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.46 -73.72 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.055 -1.028 . . . . 0.0 109.804 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 134.7 16.61 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.578 0.704 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.424 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . -127.34 -134.16 0.24 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.03 125.73 30.92 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.786 -1.196 . . . . 0.0 109.452 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.84 5.75 5.06 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.255 1.134 . . . . 0.0 110.865 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.27 -43.77 4.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 108.925 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.499 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -121.44 2.98 10.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.619 -0.676 . . . . 0.0 109.932 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 2.8 mt 54.99 25.23 6.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.278 -0.889 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.71 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.494 ' HB2' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.36 165.9 40.09 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.173 -0.954 . . . . 0.0 110.104 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 44.4 Cg_endo -71.54 -9.01 24.39 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.76 1.4 . . . . 0.0 110.672 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG12 HD22 ' A' ' 104' ' ' LEU . 3.5 t -73.87 -30.53 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.103 -0.998 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.412 ' CD2' ' OD1' ' A' ' 108' ' ' ASP . 27.0 m80 -68.64 -43.97 75.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.551 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -48.81 -49.95 36.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.331 0.586 . . . . 0.0 110.251 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -57.81 -68.7 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.0 109.766 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -51.24 -39.29 56.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.362 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.408 ' O ' ' NE2' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -44.01 -51.73 7.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.328 -0.857 . . . . 0.0 110.812 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 18.7 13.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 109.775 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.39 52.78 42.31 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.485 ' O ' HD11 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -117.07 84.36 2.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -1.157 . . . . 0.0 110.611 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 94' ' ' LEU . 1.2 mt -55.89 -43.81 77.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 0.0 110.75 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 47.9 m-20 -45.89 -35.66 4.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.496 -0.753 . . . . 0.0 111.048 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -71.9 -38.61 69.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -0.91 . . . . 0.0 110.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.489 ' CD2' ' CD2' ' A' ' 130' ' ' LEU . 1.6 mp -63.08 -59.55 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 99' ' ' ARG . 52.8 t -46.2 -49.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.58 -0.7 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 92' ' ' ASP . 23.6 t -50.39 -53.04 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.571 -0.705 . . . . 0.0 109.71 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.407 ' C ' ' HB1' ' A' ' 102' ' ' ALA . 64.6 mt -52.39 -66.11 0.44 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 0.0 109.837 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -55.78 -26.71 47.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.933 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.42 ' HG3' HG11 ' A' ' 95' ' ' VAL . 5.1 mtp180 -70.62 -13.19 61.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.977 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 78.19 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.183 -0.948 . . . . 0.0 111.001 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 52.07 101.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.407 ' HB1' ' C ' ' A' ' 97' ' ' LEU . . . -163.06 123.53 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -1.211 . . . . 0.0 110.744 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -78.41 141.63 38.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.5 OUTLIER -126.4 8.19 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.335 -0.853 . . . . 0.0 110.287 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -115.75 49.62 1.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.062 -1.024 . . . . 0.0 111.365 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 80' ' ' ARG . 7.6 p -112.45 171.64 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 24.1 mtm180 -131.42 143.8 50.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 109.59 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -68.51 58.04 0.08 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.241 -0.912 . . . . 0.0 110.17 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 77' ' ' THR . . . 50.9 -88.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.475 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.8 p90 -112.62 -1.57 14.79 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.263 -0.898 . . . . 0.0 110.758 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -77.93 -80.61 0.68 Allowed Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 4.3 mtt180 170.98 -169.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.816 -0.814 . . . . 0.0 110.069 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.447 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -80.37 166.96 36.56 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 110.417 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.1 Cg_endo -72.32 -35.91 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.813 1.428 . . . . 0.0 110.16 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.455 ' HA ' HD11 ' A' ' 130' ' ' LEU . 7.9 p -67.69 -28.45 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -50.68 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.71 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -24.71 41.95 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.272 -0.893 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.29 -62.9 1.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 111.109 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -23.77 1.16 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -37.2 23.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.285 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.579 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 1.7 mm? -86.9 7.52 26.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.31 24.03 52.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.322 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 17.0 m-70 -99.4 43.47 1.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.951 -1.323 . . . . 0.0 109.223 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -42.58 7.77 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.292 0.568 . . . . 0.0 110.158 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.09 -38.13 78.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 109.6 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 3.3 t -82.54 -38.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.41 -22.65 63.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -68.1 -71.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 0.0 110.389 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -53.88 -45.11 70.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 134' ' ' ALA . 12.9 mt -50.53 -55.26 16.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.522 -0.736 . . . . 0.0 109.488 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.434 ' CA ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -54.46 -23.14 14.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.169 -0.957 . . . . 0.0 109.95 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.31 -52.36 7.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.986 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.37 -7.13 57.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 111.134 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.811 0 O-C-N 120.921 -1.112 . . . . 0.0 110.508 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.891 0.377 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -48.04 -33.96 8.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.313 -0.867 . . . . 0.0 109.7 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -43.86 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.375 0.607 . . . . 0.0 110.849 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.405 ' HB1' ' ND2' ' A' ' 42' ' ' ASN . . . -43.89 -54.02 5.63 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.69 -0.631 . . . . 0.0 111.299 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -59.58 3.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 110.702 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . . . -55.17 -47.93 74.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.326 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 59' ' ' VAL . . . -57.06 -48.9 77.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.455 -0.778 . . . . 0.0 110.319 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.98 -25.63 67.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 110.105 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -85.78 5.45 32.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.308 -0.87 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.97 44.81 95.43 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -122.1 72.7 1.05 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.953 . . . . 0.0 109.611 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.1 t -53.38 -45.41 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.414 -0.804 . . . . 0.0 110.274 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.33 -33.99 66.14 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 0.0 110.508 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 5.7 tt0 -68.19 -41.8 80.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.871 . . . . 0.0 109.772 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.521 ' C ' HD23 ' A' ' 62' ' ' LEU . 21.4 t -77.59 -45.38 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.958 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.22 -47.77 35.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -29.83 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 28' ' ' VAL . 7.9 mt -68.34 -70.43 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.206 -0.934 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.579 HD23 ' CB ' ' A' ' 66' ' ' HIS . 1.3 mt -46.88 -49.41 20.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.373 -0.829 . . . . 0.0 111.542 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -60.9 -24.46 66.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.31 -5.79 55.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.48 29.83 3.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.46 128.35 33.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -1.099 . . . . 0.0 110.123 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -49.25 111.6 2.05 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.38 -0.825 . . . . 0.0 110.666 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HA ' HD23 ' A' ' 16' ' ' LEU . 43.3 Cg_endo -69.12 -33.15 19.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.678 1.357 . . . . 0.0 110.811 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.68 50.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.707 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.01 150.96 78.61 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.415 -0.803 . . . . 0.0 110.324 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.87 116.38 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.79 1.416 . . . . 0.0 110.188 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.405 ' ND2' ' HB1' ' A' ' 17' ' ' ALA . 12.9 m120 -94.21 170.68 9.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.961 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -89.95 33.41 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.638 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -137.06 3.63 2.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.054 -1.029 . . . . 0.0 110.725 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.14 26.87 36.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -130.78 20.8 5.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -1.15 . . . . 0.0 110.691 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.521 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 48.91 -177.51 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.707 -0.62 . . . . 0.0 111.069 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 50' ' ' GLN . 44.4 Cg_endo -72.95 -179.52 4.36 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.44 1.232 . . . . 0.0 111.165 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.594 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 56.88 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.761 -0.587 . . . . 0.0 110.322 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -47.73 -23.09 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.939 -1.101 . . . . 0.0 110.264 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.415 ' O ' HG21 ' A' ' 51' ' ' VAL . 7.4 p -115.66 6.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 110.664 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -68.98 171.65 7.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.795 -1.191 . . . . 0.0 109.211 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.2 ttm -52.79 -19.06 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.229 -0.919 . . . . 0.0 110.37 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.559 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.48 10.14 3.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -119.02 18.28 10.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.423 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -150.3 78.25 1.32 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.459 -1.024 . . . . 0.0 109.449 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.75 -28.88 0.68 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.0 110.378 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -42.71 57.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 20' ' ' ALA . 77.8 t -53.67 -60.84 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.488 -0.757 . . . . 0.0 109.409 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 64' ' ' LEU . . . -53.53 -52.34 59.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.326 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.486 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . 9.0 tt0 -45.74 -35.73 4.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.196 -0.94 . . . . 0.0 110.062 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.583 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 1.0 OUTLIER -78.3 -60.89 2.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.573 -0.704 . . . . 0.0 109.248 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.512 ' N ' ' HG ' ' A' ' 62' ' ' LEU . 2.0 mt -60.95 -56.07 25.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 110.521 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -48.68 -62.47 1.49 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.563 -0.711 . . . . 0.0 110.814 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.419 ' CD1' ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -55.16 -24.96 29.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.972 -1.08 . . . . 0.0 109.385 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.583 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -82.22 -29.26 31.48 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.416 -0.802 . . . . 0.0 109.811 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.47 38.02 0.31 Allowed Glycine 0 N--CA 1.479 1.508 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.484 ' HB1' ' C ' ' A' ' 63' ' ' LEU . . . -66.65 -148.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 0.0 109.678 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -115.65 59.04 1.45 Allowed Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.332 -0.855 . . . . 0.0 110.387 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.1 -8.64 22.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.553 1.291 . . . . 0.0 110.613 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.474 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 2.2 t30 -129.1 -65.26 0.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.314 -0.866 . . . . 0.0 109.704 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.88 144.29 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 110.532 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB1' ' HG2' ' A' ' 80' ' ' ARG . . . -136.34 -136.01 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.27 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -110.68 136.02 20.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.057 -1.027 . . . . 0.0 110.221 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.2 -5.35 16.95 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.542 1.285 . . . . 0.0 110.596 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.1 -49.67 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.619 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -120.57 9.63 10.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.377 -0.827 . . . . 0.0 110.945 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 7.4 mt 47.02 27.81 0.8 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.59 89.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.644 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.474 ' NE ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -69.14 168.78 13.99 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.864 . . . . 0.0 110.366 -179.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.593 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 54.5 Cg_endo -72.72 2.58 5.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 124.003 1.528 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 104' ' ' LEU . 19.8 t -85.09 -31.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 110.301 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 83' ' ' HIS . 9.1 m80 -67.48 -43.67 80.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.08 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.559 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.9 OUTLIER -53.52 -54.09 42.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.701 -0.624 . . . . 0.0 111.373 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.404 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -52.76 -63.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 109.934 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -58.05 -55.01 40.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.26 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 5.0 tpt180 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.507 -0.746 . . . . 0.0 111.299 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' MET . 9.9 tp10 -103.83 -4.64 23.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.025 -1.047 . . . . 0.0 111.09 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 20.83 69.14 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.46 ' O ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -102.01 96.35 6.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -1.151 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.408 HD23 ' CG ' ' A' ' 129' ' ' TYR . 1.2 tt -69.82 -38.37 76.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.724 -0.61 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -50.56 -41.62 54.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.89 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.422 ' O ' HD11 ' A' ' 97' ' ' LEU . 30.1 m -55.89 -48.27 75.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.733 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 90' ' ' PHE . 1.4 mp -59.05 -43.21 91.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.833 . . . . 0.0 109.805 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -51.47 -49.17 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.486 ' CG1' ' HA ' ' A' ' 61' ' ' GLU . 25.4 t -59.83 -43.1 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.589 0.709 . . . . 0.0 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -56.96 -58.62 7.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.618 -0.677 . . . . 0.0 110.107 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -65.41 -35.74 81.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 110.125 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 99' ' ' ARG . 2.3 ttp85 -61.57 -14.9 33.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.411 -0.806 . . . . 0.0 110.449 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . . . -140.79 54.43 1.59 Allowed 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.988 -1.07 . . . . 0.0 111.168 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.36 106.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.91 97.57 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.467 -1.02 . . . . 0.0 109.876 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -51.37 115.32 1.53 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.338 -0.851 . . . . 0.0 110.404 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HA ' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -105.36 4.08 30.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 110.611 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -112.63 51.46 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 110.535 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.453 ' HB ' ' HD2' ' A' ' 80' ' ' ARG . 4.5 p -107.55 -178.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.997 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 42.3 mtt85 -131.26 153.01 49.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 109.564 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -80.38 54.93 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 62.86 -68.65 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.626 -0.672 . . . . 0.0 111.276 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 6.6 m0 -65.67 -37.68 87.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.818 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.79 -20.56 1.0 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.46 ' HB2' ' CB ' ' A' ' 108' ' ' ASP . 12.4 mtt180 -49.75 136.77 17.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -1.106 . . . . 0.0 110.266 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.438 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -111.06 161.17 26.17 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.358 -0.839 . . . . 0.0 110.116 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.444 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 44.1 Cg_endo -70.24 -21.62 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.583 1.307 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.57 -31.74 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.053 -1.029 . . . . 0.0 110.038 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.34 -22.96 63.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.9 mt -75.67 -44.59 41.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.537 -0.727 . . . . 0.0 110.497 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.2 -36.22 79.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.94 -39.24 88.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -57.7 3.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 109.897 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.51 -85.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.478 -0.764 . . . . 0.0 110.257 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.03 39.31 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 22.6 m-70 -103.87 55.82 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.378 -1.072 . . . . 0.0 108.822 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.51 -40.81 13.15 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.45 0.643 . . . . 0.0 109.909 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.16 -42.17 90.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.646 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.3 t -82.18 -44.88 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.987 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -54.8 -37.61 66.3 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -77.14 -48.26 18.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.73 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.408 ' CG ' HD23 ' A' ' 91' ' ' LEU . 27.2 t80 -70.73 -57.16 4.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.119 -0.988 . . . . 0.0 110.503 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -54.55 -32.75 58.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.114 -0.992 . . . . 0.0 110.612 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 23.7 ttt180 -66.55 -38.13 86.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -0.847 . . . . 0.0 110.083 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.378 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.81 -19.41 23.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.733 -0.605 . . . . 0.0 110.295 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.332 -0.855 . . . . 0.0 110.721 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.83 0.347 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -85.13 -26.78 26.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 110.106 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.99 -32.48 72.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 109.457 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.34 -48.2 13.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.4 -0.813 . . . . 0.0 109.89 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -41.07 99.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.407 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -55.51 -52.44 63.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.408 -0.808 . . . . 0.0 109.775 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.529 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -58.62 -31.89 68.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.358 -0.838 . . . . 0.0 110.192 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.79 -35.47 74.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -94.18 23.46 5.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.28 42.85 89.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -105.12 67.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.877 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 85.3 t -51.75 -30.01 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.469 -0.769 . . . . 0.0 110.325 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -73.27 -39.06 65.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.325 -0.859 . . . . 0.0 110.728 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.74 -31.99 73.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.257 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.489 ' C ' HD22 ' A' ' 62' ' ' LEU . 6.5 t -83.09 -46.49 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.368 -0.833 . . . . 0.0 110.123 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.75 -35.98 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 109.728 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mt -59.09 -65.1 0.72 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.487 HD23 ' CB ' ' A' ' 66' ' ' HIS . 2.5 mt -51.39 -34.82 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 110.259 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -20.09 62.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.954 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.75 -9.23 47.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.09 28.01 2.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -57.71 151.49 17.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -1.168 . . . . 0.0 109.74 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -73.35 135.43 79.15 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 109.729 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.11 -31.41 19.02 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.546 1.287 . . . . 0.0 110.128 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -139.69 61.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.558 -0.714 . . . . 0.0 110.032 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.4 160.01 83.83 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.283 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.5 124.03 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.827 1.435 . . . . 0.0 110.487 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -108.79 158.58 17.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -95.44 27.96 3.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 110.537 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -136.48 13.33 3.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 109.953 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.96 26.9 35.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.443 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.9 tpp180 -130.66 107.04 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 110.217 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mpt_? -55.09 -175.08 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.595 -0.691 . . . . 0.0 110.259 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.2 Cg_endo -64.34 163.66 25.76 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.267 1.14 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.564 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 66.68 -59.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' PRO . 5.1 tt0 -53.22 -20.93 4.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 46' ' ' ARG . 12.0 p -114.82 -7.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.622 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -56.52 165.17 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.986 -1.071 . . . . 0.0 109.796 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -54.73 -17.07 3.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.229 -0.92 . . . . 0.0 110.397 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.485 ' SD ' ' HG3' ' A' ' 52' ' ' MET . 0.0 OUTLIER 61.96 11.46 4.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.41 18.42 20.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.47 96.08 1.75 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.674 -0.898 . . . . 0.0 109.634 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.91 -21.04 56.99 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.344 -0.848 . . . . 0.0 109.759 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -56.43 -30.49 62.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.567 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.68 -44.88 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.591 -0.693 . . . . 0.0 109.947 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.425 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 3.2 tt0 -45.73 -29.18 1.21 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.156 -0.965 . . . . 0.0 110.775 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 28' ' ' VAL . 2.7 tp -83.82 -56.8 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 110.019 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 8.2 mt -67.68 -35.06 78.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.432 HD13 ' CB ' ' A' ' 100' ' ' ALA . 2.7 tm? -61.74 -65.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.81 -0.556 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' C ' ' CD1' ' A' ' 65' ' ' LEU . 1.7 pp -54.53 -24.15 19.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.813 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CB ' HD23 ' A' ' 32' ' ' LEU . 2.0 m80 -81.6 -49.95 9.92 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.526 -0.734 . . . . 0.0 110.134 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.24 46.02 0.03 OUTLIER Glycine 0 N--CA 1.482 1.731 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.029 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -75.57 -155.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.786 -1.42 . . . . 0.0 109.192 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 6.7 tp10 -122.99 68.4 35.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 110.267 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.23 -9.13 22.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.896 1.471 . . . . 0.0 110.384 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 3.7 t30 -117.82 -70.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.711 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 152.7 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.105 -0.997 . . . . 0.0 111.082 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HB1' ' HG2' ' A' ' 80' ' ' ARG . . . -137.62 -137.42 0.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 2.2 t70 -122.13 132.11 24.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.67 -7.78 21.85 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.639 1.336 . . . . 0.0 110.88 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.35 -55.74 4.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.212 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.463 ' CG2' ' CZ2' ' A' ' 110' ' ' TRP . 61.2 p -117.26 7.34 12.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.2 mt 49.33 30.35 3.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.269 -0.894 . . . . 0.0 111.005 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -69.0 91.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.136 -0.977 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.506 ' NE ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -68.87 159.22 83.51 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.623 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.08 -6.13 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.654 1.344 . . . . 0.0 110.626 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 t -77.29 -31.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 110.021 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 35.9 m80 -69.74 -42.8 73.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -0.828 . . . . 0.0 109.301 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.7 m-20 -48.47 -49.01 37.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.708 -0.62 . . . . 0.0 110.527 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -60.79 -68.9 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.586 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . -50.64 -55.96 14.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.453 -0.78 . . . . 0.0 111.16 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 6.7 ttm180 -44.74 -27.79 0.55 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.173 -0.954 . . . . 0.0 111.683 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -102.11 -5.03 24.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.689 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.84 36.06 26.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -116.41 101.66 8.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 110.724 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 1.0 OUTLIER -83.1 -35.14 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.48 -43.06 34.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.383 -0.823 . . . . 0.0 109.784 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 m -65.07 -39.3 93.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 109.0 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.47 HD11 ' CB ' ' A' ' 85' ' ' ALA . 1.5 tp -51.81 -48.93 63.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.613 -0.68 . . . . 0.0 109.838 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 45.2 t -56.51 -51.35 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 109.68 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.3 t -49.25 -53.32 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.449 -0.782 . . . . 0.0 110.296 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.466 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -50.65 -67.76 0.23 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.468 -0.77 . . . . 0.0 110.683 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -61.86 -30.18 70.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.297 -0.877 . . . . 0.0 110.585 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -61.72 -16.6 50.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.348 -0.845 . . . . 0.0 110.764 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' CB ' HD13 ' A' ' 64' ' ' LEU . . . -129.74 -44.82 1.19 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.751 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.69 108.6 0.22 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -167.59 112.57 0.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -1.088 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.04 95.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.477 -0.765 . . . . 0.0 109.844 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 59.75 5.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.285 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -170.49 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -0.954 . . . . 0.0 110.062 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.476 HG13 ' CD ' ' A' ' 80' ' ' ARG . 1.5 p -102.54 -169.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -142.28 112.11 6.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.217 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.02 147.45 9.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.356 -0.84 . . . . 0.0 110.663 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.46 -27.24 62.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.463 ' CZ2' ' CG2' ' A' ' 77' ' ' THR . 7.0 m95 -63.41 -14.35 49.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.72 46.02 5.86 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.41 104.29 2.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -1.043 . . . . 0.0 110.156 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -54.31 167.49 0.55 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.9 . . . . 0.0 109.941 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.41 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 43.8 Cg_endo -69.93 -34.93 13.06 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.614 1.323 . . . . 0.0 109.931 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 131' ' ' ARG . 5.9 p -74.01 -27.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.398 -0.814 . . . . 0.0 110.192 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -37.94 63.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 109.69 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 87' ' ' ARG . 2.0 tt -69.39 -41.93 75.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.116 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.414 ' HB2' ' CB ' ' A' ' 127' ' ' ALA . . . -56.39 -48.49 76.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.267 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -65.51 -22.18 66.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.973 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.39 -65.62 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -83.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.182 -0.948 . . . . 0.0 110.539 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 35.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 24.0 m-70 -105.66 36.81 2.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -1.055 . . . . 0.0 108.659 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -46.87 -45.15 20.17 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.405 0.621 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 126' ' ' VAL . 14.8 p30 -56.64 -39.82 74.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.376 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 10.6 t -74.14 -52.44 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 109.841 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -48.99 -28.54 3.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.628 -0.67 . . . . 0.0 111.227 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -50.02 -70.58 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.03 -1.044 . . . . 0.0 110.626 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -73.11 -28.36 62.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.521 ' HB3' ' O ' ' A' ' 126' ' ' VAL . 0.3 OUTLIER -72.1 -14.53 61.87 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 109.634 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.47 ' HA ' HG23 ' A' ' 115' ' ' VAL . 10.6 ttt180 -88.21 -42.97 11.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.143 -0.973 . . . . 0.0 110.064 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.14 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.7 -23.89 20.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 110.547 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' OG1' ' A' ' 18' ' ' THR . 9.0 p-10 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.214 0.53 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.528 ' N ' ' CD1' ' A' ' 15' ' ' TRP . 30.6 m0 -67.7 -28.15 67.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.449 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 17' ' ' ALA . 3.9 pp -63.13 -38.93 93.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 110.063 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' A' ' 16' ' ' LEU . . . -77.25 -42.12 38.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 110.056 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -60.54 -40.95 93.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 110.318 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 28' ' ' VAL . . . -70.79 -35.92 72.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.773 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 52' ' ' MET . . . -67.08 -45.15 78.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 109.748 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.77 -29.33 68.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.617 -0.677 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -88.23 14.98 8.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 0.0 110.107 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.26 50.22 56.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.83 77.43 1.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -1.055 . . . . 0.0 110.315 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 29' ' ' ARG . 59.4 t -51.55 -46.35 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.386 -0.822 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.63 -60.7 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.594 -0.691 . . . . 0.0 110.311 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 -38.18 65.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.459 -0.776 . . . . 0.0 109.73 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.491 ' CG1' HG11 ' A' ' 59' ' ' VAL . 21.6 t -69.97 -56.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.56 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 9.8 mmm-85 -46.1 -45.17 16.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.73 . . . . 0.0 110.243 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -76.62 -36.93 57.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.483 -0.761 . . . . 0.0 109.567 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 34' ' ' ALA . 11.6 mt -62.15 -67.28 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.54 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.62 -43.56 8.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.665 -0.647 . . . . 0.0 110.164 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 2.6 tt0 -79.77 -17.43 53.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.643 -0.66 . . . . 0.0 110.798 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -80.74 -8.05 59.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 111.012 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.46 0.19 4.13 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.876 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -52.2 157.59 1.34 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.996 -1.297 . . . . 0.0 110.0 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 40' ' ' ALA . 18.3 mt -86.14 153.77 57.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.114 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 48.5 Cg_endo -77.38 -54.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.644 1.339 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -107.44 40.05 1.77 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.839 . . . . 0.0 109.571 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . . . -61.54 126.73 87.33 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.592 -0.693 . . . . 0.0 110.423 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.89 151.44 50.85 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.668 1.352 . . . . 0.0 110.099 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -122.52 171.68 8.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.865 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -4.44 59.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.325 -0.859 . . . . 0.0 110.07 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 3.3 m-30 -100.78 -3.04 30.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.93 29.02 54.47 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -119.83 39.41 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -1.065 . . . . 0.0 111.064 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 10.5 mmt180 49.59 172.68 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.424 -0.797 . . . . 0.0 111.741 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 53.4 Cg_endo -77.0 -18.63 14.43 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.638 1.336 . . . . 0.0 110.51 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.522 ' O ' ' HG2' ' A' ' 52' ' ' MET . 15.3 mt -104.94 -47.2 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -48.4 -25.03 1.43 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.05 -1.03 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 13.7 ptt? -75.55 141.14 43.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ttp -54.25 123.6 13.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.976 . . . . 0.0 108.528 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.567 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -82.02 44.12 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.967 -1.083 . . . . 0.0 110.823 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.25 2.28 11.48 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.435 ' N ' ' CZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -137.14 88.87 2.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.714 -0.874 . . . . 0.0 109.96 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -61.54 -11.67 12.03 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.115 -0.991 . . . . 0.0 109.951 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.455 ' HB3' HG12 ' A' ' 25' ' ' VAL . 2.3 mtp180 -71.1 -47.43 58.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 110.716 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 20' ' ' ALA . 42.2 t -45.52 -62.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.41 -0.806 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HB1' ' CE ' ' A' ' 52' ' ' MET . . . -49.13 -40.76 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.094 -1.004 . . . . 0.0 109.648 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 7.4 tm-20 -50.07 -27.49 5.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.77 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.56 ' CD2' ' HA ' ' A' ' 29' ' ' ARG . 8.3 tp -90.05 -54.46 4.03 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 48' ' ' PRO . 11.4 mt -55.11 -46.28 75.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -69.59 -41.04 76.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 5.4 tp -54.08 -33.67 58.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.522 ' CG ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -90.78 -47.02 7.88 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.767 -0.583 . . . . 0.0 109.555 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.25 63.84 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 C-N-CA 120.151 -1.024 . . . . 0.0 110.758 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 38' ' ' PRO . . . -77.04 -153.85 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.948 -1.324 . . . . 0.0 109.283 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.59 55.76 2.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.111 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 45.9 Cg_endo -70.81 -14.84 33.06 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.576 1.303 . . . . 0.0 110.323 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 -64.12 1.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.47 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.2 150.73 8.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 111.03 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 80' ' ' ARG . . . -128.83 -153.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.584 -0.698 . . . . 0.0 109.134 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -102.13 136.7 19.41 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 0.0 109.701 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.41 -3.2 13.56 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.396 1.208 . . . . 0.0 110.699 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.66 -30.72 18.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 0.0 109.471 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.627 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -151.11 22.07 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 109.854 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.8 OUTLIER 37.28 33.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.862 -0.524 . . . . 0.0 111.515 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -69.34 100.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.472 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -69.51 166.92 25.93 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.273 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 50' ' ' GLN . 43.9 Cg_endo -72.79 -21.08 21.91 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.578 1.304 . . . . 0.0 109.581 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 45.8 t -54.16 -30.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 32.8 m80 -71.65 -42.85 67.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.567 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 10.7 t0 -49.1 -47.46 45.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.779 -0.575 . . . . 0.0 109.926 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.413 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -59.72 -69.42 0.21 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.456 -0.777 . . . . 0.0 110.548 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 126' ' ' VAL . . . -58.58 -41.6 86.08 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.003 . . . . 0.0 111.446 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 12.1 tpt85 -45.84 -41.54 11.27 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 110.886 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.5 5.34 49.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.97 34.26 27.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -103.29 97.81 7.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -1.119 . . . . 0.0 110.999 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 3.0 tt -82.67 -40.21 21.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 109.64 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.3 m-20 -46.42 -56.11 6.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.582 -0.699 . . . . 0.0 109.846 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.444 ' O ' HD21 ' A' ' 97' ' ' LEU . 3.5 m -54.08 -43.38 70.28 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.413 ' CD1' ' CB ' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -50.59 -34.26 25.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 25.1 t -72.92 -45.2 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.582 -0.699 . . . . 0.0 109.118 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 46.6 t -61.12 -46.71 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -0.785 . . . . 0.0 109.808 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.444 HD21 ' O ' ' A' ' 93' ' ' THR . 3.7 mm? -52.58 -46.0 66.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.451 -0.78 . . . . 0.0 110.217 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -84.35 -12.84 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 2.5 mtt180 -80.06 -12.02 59.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.328 -0.858 . . . . 0.0 111.013 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.57 -66.25 0.77 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.52 108.41 0.29 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HB3' HD13 ' A' ' 97' ' ' LEU . . . -168.66 128.36 1.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -1.062 . . . . 0.0 110.578 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 112.26 23.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.485 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -104.06 5.19 35.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 110.644 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -100.31 41.14 1.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.63 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 80' ' ' ARG . 7.2 p -108.75 178.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.822 . . . . 0.0 110.925 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -131.17 143.69 50.81 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -68.06 69.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.387 -0.82 . . . . 0.0 110.803 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 77' ' ' THR . . . 60.92 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.627 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.7 m-90 -60.08 -75.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.755 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.98 32.28 0.07 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.483 ' CB ' ' HB2' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -89.42 107.96 19.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -1.129 . . . . 0.0 109.824 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.458 ' CD1' ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -82.55 159.11 64.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.434 -0.791 . . . . 0.0 110.159 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 113' ' ' LEU . 42.3 Cg_endo -71.59 -24.68 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.797 1.419 . . . . 0.0 110.398 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 130' ' ' LEU . 11.6 p -79.42 -40.16 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.127 -0.983 . . . . 0.0 110.087 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.404 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.8 OUTLIER -69.23 -30.01 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.483 -0.76 . . . . 0.0 109.884 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.418 HD23 ' HD3' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -78.4 -32.0 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.023 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.51 -44.7 50.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 109.672 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -36.42 78.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 110.02 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -59.5 4.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -0.813 . . . . 0.0 109.96 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 121' ' ' LEU . 3.3 mm? -54.83 -82.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.28 37.24 0.03 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.463 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 31.1 m-70 -113.87 52.38 0.82 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.336 -1.096 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -33.83 9.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 110.27 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.81 -39.23 93.75 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.364 -0.835 . . . . 0.0 108.938 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -83.91 -43.18 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 109.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.27 -34.02 76.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -52.25 43.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.41 -0.807 . . . . 0.0 109.48 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 129' ' ' TYR . 4.8 t80 -60.86 -30.34 70.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.747 . . . . 0.0 109.168 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 134' ' ' ALA . 36.6 mt -65.13 -60.13 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.039 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.446 ' HB2' HG22 ' A' ' 115' ' ' VAL . 5.9 ttp180 -53.24 -20.82 4.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 110.411 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.7 -60.19 2.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.48 -12.52 59.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.372 -0.83 . . . . 0.0 110.389 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 120.962 0.41 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.501 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.3 OUTLIER -66.39 -4.73 8.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.404 -0.81 . . . . 0.0 111.146 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.424 HD11 HG12 ' A' ' 28' ' ' VAL . 1.3 tp -80.55 -45.21 17.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.883 -1.135 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.7 53.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 110.171 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.501 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -61.32 -54.72 40.32 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.44 62.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.366 -0.834 . . . . 0.0 109.784 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.491 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.12 -48.03 68.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 109.317 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.06 -28.93 69.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.579 -0.701 . . . . 0.0 109.345 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.93 20.65 3.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.655 -0.653 . . . . 0.0 110.286 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.46 52.92 22.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.72 96.03 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.109 . . . . 0.0 110.526 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 98.5 t -73.11 -54.6 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -44.08 -40.98 5.24 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.56 -0.712 . . . . 0.0 111.549 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -46.5 71.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.997 -1.064 . . . . 0.0 109.902 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 32' ' ' LEU . 17.8 t -68.25 -41.29 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.819 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 13.6 mmm180 -50.43 -47.46 56.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.0 110.123 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.58 -45.1 47.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.79 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.426 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 10.6 mt -56.97 -60.45 3.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 110.198 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.454 HD21 ' ND1' ' A' ' 66' ' ' HIS . 7.2 mt -51.1 -32.57 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.313 -0.867 . . . . 0.0 109.574 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.58 -25.34 45.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.588 -0.695 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.67 -5.22 52.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.325 -0.859 . . . . 0.0 110.201 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.2 22.02 5.37 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -65.06 141.05 58.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.173 -1.192 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.72 117.45 58.86 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.471 -0.768 . . . . 0.0 109.53 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' CD2' ' A' ' 16' ' ' LEU . 43.0 Cg_endo -69.66 -29.53 24.23 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.46 1.242 . . . . 0.0 110.802 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.36 44.75 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 0.0 109.73 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.3 155.57 51.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.581 -0.7 . . . . 0.0 110.075 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.05 89.18 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.669 1.352 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 41.3 m-80 -59.55 151.22 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.541 -0.725 . . . . 0.0 110.381 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.85 26.65 2.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.438 -0.789 . . . . 0.0 110.772 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -160.64 26.1 0.15 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.33 -0.856 . . . . 0.0 110.207 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.02 35.1 53.34 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -120.21 89.6 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.7 -0.883 . . . . 0.0 110.165 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.468 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -54.84 179.24 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.557 -0.714 . . . . 0.0 109.994 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' O ' ' HB ' ' A' ' 49' ' ' ILE . 41.8 Cg_endo -66.96 156.77 64.83 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.387 1.204 . . . . 0.0 109.376 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 6.7 mt 67.2 -59.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -49.59 -21.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.919 -1.113 . . . . 0.0 109.688 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HG21 ' A' ' 51' ' ' VAL . 8.5 p -124.49 37.06 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.812 . . . . 0.0 110.017 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -101.84 37.67 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.293 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.2 ttp 64.91 -9.22 0.2 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.535 -0.728 . . . . 0.0 111.693 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.4 28.57 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.035 -1.04 . . . . 0.0 110.339 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.476 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.27 11.46 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -144.54 73.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -1.021 . . . . 0.0 109.549 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.23 -27.92 1.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.605 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -59.24 -31.88 69.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.935 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.413 HG21 HG23 ' A' ' 25' ' ' VAL . 48.4 t -71.8 -50.41 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -43.0 -46.84 5.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.71 -55.15 38.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 109.702 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -44.38 -56.21 4.39 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.652 -0.655 . . . . 0.0 110.708 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 6.2 mp -68.84 -58.84 3.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 110.541 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -48.24 -52.91 19.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.175 -0.953 . . . . 0.0 110.301 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -55.04 -33.84 63.03 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.397 -0.814 . . . . 0.0 109.319 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.454 ' ND1' HD21 ' A' ' 32' ' ' LEU . 1.5 m-70 -81.88 -48.78 11.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.302 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.39 43.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.577 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.496 ' HA ' ' CG ' ' A' ' 48' ' ' PRO . . . -69.02 -172.53 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.703 -1.469 . . . . 0.0 109.722 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 47' ' ' ARG . 3.7 mm-40 -121.02 65.14 13.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.378 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.84 -26.16 32.4 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.07 1.563 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -92.7 -63.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 173.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -164.07 -170.74 2.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.85 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.52 132.96 43.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.604 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 -15.92 39.51 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.556 1.293 . . . . 0.0 110.708 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.76 -84.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 109.991 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.459 HG23 ' CZ2' ' A' ' 110' ' ' TRP . 66.6 p -110.1 32.99 4.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.286 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 5.5 mt 49.27 32.54 4.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.472 -0.767 . . . . 0.0 110.529 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.61 97.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -72.24 147.78 90.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.457 -0.777 . . . . 0.0 109.859 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 40.8 Cg_endo -66.56 -20.59 53.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.521 1.274 . . . . 0.0 109.515 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 104' ' ' LEU . 27.6 t -58.46 -25.7 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -0.801 . . . . 0.0 109.8 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.465 ' CE1' ' HB3' ' A' ' 80' ' ' ARG . 23.9 m80 -73.27 -41.29 63.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.55 -43.85 46.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.694 -0.629 . . . . 0.0 110.23 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.35 -64.54 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.388 -0.82 . . . . 0.0 109.736 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -59.46 -52.41 65.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -41.27 -34.85 0.54 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.33 -8.99 28.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.16 -0.962 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . 82.92 23.81 54.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.476 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -98.95 84.01 3.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 110.445 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -57.9 -39.62 78.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 110.46 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -50.01 -40.96 46.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.032 -1.042 . . . . 0.0 109.959 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 50.7 m -60.03 -32.38 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.71 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 1.1 mp -72.15 -51.23 22.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.419 -0.801 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.3 t -50.17 -45.02 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.538 -0.726 . . . . 0.0 109.579 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.72 -49.04 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.578 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.443 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -55.75 -71.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.139 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -48.77 -34.42 12.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.685 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -62.03 -20.72 64.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.54 86.15 1.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.212 -0.93 . . . . 0.0 111.124 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 49.13 97.8 0.01 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 97' ' ' LEU . . . -168.19 97.5 0.43 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -1.131 . . . . 0.0 110.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.41 ' HG3' ' OD1' ' A' ' 105' ' ' ASP . 10.7 ttm180 -71.93 137.08 47.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.49 -0.756 . . . . 0.0 109.567 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.431 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.1 mp -121.32 21.37 11.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.41 ' OD1' ' HG3' ' A' ' 103' ' ' ARG . 4.8 p-10 -124.32 40.43 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.067 -1.02 . . . . 0.0 110.584 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 80' ' ' ARG . 1.7 p -101.44 -171.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 38.7 mtp180 -135.33 142.8 45.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 110' ' ' TRP . 94.0 m-20 -78.42 60.66 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 110.046 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.2 -71.18 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.756 -0.59 . . . . 0.0 111.082 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.597 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -40.57 -58.38 1.61 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.435 -0.791 . . . . 0.0 110.829 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -23.5 0.73 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -56.02 160.56 2.75 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.323 -1.104 . . . . 0.0 109.896 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 106' ' ' VAL . 36.6 mt -120.02 166.9 13.71 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 0.0 110.679 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.6 Cg_endo -66.79 -34.92 29.44 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.806 1.424 . . . . 0.0 110.392 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HA ' HD11 ' A' ' 130' ' ' LEU . 9.8 p -82.78 -33.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.57 -38.37 90.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -24.56 64.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.785 . . . . 0.0 110.14 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 123' ' ' HIS . . . -83.19 -27.7 29.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.26 -40.58 70.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.7 -47.28 32.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.85 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.32 38.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 16.6 m-70 -99.3 48.99 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.277 -1.131 . . . . 0.0 109.275 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -44.31 -38.02 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.757 -0.589 . . . . 0.0 110.646 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.53 -44.67 95.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 130' ' ' LEU . 22.7 t -78.67 -42.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.426 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -50.98 -41.41 59.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -63.94 1.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -54.0 -41.38 67.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.498 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 134' ' ' ALA . 15.5 mt -58.1 -65.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -26.04 0.89 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.076 -1.015 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.06 -58.58 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.05 -3.59 36.72 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.522 -0.736 . . . . 0.0 110.977 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 109.833 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.366 0.603 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.508 ' N ' ' CD1' ' A' ' 15' ' ' TRP . 35.6 m0 -68.19 -4.4 13.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.657 -0.652 . . . . 0.0 111.536 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 36' ' ' ALA . 25.1 mt -79.66 -52.26 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 108.825 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.428 ' O ' ' HB1' ' A' ' 21' ' ' ALA . . . -67.61 -38.42 83.92 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.029 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -75.25 -60.95 2.07 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.21 -0.931 . . . . 0.0 111.074 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.489 ' HB2' HG21 ' A' ' 28' ' ' VAL . . . -45.74 -57.68 4.07 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.159 -0.963 . . . . 0.0 110.821 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . . . -53.53 -41.43 66.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 17' ' ' ALA . . . -64.7 -33.1 75.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.712 . . . . 0.0 110.198 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 24.5 2.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.824 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.22 61.05 6.13 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.98 68.25 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.964 . . . . 0.0 109.72 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 18.1 t -52.7 -54.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.539 -0.726 . . . . 0.0 110.308 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -42.74 -38.07 1.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.0 110.747 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -66.3 -51.49 56.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 19' ' ' ALA . 5.2 t -68.62 -42.89 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.561 -0.712 . . . . 0.0 110.215 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 14.4 mmm180 -46.41 -48.02 18.82 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.375 -0.828 . . . . 0.0 110.277 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.24 -37.65 52.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.465 -0.772 . . . . 0.0 109.918 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HB3' HD22 ' A' ' 16' ' ' LEU . 14.4 mt -59.2 -66.94 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.52 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 23.7 mt -46.93 -48.52 21.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.581 -0.699 . . . . 0.0 110.427 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.08 -18.67 65.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.608 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.53 -6.68 57.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 111.012 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.21 31.79 1.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.494 ' HB3' ' CD2' ' A' ' 16' ' ' LEU . . . -74.09 157.93 35.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -1.057 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -86.96 115.26 61.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.442 -0.786 . . . . 0.0 109.911 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.45 -36.53 11.46 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.497 1.262 . . . . 0.0 110.094 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 24.2 m120 -108.05 61.05 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 110.221 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 37' ' ' LEU . . . -104.06 99.19 15.76 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.37 -0.831 . . . . 0.0 110.364 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.24 121.02 7.41 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.546 1.288 . . . . 0.0 110.343 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -98.61 178.28 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.928 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -69.55 -6.13 28.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 110.816 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 1.95 22.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 0.0 110.695 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.23 30.76 8.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -124.5 133.83 53.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.805 -0.82 . . . . 0.0 109.906 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -50.65 168.98 0.22 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.498 -0.751 . . . . 0.0 110.745 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 69' ' ' GLU . 44.2 Cg_endo -72.32 -19.95 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.03 1.542 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 49' ' ' ILE . 4.9 mt -107.03 -39.28 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.191 -0.943 . . . . 0.0 109.798 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 8.5 mt-30 -50.16 -22.11 1.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 p -113.21 34.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.033 . . . . 0.0 110.584 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.544 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -96.19 35.28 1.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.724 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.9 tmm? 72.39 -10.45 0.92 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.656 -0.652 . . . . 0.0 110.614 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.544 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 44.61 28.47 0.33 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.982 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -137.0 16.91 3.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -150.04 75.38 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -1.087 . . . . 0.0 109.579 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.85 -34.3 1.57 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 0.0 110.673 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -48.91 -40.22 29.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.49 -0.756 . . . . 0.0 109.812 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' A' ' 20' ' ' ALA . 19.4 t -62.4 -55.69 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -41.56 -54.55 3.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.626 -0.671 . . . . 0.0 109.92 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.75 -43.86 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.673 -0.642 . . . . 0.0 110.136 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.7 OUTLIER -53.66 -73.36 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.125 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 34.2 mt -58.84 -49.26 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.698 . . . . 0.0 109.533 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' CD1' ' HA ' ' A' ' 97' ' ' LEU . 3.0 tt -48.42 -67.45 0.27 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.509 -0.745 . . . . 0.0 110.705 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.83 -19.51 17.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.347 -0.846 . . . . 0.0 110.107 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.555 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -85.06 -44.35 13.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.404 -0.81 . . . . 0.0 109.777 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 139.93 37.7 0.11 Allowed Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -66.8 -147.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.867 -1.372 . . . . 0.0 109.141 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.555 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 2.3 mt-10 -121.07 67.07 15.6 Favored Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 121.625 -0.672 . . . . 0.0 109.392 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.44 -7.9 22.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.971 1.511 . . . . 0.0 110.259 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -118.81 -72.85 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.376 -0.828 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.2 t -42.27 149.11 0.17 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.375 -0.828 . . . . 0.0 110.541 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . . . -132.36 -144.86 0.25 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.811 . . . . 0.0 110.405 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -103.72 139.07 19.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.578 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.63 2.23 7.63 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.444 1.234 . . . . 0.0 110.486 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.46 -56.02 3.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 109.148 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.617 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -129.26 19.05 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.751 -0.593 . . . . 0.0 109.576 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER 44.08 43.58 5.67 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.627 -0.671 . . . . 0.0 111.559 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 81.0 m -69.96 104.45 2.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 109.857 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.635 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.4 OUTLIER -69.45 148.79 97.19 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.914 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.635 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.2 Cg_endo -64.66 -14.89 47.19 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.519 1.273 . . . . 0.0 108.919 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.04 -35.4 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.578 0.704 . . . . 0.0 109.221 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 24.0 m80 -65.38 -38.14 89.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.468 0.651 . . . . 0.0 109.501 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.538 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -55.13 -50.42 69.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.746 -0.596 . . . . 0.0 110.951 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB1' HG23 ' A' ' 93' ' ' THR . . . -56.73 -64.38 0.89 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.978 -1.076 . . . . 0.0 108.725 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -53.33 -38.34 63.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.45 -0.781 . . . . 0.0 110.259 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.7 OUTLIER -49.55 -38.77 32.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.614 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.79 8.79 39.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 110.437 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 65.15 30.04 76.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -95.01 82.05 3.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.522 -0.987 . . . . 0.0 110.654 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.2 OUTLIER -55.47 -42.39 74.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.832 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -47.33 -50.81 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 110.197 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.407 HG23 ' HB1' ' A' ' 85' ' ' ALA . 3.1 m -53.82 -45.8 70.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.407 -0.808 . . . . 0.0 109.855 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 126' ' ' VAL . 0.4 OUTLIER -58.81 -44.89 90.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.742 . . . . 0.0 110.007 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 21.4 t -56.7 -44.61 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.3 t -57.2 -54.49 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.51 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 13.3 mt -49.4 -51.0 37.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.679 -0.638 . . . . 0.0 110.16 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.66 -30.36 65.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.4 mtp180 -61.38 -14.02 24.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.33 -86.33 0.64 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.951 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.03 94.5 0.12 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.19 107.37 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 110.591 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -69.62 143.11 53.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.713 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.18 37.07 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.417 -0.802 . . . . 0.0 109.763 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.02 34.22 4.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.365 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' CG1' ' HG2' ' A' ' 80' ' ' ARG . 13.0 p -102.6 173.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.946 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -124.91 148.15 48.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -69.4 66.22 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 0.0 109.883 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . 65.51 -61.72 0.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.509 -0.744 . . . . 0.0 109.964 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.617 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.8 m-90 -70.2 -83.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 107' ' ' ARG . . . -170.06 21.62 0.08 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -84.29 136.8 33.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.06 -1.259 . . . . 0.0 109.931 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 113' ' ' LEU . 4.0 mm? -104.98 165.9 12.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.635 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.415 ' C ' HD11 ' A' ' 130' ' ' LEU . 46.2 Cg_endo -71.73 -38.86 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.841 1.443 . . . . 0.0 109.838 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 127' ' ' ALA . 9.8 p -64.98 -35.91 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 0.0 111.225 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -61.09 -47.71 85.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 111.268 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.46 -49.57 64.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.196 -0.94 . . . . 0.0 110.939 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.424 ' CB ' ' CB ' ' A' ' 127' ' ' ALA . . . -53.26 -50.25 65.2 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.235 -0.916 . . . . 0.0 110.736 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -56.86 -51.83 67.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.996 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -61.54 -57.94 10.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.466 -0.771 . . . . 0.0 110.193 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.368 -0.832 . . . . 0.0 110.419 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.59 34.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.2 m-70 -107.33 53.39 0.69 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.434 -1.039 . . . . 0.0 109.288 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -47.62 -36.7 11.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.533 -0.729 . . . . 0.0 110.069 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.23 -44.98 88.5 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.95 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 130' ' ' LEU . 20.2 t -80.27 -42.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 115' ' ' VAL . . . -52.25 -44.81 65.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 109.676 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -65.27 -64.57 0.83 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.278 -0.888 . . . . 0.0 109.323 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 94' ' ' LEU . 26.0 t80 -47.51 -40.66 19.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.655 . . . . 0.0 110.06 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.53 ' CD1' HG13 ' A' ' 126' ' ' VAL . 14.2 mt -63.28 -55.03 28.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.544 -0.723 . . . . 0.0 110.083 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.32 -27.08 0.61 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.512 -0.742 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.19 -62.94 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.036 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.9 -6.09 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.317 -0.864 . . . . 0.0 111.026 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.101 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.835 0.35 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.402 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER -43.03 -36.26 1.53 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.523 -0.736 . . . . 0.0 110.468 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.425 HD13 ' CB ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -49.88 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' H ' ' HB3' ' A' ' 16' ' ' LEU . . . -47.41 -52.67 16.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.625 -0.672 . . . . 0.0 111.394 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 4.8 p -40.57 -61.01 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.34 -0.85 . . . . 0.0 111.137 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.19 -53.59 54.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.37 -44.28 72.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.65 -17.65 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.647 -0.658 . . . . 0.0 110.276 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -100.67 19.9 16.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.366 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.4 53.67 39.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -127.64 96.24 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' CZ ' ' A' ' 29' ' ' ARG . 24.4 t -74.56 -44.49 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.292 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.19 -45.63 90.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 110.729 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 2.2 mt-10 -53.05 -44.76 67.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.357 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.515 ' C ' HD22 ' A' ' 62' ' ' LEU . 4.7 t -75.97 -46.61 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.724 . . . . 0.0 109.936 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.476 ' HD2' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.93 -44.89 40.88 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.305 -0.872 . . . . 0.0 110.204 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.51 61.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.571 -0.705 . . . . 0.0 110.232 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.412 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 2.1 mt -65.44 -67.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.524 ' HB3' ' CD2' ' A' ' 66' ' ' HIS . 2.7 mt -47.43 -33.64 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -30.4 68.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.94 -6.68 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.845 . . . . 0.0 110.193 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.27 30.88 3.22 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.487 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -56.1 162.42 1.96 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.289 -1.124 . . . . 0.0 109.929 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.1 tp -80.28 127.33 76.73 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.393 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.36 -29.58 13.69 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.765 1.403 . . . . 0.0 110.407 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -132.91 81.08 1.92 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.66 129.43 31.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 110.221 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.63 93.41 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.562 1.296 . . . . 0.0 110.259 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.8 -167.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.244 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.64 2.77 41.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.895 . . . . 0.0 110.544 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -105.26 23.1 14.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.121 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.45 23.57 19.95 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -124.02 -164.52 1.25 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.48 -1.012 . . . . 0.0 110.087 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.52 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -139.88 -174.39 0.41 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 108.997 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 47' ' ' ARG . 38.9 Cg_endo -66.2 160.82 43.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.127 1.067 . . . . 0.0 109.965 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt 68.43 -59.61 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.613 -0.679 . . . . 0.0 110.008 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -51.78 -21.16 2.58 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.82 -1.175 . . . . 0.0 110.015 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.2 9.81 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.383 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 2.6 ptt? -69.59 159.74 32.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.993 -1.067 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -46.65 -24.74 0.59 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.569 -0.707 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.454 ' HE2' ' HE3' ' A' ' 52' ' ' MET . 0.0 OUTLIER 64.54 14.44 8.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.914 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.44 14.63 27.65 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.24 87.22 1.51 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.59 -0.947 . . . . 0.0 109.818 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.55 -23.09 9.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.85 . . . . 0.0 110.03 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -60.29 -35.35 75.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 110.001 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.56 -49.09 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' LEU . . . -53.61 -55.44 25.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.792 . . . . 0.0 110.043 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 2.2 tm-20 -49.76 -41.53 44.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.094 -1.004 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.515 HD22 ' C ' ' A' ' 28' ' ' VAL . 2.6 tp -69.03 -57.18 5.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.302 -0.874 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.462 ' C ' ' HB1' ' A' ' 68' ' ' ALA . 6.8 mt -65.71 -41.02 92.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' ALA . 2.9 tt -59.46 -65.4 0.68 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 110.938 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.483 ' C ' ' CD1' ' A' ' 65' ' ' LEU . 3.5 pp -52.9 -24.56 9.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 109.697 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.524 ' CD2' ' HB3' ' A' ' 32' ' ' LEU . 1.3 m80 -80.79 -41.99 22.46 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.541 -0.724 . . . . 0.0 109.941 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.56 41.11 0.1 OUTLIER Glycine 0 N--CA 1.482 1.76 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB1' ' C ' ' A' ' 63' ' ' LEU . . . -68.2 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.986 -1.302 . . . . 0.0 109.737 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 4.3 tp10 -120.96 57.12 5.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.331 -0.856 . . . . 0.0 110.217 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.14 -25.42 19.13 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.885 1.466 . . . . 0.0 110.341 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -100.06 -76.81 0.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 0.0 110.137 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 162.91 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.568 -0.707 . . . . 0.0 110.41 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . . . -140.53 -132.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -0.842 . . . . 0.0 110.196 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 78' ' ' LEU . 41.6 t0 -121.18 129.8 25.11 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 -7.95 22.46 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.369 1.194 . . . . 0.0 110.592 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.45 -49.58 11.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.01 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.606 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -134.72 24.5 3.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.55 -0.719 . . . . 0.0 110.072 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 74' ' ' ASP . 7.7 mt 41.86 31.63 0.23 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.697 -0.627 . . . . 0.0 110.749 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.6 m -67.61 86.56 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.818 . . . . 0.0 110.236 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.544 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -69.56 167.78 20.78 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 109.787 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 51.1 Cg_endo -73.46 -2.68 12.49 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.433 1.228 . . . . 0.0 110.913 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 104' ' ' LEU . 36.1 t -78.25 -27.45 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 110.092 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.457 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 19.9 m80 -74.19 -39.32 63.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.885 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 50.2 m-20 -55.02 -56.0 24.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.645 -0.659 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.498 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -56.35 -63.01 1.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.747 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -52.65 -54.25 35.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.873 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -47.66 -39.52 17.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.394 -0.816 . . . . 0.0 110.803 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.62 12.6 20.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.97 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 55.59 56.16 25.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -129.63 90.6 3.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.468 -1.019 . . . . 0.0 111.223 -178.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.42 ' CD1' ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -73.41 -35.0 65.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.792 . . . . 0.0 109.665 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.58 -47.98 28.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.673 -0.642 . . . . 0.0 109.779 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 m -64.11 -41.64 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.498 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 1.6 tp -52.86 -55.09 25.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.6 -0.687 . . . . 0.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 87.2 t -48.92 -46.26 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.72 -0.613 . . . . 0.0 109.433 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 49.9 t -58.52 -53.31 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.512 0.672 . . . . 0.0 109.402 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -48.72 -52.74 22.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.551 -0.718 . . . . 0.0 110.071 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -74.05 -21.84 59.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 109.817 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.9 ttp180 -64.24 -16.73 62.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.495 -0.753 . . . . 0.0 110.474 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.444 ' CB ' HD22 ' A' ' 64' ' ' LEU . . . -134.1 -76.85 0.47 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.0 100.52 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . . . -152.01 94.94 2.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -1.046 . . . . 0.0 110.526 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.66 108.2 0.41 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.249 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.462 ' HA ' HG23 ' A' ' 82' ' ' VAL . 2.0 mt -98.9 32.38 2.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.04 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.47 44.64 2.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 0.0 110.373 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 80' ' ' ARG . 9.5 p -111.21 -178.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.9 mtp85 -122.83 -176.67 3.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -104.46 36.28 2.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.901 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 66.35 3.7 2.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 110.945 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.606 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 3.6 m-90 -123.65 -57.96 1.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.981 -1.074 . . . . 0.0 109.959 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.83 -30.4 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.44 165.4 4.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -1.036 . . . . 0.0 110.831 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 42.3 mt -128.82 169.62 12.57 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.644 -0.66 . . . . 0.0 109.278 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.96 -13.87 37.5 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.454 1.239 . . . . 0.0 109.806 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 131' ' ' ARG . 4.6 p -90.56 -40.09 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 110.657 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -57.01 -43.18 81.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.354 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.54 -53.19 60.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.861 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 123' ' ' HIS . . . -53.36 -53.89 44.59 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -49.46 -30.45 8.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.0 109.94 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 28.2 mm-40 -85.15 -59.12 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.565 -0.71 . . . . 0.0 109.544 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 110.053 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.68 28.34 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 12.0 m-70 -97.98 47.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.028 -1.278 . . . . 0.0 109.159 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.91 -40.92 6.73 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.606 0.717 . . . . 0.0 109.547 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.42 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 5.3 p-10 -61.74 -46.79 88.13 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.039 -0.665 . . . . 0.0 109.635 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -76.17 -40.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 109.777 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 131' ' ' ARG . . . -52.81 -62.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.348 -0.845 . . . . 0.0 110.341 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -47.02 -61.27 1.95 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.504 -0.748 . . . . 0.0 111.303 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.421 ' C ' ' CD1' ' A' ' 129' ' ' TYR . 14.8 t80 -56.64 -63.55 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.896 . . . . 0.0 110.62 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -54.29 -19.92 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 110.514 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -75.4 -40.62 57.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.036 -1.04 . . . . 0.0 110.148 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.55 77.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.61 -15.94 31.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.716 -0.615 . . . . 0.0 109.819 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.331 -0.855 . . . . 0.0 110.397 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 20.2 p-10 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.002 0.43 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.545 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.8 m0 -54.42 -21.03 8.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -75.62 -42.33 51.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.452 -0.78 . . . . 0.0 109.403 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.93 -45.12 28.92 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.823 . . . . 0.0 109.895 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -47.23 -56.26 7.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.571 -0.705 . . . . 0.0 110.434 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.83 91.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 110.163 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 59' ' ' VAL . . . -53.96 -53.81 47.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.5 -29.31 66.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.422 -0.799 . . . . 0.0 110.436 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.85 23.86 2.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.82 44.62 39.99 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.09 93.55 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -1.11 . . . . 0.0 110.017 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 58' ' ' ARG . 5.1 t -75.1 -46.46 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 110.192 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -32.92 70.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 1.6 tp10 -74.03 -46.45 43.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 0.0 109.766 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.94 -46.89 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 110.41 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.561 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 46.3 mmm-85 -55.21 -46.76 75.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.053 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.34 56.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 0.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.486 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 13.0 mt -61.15 -63.01 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.945 . . . . 0.0 110.49 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD23 ' CB ' ' A' ' 66' ' ' HIS . 1.4 mt -49.18 -43.27 42.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.392 -0.817 . . . . 0.0 110.476 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -71.09 -13.36 61.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.88 -10.17 37.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.194 -0.941 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.01 -2.83 5.57 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.333 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB1' ' C ' ' A' ' 31' ' ' LEU . . . -53.69 103.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.03 -1.276 . . . . 0.0 109.896 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 tp -50.5 123.4 17.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.494 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 40.8 Cg_endo -67.84 -43.44 5.2 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.598 1.315 . . . . 0.0 110.489 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -91.07 54.13 2.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.12 -0.988 . . . . 0.0 109.817 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.8 93.95 6.84 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.771 . . . . 0.0 110.612 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.17 97.11 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.588 1.309 . . . . 0.0 110.034 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -63.7 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.315 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.12 36.42 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -0.887 . . . . 0.0 110.319 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -7.76 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 111.073 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 24.48 19.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.44 32.45 5.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.541 -0.976 . . . . 0.0 109.369 -179.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mmt180 49.77 179.76 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 49.7 Cg_endo -86.44 -13.69 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.155 1.082 . . . . 0.0 111.065 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.69 -43.05 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.95 -1.094 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 1.5 tt0 -46.24 -28.91 1.4 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 7.1 p -109.32 40.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.457 ' HA ' ' C ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -99.48 30.38 3.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 109.669 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.3 tmm? 64.65 -4.7 0.43 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.724 -0.61 . . . . 0.0 111.292 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.491 ' CG ' ' HB3' ' A' ' 84' ' ' ASP . 13.0 mmt 42.39 28.64 0.12 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.41 6.89 8.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.75 87.34 1.77 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 110.115 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.84 49.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.805 . . . . 0.0 109.545 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.466 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -54.12 -37.47 64.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.574 -0.704 . . . . 0.0 109.273 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 20' ' ' ALA . 99.0 t -59.84 -61.17 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -54.75 -25.61 28.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.545 -0.722 . . . . 0.0 109.104 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 58' ' ' ARG . 5.2 tm-20 -53.54 -72.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.302 -0.874 . . . . 0.0 110.045 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.56 -36.57 71.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.778 -1.201 . . . . 0.0 109.393 179.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' A' ' 48' ' ' PRO . 1.1 mt -58.09 -63.41 1.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.447 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -61.38 -31.37 71.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.421 -0.799 . . . . 0.0 109.248 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 26.0 tp -68.78 -48.34 63.9 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -77.91 -16.08 58.5 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.423 -0.798 . . . . 0.0 109.951 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.5 63.63 0.58 Allowed Glycine 0 N--CA 1.483 1.825 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.618 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.436 ' HB1' ' C ' ' A' ' 63' ' ' LEU . . . -79.71 -146.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.945 -1.327 . . . . 0.0 109.145 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mm-40 -117.14 55.07 1.53 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.285 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.72 -14.07 32.75 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.497 1.262 . . . . 0.0 110.95 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -103.65 -76.44 0.59 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.127 -0.983 . . . . 0.0 110.262 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.61 144.17 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' A' ' 80' ' ' ARG . . . -119.01 -156.28 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.924 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -102.7 144.18 28.1 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.951 . . . . 0.0 110.441 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.94 -17.08 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.614 1.323 . . . . 0.0 110.327 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.66 -78.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.714 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.466 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 34.8 p -115.06 27.36 9.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.143 -0.973 . . . . 0.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.1 mt 46.64 31.06 1.27 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 111.117 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -67.09 100.37 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.502 ' CG ' HG12 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -75.86 165.48 52.88 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.315 -0.866 . . . . 0.0 109.513 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HA ' ' HG3' ' A' ' 50' ' ' GLN . 47.4 Cg_endo -71.54 -11.51 28.27 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.637 1.335 . . . . 0.0 109.625 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 114' ' ' PRO . 77.2 t -69.5 -46.39 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.436 -0.79 . . . . 0.0 109.93 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 39.9 m80 -52.03 -49.63 63.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.424 -0.797 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 54' ' ' MET . 7.0 m-20 -42.54 -54.67 3.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 122.02 -0.425 . . . . 0.0 111.437 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -53.29 -62.69 1.49 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' O ' ' ND1' ' A' ' 123' ' ' HIS . . . -63.18 -26.15 68.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.564 -0.71 . . . . 0.0 110.686 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -62.35 -28.44 69.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.018 -1.051 . . . . 0.0 109.947 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.433 ' C ' ' CE1' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -109.05 -20.82 12.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.404 -0.81 . . . . 0.0 110.089 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.486 ' HA2' HG23 ' A' ' 126' ' ' VAL . . . 94.39 32.6 7.27 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.906 -1.677 . . . . 0.0 108.906 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.556 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -99.46 88.05 3.77 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 110.406 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -60.6 -39.08 86.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 110.432 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . 31.8 m-20 -46.85 -46.15 20.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 110.081 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 97' ' ' LEU . 46.5 m -61.47 -46.42 90.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.564 -0.71 . . . . 0.0 110.055 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.443 ' CD1' ' CB ' ' A' ' 85' ' ' ALA . 1.1 tp -51.31 -57.91 7.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.38 -0.825 . . . . 0.0 110.481 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.34 -50.67 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.284 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.37 -51.07 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.532 -0.73 . . . . 0.0 110.358 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.418 HD12 HG21 ' A' ' 93' ' ' THR . 1.1 mp -51.46 -55.66 17.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -71.7 -42.41 67.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.369 -0.832 . . . . 0.0 110.882 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -7.35 6.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.77 -59.16 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.931 -1.106 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.85 108.78 0.28 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -173.03 133.62 0.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -1.167 . . . . 0.0 110.915 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -97.23 80.79 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.611 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.5 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.4 mp -69.91 67.88 0.28 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.0 110.011 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -168.02 33.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.314 -0.866 . . . . 0.0 110.43 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.502 HG12 ' CG ' ' A' ' 80' ' ' ARG . 1.2 p -105.9 -170.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.925 -1.11 . . . . 0.0 109.996 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.458 ' N ' HG11 ' A' ' 106' ' ' VAL . 30.5 mtt180 -131.29 147.52 52.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 35.7 t0 -79.1 54.89 1.71 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 58.6 -69.06 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.74 -0.6 . . . . 0.0 110.635 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.566 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -41.22 -48.65 3.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.71 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.38 -33.88 1.54 Allowed Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.425 ' CD ' ' HB2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -56.58 156.35 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -1.064 . . . . 0.0 110.35 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 29.9 mt -105.9 168.03 8.82 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.489 -0.757 . . . . 0.0 110.412 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 38.8 Cg_endo -65.81 -27.96 51.47 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.773 1.407 . . . . 0.0 110.046 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 3.4 p -77.83 -31.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.506 -0.747 . . . . 0.0 109.731 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.416 ' N ' HG11 ' A' ' 115' ' ' VAL . 3.7 t0 -60.12 -49.2 78.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.448 -0.782 . . . . 0.0 110.189 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.58 -57.25 13.5 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.317 -0.865 . . . . 0.0 110.356 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.22 -54.95 20.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -41.25 37.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.351 -0.843 . . . . 0.0 110.578 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -80.09 -26.42 39.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 0.0 110.421 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 8.3 mt -81.0 2.64 26.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.275 -0.891 . . . . 0.0 110.383 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.86 17.28 73.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 22.2 m170 -94.67 53.44 1.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -1.158 . . . . 0.0 108.949 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -39.97 -59.21 1.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.222 0.535 . . . . 0.0 111.802 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.413 ' O ' HD23 ' A' ' 91' ' ' LEU . 54.8 m-20 -48.6 -39.44 23.9 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.492 -0.755 . . . . 0.0 110.393 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.535 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 1.4 t -80.89 -38.74 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.511 -0.743 . . . . 0.0 110.012 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.79 -38.99 92.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 109.553 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -73.99 -42.62 60.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.257 -0.902 . . . . 0.0 109.841 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.469 ' CD2' HD13 ' A' ' 91' ' ' LEU . 9.5 t80 -59.79 -40.63 88.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.5 ' CD2' HD21 ' A' ' 104' ' ' LEU . 19.4 mt -68.28 -42.96 78.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.509 -0.744 . . . . 0.0 109.591 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -20.95 50.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 0.0 110.355 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.72 -47.6 11.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.881 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.71 -14.57 42.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.397 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' A' ' 18' ' ' THR . 12.1 t70 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.644 0.259 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.403 ' HB3' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.54 -3.98 17.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.933 -1.105 . . . . 0.0 111.169 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 28.0 mt -81.14 -49.63 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.128 -0.983 . . . . 0.0 109.57 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.88 -46.73 67.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.675 -0.64 . . . . 0.0 110.077 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.79 -63.67 1.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.673 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 28' ' ' VAL . . . -51.97 -46.02 64.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.482 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -57.63 -49.22 77.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' CA ' ' O ' ' A' ' 51' ' ' VAL . . . -63.77 -24.86 67.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.454 -0.778 . . . . 0.0 110.694 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -90.13 26.35 1.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.784 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.91 31.11 4.0 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -104.46 94.16 5.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.617 -0.931 . . . . 0.0 110.174 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.452 ' CG2' HG21 ' A' ' 59' ' ' VAL . 46.2 t -71.43 -54.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.592 -0.692 . . . . 0.0 110.025 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -47.82 -41.23 23.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.493 -0.755 . . . . 0.0 110.671 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 5.2 mm-40 -59.13 -54.62 44.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 62' ' ' LEU . 2.6 t -64.79 -49.67 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.619 -0.676 . . . . 0.0 109.238 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.525 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 3.4 mmt180 -36.95 -51.61 0.92 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.347 0.594 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -78.7 -52.51 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' A' ' 15' ' ' TRP . 49.3 mt -48.39 -74.23 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.317 -0.864 . . . . 0.0 111.382 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.633 ' HG ' ' CD2' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -50.1 -43.25 51.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 110.804 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.44 -10.09 59.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 0.0 110.386 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -87.33 -13.47 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.005 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.49 23.61 1.35 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.494 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -69.6 -172.95 0.53 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.259 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.436 ' O ' ' CD1' ' A' ' 16' ' ' LEU . 3.1 mm? -94.96 126.38 47.09 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 110.829 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.499 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 43.1 Cg_endo -71.34 -16.45 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.284 1.15 . . . . 0.0 110.225 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -137.79 48.08 2.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.79 137.98 76.76 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.42 169.35 22.61 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.751 1.395 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -133.39 -172.13 2.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.3 m -109.14 13.04 24.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.892 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 15.7 m-85 -117.96 8.25 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.248 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.37 31.96 79.19 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -119.1 -169.58 1.76 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.459 -1.024 . . . . 0.0 110.127 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -105.95 164.72 14.4 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.8 Cg_endo -65.85 -15.73 50.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.561 1.295 . . . . 0.0 111.266 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 60' ' ' ALA . 3.6 mt -109.12 -38.25 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.92 . . . . 0.0 108.799 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 2.8 mt-30 -49.96 -23.55 2.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.328 -0.858 . . . . 0.0 110.41 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 21' ' ' ALA . 11.1 p -110.98 36.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.456 -0.777 . . . . 0.0 110.537 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.498 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -96.8 32.25 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.955 -1.09 . . . . 0.0 110.198 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.424 ' HE2' ' HB3' ' A' ' 53' ' ' MET . 6.7 tmm? 64.98 -3.26 0.61 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.654 -0.654 . . . . 0.0 110.568 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.523 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 39.88 32.71 0.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.429 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -122.15 -3.23 9.82 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.6 85.95 1.72 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 110.212 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB3' ' N ' ' A' ' 93' ' ' THR . . . -52.6 -25.74 11.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -49.81 -43.38 48.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.725 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 20' ' ' ALA . 5.9 t -60.21 -54.79 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.476 ' HA ' HD12 ' A' ' 49' ' ' ILE . . . -48.63 -35.63 14.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.641 -0.662 . . . . 0.0 109.333 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -49.53 76.02 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD2' HD22 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -55.06 -57.03 13.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.657 0.742 . . . . 0.0 109.157 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.467 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 4.4 mm? -59.93 -27.96 67.21 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.96 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -73.42 -56.31 5.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.199 -0.938 . . . . 0.0 110.342 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD22 ' CD2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -51.47 -27.08 9.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.838 0.828 . . . . 0.0 109.253 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.633 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.0 -28.58 21.33 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.627 0.727 . . . . 0.0 109.112 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.29 63.34 0.73 Allowed Glycine 0 N--CA 1.477 1.432 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 38' ' ' PRO . . . -71.3 -154.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.079 -1.248 . . . . 0.0 108.664 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 47' ' ' ARG . 13.2 mt-10 -113.9 66.7 1.42 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.286 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.43 ' CB ' HD21 ' A' ' 97' ' ' LEU . 45.3 Cg_endo -69.69 -17.7 37.76 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.766 1.403 . . . . 0.0 110.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.432 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.4 t30 -98.02 -58.61 1.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -0.826 . . . . 0.0 110.501 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 30.7 t -47.0 147.95 1.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.9 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -128.92 -144.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.797 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.8 140.87 24.51 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.241 -0.912 . . . . 0.0 109.96 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -20.03 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.257 1.135 . . . . 0.0 109.919 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.22 -57.8 4.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 110.237 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.471 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -131.72 29.01 4.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 6.1 mt 41.29 38.76 0.84 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.539 -0.726 . . . . 0.0 111.201 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.2 m -72.8 98.28 2.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.949 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.498 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -78.0 163.2 64.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.927 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 44.4 Cg_endo -69.07 -3.99 12.67 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.414 1.218 . . . . 0.0 110.393 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 104' ' ' LEU . 31.2 t -74.99 -29.48 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 2.2 m80 -74.67 -33.21 62.44 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.523 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -55.15 -59.67 4.45 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.341 0.591 . . . . 0.0 110.033 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -53.99 -61.56 2.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.388 -0.82 . . . . 0.0 109.76 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.647 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -54.99 -58.8 6.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 3.3 ttt180 -46.5 -28.16 1.32 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.279 -0.888 . . . . 0.0 110.894 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.465 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 1.8 tm-20 -103.3 1.99 33.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 111.044 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.454 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 64.38 58.93 9.09 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.477 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -134.23 86.75 2.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 110.339 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -58.21 -44.38 88.14 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.566 -0.709 . . . . 0.0 110.077 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -43.8 -46.64 7.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.464 ' N ' ' HB3' ' A' ' 57' ' ' ALA . 52.4 m -60.21 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.48 HD21 HG11 ' A' ' 126' ' ' VAL . 1.8 tp -56.8 -45.67 82.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.178 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 60.5 t -55.63 -50.67 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.608 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.434 HG11 ' HG ' ' A' ' 64' ' ' LEU . 52.7 t -53.54 -53.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.345 -0.847 . . . . 0.0 110.401 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.43 HD21 ' CB ' ' A' ' 70' ' ' PRO . 6.2 mt -50.08 -66.92 0.31 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -56.72 -32.61 65.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 0.0 109.853 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.7 ttp85 -67.44 -8.97 37.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.602 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.35 58.21 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.969 -1.082 . . . . 0.0 111.19 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.4 109.01 0.01 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -166.41 125.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.4 -1.059 . . . . 0.0 110.757 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 114.1 7.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.424 -0.797 . . . . 0.0 109.191 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -111.06 25.01 12.21 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 110.661 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 2.0 p30 -145.19 59.8 1.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.104 -0.997 . . . . 0.0 110.355 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 80' ' ' ARG . 9.2 p -108.77 -177.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.41 ' H ' ' CG2' ' A' ' 106' ' ' VAL . 12.9 mtt180 -132.6 132.37 42.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -72.48 60.95 0.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.445 -0.785 . . . . 0.0 110.07 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.27 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.36 -0.838 . . . . 0.0 110.451 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -124.09 25.28 7.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 0.0 109.902 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -93.61 -75.99 1.32 Allowed Glycine 0 N--CA 1.48 1.605 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 2.1 mtt180 171.93 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.939 . . . . 0.0 110.072 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 2.4 mm? -104.3 170.98 5.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 44.1 Cg_endo -70.74 -22.71 27.2 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.696 1.366 . . . . 0.0 110.622 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.473 ' HA ' HD22 ' A' ' 130' ' ' LEU . 7.2 p -82.81 -39.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 110.082 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.415 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 89.3 m-20 -52.48 -38.79 60.21 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 121' ' ' LEU . 6.5 mt -59.73 -58.45 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.93 -39.82 55.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.732 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.17 -46.41 75.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.21 -24.77 57.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -87.64 -81.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.922 . . . . 0.0 110.681 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.72 42.55 0.02 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 37.3 m-70 -106.03 52.4 0.73 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.983 . . . . 0.0 108.951 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 12.2 ptm180 -42.41 -40.88 2.7 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.201 0.524 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.516 ' O ' HD22 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -60.15 -41.01 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.268 -0.895 . . . . 0.0 108.918 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.513 HG13 HD21 ' A' ' 130' ' ' LEU . 1.4 t -85.0 -41.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.675 -0.64 . . . . 0.0 109.656 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -51.67 -45.62 63.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -0.805 . . . . 0.0 110.308 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -82.57 -43.69 16.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.434 -0.791 . . . . 0.0 110.278 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.468 ' CD1' HD12 ' A' ' 91' ' ' LEU . 53.8 t80 -65.23 -61.76 1.94 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.233 -0.917 . . . . 0.0 109.953 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 HG13 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -56.32 -31.05 63.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 110.064 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 0.7 OUTLIER -66.24 -28.95 69.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.003 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.95 -39.84 65.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.006 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.93 -13.12 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 111.029 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.812 0 O-C-N 120.975 -1.078 . . . . 0.0 111.098 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.131 0.491 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.0 106.83 57.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.049 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.15 152.85 62.44 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.497 1.261 . . . . 0.0 109.927 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.29 167.99 9.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 110.037 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.73 108.94 13.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.313 -0.867 . . . . 0.0 109.786 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 7' ' ' SER . . . 112.77 -148.8 18.48 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 6' ' ' GLY . 14.9 m 60.87 59.78 2.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.258 -1.143 . . . . 0.0 110.241 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.7 p -154.7 135.7 13.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 110.34 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -96.75 86.05 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.41 -0.806 . . . . 0.0 110.652 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.52 72.77 0.74 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.12 -0.987 . . . . 0.0 110.921 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.67 63.72 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.782 1.412 . . . . 0.0 111.131 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.94 112.04 24.12 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.301 -0.874 . . . . 0.0 109.574 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.75 -62.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 110.575 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -88.83 3.05 52.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.222 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.517 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.4 m0 -72.31 -11.46 60.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.484 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -74.86 -58.5 3.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.441 -0.787 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.522 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.2 -49.43 77.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -43.89 -67.9 0.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.835 -0.541 . . . . 0.0 110.737 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -46.24 -51.21 14.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.33 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 52' ' ' MET . . . -46.59 -54.18 9.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.667 . . . . 0.0 110.334 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.14 -20.11 65.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.409 -0.807 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.447 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 26.4 mtm180 -99.38 22.2 10.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 111.364 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.513 ' CA ' ' HG3' ' A' ' 53' ' ' MET . . . 54.38 52.61 43.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 14.7 mmt180 -124.97 89.93 3.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.2 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 81.2 t -74.36 -40.51 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.443 -0.786 . . . . 0.0 110.041 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -34.7 76.75 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.385 -0.822 . . . . 0.0 110.729 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 1.6 tp10 -61.07 -50.71 72.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG21 ' CB ' ' A' ' 19' ' ' ALA . 20.6 t -71.55 -48.54 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.903 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.524 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -41.18 -42.1 1.97 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 -179.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.72 -50.33 13.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.49 -0.756 . . . . 0.0 109.09 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -61.56 -60.19 4.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.502 -0.749 . . . . 0.0 110.049 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.56 ' HG ' ' CD2' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -42.95 -46.27 5.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.75 -0.594 . . . . 0.0 110.83 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -75.53 -14.85 60.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 110.318 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.36 -8.39 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.843 . . . . 0.0 110.769 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.58 16.95 3.28 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.119 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 32' ' ' LEU . . . -56.81 135.65 55.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.892 -1.357 . . . . 0.0 110.292 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.0 tp -83.19 116.71 65.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.669 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HA ' HD22 ' A' ' 16' ' ' LEU . 43.6 Cg_endo -73.1 -36.72 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.488 1.257 . . . . 0.0 110.944 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -91.94 24.09 3.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.306 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.32 148.32 64.03 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.381 -0.824 . . . . 0.0 110.444 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.67 93.4 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.782 1.412 . . . . 0.0 110.258 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -65.43 158.89 25.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.65 -0.656 . . . . 0.0 110.356 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.9 3.51 55.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 110.65 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 11.6 m-85 -114.3 23.12 13.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 74' ' ' ASP . . . 47.18 31.22 6.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HD3' ' HG2' ' A' ' 50' ' ' GLN . 15.1 mtt-85 -114.18 -161.09 0.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.684 -0.892 . . . . 0.0 110.427 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.472 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.98 179.13 0.82 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.955 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 47.5 Cg_endo -71.21 -26.42 21.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.935 1.492 . . . . 0.0 110.126 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 52' ' ' MET . 4.4 mt -109.31 -37.57 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.376 -0.828 . . . . 0.0 109.826 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.415 ' HG2' ' HD3' ' A' ' 46' ' ' ARG . 2.0 tt0 -49.4 -22.04 1.05 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.079 -1.013 . . . . 0.0 110.05 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -104.43 -10.28 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.454 -0.779 . . . . 0.0 110.585 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.481 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -65.08 161.54 18.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.159 -0.963 . . . . 0.0 110.557 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.513 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.54 105.82 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.552 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -62.62 -10.53 12.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.469 -0.769 . . . . 0.0 110.881 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -90.33 28.38 7.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.461 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -161.39 81.24 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -1.123 . . . . 0.0 110.07 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.11 -24.45 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -52.47 -49.86 63.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 56' ' ' SER . 2.7 t -56.66 -65.15 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.267 -0.896 . . . . 0.0 110.086 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' VAL . . . -40.53 -42.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.606 -0.683 . . . . 0.0 110.008 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -46.37 84.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.458 -0.776 . . . . 0.0 109.055 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -53.05 -55.2 25.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 48' ' ' PRO . 2.5 mp -66.54 -43.89 83.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.853 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.483 HD21 HG11 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -64.24 -55.07 24.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.462 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.5 tp -49.18 -34.36 14.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.849 0.833 . . . . 0.0 108.912 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.56 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 2.7 m-70 -83.14 -35.02 25.9 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.4 58.62 0.18 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.644 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.439 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . . . -78.05 -156.57 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 72' ' ' CYS . 1.8 mt-10 -114.92 64.42 1.61 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.454 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . 40.9 Cg_endo -67.19 -13.95 41.42 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.786 1.413 . . . . 0.0 110.409 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.409 ' O ' ' HD2' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -107.26 -57.6 2.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -48.32 150.27 1.32 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 110.751 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HB1' ' CD ' ' A' ' 80' ' ' ARG . . . -136.54 -139.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.737 . . . . 0.0 109.757 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' LEU . 2.8 t0 -116.32 126.78 27.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.19 -8.89 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.143 1.076 . . . . 0.0 110.142 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.33 -46.87 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.581 HG21 ' CH2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -116.3 -0.52 12.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.1 mt 46.92 23.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.911 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.9 m -61.54 94.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.18 -0.95 . . . . 0.0 108.8 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.547 ' NH2' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -66.49 143.56 98.25 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.567 -0.708 . . . . 0.0 109.2 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 39.1 Cg_endo -66.56 -9.6 24.86 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.784 1.413 . . . . 0.0 110.142 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.454 HG13 ' CB ' ' A' ' 114' ' ' PRO . 42.7 t -70.56 -25.12 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.537 ' NE2' ' OD1' ' A' ' 108' ' ' ASP . 5.9 m80 -72.78 -41.8 64.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.212 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.552 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 15.9 m-20 -47.47 -42.88 23.64 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.277 0.561 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -66.28 -65.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.959 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -59.58 -48.57 81.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -0.899 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.437 ' O ' HD21 ' A' ' 121' ' ' LEU . 5.4 tmm_? -51.51 -35.69 41.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.987 -1.071 . . . . 0.0 109.872 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.482 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 2.3 tp10 -88.85 4.07 49.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.09 -1.006 . . . . 0.0 110.218 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 69.56 28.38 72.37 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.8 OUTLIER -106.21 120.12 41.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.448 -1.031 . . . . 0.0 110.046 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.47 -41.27 9.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 0.0 110.01 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 1.2 m-20 -52.58 -25.35 10.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.905 . . . . 0.0 110.471 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 85' ' ' ALA . 5.6 m -74.85 -45.95 39.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.191 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.531 ' CD1' ' CG1' ' A' ' 126' ' ' VAL . 0.4 OUTLIER -57.96 -54.97 40.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.37 -50.68 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.394 -0.816 . . . . 0.0 109.379 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.483 HG11 HD21 ' A' ' 64' ' ' LEU . 85.3 t -51.07 -55.99 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.748 -0.595 . . . . 0.0 110.162 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.454 ' HG ' ' CB ' ' A' ' 70' ' ' PRO . 7.6 mp -49.73 -53.51 24.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -61.62 -31.14 71.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.0 109.977 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -71.05 -11.96 61.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.935 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB1' ' CD2' ' A' ' 64' ' ' LEU . . . -140.63 66.32 1.38 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.185 -0.947 . . . . 0.0 111.004 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.87 97.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 70' ' ' PRO . . . -160.41 108.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -1.147 . . . . 0.0 110.445 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.7 ttt85 -64.75 128.46 35.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.325 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.21 19.72 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.388 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -124.48 58.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 110.077 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.547 HG22 ' NH2' ' A' ' 80' ' ' ARG . 5.2 p -117.4 -175.39 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.345 -0.847 . . . . 0.0 109.731 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.02 127.96 23.64 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.56 -0.712 . . . . 0.0 110.235 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.537 ' OD1' ' NE2' ' A' ' 83' ' ' HIS . 1.7 m-20 -51.31 150.64 3.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 109.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.19 -35.76 2.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.463 -0.773 . . . . 0.0 111.034 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.581 ' CH2' HG21 ' A' ' 77' ' ' THR . 13.4 m-90 -59.57 -79.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.18 29.36 0.02 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.427 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -107.42 -165.04 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -1.21 . . . . 0.0 110.975 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.402 HD21 HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -147.03 160.51 39.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 39.5 Cg_endo -67.66 -33.64 27.46 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.433 1.228 . . . . 0.0 110.645 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 5.4 p -78.33 -37.81 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.0 110.082 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.99 -43.64 91.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.51 -0.744 . . . . 0.0 109.978 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mt -52.27 -39.29 60.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 123' ' ' HIS . . . -69.12 -34.08 74.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.532 -0.73 . . . . 0.0 110.008 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.0 -20.08 64.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.427 ' OE2' ' NH2' ' A' ' 112' ' ' ARG . 29.2 tt0 -86.25 -57.98 2.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.706 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 6.7 mp -57.07 -81.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.008 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.3 40.41 0.02 OUTLIER Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . 21.5 m-70 -115.09 43.39 2.0 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.43 -1.041 . . . . 0.0 109.759 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -45.65 -37.19 5.45 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -62.33 -37.46 85.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.62 -0.675 . . . . 0.0 109.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.557 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -80.93 -36.19 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 118' ' ' ALA . . . -68.34 -32.93 73.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.544 -0.722 . . . . 0.0 109.602 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -59.3 -66.27 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.406 -0.809 . . . . 0.0 109.741 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -52.13 -25.51 9.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.36 -0.838 . . . . 0.0 109.352 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.488 HD12 ' HB1' ' A' ' 86' ' ' ALA . 8.7 mt -73.88 -58.82 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 110.427 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -24.06 0.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.84 -51.04 9.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.955 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.15 -13.19 53.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.0 110.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -97.42 54.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 110.715 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.43 133.93 4.59 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.52 -43.93 66.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 t -50.01 138.13 16.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.577 -0.955 . . . . 0.0 110.494 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -151.77 63.55 0.86 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.828 . . . . 0.0 110.278 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -104.88 123.93 7.82 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -53.79 6.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.209 -1.171 . . . . 0.0 110.478 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -102.07 39.05 1.53 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 109.854 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.37 -161.71 0.83 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.502 -0.749 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -176.88 115.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.692 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -56.05 -175.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.823 . . . . 0.0 109.689 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 tp -68.81 142.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.902 . . . . 0.0 109.733 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -44.98 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.486 -0.759 . . . . 0.0 111.055 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.82 63.55 1.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.007 . . . . 0.0 110.75 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.58 119.11 2.86 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.18 -0.95 . . . . 0.0 109.799 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -101.78 106.19 17.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.886 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 170.99 -137.43 4.41 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.93 146.61 37.68 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.786 1.414 . . . . 0.0 110.607 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 153' ' ' ASP . 9.7 p -60.63 167.78 2.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 152' ' ' SER . 1.9 t0 65.29 137.31 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.381 -0.824 . . . . 0.0 110.421 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.85 84.71 62.56 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 0.0 109.532 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.88 115.57 4.37 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 124.029 1.541 . . . . 0.0 110.849 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.104 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tpp . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.13 0.49 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -110.95 81.31 2.57 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.46 179.24 4.76 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.827 1.435 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.35 92.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.445 -0.785 . . . . 0.0 110.606 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -166.7 138.74 3.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 110.245 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.9 -51.33 0.72 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 p -55.47 175.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.394 -1.062 . . . . 0.0 110.067 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 9' ' ' MET . 0.4 OUTLIER -109.44 -44.58 3.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.941 . . . . 0.0 110.723 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.402 ' CB ' ' O ' ' A' ' 8' ' ' SER . 1.7 ttm 65.72 174.86 0.22 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.377 -0.827 . . . . 0.0 110.213 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.78 72.28 0.86 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.345 -0.847 . . . . 0.0 110.241 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.42 164.3 35.7 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.671 1.353 . . . . 0.0 110.629 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.43 124.75 23.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.087 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -179.97 -37.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.269 -0.895 . . . . 0.0 110.525 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.74 -17.13 51.99 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 0.0 110.885 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.537 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.9 m0 -79.78 -9.97 59.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -74.92 -50.75 15.73 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.164 -0.96 . . . . 0.0 109.354 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.46 -47.78 66.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.368 -0.833 . . . . 0.0 109.799 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -50.89 -49.81 58.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.456 -0.777 . . . . 0.0 110.411 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.89 -55.71 30.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 52' ' ' MET . . . -48.21 -44.25 32.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.315 -0.866 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.33 -32.09 54.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 111.034 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 1.1 ttt-85 -90.99 32.25 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.264 -0.898 . . . . 0.0 111.196 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.38 71.17 0.62 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -137.49 50.4 1.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.386 -1.067 . . . . 0.0 110.061 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' A' ' 59' ' ' VAL . 70.7 t -45.96 -37.41 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.459 -0.776 . . . . 0.0 110.282 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.83 -46.6 62.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.38 -44.89 89.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.315 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.426 HG13 HD13 ' A' ' 32' ' ' LEU . 23.7 t -66.02 -46.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.886 . . . . 0.0 109.958 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -51.27 -46.04 62.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.07 -39.8 65.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.496 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.3 -56.31 11.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.498 -0.751 . . . . 0.0 110.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD13 ' CD2' ' A' ' 62' ' ' LEU . 14.3 mt -50.1 -50.38 48.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 110.16 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.22 -13.62 60.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.361 -0.837 . . . . 0.0 110.742 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 -11.53 36.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.977 -1.077 . . . . 0.0 111.006 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.55 37.0 0.7 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -66.84 162.36 21.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -1.125 . . . . 0.0 109.905 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.482 ' O ' ' CD2' ' A' ' 16' ' ' LEU . 5.5 tp -92.18 115.23 64.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 0.0 109.663 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.39 -28.58 39.06 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.461 1.243 . . . . 0.0 110.195 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.414 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 28.6 m120 -129.74 66.49 1.47 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 109.753 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.33 108.52 22.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 47.5 Cg_endo -71.63 94.31 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.622 1.327 . . . . 0.0 110.061 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -94.02 -174.81 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.812 . . . . 0.0 110.644 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.46 5.59 41.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 110.914 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.9 -5.56 53.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.83 22.84 12.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -115.03 134.74 54.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -1.064 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.598 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -60.37 169.16 1.86 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 39.6 Cg_endo -66.35 -23.23 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.542 1.285 . . . . 0.0 111.296 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.42 HG13 ' CB ' ' A' ' 68' ' ' ALA . 6.1 mt -107.99 -36.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.973 -1.079 . . . . 0.0 109.065 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HG3' ' OD2' ' A' ' 84' ' ' ASP . 2.7 tt0 -52.18 -19.85 2.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.734 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.37 2.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.497 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -76.91 165.16 25.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.999 -1.063 . . . . 0.0 110.147 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.404 ' N ' ' O ' ' A' ' 20' ' ' ALA . 3.3 tpp -61.1 96.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.218 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.56 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -55.82 -13.64 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.038 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -90.5 8.94 79.01 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.18 88.84 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.204 -1.174 . . . . 0.0 109.856 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . . . -59.22 -24.34 63.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -52.15 -49.96 62.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' A' ' 25' ' ' VAL . 40.6 t -56.72 -56.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 110.109 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -41.7 -57.56 2.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.606 -0.684 . . . . 0.0 110.64 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -47.02 -48.87 21.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.37 -0.831 . . . . 0.0 110.232 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.7 OUTLIER -49.62 -70.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.523 -0.735 . . . . 0.0 109.854 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' CG ' HD12 ' A' ' 16' ' ' LEU . 3.8 mt -59.96 -48.73 80.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.641 0.734 . . . . 0.0 110.024 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.491 ' CD2' ' HG3' ' A' ' 70' ' ' PRO . 3.4 tm? -50.96 -69.53 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.692 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 62' ' ' LEU . 1.4 pp -53.01 -24.88 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 110.027 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.59 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.35 -55.36 5.46 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.481 -0.762 . . . . 0.0 109.319 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.02 44.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.563 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 63' ' ' LEU . . . -76.05 -158.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.019 -1.283 . . . . 0.0 109.117 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.55 74.63 3.21 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.357 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.491 ' HG3' ' CD2' ' A' ' 64' ' ' LEU . 55.8 Cg_endo -78.69 10.15 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.955 1.502 . . . . 0.0 110.351 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.487 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -139.53 -60.92 0.55 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.43 152.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.624 -0.672 . . . . 0.0 110.316 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB1' ' HG2' ' A' ' 80' ' ' ARG . . . -143.14 -161.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.316 -0.865 . . . . 0.0 110.512 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.6 140.17 25.18 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 110.267 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 1.32 9.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.453 1.239 . . . . 0.0 110.564 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.0 -39.39 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 109.631 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.523 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -128.98 2.07 5.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.49 -0.756 . . . . 0.0 110.279 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.3 mt 47.76 21.73 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.941 . . . . 0.0 111.684 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -59.08 102.81 0.14 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.926 -1.109 . . . . 0.0 109.115 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' CZ ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -77.89 159.1 76.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.757 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 42.2 Cg_endo -68.13 -13.92 39.36 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.154 1.607 . . . . 0.0 110.267 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.2 -28.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.569 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.487 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.3 m80 -70.74 -44.07 67.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.56 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.11 -47.05 45.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.732 -0.605 . . . . 0.0 110.982 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -62.2 -66.23 0.57 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.562 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.551 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -54.32 -43.4 71.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.449 -0.782 . . . . 0.0 110.592 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -46.38 -41.95 14.33 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.514 -0.741 . . . . 0.0 110.559 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.59 -2.27 45.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.195 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 75.99 47.25 11.69 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -115.87 95.2 5.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.304 -1.115 . . . . 0.0 111.18 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.424 HD23 ' CD2' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.3 -36.33 79.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.534 179.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 1.7 m-20 -50.46 -58.59 5.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 0.0 109.357 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 92.4 m -52.77 -44.48 66.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.491 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 5.9 tp -54.89 -53.22 58.3 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.32 -40.16 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.409 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.8 t -62.75 -40.41 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.38 -61.48 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.42 -17.66 3.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -39.01 66.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.382 -0.824 . . . . 0.0 110.963 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.455 ' CB ' HD12 ' A' ' 64' ' ' LEU . . . -118.98 70.83 0.83 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 111.457 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.65 90.78 0.01 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -143.94 82.5 1.72 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -1.167 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.16 143.81 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.51 -0.744 . . . . 0.0 110.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 mp -129.74 0.53 4.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.654 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.68 56.65 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.245 -0.909 . . . . 0.0 110.296 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.459 HG13 ' CG ' ' A' ' 80' ' ' ARG . 1.7 p -114.99 -164.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -147.37 140.33 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.518 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 110' ' ' TRP . 45.2 t0 -68.73 63.75 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 57.06 -77.17 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.4 m-90 -45.94 -70.7 0.09 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.728 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.36 -34.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -43.73 144.79 0.76 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.651 -0.911 . . . . 0.0 110.855 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.405 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -114.67 167.03 10.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.371 -0.831 . . . . 0.0 110.464 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.45 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 40.9 Cg_endo -68.61 -34.76 18.64 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.884 1.465 . . . . 0.0 110.563 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -80.77 -23.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.767 . . . . 0.0 110.337 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.78 -44.69 40.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.638 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.414 ' CD2' ' HA ' ' A' ' 114' ' ' PRO . 4.5 pp -63.0 -21.42 66.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.637 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.39 -49.91 13.88 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -31.02 28.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.159 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -86.69 -51.29 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.77 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.524 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -178.46 39.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 39.0 m-70 -120.05 49.19 1.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.383 -1.069 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -53.91 11.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.728 -0.608 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.13 -34.98 24.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.488 -0.758 . . . . 0.0 109.722 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -83.41 -35.73 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.151 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.33 94.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.513 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -55.23 20.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.383 -0.823 . . . . 0.0 109.446 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.424 ' CD2' HD23 ' A' ' 91' ' ' LEU . 20.5 t80 -55.19 -40.52 70.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.346 -0.846 . . . . 0.0 109.539 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HG ' ' CD2' ' A' ' 94' ' ' LEU . 12.1 mt -64.52 -50.48 67.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 109.312 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -53.23 -27.64 23.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 0.0 110.328 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.3 -42.8 20.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.48 -11.01 50.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.416 -0.802 . . . . 0.0 110.729 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -116.89 -25.68 7.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.35 109.27 2.81 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -100.32 70.19 0.47 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.2 t -53.36 135.64 38.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.339 -1.095 . . . . 0.0 110.007 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.15 170.18 16.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 110.525 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -151.21 -107.28 0.36 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.41 39.13 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.399 -1.06 . . . . 0.0 110.763 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.56 166.64 5.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.279 -0.888 . . . . 0.0 110.686 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.85 74.72 0.92 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.454 -0.779 . . . . 0.0 109.732 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -135.86 -43.96 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.494 -0.754 . . . . 0.0 110.125 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.07 142.89 34.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.819 . . . . 0.0 110.574 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 145' ' ' ILE . 1.0 OUTLIER -177.52 67.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.16 115.56 1.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.697 -0.627 . . . . 0.0 110.768 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 55.08 93.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 0.0 110.303 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.53 123.14 13.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.459 -0.776 . . . . 0.0 110.392 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -81.67 165.23 21.2 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 109.99 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 135.53 159.76 8.69 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -82.27 105.43 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.877 1.462 . . . . 0.0 110.329 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.24 -157.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.454 -0.779 . . . . 0.0 109.789 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -73.51 151.48 40.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 110.029 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.7 tt -178.9 93.83 0.21 Allowed Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.307 -0.87 . . . . 0.0 109.677 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.27 129.46 17.09 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.787 1.414 . . . . 0.0 110.777 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.07 179.838 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 tpt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.163 0.506 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.466 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -62.75 -55.0 42.44 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.344 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 47.6 Cg_endo -74.18 102.14 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.518 1.273 . . . . 0.0 110.435 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.7 48.66 2.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.106 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.73 72.4 0.26 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.594 -0.692 . . . . 0.0 110.529 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.88 -93.44 0.65 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t -134.78 -163.56 1.39 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.501 -0.999 . . . . 0.0 110.095 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.59 17.92 8.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.3 ttp -76.29 106.06 7.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.761 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.03 174.98 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.267 -0.896 . . . . 0.0 110.185 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.83 145.15 35.9 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.724 1.381 . . . . 0.0 110.237 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 15' ' ' TRP . 24.5 t -85.63 118.94 25.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -0.836 . . . . 0.0 109.857 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.13 -12.97 61.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 110.828 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.42 ' O ' ' HB ' ' A' ' 18' ' ' THR . 9.4 t70 -74.27 -5.56 42.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.252 -0.905 . . . . 0.0 110.524 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.445 ' HA ' ' CG2' ' A' ' 18' ' ' THR . 42.2 m0 -76.51 -8.27 56.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.211 -0.931 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.438 HD12 HD22 ' A' ' 63' ' ' LEU . 1.2 tp -79.41 -50.89 10.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.31 -0.869 . . . . 0.0 109.036 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.49 46.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -63.96 -40.66 96.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.934 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . . . -63.35 -45.5 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 108.894 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 59' ' ' VAL . . . -62.68 -54.3 41.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.95 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 51' ' ' VAL . . . -54.82 -22.03 13.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.548 -0.72 . . . . 0.0 110.979 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.94 27.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.943 . . . . 0.0 110.581 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.05 34.12 4.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 1.2 tpt180 -118.69 105.76 11.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.474 -1.015 . . . . 0.0 110.527 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.477 HG23 HG21 ' A' ' 59' ' ' VAL . 71.6 t -72.46 -56.93 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.299 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -48.92 -26.89 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.533 -0.729 . . . . 0.0 110.909 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 3.0 mm-40 -71.52 -44.73 64.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 108.84 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.447 ' CG1' HD22 ' A' ' 62' ' ' LEU . 22.7 t -75.75 -52.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -0.807 . . . . 0.0 109.103 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HD2' ' HB2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -43.57 -50.43 7.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.599 -0.688 . . . . 0.0 110.406 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -73.02 -48.84 32.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.597 -0.689 . . . . 0.0 109.99 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 13.5 mt -55.27 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 111.251 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.498 ' HB2' HD22 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -45.64 -49.42 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.0 111.537 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -68.98 -9.1 50.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 110.804 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -102.03 -23.2 14.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.937 -1.102 . . . . 0.0 111.261 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 162.5 -28.62 0.26 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.635 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' A' ' 31' ' ' LEU . . . -41.87 141.03 0.9 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.286 -1.126 . . . . 0.0 110.464 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 154.81 13.25 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.2 -38.9 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.818 1.431 . . . . 0.0 109.844 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 68' ' ' ALA . 7.9 m120 -122.63 -65.54 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.58 -0.7 . . . . 0.0 109.817 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.59 154.19 0.1 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.586 -0.696 . . . . 0.0 110.275 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.17 177.27 8.04 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.7 1.368 . . . . 0.0 110.171 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.7 155.62 47.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 110.077 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.42 16.14 18.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.5 23.18 34.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -110.14 174.5 5.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.498 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.8 mmp_? -86.49 165.45 33.06 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.0 Cg_endo -68.69 -12.6 35.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.773 1.407 . . . . 0.0 110.374 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 49' ' ' ILE . 5.9 mt -109.37 -36.67 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 108.731 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.46 -21.72 38.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.871 -1.143 . . . . 0.0 108.979 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 14.6 p -114.87 31.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.443 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.53 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -96.89 33.65 1.85 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 109.798 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.8 tmm? 72.5 -14.5 0.56 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.781 -0.574 . . . . 0.0 111.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.53 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 50.28 25.25 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.983 -1.073 . . . . 0.0 110.075 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -126.33 15.75 6.77 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.431 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -156.22 93.41 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 109.866 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.37 -22.74 33.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.347 -0.845 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.421 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -58.33 -39.57 79.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.458 -0.776 . . . . 0.0 110.16 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 20' ' ' ALA . 11.0 t -53.98 -65.17 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -52.72 -33.63 48.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HA ' HG12 ' A' ' 96' ' ' VAL . 19.4 tt0 -47.23 -42.15 19.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 32' ' ' LEU . 1.7 tp -82.7 -41.47 19.27 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -63.83 -62.87 1.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.629 -0.669 . . . . 0.0 109.739 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -48.54 -43.73 35.77 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.355 -0.841 . . . . 0.0 109.756 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.95 -43.16 91.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.183 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CG ' HD23 ' A' ' 32' ' ' LEU . 3.5 m80 -81.06 0.03 37.78 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.729 -0.607 . . . . 0.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.11 60.13 1.98 Allowed Glycine 0 N--CA 1.48 1.609 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 63' ' ' LEU . . . -66.83 -148.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.252 . . . . 0.0 109.014 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -115.17 52.75 0.76 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.867 . . . . 0.0 109.662 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' CD ' ' C ' ' A' ' 68' ' ' ALA . 48.6 Cg_endo -70.77 -31.32 16.24 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.461 1.243 . . . . 0.0 109.628 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.6 OUTLIER -82.85 -75.46 0.31 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.563 -0.711 . . . . 0.0 109.139 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.13 164.43 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.566 -0.709 . . . . 0.0 110.534 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.03 -126.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.027 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.2 m-20 -110.31 132.79 21.32 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.783 -1.198 . . . . 0.0 109.932 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.92 -9.91 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.313 1.165 . . . . 0.0 110.655 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.72 -74.63 0.42 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.377 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.449 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -100.3 9.11 43.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 110.473 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.3 mt 51.09 39.75 24.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -0.896 . . . . 0.0 110.318 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.19 96.21 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 110.019 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.58 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -73.19 148.58 88.83 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 110.636 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.58 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.7 Cg_endo -67.99 -14.49 41.25 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.699 1.368 . . . . 0.0 109.129 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 94.3 t -64.36 -31.51 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 26.1 m80 -67.74 -41.23 83.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.497 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 4.0 m-20 -52.35 -51.16 60.35 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.211 0.529 . . . . 0.0 110.58 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -53.52 -64.98 0.65 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.442 -0.787 . . . . 0.0 109.452 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.531 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -58.7 -27.9 65.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -49.61 68.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.15 -0.969 . . . . 0.0 110.591 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.84 4.5 53.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 110.321 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.521 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 71.89 36.33 61.29 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -102.53 83.25 2.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.358 -1.083 . . . . 0.0 110.87 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.436 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.88 -39.06 80.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.431 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . 1.2 m-20 -47.67 -37.43 12.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.502 -0.749 . . . . 0.0 110.006 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.7 m -64.3 -46.59 82.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.437 ' HG ' ' CB ' ' A' ' 85' ' ' ALA . 1.2 mp -63.3 -45.11 92.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 110.138 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 55.6 t -48.79 -44.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 61' ' ' GLU . 10.9 t -67.02 -45.4 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.689 . . . . 0.0 109.147 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -53.09 -43.34 66.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.448 -0.782 . . . . 0.0 109.859 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -83.49 -33.48 25.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.074 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.43 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 5.6 ttt85 -66.09 -11.22 47.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.556 -0.715 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.1 -67.71 0.66 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.082 -1.012 . . . . 0.0 111.071 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.57 107.1 0.23 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -167.29 117.07 0.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.452 -1.028 . . . . 0.0 110.271 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.8 113.88 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 1.1 mp -106.41 25.68 10.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 110.225 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 134' ' ' ALA . 1.6 p30 -128.79 47.71 2.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.365 -0.834 . . . . 0.0 110.59 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.441 HG12 ' CG ' ' A' ' 80' ' ' ARG . 1.6 p -112.14 -169.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.857 . . . . 0.0 109.961 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.422 ' N ' HG11 ' A' ' 106' ' ' VAL . 19.3 ptt180 -140.64 146.74 38.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.96 66.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 110.117 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.78 -84.9 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.611 -0.681 . . . . 0.0 110.67 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.506 ' N ' ' O ' ' A' ' 108' ' ' ASP . 23.9 p90 -122.94 15.16 9.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.98 -81.0 1.35 Allowed Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.79 -164.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.228 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 41.8 mt -95.79 163.42 21.27 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.75 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.3 Cg_endo -65.6 -19.14 60.26 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.88 1.463 . . . . 0.0 110.379 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.445 ' HA ' HD11 ' A' ' 130' ' ' LEU . 14.3 p -79.36 -36.59 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.824 . . . . 0.0 110.152 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.95 -39.66 87.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.854 . . . . 0.0 110.353 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 tt -69.04 -35.74 76.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.951 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.07 -55.96 26.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.531 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -60.52 -41.97 95.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.803 . . . . 0.0 110.473 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.18 -37.89 67.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 109.984 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.463 ' CB ' ' CD2' ' A' ' 123' ' ' HIS . 11.7 mt -86.47 -2.32 58.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 110.416 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.44 33.64 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 71.9 m-70 -102.77 46.18 0.93 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.89 -1.359 . . . . 0.0 109.56 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -45.82 -37.97 6.71 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.29 0.566 . . . . 0.0 110.346 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.15 -42.95 87.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.725 . . . . 0.0 109.195 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 13.6 t -76.09 -37.79 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.72 85.43 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -56.51 -61.34 2.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.905 . . . . 0.0 109.625 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -57.63 -24.92 59.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 109.454 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 115' ' ' VAL . 11.3 mt -75.73 -52.87 9.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.79 . . . . 0.0 109.545 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -23.28 2.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.814 . . . . 0.0 110.169 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.24 -57.43 3.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.981 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.45 -1.65 34.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 111.013 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 105' ' ' ASP . . . -106.97 -41.87 5.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.55 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.29 -103.18 2.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.08 95.85 0.64 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.5 p -89.01 17.31 5.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -1.078 . . . . 0.0 110.703 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -103.29 147.85 26.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.123 -0.985 . . . . 0.0 110.006 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 157.46 -99.33 0.18 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.3 p -171.46 172.87 4.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -1.01 . . . . 0.0 110.234 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 52.31 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.403 -0.811 . . . . 0.0 110.765 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -54.74 -90.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.358 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 48.41 26.17 1.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.091 -1.006 . . . . 0.0 110.476 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -80.48 146.66 31.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.909 . . . . 0.0 110.275 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 1.1 tt -74.3 146.68 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.891 . . . . 0.0 110.916 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 0.2 OUTLIER 173.34 53.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.366 -0.834 . . . . 0.0 109.929 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -173.67 86.85 0.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.371 -0.831 . . . . 0.0 109.949 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.41 114.83 1.34 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.253 -0.904 . . . . 0.0 110.454 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -81.76 148.35 28.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.772 . . . . 0.0 110.077 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 67.03 102.19 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.26 147.39 53.25 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.72 1.379 . . . . 0.0 110.592 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.7 m -96.19 114.44 26.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.382 -0.824 . . . . 0.0 110.243 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -65.11 156.54 31.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.355 -0.841 . . . . 0.0 110.457 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.1 mm -124.55 97.84 38.66 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 110.492 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.62 117.86 5.36 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.577 1.303 . . . . 0.0 110.08 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.893 -1.051 . . . . 0.0 110.317 -179.752 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.486 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -51.59 -55.84 26.11 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.366 -0.833 . . . . 0.0 109.924 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 5' ' ' ALA . 43.6 Cg_endo -72.13 72.68 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.647 1.341 . . . . 0.0 110.188 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -47.71 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.642 -0.661 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 3' ' ' PRO . . . 47.86 75.52 0.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.776 . . . . 0.0 110.329 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.12 -115.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -62.39 -71.75 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.491 -1.005 . . . . 0.0 110.843 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.9 m -101.32 146.75 27.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.302 -0.874 . . . . 0.0 110.684 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.5 tpp -46.25 -61.98 1.55 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.622 -0.673 . . . . 0.0 110.059 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 178.78 92.01 0.16 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.766 -0.583 . . . . 0.0 109.684 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.76 153.35 64.4 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.717 1.377 . . . . 0.0 110.409 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.24 137.14 35.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.338 -0.851 . . . . 0.0 110.141 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.498 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . . . -71.8 142.54 49.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' O ' ' OG1' ' A' ' 18' ' ' THR . 20.5 t70 -177.44 -50.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.385 -0.822 . . . . 0.0 110.133 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.446 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 31.1 m0 -40.19 -30.55 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.619 . . . . 0.0 111.012 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' CB ' ' A' ' 36' ' ' ALA . 9.8 mt -75.68 -54.57 6.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.512 -0.742 . . . . 0.0 109.144 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.41 69.43 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.783 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -73.9 -59.31 2.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.755 -0.591 . . . . 0.0 110.633 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.414 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -49.67 -54.43 18.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB3' HG13 ' A' ' 59' ' ' VAL . . . -47.73 -50.22 25.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -36.8 82.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.184 -0.947 . . . . 0.0 109.952 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.84 15.1 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.81 72.05 0.6 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 93.0 mtt180 -136.74 67.95 1.44 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.517 -0.99 . . . . 0.0 109.739 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.497 HG11 ' HD3' ' A' ' 29' ' ' ARG . 50.4 t -57.27 -62.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.451 -0.78 . . . . 0.0 110.058 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 25' ' ' VAL . 9.3 mt-10 -39.73 -36.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.75 -0.594 . . . . 0.0 110.943 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -72.34 -50.11 29.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.554 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.432 ' CG1' HD11 ' A' ' 62' ' ' LEU . 43.6 t -62.58 -38.87 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.181 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -55.2 -38.44 68.4 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.855 -1.153 . . . . 0.0 108.434 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.88 12.11 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.93 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 4.2 mt -56.35 -65.86 0.53 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 110.339 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 13.5 mt -43.42 -51.04 6.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.296 -0.877 . . . . 0.0 109.68 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 43.0 mt-10 -69.79 -15.25 63.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.61 -5.46 58.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.0 110.732 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.05 2.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -75.91 165.44 24.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.547 -0.972 . . . . 0.0 110.253 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.43 137.92 51.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 110.344 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.14 -40.8 0.58 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.888 1.467 . . . . 0.0 110.323 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 25.6 m120 -101.71 -83.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.653 -0.654 . . . . 0.0 110.087 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . . . 57.41 69.66 1.56 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 45.4 Cg_endo -71.44 101.97 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.048 1.552 . . . . 0.0 111.708 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 3.9 p30 -178.75 -156.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.52 -0.737 . . . . 0.0 109.706 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 1.1 t 61.72 85.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.42 -0.8 . . . . 0.0 109.747 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.597 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.1 m-85 65.89 8.37 5.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 109.836 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.13 23.57 52.71 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.555 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 16.2 mmt-85 -99.62 35.49 1.98 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.07 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.498 ' CB ' ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 53.23 -178.34 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 47' ' ' ARG . 55.7 Cg_endo -82.58 -29.27 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.426 1.224 . . . . 0.0 111.337 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.494 HG13 ' CB ' ' A' ' 68' ' ' ALA . 6.4 mt -107.47 -35.53 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.498 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 20.4 tt0 -60.51 -11.72 7.79 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.019 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 12.9 p -105.79 3.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.873 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -73.11 166.28 23.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.967 -1.083 . . . . 0.0 109.024 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.3 ttm -63.87 -6.74 6.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.355 -0.841 . . . . 0.0 111.204 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.466 ' HE2' ' CB ' ' A' ' 84' ' ' ASP . 8.5 mmt 56.1 17.22 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.885 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.47 -0.65 24.82 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.533 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -139.32 88.74 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -1.027 . . . . 0.0 109.873 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -53.35 -24.55 12.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.314 -0.867 . . . . 0.0 110.651 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -48.23 70.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 108.84 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 56' ' ' SER . 67.3 t -52.4 -49.5 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -51.71 -53.51 38.54 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -49.23 -47.11 46.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.715 -0.615 . . . . 0.0 110.04 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -56.26 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 110.176 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD22 HD13 ' A' ' 32' ' ' LEU . 69.1 mt -53.67 -49.85 67.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.481 -0.762 . . . . 0.0 110.396 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.519 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -50.7 -69.19 0.12 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.427 -0.796 . . . . 0.0 111.045 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -51.26 -22.32 2.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.412 -0.805 . . . . 0.0 109.697 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -83.87 -49.11 9.34 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.646 -0.659 . . . . 0.0 109.596 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 154.51 39.07 0.02 OUTLIER Glycine 0 N--CA 1.478 1.46 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.744 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 49' ' ' ILE . . . -71.09 -173.94 0.9 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.557 -1.555 . . . . 0.0 108.593 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 3.6 mt-10 -113.72 64.71 1.17 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.072 -1.017 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 46.3 Cg_endo -70.77 -10.31 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.093 1.575 . . . . 0.0 109.857 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.469 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 10.2 t-20 -107.89 -29.06 9.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -0.774 . . . . 0.0 109.688 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 158.71 16.94 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.652 -0.655 . . . . 0.0 110.099 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB1' ' CD ' ' A' ' 80' ' ' ARG . . . -137.24 -145.92 0.21 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.409 -0.807 . . . . 0.0 110.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.9 143.05 26.1 Favored Pre-proline 0 C--N 1.306 -1.304 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.31 -12.22 23.0 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.82 1.432 . . . . 0.0 110.019 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.86 -71.22 0.46 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.573 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -103.04 -2.53 27.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 111.017 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 mt 63.58 20.92 12.5 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.224 -0.923 . . . . 0.0 111.282 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.7 m -65.51 97.03 0.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.572 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 11.9 mmt85 -69.62 164.21 52.44 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.148 -0.97 . . . . 0.0 109.217 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.509 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -67.18 -21.46 48.39 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.879 1.463 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 103' ' ' ARG . 13.4 t -59.99 -27.26 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.567 0.699 . . . . 0.0 109.491 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.511 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.1 m80 -80.47 -32.09 37.23 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.466 ' CB ' ' HE2' ' A' ' 54' ' ' MET . 5.0 m-20 -61.07 -43.03 99.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' CB ' HG23 ' A' ' 93' ' ' THR . . . -60.32 -64.41 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.368 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.591 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -59.59 -35.32 74.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.516 -0.74 . . . . 0.0 110.107 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -45.41 -55.88 5.6 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.249 -0.907 . . . . 0.0 110.717 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.64 5.02 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 72.74 27.72 68.56 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 1.6 t80 -94.99 103.75 15.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.304 -1.115 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.96 -43.69 34.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.862 -0.524 . . . . 0.0 110.807 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.532 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.1 m-20 -44.39 -34.89 2.16 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.547 0.689 . . . . 0.0 109.748 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.44 HG23 ' CB ' ' A' ' 85' ' ' ALA . 95.2 m -66.37 -39.89 89.41 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.338 0.589 . . . . 0.0 109.901 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 91' ' ' LEU . 1.0 OUTLIER -64.02 -58.28 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 40.0 t -38.21 -53.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.732 -0.605 . . . . 0.0 110.208 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 64' ' ' LEU . 24.7 t -55.74 -56.34 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.783 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -44.35 -44.35 8.17 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.351 -0.843 . . . . 0.0 110.509 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -82.4 -26.87 32.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.1 ttt85 -65.05 -10.3 28.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.697 -0.627 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.11 -68.7 0.58 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 111.153 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.12 107.85 0.25 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 97' ' ' LEU . . . -152.39 -155.61 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.572 -0.958 . . . . 0.0 109.629 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.468 ' O ' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -162.63 105.92 1.1 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.9 OUTLIER -98.9 68.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.585 -0.697 . . . . 0.0 110.812 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -175.34 42.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.498 HG13 ' HG3' ' A' ' 80' ' ' ARG . 1.4 p -107.16 -175.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 109' ' ' ALA . 2.5 mtp85 -125.8 133.83 51.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -67.05 64.23 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.752 -0.592 . . . . 0.0 110.197 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . 57.87 -80.85 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.449 -0.782 . . . . 0.0 110.947 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.573 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.2 m-90 -45.68 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.0 110.266 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.24 73.05 0.06 OUTLIER Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -134.34 -164.02 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.395 -1.062 . . . . 0.0 109.884 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -153.07 166.48 15.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.6 Cg_endo -70.33 -54.9 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.875 1.46 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.478 ' HA ' HD11 ' A' ' 130' ' ' LEU . 4.2 p -62.16 -26.03 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.626 -0.671 . . . . 0.0 110.482 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.473 ' N ' HG11 ' A' ' 115' ' ' VAL . 12.7 t0 -62.38 -30.24 71.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.449 -0.782 . . . . 0.0 110.494 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -44.31 18.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 109.666 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . . . -52.84 -47.03 68.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 127' ' ' ALA . 64.5 mm-40 -63.98 -35.0 79.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.024 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.48 -25.07 50.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.772 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.61 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 42.6 mt -101.7 2.57 38.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.44 43.51 24.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 20.4 m-70 -106.63 55.52 0.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.086 -1.244 . . . . 0.0 110.154 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 12.4 mmt180 -41.05 -57.31 2.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.843 -0.536 . . . . 0.0 110.418 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -43.59 -43.98 5.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.555 HG13 ' CB ' ' A' ' 86' ' ' ALA . 1.4 t -86.9 -50.96 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.353 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 119' ' ' GLU . . . -49.94 -50.69 45.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -62.24 -66.12 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.445 ' CD2' HD23 ' A' ' 91' ' ' LEU . 56.6 t80 -47.66 -40.58 20.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.717 . . . . 0.0 109.844 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 134' ' ' ALA . 10.0 mt -60.24 -54.12 49.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.659 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -45.28 -36.72 4.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.565 -0.709 . . . . 0.0 110.656 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.82 62.3 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.408 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -83.56 -1.22 53.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.714 -0.616 . . . . 0.0 110.602 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -112.11 -19.35 12.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 110.283 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.8 -121.96 0.58 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 110.45 -10.76 30.75 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.7 p -153.46 -63.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -1.202 . . . . 0.0 110.126 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.18 155.3 34.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.101 -0.999 . . . . 0.0 110.023 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.07 86.37 0.11 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.68 -62.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -1.173 . . . . 0.0 110.959 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -138.27 -64.34 0.53 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.087 -1.008 . . . . 0.0 110.948 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -89.07 66.91 7.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.783 . . . . 0.0 110.003 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.27 144.43 2.82 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.402 -0.811 . . . . 0.0 110.211 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.421 ' HG2' HG21 ' A' ' 145' ' ' ILE . 25.0 ttt180 -59.05 161.84 4.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.274 -0.891 . . . . 0.0 110.126 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.421 HG21 ' HG2' ' A' ' 144' ' ' ARG . 1.3 tt -42.34 150.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.66 -0.65 . . . . 0.0 111.156 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 0.9 OUTLIER 174.14 85.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.708 -0.62 . . . . 0.0 109.88 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 57.26 -169.12 0.11 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.168 -0.957 . . . . 0.0 110.184 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 149' ' ' GLU . . . 58.02 -168.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.192 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -58.6 -153.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.603 -0.686 . . . . 0.0 109.993 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.18 152.12 8.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.74 135.89 24.53 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.558 1.294 . . . . 0.0 109.894 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 154' ' ' ILE . 2.0 t -177.08 84.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.454 -0.779 . . . . 0.0 110.395 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.49 148.58 3.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.281 -0.887 . . . . 0.0 109.707 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 152' ' ' SER . 4.0 mt -127.71 77.32 76.34 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.048 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.3 119.96 5.47 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 124.225 1.645 . . . . 0.0 110.613 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 t70 . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.692 179.54 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.181 0.515 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.19 148.18 39.52 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.64 -175.58 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.754 1.397 . . . . 0.0 110.299 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.78 86.21 1.98 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.423 -0.798 . . . . 0.0 110.211 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.03 -167.02 0.78 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.426 -0.797 . . . . 0.0 110.301 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.25 -173.7 16.1 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t 52.42 74.22 0.29 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.319 -1.106 . . . . 0.0 110.352 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.91 -34.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.34 -0.85 . . . . 0.0 110.368 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 71.3 mmm -85.75 -16.3 39.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.968 . . . . 0.0 110.308 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -172.9 112.71 0.36 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.391 -0.818 . . . . 0.0 109.508 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.61 80.74 1.1 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.436 1.23 . . . . 0.0 110.683 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.96 12.16 36.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.924 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.07 64.2 0.34 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.938 . . . . 0.0 109.918 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 18' ' ' THR . 16.6 p30 -91.59 17.51 8.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.429 -0.794 . . . . 0.0 110.175 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.473 ' HB3' HD11 ' A' ' 31' ' ' LEU . 42.3 m0 -45.49 -43.6 11.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.593 -0.692 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.445 HD11 ' CD2' ' A' ' 32' ' ' LEU . 12.4 mt -58.1 -58.61 7.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.0 109.158 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.4 -51.64 66.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.729 -0.607 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -51.51 -66.14 0.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.342 -0.849 . . . . 0.0 110.845 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' ARG . . . -58.47 -52.2 66.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.98 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' CB ' HG12 ' A' ' 59' ' ' VAL . . . -50.4 -58.31 6.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.358 -0.839 . . . . 0.0 110.399 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -52.58 -24.55 8.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.798 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.2 7.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.43 47.81 61.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 10.6 mtt180 -118.62 73.03 0.9 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.443 -1.034 . . . . 0.0 109.896 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG13 ' CB ' ' A' ' 58' ' ' ARG . 49.2 t -60.59 -60.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.334 -0.854 . . . . 0.0 111.125 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -47.63 -35.19 8.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 110.969 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -70.29 -39.41 74.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.277 -0.889 . . . . 0.0 109.584 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.435 ' CG1' HD22 ' A' ' 62' ' ' LEU . 39.1 t -76.13 -49.84 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.187 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -42.32 -46.51 4.61 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.446 -0.784 . . . . 0.0 110.039 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -72.39 -51.86 18.58 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.852 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 15' ' ' TRP . 60.4 mt -51.99 -66.88 0.31 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.542 -0.724 . . . . 0.0 110.964 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.516 HD12 ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -41.51 -59.24 1.66 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.707 -0.621 . . . . 0.0 111.282 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -13.44 61.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.822 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -85.04 -6.93 59.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.97 -1.082 . . . . 0.0 110.86 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.51 -10.29 6.45 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.535 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 32' ' ' LEU . . . -50.92 143.6 9.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.274 . . . . 0.0 110.264 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 37' ' ' LEU . 5.8 mp -59.82 153.77 51.57 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.395 -0.816 . . . . 0.0 109.957 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.02 -56.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.679 1.357 . . . . 0.0 110.932 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -96.96 -66.97 0.87 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.11 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.34 101.55 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.17 122.41 9.47 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.579 1.305 . . . . 0.0 110.705 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -103.87 -166.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.592 -0.693 . . . . 0.0 109.739 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.1 38.5 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.287 -0.883 . . . . 0.0 110.519 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 18.9 m-85 -122.49 13.75 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.82 49.78 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HD3' ' HB3' ' A' ' 44' ' ' TYR . 2.9 ptm180 -159.73 131.67 6.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -1.143 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.605 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.86 -173.66 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.668 -0.645 . . . . 0.0 110.169 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.5 Cg_endo -64.44 -173.7 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.196 1.103 . . . . 0.0 111.467 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 3.2 mt 62.97 -64.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.6 tt0 -48.08 -25.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.001 -1.062 . . . . 0.0 109.344 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 12.5 p -120.7 34.18 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.611 -0.681 . . . . 0.0 109.556 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.51 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -94.11 38.25 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.0 110.068 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.434 ' CB ' ' O ' ' A' ' 52' ' ' MET . 7.5 tmm? 66.98 -10.62 0.3 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.509 -0.745 . . . . 0.0 110.751 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.51 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 48.56 27.76 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.989 -1.069 . . . . 0.0 110.127 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.454 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -133.05 13.76 4.95 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m -144.13 78.13 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -1.044 . . . . 0.0 109.941 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . . . -50.63 -29.53 11.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 110.006 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.41 ' CB ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -56.91 -31.53 65.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.618 -0.677 . . . . 0.0 109.464 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.473 HG12 ' CB ' ' A' ' 20' ' ' ALA . 53.1 t -58.59 -65.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.082 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -50.76 -39.21 51.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 110.22 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.479 ' HA ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -51.44 -36.91 46.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.189 -0.945 . . . . 0.0 110.038 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 29' ' ' ARG . 6.9 tp -89.97 -43.8 10.31 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.455 -0.778 . . . . 0.0 109.158 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' CD2' HD11 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -63.7 -55.59 22.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.19 -47.36 85.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.335 -0.853 . . . . 0.0 109.7 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -52.54 -28.35 20.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.213 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.516 ' CG ' HD12 ' A' ' 32' ' ' LEU . 1.1 m-70 -93.36 -41.36 9.88 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.551 -0.718 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.34 47.49 0.04 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.593 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 49' ' ' ILE . . . -67.01 -149.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.008 -1.29 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.473 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 3.1 pt-20 -116.71 56.71 1.59 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.981 . . . . 0.0 110.872 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 40.1 Cg_endo -68.28 -15.04 41.86 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.635 1.334 . . . . 0.0 109.886 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -110.27 -77.9 0.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.528 -0.733 . . . . 0.0 110.095 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -43.0 145.04 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 110.95 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.72 -143.0 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 11.3 m-20 -112.58 134.44 21.64 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 109.978 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.54 -19.91 36.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.489 1.257 . . . . 0.0 110.062 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.54 -76.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 108.915 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 69.6 p -122.36 36.15 4.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.931 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.7 mt 48.17 34.13 4.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.498 -0.751 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.0 101.67 0.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.44 ' CZ ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -85.36 173.18 7.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.47 -11.62 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.07 1.563 . . . . 0.0 110.14 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.91 -30.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 26.6 m80 -73.1 -47.03 47.92 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 20.6 m-20 -47.28 -47.0 25.24 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.894 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.16 -59.98 4.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.827 . . . . 0.0 109.669 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.584 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -61.07 -51.52 68.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.399 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.443 ' HD3' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -41.88 -30.54 0.26 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.522 -0.736 . . . . 0.0 111.058 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.12 -18.89 15.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 110.391 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.84 23.81 34.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.454 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -97.0 85.02 3.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -1.067 . . . . 0.0 111.018 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -58.89 -38.39 78.74 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -50.67 -36.99 38.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.3 m -62.96 -47.96 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.404 HD12 HG12 ' A' ' 126' ' ' VAL . 1.4 mp -60.84 -43.61 98.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.488 -0.758 . . . . 0.0 109.68 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.71 -47.67 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.366 -0.834 . . . . 0.0 109.183 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.536 HG13 HD11 ' A' ' 64' ' ' LEU . 45.2 t -60.02 -48.12 89.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 1.7 mp -54.98 -40.96 70.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -82.9 -33.11 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.084 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -65.69 -12.2 51.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -0.775 . . . . 0.0 110.439 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.84 -82.15 0.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.715 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.71 56.04 0.13 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . . . -105.7 122.62 46.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -1.132 . . . . 0.0 110.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -54.87 162.13 1.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 109.849 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.59 36.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.301 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -150.64 40.63 0.75 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 111.34 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' A' ' 80' ' ' ARG . 5.1 p -97.87 -176.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HG3' ' C ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -130.2 146.93 51.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.341 -0.849 . . . . 0.0 109.681 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 110' ' ' TRP . 15.1 p-10 -74.53 50.36 0.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 109.851 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 61.66 -60.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.694 -0.628 . . . . 0.0 110.795 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.555 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.41 -54.94 14.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.62 -25.4 0.75 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -60.87 -174.15 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.228 -1.16 . . . . 0.0 110.697 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.451 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -138.55 175.46 3.32 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 46.5 Cg_endo -73.48 -47.61 0.29 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.539 1.284 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 130' ' ' LEU . 9.2 p -54.46 -33.0 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 0.0 109.1 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -37.72 69.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.639 -0.663 . . . . 0.0 109.321 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -30.78 67.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.217 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 127' ' ' ALA . . . -69.38 -53.41 19.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.49 ' N ' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -65.37 -16.13 63.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.431 -0.793 . . . . 0.0 110.06 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -38.4 36.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.502 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 5.1 mt -92.23 1.46 57.2 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 110.955 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.06 12.87 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.617 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 80.3 m-70 -95.78 46.69 1.09 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.974 -1.309 . . . . 0.0 109.318 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -43.79 -38.1 3.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.747 -0.595 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.419 ' HB2' HD13 ' A' ' 91' ' ' LEU . 15.9 p-10 -64.23 -40.8 96.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.371 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -82.94 -40.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.49 ' HB3' ' N ' ' A' ' 119' ' ' GLU . . . -57.51 -53.89 53.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.082 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 mtt-85 -52.99 -59.75 4.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 110.264 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -59.32 -39.88 84.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 126' ' ' VAL . 12.6 mt -60.06 -30.66 69.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -67.6 -36.74 81.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.875 . . . . 0.0 109.634 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.13 -35.88 36.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.448 -0.782 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.08 23.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.0 110.119 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . -102.17 18.9 19.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 0.0 110.091 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.01 128.87 9.44 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.77 23.56 0.92 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.08 118.36 6.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.23 -1.159 . . . . 0.0 110.312 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 75.09 2.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.462 -0.774 . . . . 0.0 109.949 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 59.6 -145.33 45.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.7 p -147.75 95.42 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -1.13 . . . . 0.0 110.113 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.23 -62.77 1.48 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 110.376 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.56 -57.65 1.27 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -0.929 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.09 109.09 4.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.821 . . . . 0.0 110.249 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.5 ttp85 -48.34 125.81 10.17 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.691 -0.631 . . . . 0.0 110.319 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 60.0 mt 57.14 164.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.517 -0.74 . . . . 0.0 110.048 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.5 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.68 99.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.266 -0.896 . . . . 0.0 110.374 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.35 130.21 45.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.422 -0.799 . . . . 0.0 110.185 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.49 148.97 22.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.38 144.67 1.22 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.4 134.99 25.7 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.632 1.333 . . . . 0.0 110.541 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.1 m -111.22 -20.86 12.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.502 -0.749 . . . . 0.0 110.711 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -51.1 157.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.387 -0.821 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mt -110.32 88.94 7.91 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.335 -0.853 . . . . 0.0 109.977 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 113.69 3.83 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.774 1.407 . . . . 0.0 110.637 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.243 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.052 0.453 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -176.75 124.02 0.29 Allowed Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.194 -0.941 . . . . 0.0 110.122 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.66 128.86 9.68 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.477 1.251 . . . . 0.0 110.508 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.2 68.18 0.48 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.441 -0.787 . . . . 0.0 110.309 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.69 83.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.428 -0.795 . . . . 0.0 110.032 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.47 -177.28 41.43 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.0 m -118.46 169.05 10.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.936 . . . . 0.0 109.56 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.4 m 51.18 51.26 17.34 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.64 9.47 5.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.771 -0.581 . . . . 0.0 110.305 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.38 67.12 4.81 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.318 -0.864 . . . . 0.0 110.457 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.9 -179.65 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.774 1.408 . . . . 0.0 110.105 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 m -112.46 -22.52 10.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.174 -0.954 . . . . 0.0 110.635 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.76 -26.81 15.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.109 -0.994 . . . . 0.0 110.436 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -80.12 10.44 4.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.452 -0.78 . . . . 0.0 110.427 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.491 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 16.2 m0 -69.88 -5.5 26.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.454 HD21 HG12 ' A' ' 28' ' ' VAL . 30.7 mt -76.62 -54.33 6.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.981 -1.074 . . . . 0.0 109.689 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -66.16 -33.04 74.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.73 -0.606 . . . . 0.0 110.513 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -71.84 -59.99 2.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 15' ' ' TRP . . . -55.86 -47.73 76.79 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.887 -1.133 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -47.95 -62.89 1.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.449 -0.782 . . . . 0.0 110.186 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -51.34 -24.25 4.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.233 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -90.27 28.86 1.34 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.521 -0.737 . . . . 0.0 111.028 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.29 43.48 9.77 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.483 ' HD2' ' HB3' ' A' ' 22' ' ' ARG . 1.7 mtt180 -122.91 96.66 5.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.435 -1.038 . . . . 0.0 109.661 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 60.1 t -82.05 -55.48 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.07 -33.22 1.4 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.668 -0.645 . . . . 0.0 111.685 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.572 ' O ' ' HB3' ' A' ' 31' ' ' LEU . 1.3 mt-10 -67.77 -65.87 0.64 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.896 -1.127 . . . . 0.0 108.621 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 32' ' ' LEU . 6.7 t -58.01 -44.47 87.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.5 tpt85 -47.51 -48.93 27.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.947 -1.096 . . . . 0.0 110.31 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.37 -51.28 5.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -58.28 -40.64 82.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HB2' HG11 ' A' ' 28' ' ' VAL . 6.6 tt -67.92 -47.69 68.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.338 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -59.93 -15.14 19.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.0 110.407 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.33 -62.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.71 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.14 28.1 0.08 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -70.17 167.37 17.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 110.469 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' O ' ' CD1' ' A' ' 16' ' ' LEU . 4.0 mm? -98.23 134.22 22.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.846 . . . . 0.0 110.975 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 44.6 Cg_endo -71.6 -22.95 23.68 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.587 1.309 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -129.81 53.92 1.88 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.578 -0.701 . . . . 0.0 109.279 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.06 145.91 44.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.612 -0.68 . . . . 0.0 111.051 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.44 136.9 29.63 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.95 1.5 . . . . 0.0 109.92 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 8.7 m-80 -100.71 -161.8 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -0.889 . . . . 0.0 110.562 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.24 13.34 16.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.488 -0.757 . . . . 0.0 110.246 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -149.1 27.12 0.86 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 110.137 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.86 56.29 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.501 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -115.27 96.48 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.534 -0.98 . . . . 0.0 110.138 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 29.0 mmt-85 -52.27 171.89 0.19 Allowed Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.332 -0.855 . . . . 0.0 110.45 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' O ' ' HB ' ' A' ' 49' ' ' ILE . 38.9 Cg_endo -65.89 166.68 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.566 1.298 . . . . 0.0 110.215 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 52' ' ' MET . 1.2 mt 64.21 -64.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.808 -0.557 . . . . 0.0 109.625 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' PRO . 17.7 tt0 -45.55 -27.61 0.78 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.861 -1.149 . . . . 0.0 109.35 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.501 ' HB ' ' CG ' ' A' ' 46' ' ' ARG . 9.9 p -117.35 43.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.313 -0.867 . . . . 0.0 110.541 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -104.08 33.65 3.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 109.173 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.456 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 9.7 ttp 70.76 -6.62 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.883 -0.511 . . . . 0.0 110.318 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.554 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.92 25.78 0.11 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.0 110.736 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.28 19.16 4.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.02 75.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.455 -1.026 . . . . 0.0 109.697 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.492 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -45.03 -27.48 0.56 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.895 . . . . 0.0 109.756 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -49.84 20.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.654 -0.654 . . . . 0.0 109.503 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG2' HG23 ' A' ' 25' ' ' VAL . 62.9 t -56.61 -64.29 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -0.758 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 61' ' ' GLU . . . -44.54 -52.16 8.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.432 -0.792 . . . . 0.0 109.827 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.456 ' O ' HD21 ' A' ' 65' ' ' LEU . 7.0 tm-20 -41.75 -53.38 3.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.517 HD21 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -59.57 -53.44 58.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.671 -0.643 . . . . 0.0 109.992 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -65.31 -50.9 63.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.588 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -48.88 -59.4 3.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.797 . . . . 0.0 110.424 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 1.2 pp -57.67 -23.32 50.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.077 -1.015 . . . . 0.0 108.776 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.538 ' CD2' ' CD2' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -86.76 -3.12 59.01 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.639 -0.663 . . . . 0.0 109.915 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 84.92 46.91 5.5 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' CB ' HG13 ' A' ' 49' ' ' ILE . . . -64.26 -146.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -1.164 . . . . 0.0 109.301 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 2.0 tp10 -120.72 64.36 11.58 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.04 -35.23 4.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.916 1.482 . . . . 0.0 110.468 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 3.5 m-80 -85.28 -69.3 0.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.294 -0.879 . . . . 0.0 110.242 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.453 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.3 t -48.71 144.02 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -0.757 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.92 -152.83 0.53 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.512 -0.743 . . . . 0.0 109.815 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.65 149.51 37.53 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.205 -0.934 . . . . 0.0 109.823 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.88 -21.42 24.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.645 1.339 . . . . 0.0 109.098 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.09 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.72 -0.613 . . . . 0.0 109.593 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 27.2 p -133.48 40.98 3.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.445 -0.784 . . . . 0.0 109.079 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mt 41.82 42.8 2.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.729 -0.607 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 m -78.7 103.5 8.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.579 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -76.4 155.13 83.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 109.388 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 39.5 Cg_endo -64.57 -15.67 51.16 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.422 1.222 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 114' ' ' PRO . 11.1 t -61.07 -33.29 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 87' ' ' ARG . 7.4 m80 -71.72 -35.36 70.16 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.554 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -54.84 -46.89 74.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -57.99 -58.09 9.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.458 -0.776 . . . . 0.0 109.384 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HB1' HD13 ' A' ' 130' ' ' LEU . . . -69.67 -15.83 63.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.7 tpt180 -80.81 -22.73 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.52 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -112.32 -12.93 13.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 110.134 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' CE1' ' A' ' 123' ' ' HIS . . . 80.99 61.02 2.18 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.492 ' CE1' ' HB1' ' A' ' 57' ' ' ALA . 1.2 t80 -135.97 86.08 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -1.069 . . . . 0.0 110.335 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.452 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.2 OUTLIER -60.36 -40.52 91.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 111.047 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -45.7 -37.14 5.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.83 . . . . 0.0 109.851 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.412 HG22 ' CE ' ' A' ' 52' ' ' MET . 8.5 m -73.8 -42.81 60.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.498 -0.751 . . . . 0.0 109.417 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.49 -45.51 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.662 0.744 . . . . 0.0 109.203 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 92' ' ' ASP . 6.5 t -60.31 -50.34 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -48.26 -44.32 33.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.512 -0.743 . . . . 0.0 110.141 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -84.94 -36.91 21.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.258 -0.901 . . . . 0.0 110.58 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -59.52 -15.12 15.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.2 -81.64 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.662 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.33 106.15 0.27 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . . . -159.06 120.87 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.372 -1.075 . . . . 0.0 110.378 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.543 ' HD3' ' NH1' ' A' ' 80' ' ' ARG . 41.6 ttt85 -74.71 102.08 4.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.513 -0.742 . . . . 0.0 110.073 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 1.2 mp -98.31 56.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.25 -0.906 . . . . 0.0 110.396 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -162.36 50.79 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.874 -1.141 . . . . 0.0 110.7 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG1' ' HD2' ' A' ' 80' ' ' ARG . 2.5 p -111.61 -169.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.929 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.41 ' HG2' HD22 ' A' ' 113' ' ' LEU . 20.0 mtt180 -127.95 138.25 52.56 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.529 -0.732 . . . . 0.0 109.967 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.4 m-20 -75.34 57.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 110.264 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 57.65 -69.56 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.704 -0.623 . . . . 0.0 111.376 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.566 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.03 -50.49 36.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.328 -0.858 . . . . 0.0 110.425 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.48 -21.33 0.83 Allowed Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -49.27 168.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.416 -1.049 . . . . 0.0 110.778 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 30.9 mt -131.68 167.75 20.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -69.6 -42.19 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.7 1.368 . . . . 0.0 109.699 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 116' ' ' ASP . 5.7 p -71.25 -25.73 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 110.203 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t70 -67.68 -58.19 5.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.57 -60.03 2.41 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.445 -0.784 . . . . 0.0 110.653 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 86' ' ' ALA . . . -47.22 -53.1 14.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -31.25 64.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -26.91 46.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.049 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.52 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 12.4 mt -92.66 -0.72 57.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.72 23.95 40.52 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.52 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 15.6 m170 -95.33 49.34 1.19 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.268 -1.136 . . . . 0.0 109.704 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' HIS . 10.7 mmm-85 -43.16 -33.71 0.96 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.527 -0.733 . . . . 0.0 109.616 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -46.4 79.7 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 123' ' ' HIS . 2.4 t -82.81 -34.85 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.478 -0.763 . . . . 0.0 109.544 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.1 -51.36 61.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 108.961 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -64.65 -52.5 57.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.655 -0.653 . . . . 0.0 109.482 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.471 ' C ' ' CD1' ' A' ' 129' ' ' TYR . 7.7 t80 -50.76 -40.08 53.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.41 -0.807 . . . . 0.0 109.136 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.478 HD13 ' HB1' ' A' ' 86' ' ' ALA . 24.0 mt -65.57 -53.51 40.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.695 -0.628 . . . . 0.0 109.587 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -21.32 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.123 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.26 -54.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 110.566 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.94 56.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -98.96 -24.18 15.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.755 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.54 143.93 43.14 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.96 -7.89 76.88 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 55.1 p -113.22 62.49 0.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -1.235 . . . . 0.0 110.532 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -69.99 105.23 2.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.352 -0.842 . . . . 0.0 109.947 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.84 87.18 1.75 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.97 75.6 0.91 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.359 -1.083 . . . . 0.0 110.003 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -176.95 51.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 0.0 109.876 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.57 -177.05 6.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.385 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.93 110.21 22.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.632 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -171.79 73.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.862 . . . . 0.0 109.881 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 pp -60.47 150.0 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.321 -0.862 . . . . 0.0 110.206 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.06 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.387 -0.821 . . . . 0.0 109.971 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -164.53 78.87 0.36 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 110.422 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 53.61 178.69 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.375 -0.828 . . . . 0.0 110.341 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -121.62 -14.69 8.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 134.47 -115.16 1.4 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.15 144.21 33.26 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.578 1.304 . . . . 0.0 109.975 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.7 m -72.08 133.88 45.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 0.0 110.99 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.63 96.44 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.197 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 12.4 tt -112.49 79.27 2.99 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 110.293 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.65 152.37 53.42 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 124.113 1.586 . . . . 0.0 110.575 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.221 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.264 0.554 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.11 149.16 39.31 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.432 -0.793 . . . . 0.0 109.936 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.44 87.22 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.758 1.399 . . . . 0.0 110.765 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.4 62.44 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.125 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.22 66.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.467 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.4 135.38 5.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 p -123.31 21.02 9.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.42 -1.047 . . . . 0.0 110.274 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.4 134.18 8.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.323 -0.86 . . . . 0.0 109.991 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -67.59 135.17 52.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.342 -0.849 . . . . 0.0 109.844 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.88 139.02 93.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.799 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.6 89.57 0.72 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.579 1.305 . . . . 0.0 109.992 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 t -49.9 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.524 -0.735 . . . . 0.0 110.028 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -50.92 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.801 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -136.49 -16.84 1.55 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.593 -0.692 . . . . 0.0 110.795 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.447 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 24.6 m0 -52.05 -52.2 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.996 -1.065 . . . . 0.0 110.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -51.01 -27.49 7.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.26 -0.9 . . . . 0.0 109.899 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.68 -44.04 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 0.0 109.492 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -65.86 -44.55 85.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.65 -45.86 88.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.537 ' HB3' HG13 ' A' ' 59' ' ' VAL . . . -58.61 -44.54 89.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.909 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.63 -30.03 71.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.555 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -97.61 22.38 9.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.432 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.39 60.64 6.59 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 67.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -1.085 . . . . 0.0 110.464 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 64.0 t -52.53 -58.92 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -43.12 -41.62 3.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.713 -0.617 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HG3' HD13 ' A' ' 31' ' ' LEU . 3.3 tp10 -66.4 -46.55 76.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 62' ' ' LEU . 22.1 t -70.24 -41.03 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.325 -0.86 . . . . 0.0 110.893 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 24.9 mmm-85 -51.0 -46.01 61.37 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.186 -0.946 . . . . 0.0 109.93 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.43 -43.45 32.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 0.0 109.956 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD13 ' HG3' ' A' ' 27' ' ' GLU . 1.4 mt -57.78 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 62' ' ' LEU . 12.4 mt -53.25 -44.49 68.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 0.0 110.048 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.19 -16.04 63.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.862 . . . . 0.0 109.917 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.21 -9.79 55.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 110.311 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 22.95 3.53 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -62.04 134.96 57.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -1.221 . . . . 0.0 109.906 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 3.6 tp -83.3 116.87 66.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -71.74 -41.74 2.05 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.671 1.353 . . . . 0.0 110.489 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.83 48.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.02 118.57 67.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.72 94.99 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.618 1.325 . . . . 0.0 110.524 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -78.44 179.29 7.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 110.005 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -90.93 23.11 3.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.441 ' CD1' ' HD2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -113.66 -19.05 11.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.73 37.11 93.02 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 47' ' ' ARG . 32.6 mtt-85 -124.34 31.62 5.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -1.12 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 12.7 mmt-85 49.32 177.31 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.522 -0.736 . . . . 0.0 110.585 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 51.6 Cg_endo -79.71 -19.64 9.76 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.357 1.188 . . . . 0.0 109.92 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CG ' ' A' ' 52' ' ' MET . 7.0 mt -109.06 -42.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.688 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -50.73 -22.91 2.33 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.881 -1.137 . . . . 0.0 110.295 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.8 5.31 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.605 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.494 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.94 146.49 24.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.844 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 106.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.333 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.514 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 13.5 mmt -59.67 -8.46 2.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.814 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -82.0 11.56 47.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 m -144.95 88.65 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.216 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.68 -29.68 70.24 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.16 -0.963 . . . . 0.0 109.546 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -29.75 10.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.681 -0.637 . . . . 0.0 109.821 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 20' ' ' ALA . 11.2 t -74.85 -55.3 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.144 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.454 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -50.22 -47.77 54.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.382 -0.824 . . . . 0.0 109.5 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -51.36 -66.31 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.481 0.658 . . . . 0.0 109.943 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.4 mt -68.25 -49.54 59.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 110.858 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 1.8 tt -44.9 -67.37 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.439 -0.788 . . . . 0.0 110.858 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -23.5 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -79.19 -43.35 24.07 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.409 -0.807 . . . . 0.0 109.534 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.96 36.05 0.06 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -68.89 -171.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.657 -1.496 . . . . 0.0 109.257 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -111.18 73.07 0.91 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.5 -7.84 22.21 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.959 1.505 . . . . 0.0 110.64 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.34 -57.17 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.63 161.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 111.566 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.08 -143.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.512 -0.743 . . . . 0.0 109.966 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' LEU . 31.3 t0 -114.37 134.57 22.26 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 109.416 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD2' ' OD1' ' A' ' 74' ' ' ASP . 48.8 Cg_endo -72.71 -3.06 12.84 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.29 1.153 . . . . 0.0 111.011 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.37 -41.3 9.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.0 110.256 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.508 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -131.15 5.98 4.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.09 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.8 mt 48.48 42.63 18.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -0.838 . . . . 0.0 111.008 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 m -75.65 93.32 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 110.401 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -70.72 168.77 17.63 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 108.777 179.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.495 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -75.62 -0.87 10.66 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.096 1.051 . . . . 0.0 110.289 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 104' ' ' LEU . 11.4 t -76.31 -34.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -68.08 -36.34 79.67 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.251 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 1.8 m-20 -55.46 -56.12 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.695 -0.628 . . . . 0.0 110.474 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' N ' ' SD ' ' A' ' 54' ' ' MET . . . -55.12 -62.06 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.355 -0.84 . . . . 0.0 109.985 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -56.59 -49.3 75.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 111.108 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -32.35 12.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.081 -1.012 . . . . 0.0 111.045 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -94.3 -4.28 49.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 81.8 25.51 52.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.521 ' CE1' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -98.76 143.7 28.81 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.328 -1.101 . . . . 0.0 110.63 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.429 ' HA ' HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -117.04 -39.36 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -52.83 -36.66 58.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.5 m -60.53 -49.66 76.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.667 -0.646 . . . . 0.0 109.635 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' A' ' 91' ' ' LEU . 1.8 mp -57.65 -45.23 85.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 109.685 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.0 t -55.89 -43.29 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.343 -0.848 . . . . 0.0 108.922 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 64' ' ' LEU . 46.2 t -61.13 -45.27 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.42 0.629 . . . . 0.0 109.479 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.415 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 96.0 mt -57.43 -46.89 83.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.513 -0.742 . . . . 0.0 110.313 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -77.77 -25.94 49.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.498 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -67.04 -13.52 62.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 110.11 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.22 -74.24 0.59 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.19 105.83 0.21 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.18 -165.0 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -1.084 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.86 102.59 3.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.489 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.485 ' CD2' HG12 ' A' ' 82' ' ' VAL . 1.7 mp -93.26 11.31 28.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.843 . . . . 0.0 109.444 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.34 31.06 4.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.407 HG22 ' CZ ' ' A' ' 80' ' ' ARG . 4.1 p -104.01 -176.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 110.055 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.7 ptt-85 -139.21 145.4 39.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.581 -0.7 . . . . 0.0 109.568 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -70.55 63.11 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.124 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 60.04 -65.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.697 -0.627 . . . . 0.0 111.007 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.1 m-90 -57.47 -74.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 110.873 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.76 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -49.69 124.26 9.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -1.12 . . . . 0.0 110.634 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.4 mt -85.97 164.79 37.67 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -20.3 46.04 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.719 1.378 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 7.4 p -83.65 -37.88 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.382 -0.824 . . . . 0.0 109.832 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.408 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.3 OUTLIER -70.96 -38.13 72.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.852 . . . . 0.0 109.898 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.36 -41.54 89.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.126 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.6 -59.42 5.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.619 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -30.9 35.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.314 -0.866 . . . . 0.0 110.433 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -24.75 56.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.534 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -90.28 -3.65 57.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 110.607 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.35 14.72 46.85 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 44.2 m-70 -98.42 48.95 0.99 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.91 -1.347 . . . . 0.0 109.478 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -30.17 2.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.687 -0.633 . . . . 0.0 110.229 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -65.41 -41.88 93.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 4.7 t -81.6 -38.32 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.42 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.86 97.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -57.96 -67.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.429 -0.795 . . . . 0.0 109.494 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -50.59 -40.89 53.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 134' ' ' ALA . 13.8 mt -57.02 -50.3 73.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.401 ' CA ' HG22 ' A' ' 115' ' ' VAL . 4.7 ttp180 -56.23 -22.13 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.753 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.02 -66.39 0.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.083 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.97 -7.31 53.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 111.105 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -128.4 -42.74 1.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.144 -0.973 . . . . 0.0 110.355 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.82 64.68 1.51 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.85 120.43 20.11 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 82.6 p -85.14 104.13 14.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -1.097 . . . . 0.0 110.213 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.79 131.93 31.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 145.22 92.05 0.13 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.21 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.385 -1.068 . . . . 0.0 110.053 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -65.71 -79.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.676 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.06 -177.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.09 -1.006 . . . . 0.0 110.293 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -122.19 97.49 5.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.989 . . . . 0.0 110.048 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.11 131.31 19.38 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.404 -0.81 . . . . 0.0 110.079 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 32.3 mm 51.26 69.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.878 . . . . 0.0 109.076 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -44.16 168.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.465 0.65 . . . . 0.0 111.507 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -43.93 106.59 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 110.411 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 63.54 154.3 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.587 -0.696 . . . . 0.0 110.264 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.19 160.27 32.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.481 -0.762 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 71.23 152.63 1.11 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.29 113.77 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.74 1.389 . . . . 0.0 110.69 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.0 t -118.27 7.88 12.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.392 -0.818 . . . . 0.0 110.388 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 162.31 28.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.236 -0.915 . . . . 0.0 110.294 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.67 83.44 58.64 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.963 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.74 130.94 15.25 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.838 1.441 . . . . 0.0 110.802 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 42.4 t0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.796 179.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.148 0.499 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -53.5 -52.8 63.48 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.227 -0.921 . . . . 0.0 110.479 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 43.0 Cg_endo -74.79 151.99 41.33 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.619 1.326 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.58 141.62 51.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.376 -0.828 . . . . 0.0 110.187 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.79 131.5 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.374 -0.829 . . . . 0.0 109.853 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.18 -73.02 0.44 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.54 -153.03 0.38 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.257 -1.143 . . . . 0.0 109.875 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 t -155.78 143.14 19.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.95 . . . . 0.0 110.376 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.6 ttp -162.1 -55.35 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.433 -0.792 . . . . 0.0 109.718 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 52.61 81.65 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.321 -0.862 . . . . 0.0 110.254 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 12' ' ' SER . 42.8 Cg_endo -71.74 71.9 2.58 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.821 1.432 . . . . 0.0 110.179 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' PRO . 5.1 m 62.04 12.98 5.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.674 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.39 36.84 23.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.911 -1.118 . . . . 0.0 109.954 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -86.29 19.9 2.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -0.854 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 38.2 m0 -74.42 -24.5 59.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.257 -0.902 . . . . 0.0 109.877 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.56 -35.54 79.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 110.151 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.88 -50.56 12.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.457 -0.777 . . . . 0.0 109.184 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -51.36 -51.56 53.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.333 -0.854 . . . . 0.0 109.669 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . . . -58.64 -37.93 76.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.16 -61.02 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.48 ' CA ' ' O ' ' A' ' 51' ' ' VAL . . . -46.46 -29.1 1.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.702 -0.624 . . . . 0.0 111.105 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 21.2 mtm-85 -91.9 32.43 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.451 -0.78 . . . . 0.0 111.04 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.39 36.2 3.01 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 3.0 mpt_? -108.5 94.74 5.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -1.12 . . . . 0.0 109.609 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.442 HG21 ' CG2' ' A' ' 59' ' ' VAL . 89.8 t -74.46 -59.73 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.646 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -43.15 -30.75 0.49 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 111.668 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.477 ' OE1' ' HB3' ' A' ' 19' ' ' ALA . 1.5 mt-10 -68.0 -52.46 35.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 32' ' ' LEU . 6.1 t -68.49 -41.22 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.578 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.574 ' CD ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.02 -50.42 27.77 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.439 -0.788 . . . . 0.0 109.616 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.82 -49.1 66.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.643 -0.661 . . . . 0.0 109.84 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' ALA . 4.1 mt -58.78 -60.25 4.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 63' ' ' LEU . 11.7 mt -44.41 -49.25 9.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.595 -0.691 . . . . 0.0 109.95 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.08 -14.29 61.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.471 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -94.63 -3.42 49.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.992 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.35 33.05 1.26 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.684 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -79.36 140.22 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.296 . . . . 0.0 108.761 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 3.0 tp -79.72 123.34 84.01 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.083 -1.01 . . . . 0.0 111.058 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 42.2 Cg_endo -70.72 -21.33 29.18 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.827 1.435 . . . . 0.0 109.84 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.78 52.65 1.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.067 -1.02 . . . . 0.0 110.03 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . . . -86.32 154.99 57.38 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.843 . . . . 0.0 110.131 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -79.04 132.04 10.27 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.868 1.457 . . . . 0.0 109.858 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -97.95 -171.84 2.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.38 -0.825 . . . . 0.0 110.822 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 m -113.47 2.78 15.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.79 . . . . 0.0 110.271 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.488 ' CB ' ' HD3' ' A' ' 46' ' ' ARG . 72.5 m-85 -118.24 20.06 13.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.595 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.91 22.69 35.45 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.488 ' HD3' ' CB ' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -109.5 -169.64 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -1.201 . . . . 0.0 109.896 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 23.7 mmt180 -106.02 165.9 12.21 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.379 -0.826 . . . . 0.0 109.72 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.2 Cg_endo -62.85 -12.79 30.86 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.665 1.35 . . . . 0.0 109.885 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.8 mt -110.96 -35.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.431 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 4.1 tt0 -59.17 -15.9 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.48 ' O ' ' CA ' ' A' ' 21' ' ' ALA . 7.7 p -118.12 38.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.358 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.523 ' CE ' ' HB1' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.96 29.96 4.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.755 -1.216 . . . . 0.0 109.578 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 7.5 tmm? 74.21 -8.78 1.38 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.792 -0.567 . . . . 0.0 110.46 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 45.11 24.22 0.12 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.596 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -130.05 18.01 5.35 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 57' ' ' ALA . 1.1 t -149.54 64.58 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.486 -1.008 . . . . 0.0 110.586 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -38.33 -32.76 0.08 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.568 -0.707 . . . . 0.0 110.087 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 56' ' ' SER . 3.9 mmt85 -49.74 -41.13 43.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.591 -0.693 . . . . 0.0 109.201 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ALA . 40.8 t -62.22 -61.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.578 -0.701 . . . . 0.0 109.492 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.523 ' HB1' ' CE ' ' A' ' 52' ' ' MET . . . -35.55 -52.84 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.481 -0.762 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.33 -55.39 15.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.006 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.574 HD13 ' CD ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -43.45 -65.8 0.45 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.641 -0.662 . . . . 0.0 110.506 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CD2' HD13 ' A' ' 32' ' ' LEU . 74.2 mt -66.78 -49.88 64.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.526 -0.734 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.505 HD21 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -41.82 -72.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.629 -0.669 . . . . 0.0 110.648 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 1.3 pp -52.46 -23.64 6.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -79.04 -31.55 44.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.649 -0.657 . . . . 0.0 109.545 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 124.76 41.1 0.39 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.497 ' HB3' HG13 ' A' ' 49' ' ' ILE . . . -63.51 -156.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.07 -1.253 . . . . 0.0 109.745 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.492 ' HG2' ' CB ' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -118.87 59.08 4.05 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.426 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.495 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 51.9 Cg_endo -69.89 -22.09 31.97 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 124.149 1.605 . . . . 0.0 110.178 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.31 -52.32 3.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.731 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.492 ' CB ' ' HG2' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -60.51 133.27 55.93 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.545 0.688 . . . . 0.0 110.649 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.554 ' HB3' ' HA ' ' A' ' 80' ' ' ARG . . . -123.81 -177.27 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.35 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.48 138.48 36.07 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.192 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.0 -29.26 18.21 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 124.089 1.573 . . . . 0.0 110.539 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.15 -61.03 1.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.481 ' CG2' ' CZ2' ' A' ' 110' ' ' TRP . 13.2 p -137.66 41.56 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.691 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 1.7 mt 37.56 56.21 1.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.311 0.577 . . . . 0.0 111.401 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 58.3 m -77.54 104.4 8.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.596 -0.69 . . . . 0.0 110.048 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.554 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -79.37 142.92 59.05 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.495 ' HG2' ' O ' ' A' ' 70' ' ' PRO . 42.9 Cg_endo -66.92 -10.65 29.2 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.804 1.423 . . . . 0.0 109.654 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG23 HD22 ' A' ' 104' ' ' LEU . 6.0 t -70.46 -36.84 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.911 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.477 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 16.4 m80 -57.37 -40.47 78.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HB3' ' CG ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -50.01 -58.69 4.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.999 -0.438 . . . . 0.0 111.314 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB1' HG23 ' A' ' 93' ' ' THR . . . -46.41 -55.11 7.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.617 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.534 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -67.21 -35.76 80.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 0.0 110.767 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HD2' ' C ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -46.27 -39.46 10.03 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 111.286 -178.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -105.37 -3.63 22.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 110.46 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.43 35.45 23.05 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.596 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 1.0 OUTLIER -105.83 83.55 1.94 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.393 -1.063 . . . . 0.0 110.336 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.438 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -56.97 -46.35 82.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 111.575 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -42.93 -37.95 2.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.39 -0.819 . . . . 0.0 110.338 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' HB1' ' A' ' 85' ' ' ALA . 52.4 m -62.63 -44.32 96.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.579 -0.701 . . . . 0.0 109.327 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.501 HD12 HG11 ' A' ' 126' ' ' VAL . 1.4 mp -61.51 -55.94 25.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 0.0 109.769 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 94' ' ' LEU . 39.1 t -38.97 -45.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.731 -0.606 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.505 ' CG1' HD21 ' A' ' 64' ' ' LEU . 11.9 t -63.42 -53.75 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.664 0.745 . . . . 0.0 109.013 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 mt -47.99 -58.95 3.75 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.456 0.646 . . . . 0.0 110.266 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.99 -28.34 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -72.73 -3.86 27.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.353 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -146.56 53.81 1.12 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.965 -1.084 . . . . 0.0 111.438 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . 56.84 107.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.11 86.59 0.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -1.049 . . . . 0.0 109.68 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -51.14 116.9 2.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 110.683 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.436 HD22 HG23 ' A' ' 82' ' ' VAL . 1.3 mp -101.22 -16.21 17.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 26.1 t0 -85.1 55.13 3.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 80' ' ' ARG . 1.9 p -110.49 -170.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.161 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.415 ' N ' HG11 ' A' ' 106' ' ' VAL . 1.9 mtt180 -137.04 135.69 37.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.213 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.9 m-20 -73.82 58.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.51 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 54.27 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.376 -0.828 . . . . 0.0 110.555 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.54 ' CE3' ' N ' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -37.32 -63.38 0.44 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.412 0.625 . . . . 0.0 110.7 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.32 -34.74 0.23 Allowed Glycine 0 N--CA 1.478 1.471 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -48.42 141.94 6.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -1.11 . . . . 0.0 109.976 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -109.89 170.49 5.29 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.408 -0.808 . . . . 0.0 109.742 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 42.4 Cg_endo -70.44 -40.25 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.856 1.45 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.3 p -70.51 -34.15 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.588 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.73 -51.67 25.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.513 -0.742 . . . . 0.0 109.812 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 117' ' ' LEU . 14.2 tp -51.78 -32.33 30.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.267 -0.896 . . . . 0.0 109.746 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 86' ' ' ALA . . . -73.7 -46.58 45.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.876 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -30.29 69.68 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -67.69 -41.48 83.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.545 -0.722 . . . . 0.0 110.091 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.525 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -83.32 -4.31 58.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 111.022 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.3 25.78 17.91 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.306 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 74.7 m-70 -98.27 47.11 1.0 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.069 -1.254 . . . . 0.0 109.39 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.48 -38.01 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.672 -0.643 . . . . 0.0 109.739 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.424 ' CG ' HD13 ' A' ' 91' ' ' LEU . 11.2 t70 -55.19 -47.03 75.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 94' ' ' LEU . 3.2 t -79.65 -46.28 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 108.88 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.29 -43.72 61.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.607 -0.683 . . . . 0.0 110.369 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -68.16 -54.81 15.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 110.058 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -58.8 -39.59 81.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.171 -0.956 . . . . 0.0 109.143 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 86' ' ' ALA . 10.7 mt -62.21 -35.0 77.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.529 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -65.13 -27.28 68.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.93 28.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.418 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -89.51 -16.05 31.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.287 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -129.13 -50.21 1.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 0.0 110.452 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.22 -112.53 2.05 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 146.04 45.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.1 t -70.85 139.93 50.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.459 -1.024 . . . . 0.0 110.764 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -164.92 28.11 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.503 -0.748 . . . . 0.0 109.808 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.34 -156.96 8.4 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 m -137.16 67.02 1.45 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.309 -1.112 . . . . 0.0 110.104 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -140.19 -60.53 0.53 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 110.626 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -120.6 36.03 4.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 110.536 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -145.89 165.08 29.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 109.735 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 53.11 176.19 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.21 -0.931 . . . . 0.0 110.449 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 145' ' ' ILE . 1.2 tt -124.19 44.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 109.888 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.89 52.14 2.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.455 -0.778 . . . . 0.0 109.591 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.42 139.31 15.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.462 -0.774 . . . . 0.0 110.332 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 63.17 -177.84 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.415 -0.803 . . . . 0.0 109.963 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -99.86 20.84 13.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.454 -0.779 . . . . 0.0 109.467 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 55.16 177.91 0.19 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -72.23 -85.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.765 1.402 . . . . 0.0 110.144 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.04 13.02 7.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.194 -0.941 . . . . 0.0 110.684 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 51.3 85.25 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.334 -0.854 . . . . 0.0 110.497 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.5 tt -131.81 65.85 76.58 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.513 -0.742 . . . . 0.0 109.846 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.62 127.56 5.02 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.91 1.479 . . . . 0.0 109.958 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 117.864 -1.065 . . . . 0.0 109.861 179.788 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 mtt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 66.7 mt-10 -79.49 163.26 59.92 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.418 -0.801 . . . . 0.0 110.607 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 45.3 Cg_endo -70.41 113.06 3.36 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.815 1.429 . . . . 0.0 110.623 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.64 -177.16 0.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 110.071 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.27 -43.22 24.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.41 -158.65 17.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.55 -172.06 0.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.241 -1.152 . . . . 0.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.09 121.42 0.9 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.402 -0.811 . . . . 0.0 109.85 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.4 mtt -46.59 -29.34 1.77 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -0.766 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.67 144.37 17.71 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.92 83.91 1.88 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.709 1.373 . . . . 0.0 110.358 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.55 -69.41 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.959 . . . . 0.0 110.377 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.31 28.46 4.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -0.826 . . . . 0.0 110.685 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -99.56 22.31 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.255 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 15' ' ' TRP . 40.2 m0 -73.01 -31.82 64.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.058 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -53.06 -33.49 52.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 0.0 110.795 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.9 -48.49 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -51.8 37.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -65.89 -40.54 91.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' CB ' HG12 ' A' ' 59' ' ' VAL . . . -56.81 -52.36 65.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.203 -0.936 . . . . 0.0 109.62 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.491 ' HA ' ' N ' ' A' ' 53' ' ' MET . . . -57.3 -29.39 63.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.38 23.16 4.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.0 110.765 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.72 61.42 6.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.54 53.89 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.396 -1.061 . . . . 0.0 110.01 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 98.0 t -42.36 -59.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.848 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -45.98 -38.57 7.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.773 . . . . 0.0 110.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.93 -36.32 72.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.979 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 ' CB ' ' A' ' 19' ' ' ALA . 5.2 t -79.6 -41.4 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 3.0 mmm180 -51.59 -41.91 61.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.874 . . . . 0.0 109.363 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' O ' ' HB1' ' A' ' 34' ' ' ALA . . . -80.39 -56.07 4.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.673 -0.642 . . . . 0.0 109.461 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.8 mt -45.0 -60.16 2.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.554 -0.717 . . . . 0.0 110.597 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.483 ' CD2' ' CD2' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -51.83 -51.88 53.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.5 -0.75 . . . . 0.0 110.258 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.98 -9.29 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 110.428 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 30' ' ' ALA . . . -92.05 -13.56 30.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.07 -1.019 . . . . 0.0 110.895 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.02 -20.59 1.59 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.462 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -47.73 136.93 10.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.282 -1.128 . . . . 0.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.13 155.75 89.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.975 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.59 -54.8 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.737 1.388 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -98.63 21.22 11.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 39' ' ' ASN . . . -39.53 100.22 0.21 Allowed Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.71 -0.619 . . . . 0.0 110.689 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.63 146.8 44.35 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.875 1.46 . . . . 0.0 110.963 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -139.28 174.47 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.618 -0.676 . . . . 0.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.07 50.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.926 . . . . 0.0 110.574 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -3.47 5.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.17 23.51 25.31 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -138.64 106.15 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -1.051 . . . . 0.0 110.46 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.517 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -58.11 -177.2 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' GLN . 41.1 Cg_endo -66.52 175.68 4.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.319 1.168 . . . . 0.0 111.263 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.7 mt 61.92 -64.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.919 -0.488 . . . . 0.0 110.045 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' PRO . 50.2 tt0 -44.16 -26.91 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 47' ' ' ARG . 7.3 p -123.56 36.57 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.641 -0.662 . . . . 0.0 109.891 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.522 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -94.24 38.32 1.09 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.772 -1.205 . . . . 0.0 110.653 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.491 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 6.1 tmm? 71.15 -14.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.52 -0.737 . . . . 0.0 110.672 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.522 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.43 27.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.71 13.47 5.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.47 82.91 1.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -1.013 . . . . 0.0 109.734 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -50.66 -25.24 4.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.0 110.394 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -53.56 -41.09 66.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.279 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 52' ' ' MET . 24.1 t -55.57 -58.47 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.233 -0.917 . . . . 0.0 109.566 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.67 -52.78 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.675 . . . . 0.0 109.708 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.497 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -45.23 -42.75 9.72 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' A' ' 63' ' ' LEU . 2.9 tp -73.83 -61.33 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.588 -0.695 . . . . 0.0 110.087 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.526 ' N ' ' HG ' ' A' ' 62' ' ' LEU . 5.3 mt -64.7 -55.87 17.3 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 110.993 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -46.68 -61.75 1.69 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.447 -0.783 . . . . 0.0 111.118 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' CD2' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -57.55 -23.58 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.935 -1.103 . . . . 0.0 109.655 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CD2' ' CD2' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -81.98 -38.88 24.45 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.457 -0.777 . . . . 0.0 109.969 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.01 46.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB3' HG13 ' A' ' 49' ' ' ILE . . . -75.98 -151.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.008 -1.289 . . . . 0.0 109.583 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -117.14 53.51 1.3 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.003 . . . . 0.0 110.718 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.2 Cg_endo -66.85 -15.32 46.83 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.444 1.234 . . . . 0.0 109.877 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.473 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 4.1 m-20 -107.93 -72.56 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 171.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.33 -152.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.276 -0.89 . . . . 0.0 110.114 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -98.59 131.77 25.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.25 -27.55 34.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.337 1.177 . . . . 0.0 110.729 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.1 -64.43 0.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.508 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 27.5 p -130.29 36.31 3.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 4.3 mt 43.29 37.91 1.48 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.639 -0.663 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.9 OUTLIER -70.05 99.51 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.514 ' NH1' ' O ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -76.43 165.4 53.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.494 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 47.1 Cg_endo -69.8 -23.2 30.86 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.655 1.345 . . . . 0.0 109.536 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.8 t -55.89 -29.29 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.676 -0.64 . . . . 0.0 109.968 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 12.2 m80 -74.15 -50.16 20.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.509 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -45.24 -43.96 10.81 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -64.46 -67.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -54.14 -45.68 72.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.776 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -48.56 -33.33 9.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.277 -0.89 . . . . 0.0 110.627 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.28 -11.97 20.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 110.342 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.487 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 83.78 33.84 20.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.435 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -104.99 92.28 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -1.052 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -67.66 -32.55 73.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 110.063 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -52.26 -50.06 62.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.873 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 m -56.95 -36.28 70.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 1.2 mp -60.84 -44.12 97.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.503 -0.748 . . . . 0.0 109.701 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 16.5 t -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.6 t -55.51 -46.01 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.411 -0.806 . . . . 0.0 109.571 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.404 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -54.94 -69.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 110.057 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.12 -22.25 50.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.369 -0.832 . . . . 0.0 110.158 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -72.04 -16.54 62.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.25 72.68 1.35 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.338 -0.851 . . . . 0.0 110.596 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.52 101.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -161.93 79.28 0.54 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -1.087 . . . . 0.0 110.411 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.514 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 1.2 ttp180 -56.89 119.64 6.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.121 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 12.0 mt -99.13 15.49 25.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.059 . . . . 0.0 109.544 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.65 43.29 1.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.822 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.445 HG13 ' CG ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -103.19 -169.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -142.0 140.69 32.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.652 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 110' ' ' TRP . 10.8 t0 -73.46 54.81 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.02 -75.59 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.616 -0.677 . . . . 0.0 111.483 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -46.73 -39.15 11.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.294 -0.879 . . . . 0.0 110.37 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.23 -28.74 2.21 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -56.23 128.87 37.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -1.065 . . . . 0.0 110.569 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -93.09 171.64 7.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.63 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.465 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 41.7 Cg_endo -69.46 -38.64 8.16 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.488 1.257 . . . . 0.0 110.048 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.55 -31.03 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.276 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.36 -26.06 66.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.548 -0.72 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.02 -55.05 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.39 -0.819 . . . . 0.0 110.551 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 127' ' ' ALA . . . -47.97 -40.92 23.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 110.285 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -47.66 81.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.526 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -60.91 -54.13 48.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 109.627 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 1.9 mm? -55.16 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.0 110.427 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.19 41.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 49.4 m-70 -122.23 63.32 0.94 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.388 -1.066 . . . . 0.0 109.546 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -45.3 46.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.488 ' O ' HD13 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -52.83 -46.16 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.867 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -74.83 -42.01 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.408 ' CB ' ' HB2' ' A' ' 118' ' ' ALA . . . -59.77 -47.72 84.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 109.64 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -52.93 -67.45 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.86 -30.4 33.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.919 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 5.8 mt -70.75 -53.58 15.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.596 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -55.23 -29.79 58.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.182 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.86 -54.23 4.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.664 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.87 -9.14 58.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.327 -0.858 . . . . 0.0 110.781 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 104' ' ' LEU . . . -122.84 -44.92 2.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.164 -0.96 . . . . 0.0 110.693 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -49.77 120.28 7.69 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.61 8.02 73.99 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 44.9 p -59.54 109.81 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -1.204 . . . . 0.0 110.299 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -123.44 -76.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 109.763 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.54 48.92 0.36 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.8 m -62.91 -18.16 62.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -1.064 . . . . 0.0 109.887 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -108.09 -37.33 6.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -144.71 -162.71 1.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.332 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.74 133.59 55.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 110.269 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.48 112.8 7.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.192 -0.943 . . . . 0.0 109.834 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.9 mt 51.79 86.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.293 -0.879 . . . . 0.0 109.69 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -48.07 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.426 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.75 103.63 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.535 -0.728 . . . . 0.0 110.392 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.45 124.57 8.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.542 -0.724 . . . . 0.0 110.37 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -46.69 119.92 2.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.538 -0.726 . . . . 0.0 110.284 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -83.32 150.75 27.56 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.29 -85.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.907 1.477 . . . . 0.0 110.299 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.7 m -165.91 105.34 0.69 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.215 -0.928 . . . . 0.0 110.345 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -59.06 173.95 0.41 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 mt -125.18 85.68 57.85 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.357 -0.84 . . . . 0.0 110.023 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.59 120.01 6.45 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.848 1.446 . . . . 0.0 110.389 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.293 -179.884 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.138 0.494 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.466 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -68.54 -56.77 9.46 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 109.85 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 48.0 Cg_endo -72.98 147.13 42.92 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.484 1.254 . . . . 0.0 110.478 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -174.9 161.18 2.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.462 -0.774 . . . . 0.0 109.85 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 176.12 91.31 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.32 -0.862 . . . . 0.0 110.114 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.84 -78.44 0.05 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.61 55.33 3.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.194 -1.18 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.93 24.44 0.56 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.841 . . . . 0.0 110.524 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.7 ttp -96.19 54.93 1.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.167 -0.958 . . . . 0.0 110.773 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.14 79.24 5.67 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.029 -1.044 . . . . 0.0 110.563 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -79.15 86.03 1.76 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.875 1.46 . . . . 0.0 110.358 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 m -61.89 143.53 56.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.262 -0.899 . . . . 0.0 110.351 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.77 -51.3 0.1 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.45 -6.15 41.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.283 -0.886 . . . . 0.0 110.573 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.469 ' HB3' HD23 ' A' ' 31' ' ' LEU . 16.3 m0 -57.03 -17.22 9.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 110.457 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -69.85 -56.03 8.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.481 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -71.81 -42.96 66.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -47.81 -62.51 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.166 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . . . -52.0 -42.96 63.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.816 . . . . 0.0 109.936 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.487 ' HB3' ' CB ' ' A' ' 52' ' ' MET . . . -57.63 -52.15 66.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.679 -0.638 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 51' ' ' VAL . . . -50.38 -25.63 4.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.451 -0.781 . . . . 0.0 110.607 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . 37.6 mtt180 -103.74 28.93 6.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.656 -0.652 . . . . 0.0 109.849 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.76 41.89 10.43 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 28' ' ' VAL . 11.7 mtt180 -99.85 54.93 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -1.081 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 58' ' ' ARG . 99.3 t -38.9 -53.61 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.769 -0.582 . . . . 0.0 111.07 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -49.81 -56.29 10.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.755 . . . . 0.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 tp10 -54.45 -39.0 67.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.383 -0.823 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' CG1' HD22 ' A' ' 62' ' ' LEU . 14.0 t -71.74 -56.0 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.707 -0.621 . . . . 0.0 110.279 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -39.41 -52.48 2.08 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.428 -0.795 . . . . 0.0 110.668 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -73.82 -50.75 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.76 . . . . 0.0 109.907 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 15' ' ' TRP . 14.0 mt -47.37 -57.05 5.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.59 -0.694 . . . . 0.0 110.728 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.604 ' CD1' ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -49.86 -50.36 45.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 109.491 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -70.53 -17.38 62.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.714 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -81.83 -6.35 59.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.067 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.06 16.68 6.1 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.565 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -58.15 160.87 4.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.074 -1.25 . . . . 0.0 109.975 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.417 HD21 ' CA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -101.39 113.26 65.85 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 111.269 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.41 -5.17 16.62 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.753 1.396 . . . . 0.0 110.421 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -131.59 40.06 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 110.075 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.417 ' CA ' HD21 ' A' ' 37' ' ' LEU . . . -84.18 133.85 44.51 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.268 -0.895 . . . . 0.0 110.546 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.3 89.65 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.726 1.382 . . . . 0.0 110.375 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.76 166.18 5.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -85.41 21.71 1.7 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -119.38 15.35 12.99 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.16 24.15 20.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.4 -170.33 1.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.447 -1.031 . . . . 0.0 110.256 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.499 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.3 mmt180 -103.45 167.51 10.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.673 . . . . 0.0 109.547 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.517 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 42.6 Cg_endo -67.26 -12.0 34.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.582 1.306 . . . . 0.0 110.414 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.1 mt -107.2 -42.76 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 108.637 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -49.44 -20.95 0.79 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.383 -0.823 . . . . 0.0 110.472 179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 10.8 p -115.91 35.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 110.477 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -96.4 34.57 1.6 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 109.729 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 10.0 ttp 67.67 -6.69 0.65 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 110.821 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.551 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.66 27.19 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.235 -0.916 . . . . 0.0 110.41 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.35 11.65 7.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.442 ' HB3' HG21 ' A' ' 59' ' ' VAL . 1.8 m -148.91 93.22 2.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.482 -1.011 . . . . 0.0 109.615 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.42 -34.15 70.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.468 -0.77 . . . . 0.0 109.872 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.447 ' HB3' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -52.15 -42.04 63.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 110.093 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 20' ' ' ALA . 91.0 t -48.15 -53.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -62.79 -43.69 98.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.565 -0.709 . . . . 0.0 109.315 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 4.0 tt0 -46.8 -31.73 3.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.248 -0.908 . . . . 0.0 110.276 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.537 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 7.5 tp -89.87 -49.66 6.49 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -56.65 -55.41 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.451 0.643 . . . . 0.0 109.387 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -61.23 -45.76 93.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.671 -0.643 . . . . 0.0 109.756 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 2.4 tp -53.04 -32.97 49.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -0.874 . . . . 0.0 108.719 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CG ' ' CD1' ' A' ' 32' ' ' LEU . 2.0 m80 -92.6 -1.04 57.21 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.426 0.631 . . . . 0.0 110.355 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.0 63.48 1.97 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' HD21 ' A' ' 63' ' ' LEU . . . -72.26 -149.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -1.067 . . . . 0.0 109.228 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mt-10 -114.88 57.22 0.97 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HB3' HD13 ' A' ' 64' ' ' LEU . 53.6 Cg_endo -72.17 -0.89 9.26 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.315 1.166 . . . . 0.0 110.585 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.46 -73.72 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.055 -1.028 . . . . 0.0 109.804 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 134.7 16.61 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.578 0.704 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.424 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . -127.34 -134.16 0.24 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.03 125.73 30.92 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.786 -1.196 . . . . 0.0 109.452 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.84 5.75 5.06 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.255 1.134 . . . . 0.0 110.865 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.27 -43.77 4.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 108.925 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.499 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -121.44 2.98 10.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.619 -0.676 . . . . 0.0 109.932 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 2.8 mt 54.99 25.23 6.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.278 -0.889 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.71 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.494 ' HB2' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.36 165.9 40.09 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.173 -0.954 . . . . 0.0 110.104 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 44.4 Cg_endo -71.54 -9.01 24.39 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.76 1.4 . . . . 0.0 110.672 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG12 HD22 ' A' ' 104' ' ' LEU . 3.5 t -73.87 -30.53 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.103 -0.998 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.412 ' CD2' ' OD1' ' A' ' 108' ' ' ASP . 27.0 m80 -68.64 -43.97 75.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.551 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -48.81 -49.95 36.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.331 0.586 . . . . 0.0 110.251 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -57.81 -68.7 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.0 109.766 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -51.24 -39.29 56.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.362 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.408 ' O ' ' NE2' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -44.01 -51.73 7.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.328 -0.857 . . . . 0.0 110.812 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 18.7 13.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 109.775 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.39 52.78 42.31 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.485 ' O ' HD11 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -117.07 84.36 2.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -1.157 . . . . 0.0 110.611 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 94' ' ' LEU . 1.2 mt -55.89 -43.81 77.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 0.0 110.75 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 47.9 m-20 -45.89 -35.66 4.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.496 -0.753 . . . . 0.0 111.048 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -71.9 -38.61 69.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -0.91 . . . . 0.0 110.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.489 ' CD2' ' CD2' ' A' ' 130' ' ' LEU . 1.6 mp -63.08 -59.55 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 99' ' ' ARG . 52.8 t -46.2 -49.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.58 -0.7 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 92' ' ' ASP . 23.6 t -50.39 -53.04 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.571 -0.705 . . . . 0.0 109.71 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.407 ' C ' ' HB1' ' A' ' 102' ' ' ALA . 64.6 mt -52.39 -66.11 0.44 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 0.0 109.837 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -55.78 -26.71 47.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.933 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' HG3' HG11 ' A' ' 95' ' ' VAL . 5.1 mtp180 -70.62 -13.19 61.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.977 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 78.19 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.183 -0.948 . . . . 0.0 111.001 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 52.07 101.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.407 ' HB1' ' C ' ' A' ' 97' ' ' LEU . . . -163.06 123.53 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -1.211 . . . . 0.0 110.744 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -78.41 141.63 38.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.5 OUTLIER -126.4 8.19 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.335 -0.853 . . . . 0.0 110.287 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -115.75 49.62 1.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.062 -1.024 . . . . 0.0 111.365 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 80' ' ' ARG . 7.6 p -112.45 171.64 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 24.1 mtm180 -131.42 143.8 50.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 109.59 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -68.51 58.04 0.08 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.241 -0.912 . . . . 0.0 110.17 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 77' ' ' THR . . . 50.9 -88.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.475 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.8 p90 -112.62 -1.57 14.79 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.263 -0.898 . . . . 0.0 110.758 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -77.93 -80.61 0.68 Allowed Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 4.3 mtt180 170.98 -169.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.816 -0.814 . . . . 0.0 110.069 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.447 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -80.37 166.96 36.56 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 110.417 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.1 Cg_endo -72.32 -35.91 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.813 1.428 . . . . 0.0 110.16 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.455 ' HA ' HD11 ' A' ' 130' ' ' LEU . 7.9 p -67.69 -28.45 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -50.68 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.71 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -24.71 41.95 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.272 -0.893 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.29 -62.9 1.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 111.109 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -23.77 1.16 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -37.2 23.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.285 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.579 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 1.7 mm? -86.9 7.52 26.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.31 24.03 52.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.322 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 17.0 m-70 -99.4 43.47 1.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.951 -1.323 . . . . 0.0 109.223 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -42.58 7.77 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.292 0.568 . . . . 0.0 110.158 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.09 -38.13 78.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 109.6 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 3.3 t -82.54 -38.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.41 -22.65 63.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -68.1 -71.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 0.0 110.389 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -53.88 -45.11 70.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 134' ' ' ALA . 12.9 mt -50.53 -55.26 16.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.522 -0.736 . . . . 0.0 109.488 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.434 ' CA ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -54.46 -23.14 14.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.169 -0.957 . . . . 0.0 109.95 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.31 -52.36 7.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.986 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.37 -7.13 57.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 111.134 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -107.68 -31.59 8.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.921 -1.112 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.5 98.77 0.95 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.05 83.83 0.34 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.08 107.13 0.59 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.529 -0.983 . . . . 0.0 109.856 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.25 74.88 1.46 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.362 -0.836 . . . . 0.0 110.182 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -177.84 -133.35 1.85 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.54 51.71 1.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -1.178 . . . . 0.0 110.295 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 48.84 43.34 21.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.589 -0.695 . . . . 0.0 111.037 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' A' ' 142' ' ' HIS . 55.0 p-80 -57.59 112.56 1.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.0 109.396 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 54.14 -155.35 0.24 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.036 -1.04 . . . . 0.0 109.83 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.424 ' O ' ' HB ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER 58.04 60.06 2.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.129 -0.982 . . . . 0.0 110.354 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 37.7 mm 60.27 157.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.385 -0.822 . . . . 0.0 110.377 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.4 76.11 0.38 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.128 -0.982 . . . . 0.0 110.67 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.0 129.51 37.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.305 -0.872 . . . . 0.0 109.446 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -45.14 120.15 2.31 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.429 -0.795 . . . . 0.0 110.86 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.61 167.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -0.893 . . . . 0.0 110.152 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.0 113.85 0.22 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.33 129.38 16.9 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.501 1.264 . . . . 0.0 110.681 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.0 t -138.44 -0.91 1.94 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.512 -0.742 . . . . 0.0 110.757 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.412 ' C ' ' HD3' ' A' ' 155' ' ' PRO . 28.9 p-10 -96.15 63.91 2.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.984 -1.072 . . . . 0.0 110.578 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 31.3 mm -112.38 75.56 1.75 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.104 -0.998 . . . . 0.0 110.019 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 153' ' ' ASP . 51.9 Cg_endo -77.8 117.59 4.27 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.793 1.417 . . . . 0.0 110.266 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.0 t0 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.469 179.638 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.345 0.593 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 60.08 72.13 0.79 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.386 -0.821 . . . . 0.0 110.846 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.79 74.12 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.63 1.331 . . . . 0.0 109.876 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.05 128.84 14.35 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.538 -0.726 . . . . 0.0 110.979 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.05 175.49 5.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.434 -0.791 . . . . 0.0 110.394 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.08 -113.4 2.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.4 p -75.17 148.16 39.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 109.804 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.98 120.94 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.311 -0.868 . . . . 0.0 110.246 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -98.71 -42.95 6.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.38 -0.825 . . . . 0.0 110.507 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.44 157.29 51.93 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.431 -0.793 . . . . 0.0 110.637 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.91 170.12 20.4 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.895 1.471 . . . . 0.0 110.411 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -58.55 122.75 14.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.323 -0.86 . . . . 0.0 110.091 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 37' ' ' LEU . . . -79.24 -18.37 52.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.512 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -54.86 -20.46 8.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.144 -0.972 . . . . 0.0 110.292 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -48.04 -33.96 8.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.313 -0.867 . . . . 0.0 109.7 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -43.86 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.375 0.607 . . . . 0.0 110.849 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.405 ' HB1' ' ND2' ' A' ' 42' ' ' ASN . . . -43.89 -54.02 5.63 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.69 -0.631 . . . . 0.0 111.299 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -59.58 3.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 110.702 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . . . -55.17 -47.93 74.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.326 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 59' ' ' VAL . . . -57.06 -48.9 77.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.455 -0.778 . . . . 0.0 110.319 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.98 -25.63 67.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 110.105 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -85.78 5.45 32.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.308 -0.87 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.97 44.81 95.43 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -122.1 72.7 1.05 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.953 . . . . 0.0 109.611 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.1 t -53.38 -45.41 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.414 -0.804 . . . . 0.0 110.274 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.33 -33.99 66.14 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 0.0 110.508 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 5.7 tt0 -68.19 -41.8 80.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.871 . . . . 0.0 109.772 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.521 ' C ' HD23 ' A' ' 62' ' ' LEU . 21.4 t -77.59 -45.38 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.958 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.22 -47.77 35.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -29.83 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 28' ' ' VAL . 7.9 mt -68.34 -70.43 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.206 -0.934 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.579 HD23 ' CB ' ' A' ' 66' ' ' HIS . 1.3 mt -46.88 -49.41 20.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.373 -0.829 . . . . 0.0 111.542 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -60.9 -24.46 66.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.31 -5.79 55.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.48 29.83 3.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.46 128.35 33.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -1.099 . . . . 0.0 110.123 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -49.25 111.6 2.05 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.38 -0.825 . . . . 0.0 110.666 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HA ' HD23 ' A' ' 16' ' ' LEU . 43.3 Cg_endo -69.12 -33.15 19.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.678 1.357 . . . . 0.0 110.811 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.68 50.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.707 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.01 150.96 78.61 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.415 -0.803 . . . . 0.0 110.324 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.87 116.38 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.79 1.416 . . . . 0.0 110.188 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.405 ' ND2' ' HB1' ' A' ' 17' ' ' ALA . 12.9 m120 -94.21 170.68 9.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.961 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -89.95 33.41 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.638 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -137.06 3.63 2.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.054 -1.029 . . . . 0.0 110.725 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.14 26.87 36.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -130.78 20.8 5.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -1.15 . . . . 0.0 110.691 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 48.91 -177.51 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.707 -0.62 . . . . 0.0 111.069 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 50' ' ' GLN . 44.4 Cg_endo -72.95 -179.52 4.36 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.44 1.232 . . . . 0.0 111.165 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.594 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 56.88 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.761 -0.587 . . . . 0.0 110.322 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -47.73 -23.09 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.939 -1.101 . . . . 0.0 110.264 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.415 ' O ' HG21 ' A' ' 51' ' ' VAL . 7.4 p -115.66 6.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 110.664 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -68.98 171.65 7.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.795 -1.191 . . . . 0.0 109.211 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.2 ttm -52.79 -19.06 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.229 -0.919 . . . . 0.0 110.37 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.559 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.48 10.14 3.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -119.02 18.28 10.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.423 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -150.3 78.25 1.32 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.459 -1.024 . . . . 0.0 109.449 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.75 -28.88 0.68 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.0 110.378 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -42.71 57.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 20' ' ' ALA . 77.8 t -53.67 -60.84 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.488 -0.757 . . . . 0.0 109.409 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 64' ' ' LEU . . . -53.53 -52.34 59.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.326 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.486 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . 9.0 tt0 -45.74 -35.73 4.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.196 -0.94 . . . . 0.0 110.062 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.583 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 1.0 OUTLIER -78.3 -60.89 2.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.573 -0.704 . . . . 0.0 109.248 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.512 ' N ' ' HG ' ' A' ' 62' ' ' LEU . 2.0 mt -60.95 -56.07 25.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 110.521 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -48.68 -62.47 1.49 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.563 -0.711 . . . . 0.0 110.814 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.419 ' CD1' ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -55.16 -24.96 29.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.972 -1.08 . . . . 0.0 109.385 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.583 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -82.22 -29.26 31.48 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.416 -0.802 . . . . 0.0 109.811 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.47 38.02 0.31 Allowed Glycine 0 N--CA 1.479 1.508 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.484 ' HB1' ' C ' ' A' ' 63' ' ' LEU . . . -66.65 -148.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 0.0 109.678 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -115.65 59.04 1.45 Allowed Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.332 -0.855 . . . . 0.0 110.387 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.1 -8.64 22.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.553 1.291 . . . . 0.0 110.613 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 2.2 t30 -129.1 -65.26 0.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.314 -0.866 . . . . 0.0 109.704 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.88 144.29 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 110.532 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB1' ' HG2' ' A' ' 80' ' ' ARG . . . -136.34 -136.01 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.27 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -110.68 136.02 20.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.057 -1.027 . . . . 0.0 110.221 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.2 -5.35 16.95 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.542 1.285 . . . . 0.0 110.596 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.1 -49.67 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.619 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -120.57 9.63 10.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.377 -0.827 . . . . 0.0 110.945 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 7.4 mt 47.02 27.81 0.8 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.59 89.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.644 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.474 ' NE ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -69.14 168.78 13.99 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.864 . . . . 0.0 110.366 -179.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.593 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 54.5 Cg_endo -72.72 2.58 5.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 124.003 1.528 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 104' ' ' LEU . 19.8 t -85.09 -31.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 110.301 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 83' ' ' HIS . 9.1 m80 -67.48 -43.67 80.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.08 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.559 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.9 OUTLIER -53.52 -54.09 42.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.701 -0.624 . . . . 0.0 111.373 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.404 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -52.76 -63.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 109.934 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -58.05 -55.01 40.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.26 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 5.0 tpt180 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.507 -0.746 . . . . 0.0 111.299 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' MET . 9.9 tp10 -103.83 -4.64 23.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.025 -1.047 . . . . 0.0 111.09 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 20.83 69.14 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.46 ' O ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -102.01 96.35 6.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -1.151 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.408 HD23 ' CG ' ' A' ' 129' ' ' TYR . 1.2 tt -69.82 -38.37 76.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.724 -0.61 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -50.56 -41.62 54.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.89 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.422 ' O ' HD11 ' A' ' 97' ' ' LEU . 30.1 m -55.89 -48.27 75.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.733 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 90' ' ' PHE . 1.4 mp -59.05 -43.21 91.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.833 . . . . 0.0 109.805 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -51.47 -49.17 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.486 ' CG1' ' HA ' ' A' ' 61' ' ' GLU . 25.4 t -59.83 -43.1 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.589 0.709 . . . . 0.0 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -56.96 -58.62 7.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.618 -0.677 . . . . 0.0 110.107 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -65.41 -35.74 81.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 110.125 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 99' ' ' ARG . 2.3 ttp85 -61.57 -14.9 33.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.411 -0.806 . . . . 0.0 110.449 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . . . -140.79 54.43 1.59 Allowed 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.988 -1.07 . . . . 0.0 111.168 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.36 106.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.91 97.57 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.467 -1.02 . . . . 0.0 109.876 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -51.37 115.32 1.53 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.338 -0.851 . . . . 0.0 110.404 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HA ' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -105.36 4.08 30.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 110.611 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -112.63 51.46 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 110.535 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.453 ' HB ' ' HD2' ' A' ' 80' ' ' ARG . 4.5 p -107.55 -178.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.997 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 42.3 mtt85 -131.26 153.01 49.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 109.564 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -80.38 54.93 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 62.86 -68.65 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.626 -0.672 . . . . 0.0 111.276 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 6.6 m0 -65.67 -37.68 87.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.818 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.79 -20.56 1.0 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.46 ' HB2' ' CB ' ' A' ' 108' ' ' ASP . 12.4 mtt180 -49.75 136.77 17.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -1.106 . . . . 0.0 110.266 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.438 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -111.06 161.17 26.17 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.358 -0.839 . . . . 0.0 110.116 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.444 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 44.1 Cg_endo -70.24 -21.62 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.583 1.307 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.57 -31.74 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.053 -1.029 . . . . 0.0 110.038 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.34 -22.96 63.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.9 mt -75.67 -44.59 41.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.537 -0.727 . . . . 0.0 110.497 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.2 -36.22 79.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.94 -39.24 88.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -57.7 3.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 109.897 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.51 -85.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.478 -0.764 . . . . 0.0 110.257 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.03 39.31 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 22.6 m-70 -103.87 55.82 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.378 -1.072 . . . . 0.0 108.822 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.51 -40.81 13.15 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.45 0.643 . . . . 0.0 109.909 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.16 -42.17 90.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.646 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.3 t -82.18 -44.88 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.987 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -54.8 -37.61 66.3 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -77.14 -48.26 18.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.73 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.408 ' CG ' HD23 ' A' ' 91' ' ' LEU . 27.2 t80 -70.73 -57.16 4.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.119 -0.988 . . . . 0.0 110.503 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -54.55 -32.75 58.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.114 -0.992 . . . . 0.0 110.612 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 23.7 ttt180 -66.55 -38.13 86.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -0.847 . . . . 0.0 110.083 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.378 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.81 -19.41 23.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.733 -0.605 . . . . 0.0 110.295 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . . . -94.3 -13.35 26.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.332 -0.855 . . . . 0.0 110.721 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 173.6 -80.49 0.08 OUTLIER Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 55.76 40.46 80.22 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 t -50.47 133.2 25.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -1.024 . . . . 0.0 110.137 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.94 114.19 28.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 110.163 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 154.39 -175.57 32.51 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.91 -31.29 8.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.296 -1.12 . . . . 0.0 110.167 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -161.87 28.88 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.846 . . . . 0.0 110.755 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -78.08 -47.69 17.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 109.073 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 144' ' ' ARG . . . -87.9 -179.32 6.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.588 -0.695 . . . . 0.0 109.257 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 143' ' ' ALA . 0.0 OUTLIER 60.45 147.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.134 -0.979 . . . . 0.0 109.776 -179.435 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 tt -80.38 158.8 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.042 -1.036 . . . . 0.0 110.39 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -49.34 162.15 0.15 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.426 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -166.61 64.88 0.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.273 -0.892 . . . . 0.0 110.434 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 144.8 54.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.775 . . . . 0.0 109.968 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.71 137.47 37.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.03 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.68 121.09 5.87 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -79.63 5.72 5.68 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.577 1.304 . . . . 0.0 110.761 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.57 -13.51 12.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.14 -0.975 . . . . 0.0 110.394 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -48.0 149.55 1.36 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.32 -0.862 . . . . 0.0 110.365 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.74 110.51 42.14 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.162 -0.961 . . . . 0.0 110.795 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.86 111.8 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.751 1.395 . . . . 0.0 110.277 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.228 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.152 0.501 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.68 162.02 21.02 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.63 77.44 2.98 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.789 1.415 . . . . 0.0 110.421 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.6 111.44 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.387 -0.821 . . . . 0.0 110.516 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.67 -18.44 61.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.886 . . . . 0.0 110.336 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.19 136.86 47.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.3 p -100.51 38.8 1.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -1.081 . . . . 0.0 110.11 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 p -161.39 165.74 28.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.845 . . . . 0.0 110.317 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.63 103.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.486 -0.758 . . . . 0.0 110.227 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -103.07 163.33 17.73 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.376 -0.827 . . . . 0.0 110.182 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.17 123.24 7.1 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.727 1.383 . . . . 0.0 110.292 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 t -171.99 -52.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.273 -0.892 . . . . 0.0 110.338 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.88 -16.12 64.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 110.355 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -89.64 12.25 17.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.884 . . . . 0.0 110.634 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -85.13 -26.78 26.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 110.106 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.99 -32.48 72.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 109.457 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.34 -48.2 13.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.4 -0.813 . . . . 0.0 109.89 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -41.07 99.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -55.51 -52.44 63.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.408 -0.808 . . . . 0.0 109.775 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.529 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -58.62 -31.89 68.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.358 -0.838 . . . . 0.0 110.192 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.79 -35.47 74.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -94.18 23.46 5.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.28 42.85 89.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -105.12 67.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.877 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 85.3 t -51.75 -30.01 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.469 -0.769 . . . . 0.0 110.325 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -73.27 -39.06 65.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.325 -0.859 . . . . 0.0 110.728 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.74 -31.99 73.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.257 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.489 ' C ' HD22 ' A' ' 62' ' ' LEU . 6.5 t -83.09 -46.49 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.368 -0.833 . . . . 0.0 110.123 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.75 -35.98 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 109.728 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mt -59.09 -65.1 0.72 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.487 HD23 ' CB ' ' A' ' 66' ' ' HIS . 2.5 mt -51.39 -34.82 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 110.259 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -20.09 62.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.954 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.75 -9.23 47.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.09 28.01 2.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -57.71 151.49 17.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -1.168 . . . . 0.0 109.74 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -73.35 135.43 79.15 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 109.729 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.11 -31.41 19.02 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.546 1.287 . . . . 0.0 110.128 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -139.69 61.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.558 -0.714 . . . . 0.0 110.032 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.4 160.01 83.83 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.283 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.5 124.03 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.827 1.435 . . . . 0.0 110.487 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -108.79 158.58 17.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -95.44 27.96 3.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 110.537 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -136.48 13.33 3.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 109.953 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.96 26.9 35.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.9 tpp180 -130.66 107.04 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 110.217 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mpt_? -55.09 -175.08 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.595 -0.691 . . . . 0.0 110.259 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.2 Cg_endo -64.34 163.66 25.76 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.267 1.14 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.564 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 66.68 -59.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' PRO . 5.1 tt0 -53.22 -20.93 4.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 46' ' ' ARG . 12.0 p -114.82 -7.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.622 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -56.52 165.17 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.986 -1.071 . . . . 0.0 109.796 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -54.73 -17.07 3.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.229 -0.92 . . . . 0.0 110.397 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.485 ' SD ' ' HG3' ' A' ' 52' ' ' MET . 0.0 OUTLIER 61.96 11.46 4.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.41 18.42 20.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.47 96.08 1.75 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.674 -0.898 . . . . 0.0 109.634 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.91 -21.04 56.99 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.344 -0.848 . . . . 0.0 109.759 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -56.43 -30.49 62.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.567 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.68 -44.88 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.591 -0.693 . . . . 0.0 109.947 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.425 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 3.2 tt0 -45.73 -29.18 1.21 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.156 -0.965 . . . . 0.0 110.775 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 28' ' ' VAL . 2.7 tp -83.82 -56.8 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 110.019 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 8.2 mt -67.68 -35.06 78.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.432 HD13 ' CB ' ' A' ' 100' ' ' ALA . 2.7 tm? -61.74 -65.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.81 -0.556 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' C ' ' CD1' ' A' ' 65' ' ' LEU . 1.7 pp -54.53 -24.15 19.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.813 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CB ' HD23 ' A' ' 32' ' ' LEU . 2.0 m80 -81.6 -49.95 9.92 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.526 -0.734 . . . . 0.0 110.134 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.24 46.02 0.03 OUTLIER Glycine 0 N--CA 1.482 1.731 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.029 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -75.57 -155.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.786 -1.42 . . . . 0.0 109.192 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 6.7 tp10 -122.99 68.4 35.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 110.267 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.23 -9.13 22.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.896 1.471 . . . . 0.0 110.384 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 3.7 t30 -117.82 -70.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.711 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 152.7 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.105 -0.997 . . . . 0.0 111.082 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HB1' ' HG2' ' A' ' 80' ' ' ARG . . . -137.62 -137.42 0.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 2.2 t70 -122.13 132.11 24.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.67 -7.78 21.85 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.639 1.336 . . . . 0.0 110.88 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.35 -55.74 4.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.212 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.463 ' CG2' ' CZ2' ' A' ' 110' ' ' TRP . 61.2 p -117.26 7.34 12.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.2 mt 49.33 30.35 3.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.269 -0.894 . . . . 0.0 111.005 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -69.0 91.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.136 -0.977 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.506 ' NE ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -68.87 159.22 83.51 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.623 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.08 -6.13 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.654 1.344 . . . . 0.0 110.626 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 t -77.29 -31.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 110.021 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 35.9 m80 -69.74 -42.8 73.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -0.828 . . . . 0.0 109.301 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.7 m-20 -48.47 -49.01 37.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.708 -0.62 . . . . 0.0 110.527 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -60.79 -68.9 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.586 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . -50.64 -55.96 14.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.453 -0.78 . . . . 0.0 111.16 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 6.7 ttm180 -44.74 -27.79 0.55 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.173 -0.954 . . . . 0.0 111.683 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -102.11 -5.03 24.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.689 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.84 36.06 26.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -116.41 101.66 8.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 110.724 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 1.0 OUTLIER -83.1 -35.14 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.48 -43.06 34.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.383 -0.823 . . . . 0.0 109.784 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 m -65.07 -39.3 93.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 109.0 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.47 HD11 ' CB ' ' A' ' 85' ' ' ALA . 1.5 tp -51.81 -48.93 63.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.613 -0.68 . . . . 0.0 109.838 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 45.2 t -56.51 -51.35 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 109.68 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.3 t -49.25 -53.32 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.449 -0.782 . . . . 0.0 110.296 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.466 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -50.65 -67.76 0.23 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.468 -0.77 . . . . 0.0 110.683 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -61.86 -30.18 70.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.297 -0.877 . . . . 0.0 110.585 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -61.72 -16.6 50.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.348 -0.845 . . . . 0.0 110.764 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' CB ' HD13 ' A' ' 64' ' ' LEU . . . -129.74 -44.82 1.19 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.751 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.69 108.6 0.22 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -167.59 112.57 0.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -1.088 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.04 95.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.477 -0.765 . . . . 0.0 109.844 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 59.75 5.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.285 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -170.49 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -0.954 . . . . 0.0 110.062 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.476 HG13 ' CD ' ' A' ' 80' ' ' ARG . 1.5 p -102.54 -169.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -142.28 112.11 6.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.217 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.02 147.45 9.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.356 -0.84 . . . . 0.0 110.663 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.46 -27.24 62.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.463 ' CZ2' ' CG2' ' A' ' 77' ' ' THR . 7.0 m95 -63.41 -14.35 49.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.72 46.02 5.86 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.41 104.29 2.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -1.043 . . . . 0.0 110.156 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -54.31 167.49 0.55 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.9 . . . . 0.0 109.941 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.41 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 43.8 Cg_endo -69.93 -34.93 13.06 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.614 1.323 . . . . 0.0 109.931 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 131' ' ' ARG . 5.9 p -74.01 -27.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.398 -0.814 . . . . 0.0 110.192 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -37.94 63.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 109.69 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 87' ' ' ARG . 2.0 tt -69.39 -41.93 75.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.116 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.414 ' HB2' ' CB ' ' A' ' 127' ' ' ALA . . . -56.39 -48.49 76.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.267 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -65.51 -22.18 66.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.973 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.39 -65.62 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -83.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.182 -0.948 . . . . 0.0 110.539 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 35.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 24.0 m-70 -105.66 36.81 2.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -1.055 . . . . 0.0 108.659 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -46.87 -45.15 20.17 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.405 0.621 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 126' ' ' VAL . 14.8 p30 -56.64 -39.82 74.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.376 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 10.6 t -74.14 -52.44 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 109.841 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -48.99 -28.54 3.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.628 -0.67 . . . . 0.0 111.227 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -50.02 -70.58 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.03 -1.044 . . . . 0.0 110.626 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -73.11 -28.36 62.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.521 ' HB3' ' O ' ' A' ' 126' ' ' VAL . 0.3 OUTLIER -72.1 -14.53 61.87 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 109.634 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.47 ' HA ' HG23 ' A' ' 115' ' ' VAL . 10.6 ttt180 -88.21 -42.97 11.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.143 -0.973 . . . . 0.0 110.064 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.14 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.7 -23.89 20.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 110.547 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -120.29 60.91 0.87 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.61 99.96 0.17 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.17 -7.97 27.95 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.9 p -72.97 103.11 3.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 110.291 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.95 105.24 17.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.323 -0.861 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.79 -90.82 1.33 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.7 m -64.08 146.57 53.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -1.086 . . . . 0.0 109.829 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.94 1.17 32.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.0 110.704 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.94 -177.05 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.083 -1.011 . . . . 0.0 110.399 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.87 130.32 48.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -0.809 . . . . 0.0 110.111 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.54 85.77 0.78 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.401 -0.812 . . . . 0.0 110.245 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 145' ' ' ILE . 1.0 OUTLIER -165.38 94.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 109.978 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -50.52 98.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.402 -0.811 . . . . 0.0 110.537 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.82 124.2 9.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.424 -0.797 . . . . 0.0 110.28 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 55.05 -171.75 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.368 -0.833 . . . . 0.0 110.14 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -76.12 154.9 35.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.867 . . . . 0.0 110.14 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.38 114.43 0.08 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.7 143.6 42.24 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.542 1.285 . . . . 0.0 110.09 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.5 m 55.55 19.83 3.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.412 -0.805 . . . . 0.0 110.774 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 51.57 -170.5 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.154 -0.966 . . . . 0.0 110.671 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.1 tt -121.06 88.95 45.68 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.425 -0.797 . . . . 0.0 109.821 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.34 126.29 12.77 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.792 1.417 . . . . 0.0 110.702 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.284 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.231 0.539 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.98 62.14 3.61 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.286 -0.884 . . . . 0.0 110.348 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.46 173.2 14.91 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.722 1.38 . . . . 0.0 110.679 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.31 152.0 38.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.379 -0.826 . . . . 0.0 110.069 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.21 39.7 1.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.0 110.372 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.94 -86.33 0.52 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 p -74.81 55.2 0.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -1.088 . . . . 0.0 110.261 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 t -112.7 -16.29 12.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.322 -0.861 . . . . 0.0 110.219 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.54 -9.62 21.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.496 -0.753 . . . . 0.0 110.787 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -102.26 129.95 25.17 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.072 -1.018 . . . . 0.0 110.621 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HB3' ' HG2' ' A' ' 41' ' ' PRO . 49.0 Cg_endo -72.2 68.5 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.705 1.371 . . . . 0.0 110.329 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -173.81 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 110.32 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 63.31 13.85 7.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.445 -0.785 . . . . 0.0 110.913 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' OG1' ' A' ' 18' ' ' THR . 9.0 p-10 -89.83 24.73 2.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.059 -1.025 . . . . 0.0 109.944 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.528 ' N ' ' CD1' ' A' ' 15' ' ' TRP . 30.6 m0 -67.7 -28.15 67.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.449 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 17' ' ' ALA . 3.9 pp -63.13 -38.93 93.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 110.063 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' A' ' 16' ' ' LEU . . . -77.25 -42.12 38.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 110.056 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -60.54 -40.95 93.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 110.318 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 28' ' ' VAL . . . -70.79 -35.92 72.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.773 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 52' ' ' MET . . . -67.08 -45.15 78.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 109.748 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.77 -29.33 68.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.617 -0.677 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -88.23 14.98 8.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 0.0 110.107 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.26 50.22 56.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.83 77.43 1.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -1.055 . . . . 0.0 110.315 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 29' ' ' ARG . 59.4 t -51.55 -46.35 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.386 -0.822 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.63 -60.7 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.594 -0.691 . . . . 0.0 110.311 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 -38.18 65.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.459 -0.776 . . . . 0.0 109.73 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.491 ' CG1' HG11 ' A' ' 59' ' ' VAL . 21.6 t -69.97 -56.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.56 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 9.8 mmm-85 -46.1 -45.17 16.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.73 . . . . 0.0 110.243 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -76.62 -36.93 57.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.483 -0.761 . . . . 0.0 109.567 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 34' ' ' ALA . 11.6 mt -62.15 -67.28 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.54 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.62 -43.56 8.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.665 -0.647 . . . . 0.0 110.164 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 2.6 tt0 -79.77 -17.43 53.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.643 -0.66 . . . . 0.0 110.798 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -80.74 -8.05 59.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 111.012 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.46 0.19 4.13 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.876 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -52.2 157.59 1.34 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.996 -1.297 . . . . 0.0 110.0 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 40' ' ' ALA . 18.3 mt -86.14 153.77 57.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.114 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 48.5 Cg_endo -77.38 -54.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.644 1.339 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -107.44 40.05 1.77 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.839 . . . . 0.0 109.571 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . . . -61.54 126.73 87.33 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.592 -0.693 . . . . 0.0 110.423 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HG2' ' HB3' ' A' ' 11' ' ' PRO . 45.7 Cg_endo -72.89 151.44 50.85 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.668 1.352 . . . . 0.0 110.099 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -122.52 171.68 8.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.865 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -4.44 59.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.325 -0.859 . . . . 0.0 110.07 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 3.3 m-30 -100.78 -3.04 30.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.93 29.02 54.47 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -119.83 39.41 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -1.065 . . . . 0.0 111.064 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 10.5 mmt180 49.59 172.68 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.424 -0.797 . . . . 0.0 111.741 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 53.4 Cg_endo -77.0 -18.63 14.43 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.638 1.336 . . . . 0.0 110.51 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.522 ' O ' ' HG2' ' A' ' 52' ' ' MET . 15.3 mt -104.94 -47.2 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -48.4 -25.03 1.43 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.05 -1.03 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 13.7 ptt? -75.55 141.14 43.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ttp -54.25 123.6 13.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.976 . . . . 0.0 108.528 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.567 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -82.02 44.12 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.967 -1.083 . . . . 0.0 110.823 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.25 2.28 11.48 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.435 ' N ' ' CZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -137.14 88.87 2.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.714 -0.874 . . . . 0.0 109.96 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -61.54 -11.67 12.03 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.115 -0.991 . . . . 0.0 109.951 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.455 ' HB3' HG12 ' A' ' 25' ' ' VAL . 2.3 mtp180 -71.1 -47.43 58.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 110.716 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 20' ' ' ALA . 42.2 t -45.52 -62.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.41 -0.806 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HB1' ' CE ' ' A' ' 52' ' ' MET . . . -49.13 -40.76 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.094 -1.004 . . . . 0.0 109.648 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 7.4 tm-20 -50.07 -27.49 5.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.77 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.56 ' CD2' ' HA ' ' A' ' 29' ' ' ARG . 8.3 tp -90.05 -54.46 4.03 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 48' ' ' PRO . 11.4 mt -55.11 -46.28 75.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -69.59 -41.04 76.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 5.4 tp -54.08 -33.67 58.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.522 ' CG ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -90.78 -47.02 7.88 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.767 -0.583 . . . . 0.0 109.555 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.25 63.84 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 C-N-CA 120.151 -1.024 . . . . 0.0 110.758 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 38' ' ' PRO . . . -77.04 -153.85 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.948 -1.324 . . . . 0.0 109.283 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.59 55.76 2.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.111 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 45.9 Cg_endo -70.81 -14.84 33.06 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.576 1.303 . . . . 0.0 110.323 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 -64.12 1.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.47 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.2 150.73 8.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 111.03 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 80' ' ' ARG . . . -128.83 -153.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.584 -0.698 . . . . 0.0 109.134 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -102.13 136.7 19.41 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 0.0 109.701 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.41 -3.2 13.56 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.396 1.208 . . . . 0.0 110.699 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.66 -30.72 18.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 0.0 109.471 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.627 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -151.11 22.07 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 109.854 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.8 OUTLIER 37.28 33.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.862 -0.524 . . . . 0.0 111.515 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -69.34 100.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.472 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -69.51 166.92 25.93 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.273 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 50' ' ' GLN . 43.9 Cg_endo -72.79 -21.08 21.91 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.578 1.304 . . . . 0.0 109.581 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 45.8 t -54.16 -30.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 32.8 m80 -71.65 -42.85 67.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.567 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 10.7 t0 -49.1 -47.46 45.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.779 -0.575 . . . . 0.0 109.926 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.413 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -59.72 -69.42 0.21 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.456 -0.777 . . . . 0.0 110.548 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 126' ' ' VAL . . . -58.58 -41.6 86.08 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.003 . . . . 0.0 111.446 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 12.1 tpt85 -45.84 -41.54 11.27 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 110.886 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.5 5.34 49.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.97 34.26 27.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -103.29 97.81 7.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -1.119 . . . . 0.0 110.999 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 3.0 tt -82.67 -40.21 21.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 109.64 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.3 m-20 -46.42 -56.11 6.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.582 -0.699 . . . . 0.0 109.846 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.444 ' O ' HD21 ' A' ' 97' ' ' LEU . 3.5 m -54.08 -43.38 70.28 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.413 ' CD1' ' CB ' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -50.59 -34.26 25.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 25.1 t -72.92 -45.2 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.582 -0.699 . . . . 0.0 109.118 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 46.6 t -61.12 -46.71 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -0.785 . . . . 0.0 109.808 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.444 HD21 ' O ' ' A' ' 93' ' ' THR . 3.7 mm? -52.58 -46.0 66.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.451 -0.78 . . . . 0.0 110.217 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -84.35 -12.84 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 2.5 mtt180 -80.06 -12.02 59.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.328 -0.858 . . . . 0.0 111.013 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.57 -66.25 0.77 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.52 108.41 0.29 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HB3' HD13 ' A' ' 97' ' ' LEU . . . -168.66 128.36 1.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -1.062 . . . . 0.0 110.578 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 112.26 23.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.485 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -104.06 5.19 35.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 110.644 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -100.31 41.14 1.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.63 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 80' ' ' ARG . 7.2 p -108.75 178.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.822 . . . . 0.0 110.925 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -131.17 143.69 50.81 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -68.06 69.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.387 -0.82 . . . . 0.0 110.803 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 77' ' ' THR . . . 60.92 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.627 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.7 m-90 -60.08 -75.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.755 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.98 32.28 0.07 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.483 ' CB ' ' HB2' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -89.42 107.96 19.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -1.129 . . . . 0.0 109.824 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 ' CD1' ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -82.55 159.11 64.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.434 -0.791 . . . . 0.0 110.159 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 113' ' ' LEU . 42.3 Cg_endo -71.59 -24.68 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.797 1.419 . . . . 0.0 110.398 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 130' ' ' LEU . 11.6 p -79.42 -40.16 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.127 -0.983 . . . . 0.0 110.087 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.404 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.8 OUTLIER -69.23 -30.01 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.483 -0.76 . . . . 0.0 109.884 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.418 HD23 ' HD3' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -78.4 -32.0 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.023 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.51 -44.7 50.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 109.672 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -36.42 78.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 110.02 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -59.5 4.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -0.813 . . . . 0.0 109.96 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 121' ' ' LEU . 3.3 mm? -54.83 -82.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.28 37.24 0.03 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.463 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 31.1 m-70 -113.87 52.38 0.82 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.336 -1.096 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -33.83 9.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 110.27 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.81 -39.23 93.75 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.364 -0.835 . . . . 0.0 108.938 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -83.91 -43.18 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 109.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.27 -34.02 76.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -52.25 43.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.41 -0.807 . . . . 0.0 109.48 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 129' ' ' TYR . 4.8 t80 -60.86 -30.34 70.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.747 . . . . 0.0 109.168 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 134' ' ' ALA . 36.6 mt -65.13 -60.13 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.039 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.446 ' HB2' HG22 ' A' ' 115' ' ' VAL . 5.9 ttp180 -53.24 -20.82 4.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 110.411 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.7 -60.19 2.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.48 -12.52 59.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.372 -0.83 . . . . 0.0 110.389 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -108.95 41.04 1.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 110.002 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.82 108.72 0.64 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 131' ' ' ARG . . . -99.7 124.86 8.37 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.5 p -90.03 149.55 22.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.57 -0.959 . . . . 0.0 110.275 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.04 32.84 0.59 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.403 -0.81 . . . . 0.0 110.547 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -93.48 -9.53 60.13 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.05 116.44 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.294 -1.121 . . . . 0.0 110.946 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.8 m120 47.15 47.41 16.31 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.541 -0.724 . . . . 0.0 110.52 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.26 -171.16 3.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.441 -0.787 . . . . 0.0 109.722 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -170.6 53.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.206 -0.934 . . . . 0.0 110.676 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.9 -174.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.45 -0.781 . . . . 0.0 111.398 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 145' ' ' ILE . 9.6 tp -153.48 68.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 110.776 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 145' ' ' ILE . 1.8 m-20 -39.62 124.29 1.64 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.221 -0.924 . . . . 0.0 110.431 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.95 130.47 15.22 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.293 -0.88 . . . . 0.0 110.284 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.35 134.79 45.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.365 -0.835 . . . . 0.0 110.793 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.56 161.81 30.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.504 -0.747 . . . . 0.0 110.021 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 58.18 -174.96 2.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.57 128.35 15.17 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.839 1.441 . . . . 0.0 111.133 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.93 12.95 22.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.563 -0.711 . . . . 0.0 109.542 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.44 160.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.566 -0.709 . . . . 0.0 111.226 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 154' ' ' ILE . 1.1 pp -119.39 82.76 24.83 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.0 109.978 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.69 111.05 2.48 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.55 1.289 . . . . 0.0 110.855 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.896 179.476 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.095 0.474 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -125.15 115.15 25.99 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 109.842 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.69 157.49 48.17 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.692 1.364 . . . . 0.0 110.663 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . 177.75 61.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.357 -0.839 . . . . 0.0 109.904 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.81 -87.7 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.337 -0.852 . . . . 0.0 110.226 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 4' ' ' ALA . . . 51.5 32.85 31.85 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.6 p -147.54 -50.93 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.361 -1.082 . . . . 0.0 110.13 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -88.07 42.69 1.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 110.231 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -72.36 175.12 6.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.231 -0.918 . . . . 0.0 109.888 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.19 110.35 1.29 Allowed Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.417 -0.802 . . . . 0.0 110.566 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.06 111.86 3.37 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.611 1.321 . . . . 0.0 110.734 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.81 -37.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.472 -0.768 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.66 -51.58 7.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 110.05 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -65.33 -13.55 58.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 110.4 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.501 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.3 OUTLIER -66.39 -4.73 8.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.404 -0.81 . . . . 0.0 111.146 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.424 HD11 HG12 ' A' ' 28' ' ' VAL . 1.3 tp -80.55 -45.21 17.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.883 -1.135 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.7 53.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 110.171 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.501 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -61.32 -54.72 40.32 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.44 62.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.366 -0.834 . . . . 0.0 109.784 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.491 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.12 -48.03 68.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 109.317 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.06 -28.93 69.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.579 -0.701 . . . . 0.0 109.345 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.93 20.65 3.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.655 -0.653 . . . . 0.0 110.286 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.46 52.92 22.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.72 96.03 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.109 . . . . 0.0 110.526 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 98.5 t -73.11 -54.6 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -44.08 -40.98 5.24 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.56 -0.712 . . . . 0.0 111.549 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -46.5 71.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.997 -1.064 . . . . 0.0 109.902 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 32' ' ' LEU . 17.8 t -68.25 -41.29 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.819 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 13.6 mmm180 -50.43 -47.46 56.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.0 110.123 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.58 -45.1 47.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.79 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.426 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 10.6 mt -56.97 -60.45 3.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 110.198 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.454 HD21 ' ND1' ' A' ' 66' ' ' HIS . 7.2 mt -51.1 -32.57 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.313 -0.867 . . . . 0.0 109.574 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.58 -25.34 45.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.588 -0.695 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.67 -5.22 52.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.325 -0.859 . . . . 0.0 110.201 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.2 22.02 5.37 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -65.06 141.05 58.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.173 -1.192 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.72 117.45 58.86 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.471 -0.768 . . . . 0.0 109.53 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' CD2' ' A' ' 16' ' ' LEU . 43.0 Cg_endo -69.66 -29.53 24.23 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.46 1.242 . . . . 0.0 110.802 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.36 44.75 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 0.0 109.73 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.3 155.57 51.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.581 -0.7 . . . . 0.0 110.075 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.05 89.18 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.669 1.352 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 41.3 m-80 -59.55 151.22 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.541 -0.725 . . . . 0.0 110.381 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.85 26.65 2.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.438 -0.789 . . . . 0.0 110.772 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -160.64 26.1 0.15 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.33 -0.856 . . . . 0.0 110.207 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.02 35.1 53.34 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -120.21 89.6 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.7 -0.883 . . . . 0.0 110.165 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.468 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -54.84 179.24 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.557 -0.714 . . . . 0.0 109.994 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' O ' ' HB ' ' A' ' 49' ' ' ILE . 41.8 Cg_endo -66.96 156.77 64.83 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.387 1.204 . . . . 0.0 109.376 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 6.7 mt 67.2 -59.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -49.59 -21.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.919 -1.113 . . . . 0.0 109.688 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HG21 ' A' ' 51' ' ' VAL . 8.5 p -124.49 37.06 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.812 . . . . 0.0 110.017 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -101.84 37.67 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.293 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.2 ttp 64.91 -9.22 0.2 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.535 -0.728 . . . . 0.0 111.693 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.4 28.57 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.035 -1.04 . . . . 0.0 110.339 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.476 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.27 11.46 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -144.54 73.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -1.021 . . . . 0.0 109.549 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.23 -27.92 1.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.605 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -59.24 -31.88 69.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.935 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.413 HG21 HG23 ' A' ' 25' ' ' VAL . 48.4 t -71.8 -50.41 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -43.0 -46.84 5.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.71 -55.15 38.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 109.702 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -44.38 -56.21 4.39 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.652 -0.655 . . . . 0.0 110.708 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 6.2 mp -68.84 -58.84 3.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 110.541 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -48.24 -52.91 19.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.175 -0.953 . . . . 0.0 110.301 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -55.04 -33.84 63.03 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.397 -0.814 . . . . 0.0 109.319 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.454 ' ND1' HD21 ' A' ' 32' ' ' LEU . 1.5 m-70 -81.88 -48.78 11.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.302 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.39 43.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.577 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.496 ' HA ' ' CG ' ' A' ' 48' ' ' PRO . . . -69.02 -172.53 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.703 -1.469 . . . . 0.0 109.722 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 47' ' ' ARG . 3.7 mm-40 -121.02 65.14 13.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.378 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.84 -26.16 32.4 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.07 1.563 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -92.7 -63.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 173.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -164.07 -170.74 2.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.85 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.52 132.96 43.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.604 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 -15.92 39.51 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.556 1.293 . . . . 0.0 110.708 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.76 -84.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 109.991 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.459 HG23 ' CZ2' ' A' ' 110' ' ' TRP . 66.6 p -110.1 32.99 4.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.286 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 5.5 mt 49.27 32.54 4.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.472 -0.767 . . . . 0.0 110.529 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.61 97.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -72.24 147.78 90.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.457 -0.777 . . . . 0.0 109.859 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 40.8 Cg_endo -66.56 -20.59 53.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.521 1.274 . . . . 0.0 109.515 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 104' ' ' LEU . 27.6 t -58.46 -25.7 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -0.801 . . . . 0.0 109.8 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.465 ' CE1' ' HB3' ' A' ' 80' ' ' ARG . 23.9 m80 -73.27 -41.29 63.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.55 -43.85 46.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.694 -0.629 . . . . 0.0 110.23 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.35 -64.54 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.388 -0.82 . . . . 0.0 109.736 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -59.46 -52.41 65.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -41.27 -34.85 0.54 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.33 -8.99 28.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.16 -0.962 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . 82.92 23.81 54.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.476 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -98.95 84.01 3.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 110.445 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -57.9 -39.62 78.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 110.46 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -50.01 -40.96 46.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.032 -1.042 . . . . 0.0 109.959 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 50.7 m -60.03 -32.38 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.71 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 1.1 mp -72.15 -51.23 22.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.419 -0.801 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.3 t -50.17 -45.02 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.538 -0.726 . . . . 0.0 109.579 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.72 -49.04 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.578 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -55.75 -71.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.139 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -48.77 -34.42 12.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.685 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -62.03 -20.72 64.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.54 86.15 1.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.212 -0.93 . . . . 0.0 111.124 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 49.13 97.8 0.01 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 97' ' ' LEU . . . -168.19 97.5 0.43 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -1.131 . . . . 0.0 110.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.41 ' HG3' ' OD1' ' A' ' 105' ' ' ASP . 10.7 ttm180 -71.93 137.08 47.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.49 -0.756 . . . . 0.0 109.567 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.431 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.1 mp -121.32 21.37 11.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.41 ' OD1' ' HG3' ' A' ' 103' ' ' ARG . 4.8 p-10 -124.32 40.43 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.067 -1.02 . . . . 0.0 110.584 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 80' ' ' ARG . 1.7 p -101.44 -171.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 38.7 mtp180 -135.33 142.8 45.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 110' ' ' TRP . 94.0 m-20 -78.42 60.66 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 110.046 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.2 -71.18 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.756 -0.59 . . . . 0.0 111.082 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.597 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -40.57 -58.38 1.61 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.435 -0.791 . . . . 0.0 110.829 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -23.5 0.73 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -56.02 160.56 2.75 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.323 -1.104 . . . . 0.0 109.896 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 106' ' ' VAL . 36.6 mt -120.02 166.9 13.71 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 0.0 110.679 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.6 Cg_endo -66.79 -34.92 29.44 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.806 1.424 . . . . 0.0 110.392 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HA ' HD11 ' A' ' 130' ' ' LEU . 9.8 p -82.78 -33.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.57 -38.37 90.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -24.56 64.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.785 . . . . 0.0 110.14 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 123' ' ' HIS . . . -83.19 -27.7 29.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.26 -40.58 70.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.7 -47.28 32.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.85 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.32 38.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 16.6 m-70 -99.3 48.99 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.277 -1.131 . . . . 0.0 109.275 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -44.31 -38.02 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.757 -0.589 . . . . 0.0 110.646 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.53 -44.67 95.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 130' ' ' LEU . 22.7 t -78.67 -42.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.426 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -50.98 -41.41 59.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -63.94 1.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -54.0 -41.38 67.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.498 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 134' ' ' ALA . 15.5 mt -58.1 -65.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -26.04 0.89 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.076 -1.015 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.06 -58.58 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.05 -3.59 36.72 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.522 -0.736 . . . . 0.0 110.977 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -108.06 -39.58 5.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 109.833 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.4 -69.84 0.51 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.59 -68.34 3.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.5 t -53.96 130.86 39.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.316 -1.108 . . . . 0.0 110.489 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -85.03 -156.98 0.27 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.0 110.412 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 67.69 -91.88 0.22 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.08 -172.87 3.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.42 -1.047 . . . . 0.0 110.498 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -141.76 136.23 30.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.512 -0.742 . . . . 0.0 109.751 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.86 50.38 8.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.375 -0.828 . . . . 0.0 110.088 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -128.32 -6.06 5.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.333 -0.855 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.03 102.91 12.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.89 135.87 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.313 -0.867 . . . . 0.0 109.924 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.12 111.77 20.66 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.224 -0.922 . . . . 0.0 111.147 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 174.69 69.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.315 -0.866 . . . . 0.0 110.582 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 60.21 119.98 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.406 -0.809 . . . . 0.0 110.883 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.47 118.88 37.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.0 109.772 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.55 134.89 12.2 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.71 -83.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.777 1.409 . . . . 0.0 110.928 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.55 22.36 10.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.176 -0.952 . . . . 0.0 110.765 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -50.37 162.94 0.19 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.331 -0.855 . . . . 0.0 110.001 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.74 81.11 3.2 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.237 -0.915 . . . . 0.0 109.832 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.97 100.77 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.911 1.48 . . . . 0.0 110.956 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.063 179.871 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.242 0.544 . . . . 0.0 110.066 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -56.39 -63.67 3.18 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.342 -0.849 . . . . 0.0 110.94 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 47.7 Cg_endo -72.55 153.94 54.99 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.239 1.126 . . . . 0.0 110.638 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 62.22 118.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.674 -0.641 . . . . 0.0 110.514 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.4 147.15 49.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.442 -0.786 . . . . 0.0 110.116 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.77 148.42 4.79 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.3 p -100.86 143.98 30.36 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.378 -1.072 . . . . 0.0 109.88 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.6 129.58 31.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.184 -0.947 . . . . 0.0 110.648 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.9 mtp -140.81 141.85 34.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.421 -0.799 . . . . 0.0 109.912 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -174.66 165.0 2.41 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 10' ' ' GLU . 43.3 Cg_endo -70.8 -171.07 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.759 1.399 . . . . 0.0 109.901 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.7 t -136.33 -13.9 1.77 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.257 -0.902 . . . . 0.0 110.975 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 37' ' ' LEU . . . -64.46 117.45 7.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.022 -1.049 . . . . 0.0 109.698 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.8 OUTLIER -175.16 -49.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 110.75 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.508 ' N ' ' CD1' ' A' ' 15' ' ' TRP . 35.6 m0 -68.19 -4.4 13.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.657 -0.652 . . . . 0.0 111.536 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 36' ' ' ALA . 25.1 mt -79.66 -52.26 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 108.825 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.428 ' O ' ' HB1' ' A' ' 21' ' ' ALA . . . -67.61 -38.42 83.92 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.029 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -75.25 -60.95 2.07 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.21 -0.931 . . . . 0.0 111.074 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.489 ' HB2' HG21 ' A' ' 28' ' ' VAL . . . -45.74 -57.68 4.07 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.159 -0.963 . . . . 0.0 110.821 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . . . -53.53 -41.43 66.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 17' ' ' ALA . . . -64.7 -33.1 75.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.712 . . . . 0.0 110.198 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 24.5 2.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.824 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.22 61.05 6.13 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.98 68.25 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.964 . . . . 0.0 109.72 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 18.1 t -52.7 -54.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.539 -0.726 . . . . 0.0 110.308 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -42.74 -38.07 1.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.0 110.747 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -66.3 -51.49 56.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 19' ' ' ALA . 5.2 t -68.62 -42.89 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.561 -0.712 . . . . 0.0 110.215 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 14.4 mmm180 -46.41 -48.02 18.82 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.375 -0.828 . . . . 0.0 110.277 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.24 -37.65 52.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.465 -0.772 . . . . 0.0 109.918 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HB3' HD22 ' A' ' 16' ' ' LEU . 14.4 mt -59.2 -66.94 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.52 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 23.7 mt -46.93 -48.52 21.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.581 -0.699 . . . . 0.0 110.427 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.08 -18.67 65.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.608 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.53 -6.68 57.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 111.012 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.21 31.79 1.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.494 ' HB3' ' CD2' ' A' ' 16' ' ' LEU . . . -74.09 157.93 35.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -1.057 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -86.96 115.26 61.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.442 -0.786 . . . . 0.0 109.911 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.45 -36.53 11.46 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.497 1.262 . . . . 0.0 110.094 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 24.2 m120 -108.05 61.05 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 110.221 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 37' ' ' LEU . . . -104.06 99.19 15.76 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.37 -0.831 . . . . 0.0 110.364 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.24 121.02 7.41 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.546 1.288 . . . . 0.0 110.343 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -98.61 178.28 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.928 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -69.55 -6.13 28.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 110.816 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 1.95 22.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 0.0 110.695 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.23 30.76 8.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -124.5 133.83 53.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.805 -0.82 . . . . 0.0 109.906 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -50.65 168.98 0.22 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.498 -0.751 . . . . 0.0 110.745 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 69' ' ' GLU . 44.2 Cg_endo -72.32 -19.95 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.03 1.542 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 49' ' ' ILE . 4.9 mt -107.03 -39.28 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.191 -0.943 . . . . 0.0 109.798 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 8.5 mt-30 -50.16 -22.11 1.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 p -113.21 34.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.033 . . . . 0.0 110.584 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.544 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -96.19 35.28 1.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.724 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.9 tmm? 72.39 -10.45 0.92 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.656 -0.652 . . . . 0.0 110.614 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.544 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 44.61 28.47 0.33 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.982 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -137.0 16.91 3.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -150.04 75.38 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -1.087 . . . . 0.0 109.579 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.85 -34.3 1.57 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 0.0 110.673 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -48.91 -40.22 29.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.49 -0.756 . . . . 0.0 109.812 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' A' ' 20' ' ' ALA . 19.4 t -62.4 -55.69 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -41.56 -54.55 3.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.626 -0.671 . . . . 0.0 109.92 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.75 -43.86 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.673 -0.642 . . . . 0.0 110.136 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.7 OUTLIER -53.66 -73.36 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.125 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 34.2 mt -58.84 -49.26 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.698 . . . . 0.0 109.533 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' CD1' ' HA ' ' A' ' 97' ' ' LEU . 3.0 tt -48.42 -67.45 0.27 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.509 -0.745 . . . . 0.0 110.705 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.83 -19.51 17.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.347 -0.846 . . . . 0.0 110.107 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.555 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -85.06 -44.35 13.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.404 -0.81 . . . . 0.0 109.777 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 139.93 37.7 0.11 Allowed Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -66.8 -147.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.867 -1.372 . . . . 0.0 109.141 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.555 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 2.3 mt-10 -121.07 67.07 15.6 Favored Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 121.625 -0.672 . . . . 0.0 109.392 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.44 -7.9 22.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.971 1.511 . . . . 0.0 110.259 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -118.81 -72.85 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.376 -0.828 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.2 t -42.27 149.11 0.17 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.375 -0.828 . . . . 0.0 110.541 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . . . -132.36 -144.86 0.25 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.811 . . . . 0.0 110.405 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -103.72 139.07 19.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.578 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.63 2.23 7.63 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.444 1.234 . . . . 0.0 110.486 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.46 -56.02 3.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 109.148 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.617 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -129.26 19.05 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.751 -0.593 . . . . 0.0 109.576 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER 44.08 43.58 5.67 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.627 -0.671 . . . . 0.0 111.559 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 81.0 m -69.96 104.45 2.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 109.857 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.635 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.4 OUTLIER -69.45 148.79 97.19 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.914 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.635 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.2 Cg_endo -64.66 -14.89 47.19 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.519 1.273 . . . . 0.0 108.919 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.04 -35.4 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.578 0.704 . . . . 0.0 109.221 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 24.0 m80 -65.38 -38.14 89.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.468 0.651 . . . . 0.0 109.501 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.538 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -55.13 -50.42 69.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.746 -0.596 . . . . 0.0 110.951 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB1' HG23 ' A' ' 93' ' ' THR . . . -56.73 -64.38 0.89 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.978 -1.076 . . . . 0.0 108.725 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -53.33 -38.34 63.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.45 -0.781 . . . . 0.0 110.259 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.7 OUTLIER -49.55 -38.77 32.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.614 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.79 8.79 39.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 110.437 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 65.15 30.04 76.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -95.01 82.05 3.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.522 -0.987 . . . . 0.0 110.654 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.2 OUTLIER -55.47 -42.39 74.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.832 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -47.33 -50.81 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 110.197 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.407 HG23 ' HB1' ' A' ' 85' ' ' ALA . 3.1 m -53.82 -45.8 70.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.407 -0.808 . . . . 0.0 109.855 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 126' ' ' VAL . 0.4 OUTLIER -58.81 -44.89 90.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.742 . . . . 0.0 110.007 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 21.4 t -56.7 -44.61 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.3 t -57.2 -54.49 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.51 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 13.3 mt -49.4 -51.0 37.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.679 -0.638 . . . . 0.0 110.16 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.66 -30.36 65.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.4 mtp180 -61.38 -14.02 24.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.33 -86.33 0.64 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.951 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.03 94.5 0.12 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.19 107.37 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 110.591 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -69.62 143.11 53.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.713 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.18 37.07 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.417 -0.802 . . . . 0.0 109.763 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.02 34.22 4.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.365 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' CG1' ' HG2' ' A' ' 80' ' ' ARG . 13.0 p -102.6 173.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.946 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -124.91 148.15 48.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -69.4 66.22 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 0.0 109.883 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . 65.51 -61.72 0.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.509 -0.744 . . . . 0.0 109.964 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.617 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.8 m-90 -70.2 -83.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 107' ' ' ARG . . . -170.06 21.62 0.08 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -84.29 136.8 33.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.06 -1.259 . . . . 0.0 109.931 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 113' ' ' LEU . 4.0 mm? -104.98 165.9 12.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.635 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' C ' HD11 ' A' ' 130' ' ' LEU . 46.2 Cg_endo -71.73 -38.86 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.841 1.443 . . . . 0.0 109.838 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 127' ' ' ALA . 9.8 p -64.98 -35.91 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 0.0 111.225 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -61.09 -47.71 85.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 111.268 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.46 -49.57 64.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.196 -0.94 . . . . 0.0 110.939 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.424 ' CB ' ' CB ' ' A' ' 127' ' ' ALA . . . -53.26 -50.25 65.2 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.235 -0.916 . . . . 0.0 110.736 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -56.86 -51.83 67.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.996 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -61.54 -57.94 10.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.466 -0.771 . . . . 0.0 110.193 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.368 -0.832 . . . . 0.0 110.419 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.59 34.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.2 m-70 -107.33 53.39 0.69 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.434 -1.039 . . . . 0.0 109.288 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -47.62 -36.7 11.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.533 -0.729 . . . . 0.0 110.069 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.23 -44.98 88.5 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.95 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 130' ' ' LEU . 20.2 t -80.27 -42.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 115' ' ' VAL . . . -52.25 -44.81 65.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 109.676 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -65.27 -64.57 0.83 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.278 -0.888 . . . . 0.0 109.323 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 94' ' ' LEU . 26.0 t80 -47.51 -40.66 19.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.655 . . . . 0.0 110.06 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.53 ' CD1' HG13 ' A' ' 126' ' ' VAL . 14.2 mt -63.28 -55.03 28.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.544 -0.723 . . . . 0.0 110.083 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.32 -27.08 0.61 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.512 -0.742 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.19 -62.94 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.036 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.9 -6.09 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.317 -0.864 . . . . 0.0 111.026 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . -108.37 0.8 21.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.101 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.78 71.81 0.05 OUTLIER Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -88.92 27.45 7.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.8 p -90.46 -2.73 57.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.251 . . . . 0.0 110.323 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.5 mtp-105 60.9 -153.64 0.37 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.363 -0.836 . . . . 0.0 110.378 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.02 -96.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.4 p -96.07 -140.05 0.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.316 -1.108 . . . . 0.0 110.05 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.16 117.09 26.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.001 . . . . 0.0 109.925 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.19 -72.96 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.871 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 144' ' ' ARG . . . -64.54 -157.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.44 -0.787 . . . . 0.0 109.629 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 143' ' ' ALA . 3.7 ttt180 61.18 142.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.377 -0.827 . . . . 0.0 110.375 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' A' ' 147' ' ' ALA . 3.6 tp -98.42 112.36 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.284 -0.885 . . . . 0.0 109.968 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -50.66 93.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 145' ' ' ILE . . . -44.59 119.13 1.78 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.503 -0.748 . . . . 0.0 110.85 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.4 132.52 20.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.56 -0.712 . . . . 0.0 110.185 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.59 -1.29 15.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 110.574 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.79 125.36 4.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.37 109.69 2.67 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.46 1.242 . . . . 0.0 110.37 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.18 2.43 2.78 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.43 -0.794 . . . . 0.0 111.518 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.18 -177.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.054 -1.029 . . . . 0.0 110.697 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.59 94.15 15.42 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.32 126.99 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.663 1.349 . . . . 0.0 110.624 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.145 179.764 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.185 0.517 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.87 131.23 23.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.394 -0.817 . . . . 0.0 109.931 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.92 117.71 4.56 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.702 1.369 . . . . 0.0 110.547 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.05 156.03 21.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 0.0 110.093 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.85 -160.21 1.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.411 -0.806 . . . . 0.0 110.177 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.43 65.19 3.42 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 p 50.13 -173.32 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.617 -0.931 . . . . 0.0 110.385 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.2 p -83.12 -178.51 7.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 109.927 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.7 mtm -58.11 -171.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.22 -0.925 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -47.72 123.19 9.37 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.316 -0.865 . . . . 0.0 110.557 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -74.29 -179.47 4.78 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.516 1.272 . . . . 0.0 110.894 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 13' ' ' ALA . 1.6 t -65.09 -177.47 0.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.693 . . . . 0.0 110.016 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . -93.31 55.09 2.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.367 -0.833 . . . . 0.0 110.381 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.12 -36.08 78.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.353 -0.842 . . . . 0.0 110.285 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.402 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER -43.03 -36.26 1.53 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.523 -0.736 . . . . 0.0 110.468 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.425 HD13 ' CB ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -49.88 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' H ' ' HB3' ' A' ' 16' ' ' LEU . . . -47.41 -52.67 16.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.625 -0.672 . . . . 0.0 111.394 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 4.8 p -40.57 -61.01 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.34 -0.85 . . . . 0.0 111.137 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.19 -53.59 54.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.37 -44.28 72.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.65 -17.65 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.647 -0.658 . . . . 0.0 110.276 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -100.67 19.9 16.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.366 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.4 53.67 39.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -127.64 96.24 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' CZ ' ' A' ' 29' ' ' ARG . 24.4 t -74.56 -44.49 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.292 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.19 -45.63 90.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 110.729 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 2.2 mt-10 -53.05 -44.76 67.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.357 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.515 ' C ' HD22 ' A' ' 62' ' ' LEU . 4.7 t -75.97 -46.61 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.724 . . . . 0.0 109.936 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.476 ' HD2' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.93 -44.89 40.88 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.305 -0.872 . . . . 0.0 110.204 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.51 61.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.571 -0.705 . . . . 0.0 110.232 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.412 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 2.1 mt -65.44 -67.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.524 ' HB3' ' CD2' ' A' ' 66' ' ' HIS . 2.7 mt -47.43 -33.64 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -30.4 68.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.94 -6.68 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.845 . . . . 0.0 110.193 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.27 30.88 3.22 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -56.1 162.42 1.96 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.289 -1.124 . . . . 0.0 109.929 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.1 tp -80.28 127.33 76.73 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.393 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.36 -29.58 13.69 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.765 1.403 . . . . 0.0 110.407 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -132.91 81.08 1.92 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.66 129.43 31.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 110.221 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.63 93.41 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.562 1.296 . . . . 0.0 110.259 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.8 -167.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.244 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.64 2.77 41.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.895 . . . . 0.0 110.544 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -105.26 23.1 14.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.121 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.45 23.57 19.95 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -124.02 -164.52 1.25 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.48 -1.012 . . . . 0.0 110.087 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.52 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -139.88 -174.39 0.41 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 108.997 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 47' ' ' ARG . 38.9 Cg_endo -66.2 160.82 43.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.127 1.067 . . . . 0.0 109.965 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt 68.43 -59.61 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.613 -0.679 . . . . 0.0 110.008 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -51.78 -21.16 2.58 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.82 -1.175 . . . . 0.0 110.015 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.2 9.81 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.383 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 2.6 ptt? -69.59 159.74 32.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.993 -1.067 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -46.65 -24.74 0.59 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.569 -0.707 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.454 ' HE2' ' HE3' ' A' ' 52' ' ' MET . 0.0 OUTLIER 64.54 14.44 8.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.914 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.44 14.63 27.65 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.24 87.22 1.51 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.59 -0.947 . . . . 0.0 109.818 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.55 -23.09 9.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.85 . . . . 0.0 110.03 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -60.29 -35.35 75.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 110.001 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.56 -49.09 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' LEU . . . -53.61 -55.44 25.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.792 . . . . 0.0 110.043 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 2.2 tm-20 -49.76 -41.53 44.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.094 -1.004 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.515 HD22 ' C ' ' A' ' 28' ' ' VAL . 2.6 tp -69.03 -57.18 5.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.302 -0.874 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.462 ' C ' ' HB1' ' A' ' 68' ' ' ALA . 6.8 mt -65.71 -41.02 92.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' ALA . 2.9 tt -59.46 -65.4 0.68 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 110.938 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.483 ' C ' ' CD1' ' A' ' 65' ' ' LEU . 3.5 pp -52.9 -24.56 9.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 109.697 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.524 ' CD2' ' HB3' ' A' ' 32' ' ' LEU . 1.3 m80 -80.79 -41.99 22.46 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.541 -0.724 . . . . 0.0 109.941 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.56 41.11 0.1 OUTLIER Glycine 0 N--CA 1.482 1.76 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB1' ' C ' ' A' ' 63' ' ' LEU . . . -68.2 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.986 -1.302 . . . . 0.0 109.737 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 4.3 tp10 -120.96 57.12 5.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.331 -0.856 . . . . 0.0 110.217 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.14 -25.42 19.13 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.885 1.466 . . . . 0.0 110.341 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -100.06 -76.81 0.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 0.0 110.137 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 162.91 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.568 -0.707 . . . . 0.0 110.41 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . . . -140.53 -132.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -0.842 . . . . 0.0 110.196 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 78' ' ' LEU . 41.6 t0 -121.18 129.8 25.11 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 -7.95 22.46 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.369 1.194 . . . . 0.0 110.592 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.45 -49.58 11.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.01 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.606 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -134.72 24.5 3.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.55 -0.719 . . . . 0.0 110.072 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 74' ' ' ASP . 7.7 mt 41.86 31.63 0.23 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.697 -0.627 . . . . 0.0 110.749 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.6 m -67.61 86.56 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.818 . . . . 0.0 110.236 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.544 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -69.56 167.78 20.78 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 109.787 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 51.1 Cg_endo -73.46 -2.68 12.49 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.433 1.228 . . . . 0.0 110.913 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 104' ' ' LEU . 36.1 t -78.25 -27.45 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 110.092 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.457 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 19.9 m80 -74.19 -39.32 63.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.885 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 50.2 m-20 -55.02 -56.0 24.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.645 -0.659 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.498 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -56.35 -63.01 1.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.747 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -52.65 -54.25 35.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.873 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -47.66 -39.52 17.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.394 -0.816 . . . . 0.0 110.803 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.62 12.6 20.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.97 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 55.59 56.16 25.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -129.63 90.6 3.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.468 -1.019 . . . . 0.0 111.223 -178.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.42 ' CD1' ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -73.41 -35.0 65.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.792 . . . . 0.0 109.665 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.58 -47.98 28.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.673 -0.642 . . . . 0.0 109.779 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 m -64.11 -41.64 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.498 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 1.6 tp -52.86 -55.09 25.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.6 -0.687 . . . . 0.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 87.2 t -48.92 -46.26 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.72 -0.613 . . . . 0.0 109.433 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 49.9 t -58.52 -53.31 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.512 0.672 . . . . 0.0 109.402 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -48.72 -52.74 22.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.551 -0.718 . . . . 0.0 110.071 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -74.05 -21.84 59.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 109.817 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.9 ttp180 -64.24 -16.73 62.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.495 -0.753 . . . . 0.0 110.474 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.444 ' CB ' HD22 ' A' ' 64' ' ' LEU . . . -134.1 -76.85 0.47 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.0 100.52 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . . . -152.01 94.94 2.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -1.046 . . . . 0.0 110.526 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.66 108.2 0.41 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.249 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.462 ' HA ' HG23 ' A' ' 82' ' ' VAL . 2.0 mt -98.9 32.38 2.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.04 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.47 44.64 2.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 0.0 110.373 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 80' ' ' ARG . 9.5 p -111.21 -178.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.9 mtp85 -122.83 -176.67 3.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -104.46 36.28 2.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.901 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 66.35 3.7 2.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 110.945 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.606 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 3.6 m-90 -123.65 -57.96 1.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.981 -1.074 . . . . 0.0 109.959 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.83 -30.4 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.44 165.4 4.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -1.036 . . . . 0.0 110.831 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 42.3 mt -128.82 169.62 12.57 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.644 -0.66 . . . . 0.0 109.278 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.96 -13.87 37.5 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.454 1.239 . . . . 0.0 109.806 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 131' ' ' ARG . 4.6 p -90.56 -40.09 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 110.657 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -57.01 -43.18 81.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.354 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.54 -53.19 60.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.861 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 123' ' ' HIS . . . -53.36 -53.89 44.59 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -49.46 -30.45 8.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.0 109.94 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 28.2 mm-40 -85.15 -59.12 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.565 -0.71 . . . . 0.0 109.544 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 110.053 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.68 28.34 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 12.0 m-70 -97.98 47.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.028 -1.278 . . . . 0.0 109.159 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.91 -40.92 6.73 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.606 0.717 . . . . 0.0 109.547 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.42 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 5.3 p-10 -61.74 -46.79 88.13 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.039 -0.665 . . . . 0.0 109.635 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -76.17 -40.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 109.777 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 131' ' ' ARG . . . -52.81 -62.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.348 -0.845 . . . . 0.0 110.341 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -47.02 -61.27 1.95 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.504 -0.748 . . . . 0.0 111.303 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.421 ' C ' ' CD1' ' A' ' 129' ' ' TYR . 14.8 t80 -56.64 -63.55 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.896 . . . . 0.0 110.62 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -54.29 -19.92 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 110.514 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -75.4 -40.62 57.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.036 -1.04 . . . . 0.0 110.148 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.55 77.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.61 -15.94 31.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.716 -0.615 . . . . 0.0 109.819 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -111.78 27.9 9.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.331 -0.855 . . . . 0.0 110.397 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.45 -103.9 0.19 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.17 -67.56 1.44 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.4 p -59.82 112.68 1.93 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.277 -1.131 . . . . 0.0 110.021 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.27 73.24 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 110.158 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 77.14 -142.55 27.51 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.57 -179.13 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.378 -1.072 . . . . 0.0 110.343 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -131.5 -43.03 1.03 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -138.27 -170.46 2.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.41 -0.806 . . . . 0.0 110.06 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 44.95 62.17 2.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.503 -0.748 . . . . 0.0 110.642 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -58.07 171.41 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 110.125 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.5 tp -77.96 137.76 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.459 -0.776 . . . . 0.0 109.906 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -43.49 110.81 0.22 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 110.704 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.4 133.39 24.53 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.787 . . . . 0.0 110.321 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.99 116.56 2.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.443 -0.786 . . . . 0.0 110.476 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -91.42 117.45 29.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 64.52 156.03 0.17 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.23 134.55 10.36 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.722 1.38 . . . . 0.0 110.421 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.08 116.18 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.331 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.01 54.64 0.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 79.0 mt -113.86 95.97 39.54 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.409 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.57 126.17 15.04 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.571 1.3 . . . . 0.0 110.065 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.2 t0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.55 -179.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.077 0.465 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -119.45 105.5 43.87 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.222 -0.924 . . . . 0.0 110.412 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.47 138.07 31.86 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.64 1.337 . . . . 0.0 111.087 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 172.78 111.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.427 -0.795 . . . . 0.0 109.793 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.88 56.59 0.43 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 110.252 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.15 163.42 20.97 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.3 p -94.05 -1.2 54.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.375 -1.073 . . . . 0.0 110.611 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 10' ' ' GLU . 27.8 p -82.3 104.43 12.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.93 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.1 ttp -54.32 91.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.46 -0.775 . . . . 0.0 110.7 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 8' ' ' SER . 2.0 mp0 49.42 91.34 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.471 -0.768 . . . . 0.0 110.554 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.8 83.05 1.63 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.697 1.367 . . . . 0.0 109.901 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.69 -67.48 0.98 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 111.021 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.51 22.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.392 -0.817 . . . . 0.0 110.118 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 20.2 p-10 -100.17 3.74 43.96 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.408 -0.808 . . . . 0.0 110.579 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.545 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.8 m0 -54.42 -21.03 8.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -75.62 -42.33 51.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.452 -0.78 . . . . 0.0 109.403 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.93 -45.12 28.92 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.823 . . . . 0.0 109.895 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -47.23 -56.26 7.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.571 -0.705 . . . . 0.0 110.434 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.83 91.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 110.163 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 59' ' ' VAL . . . -53.96 -53.81 47.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.5 -29.31 66.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.422 -0.799 . . . . 0.0 110.436 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.85 23.86 2.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.82 44.62 39.99 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.09 93.55 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -1.11 . . . . 0.0 110.017 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 58' ' ' ARG . 5.1 t -75.1 -46.46 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 110.192 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -32.92 70.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 1.6 tp10 -74.03 -46.45 43.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 0.0 109.766 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.94 -46.89 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 110.41 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.561 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 46.3 mmm-85 -55.21 -46.76 75.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.053 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.34 56.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 0.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.486 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 13.0 mt -61.15 -63.01 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.945 . . . . 0.0 110.49 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.433 HD23 ' CB ' ' A' ' 66' ' ' HIS . 1.4 mt -49.18 -43.27 42.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.392 -0.817 . . . . 0.0 110.476 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -71.09 -13.36 61.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.88 -10.17 37.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.194 -0.941 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.01 -2.83 5.57 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.333 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB1' ' C ' ' A' ' 31' ' ' LEU . . . -53.69 103.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.03 -1.276 . . . . 0.0 109.896 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 tp -50.5 123.4 17.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.494 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 40.8 Cg_endo -67.84 -43.44 5.2 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.598 1.315 . . . . 0.0 110.489 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -91.07 54.13 2.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.12 -0.988 . . . . 0.0 109.817 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.8 93.95 6.84 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.771 . . . . 0.0 110.612 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.17 97.11 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.588 1.309 . . . . 0.0 110.034 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -63.7 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.315 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.12 36.42 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -0.887 . . . . 0.0 110.319 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -7.76 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 111.073 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 24.48 19.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.44 32.45 5.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.541 -0.976 . . . . 0.0 109.369 -179.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mmt180 49.77 179.76 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 49.7 Cg_endo -86.44 -13.69 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.155 1.082 . . . . 0.0 111.065 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.69 -43.05 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.95 -1.094 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 1.5 tt0 -46.24 -28.91 1.4 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 7.1 p -109.32 40.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.457 ' HA ' ' C ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -99.48 30.38 3.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 109.669 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.3 tmm? 64.65 -4.7 0.43 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.724 -0.61 . . . . 0.0 111.292 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.491 ' CG ' ' HB3' ' A' ' 84' ' ' ASP . 13.0 mmt 42.39 28.64 0.12 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.41 6.89 8.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.75 87.34 1.77 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 110.115 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.84 49.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.805 . . . . 0.0 109.545 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.466 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -54.12 -37.47 64.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.574 -0.704 . . . . 0.0 109.273 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 20' ' ' ALA . 99.0 t -59.84 -61.17 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -54.75 -25.61 28.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.545 -0.722 . . . . 0.0 109.104 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 58' ' ' ARG . 5.2 tm-20 -53.54 -72.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.302 -0.874 . . . . 0.0 110.045 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.56 -36.57 71.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.778 -1.201 . . . . 0.0 109.393 179.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' A' ' 48' ' ' PRO . 1.1 mt -58.09 -63.41 1.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.447 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -61.38 -31.37 71.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.421 -0.799 . . . . 0.0 109.248 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 26.0 tp -68.78 -48.34 63.9 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -77.91 -16.08 58.5 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.423 -0.798 . . . . 0.0 109.951 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.5 63.63 0.58 Allowed Glycine 0 N--CA 1.483 1.825 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.618 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.436 ' HB1' ' C ' ' A' ' 63' ' ' LEU . . . -79.71 -146.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.945 -1.327 . . . . 0.0 109.145 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mm-40 -117.14 55.07 1.53 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.285 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.72 -14.07 32.75 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.497 1.262 . . . . 0.0 110.95 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -103.65 -76.44 0.59 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.127 -0.983 . . . . 0.0 110.262 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.61 144.17 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' A' ' 80' ' ' ARG . . . -119.01 -156.28 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.924 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -102.7 144.18 28.1 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.951 . . . . 0.0 110.441 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.94 -17.08 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.614 1.323 . . . . 0.0 110.327 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.66 -78.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.714 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.466 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 34.8 p -115.06 27.36 9.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.143 -0.973 . . . . 0.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.1 mt 46.64 31.06 1.27 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 111.117 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -67.09 100.37 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.502 ' CG ' HG12 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -75.86 165.48 52.88 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.315 -0.866 . . . . 0.0 109.513 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HA ' ' HG3' ' A' ' 50' ' ' GLN . 47.4 Cg_endo -71.54 -11.51 28.27 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.637 1.335 . . . . 0.0 109.625 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 114' ' ' PRO . 77.2 t -69.5 -46.39 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.436 -0.79 . . . . 0.0 109.93 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 39.9 m80 -52.03 -49.63 63.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.424 -0.797 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 54' ' ' MET . 7.0 m-20 -42.54 -54.67 3.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 122.02 -0.425 . . . . 0.0 111.437 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -53.29 -62.69 1.49 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' O ' ' ND1' ' A' ' 123' ' ' HIS . . . -63.18 -26.15 68.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.564 -0.71 . . . . 0.0 110.686 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -62.35 -28.44 69.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.018 -1.051 . . . . 0.0 109.947 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.433 ' C ' ' CE1' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -109.05 -20.82 12.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.404 -0.81 . . . . 0.0 110.089 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.486 ' HA2' HG23 ' A' ' 126' ' ' VAL . . . 94.39 32.6 7.27 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.906 -1.677 . . . . 0.0 108.906 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.556 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -99.46 88.05 3.77 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 110.406 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -60.6 -39.08 86.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 110.432 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . 31.8 m-20 -46.85 -46.15 20.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 110.081 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 97' ' ' LEU . 46.5 m -61.47 -46.42 90.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.564 -0.71 . . . . 0.0 110.055 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.443 ' CD1' ' CB ' ' A' ' 85' ' ' ALA . 1.1 tp -51.31 -57.91 7.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.38 -0.825 . . . . 0.0 110.481 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.34 -50.67 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.284 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.37 -51.07 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.532 -0.73 . . . . 0.0 110.358 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.418 HD12 HG21 ' A' ' 93' ' ' THR . 1.1 mp -51.46 -55.66 17.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -71.7 -42.41 67.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.369 -0.832 . . . . 0.0 110.882 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -7.35 6.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.77 -59.16 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.931 -1.106 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.85 108.78 0.28 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -173.03 133.62 0.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -1.167 . . . . 0.0 110.915 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -97.23 80.79 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.611 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.5 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.4 mp -69.91 67.88 0.28 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.0 110.011 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -168.02 33.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.314 -0.866 . . . . 0.0 110.43 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.502 HG12 ' CG ' ' A' ' 80' ' ' ARG . 1.2 p -105.9 -170.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.925 -1.11 . . . . 0.0 109.996 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.458 ' N ' HG11 ' A' ' 106' ' ' VAL . 30.5 mtt180 -131.29 147.52 52.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 35.7 t0 -79.1 54.89 1.71 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 58.6 -69.06 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.74 -0.6 . . . . 0.0 110.635 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.566 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -41.22 -48.65 3.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.71 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.38 -33.88 1.54 Allowed Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.425 ' CD ' ' HB2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -56.58 156.35 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -1.064 . . . . 0.0 110.35 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 29.9 mt -105.9 168.03 8.82 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.489 -0.757 . . . . 0.0 110.412 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 38.8 Cg_endo -65.81 -27.96 51.47 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.773 1.407 . . . . 0.0 110.046 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 3.4 p -77.83 -31.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.506 -0.747 . . . . 0.0 109.731 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.416 ' N ' HG11 ' A' ' 115' ' ' VAL . 3.7 t0 -60.12 -49.2 78.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.448 -0.782 . . . . 0.0 110.189 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.58 -57.25 13.5 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.317 -0.865 . . . . 0.0 110.356 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.22 -54.95 20.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -41.25 37.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.351 -0.843 . . . . 0.0 110.578 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -80.09 -26.42 39.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 0.0 110.421 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 8.3 mt -81.0 2.64 26.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.275 -0.891 . . . . 0.0 110.383 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.86 17.28 73.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 22.2 m170 -94.67 53.44 1.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -1.158 . . . . 0.0 108.949 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -39.97 -59.21 1.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.222 0.535 . . . . 0.0 111.802 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.413 ' O ' HD23 ' A' ' 91' ' ' LEU . 54.8 m-20 -48.6 -39.44 23.9 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.492 -0.755 . . . . 0.0 110.393 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.535 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 1.4 t -80.89 -38.74 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.511 -0.743 . . . . 0.0 110.012 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.79 -38.99 92.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 109.553 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -73.99 -42.62 60.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.257 -0.902 . . . . 0.0 109.841 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.469 ' CD2' HD13 ' A' ' 91' ' ' LEU . 9.5 t80 -59.79 -40.63 88.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.5 ' CD2' HD21 ' A' ' 104' ' ' LEU . 19.4 mt -68.28 -42.96 78.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.509 -0.744 . . . . 0.0 109.591 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -20.95 50.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 0.0 110.355 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.72 -47.6 11.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.881 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.71 -14.57 42.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . -102.5 -64.02 1.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.397 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.8 -158.06 53.03 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.34 91.92 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.9 p -88.12 20.53 3.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.29 -1.124 . . . . 0.0 110.731 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.01 69.3 0.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.006 . . . . 0.0 109.735 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 162.7 172.82 30.65 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.1 m 57.18 168.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.403 -1.057 . . . . 0.0 110.537 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -89.39 50.3 1.9 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.168 -0.958 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.39 -166.12 1.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.361 -0.837 . . . . 0.0 110.045 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.65 126.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.422 -0.799 . . . . 0.0 109.992 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 57.9 77.61 0.28 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.481 -0.762 . . . . 0.0 111.029 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.9 pt -76.79 157.63 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.147 -0.97 . . . . 0.0 109.784 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.87 168.4 0.06 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -0.995 . . . . 0.0 109.999 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 62.84 142.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.407 -0.808 . . . . 0.0 110.25 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.79 124.08 7.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.537 -0.727 . . . . 0.0 111.264 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.2 71.53 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.892 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.33 -145.73 16.1 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -79.98 140.64 14.41 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.58 1.305 . . . . 0.0 110.329 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.4 m -86.45 103.56 15.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.525 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.56 93.51 0.16 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.349 -0.844 . . . . 0.0 109.706 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 154' ' ' ILE . 0.8 OUTLIER -123.05 92.8 48.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.503 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.62 113.24 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.596 1.314 . . . . 0.0 110.362 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.058 -179.657 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mmm . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.237 0.541 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.508 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 2.2 mt-10 -78.72 -61.19 0.54 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.499 -0.75 . . . . 0.0 111.007 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 47.8 Cg_endo -70.28 149.06 63.02 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.284 1.149 . . . . 0.0 110.653 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.57 76.31 0.36 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.341 -0.849 . . . . 0.0 110.377 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.98 100.54 4.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.461 -0.774 . . . . 0.0 110.369 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.94 125.76 7.24 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -145.44 36.76 1.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -1.178 . . . . 0.0 110.104 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 t 46.39 83.88 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.566 -0.709 . . . . 0.0 110.565 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.7 ptp -119.22 -11.01 9.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 0.0 110.71 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.23 130.68 91.77 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 0.0 109.732 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.28 80.68 2.44 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.454 1.239 . . . . 0.0 109.837 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.3 11.02 6.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.529 -0.732 . . . . 0.0 110.336 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.17 -33.1 29.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 110.485 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' A' ' 18' ' ' THR . 12.1 t70 -81.91 -5.86 58.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.422 -0.799 . . . . 0.0 110.988 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.403 ' HB3' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.54 -3.98 17.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.933 -1.105 . . . . 0.0 111.169 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 28.0 mt -81.14 -49.63 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.128 -0.983 . . . . 0.0 109.57 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.88 -46.73 67.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.675 -0.64 . . . . 0.0 110.077 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.79 -63.67 1.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.673 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 28' ' ' VAL . . . -51.97 -46.02 64.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -57.63 -49.22 77.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' CA ' ' O ' ' A' ' 51' ' ' VAL . . . -63.77 -24.86 67.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.454 -0.778 . . . . 0.0 110.694 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -90.13 26.35 1.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.784 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.91 31.11 4.0 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -104.46 94.16 5.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.617 -0.931 . . . . 0.0 110.174 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.452 ' CG2' HG21 ' A' ' 59' ' ' VAL . 46.2 t -71.43 -54.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.592 -0.692 . . . . 0.0 110.025 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -47.82 -41.23 23.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.493 -0.755 . . . . 0.0 110.671 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 5.2 mm-40 -59.13 -54.62 44.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 62' ' ' LEU . 2.6 t -64.79 -49.67 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.619 -0.676 . . . . 0.0 109.238 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 3.4 mmt180 -36.95 -51.61 0.92 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.347 0.594 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -78.7 -52.51 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' A' ' 15' ' ' TRP . 49.3 mt -48.39 -74.23 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.317 -0.864 . . . . 0.0 111.382 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.633 ' HG ' ' CD2' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -50.1 -43.25 51.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 110.804 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.44 -10.09 59.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 0.0 110.386 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -87.33 -13.47 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.005 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.49 23.61 1.35 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.494 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -69.6 -172.95 0.53 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.259 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.436 ' O ' ' CD1' ' A' ' 16' ' ' LEU . 3.1 mm? -94.96 126.38 47.09 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 110.829 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.499 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 43.1 Cg_endo -71.34 -16.45 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.284 1.15 . . . . 0.0 110.225 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -137.79 48.08 2.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.79 137.98 76.76 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.42 169.35 22.61 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.751 1.395 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -133.39 -172.13 2.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.3 m -109.14 13.04 24.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.892 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 15.7 m-85 -117.96 8.25 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.248 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.37 31.96 79.19 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -119.1 -169.58 1.76 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.459 -1.024 . . . . 0.0 110.127 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -105.95 164.72 14.4 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.8 Cg_endo -65.85 -15.73 50.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.561 1.295 . . . . 0.0 111.266 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 60' ' ' ALA . 3.6 mt -109.12 -38.25 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.92 . . . . 0.0 108.799 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 2.8 mt-30 -49.96 -23.55 2.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.328 -0.858 . . . . 0.0 110.41 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 21' ' ' ALA . 11.1 p -110.98 36.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.456 -0.777 . . . . 0.0 110.537 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.498 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -96.8 32.25 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.955 -1.09 . . . . 0.0 110.198 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.424 ' HE2' ' HB3' ' A' ' 53' ' ' MET . 6.7 tmm? 64.98 -3.26 0.61 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.654 -0.654 . . . . 0.0 110.568 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.523 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 39.88 32.71 0.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.429 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -122.15 -3.23 9.82 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.6 85.95 1.72 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 110.212 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB3' ' N ' ' A' ' 93' ' ' THR . . . -52.6 -25.74 11.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -49.81 -43.38 48.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.725 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 20' ' ' ALA . 5.9 t -60.21 -54.79 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.476 ' HA ' HD12 ' A' ' 49' ' ' ILE . . . -48.63 -35.63 14.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.641 -0.662 . . . . 0.0 109.333 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -49.53 76.02 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD2' HD22 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -55.06 -57.03 13.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.657 0.742 . . . . 0.0 109.157 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.467 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 4.4 mm? -59.93 -27.96 67.21 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.96 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -73.42 -56.31 5.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.199 -0.938 . . . . 0.0 110.342 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD22 ' CD2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -51.47 -27.08 9.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.838 0.828 . . . . 0.0 109.253 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.633 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.0 -28.58 21.33 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.627 0.727 . . . . 0.0 109.112 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.29 63.34 0.73 Allowed Glycine 0 N--CA 1.477 1.432 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 38' ' ' PRO . . . -71.3 -154.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.079 -1.248 . . . . 0.0 108.664 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 47' ' ' ARG . 13.2 mt-10 -113.9 66.7 1.42 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.286 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.43 ' CB ' HD21 ' A' ' 97' ' ' LEU . 45.3 Cg_endo -69.69 -17.7 37.76 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.766 1.403 . . . . 0.0 110.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.432 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.4 t30 -98.02 -58.61 1.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -0.826 . . . . 0.0 110.501 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 30.7 t -47.0 147.95 1.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.9 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -128.92 -144.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.797 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.8 140.87 24.51 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.241 -0.912 . . . . 0.0 109.96 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -20.03 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.257 1.135 . . . . 0.0 109.919 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.22 -57.8 4.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 110.237 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.471 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -131.72 29.01 4.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 6.1 mt 41.29 38.76 0.84 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.539 -0.726 . . . . 0.0 111.201 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.2 m -72.8 98.28 2.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.949 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.498 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -78.0 163.2 64.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.927 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 44.4 Cg_endo -69.07 -3.99 12.67 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.414 1.218 . . . . 0.0 110.393 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 104' ' ' LEU . 31.2 t -74.99 -29.48 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 2.2 m80 -74.67 -33.21 62.44 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.523 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -55.15 -59.67 4.45 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.341 0.591 . . . . 0.0 110.033 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -53.99 -61.56 2.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.388 -0.82 . . . . 0.0 109.76 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.647 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -54.99 -58.8 6.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 3.3 ttt180 -46.5 -28.16 1.32 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.279 -0.888 . . . . 0.0 110.894 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.465 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 1.8 tm-20 -103.3 1.99 33.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 111.044 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.454 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 64.38 58.93 9.09 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.477 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -134.23 86.75 2.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 110.339 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -58.21 -44.38 88.14 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.566 -0.709 . . . . 0.0 110.077 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -43.8 -46.64 7.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.464 ' N ' ' HB3' ' A' ' 57' ' ' ALA . 52.4 m -60.21 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.48 HD21 HG11 ' A' ' 126' ' ' VAL . 1.8 tp -56.8 -45.67 82.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.178 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 60.5 t -55.63 -50.67 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.608 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.434 HG11 ' HG ' ' A' ' 64' ' ' LEU . 52.7 t -53.54 -53.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.345 -0.847 . . . . 0.0 110.401 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.43 HD21 ' CB ' ' A' ' 70' ' ' PRO . 6.2 mt -50.08 -66.92 0.31 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -56.72 -32.61 65.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 0.0 109.853 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.7 ttp85 -67.44 -8.97 37.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.602 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.35 58.21 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.969 -1.082 . . . . 0.0 111.19 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.4 109.01 0.01 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -166.41 125.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.4 -1.059 . . . . 0.0 110.757 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 114.1 7.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.424 -0.797 . . . . 0.0 109.191 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -111.06 25.01 12.21 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 110.661 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 2.0 p30 -145.19 59.8 1.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.104 -0.997 . . . . 0.0 110.355 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 80' ' ' ARG . 9.2 p -108.77 -177.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.41 ' H ' ' CG2' ' A' ' 106' ' ' VAL . 12.9 mtt180 -132.6 132.37 42.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -72.48 60.95 0.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.445 -0.785 . . . . 0.0 110.07 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.27 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.36 -0.838 . . . . 0.0 110.451 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -124.09 25.28 7.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 0.0 109.902 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -93.61 -75.99 1.32 Allowed Glycine 0 N--CA 1.48 1.605 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 2.1 mtt180 171.93 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.939 . . . . 0.0 110.072 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 2.4 mm? -104.3 170.98 5.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 44.1 Cg_endo -70.74 -22.71 27.2 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.696 1.366 . . . . 0.0 110.622 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.473 ' HA ' HD22 ' A' ' 130' ' ' LEU . 7.2 p -82.81 -39.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 110.082 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.415 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 89.3 m-20 -52.48 -38.79 60.21 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 121' ' ' LEU . 6.5 mt -59.73 -58.45 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.93 -39.82 55.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.732 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.17 -46.41 75.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.21 -24.77 57.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -87.64 -81.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.922 . . . . 0.0 110.681 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.72 42.55 0.02 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 37.3 m-70 -106.03 52.4 0.73 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.983 . . . . 0.0 108.951 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 12.2 ptm180 -42.41 -40.88 2.7 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.201 0.524 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.516 ' O ' HD22 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -60.15 -41.01 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.268 -0.895 . . . . 0.0 108.918 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.513 HG13 HD21 ' A' ' 130' ' ' LEU . 1.4 t -85.0 -41.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.675 -0.64 . . . . 0.0 109.656 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -51.67 -45.62 63.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -0.805 . . . . 0.0 110.308 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -82.57 -43.69 16.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.434 -0.791 . . . . 0.0 110.278 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.468 ' CD1' HD12 ' A' ' 91' ' ' LEU . 53.8 t80 -65.23 -61.76 1.94 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.233 -0.917 . . . . 0.0 109.953 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 HG13 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -56.32 -31.05 63.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 110.064 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 0.7 OUTLIER -66.24 -28.95 69.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.003 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.95 -39.84 65.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.006 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.93 -13.12 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 111.029 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -106.93 -35.2 6.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.975 -1.078 . . . . 0.0 111.098 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.31 90.64 0.08 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -113.78 40.29 2.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.8 p -91.44 127.24 36.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -1.137 . . . . 0.0 109.973 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -81.98 -52.56 6.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.449 -0.782 . . . . 0.0 110.182 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.79 133.42 47.8 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.4 p -59.95 -23.97 64.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.385 -1.068 . . . . 0.0 110.383 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -63.2 105.67 0.75 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.355 -0.84 . . . . 0.0 110.147 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.476 ' CG ' ' N ' ' A' ' 143' ' ' ALA . 1.0 OUTLIER -70.06 -142.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' N ' ' CG ' ' A' ' 142' ' ' HIS . . . 56.98 37.52 28.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.146 -0.971 . . . . 0.0 109.707 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.91 108.23 5.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.541 -0.725 . . . . 0.0 110.25 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.3 mt -83.73 135.73 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 109.379 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 t0 57.52 68.27 0.87 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.085 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 148' ' ' ALA . . . -69.45 117.0 10.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.248 -0.908 . . . . 0.0 110.239 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 147' ' ' ALA . . . 61.11 137.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.456 -0.778 . . . . 0.0 110.253 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.0 153.54 1.8 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.144 -0.972 . . . . 0.0 110.356 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -169.25 -144.84 4.39 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.55 157.37 61.05 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.672 1.354 . . . . 0.0 110.815 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.98 177.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.43 -0.794 . . . . 0.0 110.587 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -87.82 105.71 17.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.572 -0.705 . . . . 0.0 110.24 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 91.7 mt -129.93 78.84 74.28 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.227 -0.921 . . . . 0.0 110.463 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.05 134.5 14.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.852 1.449 . . . . 0.0 109.926 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.461 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.177 0.513 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.584 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.4 m0 -72.31 -11.46 60.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.484 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.784 HD11 ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -74.86 -58.5 3.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.441 -0.787 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.2 -49.43 77.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -43.89 -67.9 0.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.835 -0.541 . . . . 0.0 110.737 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -46.24 -51.21 14.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.33 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.604 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -46.59 -54.18 9.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.667 . . . . 0.0 110.334 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.14 -20.11 65.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.409 -0.807 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 26.4 mtm180 -99.38 22.2 10.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 111.364 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.517 ' CA ' ' HG3' ' A' ' 53' ' ' MET . . . 54.38 52.61 43.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 14.7 mmt180 -124.97 89.93 3.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.2 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 59' ' ' VAL . 81.2 t -74.36 -40.51 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.443 -0.786 . . . . 0.0 110.041 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -34.7 76.75 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.385 -0.822 . . . . 0.0 110.729 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 1.007 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.6 tp10 -61.07 -50.71 72.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.695 HG12 HD13 ' A' ' 62' ' ' LEU . 20.6 t -71.55 -48.54 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.903 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.893 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -41.18 -42.1 1.97 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 -179.377 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.72 -50.33 13.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.49 -0.756 . . . . 0.0 109.09 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.007 HD12 ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -61.56 -60.19 4.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.502 -0.749 . . . . 0.0 110.049 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.808 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -42.95 -46.27 5.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.75 -0.594 . . . . 0.0 110.83 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -75.53 -14.85 60.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 110.318 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.36 -8.39 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.843 . . . . 0.0 110.769 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.58 16.95 3.28 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.119 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.81 135.65 55.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.892 -1.357 . . . . 0.0 110.292 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.427 ' O ' HD23 ' A' ' 16' ' ' LEU . 32.0 tp -83.19 116.71 65.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.669 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HD2' HD12 ' A' ' 37' ' ' LEU . 43.6 Cg_endo -73.1 -36.72 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.488 1.257 . . . . 0.0 110.944 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -91.94 24.09 3.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.306 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.32 148.32 64.03 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.381 -0.824 . . . . 0.0 110.444 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.67 93.4 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.782 1.412 . . . . 0.0 110.258 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -65.43 158.89 25.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.65 -0.656 . . . . 0.0 110.356 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.9 3.51 55.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 110.65 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 11.6 m-85 -114.3 23.12 13.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 74' ' ' ASP . . . 47.18 31.22 6.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HD3' ' HG2' ' A' ' 50' ' ' GLN . 15.1 mtt-85 -114.18 -161.09 0.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.684 -0.892 . . . . 0.0 110.427 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.484 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.98 179.13 0.82 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.955 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.731 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 47.5 Cg_endo -71.21 -26.42 21.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.935 1.492 . . . . 0.0 110.126 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.535 HG23 ' HG2' ' A' ' 52' ' ' MET . 4.4 mt -109.31 -37.57 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.376 -0.828 . . . . 0.0 109.826 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HB3' ' H ' ' A' ' 47' ' ' ARG . 2.0 tt0 -49.4 -22.04 1.05 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.079 -1.013 . . . . 0.0 110.05 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.1 p -104.43 -10.28 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.454 -0.779 . . . . 0.0 110.585 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.73 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -65.08 161.54 18.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.159 -0.963 . . . . 0.0 110.557 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.517 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.54 105.82 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -62.62 -10.53 12.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.469 -0.769 . . . . 0.0 110.881 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -90.33 28.38 7.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -161.39 81.24 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -1.123 . . . . 0.0 110.07 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . . . -49.11 -24.45 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -52.47 -49.86 63.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 25' ' ' VAL . 2.7 t -56.66 -65.15 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.267 -0.896 . . . . 0.0 110.086 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.73 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -40.53 -42.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.606 -0.683 . . . . 0.0 110.008 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.64 -46.37 84.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.458 -0.776 . . . . 0.0 109.055 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.893 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -53.05 -55.2 25.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.784 ' CD2' HD11 ' A' ' 16' ' ' LEU . 2.5 mp -66.54 -43.89 83.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.853 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.764 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -64.24 -55.07 24.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.462 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 15.5 tp -49.18 -34.36 14.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.849 0.833 . . . . 0.0 108.912 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 2.7 m-70 -83.14 -35.02 25.9 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.4 58.62 0.18 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.644 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -78.05 -156.57 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 72' ' ' CYS . 1.8 mt-10 -114.92 64.42 1.61 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.466 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . 40.9 Cg_endo -67.19 -13.95 41.42 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.786 1.413 . . . . 0.0 110.409 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 0.4 OUTLIER -107.26 -57.6 2.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -48.32 150.27 1.32 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 110.751 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' HB2' ' CD ' ' A' ' 80' ' ' ARG . . . -136.54 -139.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.737 . . . . 0.0 109.757 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' LEU . 2.8 t0 -116.32 126.78 27.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.19 -8.89 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.143 1.076 . . . . 0.0 110.142 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.33 -46.87 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.588 HG22 ' CH2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -116.3 -0.52 12.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.1 mt 46.92 23.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.911 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.9 m -61.54 94.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.18 -0.95 . . . . 0.0 108.8 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.597 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -66.49 143.56 98.25 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.567 -0.708 . . . . 0.0 109.2 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 39.1 Cg_endo -66.56 -9.6 24.86 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.784 1.413 . . . . 0.0 110.142 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 104' ' ' LEU . 42.7 t -70.56 -25.12 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.675 ' HD2' HD12 ' A' ' 117' ' ' LEU . 5.9 m80 -72.78 -41.8 64.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.212 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.572 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 15.9 m-20 -47.47 -42.88 23.64 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.277 0.561 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.644 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -66.28 -65.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.959 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.798 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.58 -48.57 81.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -0.899 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.4 tmm_? -51.51 -35.69 41.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.987 -1.071 . . . . 0.0 109.872 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.513 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 2.3 tp10 -88.85 4.07 49.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.09 -1.006 . . . . 0.0 110.218 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 69.56 28.38 72.37 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.613 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -106.21 120.12 41.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.448 -1.031 . . . . 0.0 110.046 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.47 -41.27 9.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 0.0 110.01 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.789 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.2 m-20 -52.58 -25.35 10.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.905 . . . . 0.0 110.471 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.644 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 5.6 m -74.85 -45.95 39.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.191 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.703 ' CD2' HD21 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -57.96 -54.97 40.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.37 -50.68 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.394 -0.816 . . . . 0.0 109.379 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 92' ' ' ASP . 85.3 t -51.07 -55.99 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.748 -0.595 . . . . 0.0 110.162 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.476 ' HA ' HD11 ' A' ' 64' ' ' LEU . 7.6 mp -49.73 -53.51 24.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -61.62 -31.14 71.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.0 109.977 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -71.05 -11.96 61.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.935 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.741 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -140.63 66.32 1.38 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.185 -0.947 . . . . 0.0 111.004 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.87 97.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.445 ' HB3' ' C ' ' A' ' 97' ' ' LEU . . . -160.41 108.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -1.147 . . . . 0.0 110.445 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 4.7 ttt85 -64.75 128.46 35.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.325 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.61 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -119.21 19.72 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.388 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 44.8 t0 -124.48 58.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 110.077 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.71 HG22 ' H ' ' A' ' 107' ' ' ARG . 5.2 p -117.4 -175.39 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.345 -0.847 . . . . 0.0 109.731 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.71 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -139.02 127.96 23.64 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.56 -0.712 . . . . 0.0 110.235 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.537 ' OD1' ' NE2' ' A' ' 83' ' ' HIS . 1.7 m-20 -51.31 150.64 3.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 109.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 77' ' ' THR . . . -44.19 -35.76 2.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.463 -0.773 . . . . 0.0 111.034 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.588 ' CH2' HG22 ' A' ' 77' ' ' THR . 13.4 m-90 -59.57 -79.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.18 29.36 0.02 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.427 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -107.42 -165.04 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -1.21 . . . . 0.0 110.975 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.03 160.51 39.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 39.5 Cg_endo -67.66 -33.64 27.46 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.433 1.228 . . . . 0.0 110.645 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 5.4 p -78.33 -37.81 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.0 110.082 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.99 -43.64 91.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.51 -0.744 . . . . 0.0 109.978 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.675 HD12 ' HD2' ' A' ' 83' ' ' HIS . 2.9 mt -52.27 -39.29 60.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.738 ' HB3' ' HB2' ' A' ' 127' ' ' ALA . . . -69.12 -34.08 74.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.532 -0.73 . . . . 0.0 110.008 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.0 -20.08 64.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.427 ' OE2' ' NH2' ' A' ' 112' ' ' ARG . 29.2 tt0 -86.25 -57.98 2.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.706 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.487 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 6.7 mp -57.07 -81.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.008 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.3 40.41 0.02 OUTLIER Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.5 m-70 -115.09 43.39 2.0 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.43 -1.041 . . . . 0.0 109.759 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -45.65 -37.19 5.45 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -62.33 -37.46 85.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.62 -0.675 . . . . 0.0 109.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.751 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -80.93 -36.19 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . . . -68.34 -32.93 73.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.544 -0.722 . . . . 0.0 109.602 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -59.3 -66.27 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.406 -0.809 . . . . 0.0 109.741 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -52.13 -25.51 9.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.36 -0.838 . . . . 0.0 109.352 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 86' ' ' ALA . 8.7 mt -73.88 -58.82 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 110.427 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -24.06 0.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.84 -51.04 9.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.955 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.15 -13.19 53.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.0 110.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 110.715 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.829 0.347 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.591 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.9 m0 -79.78 -9.97 59.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.96 HD11 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -74.92 -50.75 15.73 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.164 -0.96 . . . . 0.0 109.354 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.46 -47.78 66.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.368 -0.833 . . . . 0.0 109.799 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -50.89 -49.81 58.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.456 -0.777 . . . . 0.0 110.411 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -59.89 -55.71 30.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -48.21 -44.25 32.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.315 -0.866 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -77.33 -32.09 54.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 111.034 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 1.1 ttt-85 -90.99 32.25 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.264 -0.898 . . . . 0.0 111.196 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 48.38 71.17 0.62 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -137.49 50.4 1.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.386 -1.067 . . . . 0.0 110.061 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.808 HG22 ' CG2' ' A' ' 59' ' ' VAL . 70.7 t -45.96 -37.41 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.459 -0.776 . . . . 0.0 110.282 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.83 -46.6 62.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.38 -44.89 89.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.315 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 62' ' ' LEU . 23.7 t -66.02 -46.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.886 . . . . 0.0 109.958 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.923 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -51.27 -46.04 62.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.07 -39.8 65.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.496 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.3 -56.31 11.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.498 -0.751 . . . . 0.0 110.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.885 HD23 ' HB3' ' A' ' 36' ' ' ALA . 14.3 mt -50.1 -50.38 48.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 110.16 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.22 -13.62 60.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.361 -0.837 . . . . 0.0 110.742 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 -11.53 36.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.977 -1.077 . . . . 0.0 111.006 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.55 37.0 0.7 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.885 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -66.84 162.36 21.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -1.125 . . . . 0.0 109.905 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.84 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 5.5 tp -92.18 115.23 64.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 0.0 109.663 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.39 -28.58 39.06 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.461 1.243 . . . . 0.0 110.195 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 28.6 m120 -129.74 66.49 1.47 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 109.753 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.84 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -88.33 108.52 22.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 47.5 Cg_endo -71.63 94.31 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.622 1.327 . . . . 0.0 110.061 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 34.2 p-10 -94.02 -174.81 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.812 . . . . 0.0 110.644 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.46 5.59 41.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 110.914 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.417 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -91.9 -5.56 53.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.83 22.84 12.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -115.03 134.74 54.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -1.064 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -60.37 169.16 1.86 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.813 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 39.6 Cg_endo -66.35 -23.23 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.542 1.285 . . . . 0.0 111.296 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.518 HG23 ' HG2' ' A' ' 52' ' ' MET . 6.1 mt -107.99 -36.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.973 -1.079 . . . . 0.0 109.065 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.478 ' HG3' ' OD2' ' A' ' 84' ' ' ASP . 2.7 tt0 -52.18 -19.85 2.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.734 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 7.2 p -110.37 2.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.72 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -76.91 165.16 25.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.999 -1.063 . . . . 0.0 110.147 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.412 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 3.3 tpp -61.1 96.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.218 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.598 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -55.82 -13.64 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.038 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -90.5 8.94 79.01 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.18 88.84 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.204 -1.174 . . . . 0.0 109.856 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -59.22 -24.34 63.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -52.15 -49.96 62.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.808 ' CG2' HG22 ' A' ' 25' ' ' VAL . 40.6 t -56.72 -56.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 110.109 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.72 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.7 -57.56 2.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.606 -0.684 . . . . 0.0 110.64 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.609 ' O ' HD23 ' A' ' 65' ' ' LEU . 11.0 tt0 -47.02 -48.87 21.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.37 -0.831 . . . . 0.0 110.232 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.923 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -49.62 -70.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.523 -0.735 . . . . 0.0 109.854 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.96 HD11 HD11 ' A' ' 16' ' ' LEU . 3.8 mt -59.96 -48.73 80.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.641 0.734 . . . . 0.0 110.024 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.868 ' HG ' HG12 ' A' ' 96' ' ' VAL . 3.4 tm? -50.96 -69.53 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.692 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.4 pp -53.01 -24.88 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 110.027 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.817 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.35 -55.36 5.46 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.481 -0.762 . . . . 0.0 109.319 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.02 44.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.563 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.813 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -76.05 -158.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.019 -1.283 . . . . 0.0 109.117 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.55 74.63 3.21 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.357 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.594 ' HB3' HD23 ' A' ' 97' ' ' LEU . 55.8 Cg_endo -78.69 10.15 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.955 1.502 . . . . 0.0 110.351 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.487 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -139.53 -60.92 0.55 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.43 152.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.624 -0.672 . . . . 0.0 110.316 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -143.14 -161.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.316 -0.865 . . . . 0.0 110.512 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.6 140.17 25.18 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 110.267 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 1.32 9.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.453 1.239 . . . . 0.0 110.564 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.0 -39.39 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 109.631 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.763 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -128.98 2.07 5.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.49 -0.756 . . . . 0.0 110.279 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 78' ' ' LEU . 3.3 mt 47.76 21.73 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.941 . . . . 0.0 111.684 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -59.08 102.81 0.14 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.926 -1.109 . . . . 0.0 109.115 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.854 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -77.89 159.1 76.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.757 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.417 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 42.2 Cg_endo -68.13 -13.92 39.36 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.154 1.607 . . . . 0.0 110.267 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 104' ' ' LEU . 94.8 t -68.2 -28.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.569 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.487 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.3 m80 -70.74 -44.07 67.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.598 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.11 -47.05 45.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.732 -0.605 . . . . 0.0 110.982 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -62.2 -66.23 0.57 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.562 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.868 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -54.32 -43.4 71.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.449 -0.782 . . . . 0.0 110.592 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -46.38 -41.95 14.33 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.514 -0.741 . . . . 0.0 110.559 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 1.2 mm-40 -96.59 -2.27 45.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.195 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.601 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 75.99 47.25 11.69 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -115.87 95.2 5.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.304 -1.115 . . . . 0.0 111.18 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.675 HD21 ' CD2' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.3 -36.33 79.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.534 179.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.95 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.7 m-20 -50.46 -58.59 5.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 0.0 109.357 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 92.4 m -52.77 -44.48 66.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.991 HD11 HD21 ' A' ' 130' ' ' LEU . 5.9 tp -54.89 -53.22 58.3 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.32 -40.16 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 92' ' ' ASP . 21.8 t -62.75 -40.41 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 94' ' ' LEU . 19.4 mt -63.38 -61.48 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.42 -17.66 3.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -39.01 66.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.382 -0.824 . . . . 0.0 110.963 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -118.98 70.83 0.83 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 111.457 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.65 90.78 0.01 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . . . -143.94 82.5 1.72 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -1.167 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.16 143.81 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.51 -0.744 . . . . 0.0 110.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.734 ' HA ' HG21 ' A' ' 82' ' ' VAL . 2.9 mp -129.74 0.53 4.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.654 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.68 56.65 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.245 -0.909 . . . . 0.0 110.296 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.854 HG11 ' HG3' ' A' ' 80' ' ' ARG . 1.7 p -114.99 -164.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -147.37 140.33 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.518 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 110' ' ' TRP . 45.2 t0 -68.73 63.75 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.763 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 57.06 -77.17 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.4 m-90 -45.94 -70.7 0.09 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.728 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.36 -34.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -43.73 144.79 0.76 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.651 -0.911 . . . . 0.0 110.855 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -114.67 167.03 10.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.371 -0.831 . . . . 0.0 110.464 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' A' ' 117' ' ' LEU . 40.9 Cg_endo -68.61 -34.76 18.64 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.884 1.465 . . . . 0.0 110.563 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.636 HG21 ' HG3' ' A' ' 131' ' ' ARG . 4.3 p -80.77 -23.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.767 . . . . 0.0 110.337 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.78 -44.69 40.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.638 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 117' ' ' LEU . 4.5 pp -63.0 -21.42 66.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.637 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 117' ' ' LEU . . . -77.39 -49.91 13.88 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -31.02 28.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.159 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -86.69 -51.29 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.77 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.524 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -178.46 39.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 39.0 m-70 -120.05 49.19 1.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.383 -1.069 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -53.91 11.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.728 -0.608 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.515 ' O ' HD11 ' A' ' 91' ' ' LEU . 3.0 m-20 -50.13 -34.98 24.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.488 -0.758 . . . . 0.0 109.722 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.802 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -83.41 -35.73 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.151 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -61.65 -45.33 94.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.513 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -55.23 20.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.383 -0.823 . . . . 0.0 109.446 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.675 ' CD2' HD21 ' A' ' 91' ' ' LEU . 20.5 t80 -55.19 -40.52 70.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.346 -0.846 . . . . 0.0 109.539 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.991 HD21 HD11 ' A' ' 94' ' ' LEU . 12.1 mt -64.52 -50.48 67.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 109.312 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.636 ' HG3' HG21 ' A' ' 115' ' ' VAL . 5.2 ttp180 -53.23 -27.64 23.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 0.0 110.328 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.3 -42.8 20.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.48 -11.01 50.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.416 -0.802 . . . . 0.0 110.729 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' A' ' 18' ' ' THR . 9.4 t70 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.914 0.387 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.559 ' O ' HD13 ' A' ' 31' ' ' LEU . 42.2 m0 -76.51 -8.27 56.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.211 -0.931 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 37' ' ' LEU . 1.2 tp -79.41 -50.89 10.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.31 -0.869 . . . . 0.0 109.036 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.49 46.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -63.96 -40.66 96.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.934 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.873 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -63.35 -45.5 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 108.894 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -62.68 -54.3 41.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.95 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -54.82 -22.03 13.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.548 -0.72 . . . . 0.0 110.979 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.94 27.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.943 . . . . 0.0 110.581 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.05 34.12 4.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 1.2 tpt180 -118.69 105.76 11.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.474 -1.015 . . . . 0.0 110.527 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 58' ' ' ARG . 71.6 t -72.46 -56.93 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.299 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -48.92 -26.89 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.533 -0.729 . . . . 0.0 110.909 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.873 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 3.0 mm-40 -71.52 -44.73 64.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 108.84 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.068 HG12 HD23 ' A' ' 62' ' ' LEU . 22.7 t -75.75 -52.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -0.807 . . . . 0.0 109.103 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.926 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -43.57 -50.43 7.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.599 -0.688 . . . . 0.0 110.406 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -73.02 -48.84 32.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.597 -0.689 . . . . 0.0 109.99 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 15' ' ' TRP . 13.5 mt -55.27 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 111.251 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.833 ' CB ' HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -45.64 -49.42 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.0 111.537 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -68.98 -9.1 50.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 110.804 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -102.03 -23.2 14.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.937 -1.102 . . . . 0.0 111.261 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 162.5 -28.62 0.26 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.635 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.759 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -41.87 141.03 0.9 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.286 -1.126 . . . . 0.0 110.464 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.916 ' O ' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -55.94 154.81 13.25 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.2 -38.9 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.818 1.431 . . . . 0.0 109.844 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.9 m120 -122.63 -65.54 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.58 -0.7 . . . . 0.0 109.817 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . 60.59 154.19 0.1 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.586 -0.696 . . . . 0.0 110.275 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.17 177.27 8.04 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.7 1.368 . . . . 0.0 110.171 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.7 155.62 47.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 110.077 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.42 16.14 18.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.5 23.18 34.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -110.14 174.5 5.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.714 ' O ' HG12 ' A' ' 51' ' ' VAL . 4.8 mmp_? -86.49 165.45 33.06 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 63' ' ' LEU . 42.0 Cg_endo -68.69 -12.6 35.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.773 1.407 . . . . 0.0 110.374 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.9 mt -109.37 -36.67 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 108.731 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.46 -21.72 38.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.871 -1.143 . . . . 0.0 108.979 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 47' ' ' ARG . 14.6 p -114.87 31.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.443 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.611 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -96.89 33.65 1.85 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 109.798 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.8 tmm? 72.5 -14.5 0.56 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.781 -0.574 . . . . 0.0 111.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.53 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 50.28 25.25 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.983 -1.073 . . . . 0.0 110.075 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -126.33 15.75 6.77 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.715 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -156.22 93.41 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 109.866 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.37 -22.74 33.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.347 -0.845 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.439 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -58.33 -39.57 79.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.458 -0.776 . . . . 0.0 110.16 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' A' ' 56' ' ' SER . 11.0 t -53.98 -65.17 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB1' HD12 ' A' ' 64' ' ' LEU . . . -52.72 -33.63 48.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 19.4 tt0 -47.23 -42.15 19.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.068 HD23 HG12 ' A' ' 28' ' ' VAL . 1.7 tp -82.7 -41.47 19.27 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -63.83 -62.87 1.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.629 -0.669 . . . . 0.0 109.739 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -48.54 -43.73 35.77 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.355 -0.841 . . . . 0.0 109.756 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.502 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.2 tp -58.95 -43.16 91.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.183 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CG ' HD22 ' A' ' 32' ' ' LEU . 3.5 m80 -81.06 0.03 37.78 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.729 -0.607 . . . . 0.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.11 60.13 1.98 Allowed Glycine 0 N--CA 1.48 1.609 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.83 -148.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.252 . . . . 0.0 109.014 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -115.17 52.75 0.76 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.867 . . . . 0.0 109.662 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 48.6 Cg_endo -70.77 -31.32 16.24 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.461 1.243 . . . . 0.0 109.628 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.403 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -82.85 -75.46 0.31 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.563 -0.711 . . . . 0.0 109.139 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.13 164.43 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.566 -0.709 . . . . 0.0 110.534 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 80' ' ' ARG . . . -154.03 -126.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.027 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.2 m-20 -110.31 132.79 21.32 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.783 -1.198 . . . . 0.0 109.932 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.92 -9.91 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.313 1.165 . . . . 0.0 110.655 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.72 -74.63 0.42 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.377 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.998 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -100.3 9.11 43.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 110.473 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.3 mt 51.09 39.75 24.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -0.896 . . . . 0.0 110.318 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.418 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -64.19 96.21 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 110.019 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -73.19 148.58 88.83 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 110.636 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.7 Cg_endo -67.99 -14.49 41.25 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.699 1.368 . . . . 0.0 109.129 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.886 HG21 ' HA ' ' A' ' 104' ' ' LEU . 94.3 t -64.36 -31.51 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.425 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 26.1 m80 -67.74 -41.23 83.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.53 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 4.0 m-20 -52.35 -51.16 60.35 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.211 0.529 . . . . 0.0 110.58 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.607 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -53.52 -64.98 0.65 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.442 -0.787 . . . . 0.0 109.452 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.799 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.7 -27.9 65.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.654 ' HG2' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -54.11 -49.61 68.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.15 -0.969 . . . . 0.0 110.591 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.84 4.5 53.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 110.321 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.627 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 71.89 36.33 61.29 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -102.53 83.25 2.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.358 -1.083 . . . . 0.0 110.87 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.464 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.88 -39.06 80.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.684 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.2 m-20 -47.67 -37.43 12.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.502 -0.749 . . . . 0.0 110.006 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 97' ' ' LEU . 54.7 m -64.3 -46.59 82.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.731 HD13 HG13 ' A' ' 126' ' ' VAL . 1.2 mp -63.3 -45.11 92.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 110.138 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 55.6 t -48.79 -44.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 92' ' ' ASP . 10.9 t -67.02 -45.4 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.689 . . . . 0.0 109.147 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.842 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -53.09 -43.34 66.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.448 -0.782 . . . . 0.0 109.859 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -83.49 -33.48 25.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.074 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 5.6 ttt85 -66.09 -11.22 47.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.556 -0.715 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.442 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -132.1 -67.71 0.66 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.082 -1.012 . . . . 0.0 111.071 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.57 107.1 0.23 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.842 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -167.29 117.07 0.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.452 -1.028 . . . . 0.0 110.271 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.8 113.88 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.886 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.1 mp -106.41 25.68 10.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 110.225 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.6 p30 -128.79 47.71 2.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.365 -0.834 . . . . 0.0 110.59 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.638 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.6 p -112.14 -169.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.857 . . . . 0.0 109.961 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.638 ' H ' HG22 ' A' ' 106' ' ' VAL . 19.3 ptt180 -140.64 146.74 38.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.96 66.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 110.117 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 51.78 -84.9 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.611 -0.681 . . . . 0.0 110.67 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.998 ' CH2' HG23 ' A' ' 77' ' ' THR . 23.9 p90 -122.94 15.16 9.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.98 -81.0 1.35 Allowed Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.79 -164.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.228 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 106' ' ' VAL . 41.8 mt -95.79 163.42 21.27 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.75 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.6 -19.14 60.26 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.88 1.463 . . . . 0.0 110.379 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 116' ' ' ASP . 14.3 p -79.36 -36.59 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.824 . . . . 0.0 110.152 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 2.5 m-20 -66.95 -39.66 87.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.854 . . . . 0.0 110.353 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.654 HD21 ' HG2' ' A' ' 87' ' ' ARG . 1.4 tt -69.04 -35.74 76.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.951 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.705 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -56.07 -55.96 26.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.531 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -60.52 -41.97 95.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.803 . . . . 0.0 110.473 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.18 -37.89 67.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 109.984 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 87' ' ' ARG . 11.7 mt -86.47 -2.32 58.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 110.416 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.44 33.64 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.546 ' ND1' ' HA3' ' A' ' 89' ' ' GLY . 71.9 m-70 -102.77 46.18 0.93 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.89 -1.359 . . . . 0.0 109.56 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -45.82 -37.97 6.71 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.29 0.566 . . . . 0.0 110.346 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.418 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.6 m-20 -58.15 -42.95 87.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.725 . . . . 0.0 109.195 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 86' ' ' ALA . 13.6 t -76.09 -37.79 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.72 85.43 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -56.51 -61.34 2.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.905 . . . . 0.0 109.625 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -57.63 -24.92 59.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 109.454 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' A' ' 86' ' ' ALA . 11.3 mt -75.73 -52.87 9.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.79 . . . . 0.0 109.545 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -23.28 2.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.814 . . . . 0.0 110.169 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.24 -57.43 3.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.981 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.45 -1.65 34.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 111.013 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.55 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.832 0.349 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.498 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 31.1 m0 -40.19 -30.55 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.619 . . . . 0.0 111.012 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.035 HD11 ' HB1' ' A' ' 36' ' ' ALA . 9.8 mt -75.68 -54.57 6.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.512 -0.742 . . . . 0.0 109.144 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.41 69.43 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.783 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -73.9 -59.31 2.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.755 -0.591 . . . . 0.0 110.633 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . . . -49.67 -54.43 18.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -47.73 -50.22 25.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -36.8 82.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.184 -0.947 . . . . 0.0 109.952 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.84 15.1 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.81 72.05 0.6 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 93.0 mtt180 -136.74 67.95 1.44 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.517 -0.99 . . . . 0.0 109.739 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.763 HG22 ' CG2' ' A' ' 59' ' ' VAL . 50.4 t -57.27 -62.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.451 -0.78 . . . . 0.0 110.058 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 25' ' ' VAL . 9.3 mt-10 -39.73 -36.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.75 -0.594 . . . . 0.0 110.943 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -72.34 -50.11 29.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.554 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.99 HG12 HD13 ' A' ' 62' ' ' LEU . 43.6 t -62.58 -38.87 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.181 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.986 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -55.2 -38.44 68.4 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.855 -1.153 . . . . 0.0 108.434 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.88 12.11 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.93 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' ALA . 4.2 mt -56.35 -65.86 0.53 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 110.339 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.028 HD22 ' CD2' ' A' ' 66' ' ' HIS . 13.5 mt -43.42 -51.04 6.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.296 -0.877 . . . . 0.0 109.68 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 43.0 mt-10 -69.79 -15.25 63.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.61 -5.46 58.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.0 110.732 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.05 2.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.035 ' HB1' HD11 ' A' ' 16' ' ' LEU . . . -75.91 165.44 24.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.547 -0.972 . . . . 0.0 110.253 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -80.43 137.92 51.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 110.344 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 49.9 Cg_endo -76.14 -40.8 0.58 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.888 1.467 . . . . 0.0 110.323 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 67.5 m-80 -101.71 -83.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.653 -0.654 . . . . 0.0 110.087 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . 57.41 69.66 1.56 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 45.4 Cg_endo -71.44 101.97 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.048 1.552 . . . . 0.0 111.708 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 3.9 p30 -178.75 -156.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.52 -0.737 . . . . 0.0 109.706 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 1.1 t 61.72 85.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.42 -0.8 . . . . 0.0 109.747 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.1 m-85 65.89 8.37 5.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 109.836 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.13 23.57 52.71 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.563 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 16.2 mmt-85 -99.62 35.49 1.98 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.07 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.517 ' CB ' ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 53.23 -178.34 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 47' ' ' ARG . 55.7 Cg_endo -82.58 -29.27 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.426 1.224 . . . . 0.0 111.337 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.627 HG13 ' HB1' ' A' ' 68' ' ' ALA . 6.4 mt -107.47 -35.53 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.517 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 20.4 tt0 -60.51 -11.72 7.79 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.019 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.563 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 12.9 p -105.79 3.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.873 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -73.11 166.28 23.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.967 -1.083 . . . . 0.0 109.024 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.3 ttm -63.87 -6.74 6.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.355 -0.841 . . . . 0.0 111.204 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.576 ' HE3' ' CB ' ' A' ' 84' ' ' ASP . 8.5 mmt 56.1 17.22 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.885 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.47 -0.65 24.82 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 88.74 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -1.027 . . . . 0.0 109.873 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -53.35 -24.55 12.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.314 -0.867 . . . . 0.0 110.651 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -48.23 70.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 108.84 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.763 ' CG2' HG22 ' A' ' 25' ' ' VAL . 67.3 t -52.4 -49.5 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -51.71 -53.51 38.54 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.669 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.0 tt0 -49.23 -47.11 46.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.715 -0.615 . . . . 0.0 110.04 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.99 HD13 HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -56.26 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 110.176 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 69.1 mt -53.67 -49.85 67.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.481 -0.762 . . . . 0.0 110.396 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.815 HD13 HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -50.7 -69.19 0.12 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.427 -0.796 . . . . 0.0 111.045 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.9 OUTLIER -51.26 -22.32 2.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.412 -0.805 . . . . 0.0 109.697 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 1.028 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -83.87 -49.11 9.34 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.646 -0.659 . . . . 0.0 109.596 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 38' ' ' PRO . . . 154.51 39.07 0.02 OUTLIER Glycine 0 N--CA 1.478 1.46 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.744 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -71.09 -173.94 0.9 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.557 -1.555 . . . . 0.0 108.593 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 3.6 mt-10 -113.72 64.71 1.17 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.072 -1.017 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.578 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 46.3 Cg_endo -70.77 -10.31 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.093 1.575 . . . . 0.0 109.857 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.469 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -107.89 -29.06 9.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -0.774 . . . . 0.0 109.688 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 158.71 16.94 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.652 -0.655 . . . . 0.0 110.099 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -137.24 -145.92 0.21 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.409 -0.807 . . . . 0.0 110.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.9 143.05 26.1 Favored Pre-proline 0 C--N 1.306 -1.304 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.31 -12.22 23.0 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.82 1.432 . . . . 0.0 110.019 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.86 -71.22 0.46 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.6 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -103.04 -2.53 27.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 111.017 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 mt 63.58 20.92 12.5 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.224 -0.923 . . . . 0.0 111.282 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.7 m -65.51 97.03 0.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.695 ' HG3' HG11 ' A' ' 106' ' ' VAL . 11.9 mmt85 -69.62 164.21 52.44 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.148 -0.97 . . . . 0.0 109.217 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.583 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -67.18 -21.46 48.39 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.879 1.463 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 114' ' ' PRO . 13.4 t -59.99 -27.26 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.567 0.699 . . . . 0.0 109.491 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.511 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.1 m80 -80.47 -32.09 37.23 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.576 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 5.0 m-20 -61.07 -43.03 99.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -60.32 -64.41 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.368 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.935 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -59.59 -35.32 74.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.516 -0.74 . . . . 0.0 110.107 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -45.41 -55.88 5.6 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.249 -0.907 . . . . 0.0 110.717 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.64 5.02 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.547 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 72.74 27.72 68.56 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 1.6 t80 -94.99 103.75 15.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.304 -1.115 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.52 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.96 -43.69 34.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.862 -0.524 . . . . 0.0 110.807 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.1 m-20 -44.39 -34.89 2.16 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.547 0.689 . . . . 0.0 109.748 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.475 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 95.2 m -66.37 -39.89 89.41 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.338 0.589 . . . . 0.0 109.901 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.828 HD13 HG13 ' A' ' 126' ' ' VAL . 1.0 OUTLIER -64.02 -58.28 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 40.0 t -38.21 -53.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.732 -0.605 . . . . 0.0 110.208 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.815 HG12 HD13 ' A' ' 64' ' ' LEU . 24.7 t -55.74 -56.34 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.783 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -44.35 -44.35 8.17 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.351 -0.843 . . . . 0.0 110.509 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -82.4 -26.87 32.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.1 ttt85 -65.05 -10.3 28.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.697 -0.627 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.459 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -133.11 -68.7 0.58 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 111.153 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 70' ' ' PRO . . . -174.12 107.85 0.25 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.409 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -152.39 -155.61 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.572 -0.958 . . . . 0.0 109.629 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' O ' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -162.63 105.92 1.1 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -98.9 68.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.585 -0.697 . . . . 0.0 110.812 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -175.34 42.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.695 HG11 ' HG3' ' A' ' 80' ' ' ARG . 1.4 p -107.16 -175.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 106' ' ' VAL . 2.5 mtp85 -125.8 133.83 51.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -67.05 64.23 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.752 -0.592 . . . . 0.0 110.197 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.6 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 57.87 -80.85 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.449 -0.782 . . . . 0.0 110.947 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.573 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.2 m-90 -45.68 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.0 110.266 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.24 73.05 0.06 OUTLIER Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 108' ' ' ASP . 3.9 mtt180 -134.34 -164.02 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.395 -1.062 . . . . 0.0 109.884 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.508 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -153.07 166.48 15.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 82' ' ' VAL . 43.6 Cg_endo -70.33 -54.9 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.875 1.46 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.16 -26.03 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.626 -0.671 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -62.38 -30.24 71.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.449 -0.782 . . . . 0.0 110.494 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -44.31 18.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 109.666 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.539 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -52.84 -47.03 68.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.506 ' HG2' ' HB1' ' A' ' 127' ' ' ALA . 64.5 mm-40 -63.98 -35.0 79.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.024 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.48 -25.07 50.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.772 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.639 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 42.6 mt -101.7 2.57 38.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.44 43.51 24.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 20.4 m-70 -106.63 55.52 0.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.086 -1.244 . . . . 0.0 110.154 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 12.4 mmt180 -41.05 -57.31 2.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.843 -0.536 . . . . 0.0 110.418 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.455 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -43.59 -43.98 5.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.935 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -86.9 -50.96 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.353 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.506 ' HB1' ' HG2' ' A' ' 119' ' ' GLU . . . -49.94 -50.69 45.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -62.24 -66.12 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.487 ' CD2' HD21 ' A' ' 91' ' ' LEU . 56.6 t80 -47.66 -40.58 20.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.717 . . . . 0.0 109.844 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.0 mt -60.24 -54.12 49.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.659 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -45.28 -36.72 4.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.565 -0.709 . . . . 0.0 110.656 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.82 62.3 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.598 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -83.56 -1.22 53.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.714 -0.616 . . . . 0.0 110.602 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 110.283 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 18' ' ' THR . 16.6 p30 . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.937 0.398 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.525 ' HB3' HD13 ' A' ' 31' ' ' LEU . 42.3 m0 -45.49 -43.6 11.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.593 -0.692 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 32' ' ' LEU . 12.4 mt -58.1 -58.61 7.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.0 109.158 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.4 -51.64 66.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.729 -0.607 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -51.51 -66.14 0.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.342 -0.849 . . . . 0.0 110.845 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.47 -52.2 66.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.98 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -50.4 -58.31 6.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.358 -0.839 . . . . 0.0 110.399 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -52.58 -24.55 8.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.798 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.2 7.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.43 47.81 61.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.6 mtt180 -118.62 73.03 0.9 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.443 -1.034 . . . . 0.0 109.896 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 59' ' ' VAL . 49.2 t -60.59 -60.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.334 -0.854 . . . . 0.0 111.125 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -47.63 -35.19 8.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 110.969 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -39.41 74.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.277 -0.889 . . . . 0.0 109.584 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.909 HG12 HD23 ' A' ' 62' ' ' LEU . 39.1 t -76.13 -49.84 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.187 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 1.013 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -42.32 -46.51 4.61 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.446 -0.784 . . . . 0.0 110.039 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -72.39 -51.86 18.58 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.852 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 15' ' ' TRP . 60.4 mt -51.99 -66.88 0.31 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.542 -0.724 . . . . 0.0 110.964 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -41.51 -59.24 1.66 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.707 -0.621 . . . . 0.0 111.282 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -13.44 61.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.822 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -85.04 -6.93 59.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.97 -1.082 . . . . 0.0 110.86 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.51 -10.29 6.45 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.535 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -50.92 143.6 9.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.274 . . . . 0.0 110.264 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.58 ' O ' HD11 ' A' ' 16' ' ' LEU . 5.8 mp -59.82 153.77 51.57 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.395 -0.816 . . . . 0.0 109.957 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.02 -56.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.679 1.357 . . . . 0.0 110.932 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 69.5 m-80 -96.96 -66.97 0.87 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.11 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 39' ' ' ASN . . . 58.34 101.55 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 40.5 Cg_endo -68.17 122.41 9.47 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.579 1.305 . . . . 0.0 110.705 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -103.87 -166.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.592 -0.693 . . . . 0.0 109.739 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.1 38.5 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.287 -0.883 . . . . 0.0 110.519 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.551 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 18.9 m-85 -122.49 13.75 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.82 49.78 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.551 ' HD3' ' HB3' ' A' ' 44' ' ' TYR . 2.9 ptm180 -159.73 131.67 6.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -1.143 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.596 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.86 -173.66 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.668 -0.645 . . . . 0.0 110.169 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 38.5 Cg_endo -64.44 -173.7 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.196 1.103 . . . . 0.0 111.467 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.2 mt 62.97 -64.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.6 tt0 -48.08 -25.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.001 -1.062 . . . . 0.0 109.344 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 51' ' ' VAL . 12.5 p -120.7 34.18 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.611 -0.681 . . . . 0.0 109.556 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.795 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -94.11 38.25 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.0 110.068 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.45 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 7.5 tmm? 66.98 -10.62 0.3 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.509 -0.745 . . . . 0.0 110.751 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.495 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 48.56 27.76 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.989 -1.069 . . . . 0.0 110.127 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -133.05 13.76 4.95 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.676 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.1 m -144.13 78.13 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -1.044 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -50.63 -29.53 11.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 110.006 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.453 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -56.91 -31.53 65.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.618 -0.677 . . . . 0.0 109.464 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.795 HG11 ' HB2' ' A' ' 52' ' ' MET . 53.1 t -58.59 -65.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.082 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -50.76 -39.21 51.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 110.22 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -51.44 -36.91 46.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.189 -0.945 . . . . 0.0 110.038 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.013 HD22 ' HA ' ' A' ' 29' ' ' ARG . 6.9 tp -89.97 -43.8 10.31 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.455 -0.778 . . . . 0.0 109.158 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -63.7 -55.59 22.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -59.19 -47.36 85.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.335 -0.853 . . . . 0.0 109.7 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 1.7 tp -52.54 -28.35 20.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.213 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.548 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.1 m-70 -93.36 -41.36 9.88 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.551 -0.718 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.34 47.49 0.04 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.593 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.756 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -67.01 -149.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.008 -1.29 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 3.1 pt-20 -116.71 56.71 1.59 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.981 . . . . 0.0 110.872 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.787 ' HB3' HD11 ' A' ' 64' ' ' LEU . 40.1 Cg_endo -68.28 -15.04 41.86 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.635 1.334 . . . . 0.0 109.886 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 1.9 m120 -110.27 -77.9 0.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.528 -0.733 . . . . 0.0 110.095 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -43.0 145.04 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 110.95 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -128.72 -143.0 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 11.3 m-20 -112.58 134.44 21.64 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 109.978 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.54 -19.91 36.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.489 1.257 . . . . 0.0 110.062 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.54 -76.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 108.915 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.544 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 69.6 p -122.36 36.15 4.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.931 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 78' ' ' LEU . 8.7 mt 48.17 34.13 4.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.498 -0.751 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.0 101.67 0.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -85.36 173.18 7.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.47 -11.62 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.07 1.563 . . . . 0.0 110.14 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 104' ' ' LEU . 36.2 t -69.91 -30.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 26.6 m80 -73.1 -47.03 47.92 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 20.6 m-20 -47.28 -47.0 25.24 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.894 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -60.16 -59.98 4.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.827 . . . . 0.0 109.669 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.106 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -61.07 -51.52 68.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.399 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.569 ' HD3' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -41.88 -30.54 0.26 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.522 -0.736 . . . . 0.0 111.058 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.12 -18.89 15.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 110.391 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 88.84 23.81 34.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -97.0 85.02 3.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -1.067 . . . . 0.0 111.018 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.779 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -58.89 -38.39 78.74 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 13.8 m-20 -50.67 -36.99 38.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.3 m -62.96 -47.96 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.766 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -60.84 -43.61 98.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.488 -0.758 . . . . 0.0 109.68 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 91' ' ' LEU . 91.9 t -50.71 -47.67 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.366 -0.834 . . . . 0.0 109.183 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.568 HG12 HD13 ' A' ' 64' ' ' LEU . 45.2 t -60.02 -48.12 89.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' ALA . 1.7 mp -54.98 -40.96 70.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -82.9 -33.11 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.084 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -65.69 -12.2 51.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -0.775 . . . . 0.0 110.439 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.487 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -119.84 -82.15 0.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.715 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.71 56.04 0.13 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . . . -105.7 122.62 46.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -1.132 . . . . 0.0 110.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -54.87 162.13 1.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 109.849 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -149.59 36.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.301 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -150.64 40.63 0.75 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 111.34 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.649 HG22 ' H ' ' A' ' 107' ' ' ARG . 5.1 p -97.87 -176.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -130.2 146.93 51.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.341 -0.849 . . . . 0.0 109.681 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 110' ' ' TRP . 15.1 p-10 -74.53 50.36 0.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 109.851 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 61.66 -60.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.694 -0.628 . . . . 0.0 110.795 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.41 -54.94 14.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.62 -25.4 0.75 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.489 ' O ' HD12 ' A' ' 113' ' ' LEU . 4.0 ttp180 -60.87 -174.15 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.228 -1.16 . . . . 0.0 110.697 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -138.55 175.46 3.32 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.487 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 46.5 Cg_endo -73.48 -47.61 0.29 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.539 1.284 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' CG2' ' HD3' ' A' ' 131' ' ' ARG . 9.2 p -54.46 -33.0 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 0.0 109.1 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -37.72 69.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.639 -0.663 . . . . 0.0 109.321 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -30.78 67.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.217 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.106 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -69.38 -53.41 19.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -16.13 63.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.431 -0.793 . . . . 0.0 110.06 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -38.4 36.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.569 HD13 ' HD3' ' A' ' 87' ' ' ARG . 5.1 mt -92.23 1.46 57.2 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 110.955 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.06 12.87 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.617 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 80.3 m-70 -95.78 46.69 1.09 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.974 -1.309 . . . . 0.0 109.318 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -43.79 -38.1 3.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.747 -0.595 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.779 ' O ' HD11 ' A' ' 91' ' ' LEU . 15.9 p-10 -64.23 -40.8 96.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.371 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -82.94 -40.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -57.51 -53.89 53.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.082 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 mtt-85 -52.99 -59.75 4.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 110.264 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -59.32 -39.88 84.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.882 HD11 ' HB2' ' A' ' 86' ' ' ALA . 12.6 mt -60.06 -30.66 69.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.422 ' HD3' ' CG2' ' A' ' 115' ' ' VAL . 4.1 tpp180 -67.6 -36.74 81.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.875 . . . . 0.0 109.634 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.13 -35.88 36.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.448 -0.782 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.08 23.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.0 110.119 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 0.0 110.091 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.083 0.468 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.497 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 16.2 m0 -69.88 -5.5 26.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.852 HD21 ' CB ' ' A' ' 36' ' ' ALA . 30.7 mt -76.62 -54.33 6.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.981 -1.074 . . . . 0.0 109.689 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -66.16 -33.04 74.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.73 -0.606 . . . . 0.0 110.513 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -71.84 -59.99 2.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.86 -47.73 76.79 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.887 -1.133 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -47.95 -62.89 1.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.449 -0.782 . . . . 0.0 110.186 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.924 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -51.34 -24.25 4.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.233 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -90.27 28.86 1.34 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.521 -0.737 . . . . 0.0 111.028 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.29 43.48 9.77 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HD2' ' HB3' ' A' ' 22' ' ' ARG . 1.7 mtt180 -122.91 96.66 5.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.435 -1.038 . . . . 0.0 109.661 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.738 HG22 ' CG2' ' A' ' 59' ' ' VAL . 60.1 t -82.05 -55.48 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.07 -33.22 1.4 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.668 -0.645 . . . . 0.0 111.685 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 31' ' ' LEU . 1.3 mt-10 -67.77 -65.87 0.64 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.896 -1.127 . . . . 0.0 108.621 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.994 HG12 HD21 ' A' ' 62' ' ' LEU . 6.7 t -58.01 -44.47 87.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.82 ' HA ' HD22 ' A' ' 62' ' ' LEU . 1.5 tpt85 -47.51 -48.93 27.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.947 -1.096 . . . . 0.0 110.31 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.37 -51.28 5.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.578 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -58.28 -40.64 82.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.711 HD22 HD11 ' A' ' 62' ' ' LEU . 6.6 tt -67.92 -47.69 68.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.338 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -59.93 -15.14 19.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.0 110.407 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.33 -62.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.71 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.14 28.1 0.08 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.852 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -70.17 167.37 17.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 110.469 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 16' ' ' LEU . 4.0 mm? -98.23 134.22 22.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.846 . . . . 0.0 110.975 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 44.6 Cg_endo -71.6 -22.95 23.68 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.587 1.309 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -129.81 53.92 1.88 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.578 -0.701 . . . . 0.0 109.279 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -85.06 145.91 44.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.612 -0.68 . . . . 0.0 111.051 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.44 136.9 29.63 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.95 1.5 . . . . 0.0 109.92 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 8.7 m-80 -100.71 -161.8 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -0.889 . . . . 0.0 110.562 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.24 13.34 16.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.488 -0.757 . . . . 0.0 110.246 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -149.1 27.12 0.86 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 110.137 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.86 56.29 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.511 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -115.27 96.48 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.534 -0.98 . . . . 0.0 110.138 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' CD ' ' HD2' ' A' ' 48' ' ' PRO . 29.0 mmt-85 -52.27 171.89 0.19 Allowed Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.332 -0.855 . . . . 0.0 110.45 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HB2' HD22 ' A' ' 63' ' ' LEU . 38.9 Cg_endo -65.89 166.68 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.566 1.298 . . . . 0.0 110.215 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.59 HG13 ' HB1' ' A' ' 68' ' ' ALA . 1.2 mt 64.21 -64.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.808 -0.557 . . . . 0.0 109.625 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 48' ' ' PRO . 17.7 tt0 -45.55 -27.61 0.78 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.861 -1.149 . . . . 0.0 109.35 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.924 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.9 p -117.35 43.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.313 -0.867 . . . . 0.0 110.541 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -104.08 33.65 3.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 109.173 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 9.7 ttp 70.76 -6.62 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.883 -0.511 . . . . 0.0 110.318 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.574 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.92 25.78 0.11 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.0 110.736 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.28 19.16 4.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.02 75.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.455 -1.026 . . . . 0.0 109.697 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -45.03 -27.48 0.56 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.895 . . . . 0.0 109.756 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -49.84 20.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.654 -0.654 . . . . 0.0 109.503 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.738 ' CG2' HG22 ' A' ' 25' ' ' VAL . 62.9 t -56.61 -64.29 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -0.758 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -44.54 -52.16 8.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.432 -0.792 . . . . 0.0 109.827 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.564 ' HA ' HG11 ' A' ' 96' ' ' VAL . 7.0 tm-20 -41.75 -53.38 3.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.994 HD21 HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -59.57 -53.44 58.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.671 -0.643 . . . . 0.0 109.992 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.822 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -65.31 -50.9 63.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.588 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.748 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -48.88 -59.4 3.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.797 . . . . 0.0 110.424 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.2 pp -57.67 -23.32 50.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.077 -1.015 . . . . 0.0 108.776 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.553 ' CG ' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -86.76 -3.12 59.01 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.639 -0.663 . . . . 0.0 109.915 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 84.92 46.91 5.5 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.26 -146.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -1.164 . . . . 0.0 109.301 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 2.0 tp10 -120.72 64.36 11.58 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 49.9 Cg_endo -74.04 -35.23 4.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.916 1.482 . . . . 0.0 110.468 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 3.5 m-80 -85.28 -69.3 0.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.294 -0.879 . . . . 0.0 110.242 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.5 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.3 t -48.71 144.02 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -0.757 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.92 -152.83 0.53 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.512 -0.743 . . . . 0.0 109.815 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.65 149.51 37.53 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.205 -0.934 . . . . 0.0 109.823 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.88 -21.42 24.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.645 1.339 . . . . 0.0 109.098 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.09 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.72 -0.613 . . . . 0.0 109.593 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 27.2 p -133.48 40.98 3.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.445 -0.784 . . . . 0.0 109.079 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.512 ' HA ' HD23 ' A' ' 78' ' ' LEU . 5.8 mt 41.82 42.8 2.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.729 -0.607 . . . . 0.0 111.495 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 m -78.7 103.5 8.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.604 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -76.4 155.13 83.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 109.388 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 39.5 Cg_endo -64.57 -15.67 51.16 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.422 1.222 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' A' ' 104' ' ' LEU . 11.1 t -61.07 -33.29 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 87' ' ' ARG . 7.4 m80 -71.72 -35.36 70.16 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -54.84 -46.89 74.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -57.99 -58.09 9.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.458 -0.776 . . . . 0.0 109.384 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.035 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -69.67 -15.83 63.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.7 tpt180 -80.81 -22.73 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -112.32 -12.93 13.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 110.134 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' CE1' ' A' ' 123' ' ' HIS . . . 80.99 61.02 2.18 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.445 ' O ' HD12 ' A' ' 94' ' ' LEU . 1.2 t80 -135.97 86.08 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -1.069 . . . . 0.0 110.335 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.92 HD23 HG22 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -60.36 -40.52 91.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 111.047 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -45.7 -37.14 5.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.83 . . . . 0.0 109.851 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.445 ' O ' HD12 ' A' ' 97' ' ' LEU . 8.5 m -73.8 -42.81 60.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.784 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.498 -0.751 . . . . 0.0 109.417 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 91' ' ' LEU . 57.8 t -60.49 -45.51 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.662 0.744 . . . . 0.0 109.203 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 HD22 ' A' ' 64' ' ' LEU . 6.5 t -60.31 -50.34 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.751 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -48.26 -44.32 33.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.512 -0.743 . . . . 0.0 110.141 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -84.94 -36.91 21.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.258 -0.901 . . . . 0.0 110.58 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -59.52 -15.12 15.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -128.2 -81.64 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.662 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.33 106.15 0.27 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.751 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -159.06 120.87 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.372 -1.075 . . . . 0.0 110.378 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.539 ' HD3' ' NH1' ' A' ' 80' ' ' ARG . 41.6 ttt85 -74.71 102.08 4.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.513 -0.742 . . . . 0.0 110.073 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.751 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.2 mp -98.31 56.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.25 -0.906 . . . . 0.0 110.396 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -162.36 50.79 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.874 -1.141 . . . . 0.0 110.7 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.729 HG22 ' H ' ' A' ' 107' ' ' ARG . 2.5 p -111.61 -169.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.929 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.729 ' H ' HG22 ' A' ' 106' ' ' VAL . 20.0 mtt180 -127.95 138.25 52.56 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.529 -0.732 . . . . 0.0 109.967 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.4 m-20 -75.34 57.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 110.264 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 57.65 -69.56 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.704 -0.623 . . . . 0.0 111.376 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.566 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.03 -50.49 36.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.328 -0.858 . . . . 0.0 110.425 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.48 -21.33 0.83 Allowed Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -49.27 168.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.416 -1.049 . . . . 0.0 110.778 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 30.9 mt -131.68 167.75 20.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -69.6 -42.19 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.7 1.368 . . . . 0.0 109.699 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 127' ' ' ALA . 5.7 p -71.25 -25.73 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 110.203 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t70 -67.68 -58.19 5.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.57 -60.03 2.41 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.445 -0.784 . . . . 0.0 110.653 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.035 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -47.22 -53.1 14.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -31.25 64.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -26.91 46.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.049 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.544 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 12.4 mt -92.66 -0.72 57.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.72 23.95 40.52 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.544 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 15.6 m170 -95.33 49.34 1.19 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.268 -1.136 . . . . 0.0 109.704 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' HIS . 10.7 mmm-85 -43.16 -33.71 0.96 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.527 -0.733 . . . . 0.0 109.616 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -46.4 79.7 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.92 HG22 HD23 ' A' ' 91' ' ' LEU . 2.4 t -82.81 -34.85 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.478 -0.763 . . . . 0.0 109.544 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.639 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -65.1 -51.36 61.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 108.961 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.405 ' C ' ' HD3' ' A' ' 128' ' ' ARG . 1.2 tmt_? -64.65 -52.5 57.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.655 -0.653 . . . . 0.0 109.482 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.674 ' CD2' HD11 ' A' ' 91' ' ' LEU . 7.7 t80 -50.76 -40.08 53.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.41 -0.807 . . . . 0.0 109.136 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.739 HD11 ' HB2' ' A' ' 86' ' ' ALA . 24.0 mt -65.57 -53.51 40.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.695 -0.628 . . . . 0.0 109.587 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -21.32 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.123 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.26 -54.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 110.566 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.94 56.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.755 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 11.5 p30 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.738 0.304 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.493 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 24.6 m0 -52.05 -52.2 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.996 -1.065 . . . . 0.0 110.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.597 ' CD2' ' HB1' ' A' ' 36' ' ' ALA . 1.4 pp -51.01 -27.49 7.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.26 -0.9 . . . . 0.0 109.899 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 14' ' ' ASP . . . -82.68 -44.04 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 0.0 109.492 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -65.86 -44.55 85.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.492 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.65 -45.86 88.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.852 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -58.61 -44.54 89.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.909 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.63 -30.03 71.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.555 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -97.61 22.38 9.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.432 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.39 60.64 6.59 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 67.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -1.085 . . . . 0.0 110.464 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 59' ' ' VAL . 64.0 t -52.53 -58.92 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -43.12 -41.62 3.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.713 -0.617 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.853 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.3 tp10 -66.4 -46.55 76.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.07 HG12 HD13 ' A' ' 62' ' ' LEU . 22.1 t -70.24 -41.03 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.325 -0.86 . . . . 0.0 110.893 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.769 ' CA ' HD11 ' A' ' 62' ' ' LEU . 24.9 mmm-85 -51.0 -46.01 61.37 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.186 -0.946 . . . . 0.0 109.93 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.43 -43.45 32.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 0.0 109.956 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 27' ' ' GLU . 1.4 mt -57.78 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.89 ' CD1' HD22 ' A' ' 62' ' ' LEU . 12.4 mt -53.25 -44.49 68.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 0.0 110.048 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.19 -16.04 63.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.862 . . . . 0.0 109.917 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.21 -9.79 55.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 110.311 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 22.95 3.53 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.784 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -62.04 134.96 57.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -1.221 . . . . 0.0 109.906 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.597 HD23 ' CA ' ' A' ' 40' ' ' ALA . 3.6 tp -83.3 116.87 66.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -71.74 -41.74 2.05 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.671 1.353 . . . . 0.0 110.489 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.83 48.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.597 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . -93.02 118.57 67.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.72 94.99 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.618 1.325 . . . . 0.0 110.524 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -78.44 179.29 7.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 110.005 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -90.93 23.11 3.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -113.66 -19.05 11.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.73 37.11 93.02 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 32.6 mtt-85 -124.34 31.62 5.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -1.12 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 12.7 mmt-85 49.32 177.31 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.522 -0.736 . . . . 0.0 110.585 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 51.6 Cg_endo -79.71 -19.64 9.76 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.357 1.188 . . . . 0.0 109.92 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.624 HG13 ' HB1' ' A' ' 68' ' ' ALA . 7.0 mt -109.06 -42.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.688 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -50.73 -22.91 2.33 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.881 -1.137 . . . . 0.0 110.295 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.1 p -100.8 5.31 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.605 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.852 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -89.94 146.49 24.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.844 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 106.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.333 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.555 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 13.5 mmt -59.67 -8.46 2.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.814 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -82.0 11.56 47.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 59' ' ' VAL . 3.6 m -144.95 88.65 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.216 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.656 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -61.68 -29.68 70.24 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.16 -0.963 . . . . 0.0 109.546 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -29.75 10.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.681 -0.637 . . . . 0.0 109.821 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 25' ' ' VAL . 11.2 t -74.85 -55.3 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.144 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.612 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -50.22 -47.77 54.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.382 -0.824 . . . . 0.0 109.5 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.736 ' OE1' HG13 ' A' ' 96' ' ' VAL . 3.1 tp10 -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.07 HD13 HG12 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -51.36 -66.31 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.481 0.658 . . . . 0.0 109.943 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.82 HD23 HD21 ' A' ' 32' ' ' LEU . 45.4 mt -68.25 -49.54 59.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 110.858 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD22 HG12 ' A' ' 96' ' ' VAL . 1.8 tt -44.9 -67.37 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.439 -0.788 . . . . 0.0 110.858 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -55.97 -23.5 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.852 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.19 -43.35 24.07 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.409 -0.807 . . . . 0.0 109.534 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.96 36.05 0.06 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.63 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -68.89 -171.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.657 -1.496 . . . . 0.0 109.257 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -111.18 73.07 0.91 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 44.9 Cg_endo -70.5 -7.84 22.21 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.959 1.505 . . . . 0.0 110.64 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.34 -57.17 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.63 161.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 111.566 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.08 -143.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.512 -0.743 . . . . 0.0 109.966 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' LEU . 31.3 t0 -114.37 134.57 22.26 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 109.416 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.71 -3.06 12.84 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.29 1.153 . . . . 0.0 111.011 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.37 -41.3 9.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.0 110.256 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.571 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -131.15 5.98 4.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.09 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.8 mt 48.48 42.63 18.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -0.838 . . . . 0.0 111.008 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 m -75.65 93.32 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 110.401 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.758 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.72 168.77 17.63 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 108.777 179.029 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -75.62 -0.87 10.66 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.096 1.051 . . . . 0.0 110.289 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.756 HG13 HD23 ' A' ' 104' ' ' LEU . 11.4 t -76.31 -34.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -68.08 -36.34 79.67 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.251 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 1.8 m-20 -55.46 -56.12 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.695 -0.628 . . . . 0.0 110.474 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -55.12 -62.06 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.355 -0.84 . . . . 0.0 109.985 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.922 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -56.59 -49.3 75.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 111.108 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -32.35 12.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.081 -1.012 . . . . 0.0 111.045 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -94.3 -4.28 49.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.517 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 81.8 25.51 52.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -98.76 143.7 28.81 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.328 -1.101 . . . . 0.0 110.63 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.656 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -117.04 -39.36 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.867 ' O ' HG23 ' A' ' 96' ' ' VAL . 3.3 t0 -52.83 -36.66 58.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.605 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 2.5 m -60.53 -49.66 76.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.667 -0.646 . . . . 0.0 109.635 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.638 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.8 mp -57.65 -45.23 85.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 109.685 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.0 t -55.89 -43.29 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.343 -0.848 . . . . 0.0 108.922 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 92' ' ' ASP . 46.2 t -61.13 -45.27 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.42 0.629 . . . . 0.0 109.479 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.631 HD23 ' CD1' ' A' ' 64' ' ' LEU . 96.0 mt -57.43 -46.89 83.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.513 -0.742 . . . . 0.0 110.313 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -77.77 -25.94 49.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.498 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -67.04 -13.52 62.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 110.11 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -127.22 -74.24 0.59 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 70' ' ' PRO . . . -174.19 105.83 0.21 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.18 -165.0 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -1.084 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.86 102.59 3.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.489 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.756 HD23 HG13 ' A' ' 82' ' ' VAL . 1.7 mp -93.26 11.31 28.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.843 . . . . 0.0 109.444 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.34 31.06 4.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.758 HG11 ' HB2' ' A' ' 80' ' ' ARG . 4.1 p -104.01 -176.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 110.055 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.662 ' H ' HG22 ' A' ' 106' ' ' VAL . 10.7 ptt-85 -139.21 145.4 39.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.581 -0.7 . . . . 0.0 109.568 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -70.55 63.11 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.124 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 60.04 -65.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.697 -0.627 . . . . 0.0 111.007 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.1 m-90 -57.47 -74.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 110.873 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.76 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -49.69 124.26 9.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -1.12 . . . . 0.0 110.634 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 113' ' ' LEU . 42.4 mt -85.97 164.79 37.67 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.462 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -20.3 46.04 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.719 1.378 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.496 HG23 ' CB ' ' A' ' 130' ' ' LEU . 7.4 p -83.65 -37.88 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.382 -0.824 . . . . 0.0 109.832 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.444 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -70.96 -38.13 72.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.852 . . . . 0.0 109.898 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.36 -41.54 89.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.126 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.922 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -58.6 -59.42 5.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.619 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -30.9 35.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.314 -0.866 . . . . 0.0 110.433 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -24.75 56.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.563 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -90.28 -3.65 57.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 110.607 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.35 14.72 46.85 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.563 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 44.2 m-70 -98.42 48.95 0.99 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.91 -1.347 . . . . 0.0 109.478 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -30.17 2.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.687 -0.633 . . . . 0.0 110.229 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.656 ' O ' HD11 ' A' ' 91' ' ' LEU . 30.7 m-20 -65.41 -41.88 93.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 86' ' ' ALA . 4.7 t -81.6 -38.32 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.42 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.86 97.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -57.96 -67.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.429 -0.795 . . . . 0.0 109.494 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -50.59 -40.89 53.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 86' ' ' ALA . 13.8 mt -57.02 -50.3 73.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -56.23 -22.13 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.753 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.02 -66.39 0.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.083 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.97 -7.31 53.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 111.105 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.144 -0.973 . . . . 0.0 110.355 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.77 0.319 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.487 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 38.2 m0 -74.42 -24.5 59.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.257 -0.902 . . . . 0.0 109.877 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.56 -35.54 79.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 110.151 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.88 -50.56 12.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.457 -0.777 . . . . 0.0 109.184 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -51.36 -51.56 53.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.333 -0.854 . . . . 0.0 109.669 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.64 -37.93 76.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -62.16 -61.02 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.992 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -46.46 -29.1 1.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.702 -0.624 . . . . 0.0 111.105 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 21.2 mtm-85 -91.9 32.43 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.451 -0.78 . . . . 0.0 111.04 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.39 36.2 3.01 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 3.0 mpt_? -108.5 94.74 5.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -1.12 . . . . 0.0 109.609 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.638 HG12 ' HD3' ' A' ' 29' ' ' ARG . 89.8 t -74.46 -59.73 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.646 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -43.15 -30.75 0.49 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 111.668 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.756 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.5 mt-10 -68.0 -52.46 35.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 19' ' ' ALA . 6.1 t -68.49 -41.22 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.578 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.916 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.02 -50.42 27.77 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.439 -0.788 . . . . 0.0 109.616 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.82 -49.1 66.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.643 -0.661 . . . . 0.0 109.84 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.1 mt -58.78 -60.25 4.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.083 HD22 ' CD2' ' A' ' 66' ' ' HIS . 11.7 mt -44.41 -49.25 9.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.595 -0.691 . . . . 0.0 109.95 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.08 -14.29 61.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.471 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -94.63 -3.42 49.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.992 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.35 33.05 1.26 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.684 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.888 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -79.36 140.22 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.296 . . . . 0.0 108.761 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.0 tp -79.72 123.34 84.01 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.083 -1.01 . . . . 0.0 111.058 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.503 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 42.2 Cg_endo -70.72 -21.33 29.18 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.827 1.435 . . . . 0.0 109.84 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -125.78 52.65 1.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.067 -1.02 . . . . 0.0 110.03 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -86.32 154.99 57.38 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.843 . . . . 0.0 110.131 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -79.04 132.04 10.27 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.868 1.457 . . . . 0.0 109.858 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -97.95 -171.84 2.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.38 -0.825 . . . . 0.0 110.822 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 m -113.47 2.78 15.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.79 . . . . 0.0 110.271 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.503 ' CB ' ' HD3' ' A' ' 46' ' ' ARG . 72.5 m-85 -118.24 20.06 13.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.595 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.91 22.69 35.45 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' HD3' ' CB ' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -109.5 -169.64 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -1.201 . . . . 0.0 109.896 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.719 ' O ' HG12 ' A' ' 51' ' ' VAL . 23.7 mmt180 -106.02 165.9 12.21 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.379 -0.826 . . . . 0.0 109.72 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.2 Cg_endo -62.85 -12.79 30.86 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.665 1.35 . . . . 0.0 109.885 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.658 HG13 ' HB1' ' A' ' 68' ' ' ALA . 2.8 mt -110.96 -35.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.431 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 4.1 tt0 -59.17 -15.9 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.992 HG22 ' HB2' ' A' ' 21' ' ' ALA . 7.7 p -118.12 38.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.358 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.616 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.96 29.96 4.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.755 -1.216 . . . . 0.0 109.578 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 7.5 tmm? 74.21 -8.78 1.38 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.792 -0.567 . . . . 0.0 110.46 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.553 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 45.11 24.22 0.12 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.603 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -130.05 18.01 5.35 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.1 t -149.54 64.58 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.486 -1.008 . . . . 0.0 110.586 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -38.33 -32.76 0.08 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.568 -0.707 . . . . 0.0 110.087 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 56' ' ' SER . 3.9 mmt85 -49.74 -41.13 43.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.591 -0.693 . . . . 0.0 109.201 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ALA . 40.8 t -62.22 -61.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.578 -0.701 . . . . 0.0 109.492 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -35.55 -52.84 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.481 -0.762 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.655 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -50.33 -55.39 15.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.006 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.916 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -43.45 -65.8 0.45 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.641 -0.662 . . . . 0.0 110.506 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.837 HD23 HD21 ' A' ' 32' ' ' LEU . 74.2 mt -66.78 -49.88 64.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.526 -0.734 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.764 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -41.82 -72.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.629 -0.669 . . . . 0.0 110.648 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.3 pp -52.46 -23.64 6.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 1.083 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.04 -31.55 44.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.649 -0.657 . . . . 0.0 109.545 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.503 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 124.76 41.1 0.39 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -63.51 -156.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.07 -1.253 . . . . 0.0 109.745 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.534 ' HG2' ' HB3' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -118.87 59.08 4.05 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.426 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 51.9 Cg_endo -69.89 -22.09 31.97 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 124.149 1.605 . . . . 0.0 110.178 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.31 -52.32 3.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.731 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -60.51 133.27 55.93 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.545 0.688 . . . . 0.0 110.649 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -123.81 -177.27 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.35 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.48 138.48 36.07 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.192 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.0 -29.26 18.21 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 124.089 1.573 . . . . 0.0 110.539 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.15 -61.03 1.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 13.2 p -137.66 41.56 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.691 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 78' ' ' LEU . 1.7 mt 37.56 56.21 1.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.311 0.577 . . . . 0.0 111.401 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.629 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 58.3 m -77.54 104.4 8.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.596 -0.69 . . . . 0.0 110.048 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.998 ' NH1' HG21 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -79.37 142.92 59.05 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 70' ' ' PRO . 42.9 Cg_endo -66.92 -10.65 29.2 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.804 1.423 . . . . 0.0 109.654 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.415 HG13 HD23 ' A' ' 104' ' ' LEU . 6.0 t -70.46 -36.84 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.911 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.498 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 16.4 m80 -57.37 -40.47 78.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.553 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -50.01 -58.69 4.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.999 -0.438 . . . . 0.0 111.314 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -46.41 -55.11 7.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.617 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.074 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -67.21 -35.76 80.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 0.0 110.767 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -46.27 -39.46 10.03 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 111.286 -178.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -105.37 -3.63 22.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 110.46 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.562 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 81.43 35.45 23.05 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.603 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 1.0 OUTLIER -105.83 83.55 1.94 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.393 -1.063 . . . . 0.0 110.336 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.554 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -56.97 -46.35 82.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 111.575 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 96' ' ' VAL . 31.3 m-20 -42.93 -37.95 2.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.39 -0.819 . . . . 0.0 110.338 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.4 m -62.63 -44.32 96.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.579 -0.701 . . . . 0.0 109.327 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -61.51 -55.94 25.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 0.0 109.769 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 95' ' ' VAL . 39.1 t -38.97 -45.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.731 -0.606 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.764 ' CG1' HD22 ' A' ' 64' ' ' LEU . 11.9 t -63.42 -53.75 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.664 0.745 . . . . 0.0 109.013 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 mt -47.99 -58.95 3.75 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.456 0.646 . . . . 0.0 110.266 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.99 -28.34 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 10.2 ttt85 -72.73 -3.86 27.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.353 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -146.56 53.81 1.12 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.965 -1.084 . . . . 0.0 111.438 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . 56.84 107.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.11 86.59 0.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -1.049 . . . . 0.0 109.68 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -51.14 116.9 2.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 110.683 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.958 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.3 mp -101.22 -16.21 17.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 26.1 t0 -85.1 55.13 3.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.998 HG21 ' NH1' ' A' ' 80' ' ' ARG . 1.9 p -110.49 -170.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.161 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.628 ' H ' HG22 ' A' ' 106' ' ' VAL . 1.9 mtt180 -137.04 135.69 37.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.213 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.9 m-20 -73.82 58.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.51 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 54.27 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.376 -0.828 . . . . 0.0 110.555 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.668 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -37.32 -63.38 0.44 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.412 0.625 . . . . 0.0 110.7 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.32 -34.74 0.23 Allowed Glycine 0 N--CA 1.478 1.471 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -48.42 141.94 6.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -1.11 . . . . 0.0 109.976 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.514 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -109.89 170.49 5.29 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.408 -0.808 . . . . 0.0 109.742 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 42.4 Cg_endo -70.44 -40.25 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.856 1.45 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 127' ' ' ALA . 13.3 p -70.51 -34.15 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.588 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -70.73 -51.67 25.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.513 -0.742 . . . . 0.0 109.812 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.78 -32.33 30.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.267 -0.896 . . . . 0.0 109.746 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.074 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -73.7 -46.58 45.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.876 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.478 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -67.8 -30.29 69.68 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -67.69 -41.48 83.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.545 -0.722 . . . . 0.0 110.091 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -83.32 -4.31 58.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 111.022 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.3 25.78 17.91 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.306 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.553 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 74.7 m-70 -98.27 47.11 1.0 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.069 -1.254 . . . . 0.0 109.39 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.681 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -44.48 -38.01 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.672 -0.643 . . . . 0.0 109.739 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.52 ' OD2' HD12 ' A' ' 91' ' ' LEU . 11.2 t70 -55.19 -47.03 75.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 94' ' ' LEU . 3.2 t -79.65 -46.28 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 108.88 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.681 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -51.29 -43.72 61.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.607 -0.683 . . . . 0.0 110.369 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 131' ' ' ARG . 5.6 ttp180 -68.16 -54.81 15.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 110.058 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.547 ' CG ' HD21 ' A' ' 91' ' ' LEU . 21.9 t80 -58.8 -39.59 81.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.171 -0.956 . . . . 0.0 109.143 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.7 mt -62.21 -35.0 77.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.529 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 39.7 ttt180 -65.13 -27.28 68.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.93 28.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.958 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -89.51 -16.05 31.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.287 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 0.0 110.452 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.59 ' OD1' ' HB1' ' A' ' 40' ' ' ALA . 66.5 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.244 0.545 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.584 ' HB3' HD13 ' A' ' 31' ' ' LEU . 40.2 m0 -73.01 -31.82 64.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.058 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.808 HD23 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -53.06 -33.49 52.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 0.0 110.795 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.9 -48.49 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -51.8 37.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.693 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -65.89 -40.54 91.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -56.81 -52.36 65.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.203 -0.936 . . . . 0.0 109.62 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -57.3 -29.39 63.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.38 23.16 4.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.0 110.765 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.72 61.42 6.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -131.54 53.89 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.396 -1.061 . . . . 0.0 110.01 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 59' ' ' VAL . 98.0 t -42.36 -59.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.848 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -45.98 -38.57 7.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.773 . . . . 0.0 110.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 1.6 tp10 -70.93 -36.32 72.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.979 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.854 HG12 HD21 ' A' ' 62' ' ' LEU . 5.2 t -79.6 -41.4 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.0 mmm180 -51.59 -41.91 61.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.874 . . . . 0.0 109.363 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -56.07 4.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.673 -0.642 . . . . 0.0 109.461 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 15' ' ' TRP . 12.8 mt -45.0 -60.16 2.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.554 -0.717 . . . . 0.0 110.597 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.977 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -51.83 -51.88 53.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.5 -0.75 . . . . 0.0 110.258 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.98 -9.29 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 110.428 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.05 -13.56 30.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.07 -1.019 . . . . 0.0 110.895 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.02 -20.59 1.59 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.462 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.977 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -47.73 136.93 10.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.282 -1.128 . . . . 0.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 13.0 mt -73.13 155.75 89.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.975 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.59 -54.8 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.737 1.388 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -98.63 21.22 11.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -39.53 100.22 0.21 Allowed Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.71 -0.619 . . . . 0.0 110.689 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.63 146.8 44.35 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.875 1.46 . . . . 0.0 110.963 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -139.28 174.47 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.618 -0.676 . . . . 0.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.07 50.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.926 . . . . 0.0 110.574 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -3.47 5.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.17 23.51 25.31 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -138.64 106.15 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -1.051 . . . . 0.0 110.46 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.535 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -58.11 -177.2 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CB ' HD22 ' A' ' 63' ' ' LEU . 41.1 Cg_endo -66.52 175.68 4.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.319 1.168 . . . . 0.0 111.263 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.7 mt 61.92 -64.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.919 -0.488 . . . . 0.0 110.045 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' PRO . 50.2 tt0 -44.16 -26.91 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.3 p -123.56 36.57 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.641 -0.662 . . . . 0.0 109.891 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.82 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -94.24 38.32 1.09 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.772 -1.205 . . . . 0.0 110.653 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 6.1 tmm? 71.15 -14.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.52 -0.737 . . . . 0.0 110.672 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.55 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.43 27.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.71 13.47 5.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.47 82.91 1.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -1.013 . . . . 0.0 109.734 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -50.66 -25.24 4.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.0 110.394 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.64 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -53.56 -41.09 66.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.279 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 25' ' ' VAL . 24.1 t -55.57 -58.47 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.233 -0.917 . . . . 0.0 109.566 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.67 -52.78 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.675 . . . . 0.0 109.708 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.954 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -45.23 -42.75 9.72 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 28' ' ' VAL . 2.9 tp -73.83 -61.33 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.588 -0.695 . . . . 0.0 110.087 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.614 HD22 ' CB ' ' A' ' 48' ' ' PRO . 5.3 mt -64.7 -55.87 17.3 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 110.993 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.753 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -46.68 -61.75 1.69 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.447 -0.783 . . . . 0.0 111.118 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.954 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -57.55 -23.58 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.935 -1.103 . . . . 0.0 109.655 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CD2' ' CD2' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -81.98 -38.88 24.45 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.457 -0.777 . . . . 0.0 109.969 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.01 46.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.487 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.98 -151.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.008 -1.289 . . . . 0.0 109.583 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -117.14 53.51 1.3 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.003 . . . . 0.0 110.718 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.2 Cg_endo -66.85 -15.32 46.83 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.444 1.234 . . . . 0.0 109.877 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.473 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 4.1 m-20 -107.93 -72.56 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 171.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -147.33 -152.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.276 -0.89 . . . . 0.0 110.114 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -98.59 131.77 25.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.25 -27.55 34.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.337 1.177 . . . . 0.0 110.729 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.1 -64.43 0.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.667 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 27.5 p -130.29 36.31 3.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' A' ' 78' ' ' LEU . 4.3 mt 43.29 37.91 1.48 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.639 -0.663 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.9 OUTLIER -70.05 99.51 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.532 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -76.43 165.4 53.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 47.1 Cg_endo -69.8 -23.2 30.86 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.655 1.345 . . . . 0.0 109.536 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 114' ' ' PRO . 60.8 t -55.89 -29.29 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.676 -0.64 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 12.2 m80 -74.15 -50.16 20.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -45.24 -43.96 10.81 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -64.46 -67.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.109 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -54.14 -45.68 72.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.776 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -48.56 -33.33 9.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.277 -0.89 . . . . 0.0 110.627 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 4.2 mm-40 -99.28 -11.97 20.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.555 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 83.78 33.84 20.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -104.99 92.28 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -1.052 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 0.4 OUTLIER -67.66 -32.55 73.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 110.063 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 42.9 m-20 -52.26 -50.06 62.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.873 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 m -56.95 -36.28 70.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.86 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 mp -60.84 -44.12 97.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.503 -0.748 . . . . 0.0 109.701 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 16.5 t -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.517 HG12 HD13 ' A' ' 64' ' ' LEU . 15.6 t -55.51 -46.01 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.411 -0.806 . . . . 0.0 109.571 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -54.94 -69.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 110.057 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.12 -22.25 50.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.369 -0.832 . . . . 0.0 110.158 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -72.04 -16.54 62.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.753 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -144.25 72.68 1.35 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.338 -0.851 . . . . 0.0 110.596 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.52 101.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -161.93 79.28 0.54 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -1.087 . . . . 0.0 110.411 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.541 ' CZ ' HG23 ' A' ' 106' ' ' VAL . 1.2 ttp180 -56.89 119.64 6.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.121 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' O ' ' HB1' ' A' ' 134' ' ' ALA . 12.0 mt -99.13 15.49 25.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.059 . . . . 0.0 109.544 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.65 43.29 1.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.822 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.565 HG22 ' H ' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -103.19 -169.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.565 ' H ' HG22 ' A' ' 106' ' ' VAL . 36.0 ptt180 -142.0 140.69 32.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.652 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 110' ' ' TRP . 10.8 t0 -73.46 54.81 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.636 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 56.02 -75.59 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.616 -0.677 . . . . 0.0 111.483 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.667 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.1 OUTLIER -46.73 -39.15 11.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.294 -0.879 . . . . 0.0 110.37 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.23 -28.74 2.21 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -56.23 128.87 37.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -1.065 . . . . 0.0 110.569 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.464 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -93.09 171.64 7.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.63 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HB2' HG12 ' A' ' 82' ' ' VAL . 41.7 Cg_endo -69.46 -38.64 8.16 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.488 1.257 . . . . 0.0 110.048 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.558 HG21 ' CA ' ' A' ' 131' ' ' ARG . 9.6 p -70.55 -31.03 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.276 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.36 -26.06 66.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.548 -0.72 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.504 HD23 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -78.02 -55.05 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.39 -0.819 . . . . 0.0 110.551 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.109 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -47.97 -40.92 23.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 110.285 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -47.66 81.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.526 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -60.91 -54.13 48.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 109.627 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.504 HD23 HD23 ' A' ' 117' ' ' LEU . 1.9 mm? -55.16 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.0 110.427 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.19 41.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.517 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 49.4 m-70 -122.23 63.32 0.94 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.388 -1.066 . . . . 0.0 109.546 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -45.3 46.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -46.16 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.867 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -74.83 -42.01 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.72 84.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 109.64 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -52.93 -67.45 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 49.7 t80 -52.86 -30.4 33.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.919 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.86 ' HG ' HD21 ' A' ' 94' ' ' LEU . 5.8 mt -70.75 -53.58 15.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.596 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CA ' HG21 ' A' ' 115' ' ' VAL . 8.7 ttp180 -55.23 -29.79 58.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.86 -54.23 4.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.664 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -75.87 -9.14 58.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.327 -0.858 . . . . 0.0 110.781 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.164 -0.96 . . . . 0.0 110.693 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.026 0.441 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.484 ' HE3' HD21 ' A' ' 31' ' ' LEU . 16.3 m0 -57.03 -17.22 9.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 110.457 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -69.85 -56.03 8.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -71.81 -42.96 66.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -47.81 -62.51 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.166 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -52.0 -42.96 63.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.816 . . . . 0.0 109.936 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -57.63 -52.15 66.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.679 -0.638 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -50.38 -25.63 4.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.451 -0.781 . . . . 0.0 110.607 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . 37.6 mtt180 -103.74 28.93 6.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.656 -0.652 . . . . 0.0 109.849 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.76 41.89 10.43 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 28' ' ' VAL . 11.7 mtt180 -99.85 54.93 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -1.081 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.713 HG12 ' HD3' ' A' ' 29' ' ' ARG . 99.3 t -38.9 -53.61 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.769 -0.582 . . . . 0.0 111.07 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -49.81 -56.29 10.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.755 . . . . 0.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp10 -54.45 -39.0 67.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.383 -0.823 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.06 HG12 HD23 ' A' ' 62' ' ' LEU . 14.0 t -71.74 -56.0 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.707 -0.621 . . . . 0.0 110.279 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.874 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -39.41 -52.48 2.08 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.428 -0.795 . . . . 0.0 110.668 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -73.82 -50.75 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.76 . . . . 0.0 109.907 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.484 HD21 ' HE3' ' A' ' 15' ' ' TRP . 14.0 mt -47.37 -57.05 5.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.59 -0.694 . . . . 0.0 110.728 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.973 ' HB2' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.86 -50.36 45.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 109.491 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -70.53 -17.38 62.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.714 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -81.83 -6.35 59.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.067 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.06 16.68 6.1 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.565 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.872 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -58.15 160.87 4.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.074 -1.25 . . . . 0.0 109.975 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -101.39 113.26 65.85 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 111.269 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.41 -5.17 16.62 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.753 1.396 . . . . 0.0 110.421 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.416 ' C ' HD23 ' A' ' 37' ' ' LEU . 2.2 m120 -131.59 40.06 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 110.075 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.758 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -84.18 133.85 44.51 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.268 -0.895 . . . . 0.0 110.546 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.3 89.65 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.726 1.382 . . . . 0.0 110.375 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.76 166.18 5.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -85.41 21.71 1.7 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -119.38 15.35 12.99 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.16 24.15 20.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.4 -170.33 1.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.447 -1.031 . . . . 0.0 110.256 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.3 mmt180 -103.45 167.51 10.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.673 . . . . 0.0 109.547 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 63' ' ' LEU . 42.6 Cg_endo -67.26 -12.0 34.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.582 1.306 . . . . 0.0 110.414 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.54 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.1 mt -107.2 -42.76 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 108.637 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.449 ' HB2' ' H ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -49.44 -20.95 0.79 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.383 -0.823 . . . . 0.0 110.472 179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 51' ' ' VAL . 10.8 p -115.91 35.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 110.477 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.808 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.4 34.57 1.6 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 109.729 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 10.0 ttp 67.67 -6.69 0.65 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 110.821 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.563 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.66 27.19 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.235 -0.916 . . . . 0.0 110.41 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.464 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.35 11.65 7.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.656 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.8 m -148.91 93.22 2.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.482 -1.011 . . . . 0.0 109.615 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.42 -34.15 70.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.468 -0.77 . . . . 0.0 109.872 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -52.15 -42.04 63.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 110.093 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 52' ' ' MET . 91.0 t -48.15 -53.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -62.79 -43.69 98.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.565 -0.709 . . . . 0.0 109.315 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 4.0 tt0 -46.8 -31.73 3.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.248 -0.908 . . . . 0.0 110.276 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.06 HD23 HG12 ' A' ' 28' ' ' VAL . 7.5 tp -89.87 -49.66 6.49 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -56.65 -55.41 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.451 0.643 . . . . 0.0 109.387 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.916 HD22 HG12 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -61.23 -45.76 93.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.671 -0.643 . . . . 0.0 109.756 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.4 tp -53.04 -32.97 49.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -0.874 . . . . 0.0 108.719 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CG ' ' CD1' ' A' ' 32' ' ' LEU . 2.0 m80 -92.6 -1.04 57.21 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.426 0.631 . . . . 0.0 110.355 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.0 63.48 1.97 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.447 ' C ' ' HD3' ' A' ' 70' ' ' PRO . . . -72.26 -149.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -1.067 . . . . 0.0 109.228 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mt-10 -114.88 57.22 0.97 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -72.17 -0.89 9.26 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.315 1.166 . . . . 0.0 110.585 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.46 -73.72 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.055 -1.028 . . . . 0.0 109.804 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 134.7 16.61 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.578 0.704 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.424 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . -127.34 -134.16 0.24 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.03 125.73 30.92 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.786 -1.196 . . . . 0.0 109.452 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.84 5.75 5.06 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.255 1.134 . . . . 0.0 110.865 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.27 -43.77 4.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 108.925 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.897 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -121.44 2.98 10.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.619 -0.676 . . . . 0.0 109.932 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 2.8 mt 54.99 25.23 6.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.278 -0.889 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.71 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.81 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.36 165.9 40.09 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.173 -0.954 . . . . 0.0 110.104 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 44.4 Cg_endo -71.54 -9.01 24.39 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.76 1.4 . . . . 0.0 110.672 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.618 HG11 HD23 ' A' ' 104' ' ' LEU . 3.5 t -73.87 -30.53 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.103 -0.998 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.412 ' CD2' ' OD1' ' A' ' 108' ' ' ASP . 27.0 m80 -68.64 -43.97 75.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -48.81 -49.95 36.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.331 0.586 . . . . 0.0 110.251 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.692 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -57.81 -68.7 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.0 109.766 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.912 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -51.24 -39.29 56.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.362 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -44.01 -51.73 7.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.328 -0.857 . . . . 0.0 110.812 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -96.14 18.7 13.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 109.775 179.165 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.836 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 54.39 52.78 42.31 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.489 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -117.07 84.36 2.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -1.157 . . . . 0.0 110.611 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.581 ' HA ' HD13 ' A' ' 94' ' ' LEU . 1.2 mt -55.89 -43.81 77.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 0.0 110.75 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 47.9 m-20 -45.89 -35.66 4.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.496 -0.753 . . . . 0.0 111.048 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -71.9 -38.61 69.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -0.91 . . . . 0.0 110.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.692 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 1.6 mp -63.08 -59.55 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.8 t -46.2 -49.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.58 -0.7 . . . . 0.0 110.314 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.916 HG12 HD22 ' A' ' 64' ' ' LEU . 23.6 t -50.39 -53.04 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.571 -0.705 . . . . 0.0 109.71 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.661 ' HA ' HD21 ' A' ' 64' ' ' LEU . 64.6 mt -52.39 -66.11 0.44 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 0.0 109.837 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -55.78 -26.71 47.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.933 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.62 -13.19 61.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.977 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.798 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -147.87 78.19 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.183 -0.948 . . . . 0.0 111.001 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 52.07 101.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 97' ' ' LEU . . . -163.06 123.53 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -1.211 . . . . 0.0 110.744 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -78.41 141.63 38.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 133' ' ' ALA . 0.5 OUTLIER -126.4 8.19 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.335 -0.853 . . . . 0.0 110.287 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -115.75 49.62 1.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.062 -1.024 . . . . 0.0 111.365 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.81 HG11 ' CG ' ' A' ' 80' ' ' ARG . 7.6 p -112.45 171.64 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.85 ' HG2' HD12 ' A' ' 113' ' ' LEU . 24.1 mtm180 -131.42 143.8 50.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 109.59 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -68.51 58.04 0.08 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.241 -0.912 . . . . 0.0 110.17 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 50.9 -88.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.897 ' CH2' HG23 ' A' ' 77' ' ' THR . 5.8 p90 -112.62 -1.57 14.79 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.263 -0.898 . . . . 0.0 110.758 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -77.93 -80.61 0.68 Allowed Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 4.3 mtt180 170.98 -169.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.816 -0.814 . . . . 0.0 110.069 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.85 HD12 ' HG2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -80.37 166.96 36.56 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 110.417 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.1 Cg_endo -72.32 -35.91 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.813 1.428 . . . . 0.0 110.16 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 7.9 p -67.69 -28.45 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -50.68 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.71 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -24.71 41.95 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.272 -0.893 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.29 -62.9 1.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 111.109 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -23.77 1.16 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -37.2 23.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.285 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 1.7 mm? -86.9 7.52 26.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.31 24.03 52.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.322 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 17.0 m-70 -99.4 43.47 1.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.951 -1.323 . . . . 0.0 109.223 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -42.58 7.77 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.292 0.568 . . . . 0.0 110.158 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.09 -38.13 78.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 109.6 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.912 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.3 t -82.54 -38.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.41 -22.65 63.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -68.1 -71.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 0.0 110.389 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.614 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 2.4 t80 -53.88 -45.11 70.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 86' ' ' ALA . 12.9 mt -50.53 -55.26 16.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.522 -0.736 . . . . 0.0 109.488 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.435 ' CA ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -54.46 -23.14 14.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.169 -0.957 . . . . 0.0 109.95 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -80.31 -52.36 7.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -88.37 -7.13 57.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 111.134 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.811 0 O-C-N 120.921 -1.112 . . . . 0.0 110.508 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.891 0.377 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.598 ' HB3' HD11 ' A' ' 31' ' ' LEU . 21.2 m0 -48.04 -33.96 8.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.313 -0.867 . . . . 0.0 109.7 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.825 HD22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -43.86 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.375 0.607 . . . . 0.0 110.849 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 42' ' ' ASN . . . -43.89 -54.02 5.63 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.69 -0.631 . . . . 0.0 111.299 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -59.58 3.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 110.702 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.17 -47.93 74.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.326 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -57.06 -48.9 77.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.455 -0.778 . . . . 0.0 110.319 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.98 -25.63 67.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 110.105 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -85.78 5.45 32.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.308 -0.87 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 63.97 44.81 95.43 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -122.1 72.7 1.05 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.953 . . . . 0.0 109.611 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.831 HG22 HG23 ' A' ' 59' ' ' VAL . 39.1 t -53.38 -45.41 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.414 -0.804 . . . . 0.0 110.274 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.33 -33.99 66.14 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 0.0 110.508 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' O ' HD12 ' A' ' 31' ' ' LEU . 5.7 tt0 -68.19 -41.8 80.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.871 . . . . 0.0 109.772 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.82 HG12 HD12 ' A' ' 32' ' ' LEU . 21.4 t -77.59 -45.38 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.958 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.699 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.22 -47.77 35.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -29.83 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 15' ' ' TRP . 7.9 mt -68.34 -70.43 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.206 -0.934 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.842 HD22 ' CG ' ' A' ' 66' ' ' HIS . 1.3 mt -46.88 -49.41 20.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.373 -0.829 . . . . 0.0 111.542 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -60.9 -24.46 66.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.31 -5.79 55.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.48 29.83 3.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.46 128.35 33.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -1.099 . . . . 0.0 110.123 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.825 ' O ' HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -49.25 111.6 2.05 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.38 -0.825 . . . . 0.0 110.666 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HA ' HD21 ' A' ' 16' ' ' LEU . 43.3 Cg_endo -69.12 -33.15 19.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.678 1.357 . . . . 0.0 110.811 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.68 50.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.707 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -78.01 150.96 78.61 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.415 -0.803 . . . . 0.0 110.324 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.87 116.38 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.79 1.416 . . . . 0.0 110.188 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 12.9 m120 -94.21 170.68 9.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.961 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -89.95 33.41 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.638 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -137.06 3.63 2.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.054 -1.029 . . . . 0.0 110.725 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.14 26.87 36.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -130.78 20.8 5.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -1.15 . . . . 0.0 110.691 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 48.91 -177.51 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.707 -0.62 . . . . 0.0 111.069 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 50' ' ' GLN . 44.4 Cg_endo -72.95 -179.52 4.36 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.44 1.232 . . . . 0.0 111.165 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.62 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 56.88 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.761 -0.587 . . . . 0.0 110.322 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -47.73 -23.09 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.939 -1.101 . . . . 0.0 110.264 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.66 6.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 110.664 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -68.98 171.65 7.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.795 -1.191 . . . . 0.0 109.211 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.432 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 3.2 ttm -52.79 -19.06 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.229 -0.919 . . . . 0.0 110.37 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.606 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.48 10.14 3.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.405 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -119.02 18.28 10.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.3 78.25 1.32 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.459 -1.024 . . . . 0.0 109.449 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -44.75 -28.88 0.68 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.0 110.378 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -42.71 57.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.831 HG23 HG22 ' A' ' 25' ' ' VAL . 77.8 t -53.67 -60.84 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.488 -0.757 . . . . 0.0 109.409 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -53.53 -52.34 59.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.326 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.786 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.0 tt0 -45.74 -35.73 4.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.196 -0.94 . . . . 0.0 110.062 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.775 HD21 HG12 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -78.3 -60.89 2.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.573 -0.704 . . . . 0.0 109.248 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.0 mt -60.95 -56.07 25.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 110.521 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.738 HD13 HG12 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -48.68 -62.47 1.49 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.563 -0.711 . . . . 0.0 110.814 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -55.16 -24.96 29.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.972 -1.08 . . . . 0.0 109.385 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.842 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -82.22 -29.26 31.48 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.416 -0.802 . . . . 0.0 109.811 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.47 38.02 0.31 Allowed Glycine 0 N--CA 1.479 1.508 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.65 -148.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 0.0 109.678 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -115.65 59.04 1.45 Allowed Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.332 -0.855 . . . . 0.0 110.387 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.1 -8.64 22.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.553 1.291 . . . . 0.0 110.613 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.474 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 2.2 t30 -129.1 -65.26 0.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.314 -0.866 . . . . 0.0 109.704 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.88 144.29 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 110.532 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -136.34 -136.01 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.27 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -110.68 136.02 20.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.057 -1.027 . . . . 0.0 110.221 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.2 -5.35 16.95 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.542 1.285 . . . . 0.0 110.596 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.1 -49.67 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.619 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -120.57 9.63 10.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.377 -0.827 . . . . 0.0 110.945 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.522 ' HA ' HD23 ' A' ' 78' ' ' LEU . 7.4 mt 47.02 27.81 0.8 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.479 HG23 ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -60.59 89.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.644 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.814 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -69.14 168.78 13.99 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.864 . . . . 0.0 110.366 -179.189 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.595 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 54.5 Cg_endo -72.72 2.58 5.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 124.003 1.528 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 104' ' ' LEU . 19.8 t -85.09 -31.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 110.301 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 83' ' ' HIS . 9.1 m80 -67.48 -43.67 80.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.08 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.9 OUTLIER -53.52 -54.09 42.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.701 -0.624 . . . . 0.0 111.373 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.675 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -52.76 -63.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 109.934 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.813 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.05 -55.01 40.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.26 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 5.0 tpt180 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.507 -0.746 . . . . 0.0 111.299 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 54' ' ' MET . 9.9 tp10 -103.83 -4.64 23.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.025 -1.047 . . . . 0.0 111.09 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 20.83 69.14 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.613 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -102.01 96.35 6.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -1.151 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.669 HD21 ' CG ' ' A' ' 129' ' ' TYR . 1.2 tt -69.82 -38.37 76.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.724 -0.61 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 96' ' ' VAL . 42.3 m-20 -50.56 -41.62 54.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.89 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.1 m -55.89 -48.27 75.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.733 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.704 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -59.05 -43.21 91.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.833 . . . . 0.0 109.805 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -51.47 -49.17 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 HD13 ' A' ' 64' ' ' LEU . 25.4 t -59.83 -43.1 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.589 0.709 . . . . 0.0 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.52 ' HA ' HD11 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -56.96 -58.62 7.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.618 -0.677 . . . . 0.0 110.107 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -65.41 -35.74 81.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 110.125 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 2.3 ttp85 -61.57 -14.9 33.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.411 -0.806 . . . . 0.0 110.449 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -140.79 54.43 1.59 Allowed 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.988 -1.07 . . . . 0.0 111.168 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.36 106.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -156.91 97.57 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.467 -1.02 . . . . 0.0 109.876 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -51.37 115.32 1.53 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.338 -0.851 . . . . 0.0 110.404 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -105.36 4.08 30.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 110.611 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -112.63 51.46 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 110.535 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.814 HG11 ' CG ' ' A' ' 80' ' ' ARG . 4.5 p -107.55 -178.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.997 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.641 ' H ' HG22 ' A' ' 106' ' ' VAL . 42.3 mtt85 -131.26 153.01 49.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 109.564 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -80.38 54.93 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.537 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 62.86 -68.65 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.626 -0.672 . . . . 0.0 111.276 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 6.6 m0 -65.67 -37.68 87.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.818 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.79 -20.56 1.0 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.493 ' HB2' ' HB2' ' A' ' 108' ' ' ASP . 12.4 mtt180 -49.75 136.77 17.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -1.106 . . . . 0.0 110.266 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -111.06 161.17 26.17 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.358 -0.839 . . . . 0.0 110.116 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -70.24 -21.62 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.583 1.307 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.441 ' CB ' HD11 ' A' ' 130' ' ' LEU . 4.4 p -86.57 -31.74 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.053 -1.029 . . . . 0.0 110.038 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.34 -22.96 63.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.9 mt -75.67 -44.59 41.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.537 -0.727 . . . . 0.0 110.497 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -68.2 -36.22 79.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.94 -39.24 88.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -57.7 3.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 109.897 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.51 -85.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.478 -0.764 . . . . 0.0 110.257 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.03 39.31 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 22.6 m-70 -103.87 55.82 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.378 -1.072 . . . . 0.0 108.822 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.51 -40.81 13.15 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.45 0.643 . . . . 0.0 109.909 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.16 -42.17 90.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.646 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.3 t -82.18 -44.88 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.987 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -54.8 -37.61 66.3 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -77.14 -48.26 18.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.73 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.669 ' CG ' HD21 ' A' ' 91' ' ' LEU . 27.2 t80 -70.73 -57.16 4.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.119 -0.988 . . . . 0.0 110.503 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.623 ' C ' HD12 ' A' ' 130' ' ' LEU . 0.7 OUTLIER -54.55 -32.75 58.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.114 -0.992 . . . . 0.0 110.612 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 127' ' ' ALA . 23.7 ttt180 -66.55 -38.13 86.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -0.847 . . . . 0.0 110.083 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.378 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.81 -19.41 23.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.733 -0.605 . . . . 0.0 110.295 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.332 -0.855 . . . . 0.0 110.721 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.83 0.347 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 3.0 m0 -85.13 -26.78 26.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 17' ' ' ALA . 3.8 pp -61.99 -32.48 72.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 109.457 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.545 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -80.34 -48.2 13.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.4 -0.813 . . . . 0.0 109.89 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -63.06 -41.07 99.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -55.51 -52.44 63.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.408 -0.808 . . . . 0.0 109.775 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -58.62 -31.89 68.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.358 -0.838 . . . . 0.0 110.192 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . -59.79 -35.47 74.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -94.18 23.46 5.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.28 42.85 89.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -105.12 67.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.877 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.563 HG12 ' HD3' ' A' ' 29' ' ' ARG . 85.3 t -51.75 -30.01 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.469 -0.769 . . . . 0.0 110.325 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -73.27 -39.06 65.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.325 -0.859 . . . . 0.0 110.728 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.637 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.5 tp10 -66.74 -31.99 73.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.257 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.853 HG12 HD12 ' A' ' 32' ' ' LEU . 6.5 t -83.09 -46.49 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.563 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.368 -0.833 . . . . 0.0 110.123 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.75 -35.98 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 109.728 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 27' ' ' GLU . 3.4 mt -59.09 -65.1 0.72 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.853 HD12 HG12 ' A' ' 28' ' ' VAL . 2.5 mt -51.39 -34.82 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 110.259 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -20.09 62.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.954 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.75 -9.23 47.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.09 28.01 2.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -57.71 151.49 17.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -1.168 . . . . 0.0 109.74 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' O ' HD22 ' A' ' 16' ' ' LEU . 2.3 mp -73.35 135.43 79.15 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 109.729 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.11 -31.41 19.02 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.546 1.287 . . . . 0.0 110.128 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.47 ' ND2' ' OE2' ' A' ' 69' ' ' GLU . 1.8 m120 -139.69 61.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.558 -0.714 . . . . 0.0 110.032 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.4 160.01 83.83 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.283 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.5 124.03 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.827 1.435 . . . . 0.0 110.487 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -108.79 158.58 17.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -95.44 27.96 3.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 110.537 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -136.48 13.33 3.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 109.953 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.96 26.9 35.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.9 tpp180 -130.66 107.04 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 110.217 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.574 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mpt_? -55.09 -175.08 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.595 -0.691 . . . . 0.0 110.259 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.759 ' HB2' HD13 ' A' ' 63' ' ' LEU . 38.2 Cg_endo -64.34 163.66 25.76 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.267 1.14 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 66.68 -59.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' PRO . 5.1 tt0 -53.22 -20.93 4.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 46' ' ' ARG . 12.0 p -114.82 -7.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.622 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -56.52 165.17 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.986 -1.071 . . . . 0.0 109.796 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.418 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 0.9 OUTLIER -54.73 -17.07 3.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.229 -0.92 . . . . 0.0 110.397 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.58 ' HE1' ' HE2' ' A' ' 52' ' ' MET . 0.0 OUTLIER 61.96 11.46 4.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.41 18.42 20.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -155.47 96.08 1.75 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.674 -0.898 . . . . 0.0 109.634 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.91 -21.04 56.99 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.344 -0.848 . . . . 0.0 109.759 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -56.43 -30.49 62.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.567 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.546 HG11 ' HB1' ' A' ' 20' ' ' ALA . 41.2 t -64.68 -44.88 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.591 -0.693 . . . . 0.0 109.947 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.841 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.2 tt0 -45.73 -29.18 1.21 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.156 -0.965 . . . . 0.0 110.775 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.692 ' CD1' HD13 ' A' ' 32' ' ' LEU . 2.7 tp -83.82 -56.8 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 110.019 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 8.2 mt -67.68 -35.06 78.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.729 HD11 ' CB ' ' A' ' 100' ' ' ALA . 2.7 tm? -61.74 -65.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.81 -0.556 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.7 pp -54.53 -24.15 19.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.813 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.842 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.0 m80 -81.6 -49.95 9.92 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.526 -0.734 . . . . 0.0 110.134 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.24 46.02 0.03 OUTLIER Glycine 0 N--CA 1.482 1.731 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.029 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -75.57 -155.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.786 -1.42 . . . . 0.0 109.192 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 47' ' ' ARG . 6.7 tp10 -122.99 68.4 35.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 110.267 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HG3' HD23 ' A' ' 64' ' ' LEU . 52.5 Cg_endo -73.23 -9.13 22.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.896 1.471 . . . . 0.0 110.384 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 3.7 t30 -117.82 -70.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.711 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 152.7 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.105 -0.997 . . . . 0.0 111.082 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -137.62 -137.42 0.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 2.2 t70 -122.13 132.11 24.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.67 -7.78 21.85 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.639 1.336 . . . . 0.0 110.88 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.35 -55.74 4.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.212 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.531 HG22 ' CH2' ' A' ' 110' ' ' TRP . 61.2 p -117.26 7.34 12.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.2 mt 49.33 30.35 3.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.269 -0.894 . . . . 0.0 111.005 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -69.0 91.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.136 -0.977 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.87 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.87 159.22 83.51 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.623 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HB2' HD21 ' A' ' 97' ' ' LEU . 44.0 Cg_endo -70.08 -6.13 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.654 1.344 . . . . 0.0 110.626 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 t -77.29 -31.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 110.021 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 35.9 m80 -69.74 -42.8 73.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -0.828 . . . . 0.0 109.301 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.47 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.7 m-20 -48.47 -49.01 37.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.708 -0.62 . . . . 0.0 110.527 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.489 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -60.79 -68.9 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.819 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -50.64 -55.96 14.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.453 -0.78 . . . . 0.0 111.16 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 6.7 ttm180 -44.74 -27.79 0.55 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.173 -0.954 . . . . 0.0 111.683 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.476 ' CG ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -102.11 -5.03 24.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.689 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 79.84 36.06 26.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -116.41 101.66 8.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 110.724 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 125' ' ' ASP . 1.0 OUTLIER -83.1 -35.14 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 96' ' ' VAL . 3.1 m-20 -48.48 -43.06 34.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.383 -0.823 . . . . 0.0 109.784 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 m -65.07 -39.3 93.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 109.0 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.919 HD21 ' HB2' ' A' ' 130' ' ' LEU . 1.5 tp -51.81 -48.93 63.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.613 -0.68 . . . . 0.0 109.838 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 45.2 t -56.51 -51.35 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 109.68 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.5 HG12 ' HG ' ' A' ' 64' ' ' LEU . 26.3 t -49.25 -53.32 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.449 -0.782 . . . . 0.0 110.296 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.464 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -50.65 -67.76 0.23 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.468 -0.77 . . . . 0.0 110.683 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -61.86 -30.18 70.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.297 -0.877 . . . . 0.0 110.585 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -61.72 -16.6 50.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.348 -0.845 . . . . 0.0 110.764 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.729 ' CB ' HD11 ' A' ' 64' ' ' LEU . . . -129.74 -44.82 1.19 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.751 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.69 108.6 0.22 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -167.59 112.57 0.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -1.088 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.407 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -66.04 95.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.477 -0.765 . . . . 0.0 109.844 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 59.75 5.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.285 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -170.49 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -0.954 . . . . 0.0 110.062 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.87 HG11 ' CG ' ' A' ' 80' ' ' ARG . 1.5 p -102.54 -169.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.622 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.28 112.11 6.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.217 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.02 147.45 9.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.356 -0.84 . . . . 0.0 110.663 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -57.46 -27.24 62.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.531 ' CH2' HG22 ' A' ' 77' ' ' THR . 7.0 m95 -63.41 -14.35 49.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.72 46.02 5.86 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.41 104.29 2.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -1.043 . . . . 0.0 110.156 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.448 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -54.31 167.49 0.55 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.9 . . . . 0.0 109.941 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.553 ' O ' HD21 ' A' ' 130' ' ' LEU . 43.8 Cg_endo -69.93 -34.93 13.06 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.614 1.323 . . . . 0.0 109.931 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 131' ' ' ARG . 5.9 p -74.01 -27.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.398 -0.814 . . . . 0.0 110.192 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -37.94 63.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 109.69 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 87' ' ' ARG . 2.0 tt -69.39 -41.93 75.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.116 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -56.39 -48.49 76.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.267 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -65.51 -22.18 66.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.973 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.39 -65.62 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -83.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.182 -0.948 . . . . 0.0 110.539 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 35.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 24.0 m-70 -105.66 36.81 2.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -1.055 . . . . 0.0 108.659 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -46.87 -45.15 20.17 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.405 0.621 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.723 ' O ' HD12 ' A' ' 91' ' ' LEU . 14.8 p30 -56.64 -39.82 74.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.376 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 86' ' ' ALA . 10.6 t -74.14 -52.44 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 109.841 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.674 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -48.99 -28.54 3.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.628 -0.67 . . . . 0.0 111.227 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -50.02 -70.58 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.03 -1.044 . . . . 0.0 110.626 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -73.11 -28.36 62.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.919 ' HB2' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -72.1 -14.53 61.87 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 109.634 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.477 ' HA ' HG21 ' A' ' 115' ' ' VAL . 10.6 ttt180 -88.21 -42.97 11.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.143 -0.973 . . . . 0.0 110.064 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.14 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.7 -23.89 20.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 110.547 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' OG1' ' A' ' 18' ' ' THR . 9.0 p-10 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.214 0.53 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.647 ' O ' HD13 ' A' ' 31' ' ' LEU . 30.6 m0 -67.7 -28.15 67.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.449 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.051 HD13 HD21 ' A' ' 63' ' ' LEU . 3.9 pp -63.13 -38.93 93.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 110.063 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.789 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -77.25 -42.12 38.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 110.056 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -60.54 -40.95 93.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 110.318 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -70.79 -35.92 72.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.773 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB1' ' HB2' ' A' ' 52' ' ' MET . . . -67.08 -45.15 78.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 109.748 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.77 -29.33 68.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.617 -0.677 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -88.23 14.98 8.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 0.0 110.107 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.26 50.22 56.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -123.83 77.43 1.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -1.055 . . . . 0.0 110.315 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 59' ' ' VAL . 59.4 t -51.55 -46.35 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.386 -0.822 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.63 -60.7 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.594 -0.691 . . . . 0.0 110.311 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 -38.18 65.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.459 -0.776 . . . . 0.0 109.73 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.081 HG12 HD23 ' A' ' 62' ' ' LEU . 21.6 t -69.97 -56.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.956 ' HA ' HD22 ' A' ' 62' ' ' LEU . 9.8 mmm-85 -46.1 -45.17 16.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.73 . . . . 0.0 110.243 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.62 -36.93 57.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.483 -0.761 . . . . 0.0 109.567 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 15' ' ' TRP . 11.6 mt -62.15 -67.28 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.934 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -44.62 -43.56 8.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.665 -0.647 . . . . 0.0 110.164 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 2.6 tt0 -79.77 -17.43 53.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.643 -0.66 . . . . 0.0 110.798 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -80.74 -8.05 59.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 111.012 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.46 0.19 4.13 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.876 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.934 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -52.2 157.59 1.34 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.996 -1.297 . . . . 0.0 110.0 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.958 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 18.3 mt -86.14 153.77 57.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.114 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 48.5 Cg_endo -77.38 -54.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.644 1.339 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -107.44 40.05 1.77 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.839 . . . . 0.0 109.571 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.958 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -61.54 126.73 87.33 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.592 -0.693 . . . . 0.0 110.423 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.89 151.44 50.85 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.668 1.352 . . . . 0.0 110.099 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -122.52 171.68 8.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.865 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -4.44 59.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.325 -0.859 . . . . 0.0 110.07 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' HD2' HG21 ' A' ' 51' ' ' VAL . 3.3 m-30 -100.78 -3.04 30.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.93 29.02 54.47 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -119.83 39.41 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -1.065 . . . . 0.0 111.064 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 10.5 mmt180 49.59 172.68 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.424 -0.797 . . . . 0.0 111.741 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 53.4 Cg_endo -77.0 -18.63 14.43 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.638 1.336 . . . . 0.0 110.51 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.796 HG23 ' SD ' ' A' ' 52' ' ' MET . 15.3 mt -104.94 -47.2 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -48.4 -25.03 1.43 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG21 ' HD2' ' A' ' 44' ' ' TYR . 11.5 p -100.05 -1.03 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.957 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.7 ptt? -75.55 141.14 43.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ttp -54.25 123.6 13.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.976 . . . . 0.0 108.528 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.564 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -82.02 44.12 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.967 -1.083 . . . . 0.0 110.823 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.25 2.28 11.48 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.639 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -137.14 88.87 2.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.714 -0.874 . . . . 0.0 109.96 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -61.54 -11.67 12.03 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.115 -0.991 . . . . 0.0 109.951 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.1 -47.43 58.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.994 HG13 HG11 ' A' ' 28' ' ' VAL . 42.2 t -45.52 -62.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.41 -0.806 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -49.13 -40.76 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.094 -1.004 . . . . 0.0 109.648 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 7.4 tm-20 -50.07 -27.49 5.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.77 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.081 HD23 HG12 ' A' ' 28' ' ' VAL . 8.3 tp -90.05 -54.46 4.03 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.051 HD21 HD13 ' A' ' 16' ' ' LEU . 11.4 mt -55.11 -46.28 75.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -69.59 -41.04 76.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 5.4 tp -54.08 -33.67 58.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.542 ' CG ' HD11 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -90.78 -47.02 7.88 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.767 -0.583 . . . . 0.0 109.555 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.25 63.84 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 C-N-CA 120.151 -1.024 . . . . 0.0 110.758 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.759 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -77.04 -153.85 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.948 -1.324 . . . . 0.0 109.283 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.59 55.76 2.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.111 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.572 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 45.9 Cg_endo -70.81 -14.84 33.06 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.576 1.303 . . . . 0.0 110.323 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 -64.12 1.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.47 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.2 150.73 8.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 111.03 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' NE ' ' A' ' 80' ' ' ARG . . . -128.83 -153.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.584 -0.698 . . . . 0.0 109.134 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -102.13 136.7 19.41 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 0.0 109.701 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.41 -3.2 13.56 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.396 1.208 . . . . 0.0 110.699 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.66 -30.72 18.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 0.0 109.471 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.627 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -151.11 22.07 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 109.854 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.8 OUTLIER 37.28 33.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.862 -0.524 . . . . 0.0 111.515 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -69.34 100.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.872 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.51 166.92 25.93 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.273 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 43.9 Cg_endo -72.79 -21.08 21.91 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.578 1.304 . . . . 0.0 109.581 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.953 HG21 ' HA ' ' A' ' 104' ' ' LEU . 45.8 t -54.16 -30.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 32.8 m80 -71.65 -42.85 67.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 10.7 t0 -49.1 -47.46 45.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.779 -0.575 . . . . 0.0 109.926 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.464 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -59.72 -69.42 0.21 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.456 -0.777 . . . . 0.0 110.548 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.75 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.58 -41.6 86.08 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.003 . . . . 0.0 111.446 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.48 ' NH1' HD11 ' A' ' 121' ' ' LEU . 12.1 tpt85 -45.84 -41.54 11.27 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 110.886 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.5 5.34 49.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.97 34.26 27.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -103.29 97.81 7.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -1.119 . . . . 0.0 110.999 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 91' ' ' LEU . 3.0 tt -82.67 -40.21 21.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 109.64 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.511 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.3 m-20 -46.42 -56.11 6.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.582 -0.699 . . . . 0.0 109.846 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 m -54.08 -43.38 70.28 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD23 ' CD1' ' A' ' 129' ' ' TYR . 0.7 OUTLIER -50.59 -34.26 25.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 25.1 t -72.92 -45.2 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.582 -0.699 . . . . 0.0 109.118 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 46.6 t -61.12 -46.71 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -0.785 . . . . 0.0 109.808 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' HA ' HD11 ' A' ' 64' ' ' LEU . 3.7 mm? -52.58 -46.0 66.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.451 -0.78 . . . . 0.0 110.217 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -84.35 -12.84 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 96' ' ' VAL . 2.5 mtt180 -80.06 -12.02 59.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.328 -0.858 . . . . 0.0 111.013 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.57 -66.25 0.77 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.52 108.41 0.29 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 97' ' ' LEU . . . -168.66 128.36 1.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -1.062 . . . . 0.0 110.578 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 112.26 23.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.965 HD12 ' HB2' ' A' ' 134' ' ' ALA . 0.4 OUTLIER -104.06 5.19 35.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 110.644 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 134' ' ' ALA . 5.0 m-20 -100.31 41.14 1.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.63 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.872 HG11 ' CD ' ' A' ' 80' ' ' ARG . 7.2 p -108.75 178.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.822 . . . . 0.0 110.925 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.587 ' H ' HG22 ' A' ' 106' ' ' VAL . 11.4 ptt180 -131.17 143.69 50.81 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -68.06 69.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.387 -0.82 . . . . 0.0 110.803 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 60.92 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.627 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.7 m-90 -60.08 -75.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.755 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.98 32.28 0.07 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.503 ' CB ' ' HB2' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -89.42 107.96 19.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -1.129 . . . . 0.0 109.824 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.652 HD13 ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -82.55 159.11 64.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.434 -0.791 . . . . 0.0 110.159 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.652 ' HD2' HD13 ' A' ' 113' ' ' LEU . 42.3 Cg_endo -71.59 -24.68 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.797 1.419 . . . . 0.0 110.398 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 127' ' ' ALA . 11.6 p -79.42 -40.16 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.127 -0.983 . . . . 0.0 110.087 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.497 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -69.23 -30.01 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.483 -0.76 . . . . 0.0 109.884 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.465 HD21 ' HD3' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -78.4 -32.0 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.023 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.718 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.51 -44.7 50.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 109.672 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -36.42 78.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 110.02 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -59.5 4.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -0.813 . . . . 0.0 109.96 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.48 HD11 ' NH1' ' A' ' 87' ' ' ARG . 3.3 mm? -54.83 -82.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.28 37.24 0.03 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.481 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 31.1 m-70 -113.87 52.38 0.82 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.336 -1.096 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -33.83 9.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 110.27 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.426 ' C ' HD12 ' A' ' 91' ' ' LEU . 2.0 m-20 -63.81 -39.23 93.75 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.364 -0.835 . . . . 0.0 108.938 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -83.91 -43.18 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 109.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -63.27 -34.02 76.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -52.25 43.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.41 -0.807 . . . . 0.0 109.48 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.617 ' CD1' HD23 ' A' ' 94' ' ' LEU . 4.8 t80 -60.86 -30.34 70.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.747 . . . . 0.0 109.168 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.748 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 36.6 mt -65.13 -60.13 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.039 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' A' ' 115' ' ' VAL . 5.9 ttp180 -53.24 -20.82 4.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 110.411 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.7 -60.19 2.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.48 -12.52 59.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.372 -0.83 . . . . 0.0 110.389 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.965 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 120.962 0.41 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.562 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.3 OUTLIER -66.39 -4.73 8.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.404 -0.81 . . . . 0.0 111.146 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 38' ' ' PRO . 1.3 tp -80.55 -45.21 17.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.883 -1.135 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.7 53.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 110.171 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -61.32 -54.72 40.32 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -51.85 -49.44 62.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.366 -0.834 . . . . 0.0 109.784 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.12 -48.03 68.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 109.317 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -62.06 -28.93 69.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.579 -0.701 . . . . 0.0 109.345 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.93 20.65 3.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.655 -0.653 . . . . 0.0 110.286 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.46 52.92 22.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.627 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -128.72 96.03 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.109 . . . . 0.0 110.526 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 ' CG2' ' A' ' 59' ' ' VAL . 98.5 t -73.11 -54.6 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -44.08 -40.98 5.24 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.56 -0.712 . . . . 0.0 111.549 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.565 ' OE2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.02 -46.5 71.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.997 -1.064 . . . . 0.0 109.902 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.889 HG12 HD12 ' A' ' 32' ' ' LEU . 17.8 t -68.25 -41.29 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.819 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.929 ' HA ' HD11 ' A' ' 62' ' ' LEU . 13.6 mmm180 -50.43 -47.46 56.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.0 110.123 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.58 -45.1 47.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.79 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 ' OE2' ' A' ' 27' ' ' GLU . 10.6 mt -56.97 -60.45 3.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 110.198 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.901 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 mt -51.1 -32.57 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.313 -0.867 . . . . 0.0 109.574 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.58 -25.34 45.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.588 -0.695 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.67 -5.22 52.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.325 -0.859 . . . . 0.0 110.201 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.2 22.02 5.37 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -65.06 141.05 58.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.173 -1.192 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD1' ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -104.72 117.45 58.86 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.471 -0.768 . . . . 0.0 109.53 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HA ' HD21 ' A' ' 16' ' ' LEU . 43.0 Cg_endo -69.66 -29.53 24.23 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.46 1.242 . . . . 0.0 110.802 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -91.36 44.75 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 0.0 109.73 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . . . -88.3 155.57 51.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.581 -0.7 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.05 89.18 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.669 1.352 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 47' ' ' ARG . 41.3 m-80 -59.55 151.22 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.541 -0.725 . . . . 0.0 110.381 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.85 26.65 2.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.438 -0.789 . . . . 0.0 110.772 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -160.64 26.1 0.15 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.33 -0.856 . . . . 0.0 110.207 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.02 35.1 53.34 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -120.21 89.6 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.7 -0.883 . . . . 0.0 110.165 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -54.84 179.24 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.557 -0.714 . . . . 0.0 109.994 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.774 ' CB ' HD23 ' A' ' 63' ' ' LEU . 41.8 Cg_endo -66.96 156.77 64.83 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.387 1.204 . . . . 0.0 109.376 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 6.7 mt 67.2 -59.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 48' ' ' PRO . 36.4 tt0 -49.59 -21.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.919 -1.113 . . . . 0.0 109.688 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.5 p -124.49 37.06 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.812 . . . . 0.0 110.017 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.756 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -101.84 37.67 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.293 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.2 ttp 64.91 -9.22 0.2 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.535 -0.728 . . . . 0.0 111.693 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.554 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.4 28.57 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.035 -1.04 . . . . 0.0 110.339 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.27 11.46 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -144.54 73.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -1.021 . . . . 0.0 109.549 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -47.23 -27.92 1.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.605 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -59.24 -31.88 69.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.935 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.796 ' CG2' HG22 ' A' ' 25' ' ' VAL . 48.4 t -71.8 -50.41 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.756 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -43.0 -46.84 5.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.71 -55.15 38.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 109.702 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -44.38 -56.21 4.39 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.652 -0.655 . . . . 0.0 110.708 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.774 HD23 ' CB ' ' A' ' 48' ' ' PRO . 6.2 mp -68.84 -58.84 3.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 110.541 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -48.24 -52.91 19.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.175 -0.953 . . . . 0.0 110.301 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -55.04 -33.84 63.03 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.397 -0.814 . . . . 0.0 109.319 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.792 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.9 m80 -81.88 -48.78 11.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.302 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.39 43.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.577 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' HA ' ' CG ' ' A' ' 48' ' ' PRO . . . -69.02 -172.53 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.703 -1.469 . . . . 0.0 109.722 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 47' ' ' ARG . 3.7 mm-40 -121.02 65.14 13.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.378 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.486 ' HG3' HD21 ' A' ' 64' ' ' LEU . 42.8 Cg_endo -68.84 -26.16 32.4 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.07 1.563 . . . . 0.0 110.378 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -92.7 -63.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 173.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -164.07 -170.74 2.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.85 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.52 132.96 43.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.604 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 -15.92 39.51 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.556 1.293 . . . . 0.0 110.708 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.76 -84.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 109.991 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 66.6 p -110.1 32.99 4.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.286 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 5.5 mt 49.27 32.54 4.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.472 -0.767 . . . . 0.0 110.529 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.61 97.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.503 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -72.24 147.78 90.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.457 -0.777 . . . . 0.0 109.859 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 40.8 Cg_endo -66.56 -20.59 53.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.521 1.274 . . . . 0.0 109.515 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.977 HG13 HD23 ' A' ' 104' ' ' LEU . 27.6 t -58.46 -25.7 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -0.801 . . . . 0.0 109.8 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.493 ' CE1' ' HB3' ' A' ' 80' ' ' ARG . 23.9 m80 -73.27 -41.29 63.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.554 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.55 -43.85 46.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.694 -0.629 . . . . 0.0 110.23 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.708 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -63.35 -64.54 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.388 -0.82 . . . . 0.0 109.736 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.757 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -59.46 -52.41 65.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -41.27 -34.85 0.54 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.33 -8.99 28.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.16 -0.962 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . 82.92 23.81 54.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.646 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -98.95 84.01 3.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 110.445 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -57.9 -39.62 78.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 110.46 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.588 ' O ' HG23 ' A' ' 96' ' ' VAL . 46.2 t0 -50.01 -40.96 46.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.032 -1.042 . . . . 0.0 109.959 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 85' ' ' ALA . 50.7 m -60.03 -32.38 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.71 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.708 HD12 ' HB1' ' A' ' 85' ' ' ALA . 1.1 mp -72.15 -51.23 22.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.419 -0.801 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.3 t -50.17 -45.02 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.538 -0.726 . . . . 0.0 109.579 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 92' ' ' ASP . 39.1 t -61.72 -49.04 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.578 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.593 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.75 -71.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.139 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -48.77 -34.42 12.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.685 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -62.03 -20.72 64.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.54 86.15 1.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.212 -0.93 . . . . 0.0 111.124 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 49.13 97.8 0.01 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -168.19 97.5 0.43 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -1.131 . . . . 0.0 110.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.764 ' O ' HG21 ' A' ' 82' ' ' VAL . 10.7 ttm180 -71.93 137.08 47.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.49 -0.756 . . . . 0.0 109.567 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.977 HD23 HG13 ' A' ' 82' ' ' VAL . 1.1 mp -121.32 21.37 11.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 103' ' ' ARG . 4.8 p-10 -124.32 40.43 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.067 -1.02 . . . . 0.0 110.584 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.64 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.7 p -101.44 -171.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.64 ' H ' HG22 ' A' ' 106' ' ' VAL . 38.7 mtp180 -135.33 142.8 45.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 110' ' ' TRP . 94.0 m-20 -78.42 60.66 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 110.046 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.2 -71.18 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.756 -0.59 . . . . 0.0 111.082 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.597 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -40.57 -58.38 1.61 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.435 -0.791 . . . . 0.0 110.829 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -23.5 0.73 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -56.02 160.56 2.75 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.323 -1.104 . . . . 0.0 109.896 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 106' ' ' VAL . 36.6 mt -120.02 166.9 13.71 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 0.0 110.679 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.79 -34.92 29.44 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.806 1.424 . . . . 0.0 110.392 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 130' ' ' LEU . 9.8 p -82.78 -33.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.57 -38.37 90.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -60.15 -24.56 64.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.785 . . . . 0.0 110.14 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -83.19 -27.7 29.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.26 -40.58 70.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.7 -47.28 32.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 117' ' ' LEU . 5.2 mp -69.85 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.32 38.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 16.6 m-70 -99.3 48.99 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.277 -1.131 . . . . 0.0 109.275 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -44.31 -38.02 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.757 -0.589 . . . . 0.0 110.646 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.53 -44.67 95.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.757 HG11 ' CB ' ' A' ' 86' ' ' ALA . 22.7 t -78.67 -42.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.426 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -50.98 -41.41 59.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -63.94 1.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.52 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.7 t80 -54.0 -41.38 67.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.498 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 86' ' ' ALA . 15.5 mt -58.1 -65.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -26.04 0.89 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.076 -1.015 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.06 -58.58 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.05 -3.59 36.72 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.522 -0.736 . . . . 0.0 110.977 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 109.833 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.366 0.603 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.508 ' CD1' ' N ' ' A' ' 15' ' ' TRP . 35.6 m0 -68.19 -4.4 13.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.657 -0.652 . . . . 0.0 111.536 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.747 HD11 ' HB1' ' A' ' 36' ' ' ALA . 25.1 mt -79.66 -52.26 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 108.825 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.42 83.92 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.029 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -75.25 -60.95 2.07 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.21 -0.931 . . . . 0.0 111.074 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -45.74 -57.68 4.07 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.159 -0.963 . . . . 0.0 110.821 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -53.53 -41.43 66.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -64.7 -33.1 75.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.712 . . . . 0.0 110.198 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 24.5 2.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.824 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.22 61.05 6.13 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.98 68.25 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.964 . . . . 0.0 109.72 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 59' ' ' VAL . 18.1 t -52.7 -54.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.539 -0.726 . . . . 0.0 110.308 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -42.74 -38.07 1.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.0 110.747 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -66.3 -51.49 56.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.719 HG12 HD13 ' A' ' 62' ' ' LEU . 5.2 t -68.62 -42.89 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.561 -0.712 . . . . 0.0 110.215 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.932 ' HA ' HD11 ' A' ' 62' ' ' LEU . 14.4 mmm180 -46.41 -48.02 18.82 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.375 -0.828 . . . . 0.0 110.277 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.24 -37.65 52.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.465 -0.772 . . . . 0.0 109.918 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 14.4 mt -59.2 -66.94 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.874 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 23.7 mt -46.93 -48.52 21.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.581 -0.699 . . . . 0.0 110.427 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.08 -18.67 65.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.608 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.53 -6.68 57.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 111.012 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.21 31.79 1.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.874 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -74.09 157.93 35.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -1.057 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.96 115.26 61.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.442 -0.786 . . . . 0.0 109.911 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' HD13 ' A' ' 37' ' ' LEU . 43.8 Cg_endo -69.45 -36.53 11.46 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.497 1.262 . . . . 0.0 110.094 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -108.05 61.05 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 110.221 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -104.06 99.19 15.76 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.37 -0.831 . . . . 0.0 110.364 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.24 121.02 7.41 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.546 1.288 . . . . 0.0 110.343 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -98.61 178.28 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.928 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -69.55 -6.13 28.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 110.816 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 1.95 22.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 0.0 110.695 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.23 30.76 8.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -124.5 133.83 53.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.805 -0.82 . . . . 0.0 109.906 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -50.65 168.98 0.22 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.498 -0.751 . . . . 0.0 110.745 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 69' ' ' GLU . 44.2 Cg_endo -72.32 -19.95 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.03 1.542 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.475 HG13 ' HB1' ' A' ' 68' ' ' ALA . 4.9 mt -107.03 -39.28 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.191 -0.943 . . . . 0.0 109.798 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 8.5 mt-30 -50.16 -22.11 1.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.585 HG22 ' HB2' ' A' ' 21' ' ' ALA . 13.4 p -113.21 34.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.033 . . . . 0.0 110.584 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.722 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -96.19 35.28 1.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.724 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.9 tmm? 72.39 -10.45 0.92 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.656 -0.652 . . . . 0.0 110.614 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.567 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 44.61 28.47 0.33 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.982 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -137.0 16.91 3.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.544 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.6 m -150.04 75.38 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -1.087 . . . . 0.0 109.579 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -43.85 -34.3 1.57 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 0.0 110.673 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -48.91 -40.22 29.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.49 -0.756 . . . . 0.0 109.812 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 25' ' ' VAL . 19.4 t -62.4 -55.69 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.722 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.56 -54.55 3.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.626 -0.671 . . . . 0.0 109.92 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.558 ' O ' HD23 ' A' ' 65' ' ' LEU . 1.9 tt0 -49.75 -43.86 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.673 -0.642 . . . . 0.0 110.136 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.932 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -53.66 -73.36 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.125 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.978 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 34.2 mt -58.84 -49.26 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.698 . . . . 0.0 109.533 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.831 HD22 HG12 ' A' ' 96' ' ' VAL . 3.0 tt -48.42 -67.45 0.27 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.509 -0.745 . . . . 0.0 110.705 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -56.83 -19.51 17.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.347 -0.846 . . . . 0.0 110.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -85.06 -44.35 13.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.404 -0.81 . . . . 0.0 109.777 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.93 37.7 0.11 Allowed Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.978 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.8 -147.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.867 -1.372 . . . . 0.0 109.141 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 2.3 mt-10 -121.07 67.07 15.6 Favored Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 121.625 -0.672 . . . . 0.0 109.392 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CB ' HD23 ' A' ' 97' ' ' LEU . 45.2 Cg_endo -70.44 -7.9 22.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.971 1.511 . . . . 0.0 110.259 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -118.81 -72.85 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.376 -0.828 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.2 t -42.27 149.11 0.17 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.375 -0.828 . . . . 0.0 110.541 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . . . -132.36 -144.86 0.25 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.811 . . . . 0.0 110.405 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -103.72 139.07 19.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.578 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.63 2.23 7.63 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.444 1.234 . . . . 0.0 110.486 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.46 -56.02 3.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 109.148 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.617 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -129.26 19.05 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.751 -0.593 . . . . 0.0 109.576 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER 44.08 43.58 5.67 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.627 -0.671 . . . . 0.0 111.559 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.418 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 81.0 m -69.96 104.45 2.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 109.857 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.745 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -69.45 148.79 97.19 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.914 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.633 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.2 Cg_endo -64.66 -14.89 47.19 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.519 1.273 . . . . 0.0 108.919 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.402 HG13 HD23 ' A' ' 104' ' ' LEU . 72.2 t -67.04 -35.4 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.578 0.704 . . . . 0.0 109.221 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.426 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 24.0 m80 -65.38 -38.14 89.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.468 0.651 . . . . 0.0 109.501 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.567 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -55.13 -50.42 69.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.746 -0.596 . . . . 0.0 110.951 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -56.73 -64.38 0.89 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.978 -1.076 . . . . 0.0 108.725 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.825 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -53.33 -38.34 63.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.45 -0.781 . . . . 0.0 110.259 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.7 OUTLIER -49.55 -38.77 32.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.614 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.79 8.79 39.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 110.437 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 65.15 30.04 76.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -95.01 82.05 3.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.522 -0.987 . . . . 0.0 110.654 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.47 -42.39 74.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.832 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 96' ' ' VAL . 73.4 m-20 -47.33 -50.81 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 85' ' ' ALA . 3.1 m -53.82 -45.8 70.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.407 -0.808 . . . . 0.0 109.855 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.687 HD12 ' HB1' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -58.81 -44.89 90.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.742 . . . . 0.0 110.007 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 91' ' ' LEU . 21.4 t -56.7 -44.61 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.831 HG12 HD22 ' A' ' 64' ' ' LEU . 6.3 t -57.2 -54.49 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.589 ' HA ' HD11 ' A' ' 64' ' ' LEU . 13.3 mt -49.4 -51.0 37.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.679 -0.638 . . . . 0.0 110.16 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.66 -30.36 65.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.4 mtp180 -61.38 -14.02 24.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -123.33 -86.33 0.64 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.03 94.5 0.12 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.19 107.37 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 110.591 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -69.62 143.11 53.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.713 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.548 HD13 ' HB1' ' A' ' 133' ' ' ALA . 2.1 mp -123.18 37.07 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.417 -0.802 . . . . 0.0 109.763 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.02 34.22 4.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.365 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.745 HG11 ' CG ' ' A' ' 80' ' ' ARG . 13.0 p -102.6 173.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.946 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.548 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -124.91 148.15 48.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -69.4 66.22 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 0.0 109.883 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 65.51 -61.72 0.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.509 -0.744 . . . . 0.0 109.964 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.617 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.8 m-90 -70.2 -83.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 107' ' ' ARG . . . -170.06 21.62 0.08 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.442 ' C ' HD22 ' A' ' 113' ' ' LEU . 9.9 mtm180 -84.29 136.8 33.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.06 -1.259 . . . . 0.0 109.931 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 106' ' ' VAL . 4.0 mm? -104.98 165.9 12.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.635 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.433 ' C ' HD13 ' A' ' 130' ' ' LEU . 46.2 Cg_endo -71.73 -38.86 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.841 1.443 . . . . 0.0 109.838 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 127' ' ' ALA . 9.8 p -64.98 -35.91 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 0.0 111.225 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.407 ' N ' HG13 ' A' ' 115' ' ' VAL . 14.6 t0 -61.09 -47.71 85.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 111.268 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.598 HD23 ' CD1' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -52.46 -49.57 64.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.196 -0.94 . . . . 0.0 110.939 -179.017 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.771 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -53.26 -50.25 65.2 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.235 -0.916 . . . . 0.0 110.736 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -56.86 -51.83 67.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.996 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -61.54 -57.94 10.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.466 -0.771 . . . . 0.0 110.193 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.598 ' CD1' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -59.35 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.368 -0.832 . . . . 0.0 110.419 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.59 34.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.2 m-70 -107.33 53.39 0.69 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.434 -1.039 . . . . 0.0 109.288 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -47.62 -36.7 11.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.533 -0.729 . . . . 0.0 110.069 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.413 ' C ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -58.23 -44.98 88.5 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.95 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.825 HG11 ' CB ' ' A' ' 86' ' ' ALA . 20.2 t -80.27 -42.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.771 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -52.25 -44.81 65.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 109.676 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -65.27 -64.57 0.83 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.278 -0.888 . . . . 0.0 109.323 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -47.51 -40.66 19.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.655 . . . . 0.0 110.06 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.591 ' CD1' HG12 ' A' ' 126' ' ' VAL . 14.2 mt -63.28 -55.03 28.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.544 -0.723 . . . . 0.0 110.083 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.32 -27.08 0.61 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.512 -0.742 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.19 -62.94 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.036 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.548 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -68.9 -6.09 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.317 -0.864 . . . . 0.0 111.026 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.101 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.835 0.35 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.51 ' CE3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -43.03 -36.26 1.53 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.523 -0.736 . . . . 0.0 110.468 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.733 ' CD1' ' HB1' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -49.88 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' H ' ' HB3' ' A' ' 16' ' ' LEU . . . -47.41 -52.67 16.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.625 -0.672 . . . . 0.0 111.394 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 4.8 p -40.57 -61.01 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.34 -0.85 . . . . 0.0 111.137 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.657 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.19 -53.59 54.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -54.37 -44.28 72.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.65 -17.65 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.647 -0.658 . . . . 0.0 110.276 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -100.67 19.9 16.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.366 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.4 53.67 39.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.595 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -127.64 96.24 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' CZ ' ' A' ' 29' ' ' ARG . 24.4 t -74.56 -44.49 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.292 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.19 -45.63 90.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 110.729 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.836 ' O ' HD12 ' A' ' 31' ' ' LEU . 2.2 mt-10 -53.05 -44.76 67.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.357 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.931 HG12 HD12 ' A' ' 32' ' ' LEU . 4.7 t -75.97 -46.61 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.724 . . . . 0.0 109.936 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HD2' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.93 -44.89 40.88 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.305 -0.872 . . . . 0.0 110.204 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.51 61.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.571 -0.705 . . . . 0.0 110.232 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.1 mt -65.44 -67.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.931 HD12 HG12 ' A' ' 28' ' ' VAL . 2.7 mt -47.43 -33.64 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -30.4 68.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.94 -6.68 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.845 . . . . 0.0 110.193 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.27 30.88 3.22 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.1 162.42 1.96 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.289 -1.124 . . . . 0.0 109.929 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' A' ' 37' ' ' LEU . 13.1 tp -80.28 127.33 76.73 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.393 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.36 -29.58 13.69 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.765 1.403 . . . . 0.0 110.407 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -132.91 81.08 1.92 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HA ' HD23 ' A' ' 37' ' ' LEU . . . -97.66 129.43 31.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 110.221 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.63 93.41 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.562 1.296 . . . . 0.0 110.259 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -66.8 -167.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.244 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.64 2.77 41.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.895 . . . . 0.0 110.544 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -105.26 23.1 14.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.121 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.45 23.57 19.95 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -124.02 -164.52 1.25 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.48 -1.012 . . . . 0.0 110.087 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.557 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -139.88 -174.39 0.41 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 108.997 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HB2' HD13 ' A' ' 63' ' ' LEU . 38.9 Cg_endo -66.2 160.82 43.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.127 1.067 . . . . 0.0 109.965 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt 68.43 -59.61 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.613 -0.679 . . . . 0.0 110.008 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -51.78 -21.16 2.58 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.82 -1.175 . . . . 0.0 110.015 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 51' ' ' VAL . 14.4 p -125.2 9.81 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.383 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.514 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 2.6 ptt? -69.59 159.74 32.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.993 -1.067 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -46.65 -24.74 0.59 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.569 -0.707 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.508 ' HE3' ' HE3' ' A' ' 52' ' ' MET . 0.0 OUTLIER 64.54 14.44 8.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.914 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.44 14.63 27.65 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.637 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -149.24 87.22 1.51 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.59 -0.947 . . . . 0.0 109.818 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -53.55 -23.09 9.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.85 . . . . 0.0 110.03 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -60.29 -35.35 75.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 110.001 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 56' ' ' SER . 57.4 t -59.56 -49.09 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.61 -55.44 25.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.792 . . . . 0.0 110.043 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.55 ' O ' HD23 ' A' ' 65' ' ' LEU . 2.2 tm-20 -49.76 -41.53 44.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.094 -1.004 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.672 ' CD1' HD13 ' A' ' 32' ' ' LEU . 2.6 tp -69.03 -57.18 5.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.302 -0.874 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 6.8 mt -65.71 -41.02 92.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.919 HD13 HG12 ' A' ' 96' ' ' VAL . 2.9 tt -59.46 -65.4 0.68 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 110.938 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.75 HD12 ' C ' ' A' ' 65' ' ' LEU . 3.5 pp -52.9 -24.56 9.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 109.697 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.838 ' CB ' HD22 ' A' ' 32' ' ' LEU . 1.3 m80 -80.79 -41.99 22.46 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.541 -0.724 . . . . 0.0 109.941 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.56 41.11 0.1 OUTLIER Glycine 0 N--CA 1.482 1.76 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.787 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -68.2 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.986 -1.302 . . . . 0.0 109.737 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 4.3 tp10 -120.96 57.12 5.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.331 -0.856 . . . . 0.0 110.217 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 48.9 Cg_endo -72.14 -25.42 19.13 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.885 1.466 . . . . 0.0 110.341 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 103' ' ' ARG . 2.3 m-20 -100.06 -76.81 0.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 0.0 110.137 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 162.91 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.568 -0.707 . . . . 0.0 110.41 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -140.53 -132.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -0.842 . . . . 0.0 110.196 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 78' ' ' LEU . 41.6 t0 -121.18 129.8 25.11 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 -7.95 22.46 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.369 1.194 . . . . 0.0 110.592 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.45 -49.58 11.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.01 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.606 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -134.72 24.5 3.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.55 -0.719 . . . . 0.0 110.072 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 78' ' ' LEU . 7.7 mt 41.86 31.63 0.23 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.697 -0.627 . . . . 0.0 110.749 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.6 m -67.61 86.56 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.818 . . . . 0.0 110.236 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.845 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.56 167.78 20.78 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 109.787 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 51.1 Cg_endo -73.46 -2.68 12.49 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.433 1.228 . . . . 0.0 110.913 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.004 HG13 HD23 ' A' ' 104' ' ' LEU . 36.1 t -78.25 -27.45 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 110.092 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 19.9 m80 -74.19 -39.32 63.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.885 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD2' ' HA ' ' A' ' 81' ' ' PRO . 50.2 m-20 -55.02 -56.0 24.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.645 -0.659 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.35 -63.01 1.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.747 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.814 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -52.65 -54.25 35.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.873 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -47.66 -39.52 17.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.394 -0.816 . . . . 0.0 110.803 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.62 12.6 20.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.97 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 55.59 56.16 25.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -129.63 90.6 3.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.468 -1.019 . . . . 0.0 111.223 -178.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.697 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -73.41 -35.0 65.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.792 . . . . 0.0 109.665 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -47.58 -47.98 28.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.673 -0.642 . . . . 0.0 109.779 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 m -64.11 -41.64 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.718 HD21 ' CB ' ' A' ' 130' ' ' LEU . 1.6 tp -52.86 -55.09 25.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.6 -0.687 . . . . 0.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 87.2 t -48.92 -46.26 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.72 -0.613 . . . . 0.0 109.433 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.919 HG12 HD13 ' A' ' 64' ' ' LEU . 49.9 t -58.52 -53.31 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.512 0.672 . . . . 0.0 109.402 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.922 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -48.72 -52.74 22.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.551 -0.718 . . . . 0.0 110.071 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -74.05 -21.84 59.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 109.817 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.9 ttp180 -64.24 -16.73 62.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.495 -0.753 . . . . 0.0 110.474 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.592 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -134.1 -76.85 0.47 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.0 100.52 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.922 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -152.01 94.94 2.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -1.046 . . . . 0.0 110.526 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -55.66 108.2 0.41 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.249 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.004 HD23 HG13 ' A' ' 82' ' ' VAL . 2.0 mt -98.9 32.38 2.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.04 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.47 44.64 2.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 0.0 110.373 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.845 HG11 ' HB2' ' A' ' 80' ' ' ARG . 9.5 p -111.21 -178.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.635 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.9 mtp85 -122.83 -176.67 3.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 44.4 p-10 -104.46 36.28 2.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.901 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 66.35 3.7 2.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 110.945 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.606 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 3.6 m-90 -123.65 -57.96 1.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.981 -1.074 . . . . 0.0 109.959 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.83 -30.4 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.44 165.4 4.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -1.036 . . . . 0.0 110.831 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 117' ' ' LEU . 42.3 mt -128.82 169.62 12.57 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.644 -0.66 . . . . 0.0 109.278 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.96 -13.87 37.5 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.454 1.239 . . . . 0.0 109.806 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 130' ' ' LEU . 4.6 p -90.56 -40.09 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 110.657 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -57.01 -43.18 81.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.354 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -56.54 -53.19 60.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.861 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.573 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -53.36 -53.89 44.59 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -49.46 -30.45 8.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.0 109.94 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 28.2 mm-40 -85.15 -59.12 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.565 -0.71 . . . . 0.0 109.544 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 110.053 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.68 28.34 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 12.0 m-70 -97.98 47.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.028 -1.278 . . . . 0.0 109.159 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.91 -40.92 6.73 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.606 0.717 . . . . 0.0 109.547 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.545 ' OD2' HG23 ' A' ' 126' ' ' VAL . 5.3 p-10 -61.74 -46.79 88.13 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.039 -0.665 . . . . 0.0 109.635 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.814 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -76.17 -40.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 109.777 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.573 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -52.81 -62.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.348 -0.845 . . . . 0.0 110.341 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -47.02 -61.27 1.95 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.504 -0.748 . . . . 0.0 111.303 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.697 ' CG ' HD21 ' A' ' 91' ' ' LEU . 14.8 t80 -56.64 -63.55 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.896 . . . . 0.0 110.62 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.718 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.29 -19.92 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 110.514 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.511 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -75.4 -40.62 57.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.036 -1.04 . . . . 0.0 110.148 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.55 77.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.61 -15.94 31.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.716 -0.615 . . . . 0.0 109.819 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.331 -0.855 . . . . 0.0 110.397 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 20.2 p-10 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.002 0.43 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.596 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.8 m0 -54.42 -21.03 8.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.803 HD11 HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -75.62 -42.33 51.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.452 -0.78 . . . . 0.0 109.403 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.93 -45.12 28.92 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.823 . . . . 0.0 109.895 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -47.23 -56.26 7.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.571 -0.705 . . . . 0.0 110.434 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.83 91.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 110.163 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.96 -53.81 47.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -58.5 -29.31 66.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.422 -0.799 . . . . 0.0 110.436 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.85 23.86 2.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.587 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 49.82 44.62 39.99 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -109.09 93.55 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -1.11 . . . . 0.0 110.017 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 58' ' ' ARG . 5.1 t -75.1 -46.46 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 110.192 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -32.92 70.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 1.6 tp10 -74.03 -46.45 43.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 0.0 109.766 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.537 HG21 HG13 ' A' ' 59' ' ' VAL . 51.4 t -64.94 -46.89 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 1.077 ' HA ' HD12 ' A' ' 62' ' ' LEU . 46.3 mmm-85 -55.21 -46.76 75.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.053 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.34 56.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 0.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 13.0 mt -61.15 -63.01 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.945 . . . . 0.0 110.49 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.92 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 1.4 mt -49.18 -43.27 42.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.392 -0.817 . . . . 0.0 110.476 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -71.09 -13.36 61.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.88 -10.17 37.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.194 -0.941 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.01 -2.83 5.57 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.333 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.92 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -53.69 103.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.03 -1.276 . . . . 0.0 109.896 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 17.3 tp -50.5 123.4 17.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.494 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 40.8 Cg_endo -67.84 -43.44 5.2 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.598 1.315 . . . . 0.0 110.489 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -91.07 54.13 2.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.12 -0.988 . . . . 0.0 109.817 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -104.8 93.95 6.84 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.771 . . . . 0.0 110.612 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.17 97.11 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.588 1.309 . . . . 0.0 110.034 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -63.7 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.315 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.12 36.42 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -0.887 . . . . 0.0 110.319 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -7.76 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 111.073 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 24.48 19.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.44 32.45 5.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.541 -0.976 . . . . 0.0 109.369 -179.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mmt180 49.77 179.76 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 49.7 Cg_endo -86.44 -13.69 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.155 1.082 . . . . 0.0 111.065 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 63' ' ' LEU . 5.2 mt -107.69 -43.05 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.95 -1.094 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 1.5 tt0 -46.24 -28.91 1.4 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 21' ' ' ALA . 7.1 p -109.32 40.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.599 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -99.48 30.38 3.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 109.669 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.587 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 7.3 tmm? 64.65 -4.7 0.43 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.724 -0.61 . . . . 0.0 111.292 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.599 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 13.0 mmt 42.39 28.64 0.12 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.41 6.89 8.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.662 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -145.75 87.34 1.77 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 110.115 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -54.01 -30.84 49.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.805 . . . . 0.0 109.545 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.606 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -54.12 -37.47 64.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.574 -0.704 . . . . 0.0 109.273 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.682 ' O ' HD12 ' A' ' 63' ' ' LEU . 99.0 t -59.84 -61.17 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -54.75 -25.61 28.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.545 -0.722 . . . . 0.0 109.104 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 58' ' ' ARG . 5.2 tm-20 -53.54 -72.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.302 -0.874 . . . . 0.0 110.045 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.077 HD12 ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.56 -36.57 71.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.778 -1.201 . . . . 0.0 109.393 179.279 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 16' ' ' LEU . 1.1 mt -58.09 -63.41 1.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.447 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.728 HD13 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.38 -31.37 71.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.421 -0.799 . . . . 0.0 109.248 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 26.0 tp -68.78 -48.34 63.9 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.517 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.91 -16.08 58.5 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.423 -0.798 . . . . 0.0 109.951 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.5 63.63 0.58 Allowed Glycine 0 N--CA 1.483 1.825 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.618 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -79.71 -146.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.945 -1.327 . . . . 0.0 109.145 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mm-40 -117.14 55.07 1.53 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.285 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 49.2 Cg_endo -70.72 -14.07 32.75 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.497 1.262 . . . . 0.0 110.95 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -103.65 -76.44 0.59 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.127 -0.983 . . . . 0.0 110.262 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.61 144.17 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . . . -119.01 -156.28 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.924 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -102.7 144.18 28.1 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.951 . . . . 0.0 110.441 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.94 -17.08 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.614 1.323 . . . . 0.0 110.327 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.66 -78.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.714 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.687 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 34.8 p -115.06 27.36 9.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.143 -0.973 . . . . 0.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.1 mt 46.64 31.06 1.27 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 111.117 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -67.09 100.37 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.581 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -75.86 165.48 52.88 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.315 -0.866 . . . . 0.0 109.513 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HD2' ' HG2' ' A' ' 80' ' ' ARG . 47.4 Cg_endo -71.54 -11.51 28.27 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.637 1.335 . . . . 0.0 109.625 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 114' ' ' PRO . 77.2 t -69.5 -46.39 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.436 -0.79 . . . . 0.0 109.93 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 39.9 m80 -52.03 -49.63 63.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.424 -0.797 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 7.0 m-20 -42.54 -54.67 3.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 122.02 -0.425 . . . . 0.0 111.437 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.508 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -53.29 -62.69 1.49 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.914 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -63.18 -26.15 68.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.564 -0.71 . . . . 0.0 110.686 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -62.35 -28.44 69.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.018 -1.051 . . . . 0.0 109.947 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.433 ' C ' ' CE1' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -109.05 -20.82 12.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.404 -0.81 . . . . 0.0 110.089 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.735 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 94.39 32.6 7.27 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.906 -1.677 . . . . 0.0 108.906 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.556 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -99.46 88.05 3.77 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 110.406 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.612 HD11 ' CD2' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -60.6 -39.08 86.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 110.432 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 31.8 m-20 -46.85 -46.15 20.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 110.081 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.5 m -61.47 -46.42 90.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.564 -0.71 . . . . 0.0 110.055 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.624 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -51.31 -57.91 7.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.38 -0.825 . . . . 0.0 110.481 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.34 -50.67 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.284 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.728 HG12 HD13 ' A' ' 64' ' ' LEU . 57.7 t -55.37 -51.07 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.532 -0.73 . . . . 0.0 110.358 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 1.1 mp -51.46 -55.66 17.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -71.7 -42.41 67.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.369 -0.832 . . . . 0.0 110.882 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -7.35 6.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -132.77 -59.16 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.931 -1.106 . . . . 0.0 110.74 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.85 108.78 0.28 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -173.03 133.62 0.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -1.167 . . . . 0.0 110.915 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -97.23 80.79 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.611 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.4 mp -69.91 67.88 0.28 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.0 110.011 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -168.02 33.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.314 -0.866 . . . . 0.0 110.43 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.2 p -105.9 -170.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.925 -1.11 . . . . 0.0 109.996 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 106' ' ' VAL . 30.5 mtt180 -131.29 147.52 52.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 35.7 t0 -79.1 54.89 1.71 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.687 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 58.6 -69.06 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.74 -0.6 . . . . 0.0 110.635 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.686 ' CH2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -41.22 -48.65 3.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.71 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.38 -33.88 1.54 Allowed Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.452 ' HD2' ' HB2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -56.58 156.35 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -1.064 . . . . 0.0 110.35 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 117' ' ' LEU . 29.9 mt -105.9 168.03 8.82 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.489 -0.757 . . . . 0.0 110.412 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 82' ' ' VAL . 38.8 Cg_endo -65.81 -27.96 51.47 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.773 1.407 . . . . 0.0 110.046 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 127' ' ' ALA . 3.4 p -77.83 -31.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.506 -0.747 . . . . 0.0 109.731 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -60.12 -49.2 78.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.448 -0.782 . . . . 0.0 110.189 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.658 ' C ' HD12 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -57.58 -57.25 13.5 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.317 -0.865 . . . . 0.0 110.356 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.914 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -51.22 -54.95 20.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.446 ' N ' ' HB2' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -49.31 -41.25 37.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.351 -0.843 . . . . 0.0 110.578 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -80.09 -26.42 39.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 0.0 110.421 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 117' ' ' LEU . 8.3 mt -81.0 2.64 26.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.275 -0.891 . . . . 0.0 110.383 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.86 17.28 73.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 22.2 m170 -94.67 53.44 1.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -1.158 . . . . 0.0 108.949 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -39.97 -59.21 1.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.222 0.535 . . . . 0.0 111.802 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.528 ' O ' HD21 ' A' ' 91' ' ' LEU . 54.8 m-20 -48.6 -39.44 23.9 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.492 -0.755 . . . . 0.0 110.393 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -80.89 -38.74 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.511 -0.743 . . . . 0.0 110.012 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -64.79 -38.99 92.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 109.553 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -73.99 -42.62 60.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.257 -0.902 . . . . 0.0 109.841 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.612 ' CD2' HD11 ' A' ' 91' ' ' LEU . 9.5 t80 -59.79 -40.63 88.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.624 ' HG ' HD21 ' A' ' 94' ' ' LEU . 19.4 mt -68.28 -42.96 78.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.509 -0.744 . . . . 0.0 109.591 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.445 ' HG3' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -58.53 -20.95 50.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.72 -47.6 11.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.881 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.71 -14.57 42.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.397 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' A' ' 18' ' ' THR . 12.1 t70 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.644 0.259 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -3.98 17.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.933 -1.105 . . . . 0.0 111.169 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.911 HD21 ' CB ' ' A' ' 36' ' ' ALA . 28.0 mt -81.14 -49.63 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.128 -0.983 . . . . 0.0 109.57 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.88 -46.73 67.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.675 -0.64 . . . . 0.0 110.077 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.79 -63.67 1.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.673 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -51.97 -46.02 64.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -57.63 -49.22 77.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.77 -24.86 67.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.454 -0.778 . . . . 0.0 110.694 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -90.13 26.35 1.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.784 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.91 31.11 4.0 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.619 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -104.46 94.16 5.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.617 -0.931 . . . . 0.0 110.174 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 59' ' ' VAL . 46.2 t -71.43 -54.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.592 -0.692 . . . . 0.0 110.025 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -47.82 -41.23 23.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.493 -0.755 . . . . 0.0 110.671 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 5.2 mm-40 -59.13 -54.62 44.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 24' ' ' ARG . 2.6 t -64.79 -49.67 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.619 -0.676 . . . . 0.0 109.238 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HA ' HD11 ' A' ' 62' ' ' LEU . 3.4 mmt180 -36.95 -51.61 0.92 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.347 0.594 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -78.7 -52.51 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.3 mt -48.39 -74.23 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.317 -0.864 . . . . 0.0 111.382 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.019 HD23 HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -50.1 -43.25 51.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 110.804 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.44 -10.09 59.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 0.0 110.386 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -87.33 -13.47 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.005 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.49 23.61 1.35 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.494 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.911 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -69.6 -172.95 0.53 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.259 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.53 ' H ' HD11 ' A' ' 16' ' ' LEU . 3.1 mm? -94.96 126.38 47.09 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 110.829 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 43.1 Cg_endo -71.34 -16.45 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.284 1.15 . . . . 0.0 110.225 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -137.79 48.08 2.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . . . -73.79 137.98 76.76 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.42 169.35 22.61 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.751 1.395 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -133.39 -172.13 2.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.3 m -109.14 13.04 24.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.892 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 15.7 m-85 -117.96 8.25 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.248 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.37 31.96 79.19 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -119.1 -169.58 1.76 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.459 -1.024 . . . . 0.0 110.127 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -105.95 164.72 14.4 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.8 Cg_endo -65.85 -15.73 50.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.561 1.295 . . . . 0.0 111.266 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.6 mt -109.12 -38.25 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.92 . . . . 0.0 108.799 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 2.8 mt-30 -49.96 -23.55 2.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.328 -0.858 . . . . 0.0 110.41 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 21' ' ' ALA . 11.1 p -110.98 36.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.456 -0.777 . . . . 0.0 110.537 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.545 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 0.1 OUTLIER -96.8 32.25 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.955 -1.09 . . . . 0.0 110.198 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.443 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 6.7 tmm? 64.98 -3.26 0.61 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.654 -0.654 . . . . 0.0 110.568 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.549 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 39.88 32.71 0.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.429 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -122.15 -3.23 9.82 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -145.6 85.95 1.72 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 110.212 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.6 -25.74 11.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -49.81 -43.38 48.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.725 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 25' ' ' VAL . 5.9 t -60.21 -54.79 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -48.63 -35.63 14.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.641 -0.662 . . . . 0.0 109.333 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -49.53 76.02 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.019 HD22 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -55.06 -57.03 13.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.657 0.742 . . . . 0.0 109.157 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.81 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.4 mm? -59.93 -27.96 67.21 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.96 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.821 ' HG ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -73.42 -56.31 5.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.199 -0.938 . . . . 0.0 110.342 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -51.47 -27.08 9.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.838 0.828 . . . . 0.0 109.253 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.637 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.0 -28.58 21.33 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.627 0.727 . . . . 0.0 109.112 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.29 63.34 0.73 Allowed Glycine 0 N--CA 1.477 1.432 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.81 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -71.3 -154.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.079 -1.248 . . . . 0.0 108.664 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 47' ' ' ARG . 13.2 mt-10 -113.9 66.7 1.42 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.286 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.472 ' HB3' HD23 ' A' ' 97' ' ' LEU . 45.3 Cg_endo -69.69 -17.7 37.76 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.766 1.403 . . . . 0.0 110.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.432 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.4 t30 -98.02 -58.61 1.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -0.826 . . . . 0.0 110.501 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 30.7 t -47.0 147.95 1.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.9 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.92 -144.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.797 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.8 140.87 24.51 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.241 -0.912 . . . . 0.0 109.96 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -20.03 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.257 1.135 . . . . 0.0 109.919 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.22 -57.8 4.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 110.237 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.857 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -131.72 29.01 4.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 78' ' ' LEU . 6.1 mt 41.29 38.76 0.84 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.539 -0.726 . . . . 0.0 111.201 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.2 m -72.8 98.28 2.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.949 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.786 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -78.0 163.2 64.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.927 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.4 Cg_endo -69.07 -3.99 12.67 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.414 1.218 . . . . 0.0 110.393 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 104' ' ' LEU . 31.2 t -74.99 -29.48 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 2.2 m80 -74.67 -33.21 62.44 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -55.15 -59.67 4.45 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.341 0.591 . . . . 0.0 110.033 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.668 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -53.99 -61.56 2.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.388 -0.82 . . . . 0.0 109.76 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.799 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -54.99 -58.8 6.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 3.3 ttt180 -46.5 -28.16 1.32 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.279 -0.888 . . . . 0.0 110.894 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.482 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 1.8 tm-20 -103.3 1.99 33.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 111.044 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.476 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 64.38 58.93 9.09 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.47 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -134.23 86.75 2.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 110.339 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -58.21 -44.38 88.14 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.566 -0.709 . . . . 0.0 110.077 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 96' ' ' VAL . 22.5 t0 -43.8 -46.64 7.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.541 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 52.4 m -60.21 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 97' ' ' LEU . 1.8 tp -56.8 -45.67 82.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.178 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 91' ' ' LEU . 60.5 t -55.63 -50.67 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.608 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.821 HG12 ' HG ' ' A' ' 64' ' ' LEU . 52.7 t -53.54 -53.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.345 -0.847 . . . . 0.0 110.401 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 94' ' ' LEU . 6.2 mt -50.08 -66.92 0.31 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.72 -32.61 65.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 0.0 109.853 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.7 ttp85 -67.44 -8.97 37.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.602 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.498 ' CB ' HD12 ' A' ' 64' ' ' LEU . . . -149.35 58.21 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.969 -1.082 . . . . 0.0 111.19 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.4 109.01 0.01 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -166.41 125.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.4 -1.059 . . . . 0.0 110.757 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.449 ' O ' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -69.88 114.1 7.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.424 -0.797 . . . . 0.0 109.191 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.523 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -111.06 25.01 12.21 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 110.661 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 2.0 p30 -145.19 59.8 1.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.104 -0.997 . . . . 0.0 110.355 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.786 HG11 ' HB2' ' A' ' 80' ' ' ARG . 9.2 p -108.77 -177.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.696 ' H ' HG22 ' A' ' 106' ' ' VAL . 12.9 mtt180 -132.6 132.37 42.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -72.48 60.95 0.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.445 -0.785 . . . . 0.0 110.07 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.27 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.36 -0.838 . . . . 0.0 110.451 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CH2' HG23 ' A' ' 77' ' ' THR . 0.8 OUTLIER -124.09 25.28 7.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 0.0 109.902 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -93.61 -75.99 1.32 Allowed Glycine 0 N--CA 1.48 1.605 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 2.1 mtt180 171.93 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.939 . . . . 0.0 110.072 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.439 ' CD1' ' HD2' ' A' ' 114' ' ' PRO . 2.4 mm? -104.3 170.98 5.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 44.1 Cg_endo -70.74 -22.71 27.2 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.696 1.366 . . . . 0.0 110.622 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.884 ' HB ' HD11 ' A' ' 130' ' ' LEU . 7.2 p -82.81 -39.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 110.082 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.415 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 89.3 m-20 -52.48 -38.79 60.21 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.75 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.5 mt -59.73 -58.45 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -50.93 -39.82 55.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.17 -46.41 75.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.21 -24.77 57.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -87.64 -81.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.922 . . . . 0.0 110.681 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.72 42.55 0.02 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 37.3 m-70 -106.03 52.4 0.73 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.983 . . . . 0.0 108.951 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 12.2 ptm180 -42.41 -40.88 2.7 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.201 0.524 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.496 ' O ' HD21 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -60.15 -41.01 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.268 -0.895 . . . . 0.0 108.918 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -85.0 -41.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.675 -0.64 . . . . 0.0 109.656 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -51.67 -45.62 63.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -0.805 . . . . 0.0 110.308 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -82.57 -43.69 16.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.434 -0.791 . . . . 0.0 110.278 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.752 ' CG ' HD11 ' A' ' 91' ' ' LEU . 53.8 t80 -65.23 -61.76 1.94 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.233 -0.917 . . . . 0.0 109.953 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.884 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -56.32 -31.05 63.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 110.064 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.522 ' HB2' HG21 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -66.24 -28.95 69.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.003 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.95 -39.84 65.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.006 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.93 -13.12 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 111.029 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.812 0 O-C-N 120.975 -1.078 . . . . 0.0 111.098 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.131 0.491 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.0 106.83 57.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.049 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.15 152.85 62.44 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.497 1.261 . . . . 0.0 109.927 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.29 167.99 9.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 110.037 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.73 108.94 13.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.313 -0.867 . . . . 0.0 109.786 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' SER . . . 112.77 -148.8 18.48 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' GLY . 14.9 m 60.87 59.78 2.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.258 -1.143 . . . . 0.0 110.241 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.7 p -154.7 135.7 13.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 110.34 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -96.75 86.05 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.41 -0.806 . . . . 0.0 110.652 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.52 72.77 0.74 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.12 -0.987 . . . . 0.0 110.921 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.67 63.72 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.782 1.412 . . . . 0.0 111.131 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.94 112.04 24.12 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.301 -0.874 . . . . 0.0 109.574 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.75 -62.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 110.575 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -88.83 3.05 52.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.222 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.584 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.4 m0 -72.31 -11.46 60.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.484 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.784 HD11 ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -74.86 -58.5 3.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.441 -0.787 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.2 -49.43 77.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -43.89 -67.9 0.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.835 -0.541 . . . . 0.0 110.737 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -46.24 -51.21 14.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.33 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.604 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -46.59 -54.18 9.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.667 . . . . 0.0 110.334 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.14 -20.11 65.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.409 -0.807 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 26.4 mtm180 -99.38 22.2 10.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 111.364 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.517 ' CA ' ' HG3' ' A' ' 53' ' ' MET . . . 54.38 52.61 43.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 14.7 mmt180 -124.97 89.93 3.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.2 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 59' ' ' VAL . 81.2 t -74.36 -40.51 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.443 -0.786 . . . . 0.0 110.041 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -34.7 76.75 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.385 -0.822 . . . . 0.0 110.729 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 1.007 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.6 tp10 -61.07 -50.71 72.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG12 HD13 ' A' ' 62' ' ' LEU . 20.6 t -71.55 -48.54 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.903 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.893 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -41.18 -42.1 1.97 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 -179.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.72 -50.33 13.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.49 -0.756 . . . . 0.0 109.09 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.007 HD12 ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -61.56 -60.19 4.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.502 -0.749 . . . . 0.0 110.049 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.808 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -42.95 -46.27 5.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.75 -0.594 . . . . 0.0 110.83 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -75.53 -14.85 60.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 110.318 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.36 -8.39 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.843 . . . . 0.0 110.769 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.58 16.95 3.28 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.119 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.81 135.65 55.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.892 -1.357 . . . . 0.0 110.292 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.427 ' O ' HD23 ' A' ' 16' ' ' LEU . 32.0 tp -83.19 116.71 65.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.669 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HD2' HD12 ' A' ' 37' ' ' LEU . 43.6 Cg_endo -73.1 -36.72 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.488 1.257 . . . . 0.0 110.944 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -91.94 24.09 3.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.306 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.32 148.32 64.03 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.381 -0.824 . . . . 0.0 110.444 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.67 93.4 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.782 1.412 . . . . 0.0 110.258 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -65.43 158.89 25.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.65 -0.656 . . . . 0.0 110.356 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.9 3.51 55.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 110.65 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 11.6 m-85 -114.3 23.12 13.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 74' ' ' ASP . . . 47.18 31.22 6.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HD3' ' HG2' ' A' ' 50' ' ' GLN . 15.1 mtt-85 -114.18 -161.09 0.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.684 -0.892 . . . . 0.0 110.427 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.484 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.98 179.13 0.82 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.955 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.731 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 47.5 Cg_endo -71.21 -26.42 21.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.935 1.492 . . . . 0.0 110.126 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.535 HG23 ' HG2' ' A' ' 52' ' ' MET . 4.4 mt -109.31 -37.57 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.376 -0.828 . . . . 0.0 109.826 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HB3' ' H ' ' A' ' 47' ' ' ARG . 2.0 tt0 -49.4 -22.04 1.05 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.079 -1.013 . . . . 0.0 110.05 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.1 p -104.43 -10.28 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.454 -0.779 . . . . 0.0 110.585 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.73 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -65.08 161.54 18.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.159 -0.963 . . . . 0.0 110.557 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.517 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.54 105.82 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -62.62 -10.53 12.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.469 -0.769 . . . . 0.0 110.881 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -90.33 28.38 7.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -161.39 81.24 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -1.123 . . . . 0.0 110.07 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . . . -49.11 -24.45 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -52.47 -49.86 63.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 25' ' ' VAL . 2.7 t -56.66 -65.15 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.267 -0.896 . . . . 0.0 110.086 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.73 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -40.53 -42.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.606 -0.683 . . . . 0.0 110.008 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.64 -46.37 84.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.458 -0.776 . . . . 0.0 109.055 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.893 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -53.05 -55.2 25.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.784 ' CD2' HD11 ' A' ' 16' ' ' LEU . 2.5 mp -66.54 -43.89 83.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.853 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.764 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -64.24 -55.07 24.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.462 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 15.5 tp -49.18 -34.36 14.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.849 0.833 . . . . 0.0 108.912 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 2.7 m-70 -83.14 -35.02 25.9 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.4 58.62 0.18 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.644 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -78.05 -156.57 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 72' ' ' CYS . 1.8 mt-10 -114.92 64.42 1.61 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.466 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . 40.9 Cg_endo -67.19 -13.95 41.42 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.786 1.413 . . . . 0.0 110.409 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 0.4 OUTLIER -107.26 -57.6 2.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -48.32 150.27 1.32 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 110.751 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' HB2' ' CD ' ' A' ' 80' ' ' ARG . . . -136.54 -139.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.737 . . . . 0.0 109.757 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' LEU . 2.8 t0 -116.32 126.78 27.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.19 -8.89 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.143 1.076 . . . . 0.0 110.142 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.33 -46.87 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.588 HG22 ' CH2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -116.3 -0.52 12.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.1 mt 46.92 23.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.911 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.9 m -61.54 94.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.18 -0.95 . . . . 0.0 108.8 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.597 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -66.49 143.56 98.25 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.567 -0.708 . . . . 0.0 109.2 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 39.1 Cg_endo -66.56 -9.6 24.86 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.784 1.413 . . . . 0.0 110.142 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 104' ' ' LEU . 42.7 t -70.56 -25.12 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.675 ' HD2' HD12 ' A' ' 117' ' ' LEU . 5.9 m80 -72.78 -41.8 64.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.212 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.572 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 15.9 m-20 -47.47 -42.88 23.64 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.277 0.561 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.644 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -66.28 -65.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.959 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.798 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.58 -48.57 81.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -0.899 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.4 tmm_? -51.51 -35.69 41.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.987 -1.071 . . . . 0.0 109.872 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.513 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 2.3 tp10 -88.85 4.07 49.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.09 -1.006 . . . . 0.0 110.218 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 69.56 28.38 72.37 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.613 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -106.21 120.12 41.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.448 -1.031 . . . . 0.0 110.046 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.47 -41.27 9.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 0.0 110.01 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.789 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.2 m-20 -52.58 -25.35 10.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.905 . . . . 0.0 110.471 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.644 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 5.6 m -74.85 -45.95 39.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.191 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.703 ' CD2' HD21 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -57.96 -54.97 40.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.37 -50.68 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.394 -0.816 . . . . 0.0 109.379 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 92' ' ' ASP . 85.3 t -51.07 -55.99 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.748 -0.595 . . . . 0.0 110.162 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.476 ' HA ' HD11 ' A' ' 64' ' ' LEU . 7.6 mp -49.73 -53.51 24.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -61.62 -31.14 71.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.0 109.977 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -71.05 -11.96 61.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.935 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.741 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -140.63 66.32 1.38 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.185 -0.947 . . . . 0.0 111.004 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.87 97.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.445 ' HB3' ' C ' ' A' ' 97' ' ' LEU . . . -160.41 108.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -1.147 . . . . 0.0 110.445 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 4.7 ttt85 -64.75 128.46 35.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.325 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.61 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -119.21 19.72 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.388 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 44.8 t0 -124.48 58.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 110.077 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.71 HG22 ' H ' ' A' ' 107' ' ' ARG . 5.2 p -117.4 -175.39 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.345 -0.847 . . . . 0.0 109.731 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.71 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -139.02 127.96 23.64 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.56 -0.712 . . . . 0.0 110.235 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.537 ' OD1' ' NE2' ' A' ' 83' ' ' HIS . 1.7 m-20 -51.31 150.64 3.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 109.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 77' ' ' THR . . . -44.19 -35.76 2.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.463 -0.773 . . . . 0.0 111.034 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.588 ' CH2' HG22 ' A' ' 77' ' ' THR . 13.4 m-90 -59.57 -79.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.18 29.36 0.02 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.427 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -107.42 -165.04 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -1.21 . . . . 0.0 110.975 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.03 160.51 39.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 39.5 Cg_endo -67.66 -33.64 27.46 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.433 1.228 . . . . 0.0 110.645 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 5.4 p -78.33 -37.81 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.0 110.082 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.99 -43.64 91.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.51 -0.744 . . . . 0.0 109.978 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.675 HD12 ' HD2' ' A' ' 83' ' ' HIS . 2.9 mt -52.27 -39.29 60.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.738 ' HB3' ' HB2' ' A' ' 127' ' ' ALA . . . -69.12 -34.08 74.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.532 -0.73 . . . . 0.0 110.008 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.0 -20.08 64.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.427 ' OE2' ' NH2' ' A' ' 112' ' ' ARG . 29.2 tt0 -86.25 -57.98 2.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.706 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.487 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 6.7 mp -57.07 -81.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.008 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.3 40.41 0.02 OUTLIER Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.5 m-70 -115.09 43.39 2.0 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.43 -1.041 . . . . 0.0 109.759 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -45.65 -37.19 5.45 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -62.33 -37.46 85.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.62 -0.675 . . . . 0.0 109.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.751 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -80.93 -36.19 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . . . -68.34 -32.93 73.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.544 -0.722 . . . . 0.0 109.602 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -59.3 -66.27 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.406 -0.809 . . . . 0.0 109.741 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -52.13 -25.51 9.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.36 -0.838 . . . . 0.0 109.352 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 86' ' ' ALA . 8.7 mt -73.88 -58.82 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 110.427 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -24.06 0.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.84 -51.04 9.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.955 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.15 -13.19 53.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.0 110.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . . . -97.42 54.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 110.715 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.43 133.93 4.59 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.52 -43.93 66.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 t -50.01 138.13 16.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.577 -0.955 . . . . 0.0 110.494 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -151.77 63.55 0.86 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.828 . . . . 0.0 110.278 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -104.88 123.93 7.82 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -53.79 6.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.209 -1.171 . . . . 0.0 110.478 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -102.07 39.05 1.53 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 109.854 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.7 OUTLIER -117.37 -161.71 0.83 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.502 -0.749 . . . . 0.0 110.142 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' HIS . . . -176.88 115.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.692 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -56.05 -175.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.823 . . . . 0.0 109.689 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 tp -68.81 142.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.902 . . . . 0.0 109.733 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -44.98 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.486 -0.759 . . . . 0.0 111.055 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.82 63.55 1.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.007 . . . . 0.0 110.75 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.58 119.11 2.86 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.18 -0.95 . . . . 0.0 109.799 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -101.78 106.19 17.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.886 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 170.99 -137.43 4.41 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.93 146.61 37.68 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.786 1.414 . . . . 0.0 110.607 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 153' ' ' ASP . 9.7 p -60.63 167.78 2.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 152' ' ' SER . 1.9 t0 65.29 137.31 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.381 -0.824 . . . . 0.0 110.421 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 154' ' ' ILE . 2.4 mp -127.85 84.71 62.56 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 0.0 109.532 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.88 115.57 4.37 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 124.029 1.541 . . . . 0.0 110.849 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.104 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tpp . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.13 0.49 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -110.95 81.31 2.57 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.46 179.24 4.76 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.827 1.435 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.35 92.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.445 -0.785 . . . . 0.0 110.606 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -166.7 138.74 3.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 110.245 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.9 -51.33 0.72 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 p -55.47 175.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.394 -1.062 . . . . 0.0 110.067 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 9' ' ' MET . 0.4 OUTLIER -109.44 -44.58 3.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.941 . . . . 0.0 110.723 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.402 ' CB ' ' O ' ' A' ' 8' ' ' SER . 1.7 ttm 65.72 174.86 0.22 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.377 -0.827 . . . . 0.0 110.213 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.78 72.28 0.86 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.345 -0.847 . . . . 0.0 110.241 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.42 164.3 35.7 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.671 1.353 . . . . 0.0 110.629 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -66.43 124.75 23.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.087 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . -179.97 -37.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.269 -0.895 . . . . 0.0 110.525 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.74 -17.13 51.99 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 0.0 110.885 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.591 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.9 m0 -79.78 -9.97 59.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.96 HD11 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -74.92 -50.75 15.73 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.164 -0.96 . . . . 0.0 109.354 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.46 -47.78 66.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.368 -0.833 . . . . 0.0 109.799 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -50.89 -49.81 58.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.456 -0.777 . . . . 0.0 110.411 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -59.89 -55.71 30.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -48.21 -44.25 32.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.315 -0.866 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -77.33 -32.09 54.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 111.034 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 1.1 ttt-85 -90.99 32.25 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.264 -0.898 . . . . 0.0 111.196 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 48.38 71.17 0.62 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -137.49 50.4 1.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.386 -1.067 . . . . 0.0 110.061 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.808 HG22 ' CG2' ' A' ' 59' ' ' VAL . 70.7 t -45.96 -37.41 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.459 -0.776 . . . . 0.0 110.282 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.83 -46.6 62.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.38 -44.89 89.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.315 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 62' ' ' LEU . 23.7 t -66.02 -46.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.886 . . . . 0.0 109.958 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.923 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -51.27 -46.04 62.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.07 -39.8 65.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.496 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.3 -56.31 11.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.498 -0.751 . . . . 0.0 110.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.885 HD23 ' HB3' ' A' ' 36' ' ' ALA . 14.3 mt -50.1 -50.38 48.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 110.16 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.22 -13.62 60.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.361 -0.837 . . . . 0.0 110.742 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 -11.53 36.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.977 -1.077 . . . . 0.0 111.006 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.55 37.0 0.7 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.885 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -66.84 162.36 21.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -1.125 . . . . 0.0 109.905 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.84 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 5.5 tp -92.18 115.23 64.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 0.0 109.663 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.39 -28.58 39.06 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.461 1.243 . . . . 0.0 110.195 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 28.6 m120 -129.74 66.49 1.47 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 109.753 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.84 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -88.33 108.52 22.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 47.5 Cg_endo -71.63 94.31 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.622 1.327 . . . . 0.0 110.061 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 34.2 p-10 -94.02 -174.81 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.812 . . . . 0.0 110.644 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.46 5.59 41.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 110.914 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.417 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -91.9 -5.56 53.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.83 22.84 12.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -115.03 134.74 54.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -1.064 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -60.37 169.16 1.86 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.813 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 39.6 Cg_endo -66.35 -23.23 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.542 1.285 . . . . 0.0 111.296 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.518 HG23 ' HG2' ' A' ' 52' ' ' MET . 6.1 mt -107.99 -36.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.973 -1.079 . . . . 0.0 109.065 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.478 ' HG3' ' OD2' ' A' ' 84' ' ' ASP . 2.7 tt0 -52.18 -19.85 2.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.734 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 7.2 p -110.37 2.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.72 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -76.91 165.16 25.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.999 -1.063 . . . . 0.0 110.147 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.412 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 3.3 tpp -61.1 96.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.218 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.598 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -55.82 -13.64 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.038 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -90.5 8.94 79.01 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.18 88.84 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.204 -1.174 . . . . 0.0 109.856 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -59.22 -24.34 63.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -52.15 -49.96 62.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.808 ' CG2' HG22 ' A' ' 25' ' ' VAL . 40.6 t -56.72 -56.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 110.109 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.72 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.7 -57.56 2.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.606 -0.684 . . . . 0.0 110.64 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.609 ' O ' HD23 ' A' ' 65' ' ' LEU . 11.0 tt0 -47.02 -48.87 21.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.37 -0.831 . . . . 0.0 110.232 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.923 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -49.62 -70.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.523 -0.735 . . . . 0.0 109.854 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.96 HD11 HD11 ' A' ' 16' ' ' LEU . 3.8 mt -59.96 -48.73 80.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.641 0.734 . . . . 0.0 110.024 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.868 ' HG ' HG12 ' A' ' 96' ' ' VAL . 3.4 tm? -50.96 -69.53 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.692 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.4 pp -53.01 -24.88 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 110.027 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.817 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.35 -55.36 5.46 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.481 -0.762 . . . . 0.0 109.319 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.02 44.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.563 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.813 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -76.05 -158.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.019 -1.283 . . . . 0.0 109.117 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.55 74.63 3.21 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.357 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.594 ' HB3' HD23 ' A' ' 97' ' ' LEU . 55.8 Cg_endo -78.69 10.15 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.955 1.502 . . . . 0.0 110.351 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.487 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -139.53 -60.92 0.55 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.43 152.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.624 -0.672 . . . . 0.0 110.316 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -143.14 -161.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.316 -0.865 . . . . 0.0 110.512 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.6 140.17 25.18 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 110.267 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 1.32 9.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.453 1.239 . . . . 0.0 110.564 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.0 -39.39 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 109.631 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.763 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -128.98 2.07 5.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.49 -0.756 . . . . 0.0 110.279 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 78' ' ' LEU . 3.3 mt 47.76 21.73 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.941 . . . . 0.0 111.684 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -59.08 102.81 0.14 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.926 -1.109 . . . . 0.0 109.115 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.854 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -77.89 159.1 76.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.757 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.417 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 42.2 Cg_endo -68.13 -13.92 39.36 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.154 1.607 . . . . 0.0 110.267 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 104' ' ' LEU . 94.8 t -68.2 -28.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.569 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.487 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.3 m80 -70.74 -44.07 67.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.598 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.11 -47.05 45.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.732 -0.605 . . . . 0.0 110.982 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -62.2 -66.23 0.57 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.562 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.868 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -54.32 -43.4 71.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.449 -0.782 . . . . 0.0 110.592 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -46.38 -41.95 14.33 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.514 -0.741 . . . . 0.0 110.559 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 1.2 mm-40 -96.59 -2.27 45.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.195 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.601 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 75.99 47.25 11.69 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -115.87 95.2 5.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.304 -1.115 . . . . 0.0 111.18 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.675 HD21 ' CD2' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.3 -36.33 79.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.534 179.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.95 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.7 m-20 -50.46 -58.59 5.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 0.0 109.357 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 92.4 m -52.77 -44.48 66.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.991 HD11 HD21 ' A' ' 130' ' ' LEU . 5.9 tp -54.89 -53.22 58.3 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.32 -40.16 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 92' ' ' ASP . 21.8 t -62.75 -40.41 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 94' ' ' LEU . 19.4 mt -63.38 -61.48 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.42 -17.66 3.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -39.01 66.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.382 -0.824 . . . . 0.0 110.963 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -118.98 70.83 0.83 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 111.457 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.65 90.78 0.01 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . . . -143.94 82.5 1.72 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -1.167 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.16 143.81 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.51 -0.744 . . . . 0.0 110.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.734 ' HA ' HG21 ' A' ' 82' ' ' VAL . 2.9 mp -129.74 0.53 4.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.654 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.68 56.65 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.245 -0.909 . . . . 0.0 110.296 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.854 HG11 ' HG3' ' A' ' 80' ' ' ARG . 1.7 p -114.99 -164.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -147.37 140.33 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.518 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 110' ' ' TRP . 45.2 t0 -68.73 63.75 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.763 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 57.06 -77.17 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.4 m-90 -45.94 -70.7 0.09 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.728 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.36 -34.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -43.73 144.79 0.76 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.651 -0.911 . . . . 0.0 110.855 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -114.67 167.03 10.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.371 -0.831 . . . . 0.0 110.464 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' A' ' 117' ' ' LEU . 40.9 Cg_endo -68.61 -34.76 18.64 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.884 1.465 . . . . 0.0 110.563 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.636 HG21 ' HG3' ' A' ' 131' ' ' ARG . 4.3 p -80.77 -23.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.767 . . . . 0.0 110.337 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.78 -44.69 40.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.638 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 117' ' ' LEU . 4.5 pp -63.0 -21.42 66.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.637 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 117' ' ' LEU . . . -77.39 -49.91 13.88 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -31.02 28.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.159 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -86.69 -51.29 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.77 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.524 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -178.46 39.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 39.0 m-70 -120.05 49.19 1.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.383 -1.069 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -53.91 11.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.728 -0.608 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.515 ' O ' HD11 ' A' ' 91' ' ' LEU . 3.0 m-20 -50.13 -34.98 24.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.488 -0.758 . . . . 0.0 109.722 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.802 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -83.41 -35.73 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.151 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -61.65 -45.33 94.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.513 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -55.23 20.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.383 -0.823 . . . . 0.0 109.446 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.675 ' CD2' HD21 ' A' ' 91' ' ' LEU . 20.5 t80 -55.19 -40.52 70.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.346 -0.846 . . . . 0.0 109.539 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.991 HD21 HD11 ' A' ' 94' ' ' LEU . 12.1 mt -64.52 -50.48 67.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 109.312 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.636 ' HG3' HG21 ' A' ' 115' ' ' VAL . 5.2 ttp180 -53.23 -27.64 23.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 0.0 110.328 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.3 -42.8 20.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.48 -11.01 50.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.416 -0.802 . . . . 0.0 110.729 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -116.89 -25.68 7.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.35 109.27 2.81 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -100.32 70.19 0.47 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.2 t -53.36 135.64 38.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.339 -1.095 . . . . 0.0 110.007 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.15 170.18 16.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 110.525 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -151.21 -107.28 0.36 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.41 39.13 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.399 -1.06 . . . . 0.0 110.763 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.56 166.64 5.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.279 -0.888 . . . . 0.0 110.686 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.85 74.72 0.92 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.454 -0.779 . . . . 0.0 109.732 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 145' ' ' ILE . . . -135.86 -43.96 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.494 -0.754 . . . . 0.0 110.125 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.07 142.89 34.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.819 . . . . 0.0 110.574 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 143' ' ' ALA . 1.0 OUTLIER -177.52 67.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.16 115.56 1.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.697 -0.627 . . . . 0.0 110.768 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 55.08 93.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 0.0 110.303 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.53 123.14 13.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.459 -0.776 . . . . 0.0 110.392 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -81.67 165.23 21.2 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 109.99 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 135.53 159.76 8.69 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -82.27 105.43 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.877 1.462 . . . . 0.0 110.329 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.24 -157.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.454 -0.779 . . . . 0.0 109.789 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -73.51 151.48 40.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 110.029 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.7 tt -178.9 93.83 0.21 Allowed Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.307 -0.87 . . . . 0.0 109.677 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.27 129.46 17.09 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.787 1.414 . . . . 0.0 110.777 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.07 179.838 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 tpt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.163 0.506 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.482 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -62.75 -55.0 42.44 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.344 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 47.6 Cg_endo -74.18 102.14 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.518 1.273 . . . . 0.0 110.435 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.7 48.66 2.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.106 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.73 72.4 0.26 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.594 -0.692 . . . . 0.0 110.529 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.88 -93.44 0.65 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t -134.78 -163.56 1.39 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.501 -0.999 . . . . 0.0 110.095 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.59 17.92 8.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.3 ttp -76.29 106.06 7.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.761 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.03 174.98 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.267 -0.896 . . . . 0.0 110.185 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.83 145.15 35.9 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.724 1.381 . . . . 0.0 110.237 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.441 ' HB3' ' CE2' ' A' ' 15' ' ' TRP . 24.5 t -85.63 118.94 25.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -0.836 . . . . 0.0 109.857 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.13 -12.97 61.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 110.828 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' A' ' 18' ' ' THR . 9.4 t70 -74.27 -5.56 42.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.252 -0.905 . . . . 0.0 110.524 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.559 ' O ' HD13 ' A' ' 31' ' ' LEU . 42.2 m0 -76.51 -8.27 56.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.211 -0.931 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 37' ' ' LEU . 1.2 tp -79.41 -50.89 10.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.31 -0.869 . . . . 0.0 109.036 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.49 46.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -63.96 -40.66 96.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.934 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.873 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -63.35 -45.5 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 108.894 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -62.68 -54.3 41.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.95 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -54.82 -22.03 13.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.548 -0.72 . . . . 0.0 110.979 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.94 27.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.943 . . . . 0.0 110.581 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.05 34.12 4.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 1.2 tpt180 -118.69 105.76 11.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.474 -1.015 . . . . 0.0 110.527 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 58' ' ' ARG . 71.6 t -72.46 -56.93 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.299 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -48.92 -26.89 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.533 -0.729 . . . . 0.0 110.909 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.873 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 3.0 mm-40 -71.52 -44.73 64.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 108.84 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.068 HG12 HD23 ' A' ' 62' ' ' LEU . 22.7 t -75.75 -52.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -0.807 . . . . 0.0 109.103 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.926 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -43.57 -50.43 7.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.599 -0.688 . . . . 0.0 110.406 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -73.02 -48.84 32.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.597 -0.689 . . . . 0.0 109.99 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 15' ' ' TRP . 13.5 mt -55.27 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 111.251 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.833 ' CB ' HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -45.64 -49.42 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.0 111.537 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -68.98 -9.1 50.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 110.804 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -102.03 -23.2 14.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.937 -1.102 . . . . 0.0 111.261 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 162.5 -28.62 0.26 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.635 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.759 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -41.87 141.03 0.9 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.286 -1.126 . . . . 0.0 110.464 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.916 ' O ' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -55.94 154.81 13.25 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.2 -38.9 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.818 1.431 . . . . 0.0 109.844 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.9 m120 -122.63 -65.54 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.58 -0.7 . . . . 0.0 109.817 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . 60.59 154.19 0.1 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.586 -0.696 . . . . 0.0 110.275 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.17 177.27 8.04 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.7 1.368 . . . . 0.0 110.171 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.7 155.62 47.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 110.077 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.42 16.14 18.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.5 23.18 34.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -110.14 174.5 5.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.714 ' O ' HG12 ' A' ' 51' ' ' VAL . 4.8 mmp_? -86.49 165.45 33.06 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 63' ' ' LEU . 42.0 Cg_endo -68.69 -12.6 35.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.773 1.407 . . . . 0.0 110.374 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.9 mt -109.37 -36.67 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 108.731 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.46 -21.72 38.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.871 -1.143 . . . . 0.0 108.979 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 47' ' ' ARG . 14.6 p -114.87 31.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.443 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.611 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -96.89 33.65 1.85 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 109.798 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.8 tmm? 72.5 -14.5 0.56 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.781 -0.574 . . . . 0.0 111.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.53 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 50.28 25.25 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.983 -1.073 . . . . 0.0 110.075 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -126.33 15.75 6.77 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.715 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -156.22 93.41 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 109.866 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.37 -22.74 33.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.347 -0.845 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.439 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -58.33 -39.57 79.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.458 -0.776 . . . . 0.0 110.16 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' A' ' 56' ' ' SER . 11.0 t -53.98 -65.17 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB1' HD12 ' A' ' 64' ' ' LEU . . . -52.72 -33.63 48.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 19.4 tt0 -47.23 -42.15 19.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.068 HD23 HG12 ' A' ' 28' ' ' VAL . 1.7 tp -82.7 -41.47 19.27 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -63.83 -62.87 1.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.629 -0.669 . . . . 0.0 109.739 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -48.54 -43.73 35.77 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.355 -0.841 . . . . 0.0 109.756 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.502 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.2 tp -58.95 -43.16 91.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.183 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CG ' HD22 ' A' ' 32' ' ' LEU . 3.5 m80 -81.06 0.03 37.78 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.729 -0.607 . . . . 0.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.11 60.13 1.98 Allowed Glycine 0 N--CA 1.48 1.609 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.83 -148.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.252 . . . . 0.0 109.014 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -115.17 52.75 0.76 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.867 . . . . 0.0 109.662 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 48.6 Cg_endo -70.77 -31.32 16.24 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.461 1.243 . . . . 0.0 109.628 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -82.85 -75.46 0.31 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.563 -0.711 . . . . 0.0 109.139 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.13 164.43 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.566 -0.709 . . . . 0.0 110.534 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 80' ' ' ARG . . . -154.03 -126.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.027 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.2 m-20 -110.31 132.79 21.32 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.783 -1.198 . . . . 0.0 109.932 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.92 -9.91 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.313 1.165 . . . . 0.0 110.655 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.72 -74.63 0.42 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.377 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.998 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -100.3 9.11 43.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 110.473 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.3 mt 51.09 39.75 24.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -0.896 . . . . 0.0 110.318 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.418 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -64.19 96.21 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 110.019 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -73.19 148.58 88.83 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 110.636 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.7 Cg_endo -67.99 -14.49 41.25 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.699 1.368 . . . . 0.0 109.129 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.886 HG21 ' HA ' ' A' ' 104' ' ' LEU . 94.3 t -64.36 -31.51 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.425 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 26.1 m80 -67.74 -41.23 83.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.53 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 4.0 m-20 -52.35 -51.16 60.35 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.211 0.529 . . . . 0.0 110.58 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.607 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -53.52 -64.98 0.65 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.442 -0.787 . . . . 0.0 109.452 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.799 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.7 -27.9 65.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.654 ' HG2' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -54.11 -49.61 68.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.15 -0.969 . . . . 0.0 110.591 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.84 4.5 53.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 110.321 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.627 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 71.89 36.33 61.29 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -102.53 83.25 2.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.358 -1.083 . . . . 0.0 110.87 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.464 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.88 -39.06 80.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.684 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.2 m-20 -47.67 -37.43 12.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.502 -0.749 . . . . 0.0 110.006 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 97' ' ' LEU . 54.7 m -64.3 -46.59 82.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.731 HD13 HG13 ' A' ' 126' ' ' VAL . 1.2 mp -63.3 -45.11 92.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 110.138 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 55.6 t -48.79 -44.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 92' ' ' ASP . 10.9 t -67.02 -45.4 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.689 . . . . 0.0 109.147 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.842 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -53.09 -43.34 66.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.448 -0.782 . . . . 0.0 109.859 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -83.49 -33.48 25.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.074 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 5.6 ttt85 -66.09 -11.22 47.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.556 -0.715 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.442 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -132.1 -67.71 0.66 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.082 -1.012 . . . . 0.0 111.071 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.57 107.1 0.23 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.842 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -167.29 117.07 0.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.452 -1.028 . . . . 0.0 110.271 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.8 113.88 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.886 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.1 mp -106.41 25.68 10.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 110.225 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.6 p30 -128.79 47.71 2.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.365 -0.834 . . . . 0.0 110.59 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.638 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.6 p -112.14 -169.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.857 . . . . 0.0 109.961 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.638 ' H ' HG22 ' A' ' 106' ' ' VAL . 19.3 ptt180 -140.64 146.74 38.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.96 66.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 110.117 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 51.78 -84.9 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.611 -0.681 . . . . 0.0 110.67 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.998 ' CH2' HG23 ' A' ' 77' ' ' THR . 23.9 p90 -122.94 15.16 9.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.98 -81.0 1.35 Allowed Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.79 -164.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.228 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 106' ' ' VAL . 41.8 mt -95.79 163.42 21.27 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.75 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.6 -19.14 60.26 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.88 1.463 . . . . 0.0 110.379 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 116' ' ' ASP . 14.3 p -79.36 -36.59 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.824 . . . . 0.0 110.152 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 2.5 m-20 -66.95 -39.66 87.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.854 . . . . 0.0 110.353 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.654 HD21 ' HG2' ' A' ' 87' ' ' ARG . 1.4 tt -69.04 -35.74 76.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.951 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.705 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -56.07 -55.96 26.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.531 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -60.52 -41.97 95.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.803 . . . . 0.0 110.473 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.18 -37.89 67.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 109.984 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 87' ' ' ARG . 11.7 mt -86.47 -2.32 58.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 110.416 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.44 33.64 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.546 ' ND1' ' HA3' ' A' ' 89' ' ' GLY . 71.9 m-70 -102.77 46.18 0.93 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.89 -1.359 . . . . 0.0 109.56 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -45.82 -37.97 6.71 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.29 0.566 . . . . 0.0 110.346 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.418 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.6 m-20 -58.15 -42.95 87.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.725 . . . . 0.0 109.195 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 86' ' ' ALA . 13.6 t -76.09 -37.79 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.72 85.43 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -56.51 -61.34 2.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.905 . . . . 0.0 109.625 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -57.63 -24.92 59.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 109.454 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' A' ' 86' ' ' ALA . 11.3 mt -75.73 -52.87 9.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.79 . . . . 0.0 109.545 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -23.28 2.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.814 . . . . 0.0 110.169 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.24 -57.43 3.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.981 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.45 -1.65 34.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 111.013 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . -106.97 -41.87 5.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.55 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.29 -103.18 2.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.08 95.85 0.64 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.5 p -89.01 17.31 5.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -1.078 . . . . 0.0 110.703 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -103.29 147.85 26.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.123 -0.985 . . . . 0.0 110.006 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 157.46 -99.33 0.18 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.3 p -171.46 172.87 4.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -1.01 . . . . 0.0 110.234 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 52.31 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.403 -0.811 . . . . 0.0 110.765 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -54.74 -90.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.358 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 48.41 26.17 1.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.091 -1.006 . . . . 0.0 110.476 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -80.48 146.66 31.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.909 . . . . 0.0 110.275 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 1.1 tt -74.3 146.68 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.891 . . . . 0.0 110.916 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 0.2 OUTLIER 173.34 53.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.366 -0.834 . . . . 0.0 109.929 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -173.67 86.85 0.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.371 -0.831 . . . . 0.0 109.949 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.41 114.83 1.34 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.253 -0.904 . . . . 0.0 110.454 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -81.76 148.35 28.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.772 . . . . 0.0 110.077 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 67.03 102.19 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.26 147.39 53.25 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.72 1.379 . . . . 0.0 110.592 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.7 m -96.19 114.44 26.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.382 -0.824 . . . . 0.0 110.243 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -65.11 156.54 31.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.355 -0.841 . . . . 0.0 110.457 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.1 mm -124.55 97.84 38.66 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 110.492 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.62 117.86 5.36 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.577 1.303 . . . . 0.0 110.08 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.893 -1.051 . . . . 0.0 110.317 -179.752 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -51.59 -55.84 26.11 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.366 -0.833 . . . . 0.0 109.924 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 43.6 Cg_endo -72.13 72.68 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.647 1.341 . . . . 0.0 110.188 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -47.71 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.642 -0.661 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 3' ' ' PRO . . . 47.86 75.52 0.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.776 . . . . 0.0 110.329 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.12 -115.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -62.39 -71.75 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.491 -1.005 . . . . 0.0 110.843 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.9 m -101.32 146.75 27.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.302 -0.874 . . . . 0.0 110.684 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.5 tpp -46.25 -61.98 1.55 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.622 -0.673 . . . . 0.0 110.059 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 178.78 92.01 0.16 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.766 -0.583 . . . . 0.0 109.684 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.76 153.35 64.4 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.717 1.377 . . . . 0.0 110.409 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.24 137.14 35.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.338 -0.851 . . . . 0.0 110.141 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -71.8 142.54 49.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 20.5 t70 -177.44 -50.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.385 -0.822 . . . . 0.0 110.133 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.498 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 31.1 m0 -40.19 -30.55 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.619 . . . . 0.0 111.012 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.035 HD11 ' HB1' ' A' ' 36' ' ' ALA . 9.8 mt -75.68 -54.57 6.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.512 -0.742 . . . . 0.0 109.144 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.41 69.43 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.783 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -73.9 -59.31 2.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.755 -0.591 . . . . 0.0 110.633 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . . . -49.67 -54.43 18.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -47.73 -50.22 25.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -36.8 82.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.184 -0.947 . . . . 0.0 109.952 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.84 15.1 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.81 72.05 0.6 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 93.0 mtt180 -136.74 67.95 1.44 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.517 -0.99 . . . . 0.0 109.739 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.763 HG22 ' CG2' ' A' ' 59' ' ' VAL . 50.4 t -57.27 -62.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.451 -0.78 . . . . 0.0 110.058 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 25' ' ' VAL . 9.3 mt-10 -39.73 -36.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.75 -0.594 . . . . 0.0 110.943 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -72.34 -50.11 29.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.554 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.99 HG12 HD13 ' A' ' 62' ' ' LEU . 43.6 t -62.58 -38.87 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.181 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.986 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -55.2 -38.44 68.4 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.855 -1.153 . . . . 0.0 108.434 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.88 12.11 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.93 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' ALA . 4.2 mt -56.35 -65.86 0.53 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 110.339 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.028 HD22 ' CD2' ' A' ' 66' ' ' HIS . 13.5 mt -43.42 -51.04 6.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.296 -0.877 . . . . 0.0 109.68 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 43.0 mt-10 -69.79 -15.25 63.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.61 -5.46 58.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.0 110.732 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.05 2.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.035 ' HB1' HD11 ' A' ' 16' ' ' LEU . . . -75.91 165.44 24.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.547 -0.972 . . . . 0.0 110.253 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.672 HD13 ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -80.43 137.92 51.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 110.344 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 49.9 Cg_endo -76.14 -40.8 0.58 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.888 1.467 . . . . 0.0 110.323 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 67.5 m-80 -101.71 -83.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.653 -0.654 . . . . 0.0 110.087 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . 57.41 69.66 1.56 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 45.4 Cg_endo -71.44 101.97 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.048 1.552 . . . . 0.0 111.708 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 3.9 p30 -178.75 -156.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.52 -0.737 . . . . 0.0 109.706 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 1.1 t 61.72 85.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.42 -0.8 . . . . 0.0 109.747 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.1 m-85 65.89 8.37 5.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 109.836 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.13 23.57 52.71 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.563 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 16.2 mmt-85 -99.62 35.49 1.98 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.07 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.517 ' CB ' ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 53.23 -178.34 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 47' ' ' ARG . 55.7 Cg_endo -82.58 -29.27 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.426 1.224 . . . . 0.0 111.337 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.627 HG13 ' HB1' ' A' ' 68' ' ' ALA . 6.4 mt -107.47 -35.53 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.517 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 20.4 tt0 -60.51 -11.72 7.79 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.019 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.563 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 12.9 p -105.79 3.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.873 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -73.11 166.28 23.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.967 -1.083 . . . . 0.0 109.024 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.3 ttm -63.87 -6.74 6.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.355 -0.841 . . . . 0.0 111.204 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.576 ' HE3' ' CB ' ' A' ' 84' ' ' ASP . 8.5 mmt 56.1 17.22 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.885 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.47 -0.65 24.82 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 88.74 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -1.027 . . . . 0.0 109.873 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -53.35 -24.55 12.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.314 -0.867 . . . . 0.0 110.651 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -48.23 70.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 108.84 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.763 ' CG2' HG22 ' A' ' 25' ' ' VAL . 67.3 t -52.4 -49.5 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -51.71 -53.51 38.54 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.669 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.0 tt0 -49.23 -47.11 46.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.715 -0.615 . . . . 0.0 110.04 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.99 HD13 HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -56.26 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 110.176 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 69.1 mt -53.67 -49.85 67.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.481 -0.762 . . . . 0.0 110.396 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.815 HD13 HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -50.7 -69.19 0.12 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.427 -0.796 . . . . 0.0 111.045 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.9 OUTLIER -51.26 -22.32 2.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.412 -0.805 . . . . 0.0 109.697 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 1.028 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -83.87 -49.11 9.34 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.646 -0.659 . . . . 0.0 109.596 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 38' ' ' PRO . . . 154.51 39.07 0.02 OUTLIER Glycine 0 N--CA 1.478 1.46 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.744 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -71.09 -173.94 0.9 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.557 -1.555 . . . . 0.0 108.593 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 3.6 mt-10 -113.72 64.71 1.17 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.072 -1.017 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.578 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 46.3 Cg_endo -70.77 -10.31 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.093 1.575 . . . . 0.0 109.857 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.469 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -107.89 -29.06 9.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -0.774 . . . . 0.0 109.688 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 158.71 16.94 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.652 -0.655 . . . . 0.0 110.099 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -137.24 -145.92 0.21 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.409 -0.807 . . . . 0.0 110.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.9 143.05 26.1 Favored Pre-proline 0 C--N 1.306 -1.304 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.31 -12.22 23.0 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.82 1.432 . . . . 0.0 110.019 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.86 -71.22 0.46 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.6 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -103.04 -2.53 27.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 111.017 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 mt 63.58 20.92 12.5 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.224 -0.923 . . . . 0.0 111.282 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.7 m -65.51 97.03 0.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.695 ' HG3' HG11 ' A' ' 106' ' ' VAL . 11.9 mmt85 -69.62 164.21 52.44 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.148 -0.97 . . . . 0.0 109.217 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.583 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -67.18 -21.46 48.39 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.879 1.463 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 114' ' ' PRO . 13.4 t -59.99 -27.26 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.567 0.699 . . . . 0.0 109.491 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.511 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.1 m80 -80.47 -32.09 37.23 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.576 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 5.0 m-20 -61.07 -43.03 99.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -60.32 -64.41 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.368 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.935 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -59.59 -35.32 74.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.516 -0.74 . . . . 0.0 110.107 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -45.41 -55.88 5.6 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.249 -0.907 . . . . 0.0 110.717 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.64 5.02 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.547 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 72.74 27.72 68.56 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 1.6 t80 -94.99 103.75 15.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.304 -1.115 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.52 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.96 -43.69 34.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.862 -0.524 . . . . 0.0 110.807 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.1 m-20 -44.39 -34.89 2.16 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.547 0.689 . . . . 0.0 109.748 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.475 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 95.2 m -66.37 -39.89 89.41 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.338 0.589 . . . . 0.0 109.901 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.828 HD13 HG13 ' A' ' 126' ' ' VAL . 1.0 OUTLIER -64.02 -58.28 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 40.0 t -38.21 -53.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.732 -0.605 . . . . 0.0 110.208 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.815 HG12 HD13 ' A' ' 64' ' ' LEU . 24.7 t -55.74 -56.34 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.783 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -44.35 -44.35 8.17 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.351 -0.843 . . . . 0.0 110.509 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -82.4 -26.87 32.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.1 ttt85 -65.05 -10.3 28.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.697 -0.627 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.459 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -133.11 -68.7 0.58 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 111.153 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 70' ' ' PRO . . . -174.12 107.85 0.25 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.409 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -152.39 -155.61 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.572 -0.958 . . . . 0.0 109.629 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' O ' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -162.63 105.92 1.1 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -98.9 68.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.585 -0.697 . . . . 0.0 110.812 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -175.34 42.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.695 HG11 ' HG3' ' A' ' 80' ' ' ARG . 1.4 p -107.16 -175.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 106' ' ' VAL . 2.5 mtp85 -125.8 133.83 51.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -67.05 64.23 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.752 -0.592 . . . . 0.0 110.197 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.6 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 57.87 -80.85 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.449 -0.782 . . . . 0.0 110.947 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.573 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.2 m-90 -45.68 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.0 110.266 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.24 73.05 0.06 OUTLIER Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 108' ' ' ASP . 3.9 mtt180 -134.34 -164.02 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.395 -1.062 . . . . 0.0 109.884 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.508 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -153.07 166.48 15.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 82' ' ' VAL . 43.6 Cg_endo -70.33 -54.9 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.875 1.46 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.16 -26.03 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.626 -0.671 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -62.38 -30.24 71.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.449 -0.782 . . . . 0.0 110.494 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -44.31 18.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 109.666 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.539 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -52.84 -47.03 68.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.506 ' HG2' ' HB1' ' A' ' 127' ' ' ALA . 64.5 mm-40 -63.98 -35.0 79.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.024 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.48 -25.07 50.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.772 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.639 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 42.6 mt -101.7 2.57 38.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.44 43.51 24.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 20.4 m-70 -106.63 55.52 0.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.086 -1.244 . . . . 0.0 110.154 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 12.4 mmt180 -41.05 -57.31 2.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.843 -0.536 . . . . 0.0 110.418 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.455 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -43.59 -43.98 5.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.935 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -86.9 -50.96 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.353 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.506 ' HB1' ' HG2' ' A' ' 119' ' ' GLU . . . -49.94 -50.69 45.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -62.24 -66.12 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.487 ' CD2' HD21 ' A' ' 91' ' ' LEU . 56.6 t80 -47.66 -40.58 20.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.717 . . . . 0.0 109.844 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.0 mt -60.24 -54.12 49.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.659 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -45.28 -36.72 4.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.565 -0.709 . . . . 0.0 110.656 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.82 62.3 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.598 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -83.56 -1.22 53.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.714 -0.616 . . . . 0.0 110.602 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -112.11 -19.35 12.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 110.283 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.8 -121.96 0.58 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.496 ' O ' HG23 ' A' ' 137' ' ' THR . . . 110.45 -10.76 30.75 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 136' ' ' GLY . 13.7 p -153.46 -63.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -1.202 . . . . 0.0 110.126 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.18 155.3 34.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.101 -0.999 . . . . 0.0 110.023 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.07 86.37 0.11 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.68 -62.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -1.173 . . . . 0.0 110.959 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -138.27 -64.34 0.53 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.087 -1.008 . . . . 0.0 110.948 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -89.07 66.91 7.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.783 . . . . 0.0 110.003 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.27 144.43 2.82 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.402 -0.811 . . . . 0.0 110.211 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.419 ' HG2' HG22 ' A' ' 145' ' ' ILE . 25.0 ttt180 -59.05 161.84 4.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.274 -0.891 . . . . 0.0 110.126 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.419 HG22 ' HG2' ' A' ' 144' ' ' ARG . 1.3 tt -42.34 150.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.66 -0.65 . . . . 0.0 111.156 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.9 OUTLIER 174.14 85.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.708 -0.62 . . . . 0.0 109.88 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . 57.26 -169.12 0.11 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.168 -0.957 . . . . 0.0 110.184 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 58.02 -168.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.192 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -58.6 -153.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.603 -0.686 . . . . 0.0 109.993 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.18 152.12 8.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.74 135.89 24.53 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.558 1.294 . . . . 0.0 109.894 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.415 ' O ' HG13 ' A' ' 154' ' ' ILE . 2.0 t -177.08 84.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.454 -0.779 . . . . 0.0 110.395 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.49 148.58 3.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.281 -0.887 . . . . 0.0 109.707 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 152' ' ' SER . 4.0 mt -127.71 77.32 76.34 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.048 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.3 119.96 5.47 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 124.225 1.645 . . . . 0.0 110.613 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 t70 . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.692 179.54 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.181 0.515 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.19 148.18 39.52 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.64 -175.58 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.754 1.397 . . . . 0.0 110.299 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.78 86.21 1.98 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.423 -0.798 . . . . 0.0 110.211 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.03 -167.02 0.78 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.426 -0.797 . . . . 0.0 110.301 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.25 -173.7 16.1 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t 52.42 74.22 0.29 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.319 -1.106 . . . . 0.0 110.352 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.91 -34.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.34 -0.85 . . . . 0.0 110.368 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 71.3 mmm -85.75 -16.3 39.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.968 . . . . 0.0 110.308 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -172.9 112.71 0.36 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.391 -0.818 . . . . 0.0 109.508 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.61 80.74 1.1 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.436 1.23 . . . . 0.0 110.683 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.96 12.16 36.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.924 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.627 ' HB3' HD22 ' A' ' 37' ' ' LEU . . . -71.07 64.2 0.34 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.938 . . . . 0.0 109.918 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 18' ' ' THR . 16.6 p30 -91.59 17.51 8.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.429 -0.794 . . . . 0.0 110.175 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.525 ' HB3' HD13 ' A' ' 31' ' ' LEU . 42.3 m0 -45.49 -43.6 11.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.593 -0.692 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 32' ' ' LEU . 12.4 mt -58.1 -58.61 7.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.0 109.158 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.4 -51.64 66.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.729 -0.607 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -51.51 -66.14 0.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.342 -0.849 . . . . 0.0 110.845 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.47 -52.2 66.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.98 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -50.4 -58.31 6.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.358 -0.839 . . . . 0.0 110.399 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -52.58 -24.55 8.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.798 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.2 7.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.43 47.81 61.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.6 mtt180 -118.62 73.03 0.9 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.443 -1.034 . . . . 0.0 109.896 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 59' ' ' VAL . 49.2 t -60.59 -60.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.334 -0.854 . . . . 0.0 111.125 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -47.63 -35.19 8.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 110.969 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -39.41 74.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.277 -0.889 . . . . 0.0 109.584 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.909 HG12 HD23 ' A' ' 62' ' ' LEU . 39.1 t -76.13 -49.84 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.187 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 1.013 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -42.32 -46.51 4.61 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.446 -0.784 . . . . 0.0 110.039 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -72.39 -51.86 18.58 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.852 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 15' ' ' TRP . 60.4 mt -51.99 -66.88 0.31 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.542 -0.724 . . . . 0.0 110.964 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -41.51 -59.24 1.66 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.707 -0.621 . . . . 0.0 111.282 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -13.44 61.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.822 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -85.04 -6.93 59.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.97 -1.082 . . . . 0.0 110.86 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.51 -10.29 6.45 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.535 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -50.92 143.6 9.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.274 . . . . 0.0 110.264 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD22 ' HB3' ' A' ' 13' ' ' ALA . 5.8 mp -59.82 153.77 51.57 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.395 -0.816 . . . . 0.0 109.957 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.02 -56.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.679 1.357 . . . . 0.0 110.932 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 69.5 m-80 -96.96 -66.97 0.87 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.11 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 39' ' ' ASN . . . 58.34 101.55 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 40.5 Cg_endo -68.17 122.41 9.47 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.579 1.305 . . . . 0.0 110.705 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -103.87 -166.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.592 -0.693 . . . . 0.0 109.739 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.1 38.5 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.287 -0.883 . . . . 0.0 110.519 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 18.9 m-85 -122.49 13.75 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.82 49.78 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.551 ' HD3' ' HB3' ' A' ' 44' ' ' TYR . 2.9 ptm180 -159.73 131.67 6.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -1.143 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.596 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.86 -173.66 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.668 -0.645 . . . . 0.0 110.169 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 38.5 Cg_endo -64.44 -173.7 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.196 1.103 . . . . 0.0 111.467 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.2 mt 62.97 -64.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.6 tt0 -48.08 -25.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.001 -1.062 . . . . 0.0 109.344 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 51' ' ' VAL . 12.5 p -120.7 34.18 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.611 -0.681 . . . . 0.0 109.556 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.795 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -94.11 38.25 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.0 110.068 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.45 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 7.5 tmm? 66.98 -10.62 0.3 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.509 -0.745 . . . . 0.0 110.751 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.495 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 48.56 27.76 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.989 -1.069 . . . . 0.0 110.127 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -133.05 13.76 4.95 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.676 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.1 m -144.13 78.13 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -1.044 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -50.63 -29.53 11.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 110.006 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.453 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -56.91 -31.53 65.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.618 -0.677 . . . . 0.0 109.464 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.795 HG11 ' HB2' ' A' ' 52' ' ' MET . 53.1 t -58.59 -65.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.082 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -50.76 -39.21 51.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 110.22 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -51.44 -36.91 46.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.189 -0.945 . . . . 0.0 110.038 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.013 HD22 ' HA ' ' A' ' 29' ' ' ARG . 6.9 tp -89.97 -43.8 10.31 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.455 -0.778 . . . . 0.0 109.158 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -63.7 -55.59 22.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -59.19 -47.36 85.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.335 -0.853 . . . . 0.0 109.7 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 1.7 tp -52.54 -28.35 20.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.213 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.548 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.1 m-70 -93.36 -41.36 9.88 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.551 -0.718 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.34 47.49 0.04 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.593 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.756 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -67.01 -149.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.008 -1.29 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 3.1 pt-20 -116.71 56.71 1.59 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.981 . . . . 0.0 110.872 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.787 ' HB3' HD11 ' A' ' 64' ' ' LEU . 40.1 Cg_endo -68.28 -15.04 41.86 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.635 1.334 . . . . 0.0 109.886 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 1.9 m120 -110.27 -77.9 0.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.528 -0.733 . . . . 0.0 110.095 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -43.0 145.04 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 110.95 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -128.72 -143.0 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 11.3 m-20 -112.58 134.44 21.64 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 109.978 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.54 -19.91 36.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.489 1.257 . . . . 0.0 110.062 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.54 -76.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 108.915 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.544 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 69.6 p -122.36 36.15 4.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.931 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 78' ' ' LEU . 8.7 mt 48.17 34.13 4.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.498 -0.751 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.0 101.67 0.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -85.36 173.18 7.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.47 -11.62 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.07 1.563 . . . . 0.0 110.14 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 104' ' ' LEU . 36.2 t -69.91 -30.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 26.6 m80 -73.1 -47.03 47.92 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 20.6 m-20 -47.28 -47.0 25.24 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.894 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -60.16 -59.98 4.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.827 . . . . 0.0 109.669 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.106 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -61.07 -51.52 68.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.399 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.569 ' HD3' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -41.88 -30.54 0.26 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.522 -0.736 . . . . 0.0 111.058 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.12 -18.89 15.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 110.391 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 88.84 23.81 34.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -97.0 85.02 3.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -1.067 . . . . 0.0 111.018 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.779 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -58.89 -38.39 78.74 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 13.8 m-20 -50.67 -36.99 38.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.3 m -62.96 -47.96 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.766 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -60.84 -43.61 98.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.488 -0.758 . . . . 0.0 109.68 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 91' ' ' LEU . 91.9 t -50.71 -47.67 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.366 -0.834 . . . . 0.0 109.183 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.568 HG12 HD13 ' A' ' 64' ' ' LEU . 45.2 t -60.02 -48.12 89.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' ALA . 1.7 mp -54.98 -40.96 70.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -82.9 -33.11 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.084 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -65.69 -12.2 51.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -0.775 . . . . 0.0 110.439 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.487 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -119.84 -82.15 0.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.715 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.71 56.04 0.13 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . . . -105.7 122.62 46.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -1.132 . . . . 0.0 110.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -54.87 162.13 1.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 109.849 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -149.59 36.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.301 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -150.64 40.63 0.75 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 111.34 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.649 HG22 ' H ' ' A' ' 107' ' ' ARG . 5.1 p -97.87 -176.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -130.2 146.93 51.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.341 -0.849 . . . . 0.0 109.681 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 110' ' ' TRP . 15.1 p-10 -74.53 50.36 0.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 109.851 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 61.66 -60.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.694 -0.628 . . . . 0.0 110.795 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.41 -54.94 14.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.62 -25.4 0.75 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.489 ' O ' HD12 ' A' ' 113' ' ' LEU . 4.0 ttp180 -60.87 -174.15 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.228 -1.16 . . . . 0.0 110.697 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -138.55 175.46 3.32 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.487 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 46.5 Cg_endo -73.48 -47.61 0.29 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.539 1.284 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' CG2' ' HD3' ' A' ' 131' ' ' ARG . 9.2 p -54.46 -33.0 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 0.0 109.1 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -37.72 69.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.639 -0.663 . . . . 0.0 109.321 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -30.78 67.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.217 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.106 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -69.38 -53.41 19.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -16.13 63.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.431 -0.793 . . . . 0.0 110.06 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -38.4 36.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.569 HD13 ' HD3' ' A' ' 87' ' ' ARG . 5.1 mt -92.23 1.46 57.2 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 110.955 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.06 12.87 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.617 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 80.3 m-70 -95.78 46.69 1.09 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.974 -1.309 . . . . 0.0 109.318 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -43.79 -38.1 3.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.747 -0.595 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.779 ' O ' HD11 ' A' ' 91' ' ' LEU . 15.9 p-10 -64.23 -40.8 96.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.371 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -82.94 -40.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -57.51 -53.89 53.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.082 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 mtt-85 -52.99 -59.75 4.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 110.264 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -59.32 -39.88 84.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.882 HD11 ' HB2' ' A' ' 86' ' ' ALA . 12.6 mt -60.06 -30.66 69.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.422 ' HD3' ' CG2' ' A' ' 115' ' ' VAL . 4.1 tpp180 -67.6 -36.74 81.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.875 . . . . 0.0 109.634 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.13 -35.88 36.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.448 -0.782 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.08 23.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.0 110.119 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -102.17 18.9 19.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 0.0 110.091 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.01 128.87 9.44 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.77 23.56 0.92 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.08 118.36 6.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.23 -1.159 . . . . 0.0 110.312 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 75.09 2.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.462 -0.774 . . . . 0.0 109.949 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 59.6 -145.33 45.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.7 p -147.75 95.42 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -1.13 . . . . 0.0 110.113 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -56.23 -62.77 1.48 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 110.376 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.56 -57.65 1.27 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -0.929 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.09 109.09 4.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.821 . . . . 0.0 110.249 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.5 ttp85 -48.34 125.81 10.17 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.691 -0.631 . . . . 0.0 110.319 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 146' ' ' ASP . 60.0 mt 57.14 164.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.517 -0.74 . . . . 0.0 110.048 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.419 ' N ' HG22 ' A' ' 145' ' ' ILE . 0.6 OUTLIER 175.5 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.68 99.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.266 -0.896 . . . . 0.0 110.374 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.35 130.21 45.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.422 -0.799 . . . . 0.0 110.185 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.49 148.97 22.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.38 144.67 1.22 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.4 134.99 25.7 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.632 1.333 . . . . 0.0 110.541 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.1 m -111.22 -20.86 12.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.502 -0.749 . . . . 0.0 110.711 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -51.1 157.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.387 -0.821 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mt -110.32 88.94 7.91 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.335 -0.853 . . . . 0.0 109.977 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 113.69 3.83 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.774 1.407 . . . . 0.0 110.637 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.243 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.052 0.453 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -176.75 124.02 0.29 Allowed Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.194 -0.941 . . . . 0.0 110.122 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.66 128.86 9.68 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.477 1.251 . . . . 0.0 110.508 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.2 68.18 0.48 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.441 -0.787 . . . . 0.0 110.309 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.69 83.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.428 -0.795 . . . . 0.0 110.032 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.47 -177.28 41.43 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.0 m -118.46 169.05 10.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.936 . . . . 0.0 109.56 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.4 m 51.18 51.26 17.34 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.64 9.47 5.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.771 -0.581 . . . . 0.0 110.305 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.38 67.12 4.81 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.318 -0.864 . . . . 0.0 110.457 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.9 -179.65 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.774 1.408 . . . . 0.0 110.105 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.441 ' HA ' ' CD1' ' A' ' 15' ' ' TRP . 3.5 m -112.46 -22.52 10.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.174 -0.954 . . . . 0.0 110.635 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.76 -26.81 15.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.109 -0.994 . . . . 0.0 110.436 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -80.12 10.44 4.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.452 -0.78 . . . . 0.0 110.427 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.497 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 16.2 m0 -69.88 -5.5 26.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.852 HD21 ' CB ' ' A' ' 36' ' ' ALA . 30.7 mt -76.62 -54.33 6.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.981 -1.074 . . . . 0.0 109.689 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -66.16 -33.04 74.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.73 -0.606 . . . . 0.0 110.513 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -71.84 -59.99 2.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.86 -47.73 76.79 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.887 -1.133 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -47.95 -62.89 1.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.449 -0.782 . . . . 0.0 110.186 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.924 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -51.34 -24.25 4.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.233 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -90.27 28.86 1.34 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.521 -0.737 . . . . 0.0 111.028 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.29 43.48 9.77 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HD2' ' HB3' ' A' ' 22' ' ' ARG . 1.7 mtt180 -122.91 96.66 5.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.435 -1.038 . . . . 0.0 109.661 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.738 HG22 ' CG2' ' A' ' 59' ' ' VAL . 60.1 t -82.05 -55.48 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.07 -33.22 1.4 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.668 -0.645 . . . . 0.0 111.685 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 31' ' ' LEU . 1.3 mt-10 -67.77 -65.87 0.64 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.896 -1.127 . . . . 0.0 108.621 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.994 HG12 HD21 ' A' ' 62' ' ' LEU . 6.7 t -58.01 -44.47 87.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.82 ' HA ' HD22 ' A' ' 62' ' ' LEU . 1.5 tpt85 -47.51 -48.93 27.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.947 -1.096 . . . . 0.0 110.31 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.37 -51.28 5.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.578 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -58.28 -40.64 82.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.711 HD22 HD11 ' A' ' 62' ' ' LEU . 6.6 tt -67.92 -47.69 68.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.338 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -59.93 -15.14 19.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.0 110.407 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.33 -62.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.71 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.14 28.1 0.08 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.852 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -70.17 167.37 17.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 110.469 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 16' ' ' LEU . 4.0 mm? -98.23 134.22 22.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.846 . . . . 0.0 110.975 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 44.6 Cg_endo -71.6 -22.95 23.68 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.587 1.309 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -129.81 53.92 1.88 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.578 -0.701 . . . . 0.0 109.279 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -85.06 145.91 44.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.612 -0.68 . . . . 0.0 111.051 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.44 136.9 29.63 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.95 1.5 . . . . 0.0 109.92 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 8.7 m-80 -100.71 -161.8 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -0.889 . . . . 0.0 110.562 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.24 13.34 16.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.488 -0.757 . . . . 0.0 110.246 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -149.1 27.12 0.86 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 110.137 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.86 56.29 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.511 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -115.27 96.48 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.534 -0.98 . . . . 0.0 110.138 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' CD ' ' HD2' ' A' ' 48' ' ' PRO . 29.0 mmt-85 -52.27 171.89 0.19 Allowed Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.332 -0.855 . . . . 0.0 110.45 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HB2' HD22 ' A' ' 63' ' ' LEU . 38.9 Cg_endo -65.89 166.68 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.566 1.298 . . . . 0.0 110.215 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.59 HG13 ' HB1' ' A' ' 68' ' ' ALA . 1.2 mt 64.21 -64.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.808 -0.557 . . . . 0.0 109.625 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 48' ' ' PRO . 17.7 tt0 -45.55 -27.61 0.78 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.861 -1.149 . . . . 0.0 109.35 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.924 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.9 p -117.35 43.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.313 -0.867 . . . . 0.0 110.541 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -104.08 33.65 3.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 109.173 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 9.7 ttp 70.76 -6.62 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.883 -0.511 . . . . 0.0 110.318 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.574 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.92 25.78 0.11 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.0 110.736 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.28 19.16 4.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.02 75.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.455 -1.026 . . . . 0.0 109.697 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -45.03 -27.48 0.56 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.895 . . . . 0.0 109.756 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -49.84 20.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.654 -0.654 . . . . 0.0 109.503 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.738 ' CG2' HG22 ' A' ' 25' ' ' VAL . 62.9 t -56.61 -64.29 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -0.758 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -44.54 -52.16 8.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.432 -0.792 . . . . 0.0 109.827 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.564 ' HA ' HG11 ' A' ' 96' ' ' VAL . 7.0 tm-20 -41.75 -53.38 3.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.994 HD21 HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -59.57 -53.44 58.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.671 -0.643 . . . . 0.0 109.992 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.822 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -65.31 -50.9 63.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.588 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.748 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -48.88 -59.4 3.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.797 . . . . 0.0 110.424 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.2 pp -57.67 -23.32 50.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.077 -1.015 . . . . 0.0 108.776 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.553 ' CG ' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -86.76 -3.12 59.01 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.639 -0.663 . . . . 0.0 109.915 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 84.92 46.91 5.5 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.26 -146.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -1.164 . . . . 0.0 109.301 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 2.0 tp10 -120.72 64.36 11.58 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 49.9 Cg_endo -74.04 -35.23 4.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.916 1.482 . . . . 0.0 110.468 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 3.5 m-80 -85.28 -69.3 0.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.294 -0.879 . . . . 0.0 110.242 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.5 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.3 t -48.71 144.02 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -0.757 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.92 -152.83 0.53 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.512 -0.743 . . . . 0.0 109.815 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.65 149.51 37.53 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.205 -0.934 . . . . 0.0 109.823 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.88 -21.42 24.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.645 1.339 . . . . 0.0 109.098 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.09 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.72 -0.613 . . . . 0.0 109.593 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 27.2 p -133.48 40.98 3.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.445 -0.784 . . . . 0.0 109.079 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.512 ' HA ' HD23 ' A' ' 78' ' ' LEU . 5.8 mt 41.82 42.8 2.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.729 -0.607 . . . . 0.0 111.495 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 m -78.7 103.5 8.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.604 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -76.4 155.13 83.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 109.388 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 39.5 Cg_endo -64.57 -15.67 51.16 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.422 1.222 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' A' ' 104' ' ' LEU . 11.1 t -61.07 -33.29 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 87' ' ' ARG . 7.4 m80 -71.72 -35.36 70.16 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -54.84 -46.89 74.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -57.99 -58.09 9.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.458 -0.776 . . . . 0.0 109.384 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.035 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -69.67 -15.83 63.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.7 tpt180 -80.81 -22.73 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -112.32 -12.93 13.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 110.134 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' CE1' ' A' ' 123' ' ' HIS . . . 80.99 61.02 2.18 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.445 ' O ' HD12 ' A' ' 94' ' ' LEU . 1.2 t80 -135.97 86.08 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -1.069 . . . . 0.0 110.335 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.92 HD23 HG22 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -60.36 -40.52 91.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 111.047 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -45.7 -37.14 5.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.83 . . . . 0.0 109.851 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.445 ' O ' HD12 ' A' ' 97' ' ' LEU . 8.5 m -73.8 -42.81 60.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.784 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.498 -0.751 . . . . 0.0 109.417 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 91' ' ' LEU . 57.8 t -60.49 -45.51 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.662 0.744 . . . . 0.0 109.203 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 HD22 ' A' ' 64' ' ' LEU . 6.5 t -60.31 -50.34 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.751 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -48.26 -44.32 33.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.512 -0.743 . . . . 0.0 110.141 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -84.94 -36.91 21.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.258 -0.901 . . . . 0.0 110.58 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -59.52 -15.12 15.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -128.2 -81.64 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.662 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.33 106.15 0.27 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.751 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -159.06 120.87 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.372 -1.075 . . . . 0.0 110.378 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.539 ' HD3' ' NH1' ' A' ' 80' ' ' ARG . 41.6 ttt85 -74.71 102.08 4.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.513 -0.742 . . . . 0.0 110.073 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.751 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.2 mp -98.31 56.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.25 -0.906 . . . . 0.0 110.396 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -162.36 50.79 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.874 -1.141 . . . . 0.0 110.7 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG22 ' H ' ' A' ' 107' ' ' ARG . 2.5 p -111.61 -169.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.929 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.729 ' H ' HG22 ' A' ' 106' ' ' VAL . 20.0 mtt180 -127.95 138.25 52.56 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.529 -0.732 . . . . 0.0 109.967 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.4 m-20 -75.34 57.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 110.264 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 57.65 -69.56 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.704 -0.623 . . . . 0.0 111.376 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.566 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.03 -50.49 36.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.328 -0.858 . . . . 0.0 110.425 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.48 -21.33 0.83 Allowed Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -49.27 168.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.416 -1.049 . . . . 0.0 110.778 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 30.9 mt -131.68 167.75 20.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -69.6 -42.19 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.7 1.368 . . . . 0.0 109.699 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 127' ' ' ALA . 5.7 p -71.25 -25.73 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 110.203 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t70 -67.68 -58.19 5.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.57 -60.03 2.41 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.445 -0.784 . . . . 0.0 110.653 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.035 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -47.22 -53.1 14.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -31.25 64.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -26.91 46.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.049 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.544 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 12.4 mt -92.66 -0.72 57.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.72 23.95 40.52 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.544 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 15.6 m170 -95.33 49.34 1.19 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.268 -1.136 . . . . 0.0 109.704 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' HIS . 10.7 mmm-85 -43.16 -33.71 0.96 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.527 -0.733 . . . . 0.0 109.616 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -46.4 79.7 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.92 HG22 HD23 ' A' ' 91' ' ' LEU . 2.4 t -82.81 -34.85 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.478 -0.763 . . . . 0.0 109.544 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.639 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -65.1 -51.36 61.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 108.961 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.405 ' C ' ' HD3' ' A' ' 128' ' ' ARG . 1.2 tmt_? -64.65 -52.5 57.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.655 -0.653 . . . . 0.0 109.482 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.674 ' CD2' HD11 ' A' ' 91' ' ' LEU . 7.7 t80 -50.76 -40.08 53.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.41 -0.807 . . . . 0.0 109.136 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.739 HD11 ' HB2' ' A' ' 86' ' ' ALA . 24.0 mt -65.57 -53.51 40.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.695 -0.628 . . . . 0.0 109.587 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -21.32 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.123 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.26 -54.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 110.566 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.94 56.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -98.96 -24.18 15.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.755 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.54 143.93 43.14 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.96 -7.89 76.88 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 55.1 p -113.22 62.49 0.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -1.235 . . . . 0.0 110.532 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.463 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -69.99 105.23 2.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.352 -0.842 . . . . 0.0 109.947 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.84 87.18 1.75 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.97 75.6 0.91 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.359 -1.083 . . . . 0.0 110.003 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -176.95 51.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 0.0 109.876 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.57 -177.05 6.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.385 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.93 110.21 22.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.632 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -171.79 73.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.862 . . . . 0.0 109.881 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.447 ' H ' HG23 ' A' ' 145' ' ' ILE . 1.7 pp -60.47 150.0 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.321 -0.862 . . . . 0.0 110.206 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.06 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.387 -0.821 . . . . 0.0 109.971 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -164.53 78.87 0.36 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 110.422 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 53.61 178.69 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.375 -0.828 . . . . 0.0 110.341 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -121.62 -14.69 8.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 134.47 -115.16 1.4 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.15 144.21 33.26 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.578 1.304 . . . . 0.0 109.975 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.7 m -72.08 133.88 45.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 0.0 110.99 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.63 96.44 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.197 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 154' ' ' ILE . 12.4 tt -112.49 79.27 2.99 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 110.293 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.65 152.37 53.42 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 124.113 1.586 . . . . 0.0 110.575 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.221 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.264 0.554 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.11 149.16 39.31 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.432 -0.793 . . . . 0.0 109.936 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.44 87.22 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.758 1.399 . . . . 0.0 110.765 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.4 62.44 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.125 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.22 66.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.467 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.4 135.38 5.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 p -123.31 21.02 9.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.42 -1.047 . . . . 0.0 110.274 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.4 134.18 8.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.323 -0.86 . . . . 0.0 109.991 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -67.59 135.17 52.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.342 -0.849 . . . . 0.0 109.844 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.88 139.02 93.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.799 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.6 89.57 0.72 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.579 1.305 . . . . 0.0 109.992 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 t -49.9 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.524 -0.735 . . . . 0.0 110.028 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . . . -50.92 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.801 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 11.5 p30 -136.49 -16.84 1.55 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.593 -0.692 . . . . 0.0 110.795 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.493 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 24.6 m0 -52.05 -52.2 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.996 -1.065 . . . . 0.0 110.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.597 ' CD2' ' HB1' ' A' ' 36' ' ' ALA . 1.4 pp -51.01 -27.49 7.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.26 -0.9 . . . . 0.0 109.899 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 14' ' ' ASP . . . -82.68 -44.04 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 0.0 109.492 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -65.86 -44.55 85.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.492 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.65 -45.86 88.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.852 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -58.61 -44.54 89.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.909 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.63 -30.03 71.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.555 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -97.61 22.38 9.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.432 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.39 60.64 6.59 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 67.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -1.085 . . . . 0.0 110.464 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 59' ' ' VAL . 64.0 t -52.53 -58.92 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -43.12 -41.62 3.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.713 -0.617 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.853 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.3 tp10 -66.4 -46.55 76.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.07 HG12 HD13 ' A' ' 62' ' ' LEU . 22.1 t -70.24 -41.03 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.325 -0.86 . . . . 0.0 110.893 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.769 ' CA ' HD11 ' A' ' 62' ' ' LEU . 24.9 mmm-85 -51.0 -46.01 61.37 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.186 -0.946 . . . . 0.0 109.93 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.43 -43.45 32.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 0.0 109.956 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 27' ' ' GLU . 1.4 mt -57.78 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.89 ' CD1' HD22 ' A' ' 62' ' ' LEU . 12.4 mt -53.25 -44.49 68.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 0.0 110.048 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.19 -16.04 63.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.862 . . . . 0.0 109.917 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.21 -9.79 55.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 110.311 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 22.95 3.53 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.784 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -62.04 134.96 57.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -1.221 . . . . 0.0 109.906 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.597 HD23 ' CA ' ' A' ' 40' ' ' ALA . 3.6 tp -83.3 116.87 66.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -71.74 -41.74 2.05 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.671 1.353 . . . . 0.0 110.489 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.83 48.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.597 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . -93.02 118.57 67.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.72 94.99 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.618 1.325 . . . . 0.0 110.524 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -78.44 179.29 7.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 110.005 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -90.93 23.11 3.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -113.66 -19.05 11.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.73 37.11 93.02 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 32.6 mtt-85 -124.34 31.62 5.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -1.12 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 12.7 mmt-85 49.32 177.31 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.522 -0.736 . . . . 0.0 110.585 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 51.6 Cg_endo -79.71 -19.64 9.76 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.357 1.188 . . . . 0.0 109.92 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.624 HG13 ' HB1' ' A' ' 68' ' ' ALA . 7.0 mt -109.06 -42.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.688 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -50.73 -22.91 2.33 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.881 -1.137 . . . . 0.0 110.295 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.1 p -100.8 5.31 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.605 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.852 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -89.94 146.49 24.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.844 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 106.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.333 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.555 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 13.5 mmt -59.67 -8.46 2.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.814 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -82.0 11.56 47.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 59' ' ' VAL . 3.6 m -144.95 88.65 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.216 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.656 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -61.68 -29.68 70.24 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.16 -0.963 . . . . 0.0 109.546 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -29.75 10.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.681 -0.637 . . . . 0.0 109.821 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 25' ' ' VAL . 11.2 t -74.85 -55.3 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.144 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.612 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -50.22 -47.77 54.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.382 -0.824 . . . . 0.0 109.5 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.736 ' OE1' HG13 ' A' ' 96' ' ' VAL . 3.1 tp10 -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.07 HD13 HG12 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -51.36 -66.31 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.481 0.658 . . . . 0.0 109.943 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.82 HD23 HD21 ' A' ' 32' ' ' LEU . 45.4 mt -68.25 -49.54 59.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 110.858 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD22 HG12 ' A' ' 96' ' ' VAL . 1.8 tt -44.9 -67.37 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.439 -0.788 . . . . 0.0 110.858 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -55.97 -23.5 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.852 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.19 -43.35 24.07 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.409 -0.807 . . . . 0.0 109.534 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.96 36.05 0.06 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.63 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -68.89 -171.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.657 -1.496 . . . . 0.0 109.257 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -111.18 73.07 0.91 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 44.9 Cg_endo -70.5 -7.84 22.21 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.959 1.505 . . . . 0.0 110.64 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.34 -57.17 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.63 161.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 111.566 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.08 -143.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.512 -0.743 . . . . 0.0 109.966 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' LEU . 31.3 t0 -114.37 134.57 22.26 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 109.416 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.71 -3.06 12.84 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.29 1.153 . . . . 0.0 111.011 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.37 -41.3 9.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.0 110.256 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.571 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -131.15 5.98 4.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.09 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.8 mt 48.48 42.63 18.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -0.838 . . . . 0.0 111.008 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 m -75.65 93.32 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 110.401 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.758 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.72 168.77 17.63 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 108.777 179.029 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -75.62 -0.87 10.66 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.096 1.051 . . . . 0.0 110.289 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.756 HG13 HD23 ' A' ' 104' ' ' LEU . 11.4 t -76.31 -34.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -68.08 -36.34 79.67 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.251 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 1.8 m-20 -55.46 -56.12 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.695 -0.628 . . . . 0.0 110.474 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -55.12 -62.06 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.355 -0.84 . . . . 0.0 109.985 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.922 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -56.59 -49.3 75.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 111.108 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -32.35 12.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.081 -1.012 . . . . 0.0 111.045 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -94.3 -4.28 49.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.517 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 81.8 25.51 52.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -98.76 143.7 28.81 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.328 -1.101 . . . . 0.0 110.63 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.656 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -117.04 -39.36 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.867 ' O ' HG23 ' A' ' 96' ' ' VAL . 3.3 t0 -52.83 -36.66 58.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.605 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 2.5 m -60.53 -49.66 76.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.667 -0.646 . . . . 0.0 109.635 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.638 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.8 mp -57.65 -45.23 85.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 109.685 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.0 t -55.89 -43.29 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.343 -0.848 . . . . 0.0 108.922 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 92' ' ' ASP . 46.2 t -61.13 -45.27 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.42 0.629 . . . . 0.0 109.479 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.631 HD23 ' CD1' ' A' ' 64' ' ' LEU . 96.0 mt -57.43 -46.89 83.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.513 -0.742 . . . . 0.0 110.313 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -77.77 -25.94 49.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.498 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -67.04 -13.52 62.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 110.11 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.474 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -127.22 -74.24 0.59 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 70' ' ' PRO . . . -174.19 105.83 0.21 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.18 -165.0 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -1.084 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.86 102.59 3.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.489 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.756 HD23 HG13 ' A' ' 82' ' ' VAL . 1.7 mp -93.26 11.31 28.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.843 . . . . 0.0 109.444 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.34 31.06 4.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.758 HG11 ' HB2' ' A' ' 80' ' ' ARG . 4.1 p -104.01 -176.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 110.055 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.662 ' H ' HG22 ' A' ' 106' ' ' VAL . 10.7 ptt-85 -139.21 145.4 39.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.581 -0.7 . . . . 0.0 109.568 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -70.55 63.11 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.124 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 60.04 -65.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.697 -0.627 . . . . 0.0 111.007 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.1 m-90 -57.47 -74.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 110.873 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.76 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -49.69 124.26 9.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -1.12 . . . . 0.0 110.634 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 113' ' ' LEU . 42.4 mt -85.97 164.79 37.67 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.462 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -20.3 46.04 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.719 1.378 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.496 HG23 ' CB ' ' A' ' 130' ' ' LEU . 7.4 p -83.65 -37.88 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.382 -0.824 . . . . 0.0 109.832 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.444 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -70.96 -38.13 72.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.852 . . . . 0.0 109.898 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.36 -41.54 89.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.126 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.922 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -58.6 -59.42 5.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.619 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -30.9 35.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.314 -0.866 . . . . 0.0 110.433 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -24.75 56.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.563 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -90.28 -3.65 57.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 110.607 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.35 14.72 46.85 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.563 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 44.2 m-70 -98.42 48.95 0.99 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.91 -1.347 . . . . 0.0 109.478 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -30.17 2.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.687 -0.633 . . . . 0.0 110.229 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.656 ' O ' HD11 ' A' ' 91' ' ' LEU . 30.7 m-20 -65.41 -41.88 93.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 86' ' ' ALA . 4.7 t -81.6 -38.32 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.42 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.86 97.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -57.96 -67.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.429 -0.795 . . . . 0.0 109.494 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -50.59 -40.89 53.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 86' ' ' ALA . 13.8 mt -57.02 -50.3 73.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.41 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 4.7 ttp180 -56.23 -22.13 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.753 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.02 -66.39 0.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.083 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.97 -7.31 53.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 111.105 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -128.4 -42.74 1.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.144 -0.973 . . . . 0.0 110.355 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 131' ' ' ARG . . . -72.82 64.68 1.51 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.85 120.43 20.11 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 82.6 p -85.14 104.13 14.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -1.097 . . . . 0.0 110.213 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.79 131.93 31.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 145.22 92.05 0.13 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.21 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.385 -1.068 . . . . 0.0 110.053 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -65.71 -79.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.676 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.06 -177.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.09 -1.006 . . . . 0.0 110.293 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -122.19 97.49 5.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.989 . . . . 0.0 110.048 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.11 131.31 19.38 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.404 -0.81 . . . . 0.0 110.079 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 32.3 mm 51.26 69.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.878 . . . . 0.0 109.076 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -44.16 168.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.465 0.65 . . . . 0.0 111.507 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -43.93 106.59 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 110.411 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 63.54 154.3 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.587 -0.696 . . . . 0.0 110.264 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.19 160.27 32.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.481 -0.762 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 71.23 152.63 1.11 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.29 113.77 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.74 1.389 . . . . 0.0 110.69 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.0 t -118.27 7.88 12.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.392 -0.818 . . . . 0.0 110.388 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 162.31 28.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.236 -0.915 . . . . 0.0 110.294 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 154' ' ' ILE . 3.2 mp -124.67 83.44 58.64 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.963 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.74 130.94 15.25 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.838 1.441 . . . . 0.0 110.802 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 42.4 t0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.796 179.807 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.148 0.499 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -53.5 -52.8 63.48 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.227 -0.921 . . . . 0.0 110.479 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 43.0 Cg_endo -74.79 151.99 41.33 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.619 1.326 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . -58.58 141.62 51.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.376 -0.828 . . . . 0.0 110.187 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -176.79 131.5 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.374 -0.829 . . . . 0.0 109.853 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.18 -73.02 0.44 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.54 -153.03 0.38 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.257 -1.143 . . . . 0.0 109.875 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 t -155.78 143.14 19.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.95 . . . . 0.0 110.376 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.6 ttp -162.1 -55.35 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.433 -0.792 . . . . 0.0 109.718 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 52.61 81.65 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.321 -0.862 . . . . 0.0 110.254 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.74 71.9 2.58 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.821 1.432 . . . . 0.0 110.179 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.1 m 62.04 12.98 5.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.674 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 59.39 36.84 23.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.911 -1.118 . . . . 0.0 109.954 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -86.29 19.9 2.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -0.854 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.487 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 38.2 m0 -74.42 -24.5 59.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.257 -0.902 . . . . 0.0 109.877 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.56 -35.54 79.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 110.151 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.88 -50.56 12.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.457 -0.777 . . . . 0.0 109.184 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -51.36 -51.56 53.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.333 -0.854 . . . . 0.0 109.669 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.64 -37.93 76.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -62.16 -61.02 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.992 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -46.46 -29.1 1.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.702 -0.624 . . . . 0.0 111.105 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 21.2 mtm-85 -91.9 32.43 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.451 -0.78 . . . . 0.0 111.04 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.39 36.2 3.01 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 3.0 mpt_? -108.5 94.74 5.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -1.12 . . . . 0.0 109.609 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.638 HG12 ' HD3' ' A' ' 29' ' ' ARG . 89.8 t -74.46 -59.73 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.646 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -43.15 -30.75 0.49 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 111.668 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.756 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.5 mt-10 -68.0 -52.46 35.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 19' ' ' ALA . 6.1 t -68.49 -41.22 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.578 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.916 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.02 -50.42 27.77 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.439 -0.788 . . . . 0.0 109.616 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.82 -49.1 66.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.643 -0.661 . . . . 0.0 109.84 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.1 mt -58.78 -60.25 4.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.083 HD22 ' CD2' ' A' ' 66' ' ' HIS . 11.7 mt -44.41 -49.25 9.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.595 -0.691 . . . . 0.0 109.95 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.08 -14.29 61.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.471 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -94.63 -3.42 49.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.992 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.35 33.05 1.26 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.684 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.888 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -79.36 140.22 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.296 . . . . 0.0 108.761 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.0 tp -79.72 123.34 84.01 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.083 -1.01 . . . . 0.0 111.058 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.503 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 42.2 Cg_endo -70.72 -21.33 29.18 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.827 1.435 . . . . 0.0 109.84 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -125.78 52.65 1.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.067 -1.02 . . . . 0.0 110.03 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -86.32 154.99 57.38 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.843 . . . . 0.0 110.131 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -79.04 132.04 10.27 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.868 1.457 . . . . 0.0 109.858 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -97.95 -171.84 2.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.38 -0.825 . . . . 0.0 110.822 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 m -113.47 2.78 15.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.79 . . . . 0.0 110.271 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.503 ' CB ' ' HD3' ' A' ' 46' ' ' ARG . 72.5 m-85 -118.24 20.06 13.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.595 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.91 22.69 35.45 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' HD3' ' CB ' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -109.5 -169.64 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -1.201 . . . . 0.0 109.896 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.719 ' O ' HG12 ' A' ' 51' ' ' VAL . 23.7 mmt180 -106.02 165.9 12.21 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.379 -0.826 . . . . 0.0 109.72 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.2 Cg_endo -62.85 -12.79 30.86 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.665 1.35 . . . . 0.0 109.885 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.658 HG13 ' HB1' ' A' ' 68' ' ' ALA . 2.8 mt -110.96 -35.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.431 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 4.1 tt0 -59.17 -15.9 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.992 HG22 ' HB2' ' A' ' 21' ' ' ALA . 7.7 p -118.12 38.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.358 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.616 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.96 29.96 4.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.755 -1.216 . . . . 0.0 109.578 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 7.5 tmm? 74.21 -8.78 1.38 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.792 -0.567 . . . . 0.0 110.46 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.553 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 45.11 24.22 0.12 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.603 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -130.05 18.01 5.35 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.1 t -149.54 64.58 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.486 -1.008 . . . . 0.0 110.586 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -38.33 -32.76 0.08 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.568 -0.707 . . . . 0.0 110.087 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 56' ' ' SER . 3.9 mmt85 -49.74 -41.13 43.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.591 -0.693 . . . . 0.0 109.201 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ALA . 40.8 t -62.22 -61.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.578 -0.701 . . . . 0.0 109.492 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -35.55 -52.84 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.481 -0.762 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.655 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -50.33 -55.39 15.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.006 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.916 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -43.45 -65.8 0.45 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.641 -0.662 . . . . 0.0 110.506 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.837 HD23 HD21 ' A' ' 32' ' ' LEU . 74.2 mt -66.78 -49.88 64.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.526 -0.734 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.764 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -41.82 -72.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.629 -0.669 . . . . 0.0 110.648 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.3 pp -52.46 -23.64 6.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 1.083 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.04 -31.55 44.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.649 -0.657 . . . . 0.0 109.545 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.503 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 124.76 41.1 0.39 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -63.51 -156.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.07 -1.253 . . . . 0.0 109.745 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.534 ' HG2' ' HB3' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -118.87 59.08 4.05 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.426 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 51.9 Cg_endo -69.89 -22.09 31.97 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 124.149 1.605 . . . . 0.0 110.178 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.31 -52.32 3.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.731 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -60.51 133.27 55.93 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.545 0.688 . . . . 0.0 110.649 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -123.81 -177.27 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.35 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.48 138.48 36.07 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.192 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.0 -29.26 18.21 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 124.089 1.573 . . . . 0.0 110.539 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.15 -61.03 1.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 13.2 p -137.66 41.56 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.691 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 78' ' ' LEU . 1.7 mt 37.56 56.21 1.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.311 0.577 . . . . 0.0 111.401 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.629 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 58.3 m -77.54 104.4 8.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.596 -0.69 . . . . 0.0 110.048 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.998 ' NH1' HG21 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -79.37 142.92 59.05 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 70' ' ' PRO . 42.9 Cg_endo -66.92 -10.65 29.2 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.804 1.423 . . . . 0.0 109.654 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.415 HG13 HD23 ' A' ' 104' ' ' LEU . 6.0 t -70.46 -36.84 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.911 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.498 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 16.4 m80 -57.37 -40.47 78.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.553 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -50.01 -58.69 4.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.999 -0.438 . . . . 0.0 111.314 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -46.41 -55.11 7.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.617 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.074 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -67.21 -35.76 80.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 0.0 110.767 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -46.27 -39.46 10.03 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 111.286 -178.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -105.37 -3.63 22.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 110.46 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.562 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 81.43 35.45 23.05 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.603 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 1.0 OUTLIER -105.83 83.55 1.94 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.393 -1.063 . . . . 0.0 110.336 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.554 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -56.97 -46.35 82.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 111.575 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 96' ' ' VAL . 31.3 m-20 -42.93 -37.95 2.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.39 -0.819 . . . . 0.0 110.338 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.4 m -62.63 -44.32 96.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.579 -0.701 . . . . 0.0 109.327 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -61.51 -55.94 25.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 0.0 109.769 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 95' ' ' VAL . 39.1 t -38.97 -45.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.731 -0.606 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.764 ' CG1' HD22 ' A' ' 64' ' ' LEU . 11.9 t -63.42 -53.75 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.664 0.745 . . . . 0.0 109.013 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 mt -47.99 -58.95 3.75 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.456 0.646 . . . . 0.0 110.266 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.99 -28.34 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 10.2 ttt85 -72.73 -3.86 27.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.353 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -146.56 53.81 1.12 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.965 -1.084 . . . . 0.0 111.438 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . 56.84 107.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.11 86.59 0.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -1.049 . . . . 0.0 109.68 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -51.14 116.9 2.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 110.683 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.958 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.3 mp -101.22 -16.21 17.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 26.1 t0 -85.1 55.13 3.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.998 HG21 ' NH1' ' A' ' 80' ' ' ARG . 1.9 p -110.49 -170.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.161 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.628 ' H ' HG22 ' A' ' 106' ' ' VAL . 1.9 mtt180 -137.04 135.69 37.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.213 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.9 m-20 -73.82 58.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.51 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 54.27 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.376 -0.828 . . . . 0.0 110.555 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.668 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -37.32 -63.38 0.44 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.412 0.625 . . . . 0.0 110.7 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.32 -34.74 0.23 Allowed Glycine 0 N--CA 1.478 1.471 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -48.42 141.94 6.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -1.11 . . . . 0.0 109.976 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.514 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -109.89 170.49 5.29 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.408 -0.808 . . . . 0.0 109.742 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 42.4 Cg_endo -70.44 -40.25 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.856 1.45 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 127' ' ' ALA . 13.3 p -70.51 -34.15 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.588 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -70.73 -51.67 25.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.513 -0.742 . . . . 0.0 109.812 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.78 -32.33 30.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.267 -0.896 . . . . 0.0 109.746 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.074 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -73.7 -46.58 45.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.876 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.478 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -67.8 -30.29 69.68 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -67.69 -41.48 83.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.545 -0.722 . . . . 0.0 110.091 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -83.32 -4.31 58.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 111.022 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.3 25.78 17.91 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.306 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.553 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 74.7 m-70 -98.27 47.11 1.0 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.069 -1.254 . . . . 0.0 109.39 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.681 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -44.48 -38.01 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.672 -0.643 . . . . 0.0 109.739 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.52 ' OD2' HD12 ' A' ' 91' ' ' LEU . 11.2 t70 -55.19 -47.03 75.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 94' ' ' LEU . 3.2 t -79.65 -46.28 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 108.88 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.681 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -51.29 -43.72 61.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.607 -0.683 . . . . 0.0 110.369 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 131' ' ' ARG . 5.6 ttp180 -68.16 -54.81 15.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 110.058 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.547 ' CG ' HD21 ' A' ' 91' ' ' LEU . 21.9 t80 -58.8 -39.59 81.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.171 -0.956 . . . . 0.0 109.143 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.7 mt -62.21 -35.0 77.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.529 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.417 ' HA ' ' H ' ' A' ' 135' ' ' GLY . 39.7 ttt180 -65.13 -27.28 68.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.93 28.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.958 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -89.51 -16.05 31.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.287 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -129.13 -50.21 1.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 0.0 110.452 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 131' ' ' ARG . . . 52.22 -112.53 2.05 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 146.04 45.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.529 ' OG1' ' HB1' ' A' ' 143' ' ' ALA . 10.1 t -70.85 139.93 50.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.459 -1.024 . . . . 0.0 110.764 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -164.92 28.11 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.503 -0.748 . . . . 0.0 109.808 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.34 -156.96 8.4 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 m -137.16 67.02 1.45 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.309 -1.112 . . . . 0.0 110.104 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -140.19 -60.53 0.53 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 110.626 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -120.6 36.03 4.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 110.536 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.529 ' HB1' ' OG1' ' A' ' 137' ' ' THR . . . -145.89 165.08 29.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 109.735 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 53.11 176.19 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.21 -0.931 . . . . 0.0 110.449 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 145' ' ' ILE . 1.2 tt -124.19 44.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 109.888 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.89 52.14 2.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.455 -0.778 . . . . 0.0 109.591 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -50.42 139.31 15.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.462 -0.774 . . . . 0.0 110.332 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 63.17 -177.84 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.415 -0.803 . . . . 0.0 109.963 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -99.86 20.84 13.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.454 -0.779 . . . . 0.0 109.467 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 55.16 177.91 0.19 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -72.23 -85.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.765 1.402 . . . . 0.0 110.144 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.04 13.02 7.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.194 -0.941 . . . . 0.0 110.684 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 51.3 85.25 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.334 -0.854 . . . . 0.0 110.497 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 154' ' ' ILE . 1.5 tt -131.81 65.85 76.58 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.513 -0.742 . . . . 0.0 109.846 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.62 127.56 5.02 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.91 1.479 . . . . 0.0 109.958 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 117.864 -1.065 . . . . 0.0 109.861 179.788 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 mtt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 66.7 mt-10 -79.49 163.26 59.92 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.418 -0.801 . . . . 0.0 110.607 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 45.3 Cg_endo -70.41 113.06 3.36 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.815 1.429 . . . . 0.0 110.623 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.64 -177.16 0.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 110.071 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.27 -43.22 24.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.41 -158.65 17.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.55 -172.06 0.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.241 -1.152 . . . . 0.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.09 121.42 0.9 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.402 -0.811 . . . . 0.0 109.85 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.4 mtt -46.59 -29.34 1.77 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -0.766 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.67 144.37 17.71 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.92 83.91 1.88 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.709 1.373 . . . . 0.0 110.358 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.55 -69.41 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.959 . . . . 0.0 110.377 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HB3' HD12 ' A' ' 37' ' ' LEU . . . 51.31 28.46 4.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -0.826 . . . . 0.0 110.685 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.59 ' OD1' ' HB1' ' A' ' 40' ' ' ALA . 66.5 m-20 -99.56 22.31 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.255 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.584 ' HB3' HD13 ' A' ' 31' ' ' LEU . 40.2 m0 -73.01 -31.82 64.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.058 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.808 HD23 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -53.06 -33.49 52.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 0.0 110.795 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.9 -48.49 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -51.8 37.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.693 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -65.89 -40.54 91.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -56.81 -52.36 65.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.203 -0.936 . . . . 0.0 109.62 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -57.3 -29.39 63.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.38 23.16 4.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.0 110.765 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.72 61.42 6.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -131.54 53.89 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.396 -1.061 . . . . 0.0 110.01 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 59' ' ' VAL . 98.0 t -42.36 -59.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.848 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -45.98 -38.57 7.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.773 . . . . 0.0 110.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 1.6 tp10 -70.93 -36.32 72.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.979 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.854 HG12 HD21 ' A' ' 62' ' ' LEU . 5.2 t -79.6 -41.4 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.0 mmm180 -51.59 -41.91 61.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.874 . . . . 0.0 109.363 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -56.07 4.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.673 -0.642 . . . . 0.0 109.461 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 15' ' ' TRP . 12.8 mt -45.0 -60.16 2.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.554 -0.717 . . . . 0.0 110.597 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.977 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -51.83 -51.88 53.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.5 -0.75 . . . . 0.0 110.258 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.98 -9.29 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 110.428 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.05 -13.56 30.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.07 -1.019 . . . . 0.0 110.895 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.02 -20.59 1.59 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.462 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.977 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -47.73 136.93 10.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.282 -1.128 . . . . 0.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 13.0 mt -73.13 155.75 89.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.975 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.59 -54.8 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.737 1.388 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -98.63 21.22 11.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -39.53 100.22 0.21 Allowed Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.71 -0.619 . . . . 0.0 110.689 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.63 146.8 44.35 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.875 1.46 . . . . 0.0 110.963 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -139.28 174.47 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.618 -0.676 . . . . 0.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.07 50.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.926 . . . . 0.0 110.574 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -3.47 5.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.17 23.51 25.31 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -138.64 106.15 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -1.051 . . . . 0.0 110.46 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.535 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -58.11 -177.2 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CB ' HD22 ' A' ' 63' ' ' LEU . 41.1 Cg_endo -66.52 175.68 4.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.319 1.168 . . . . 0.0 111.263 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.7 mt 61.92 -64.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.919 -0.488 . . . . 0.0 110.045 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' PRO . 50.2 tt0 -44.16 -26.91 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.3 p -123.56 36.57 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.641 -0.662 . . . . 0.0 109.891 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.82 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -94.24 38.32 1.09 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.772 -1.205 . . . . 0.0 110.653 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 6.1 tmm? 71.15 -14.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.52 -0.737 . . . . 0.0 110.672 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.55 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.43 27.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.71 13.47 5.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.47 82.91 1.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -1.013 . . . . 0.0 109.734 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -50.66 -25.24 4.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.0 110.394 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.64 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -53.56 -41.09 66.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.279 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 25' ' ' VAL . 24.1 t -55.57 -58.47 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.233 -0.917 . . . . 0.0 109.566 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.67 -52.78 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.675 . . . . 0.0 109.708 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.954 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -45.23 -42.75 9.72 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 28' ' ' VAL . 2.9 tp -73.83 -61.33 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.588 -0.695 . . . . 0.0 110.087 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.614 HD22 ' CB ' ' A' ' 48' ' ' PRO . 5.3 mt -64.7 -55.87 17.3 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 110.993 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.753 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -46.68 -61.75 1.69 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.447 -0.783 . . . . 0.0 111.118 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.954 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -57.55 -23.58 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.935 -1.103 . . . . 0.0 109.655 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CD2' ' CD2' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -81.98 -38.88 24.45 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.457 -0.777 . . . . 0.0 109.969 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.01 46.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.487 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.98 -151.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.008 -1.289 . . . . 0.0 109.583 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -117.14 53.51 1.3 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.003 . . . . 0.0 110.718 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.2 Cg_endo -66.85 -15.32 46.83 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.444 1.234 . . . . 0.0 109.877 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.473 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 4.1 m-20 -107.93 -72.56 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 171.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -147.33 -152.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.276 -0.89 . . . . 0.0 110.114 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -98.59 131.77 25.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.25 -27.55 34.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.337 1.177 . . . . 0.0 110.729 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.1 -64.43 0.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.667 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 27.5 p -130.29 36.31 3.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' A' ' 78' ' ' LEU . 4.3 mt 43.29 37.91 1.48 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.639 -0.663 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.9 OUTLIER -70.05 99.51 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.532 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -76.43 165.4 53.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 47.1 Cg_endo -69.8 -23.2 30.86 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.655 1.345 . . . . 0.0 109.536 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 114' ' ' PRO . 60.8 t -55.89 -29.29 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.676 -0.64 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 12.2 m80 -74.15 -50.16 20.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -45.24 -43.96 10.81 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -64.46 -67.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.109 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -54.14 -45.68 72.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.776 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -48.56 -33.33 9.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.277 -0.89 . . . . 0.0 110.627 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 4.2 mm-40 -99.28 -11.97 20.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.555 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 83.78 33.84 20.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -104.99 92.28 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -1.052 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 0.4 OUTLIER -67.66 -32.55 73.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 110.063 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 42.9 m-20 -52.26 -50.06 62.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.873 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 m -56.95 -36.28 70.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.86 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 mp -60.84 -44.12 97.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.503 -0.748 . . . . 0.0 109.701 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 16.5 t -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.517 HG12 HD13 ' A' ' 64' ' ' LEU . 15.6 t -55.51 -46.01 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.411 -0.806 . . . . 0.0 109.571 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -54.94 -69.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 110.057 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.12 -22.25 50.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.369 -0.832 . . . . 0.0 110.158 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -72.04 -16.54 62.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.753 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -144.25 72.68 1.35 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.338 -0.851 . . . . 0.0 110.596 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.52 101.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -161.93 79.28 0.54 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -1.087 . . . . 0.0 110.411 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.541 ' CZ ' HG23 ' A' ' 106' ' ' VAL . 1.2 ttp180 -56.89 119.64 6.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.121 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' O ' ' HB1' ' A' ' 134' ' ' ALA . 12.0 mt -99.13 15.49 25.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.059 . . . . 0.0 109.544 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.65 43.29 1.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.822 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.565 HG22 ' H ' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -103.19 -169.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.565 ' H ' HG22 ' A' ' 106' ' ' VAL . 36.0 ptt180 -142.0 140.69 32.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.652 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 110' ' ' TRP . 10.8 t0 -73.46 54.81 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.636 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 56.02 -75.59 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.616 -0.677 . . . . 0.0 111.483 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.667 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.1 OUTLIER -46.73 -39.15 11.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.294 -0.879 . . . . 0.0 110.37 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.23 -28.74 2.21 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -56.23 128.87 37.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -1.065 . . . . 0.0 110.569 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.464 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -93.09 171.64 7.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.63 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HB2' HG12 ' A' ' 82' ' ' VAL . 41.7 Cg_endo -69.46 -38.64 8.16 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.488 1.257 . . . . 0.0 110.048 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.558 HG21 ' CA ' ' A' ' 131' ' ' ARG . 9.6 p -70.55 -31.03 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.276 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.36 -26.06 66.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.548 -0.72 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.504 HD23 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -78.02 -55.05 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.39 -0.819 . . . . 0.0 110.551 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.109 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -47.97 -40.92 23.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 110.285 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -47.66 81.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.526 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -60.91 -54.13 48.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 109.627 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.504 HD23 HD23 ' A' ' 117' ' ' LEU . 1.9 mm? -55.16 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.0 110.427 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.19 41.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.517 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 49.4 m-70 -122.23 63.32 0.94 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.388 -1.066 . . . . 0.0 109.546 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -45.3 46.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -46.16 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.867 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -74.83 -42.01 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.72 84.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 109.64 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -52.93 -67.45 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 49.7 t80 -52.86 -30.4 33.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.919 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.86 ' HG ' HD21 ' A' ' 94' ' ' LEU . 5.8 mt -70.75 -53.58 15.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.596 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CA ' HG21 ' A' ' 115' ' ' VAL . 8.7 ttp180 -55.23 -29.79 58.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.86 -54.23 4.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.664 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -75.87 -9.14 58.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.327 -0.858 . . . . 0.0 110.781 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -122.84 -44.92 2.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.164 -0.96 . . . . 0.0 110.693 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -49.77 120.28 7.69 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.61 8.02 73.99 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 44.9 p -59.54 109.81 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -1.204 . . . . 0.0 110.299 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -123.44 -76.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 109.763 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.54 48.92 0.36 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.8 m -62.91 -18.16 62.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -1.064 . . . . 0.0 109.887 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -108.09 -37.33 6.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -144.71 -162.71 1.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.332 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.74 133.59 55.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 110.269 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.705 ' CZ ' HD12 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -71.48 112.8 7.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.192 -0.943 . . . . 0.0 109.834 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.705 HD12 ' CZ ' ' A' ' 144' ' ' ARG . 48.9 mt 51.79 86.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.293 -0.879 . . . . 0.0 109.69 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -48.07 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.426 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.75 103.63 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.535 -0.728 . . . . 0.0 110.392 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.45 124.57 8.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.542 -0.724 . . . . 0.0 110.37 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -46.69 119.92 2.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.538 -0.726 . . . . 0.0 110.284 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -83.32 150.75 27.56 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.29 -85.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.907 1.477 . . . . 0.0 110.299 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.7 m -165.91 105.34 0.69 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.215 -0.928 . . . . 0.0 110.345 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -59.06 173.95 0.41 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 mt -125.18 85.68 57.85 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.357 -0.84 . . . . 0.0 110.023 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.59 120.01 6.45 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.848 1.446 . . . . 0.0 110.389 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.293 -179.884 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.138 0.494 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -68.54 -56.77 9.46 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 109.85 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 48.0 Cg_endo -72.98 147.13 42.92 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.484 1.254 . . . . 0.0 110.478 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . -174.9 161.18 2.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.462 -0.774 . . . . 0.0 109.85 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . 176.12 91.31 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.32 -0.862 . . . . 0.0 110.114 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.84 -78.44 0.05 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.61 55.33 3.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.194 -1.18 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.93 24.44 0.56 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.841 . . . . 0.0 110.524 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.7 ttp -96.19 54.93 1.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.167 -0.958 . . . . 0.0 110.773 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.14 79.24 5.67 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.029 -1.044 . . . . 0.0 110.563 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -79.15 86.03 1.76 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.875 1.46 . . . . 0.0 110.358 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 m -61.89 143.53 56.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.262 -0.899 . . . . 0.0 110.351 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.77 -51.3 0.1 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.45 -6.15 41.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.283 -0.886 . . . . 0.0 110.573 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.484 ' HE3' HD21 ' A' ' 31' ' ' LEU . 16.3 m0 -57.03 -17.22 9.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 110.457 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -69.85 -56.03 8.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -71.81 -42.96 66.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -47.81 -62.51 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.166 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -52.0 -42.96 63.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.816 . . . . 0.0 109.936 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -57.63 -52.15 66.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.679 -0.638 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -50.38 -25.63 4.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.451 -0.781 . . . . 0.0 110.607 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . 37.6 mtt180 -103.74 28.93 6.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.656 -0.652 . . . . 0.0 109.849 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.76 41.89 10.43 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 28' ' ' VAL . 11.7 mtt180 -99.85 54.93 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -1.081 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.713 HG12 ' HD3' ' A' ' 29' ' ' ARG . 99.3 t -38.9 -53.61 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.769 -0.582 . . . . 0.0 111.07 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -49.81 -56.29 10.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.755 . . . . 0.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp10 -54.45 -39.0 67.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.383 -0.823 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.06 HG12 HD23 ' A' ' 62' ' ' LEU . 14.0 t -71.74 -56.0 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.707 -0.621 . . . . 0.0 110.279 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.874 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -39.41 -52.48 2.08 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.428 -0.795 . . . . 0.0 110.668 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -73.82 -50.75 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.76 . . . . 0.0 109.907 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.484 HD21 ' HE3' ' A' ' 15' ' ' TRP . 14.0 mt -47.37 -57.05 5.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.59 -0.694 . . . . 0.0 110.728 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.973 ' HB2' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.86 -50.36 45.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 109.491 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -70.53 -17.38 62.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.714 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -81.83 -6.35 59.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.067 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.06 16.68 6.1 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.565 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.872 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -58.15 160.87 4.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.074 -1.25 . . . . 0.0 109.975 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -101.39 113.26 65.85 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 111.269 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.41 -5.17 16.62 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.753 1.396 . . . . 0.0 110.421 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.416 ' C ' HD23 ' A' ' 37' ' ' LEU . 2.2 m120 -131.59 40.06 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 110.075 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.758 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -84.18 133.85 44.51 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.268 -0.895 . . . . 0.0 110.546 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.3 89.65 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.726 1.382 . . . . 0.0 110.375 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.76 166.18 5.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -85.41 21.71 1.7 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -119.38 15.35 12.99 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.16 24.15 20.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.4 -170.33 1.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.447 -1.031 . . . . 0.0 110.256 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.3 mmt180 -103.45 167.51 10.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.673 . . . . 0.0 109.547 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 63' ' ' LEU . 42.6 Cg_endo -67.26 -12.0 34.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.582 1.306 . . . . 0.0 110.414 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.54 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.1 mt -107.2 -42.76 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 108.637 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.449 ' HB2' ' H ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -49.44 -20.95 0.79 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.383 -0.823 . . . . 0.0 110.472 179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 51' ' ' VAL . 10.8 p -115.91 35.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 110.477 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.808 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.4 34.57 1.6 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 109.729 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 10.0 ttp 67.67 -6.69 0.65 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 110.821 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.563 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.66 27.19 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.235 -0.916 . . . . 0.0 110.41 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.35 11.65 7.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.656 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.8 m -148.91 93.22 2.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.482 -1.011 . . . . 0.0 109.615 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.42 -34.15 70.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.468 -0.77 . . . . 0.0 109.872 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -52.15 -42.04 63.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 110.093 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 52' ' ' MET . 91.0 t -48.15 -53.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -62.79 -43.69 98.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.565 -0.709 . . . . 0.0 109.315 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 4.0 tt0 -46.8 -31.73 3.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.248 -0.908 . . . . 0.0 110.276 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.06 HD23 HG12 ' A' ' 28' ' ' VAL . 7.5 tp -89.87 -49.66 6.49 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -56.65 -55.41 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.451 0.643 . . . . 0.0 109.387 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.916 HD22 HG12 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -61.23 -45.76 93.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.671 -0.643 . . . . 0.0 109.756 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.4 tp -53.04 -32.97 49.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -0.874 . . . . 0.0 108.719 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CG ' ' CD1' ' A' ' 32' ' ' LEU . 2.0 m80 -92.6 -1.04 57.21 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.426 0.631 . . . . 0.0 110.355 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.0 63.48 1.97 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.447 ' C ' ' HD3' ' A' ' 70' ' ' PRO . . . -72.26 -149.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -1.067 . . . . 0.0 109.228 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mt-10 -114.88 57.22 0.97 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -72.17 -0.89 9.26 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.315 1.166 . . . . 0.0 110.585 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.46 -73.72 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.055 -1.028 . . . . 0.0 109.804 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 134.7 16.61 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.578 0.704 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.424 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . -127.34 -134.16 0.24 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.03 125.73 30.92 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.786 -1.196 . . . . 0.0 109.452 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.84 5.75 5.06 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.255 1.134 . . . . 0.0 110.865 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.27 -43.77 4.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 108.925 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.897 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -121.44 2.98 10.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.619 -0.676 . . . . 0.0 109.932 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 2.8 mt 54.99 25.23 6.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.278 -0.889 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.71 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.81 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.36 165.9 40.09 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.173 -0.954 . . . . 0.0 110.104 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 44.4 Cg_endo -71.54 -9.01 24.39 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.76 1.4 . . . . 0.0 110.672 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.618 HG11 HD23 ' A' ' 104' ' ' LEU . 3.5 t -73.87 -30.53 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.103 -0.998 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.412 ' CD2' ' OD1' ' A' ' 108' ' ' ASP . 27.0 m80 -68.64 -43.97 75.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -48.81 -49.95 36.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.331 0.586 . . . . 0.0 110.251 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.692 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -57.81 -68.7 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.0 109.766 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.912 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -51.24 -39.29 56.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.362 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -44.01 -51.73 7.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.328 -0.857 . . . . 0.0 110.812 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -96.14 18.7 13.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 109.775 179.165 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.836 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 54.39 52.78 42.31 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.489 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -117.07 84.36 2.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -1.157 . . . . 0.0 110.611 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.581 ' HA ' HD13 ' A' ' 94' ' ' LEU . 1.2 mt -55.89 -43.81 77.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 0.0 110.75 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 47.9 m-20 -45.89 -35.66 4.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.496 -0.753 . . . . 0.0 111.048 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -71.9 -38.61 69.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -0.91 . . . . 0.0 110.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.692 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 1.6 mp -63.08 -59.55 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.8 t -46.2 -49.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.58 -0.7 . . . . 0.0 110.314 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.916 HG12 HD22 ' A' ' 64' ' ' LEU . 23.6 t -50.39 -53.04 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.571 -0.705 . . . . 0.0 109.71 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.661 ' HA ' HD21 ' A' ' 64' ' ' LEU . 64.6 mt -52.39 -66.11 0.44 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 0.0 109.837 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -55.78 -26.71 47.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.933 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.62 -13.19 61.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.977 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.798 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -147.87 78.19 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.183 -0.948 . . . . 0.0 111.001 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 52.07 101.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 97' ' ' LEU . . . -163.06 123.53 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -1.211 . . . . 0.0 110.744 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -78.41 141.63 38.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 133' ' ' ALA . 0.5 OUTLIER -126.4 8.19 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.335 -0.853 . . . . 0.0 110.287 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -115.75 49.62 1.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.062 -1.024 . . . . 0.0 111.365 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.81 HG11 ' CG ' ' A' ' 80' ' ' ARG . 7.6 p -112.45 171.64 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.85 ' HG2' HD12 ' A' ' 113' ' ' LEU . 24.1 mtm180 -131.42 143.8 50.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 109.59 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -68.51 58.04 0.08 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.241 -0.912 . . . . 0.0 110.17 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 50.9 -88.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.897 ' CH2' HG23 ' A' ' 77' ' ' THR . 5.8 p90 -112.62 -1.57 14.79 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.263 -0.898 . . . . 0.0 110.758 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -77.93 -80.61 0.68 Allowed Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 4.3 mtt180 170.98 -169.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.816 -0.814 . . . . 0.0 110.069 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.85 HD12 ' HG2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -80.37 166.96 36.56 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 110.417 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.1 Cg_endo -72.32 -35.91 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.813 1.428 . . . . 0.0 110.16 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 7.9 p -67.69 -28.45 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -50.68 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.71 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -24.71 41.95 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.272 -0.893 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.29 -62.9 1.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 111.109 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -23.77 1.16 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -37.2 23.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.285 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 1.7 mm? -86.9 7.52 26.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.31 24.03 52.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.322 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 17.0 m-70 -99.4 43.47 1.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.951 -1.323 . . . . 0.0 109.223 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -42.58 7.77 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.292 0.568 . . . . 0.0 110.158 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.09 -38.13 78.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 109.6 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.912 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.3 t -82.54 -38.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.41 -22.65 63.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -68.1 -71.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 0.0 110.389 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.614 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 2.4 t80 -53.88 -45.11 70.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 86' ' ' ALA . 12.9 mt -50.53 -55.26 16.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.522 -0.736 . . . . 0.0 109.488 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.435 ' CA ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -54.46 -23.14 14.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.169 -0.957 . . . . 0.0 109.95 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -80.31 -52.36 7.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -88.37 -7.13 57.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 111.134 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -107.68 -31.59 8.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.921 -1.112 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.5 98.77 0.95 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.05 83.83 0.34 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.412 HG21 ' CD ' ' A' ' 144' ' ' ARG . 0.1 OUTLIER -60.08 107.13 0.59 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.529 -0.983 . . . . 0.0 109.856 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.25 74.88 1.46 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.362 -0.836 . . . . 0.0 110.182 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -177.84 -133.35 1.85 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.54 51.71 1.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -1.178 . . . . 0.0 110.295 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 48.84 43.34 21.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.589 -0.695 . . . . 0.0 111.037 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' A' ' 142' ' ' HIS . 55.0 p-80 -57.59 112.56 1.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.0 109.396 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 54.14 -155.35 0.24 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.036 -1.04 . . . . 0.0 109.83 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.437 ' O ' ' HB ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER 58.04 60.06 2.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.129 -0.982 . . . . 0.0 110.354 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 37.7 mm 60.27 157.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.385 -0.822 . . . . 0.0 110.377 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.4 76.11 0.38 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.128 -0.982 . . . . 0.0 110.67 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.0 129.51 37.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.305 -0.872 . . . . 0.0 109.446 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -45.14 120.15 2.31 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.429 -0.795 . . . . 0.0 110.86 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.61 167.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -0.893 . . . . 0.0 110.152 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.0 113.85 0.22 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.33 129.38 16.9 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.501 1.264 . . . . 0.0 110.681 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.0 t -138.44 -0.91 1.94 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.512 -0.742 . . . . 0.0 110.757 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' A' ' 155' ' ' PRO . 28.9 p-10 -96.15 63.91 2.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.984 -1.072 . . . . 0.0 110.578 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 31.3 mm -112.38 75.56 1.75 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.104 -0.998 . . . . 0.0 110.019 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 153' ' ' ASP . 51.9 Cg_endo -77.8 117.59 4.27 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.793 1.417 . . . . 0.0 110.266 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.0 t0 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.469 179.638 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.345 0.593 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 60.08 72.13 0.79 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.386 -0.821 . . . . 0.0 110.846 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.79 74.12 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.63 1.331 . . . . 0.0 109.876 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.05 128.84 14.35 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.538 -0.726 . . . . 0.0 110.979 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.05 175.49 5.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.434 -0.791 . . . . 0.0 110.394 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.08 -113.4 2.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.4 p -75.17 148.16 39.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 109.804 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.98 120.94 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.311 -0.868 . . . . 0.0 110.246 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -98.71 -42.95 6.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.38 -0.825 . . . . 0.0 110.507 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.44 157.29 51.93 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.431 -0.793 . . . . 0.0 110.637 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.91 170.12 20.4 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.895 1.471 . . . . 0.0 110.411 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -58.55 122.75 14.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.323 -0.86 . . . . 0.0 110.091 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.24 -18.37 52.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.512 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -54.86 -20.46 8.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.144 -0.972 . . . . 0.0 110.292 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.598 ' HB3' HD11 ' A' ' 31' ' ' LEU . 21.2 m0 -48.04 -33.96 8.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.313 -0.867 . . . . 0.0 109.7 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.825 HD22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -43.86 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.375 0.607 . . . . 0.0 110.849 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 42' ' ' ASN . . . -43.89 -54.02 5.63 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.69 -0.631 . . . . 0.0 111.299 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -59.58 3.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 110.702 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.17 -47.93 74.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.326 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -57.06 -48.9 77.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.455 -0.778 . . . . 0.0 110.319 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.98 -25.63 67.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 110.105 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -85.78 5.45 32.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.308 -0.87 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 63.97 44.81 95.43 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -122.1 72.7 1.05 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.953 . . . . 0.0 109.611 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.831 HG22 HG23 ' A' ' 59' ' ' VAL . 39.1 t -53.38 -45.41 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.414 -0.804 . . . . 0.0 110.274 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.33 -33.99 66.14 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 0.0 110.508 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' O ' HD12 ' A' ' 31' ' ' LEU . 5.7 tt0 -68.19 -41.8 80.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.871 . . . . 0.0 109.772 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.82 HG12 HD12 ' A' ' 32' ' ' LEU . 21.4 t -77.59 -45.38 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.958 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.699 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.22 -47.77 35.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -29.83 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 15' ' ' TRP . 7.9 mt -68.34 -70.43 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.206 -0.934 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.842 HD22 ' CG ' ' A' ' 66' ' ' HIS . 1.3 mt -46.88 -49.41 20.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.373 -0.829 . . . . 0.0 111.542 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -60.9 -24.46 66.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.31 -5.79 55.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.48 29.83 3.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.46 128.35 33.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -1.099 . . . . 0.0 110.123 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.825 ' O ' HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -49.25 111.6 2.05 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.38 -0.825 . . . . 0.0 110.666 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HA ' HD21 ' A' ' 16' ' ' LEU . 43.3 Cg_endo -69.12 -33.15 19.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.678 1.357 . . . . 0.0 110.811 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.68 50.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.707 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -78.01 150.96 78.61 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.415 -0.803 . . . . 0.0 110.324 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.87 116.38 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.79 1.416 . . . . 0.0 110.188 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 12.9 m120 -94.21 170.68 9.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.961 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -89.95 33.41 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.638 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -137.06 3.63 2.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.054 -1.029 . . . . 0.0 110.725 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.14 26.87 36.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -130.78 20.8 5.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -1.15 . . . . 0.0 110.691 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 48.91 -177.51 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.707 -0.62 . . . . 0.0 111.069 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 50' ' ' GLN . 44.4 Cg_endo -72.95 -179.52 4.36 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.44 1.232 . . . . 0.0 111.165 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.62 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 56.88 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.761 -0.587 . . . . 0.0 110.322 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -47.73 -23.09 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.939 -1.101 . . . . 0.0 110.264 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.66 6.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 110.664 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -68.98 171.65 7.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.795 -1.191 . . . . 0.0 109.211 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.432 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 3.2 ttm -52.79 -19.06 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.229 -0.919 . . . . 0.0 110.37 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.606 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.48 10.14 3.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.405 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -119.02 18.28 10.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.3 78.25 1.32 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.459 -1.024 . . . . 0.0 109.449 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -44.75 -28.88 0.68 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.0 110.378 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -42.71 57.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.831 HG23 HG22 ' A' ' 25' ' ' VAL . 77.8 t -53.67 -60.84 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.488 -0.757 . . . . 0.0 109.409 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -53.53 -52.34 59.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.326 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.786 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.0 tt0 -45.74 -35.73 4.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.196 -0.94 . . . . 0.0 110.062 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.775 HD21 HG12 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -78.3 -60.89 2.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.573 -0.704 . . . . 0.0 109.248 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.0 mt -60.95 -56.07 25.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 110.521 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.738 HD13 HG12 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -48.68 -62.47 1.49 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.563 -0.711 . . . . 0.0 110.814 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -55.16 -24.96 29.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.972 -1.08 . . . . 0.0 109.385 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.842 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -82.22 -29.26 31.48 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.416 -0.802 . . . . 0.0 109.811 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.47 38.02 0.31 Allowed Glycine 0 N--CA 1.479 1.508 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.65 -148.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 0.0 109.678 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -115.65 59.04 1.45 Allowed Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.332 -0.855 . . . . 0.0 110.387 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.1 -8.64 22.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.553 1.291 . . . . 0.0 110.613 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 2.2 t30 -129.1 -65.26 0.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.314 -0.866 . . . . 0.0 109.704 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.88 144.29 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 110.532 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -136.34 -136.01 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.27 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -110.68 136.02 20.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.057 -1.027 . . . . 0.0 110.221 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.2 -5.35 16.95 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.542 1.285 . . . . 0.0 110.596 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.1 -49.67 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.619 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -120.57 9.63 10.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.377 -0.827 . . . . 0.0 110.945 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.522 ' HA ' HD23 ' A' ' 78' ' ' LEU . 7.4 mt 47.02 27.81 0.8 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.479 HG23 ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -60.59 89.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.644 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.814 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -69.14 168.78 13.99 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.864 . . . . 0.0 110.366 -179.189 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.595 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 54.5 Cg_endo -72.72 2.58 5.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 124.003 1.528 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 104' ' ' LEU . 19.8 t -85.09 -31.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 110.301 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 83' ' ' HIS . 9.1 m80 -67.48 -43.67 80.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.08 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.9 OUTLIER -53.52 -54.09 42.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.701 -0.624 . . . . 0.0 111.373 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.675 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -52.76 -63.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 109.934 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.813 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.05 -55.01 40.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.26 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 5.0 tpt180 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.507 -0.746 . . . . 0.0 111.299 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 54' ' ' MET . 9.9 tp10 -103.83 -4.64 23.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.025 -1.047 . . . . 0.0 111.09 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 20.83 69.14 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.613 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -102.01 96.35 6.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -1.151 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.669 HD21 ' CG ' ' A' ' 129' ' ' TYR . 1.2 tt -69.82 -38.37 76.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.724 -0.61 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 96' ' ' VAL . 42.3 m-20 -50.56 -41.62 54.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.89 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.1 m -55.89 -48.27 75.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.733 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.704 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -59.05 -43.21 91.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.833 . . . . 0.0 109.805 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -51.47 -49.17 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 HD13 ' A' ' 64' ' ' LEU . 25.4 t -59.83 -43.1 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.589 0.709 . . . . 0.0 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.52 ' HA ' HD11 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -56.96 -58.62 7.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.618 -0.677 . . . . 0.0 110.107 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -65.41 -35.74 81.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 110.125 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 2.3 ttp85 -61.57 -14.9 33.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.411 -0.806 . . . . 0.0 110.449 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -140.79 54.43 1.59 Allowed 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.988 -1.07 . . . . 0.0 111.168 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.36 106.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -156.91 97.57 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.467 -1.02 . . . . 0.0 109.876 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -51.37 115.32 1.53 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.338 -0.851 . . . . 0.0 110.404 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -105.36 4.08 30.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 110.611 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -112.63 51.46 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 110.535 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.814 HG11 ' CG ' ' A' ' 80' ' ' ARG . 4.5 p -107.55 -178.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.997 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.641 ' H ' HG22 ' A' ' 106' ' ' VAL . 42.3 mtt85 -131.26 153.01 49.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 109.564 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -80.38 54.93 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.537 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 62.86 -68.65 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.626 -0.672 . . . . 0.0 111.276 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 6.6 m0 -65.67 -37.68 87.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.818 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.79 -20.56 1.0 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.493 ' HB2' ' HB2' ' A' ' 108' ' ' ASP . 12.4 mtt180 -49.75 136.77 17.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -1.106 . . . . 0.0 110.266 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -111.06 161.17 26.17 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.358 -0.839 . . . . 0.0 110.116 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -70.24 -21.62 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.583 1.307 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' CB ' HD11 ' A' ' 130' ' ' LEU . 4.4 p -86.57 -31.74 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.053 -1.029 . . . . 0.0 110.038 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.34 -22.96 63.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.9 mt -75.67 -44.59 41.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.537 -0.727 . . . . 0.0 110.497 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -68.2 -36.22 79.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.94 -39.24 88.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -57.7 3.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 109.897 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.51 -85.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.478 -0.764 . . . . 0.0 110.257 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.03 39.31 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 22.6 m-70 -103.87 55.82 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.378 -1.072 . . . . 0.0 108.822 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.51 -40.81 13.15 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.45 0.643 . . . . 0.0 109.909 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.16 -42.17 90.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.646 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.3 t -82.18 -44.88 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.987 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -54.8 -37.61 66.3 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -77.14 -48.26 18.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.73 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.669 ' CG ' HD21 ' A' ' 91' ' ' LEU . 27.2 t80 -70.73 -57.16 4.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.119 -0.988 . . . . 0.0 110.503 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.623 ' C ' HD12 ' A' ' 130' ' ' LEU . 0.7 OUTLIER -54.55 -32.75 58.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.114 -0.992 . . . . 0.0 110.612 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 127' ' ' ALA . 23.7 ttt180 -66.55 -38.13 86.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -0.847 . . . . 0.0 110.083 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.378 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.81 -19.41 23.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.733 -0.605 . . . . 0.0 110.295 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 104' ' ' LEU . . . -94.3 -13.35 26.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.332 -0.855 . . . . 0.0 110.721 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 173.6 -80.49 0.08 OUTLIER Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 55.76 40.46 80.22 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 t -50.47 133.2 25.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -1.024 . . . . 0.0 110.137 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.94 114.19 28.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 110.163 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 154.39 -175.57 32.51 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.91 -31.29 8.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.296 -1.12 . . . . 0.0 110.167 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -161.87 28.88 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.846 . . . . 0.0 110.755 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -78.08 -47.69 17.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 109.073 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 144' ' ' ARG . . . -87.9 -179.32 6.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.588 -0.695 . . . . 0.0 109.257 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 143' ' ' ALA . 0.0 OUTLIER 60.45 147.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.134 -0.979 . . . . 0.0 109.776 -179.435 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 tt -80.38 158.8 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.042 -1.036 . . . . 0.0 110.39 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -49.34 162.15 0.15 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.426 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -166.61 64.88 0.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.273 -0.892 . . . . 0.0 110.434 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 144.8 54.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.775 . . . . 0.0 109.968 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.71 137.47 37.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.03 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.68 121.09 5.87 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -79.63 5.72 5.68 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.577 1.304 . . . . 0.0 110.761 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.57 -13.51 12.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.14 -0.975 . . . . 0.0 110.394 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -48.0 149.55 1.36 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.32 -0.862 . . . . 0.0 110.365 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.74 110.51 42.14 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.162 -0.961 . . . . 0.0 110.795 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.86 111.8 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.751 1.395 . . . . 0.0 110.277 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.228 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.152 0.501 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.68 162.02 21.02 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 49.1 Cg_endo -74.63 77.44 2.98 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.789 1.415 . . . . 0.0 110.421 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 3' ' ' PRO . . . 59.6 111.44 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.387 -0.821 . . . . 0.0 110.516 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.67 -18.44 61.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.886 . . . . 0.0 110.336 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.19 136.86 47.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.3 p -100.51 38.8 1.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -1.081 . . . . 0.0 110.11 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 p -161.39 165.74 28.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.845 . . . . 0.0 110.317 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.63 103.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.486 -0.758 . . . . 0.0 110.227 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -103.07 163.33 17.73 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.376 -0.827 . . . . 0.0 110.182 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.17 123.24 7.1 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.727 1.383 . . . . 0.0 110.292 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 t -171.99 -52.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.273 -0.892 . . . . 0.0 110.338 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -66.88 -16.12 64.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 110.355 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -89.64 12.25 17.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.884 . . . . 0.0 110.634 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 3.0 m0 -85.13 -26.78 26.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 17' ' ' ALA . 3.8 pp -61.99 -32.48 72.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 109.457 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.545 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -80.34 -48.2 13.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.4 -0.813 . . . . 0.0 109.89 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -63.06 -41.07 99.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -55.51 -52.44 63.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.408 -0.808 . . . . 0.0 109.775 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -58.62 -31.89 68.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.358 -0.838 . . . . 0.0 110.192 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . -59.79 -35.47 74.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -94.18 23.46 5.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.28 42.85 89.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -105.12 67.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.877 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.563 HG12 ' HD3' ' A' ' 29' ' ' ARG . 85.3 t -51.75 -30.01 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.469 -0.769 . . . . 0.0 110.325 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -73.27 -39.06 65.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.325 -0.859 . . . . 0.0 110.728 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.637 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.5 tp10 -66.74 -31.99 73.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.257 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.853 HG12 HD12 ' A' ' 32' ' ' LEU . 6.5 t -83.09 -46.49 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.563 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.368 -0.833 . . . . 0.0 110.123 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.75 -35.98 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 109.728 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 27' ' ' GLU . 3.4 mt -59.09 -65.1 0.72 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.853 HD12 HG12 ' A' ' 28' ' ' VAL . 2.5 mt -51.39 -34.82 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 110.259 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -20.09 62.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.954 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.75 -9.23 47.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.09 28.01 2.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -57.71 151.49 17.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -1.168 . . . . 0.0 109.74 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 2.3 mp -73.35 135.43 79.15 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 109.729 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.11 -31.41 19.02 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.546 1.287 . . . . 0.0 110.128 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.47 ' ND2' ' OE2' ' A' ' 69' ' ' GLU . 1.8 m120 -139.69 61.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.558 -0.714 . . . . 0.0 110.032 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.4 160.01 83.83 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.283 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.5 124.03 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.827 1.435 . . . . 0.0 110.487 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -108.79 158.58 17.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -95.44 27.96 3.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 110.537 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -136.48 13.33 3.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 109.953 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.96 26.9 35.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.9 tpp180 -130.66 107.04 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 110.217 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.574 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mpt_? -55.09 -175.08 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.595 -0.691 . . . . 0.0 110.259 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.759 ' HB2' HD13 ' A' ' 63' ' ' LEU . 38.2 Cg_endo -64.34 163.66 25.76 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.267 1.14 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 66.68 -59.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' PRO . 5.1 tt0 -53.22 -20.93 4.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 46' ' ' ARG . 12.0 p -114.82 -7.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.622 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -56.52 165.17 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.986 -1.071 . . . . 0.0 109.796 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.418 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 0.9 OUTLIER -54.73 -17.07 3.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.229 -0.92 . . . . 0.0 110.397 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.58 ' HE1' ' HE2' ' A' ' 52' ' ' MET . 0.0 OUTLIER 61.96 11.46 4.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.41 18.42 20.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -155.47 96.08 1.75 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.674 -0.898 . . . . 0.0 109.634 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.91 -21.04 56.99 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.344 -0.848 . . . . 0.0 109.759 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -56.43 -30.49 62.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.567 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.546 HG11 ' HB1' ' A' ' 20' ' ' ALA . 41.2 t -64.68 -44.88 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.591 -0.693 . . . . 0.0 109.947 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.841 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.2 tt0 -45.73 -29.18 1.21 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.156 -0.965 . . . . 0.0 110.775 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.692 ' CD1' HD13 ' A' ' 32' ' ' LEU . 2.7 tp -83.82 -56.8 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 110.019 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 8.2 mt -67.68 -35.06 78.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.729 HD11 ' CB ' ' A' ' 100' ' ' ALA . 2.7 tm? -61.74 -65.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.81 -0.556 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.7 pp -54.53 -24.15 19.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.813 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.842 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.0 m80 -81.6 -49.95 9.92 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.526 -0.734 . . . . 0.0 110.134 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.24 46.02 0.03 OUTLIER Glycine 0 N--CA 1.482 1.731 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.029 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -75.57 -155.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.786 -1.42 . . . . 0.0 109.192 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 47' ' ' ARG . 6.7 tp10 -122.99 68.4 35.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 110.267 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HG3' HD23 ' A' ' 64' ' ' LEU . 52.5 Cg_endo -73.23 -9.13 22.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.896 1.471 . . . . 0.0 110.384 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 3.7 t30 -117.82 -70.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.711 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 152.7 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.105 -0.997 . . . . 0.0 111.082 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -137.62 -137.42 0.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 2.2 t70 -122.13 132.11 24.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.67 -7.78 21.85 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.639 1.336 . . . . 0.0 110.88 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.35 -55.74 4.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.212 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.531 HG22 ' CH2' ' A' ' 110' ' ' TRP . 61.2 p -117.26 7.34 12.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.2 mt 49.33 30.35 3.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.269 -0.894 . . . . 0.0 111.005 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -69.0 91.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.136 -0.977 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.87 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.87 159.22 83.51 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.623 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HB2' HD21 ' A' ' 97' ' ' LEU . 44.0 Cg_endo -70.08 -6.13 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.654 1.344 . . . . 0.0 110.626 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 t -77.29 -31.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 110.021 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 35.9 m80 -69.74 -42.8 73.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -0.828 . . . . 0.0 109.301 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.47 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.7 m-20 -48.47 -49.01 37.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.708 -0.62 . . . . 0.0 110.527 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.489 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -60.79 -68.9 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.819 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -50.64 -55.96 14.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.453 -0.78 . . . . 0.0 111.16 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 6.7 ttm180 -44.74 -27.79 0.55 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.173 -0.954 . . . . 0.0 111.683 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.476 ' CG ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -102.11 -5.03 24.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.689 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 79.84 36.06 26.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -116.41 101.66 8.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 110.724 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 125' ' ' ASP . 1.0 OUTLIER -83.1 -35.14 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 96' ' ' VAL . 3.1 m-20 -48.48 -43.06 34.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.383 -0.823 . . . . 0.0 109.784 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 m -65.07 -39.3 93.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 109.0 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.919 HD21 ' HB2' ' A' ' 130' ' ' LEU . 1.5 tp -51.81 -48.93 63.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.613 -0.68 . . . . 0.0 109.838 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 45.2 t -56.51 -51.35 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 109.68 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.5 HG12 ' HG ' ' A' ' 64' ' ' LEU . 26.3 t -49.25 -53.32 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.449 -0.782 . . . . 0.0 110.296 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.464 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -50.65 -67.76 0.23 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.468 -0.77 . . . . 0.0 110.683 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -61.86 -30.18 70.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.297 -0.877 . . . . 0.0 110.585 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -61.72 -16.6 50.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.348 -0.845 . . . . 0.0 110.764 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.729 ' CB ' HD11 ' A' ' 64' ' ' LEU . . . -129.74 -44.82 1.19 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.751 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.69 108.6 0.22 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -167.59 112.57 0.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -1.088 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.407 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -66.04 95.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.477 -0.765 . . . . 0.0 109.844 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 59.75 5.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.285 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -170.49 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -0.954 . . . . 0.0 110.062 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.87 HG11 ' CG ' ' A' ' 80' ' ' ARG . 1.5 p -102.54 -169.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.622 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.28 112.11 6.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.217 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.02 147.45 9.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.356 -0.84 . . . . 0.0 110.663 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -57.46 -27.24 62.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.531 ' CH2' HG22 ' A' ' 77' ' ' THR . 7.0 m95 -63.41 -14.35 49.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.72 46.02 5.86 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.41 104.29 2.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -1.043 . . . . 0.0 110.156 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.448 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -54.31 167.49 0.55 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.9 . . . . 0.0 109.941 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.553 ' O ' HD21 ' A' ' 130' ' ' LEU . 43.8 Cg_endo -69.93 -34.93 13.06 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.614 1.323 . . . . 0.0 109.931 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 131' ' ' ARG . 5.9 p -74.01 -27.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.398 -0.814 . . . . 0.0 110.192 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -37.94 63.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 109.69 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 87' ' ' ARG . 2.0 tt -69.39 -41.93 75.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.116 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -56.39 -48.49 76.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.267 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -65.51 -22.18 66.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.973 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.39 -65.62 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -83.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.182 -0.948 . . . . 0.0 110.539 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 35.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 24.0 m-70 -105.66 36.81 2.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -1.055 . . . . 0.0 108.659 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -46.87 -45.15 20.17 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.405 0.621 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.723 ' O ' HD12 ' A' ' 91' ' ' LEU . 14.8 p30 -56.64 -39.82 74.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.376 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 86' ' ' ALA . 10.6 t -74.14 -52.44 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 109.841 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.674 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -48.99 -28.54 3.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.628 -0.67 . . . . 0.0 111.227 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -50.02 -70.58 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.03 -1.044 . . . . 0.0 110.626 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -73.11 -28.36 62.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.919 ' HB2' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -72.1 -14.53 61.87 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 109.634 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.477 ' HA ' HG21 ' A' ' 115' ' ' VAL . 10.6 ttt180 -88.21 -42.97 11.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.143 -0.973 . . . . 0.0 110.064 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.14 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.7 -23.89 20.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 110.547 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -120.29 60.91 0.87 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.61 99.96 0.17 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.17 -7.97 27.95 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.9 p -72.97 103.11 3.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 110.291 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.95 105.24 17.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.323 -0.861 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.79 -90.82 1.33 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.7 m -64.08 146.57 53.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -1.086 . . . . 0.0 109.829 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.94 1.17 32.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.0 110.704 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.94 -177.05 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.083 -1.011 . . . . 0.0 110.399 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.87 130.32 48.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -0.809 . . . . 0.0 110.111 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.54 85.77 0.78 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.401 -0.812 . . . . 0.0 110.245 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 145' ' ' ILE . 1.0 OUTLIER -165.38 94.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 109.978 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -50.52 98.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.402 -0.811 . . . . 0.0 110.537 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.82 124.2 9.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.424 -0.797 . . . . 0.0 110.28 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 55.05 -171.75 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.368 -0.833 . . . . 0.0 110.14 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -76.12 154.9 35.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.867 . . . . 0.0 110.14 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.38 114.43 0.08 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.7 143.6 42.24 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.542 1.285 . . . . 0.0 110.09 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.5 m 55.55 19.83 3.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.412 -0.805 . . . . 0.0 110.774 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 51.57 -170.5 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.154 -0.966 . . . . 0.0 110.671 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 154' ' ' ILE . 1.1 tt -121.06 88.95 45.68 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.425 -0.797 . . . . 0.0 109.821 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.34 126.29 12.77 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.792 1.417 . . . . 0.0 110.702 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.284 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.231 0.539 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.98 62.14 3.61 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.286 -0.884 . . . . 0.0 110.348 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.46 173.2 14.91 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.722 1.38 . . . . 0.0 110.679 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.31 152.0 38.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.379 -0.826 . . . . 0.0 110.069 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.21 39.7 1.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.0 110.372 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.94 -86.33 0.52 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 p -74.81 55.2 0.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -1.088 . . . . 0.0 110.261 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 t -112.7 -16.29 12.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.322 -0.861 . . . . 0.0 110.219 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.54 -9.62 21.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.496 -0.753 . . . . 0.0 110.787 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -102.26 129.95 25.17 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.072 -1.018 . . . . 0.0 110.621 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HB3' ' HG2' ' A' ' 41' ' ' PRO . 49.0 Cg_endo -72.2 68.5 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.705 1.371 . . . . 0.0 110.329 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -59.69 -173.81 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 110.32 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 63.31 13.85 7.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.445 -0.785 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' OG1' ' A' ' 18' ' ' THR . 9.0 p-10 -89.83 24.73 2.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.059 -1.025 . . . . 0.0 109.944 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.647 ' O ' HD13 ' A' ' 31' ' ' LEU . 30.6 m0 -67.7 -28.15 67.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.449 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.051 HD13 HD21 ' A' ' 63' ' ' LEU . 3.9 pp -63.13 -38.93 93.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 110.063 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.789 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -77.25 -42.12 38.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 110.056 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -60.54 -40.95 93.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 110.318 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -70.79 -35.92 72.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.773 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB1' ' HB2' ' A' ' 52' ' ' MET . . . -67.08 -45.15 78.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 109.748 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.77 -29.33 68.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.617 -0.677 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -88.23 14.98 8.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 0.0 110.107 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.26 50.22 56.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -123.83 77.43 1.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -1.055 . . . . 0.0 110.315 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 59' ' ' VAL . 59.4 t -51.55 -46.35 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.386 -0.822 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.63 -60.7 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.594 -0.691 . . . . 0.0 110.311 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 -38.18 65.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.459 -0.776 . . . . 0.0 109.73 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.081 HG12 HD23 ' A' ' 62' ' ' LEU . 21.6 t -69.97 -56.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.956 ' HA ' HD22 ' A' ' 62' ' ' LEU . 9.8 mmm-85 -46.1 -45.17 16.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.73 . . . . 0.0 110.243 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.62 -36.93 57.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.483 -0.761 . . . . 0.0 109.567 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 15' ' ' TRP . 11.6 mt -62.15 -67.28 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.934 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -44.62 -43.56 8.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.665 -0.647 . . . . 0.0 110.164 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 2.6 tt0 -79.77 -17.43 53.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.643 -0.66 . . . . 0.0 110.798 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -80.74 -8.05 59.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 111.012 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.46 0.19 4.13 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.876 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.934 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -52.2 157.59 1.34 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.996 -1.297 . . . . 0.0 110.0 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.958 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 18.3 mt -86.14 153.77 57.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.114 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 48.5 Cg_endo -77.38 -54.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.644 1.339 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -107.44 40.05 1.77 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.839 . . . . 0.0 109.571 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.958 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -61.54 126.73 87.33 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.592 -0.693 . . . . 0.0 110.423 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HG2' ' HB3' ' A' ' 11' ' ' PRO . 45.7 Cg_endo -72.89 151.44 50.85 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.668 1.352 . . . . 0.0 110.099 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -122.52 171.68 8.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.865 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -4.44 59.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.325 -0.859 . . . . 0.0 110.07 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' HD2' HG21 ' A' ' 51' ' ' VAL . 3.3 m-30 -100.78 -3.04 30.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.93 29.02 54.47 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -119.83 39.41 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -1.065 . . . . 0.0 111.064 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 10.5 mmt180 49.59 172.68 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.424 -0.797 . . . . 0.0 111.741 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 53.4 Cg_endo -77.0 -18.63 14.43 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.638 1.336 . . . . 0.0 110.51 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.796 HG23 ' SD ' ' A' ' 52' ' ' MET . 15.3 mt -104.94 -47.2 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -48.4 -25.03 1.43 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG21 ' HD2' ' A' ' 44' ' ' TYR . 11.5 p -100.05 -1.03 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.957 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.7 ptt? -75.55 141.14 43.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ttp -54.25 123.6 13.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.976 . . . . 0.0 108.528 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.564 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -82.02 44.12 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.967 -1.083 . . . . 0.0 110.823 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.25 2.28 11.48 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.639 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -137.14 88.87 2.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.714 -0.874 . . . . 0.0 109.96 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -61.54 -11.67 12.03 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.115 -0.991 . . . . 0.0 109.951 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.1 -47.43 58.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.994 HG13 HG11 ' A' ' 28' ' ' VAL . 42.2 t -45.52 -62.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.41 -0.806 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -49.13 -40.76 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.094 -1.004 . . . . 0.0 109.648 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 7.4 tm-20 -50.07 -27.49 5.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.77 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.081 HD23 HG12 ' A' ' 28' ' ' VAL . 8.3 tp -90.05 -54.46 4.03 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.051 HD21 HD13 ' A' ' 16' ' ' LEU . 11.4 mt -55.11 -46.28 75.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -69.59 -41.04 76.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 5.4 tp -54.08 -33.67 58.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.542 ' CG ' HD11 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -90.78 -47.02 7.88 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.767 -0.583 . . . . 0.0 109.555 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.25 63.84 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 C-N-CA 120.151 -1.024 . . . . 0.0 110.758 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.759 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -77.04 -153.85 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.948 -1.324 . . . . 0.0 109.283 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.59 55.76 2.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.111 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.572 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 45.9 Cg_endo -70.81 -14.84 33.06 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.576 1.303 . . . . 0.0 110.323 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 -64.12 1.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.47 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.2 150.73 8.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 111.03 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' NE ' ' A' ' 80' ' ' ARG . . . -128.83 -153.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.584 -0.698 . . . . 0.0 109.134 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -102.13 136.7 19.41 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 0.0 109.701 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.41 -3.2 13.56 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.396 1.208 . . . . 0.0 110.699 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.66 -30.72 18.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 0.0 109.471 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.627 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -151.11 22.07 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 109.854 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.8 OUTLIER 37.28 33.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.862 -0.524 . . . . 0.0 111.515 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -69.34 100.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.872 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.51 166.92 25.93 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.273 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 43.9 Cg_endo -72.79 -21.08 21.91 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.578 1.304 . . . . 0.0 109.581 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.953 HG21 ' HA ' ' A' ' 104' ' ' LEU . 45.8 t -54.16 -30.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 32.8 m80 -71.65 -42.85 67.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 10.7 t0 -49.1 -47.46 45.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.779 -0.575 . . . . 0.0 109.926 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.464 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -59.72 -69.42 0.21 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.456 -0.777 . . . . 0.0 110.548 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.75 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.58 -41.6 86.08 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.003 . . . . 0.0 111.446 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.48 ' NH1' HD11 ' A' ' 121' ' ' LEU . 12.1 tpt85 -45.84 -41.54 11.27 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 110.886 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.5 5.34 49.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.97 34.26 27.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -103.29 97.81 7.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -1.119 . . . . 0.0 110.999 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 91' ' ' LEU . 3.0 tt -82.67 -40.21 21.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 109.64 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.511 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.3 m-20 -46.42 -56.11 6.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.582 -0.699 . . . . 0.0 109.846 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 m -54.08 -43.38 70.28 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD23 ' CD1' ' A' ' 129' ' ' TYR . 0.7 OUTLIER -50.59 -34.26 25.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 25.1 t -72.92 -45.2 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.582 -0.699 . . . . 0.0 109.118 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 46.6 t -61.12 -46.71 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -0.785 . . . . 0.0 109.808 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' HA ' HD11 ' A' ' 64' ' ' LEU . 3.7 mm? -52.58 -46.0 66.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.451 -0.78 . . . . 0.0 110.217 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -84.35 -12.84 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 96' ' ' VAL . 2.5 mtt180 -80.06 -12.02 59.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.328 -0.858 . . . . 0.0 111.013 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.57 -66.25 0.77 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.52 108.41 0.29 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 97' ' ' LEU . . . -168.66 128.36 1.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -1.062 . . . . 0.0 110.578 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 112.26 23.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.965 HD12 ' HB2' ' A' ' 134' ' ' ALA . 0.4 OUTLIER -104.06 5.19 35.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 110.644 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 134' ' ' ALA . 5.0 m-20 -100.31 41.14 1.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.63 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.872 HG11 ' CD ' ' A' ' 80' ' ' ARG . 7.2 p -108.75 178.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.822 . . . . 0.0 110.925 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.587 ' H ' HG22 ' A' ' 106' ' ' VAL . 11.4 ptt180 -131.17 143.69 50.81 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -68.06 69.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.387 -0.82 . . . . 0.0 110.803 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 60.92 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.627 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.7 m-90 -60.08 -75.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.755 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.98 32.28 0.07 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.503 ' CB ' ' HB2' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -89.42 107.96 19.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -1.129 . . . . 0.0 109.824 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.652 HD13 ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -82.55 159.11 64.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.434 -0.791 . . . . 0.0 110.159 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.652 ' HD2' HD13 ' A' ' 113' ' ' LEU . 42.3 Cg_endo -71.59 -24.68 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.797 1.419 . . . . 0.0 110.398 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 127' ' ' ALA . 11.6 p -79.42 -40.16 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.127 -0.983 . . . . 0.0 110.087 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.497 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -69.23 -30.01 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.483 -0.76 . . . . 0.0 109.884 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.465 HD21 ' HD3' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -78.4 -32.0 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.023 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.718 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.51 -44.7 50.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 109.672 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -36.42 78.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 110.02 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -59.5 4.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -0.813 . . . . 0.0 109.96 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.48 HD11 ' NH1' ' A' ' 87' ' ' ARG . 3.3 mm? -54.83 -82.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.28 37.24 0.03 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.481 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 31.1 m-70 -113.87 52.38 0.82 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.336 -1.096 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -33.83 9.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 110.27 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.426 ' C ' HD12 ' A' ' 91' ' ' LEU . 2.0 m-20 -63.81 -39.23 93.75 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.364 -0.835 . . . . 0.0 108.938 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -83.91 -43.18 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 109.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -63.27 -34.02 76.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -52.25 43.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.41 -0.807 . . . . 0.0 109.48 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.617 ' CD1' HD23 ' A' ' 94' ' ' LEU . 4.8 t80 -60.86 -30.34 70.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.747 . . . . 0.0 109.168 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.748 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 36.6 mt -65.13 -60.13 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.039 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' A' ' 115' ' ' VAL . 5.9 ttp180 -53.24 -20.82 4.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 110.411 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.7 -60.19 2.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.48 -12.52 59.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.372 -0.83 . . . . 0.0 110.389 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.965 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -108.95 41.04 1.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 110.002 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.82 108.72 0.64 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 131' ' ' ARG . . . -99.7 124.86 8.37 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.5 p -90.03 149.55 22.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.57 -0.959 . . . . 0.0 110.275 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.04 32.84 0.59 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.403 -0.81 . . . . 0.0 110.547 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -93.48 -9.53 60.13 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.05 116.44 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.294 -1.121 . . . . 0.0 110.946 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.8 m120 47.15 47.41 16.31 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.541 -0.724 . . . . 0.0 110.52 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.26 -171.16 3.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.441 -0.787 . . . . 0.0 109.722 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -170.6 53.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.206 -0.934 . . . . 0.0 110.676 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.9 -174.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.45 -0.781 . . . . 0.0 111.398 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 145' ' ' ILE . 9.6 tp -153.48 68.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 110.776 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 145' ' ' ILE . 1.8 m-20 -39.62 124.29 1.64 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.221 -0.924 . . . . 0.0 110.431 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.95 130.47 15.22 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.293 -0.88 . . . . 0.0 110.284 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.35 134.79 45.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.365 -0.835 . . . . 0.0 110.793 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.56 161.81 30.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.504 -0.747 . . . . 0.0 110.021 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 58.18 -174.96 2.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.57 128.35 15.17 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.839 1.441 . . . . 0.0 111.133 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.93 12.95 22.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.563 -0.711 . . . . 0.0 109.542 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.44 160.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.566 -0.709 . . . . 0.0 111.226 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.409 ' O ' HD12 ' A' ' 154' ' ' ILE . 1.1 pp -119.39 82.76 24.83 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.0 109.978 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.69 111.05 2.48 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.55 1.289 . . . . 0.0 110.855 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.896 179.476 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.095 0.474 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -125.15 115.15 25.99 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 109.842 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.518 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 50.0 Cg_endo -73.69 157.49 48.17 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.692 1.364 . . . . 0.0 110.663 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . 177.75 61.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.357 -0.839 . . . . 0.0 109.904 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.81 -87.7 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.337 -0.852 . . . . 0.0 110.226 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 4' ' ' ALA . . . 51.5 32.85 31.85 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.6 p -147.54 -50.93 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.361 -1.082 . . . . 0.0 110.13 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -88.07 42.69 1.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 110.231 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -72.36 175.12 6.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.231 -0.918 . . . . 0.0 109.888 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.19 110.35 1.29 Allowed Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.417 -0.802 . . . . 0.0 110.566 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.06 111.86 3.37 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.611 1.321 . . . . 0.0 110.734 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.81 -37.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.472 -0.768 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.66 -51.58 7.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 110.05 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -65.33 -13.55 58.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 110.4 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.562 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.3 OUTLIER -66.39 -4.73 8.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.404 -0.81 . . . . 0.0 111.146 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 38' ' ' PRO . 1.3 tp -80.55 -45.21 17.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.883 -1.135 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.7 53.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 110.171 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -61.32 -54.72 40.32 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -51.85 -49.44 62.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.366 -0.834 . . . . 0.0 109.784 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.12 -48.03 68.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 109.317 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -62.06 -28.93 69.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.579 -0.701 . . . . 0.0 109.345 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.93 20.65 3.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.655 -0.653 . . . . 0.0 110.286 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.46 52.92 22.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.627 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -128.72 96.03 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.109 . . . . 0.0 110.526 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 ' CG2' ' A' ' 59' ' ' VAL . 98.5 t -73.11 -54.6 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -44.08 -40.98 5.24 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.56 -0.712 . . . . 0.0 111.549 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.565 ' OE2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.02 -46.5 71.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.997 -1.064 . . . . 0.0 109.902 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.889 HG12 HD12 ' A' ' 32' ' ' LEU . 17.8 t -68.25 -41.29 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.819 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.929 ' HA ' HD11 ' A' ' 62' ' ' LEU . 13.6 mmm180 -50.43 -47.46 56.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.0 110.123 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.58 -45.1 47.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.79 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 ' OE2' ' A' ' 27' ' ' GLU . 10.6 mt -56.97 -60.45 3.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 110.198 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.901 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 mt -51.1 -32.57 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.313 -0.867 . . . . 0.0 109.574 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.58 -25.34 45.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.588 -0.695 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.67 -5.22 52.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.325 -0.859 . . . . 0.0 110.201 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.2 22.02 5.37 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -65.06 141.05 58.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.173 -1.192 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD1' ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -104.72 117.45 58.86 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.471 -0.768 . . . . 0.0 109.53 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HA ' HD21 ' A' ' 16' ' ' LEU . 43.0 Cg_endo -69.66 -29.53 24.23 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.46 1.242 . . . . 0.0 110.802 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -91.36 44.75 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 0.0 109.73 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . . . -88.3 155.57 51.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.581 -0.7 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.05 89.18 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.669 1.352 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 47' ' ' ARG . 41.3 m-80 -59.55 151.22 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.541 -0.725 . . . . 0.0 110.381 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.85 26.65 2.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.438 -0.789 . . . . 0.0 110.772 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -160.64 26.1 0.15 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.33 -0.856 . . . . 0.0 110.207 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.02 35.1 53.34 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -120.21 89.6 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.7 -0.883 . . . . 0.0 110.165 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -54.84 179.24 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.557 -0.714 . . . . 0.0 109.994 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.774 ' CB ' HD23 ' A' ' 63' ' ' LEU . 41.8 Cg_endo -66.96 156.77 64.83 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.387 1.204 . . . . 0.0 109.376 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 6.7 mt 67.2 -59.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 48' ' ' PRO . 36.4 tt0 -49.59 -21.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.919 -1.113 . . . . 0.0 109.688 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.5 p -124.49 37.06 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.812 . . . . 0.0 110.017 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.756 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -101.84 37.67 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.293 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.2 ttp 64.91 -9.22 0.2 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.535 -0.728 . . . . 0.0 111.693 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.554 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.4 28.57 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.035 -1.04 . . . . 0.0 110.339 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.27 11.46 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -144.54 73.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -1.021 . . . . 0.0 109.549 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -47.23 -27.92 1.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.605 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -59.24 -31.88 69.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.935 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.796 ' CG2' HG22 ' A' ' 25' ' ' VAL . 48.4 t -71.8 -50.41 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.756 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -43.0 -46.84 5.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.71 -55.15 38.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 109.702 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -44.38 -56.21 4.39 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.652 -0.655 . . . . 0.0 110.708 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.774 HD23 ' CB ' ' A' ' 48' ' ' PRO . 6.2 mp -68.84 -58.84 3.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 110.541 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -48.24 -52.91 19.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.175 -0.953 . . . . 0.0 110.301 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -55.04 -33.84 63.03 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.397 -0.814 . . . . 0.0 109.319 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.792 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.9 m80 -81.88 -48.78 11.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.302 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.39 43.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.577 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' HA ' ' CG ' ' A' ' 48' ' ' PRO . . . -69.02 -172.53 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.703 -1.469 . . . . 0.0 109.722 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 47' ' ' ARG . 3.7 mm-40 -121.02 65.14 13.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.378 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.486 ' HG3' HD21 ' A' ' 64' ' ' LEU . 42.8 Cg_endo -68.84 -26.16 32.4 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.07 1.563 . . . . 0.0 110.378 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -92.7 -63.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 173.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -164.07 -170.74 2.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.85 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.52 132.96 43.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.604 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 -15.92 39.51 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.556 1.293 . . . . 0.0 110.708 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.76 -84.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 109.991 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 66.6 p -110.1 32.99 4.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.286 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 5.5 mt 49.27 32.54 4.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.472 -0.767 . . . . 0.0 110.529 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.61 97.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.503 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -72.24 147.78 90.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.457 -0.777 . . . . 0.0 109.859 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 40.8 Cg_endo -66.56 -20.59 53.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.521 1.274 . . . . 0.0 109.515 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.977 HG13 HD23 ' A' ' 104' ' ' LEU . 27.6 t -58.46 -25.7 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -0.801 . . . . 0.0 109.8 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.493 ' CE1' ' HB3' ' A' ' 80' ' ' ARG . 23.9 m80 -73.27 -41.29 63.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.554 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.55 -43.85 46.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.694 -0.629 . . . . 0.0 110.23 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.708 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -63.35 -64.54 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.388 -0.82 . . . . 0.0 109.736 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.757 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -59.46 -52.41 65.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -41.27 -34.85 0.54 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.33 -8.99 28.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.16 -0.962 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . 82.92 23.81 54.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.646 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -98.95 84.01 3.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 110.445 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -57.9 -39.62 78.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 110.46 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.588 ' O ' HG23 ' A' ' 96' ' ' VAL . 46.2 t0 -50.01 -40.96 46.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.032 -1.042 . . . . 0.0 109.959 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 85' ' ' ALA . 50.7 m -60.03 -32.38 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.71 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.708 HD12 ' HB1' ' A' ' 85' ' ' ALA . 1.1 mp -72.15 -51.23 22.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.419 -0.801 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.3 t -50.17 -45.02 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.538 -0.726 . . . . 0.0 109.579 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 92' ' ' ASP . 39.1 t -61.72 -49.04 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.578 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.593 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.75 -71.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.139 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -48.77 -34.42 12.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.685 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -62.03 -20.72 64.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.54 86.15 1.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.212 -0.93 . . . . 0.0 111.124 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 49.13 97.8 0.01 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -168.19 97.5 0.43 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -1.131 . . . . 0.0 110.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.764 ' O ' HG21 ' A' ' 82' ' ' VAL . 10.7 ttm180 -71.93 137.08 47.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.49 -0.756 . . . . 0.0 109.567 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.977 HD23 HG13 ' A' ' 82' ' ' VAL . 1.1 mp -121.32 21.37 11.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 103' ' ' ARG . 4.8 p-10 -124.32 40.43 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.067 -1.02 . . . . 0.0 110.584 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.64 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.7 p -101.44 -171.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.64 ' H ' HG22 ' A' ' 106' ' ' VAL . 38.7 mtp180 -135.33 142.8 45.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 110' ' ' TRP . 94.0 m-20 -78.42 60.66 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 110.046 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.2 -71.18 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.756 -0.59 . . . . 0.0 111.082 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.597 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -40.57 -58.38 1.61 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.435 -0.791 . . . . 0.0 110.829 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -23.5 0.73 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -56.02 160.56 2.75 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.323 -1.104 . . . . 0.0 109.896 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 106' ' ' VAL . 36.6 mt -120.02 166.9 13.71 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 0.0 110.679 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.79 -34.92 29.44 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.806 1.424 . . . . 0.0 110.392 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 130' ' ' LEU . 9.8 p -82.78 -33.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.57 -38.37 90.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -60.15 -24.56 64.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.785 . . . . 0.0 110.14 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -83.19 -27.7 29.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.26 -40.58 70.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.7 -47.28 32.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 117' ' ' LEU . 5.2 mp -69.85 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.32 38.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 16.6 m-70 -99.3 48.99 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.277 -1.131 . . . . 0.0 109.275 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -44.31 -38.02 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.757 -0.589 . . . . 0.0 110.646 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.53 -44.67 95.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.757 HG11 ' CB ' ' A' ' 86' ' ' ALA . 22.7 t -78.67 -42.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.426 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -50.98 -41.41 59.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -63.94 1.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.52 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.7 t80 -54.0 -41.38 67.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.498 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 86' ' ' ALA . 15.5 mt -58.1 -65.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.412 ' HG2' ' HA3' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -46.84 -26.04 0.89 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.076 -1.015 . . . . 0.0 110.499 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.06 -58.58 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.05 -3.59 36.72 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.522 -0.736 . . . . 0.0 110.977 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -108.06 -39.58 5.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 109.833 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.4 -69.84 0.51 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.412 ' HA3' ' HG2' ' A' ' 131' ' ' ARG . . . 79.59 -68.34 3.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 137' ' ' THR . 9.5 t -53.96 130.86 39.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.316 -1.108 . . . . 0.0 110.489 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -85.03 -156.98 0.27 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.0 110.412 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 67.69 -91.88 0.22 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.08 -172.87 3.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.42 -1.047 . . . . 0.0 110.498 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -141.76 136.23 30.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.512 -0.742 . . . . 0.0 109.751 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.86 50.38 8.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.375 -0.828 . . . . 0.0 110.088 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -128.32 -6.06 5.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.333 -0.855 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.03 102.91 12.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.89 135.87 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.313 -0.867 . . . . 0.0 109.924 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -86.12 111.77 20.66 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.224 -0.922 . . . . 0.0 111.147 -178.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 146' ' ' ASP . . . 174.69 69.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.315 -0.866 . . . . 0.0 110.582 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 60.21 119.98 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.406 -0.809 . . . . 0.0 110.883 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.47 118.88 37.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.0 109.772 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.55 134.89 12.2 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.71 -83.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.777 1.409 . . . . 0.0 110.928 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.55 22.36 10.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.176 -0.952 . . . . 0.0 110.765 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -50.37 162.94 0.19 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.331 -0.855 . . . . 0.0 110.001 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.74 81.11 3.2 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.237 -0.915 . . . . 0.0 109.832 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.97 100.77 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.911 1.48 . . . . 0.0 110.956 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.063 179.871 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.242 0.544 . . . . 0.0 110.066 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -56.39 -63.67 3.18 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.342 -0.849 . . . . 0.0 110.94 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.526 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 47.7 Cg_endo -72.55 153.94 54.99 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.239 1.126 . . . . 0.0 110.638 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 3' ' ' PRO . . . 62.22 118.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.674 -0.641 . . . . 0.0 110.514 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.4 147.15 49.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.442 -0.786 . . . . 0.0 110.116 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.77 148.42 4.79 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.3 p -100.86 143.98 30.36 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.378 -1.072 . . . . 0.0 109.88 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.6 129.58 31.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.184 -0.947 . . . . 0.0 110.648 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.9 mtp -140.81 141.85 34.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.421 -0.799 . . . . 0.0 109.912 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.469 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -174.66 165.0 2.41 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 10' ' ' GLU . 43.3 Cg_endo -70.8 -171.07 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.759 1.399 . . . . 0.0 109.901 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.7 t -136.33 -13.9 1.77 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.257 -0.902 . . . . 0.0 110.975 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -64.46 117.45 7.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.022 -1.049 . . . . 0.0 109.698 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.8 OUTLIER -175.16 -49.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 110.75 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.508 ' CD1' ' N ' ' A' ' 15' ' ' TRP . 35.6 m0 -68.19 -4.4 13.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.657 -0.652 . . . . 0.0 111.536 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.747 HD11 ' HB1' ' A' ' 36' ' ' ALA . 25.1 mt -79.66 -52.26 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 108.825 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.42 83.92 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.029 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -75.25 -60.95 2.07 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.21 -0.931 . . . . 0.0 111.074 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -45.74 -57.68 4.07 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.159 -0.963 . . . . 0.0 110.821 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -53.53 -41.43 66.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -64.7 -33.1 75.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.712 . . . . 0.0 110.198 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 24.5 2.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.824 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.22 61.05 6.13 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.98 68.25 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.964 . . . . 0.0 109.72 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 59' ' ' VAL . 18.1 t -52.7 -54.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.539 -0.726 . . . . 0.0 110.308 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -42.74 -38.07 1.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.0 110.747 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -66.3 -51.49 56.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.719 HG12 HD13 ' A' ' 62' ' ' LEU . 5.2 t -68.62 -42.89 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.561 -0.712 . . . . 0.0 110.215 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.932 ' HA ' HD11 ' A' ' 62' ' ' LEU . 14.4 mmm180 -46.41 -48.02 18.82 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.375 -0.828 . . . . 0.0 110.277 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.24 -37.65 52.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.465 -0.772 . . . . 0.0 109.918 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 14.4 mt -59.2 -66.94 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.874 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 23.7 mt -46.93 -48.52 21.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.581 -0.699 . . . . 0.0 110.427 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.08 -18.67 65.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.608 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.53 -6.68 57.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 111.012 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.21 31.79 1.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.874 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -74.09 157.93 35.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -1.057 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.96 115.26 61.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.442 -0.786 . . . . 0.0 109.911 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' HD13 ' A' ' 37' ' ' LEU . 43.8 Cg_endo -69.45 -36.53 11.46 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.497 1.262 . . . . 0.0 110.094 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -108.05 61.05 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 110.221 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -104.06 99.19 15.76 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.37 -0.831 . . . . 0.0 110.364 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.24 121.02 7.41 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.546 1.288 . . . . 0.0 110.343 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -98.61 178.28 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.928 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -69.55 -6.13 28.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 110.816 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 1.95 22.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 0.0 110.695 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.23 30.76 8.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -124.5 133.83 53.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.805 -0.82 . . . . 0.0 109.906 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -50.65 168.98 0.22 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.498 -0.751 . . . . 0.0 110.745 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 69' ' ' GLU . 44.2 Cg_endo -72.32 -19.95 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.03 1.542 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.475 HG13 ' HB1' ' A' ' 68' ' ' ALA . 4.9 mt -107.03 -39.28 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.191 -0.943 . . . . 0.0 109.798 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 8.5 mt-30 -50.16 -22.11 1.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.585 HG22 ' HB2' ' A' ' 21' ' ' ALA . 13.4 p -113.21 34.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.033 . . . . 0.0 110.584 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.722 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -96.19 35.28 1.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.724 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.9 tmm? 72.39 -10.45 0.92 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.656 -0.652 . . . . 0.0 110.614 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.567 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 44.61 28.47 0.33 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.982 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -137.0 16.91 3.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.544 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.6 m -150.04 75.38 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -1.087 . . . . 0.0 109.579 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -43.85 -34.3 1.57 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 0.0 110.673 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -48.91 -40.22 29.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.49 -0.756 . . . . 0.0 109.812 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 25' ' ' VAL . 19.4 t -62.4 -55.69 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.722 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.56 -54.55 3.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.626 -0.671 . . . . 0.0 109.92 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.558 ' O ' HD23 ' A' ' 65' ' ' LEU . 1.9 tt0 -49.75 -43.86 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.673 -0.642 . . . . 0.0 110.136 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.932 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -53.66 -73.36 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.125 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.978 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 34.2 mt -58.84 -49.26 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.698 . . . . 0.0 109.533 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.831 HD22 HG12 ' A' ' 96' ' ' VAL . 3.0 tt -48.42 -67.45 0.27 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.509 -0.745 . . . . 0.0 110.705 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -56.83 -19.51 17.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.347 -0.846 . . . . 0.0 110.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -85.06 -44.35 13.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.404 -0.81 . . . . 0.0 109.777 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.93 37.7 0.11 Allowed Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.978 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.8 -147.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.867 -1.372 . . . . 0.0 109.141 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 2.3 mt-10 -121.07 67.07 15.6 Favored Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 121.625 -0.672 . . . . 0.0 109.392 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CB ' HD23 ' A' ' 97' ' ' LEU . 45.2 Cg_endo -70.44 -7.9 22.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.971 1.511 . . . . 0.0 110.259 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -118.81 -72.85 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.376 -0.828 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.2 t -42.27 149.11 0.17 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.375 -0.828 . . . . 0.0 110.541 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . . . -132.36 -144.86 0.25 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.811 . . . . 0.0 110.405 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -103.72 139.07 19.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.578 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.63 2.23 7.63 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.444 1.234 . . . . 0.0 110.486 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.46 -56.02 3.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 109.148 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.617 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -129.26 19.05 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.751 -0.593 . . . . 0.0 109.576 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER 44.08 43.58 5.67 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.627 -0.671 . . . . 0.0 111.559 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.418 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 81.0 m -69.96 104.45 2.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 109.857 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.745 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -69.45 148.79 97.19 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.914 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.633 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.2 Cg_endo -64.66 -14.89 47.19 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.519 1.273 . . . . 0.0 108.919 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.402 HG13 HD23 ' A' ' 104' ' ' LEU . 72.2 t -67.04 -35.4 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.578 0.704 . . . . 0.0 109.221 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.426 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 24.0 m80 -65.38 -38.14 89.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.468 0.651 . . . . 0.0 109.501 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.567 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -55.13 -50.42 69.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.746 -0.596 . . . . 0.0 110.951 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -56.73 -64.38 0.89 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.978 -1.076 . . . . 0.0 108.725 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.825 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -53.33 -38.34 63.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.45 -0.781 . . . . 0.0 110.259 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.7 OUTLIER -49.55 -38.77 32.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.614 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.79 8.79 39.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 110.437 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 65.15 30.04 76.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -95.01 82.05 3.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.522 -0.987 . . . . 0.0 110.654 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.47 -42.39 74.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.832 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 96' ' ' VAL . 73.4 m-20 -47.33 -50.81 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 85' ' ' ALA . 3.1 m -53.82 -45.8 70.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.407 -0.808 . . . . 0.0 109.855 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.687 HD12 ' HB1' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -58.81 -44.89 90.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.742 . . . . 0.0 110.007 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 91' ' ' LEU . 21.4 t -56.7 -44.61 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.831 HG12 HD22 ' A' ' 64' ' ' LEU . 6.3 t -57.2 -54.49 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.589 ' HA ' HD11 ' A' ' 64' ' ' LEU . 13.3 mt -49.4 -51.0 37.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.679 -0.638 . . . . 0.0 110.16 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.66 -30.36 65.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.4 mtp180 -61.38 -14.02 24.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -123.33 -86.33 0.64 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.03 94.5 0.12 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.19 107.37 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 110.591 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -69.62 143.11 53.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.713 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.548 HD13 ' HB1' ' A' ' 133' ' ' ALA . 2.1 mp -123.18 37.07 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.417 -0.802 . . . . 0.0 109.763 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.02 34.22 4.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.365 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.745 HG11 ' CG ' ' A' ' 80' ' ' ARG . 13.0 p -102.6 173.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.946 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.548 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -124.91 148.15 48.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -69.4 66.22 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 0.0 109.883 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 65.51 -61.72 0.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.509 -0.744 . . . . 0.0 109.964 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.617 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.8 m-90 -70.2 -83.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 107' ' ' ARG . . . -170.06 21.62 0.08 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.442 ' C ' HD22 ' A' ' 113' ' ' LEU . 9.9 mtm180 -84.29 136.8 33.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.06 -1.259 . . . . 0.0 109.931 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 106' ' ' VAL . 4.0 mm? -104.98 165.9 12.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.635 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.433 ' C ' HD13 ' A' ' 130' ' ' LEU . 46.2 Cg_endo -71.73 -38.86 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.841 1.443 . . . . 0.0 109.838 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 127' ' ' ALA . 9.8 p -64.98 -35.91 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 0.0 111.225 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.407 ' N ' HG13 ' A' ' 115' ' ' VAL . 14.6 t0 -61.09 -47.71 85.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 111.268 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.598 HD23 ' CD1' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -52.46 -49.57 64.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.196 -0.94 . . . . 0.0 110.939 -179.017 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.771 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -53.26 -50.25 65.2 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.235 -0.916 . . . . 0.0 110.736 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -56.86 -51.83 67.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.996 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -61.54 -57.94 10.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.466 -0.771 . . . . 0.0 110.193 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.598 ' CD1' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -59.35 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.368 -0.832 . . . . 0.0 110.419 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.59 34.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.2 m-70 -107.33 53.39 0.69 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.434 -1.039 . . . . 0.0 109.288 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -47.62 -36.7 11.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.533 -0.729 . . . . 0.0 110.069 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.413 ' C ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -58.23 -44.98 88.5 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.95 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.825 HG11 ' CB ' ' A' ' 86' ' ' ALA . 20.2 t -80.27 -42.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.771 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -52.25 -44.81 65.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 109.676 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -65.27 -64.57 0.83 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.278 -0.888 . . . . 0.0 109.323 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -47.51 -40.66 19.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.655 . . . . 0.0 110.06 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.591 ' CD1' HG12 ' A' ' 126' ' ' VAL . 14.2 mt -63.28 -55.03 28.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.544 -0.723 . . . . 0.0 110.083 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.32 -27.08 0.61 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.512 -0.742 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.19 -62.94 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.036 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.548 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -68.9 -6.09 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.317 -0.864 . . . . 0.0 111.026 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -108.37 0.8 21.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.101 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.78 71.81 0.05 OUTLIER Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -88.92 27.45 7.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.8 p -90.46 -2.73 57.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.251 . . . . 0.0 110.323 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.5 mtp-105 60.9 -153.64 0.37 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.363 -0.836 . . . . 0.0 110.378 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.02 -96.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.4 p -96.07 -140.05 0.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.316 -1.108 . . . . 0.0 110.05 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.16 117.09 26.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.001 . . . . 0.0 109.925 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.19 -72.96 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.871 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 144' ' ' ARG . . . -64.54 -157.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.44 -0.787 . . . . 0.0 109.629 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 143' ' ' ALA . 3.7 ttt180 61.18 142.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.377 -0.827 . . . . 0.0 110.375 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 145' ' ' ILE . 3.6 tp -98.42 112.36 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.284 -0.885 . . . . 0.0 109.968 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -50.66 93.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 145' ' ' ILE . . . -44.59 119.13 1.78 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.503 -0.748 . . . . 0.0 110.85 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.4 132.52 20.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.56 -0.712 . . . . 0.0 110.185 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.59 -1.29 15.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 110.574 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.79 125.36 4.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.37 109.69 2.67 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.46 1.242 . . . . 0.0 110.37 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.18 2.43 2.78 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.43 -0.794 . . . . 0.0 111.518 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.461 ' C ' HD12 ' A' ' 154' ' ' ILE . 0.7 OUTLIER 50.18 -177.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.054 -1.029 . . . . 0.0 110.697 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 154' ' ' ILE . 5.4 mp -135.59 94.15 15.42 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.32 126.99 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.663 1.349 . . . . 0.0 110.624 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.145 179.764 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.185 0.517 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.87 131.23 23.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.394 -0.817 . . . . 0.0 109.931 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.92 117.71 4.56 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.702 1.369 . . . . 0.0 110.547 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.05 156.03 21.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 0.0 110.093 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.85 -160.21 1.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.411 -0.806 . . . . 0.0 110.177 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.43 65.19 3.42 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 p 50.13 -173.32 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.617 -0.931 . . . . 0.0 110.385 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.2 p -83.12 -178.51 7.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 109.927 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.7 mtm -58.11 -171.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.22 -0.925 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -47.72 123.19 9.37 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.316 -0.865 . . . . 0.0 110.557 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -74.29 -179.47 4.78 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.516 1.272 . . . . 0.0 110.894 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 13' ' ' ALA . 1.6 t -65.09 -177.47 0.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.693 . . . . 0.0 110.016 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . -93.31 55.09 2.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.367 -0.833 . . . . 0.0 110.381 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.12 -36.08 78.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.353 -0.842 . . . . 0.0 110.285 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.51 ' CE3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -43.03 -36.26 1.53 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.523 -0.736 . . . . 0.0 110.468 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.733 ' CD1' ' HB1' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -49.88 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' H ' ' HB3' ' A' ' 16' ' ' LEU . . . -47.41 -52.67 16.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.625 -0.672 . . . . 0.0 111.394 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 4.8 p -40.57 -61.01 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.34 -0.85 . . . . 0.0 111.137 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.657 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.19 -53.59 54.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -54.37 -44.28 72.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.65 -17.65 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.647 -0.658 . . . . 0.0 110.276 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -100.67 19.9 16.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.366 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.4 53.67 39.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.595 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -127.64 96.24 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' CZ ' ' A' ' 29' ' ' ARG . 24.4 t -74.56 -44.49 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.292 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.19 -45.63 90.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 110.729 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.836 ' O ' HD12 ' A' ' 31' ' ' LEU . 2.2 mt-10 -53.05 -44.76 67.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.357 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.931 HG12 HD12 ' A' ' 32' ' ' LEU . 4.7 t -75.97 -46.61 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.724 . . . . 0.0 109.936 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HD2' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.93 -44.89 40.88 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.305 -0.872 . . . . 0.0 110.204 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.51 61.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.571 -0.705 . . . . 0.0 110.232 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.1 mt -65.44 -67.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.931 HD12 HG12 ' A' ' 28' ' ' VAL . 2.7 mt -47.43 -33.64 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -30.4 68.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.94 -6.68 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.845 . . . . 0.0 110.193 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.27 30.88 3.22 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.1 162.42 1.96 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.289 -1.124 . . . . 0.0 109.929 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' A' ' 37' ' ' LEU . 13.1 tp -80.28 127.33 76.73 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.393 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.36 -29.58 13.69 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.765 1.403 . . . . 0.0 110.407 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -132.91 81.08 1.92 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HA ' HD23 ' A' ' 37' ' ' LEU . . . -97.66 129.43 31.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 110.221 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.63 93.41 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.562 1.296 . . . . 0.0 110.259 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -66.8 -167.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.244 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.64 2.77 41.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.895 . . . . 0.0 110.544 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -105.26 23.1 14.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.121 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.45 23.57 19.95 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -124.02 -164.52 1.25 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.48 -1.012 . . . . 0.0 110.087 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.557 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -139.88 -174.39 0.41 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 108.997 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HB2' HD13 ' A' ' 63' ' ' LEU . 38.9 Cg_endo -66.2 160.82 43.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.127 1.067 . . . . 0.0 109.965 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt 68.43 -59.61 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.613 -0.679 . . . . 0.0 110.008 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -51.78 -21.16 2.58 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.82 -1.175 . . . . 0.0 110.015 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 51' ' ' VAL . 14.4 p -125.2 9.81 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.383 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.514 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 2.6 ptt? -69.59 159.74 32.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.993 -1.067 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -46.65 -24.74 0.59 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.569 -0.707 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.508 ' HE3' ' HE3' ' A' ' 52' ' ' MET . 0.0 OUTLIER 64.54 14.44 8.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.914 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.44 14.63 27.65 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.637 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -149.24 87.22 1.51 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.59 -0.947 . . . . 0.0 109.818 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -53.55 -23.09 9.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.85 . . . . 0.0 110.03 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -60.29 -35.35 75.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 110.001 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 56' ' ' SER . 57.4 t -59.56 -49.09 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.61 -55.44 25.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.792 . . . . 0.0 110.043 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.55 ' O ' HD23 ' A' ' 65' ' ' LEU . 2.2 tm-20 -49.76 -41.53 44.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.094 -1.004 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.672 ' CD1' HD13 ' A' ' 32' ' ' LEU . 2.6 tp -69.03 -57.18 5.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.302 -0.874 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 6.8 mt -65.71 -41.02 92.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.919 HD13 HG12 ' A' ' 96' ' ' VAL . 2.9 tt -59.46 -65.4 0.68 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 110.938 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.75 HD12 ' C ' ' A' ' 65' ' ' LEU . 3.5 pp -52.9 -24.56 9.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 109.697 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.838 ' CB ' HD22 ' A' ' 32' ' ' LEU . 1.3 m80 -80.79 -41.99 22.46 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.541 -0.724 . . . . 0.0 109.941 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.56 41.11 0.1 OUTLIER Glycine 0 N--CA 1.482 1.76 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.787 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -68.2 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.986 -1.302 . . . . 0.0 109.737 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 4.3 tp10 -120.96 57.12 5.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.331 -0.856 . . . . 0.0 110.217 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 48.9 Cg_endo -72.14 -25.42 19.13 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.885 1.466 . . . . 0.0 110.341 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 103' ' ' ARG . 2.3 m-20 -100.06 -76.81 0.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 0.0 110.137 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 162.91 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.568 -0.707 . . . . 0.0 110.41 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -140.53 -132.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -0.842 . . . . 0.0 110.196 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 78' ' ' LEU . 41.6 t0 -121.18 129.8 25.11 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 -7.95 22.46 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.369 1.194 . . . . 0.0 110.592 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.45 -49.58 11.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.01 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.606 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -134.72 24.5 3.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.55 -0.719 . . . . 0.0 110.072 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 78' ' ' LEU . 7.7 mt 41.86 31.63 0.23 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.697 -0.627 . . . . 0.0 110.749 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.6 m -67.61 86.56 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.818 . . . . 0.0 110.236 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.845 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.56 167.78 20.78 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 109.787 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 51.1 Cg_endo -73.46 -2.68 12.49 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.433 1.228 . . . . 0.0 110.913 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.004 HG13 HD23 ' A' ' 104' ' ' LEU . 36.1 t -78.25 -27.45 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 110.092 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 19.9 m80 -74.19 -39.32 63.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.885 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD2' ' HA ' ' A' ' 81' ' ' PRO . 50.2 m-20 -55.02 -56.0 24.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.645 -0.659 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.35 -63.01 1.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.747 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.814 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -52.65 -54.25 35.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.873 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -47.66 -39.52 17.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.394 -0.816 . . . . 0.0 110.803 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.62 12.6 20.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.97 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 55.59 56.16 25.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -129.63 90.6 3.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.468 -1.019 . . . . 0.0 111.223 -178.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.697 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -73.41 -35.0 65.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.792 . . . . 0.0 109.665 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -47.58 -47.98 28.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.673 -0.642 . . . . 0.0 109.779 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 m -64.11 -41.64 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.718 HD21 ' CB ' ' A' ' 130' ' ' LEU . 1.6 tp -52.86 -55.09 25.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.6 -0.687 . . . . 0.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 87.2 t -48.92 -46.26 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.72 -0.613 . . . . 0.0 109.433 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.919 HG12 HD13 ' A' ' 64' ' ' LEU . 49.9 t -58.52 -53.31 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.512 0.672 . . . . 0.0 109.402 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.922 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -48.72 -52.74 22.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.551 -0.718 . . . . 0.0 110.071 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -74.05 -21.84 59.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 109.817 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.9 ttp180 -64.24 -16.73 62.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.495 -0.753 . . . . 0.0 110.474 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.592 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -134.1 -76.85 0.47 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.0 100.52 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.922 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -152.01 94.94 2.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -1.046 . . . . 0.0 110.526 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -55.66 108.2 0.41 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.249 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.004 HD23 HG13 ' A' ' 82' ' ' VAL . 2.0 mt -98.9 32.38 2.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.04 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.47 44.64 2.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 0.0 110.373 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.845 HG11 ' HB2' ' A' ' 80' ' ' ARG . 9.5 p -111.21 -178.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.635 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.9 mtp85 -122.83 -176.67 3.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 44.4 p-10 -104.46 36.28 2.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.901 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 66.35 3.7 2.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 110.945 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.606 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 3.6 m-90 -123.65 -57.96 1.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.981 -1.074 . . . . 0.0 109.959 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.83 -30.4 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.44 165.4 4.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -1.036 . . . . 0.0 110.831 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 117' ' ' LEU . 42.3 mt -128.82 169.62 12.57 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.644 -0.66 . . . . 0.0 109.278 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.96 -13.87 37.5 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.454 1.239 . . . . 0.0 109.806 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 130' ' ' LEU . 4.6 p -90.56 -40.09 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 110.657 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -57.01 -43.18 81.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.354 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -56.54 -53.19 60.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.861 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.573 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -53.36 -53.89 44.59 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -49.46 -30.45 8.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.0 109.94 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 28.2 mm-40 -85.15 -59.12 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.565 -0.71 . . . . 0.0 109.544 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 110.053 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.68 28.34 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 12.0 m-70 -97.98 47.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.028 -1.278 . . . . 0.0 109.159 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.91 -40.92 6.73 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.606 0.717 . . . . 0.0 109.547 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.545 ' OD2' HG23 ' A' ' 126' ' ' VAL . 5.3 p-10 -61.74 -46.79 88.13 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.039 -0.665 . . . . 0.0 109.635 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.814 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -76.17 -40.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 109.777 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.573 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -52.81 -62.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.348 -0.845 . . . . 0.0 110.341 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -47.02 -61.27 1.95 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.504 -0.748 . . . . 0.0 111.303 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.697 ' CG ' HD21 ' A' ' 91' ' ' LEU . 14.8 t80 -56.64 -63.55 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.896 . . . . 0.0 110.62 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.718 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.29 -19.92 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 110.514 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.511 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -75.4 -40.62 57.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.036 -1.04 . . . . 0.0 110.148 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.55 77.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.61 -15.94 31.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.716 -0.615 . . . . 0.0 109.819 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -111.78 27.9 9.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.331 -0.855 . . . . 0.0 110.397 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.45 -103.9 0.19 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.17 -67.56 1.44 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.4 p -59.82 112.68 1.93 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.277 -1.131 . . . . 0.0 110.021 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.27 73.24 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 110.158 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 77.14 -142.55 27.51 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.57 -179.13 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.378 -1.072 . . . . 0.0 110.343 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -131.5 -43.03 1.03 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -138.27 -170.46 2.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.41 -0.806 . . . . 0.0 110.06 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 44.95 62.17 2.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.503 -0.748 . . . . 0.0 110.642 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -58.07 171.41 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 110.125 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.5 tp -77.96 137.76 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.459 -0.776 . . . . 0.0 109.906 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -43.49 110.81 0.22 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 110.704 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.4 133.39 24.53 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.787 . . . . 0.0 110.321 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.99 116.56 2.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.443 -0.786 . . . . 0.0 110.476 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -91.42 117.45 29.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 64.52 156.03 0.17 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.23 134.55 10.36 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.722 1.38 . . . . 0.0 110.421 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.08 116.18 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.331 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.01 54.64 0.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 79.0 mt -113.86 95.97 39.54 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.409 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.57 126.17 15.04 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.571 1.3 . . . . 0.0 110.065 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.2 t0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.55 -179.58 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.077 0.465 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -119.45 105.5 43.87 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.222 -0.924 . . . . 0.0 110.412 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.593 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 46.4 Cg_endo -71.47 138.07 31.86 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.64 1.337 . . . . 0.0 111.087 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . 172.78 111.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.427 -0.795 . . . . 0.0 109.793 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.88 56.59 0.43 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 110.252 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.15 163.42 20.97 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.3 p -94.05 -1.2 54.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.375 -1.073 . . . . 0.0 110.611 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 10' ' ' GLU . 27.8 p -82.3 104.43 12.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.93 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.1 ttp -54.32 91.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.46 -0.775 . . . . 0.0 110.7 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 8' ' ' SER . 2.0 mp0 49.42 91.34 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.471 -0.768 . . . . 0.0 110.554 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.8 83.05 1.63 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.697 1.367 . . . . 0.0 109.901 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.69 -67.48 0.98 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 111.021 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.51 22.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.392 -0.817 . . . . 0.0 110.118 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 20.2 p-10 -100.17 3.74 43.96 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.408 -0.808 . . . . 0.0 110.579 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.596 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.8 m0 -54.42 -21.03 8.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.803 HD11 HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -75.62 -42.33 51.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.452 -0.78 . . . . 0.0 109.403 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.93 -45.12 28.92 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.823 . . . . 0.0 109.895 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -47.23 -56.26 7.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.571 -0.705 . . . . 0.0 110.434 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.83 91.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 110.163 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.96 -53.81 47.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -58.5 -29.31 66.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.422 -0.799 . . . . 0.0 110.436 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.85 23.86 2.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.587 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 49.82 44.62 39.99 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -109.09 93.55 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -1.11 . . . . 0.0 110.017 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 58' ' ' ARG . 5.1 t -75.1 -46.46 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 110.192 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -32.92 70.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 1.6 tp10 -74.03 -46.45 43.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 0.0 109.766 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.537 HG21 HG13 ' A' ' 59' ' ' VAL . 51.4 t -64.94 -46.89 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 1.077 ' HA ' HD12 ' A' ' 62' ' ' LEU . 46.3 mmm-85 -55.21 -46.76 75.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.053 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.34 56.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 0.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 13.0 mt -61.15 -63.01 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.945 . . . . 0.0 110.49 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.92 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 1.4 mt -49.18 -43.27 42.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.392 -0.817 . . . . 0.0 110.476 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -71.09 -13.36 61.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.88 -10.17 37.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.194 -0.941 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.01 -2.83 5.57 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.333 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.92 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -53.69 103.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.03 -1.276 . . . . 0.0 109.896 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 17.3 tp -50.5 123.4 17.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.494 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 40.8 Cg_endo -67.84 -43.44 5.2 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.598 1.315 . . . . 0.0 110.489 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -91.07 54.13 2.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.12 -0.988 . . . . 0.0 109.817 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -104.8 93.95 6.84 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.771 . . . . 0.0 110.612 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.17 97.11 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.588 1.309 . . . . 0.0 110.034 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -63.7 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.315 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.12 36.42 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -0.887 . . . . 0.0 110.319 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -7.76 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 111.073 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 24.48 19.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.44 32.45 5.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.541 -0.976 . . . . 0.0 109.369 -179.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mmt180 49.77 179.76 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 49.7 Cg_endo -86.44 -13.69 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.155 1.082 . . . . 0.0 111.065 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 63' ' ' LEU . 5.2 mt -107.69 -43.05 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.95 -1.094 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 1.5 tt0 -46.24 -28.91 1.4 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 21' ' ' ALA . 7.1 p -109.32 40.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.599 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -99.48 30.38 3.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 109.669 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.587 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 7.3 tmm? 64.65 -4.7 0.43 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.724 -0.61 . . . . 0.0 111.292 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.599 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 13.0 mmt 42.39 28.64 0.12 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.41 6.89 8.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.662 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -145.75 87.34 1.77 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 110.115 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -54.01 -30.84 49.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.805 . . . . 0.0 109.545 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.606 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -54.12 -37.47 64.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.574 -0.704 . . . . 0.0 109.273 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.682 ' O ' HD12 ' A' ' 63' ' ' LEU . 99.0 t -59.84 -61.17 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -54.75 -25.61 28.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.545 -0.722 . . . . 0.0 109.104 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 58' ' ' ARG . 5.2 tm-20 -53.54 -72.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.302 -0.874 . . . . 0.0 110.045 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.077 HD12 ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.56 -36.57 71.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.778 -1.201 . . . . 0.0 109.393 179.279 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 16' ' ' LEU . 1.1 mt -58.09 -63.41 1.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.447 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.728 HD13 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.38 -31.37 71.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.421 -0.799 . . . . 0.0 109.248 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 26.0 tp -68.78 -48.34 63.9 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.517 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.91 -16.08 58.5 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.423 -0.798 . . . . 0.0 109.951 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.5 63.63 0.58 Allowed Glycine 0 N--CA 1.483 1.825 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.618 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -79.71 -146.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.945 -1.327 . . . . 0.0 109.145 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mm-40 -117.14 55.07 1.53 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.285 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 49.2 Cg_endo -70.72 -14.07 32.75 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.497 1.262 . . . . 0.0 110.95 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -103.65 -76.44 0.59 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.127 -0.983 . . . . 0.0 110.262 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.61 144.17 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . . . -119.01 -156.28 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.924 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -102.7 144.18 28.1 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.951 . . . . 0.0 110.441 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.94 -17.08 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.614 1.323 . . . . 0.0 110.327 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.66 -78.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.714 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.687 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 34.8 p -115.06 27.36 9.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.143 -0.973 . . . . 0.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.1 mt 46.64 31.06 1.27 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 111.117 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -67.09 100.37 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.581 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -75.86 165.48 52.88 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.315 -0.866 . . . . 0.0 109.513 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HD2' ' HG2' ' A' ' 80' ' ' ARG . 47.4 Cg_endo -71.54 -11.51 28.27 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.637 1.335 . . . . 0.0 109.625 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 114' ' ' PRO . 77.2 t -69.5 -46.39 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.436 -0.79 . . . . 0.0 109.93 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 39.9 m80 -52.03 -49.63 63.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.424 -0.797 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 7.0 m-20 -42.54 -54.67 3.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 122.02 -0.425 . . . . 0.0 111.437 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.508 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -53.29 -62.69 1.49 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.914 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -63.18 -26.15 68.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.564 -0.71 . . . . 0.0 110.686 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -62.35 -28.44 69.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.018 -1.051 . . . . 0.0 109.947 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.433 ' C ' ' CE1' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -109.05 -20.82 12.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.404 -0.81 . . . . 0.0 110.089 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.735 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 94.39 32.6 7.27 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.906 -1.677 . . . . 0.0 108.906 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.556 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -99.46 88.05 3.77 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 110.406 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.612 HD11 ' CD2' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -60.6 -39.08 86.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 110.432 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 31.8 m-20 -46.85 -46.15 20.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 110.081 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.5 m -61.47 -46.42 90.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.564 -0.71 . . . . 0.0 110.055 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.624 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -51.31 -57.91 7.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.38 -0.825 . . . . 0.0 110.481 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.34 -50.67 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.284 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.728 HG12 HD13 ' A' ' 64' ' ' LEU . 57.7 t -55.37 -51.07 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.532 -0.73 . . . . 0.0 110.358 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 1.1 mp -51.46 -55.66 17.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -71.7 -42.41 67.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.369 -0.832 . . . . 0.0 110.882 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -7.35 6.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -132.77 -59.16 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.931 -1.106 . . . . 0.0 110.74 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.85 108.78 0.28 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -173.03 133.62 0.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -1.167 . . . . 0.0 110.915 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -97.23 80.79 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.611 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.4 mp -69.91 67.88 0.28 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.0 110.011 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -168.02 33.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.314 -0.866 . . . . 0.0 110.43 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.2 p -105.9 -170.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.925 -1.11 . . . . 0.0 109.996 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 106' ' ' VAL . 30.5 mtt180 -131.29 147.52 52.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 35.7 t0 -79.1 54.89 1.71 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.687 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 58.6 -69.06 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.74 -0.6 . . . . 0.0 110.635 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.686 ' CH2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -41.22 -48.65 3.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.71 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.38 -33.88 1.54 Allowed Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.452 ' HD2' ' HB2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -56.58 156.35 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -1.064 . . . . 0.0 110.35 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 117' ' ' LEU . 29.9 mt -105.9 168.03 8.82 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.489 -0.757 . . . . 0.0 110.412 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 82' ' ' VAL . 38.8 Cg_endo -65.81 -27.96 51.47 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.773 1.407 . . . . 0.0 110.046 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 127' ' ' ALA . 3.4 p -77.83 -31.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.506 -0.747 . . . . 0.0 109.731 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -60.12 -49.2 78.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.448 -0.782 . . . . 0.0 110.189 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.658 ' C ' HD12 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -57.58 -57.25 13.5 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.317 -0.865 . . . . 0.0 110.356 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.914 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -51.22 -54.95 20.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.446 ' N ' ' HB2' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -49.31 -41.25 37.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.351 -0.843 . . . . 0.0 110.578 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -80.09 -26.42 39.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 0.0 110.421 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 117' ' ' LEU . 8.3 mt -81.0 2.64 26.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.275 -0.891 . . . . 0.0 110.383 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.86 17.28 73.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 22.2 m170 -94.67 53.44 1.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -1.158 . . . . 0.0 108.949 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -39.97 -59.21 1.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.222 0.535 . . . . 0.0 111.802 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.528 ' O ' HD21 ' A' ' 91' ' ' LEU . 54.8 m-20 -48.6 -39.44 23.9 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.492 -0.755 . . . . 0.0 110.393 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -80.89 -38.74 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.511 -0.743 . . . . 0.0 110.012 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -64.79 -38.99 92.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 109.553 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -73.99 -42.62 60.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.257 -0.902 . . . . 0.0 109.841 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.612 ' CD2' HD11 ' A' ' 91' ' ' LEU . 9.5 t80 -59.79 -40.63 88.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.624 ' HG ' HD21 ' A' ' 94' ' ' LEU . 19.4 mt -68.28 -42.96 78.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.509 -0.744 . . . . 0.0 109.591 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.445 ' HG3' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -58.53 -20.95 50.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.72 -47.6 11.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.881 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.71 -14.57 42.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -102.5 -64.02 1.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.397 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.8 -158.06 53.03 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.34 91.92 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.9 p -88.12 20.53 3.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.29 -1.124 . . . . 0.0 110.731 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.01 69.3 0.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.006 . . . . 0.0 109.735 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 162.7 172.82 30.65 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.1 m 57.18 168.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.403 -1.057 . . . . 0.0 110.537 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -89.39 50.3 1.9 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.168 -0.958 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.6 OUTLIER -138.39 -166.12 1.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.361 -0.837 . . . . 0.0 110.045 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' HIS . . . -178.65 126.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.422 -0.799 . . . . 0.0 109.992 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 57.9 77.61 0.28 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.481 -0.762 . . . . 0.0 111.029 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.9 pt -76.79 157.63 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.147 -0.97 . . . . 0.0 109.784 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.9 OUTLIER 58.87 168.4 0.06 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -0.995 . . . . 0.0 109.999 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . 62.84 142.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.407 -0.808 . . . . 0.0 110.25 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.79 124.08 7.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.537 -0.727 . . . . 0.0 111.264 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.2 71.53 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.892 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.33 -145.73 16.1 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -79.98 140.64 14.41 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.58 1.305 . . . . 0.0 110.329 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.4 m -86.45 103.56 15.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.525 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.56 93.51 0.16 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.349 -0.844 . . . . 0.0 109.706 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 154' ' ' ILE . 0.8 OUTLIER -123.05 92.8 48.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.503 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.62 113.24 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.596 1.314 . . . . 0.0 110.362 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.058 -179.657 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mmm . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.237 0.541 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.508 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 2.2 mt-10 -78.72 -61.19 0.54 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.499 -0.75 . . . . 0.0 111.007 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 47.8 Cg_endo -70.28 149.06 63.02 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.284 1.149 . . . . 0.0 110.653 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 3' ' ' PRO . . . 59.57 76.31 0.36 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.341 -0.849 . . . . 0.0 110.377 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.98 100.54 4.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.461 -0.774 . . . . 0.0 110.369 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.94 125.76 7.24 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -145.44 36.76 1.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -1.178 . . . . 0.0 110.104 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 t 46.39 83.88 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.566 -0.709 . . . . 0.0 110.565 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.7 ptp -119.22 -11.01 9.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 0.0 110.71 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 1.7 mp0 -61.23 130.68 91.77 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 0.0 109.732 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.28 80.68 2.44 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.454 1.239 . . . . 0.0 109.837 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.3 11.02 6.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.529 -0.732 . . . . 0.0 110.336 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . . . -82.17 -33.1 29.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 110.485 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' A' ' 18' ' ' THR . 12.1 t70 -81.91 -5.86 58.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.422 -0.799 . . . . 0.0 110.988 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -3.98 17.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.933 -1.105 . . . . 0.0 111.169 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.911 HD21 ' CB ' ' A' ' 36' ' ' ALA . 28.0 mt -81.14 -49.63 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.128 -0.983 . . . . 0.0 109.57 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.88 -46.73 67.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.675 -0.64 . . . . 0.0 110.077 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.79 -63.67 1.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.673 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -51.97 -46.02 64.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -57.63 -49.22 77.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.77 -24.86 67.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.454 -0.778 . . . . 0.0 110.694 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -90.13 26.35 1.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.784 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.91 31.11 4.0 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.619 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -104.46 94.16 5.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.617 -0.931 . . . . 0.0 110.174 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 59' ' ' VAL . 46.2 t -71.43 -54.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.592 -0.692 . . . . 0.0 110.025 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -47.82 -41.23 23.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.493 -0.755 . . . . 0.0 110.671 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 5.2 mm-40 -59.13 -54.62 44.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 24' ' ' ARG . 2.6 t -64.79 -49.67 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.619 -0.676 . . . . 0.0 109.238 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HA ' HD11 ' A' ' 62' ' ' LEU . 3.4 mmt180 -36.95 -51.61 0.92 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.347 0.594 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -78.7 -52.51 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.3 mt -48.39 -74.23 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.317 -0.864 . . . . 0.0 111.382 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.019 HD23 HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -50.1 -43.25 51.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 110.804 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.44 -10.09 59.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 0.0 110.386 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -87.33 -13.47 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.005 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.49 23.61 1.35 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.494 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.911 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -69.6 -172.95 0.53 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.259 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.53 ' H ' HD11 ' A' ' 16' ' ' LEU . 3.1 mm? -94.96 126.38 47.09 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 110.829 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 43.1 Cg_endo -71.34 -16.45 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.284 1.15 . . . . 0.0 110.225 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -137.79 48.08 2.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . . . -73.79 137.98 76.76 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.42 169.35 22.61 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.751 1.395 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -133.39 -172.13 2.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.3 m -109.14 13.04 24.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.892 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 15.7 m-85 -117.96 8.25 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.248 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.37 31.96 79.19 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -119.1 -169.58 1.76 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.459 -1.024 . . . . 0.0 110.127 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -105.95 164.72 14.4 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.8 Cg_endo -65.85 -15.73 50.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.561 1.295 . . . . 0.0 111.266 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.6 mt -109.12 -38.25 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.92 . . . . 0.0 108.799 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 2.8 mt-30 -49.96 -23.55 2.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.328 -0.858 . . . . 0.0 110.41 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 21' ' ' ALA . 11.1 p -110.98 36.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.456 -0.777 . . . . 0.0 110.537 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.545 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 0.1 OUTLIER -96.8 32.25 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.955 -1.09 . . . . 0.0 110.198 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.443 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 6.7 tmm? 64.98 -3.26 0.61 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.654 -0.654 . . . . 0.0 110.568 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.549 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 39.88 32.71 0.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.429 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -122.15 -3.23 9.82 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -145.6 85.95 1.72 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 110.212 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.6 -25.74 11.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -49.81 -43.38 48.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.725 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 25' ' ' VAL . 5.9 t -60.21 -54.79 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -48.63 -35.63 14.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.641 -0.662 . . . . 0.0 109.333 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -49.53 76.02 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.019 HD22 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -55.06 -57.03 13.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.657 0.742 . . . . 0.0 109.157 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.81 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.4 mm? -59.93 -27.96 67.21 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.96 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.821 ' HG ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -73.42 -56.31 5.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.199 -0.938 . . . . 0.0 110.342 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -51.47 -27.08 9.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.838 0.828 . . . . 0.0 109.253 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.637 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.0 -28.58 21.33 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.627 0.727 . . . . 0.0 109.112 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.29 63.34 0.73 Allowed Glycine 0 N--CA 1.477 1.432 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.81 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -71.3 -154.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.079 -1.248 . . . . 0.0 108.664 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 47' ' ' ARG . 13.2 mt-10 -113.9 66.7 1.42 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.286 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.472 ' HB3' HD23 ' A' ' 97' ' ' LEU . 45.3 Cg_endo -69.69 -17.7 37.76 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.766 1.403 . . . . 0.0 110.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.432 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.4 t30 -98.02 -58.61 1.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -0.826 . . . . 0.0 110.501 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 30.7 t -47.0 147.95 1.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.9 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.92 -144.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.797 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.8 140.87 24.51 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.241 -0.912 . . . . 0.0 109.96 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -20.03 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.257 1.135 . . . . 0.0 109.919 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.22 -57.8 4.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 110.237 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.857 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -131.72 29.01 4.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 78' ' ' LEU . 6.1 mt 41.29 38.76 0.84 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.539 -0.726 . . . . 0.0 111.201 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.2 m -72.8 98.28 2.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.949 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.786 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -78.0 163.2 64.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.927 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.4 Cg_endo -69.07 -3.99 12.67 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.414 1.218 . . . . 0.0 110.393 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 104' ' ' LEU . 31.2 t -74.99 -29.48 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 2.2 m80 -74.67 -33.21 62.44 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -55.15 -59.67 4.45 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.341 0.591 . . . . 0.0 110.033 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.668 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -53.99 -61.56 2.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.388 -0.82 . . . . 0.0 109.76 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.799 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -54.99 -58.8 6.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 3.3 ttt180 -46.5 -28.16 1.32 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.279 -0.888 . . . . 0.0 110.894 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.482 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 1.8 tm-20 -103.3 1.99 33.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 111.044 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.476 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 64.38 58.93 9.09 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.47 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -134.23 86.75 2.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 110.339 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -58.21 -44.38 88.14 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.566 -0.709 . . . . 0.0 110.077 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 96' ' ' VAL . 22.5 t0 -43.8 -46.64 7.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.541 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 52.4 m -60.21 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 97' ' ' LEU . 1.8 tp -56.8 -45.67 82.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.178 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 91' ' ' LEU . 60.5 t -55.63 -50.67 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.608 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.821 HG12 ' HG ' ' A' ' 64' ' ' LEU . 52.7 t -53.54 -53.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.345 -0.847 . . . . 0.0 110.401 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 94' ' ' LEU . 6.2 mt -50.08 -66.92 0.31 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.72 -32.61 65.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 0.0 109.853 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.7 ttp85 -67.44 -8.97 37.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.602 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.498 ' CB ' HD12 ' A' ' 64' ' ' LEU . . . -149.35 58.21 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.969 -1.082 . . . . 0.0 111.19 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.4 109.01 0.01 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -166.41 125.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.4 -1.059 . . . . 0.0 110.757 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.449 ' O ' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -69.88 114.1 7.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.424 -0.797 . . . . 0.0 109.191 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.523 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -111.06 25.01 12.21 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 110.661 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 2.0 p30 -145.19 59.8 1.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.104 -0.997 . . . . 0.0 110.355 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.786 HG11 ' HB2' ' A' ' 80' ' ' ARG . 9.2 p -108.77 -177.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.696 ' H ' HG22 ' A' ' 106' ' ' VAL . 12.9 mtt180 -132.6 132.37 42.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -72.48 60.95 0.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.445 -0.785 . . . . 0.0 110.07 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.27 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.36 -0.838 . . . . 0.0 110.451 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CH2' HG23 ' A' ' 77' ' ' THR . 0.8 OUTLIER -124.09 25.28 7.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 0.0 109.902 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -93.61 -75.99 1.32 Allowed Glycine 0 N--CA 1.48 1.605 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 2.1 mtt180 171.93 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.939 . . . . 0.0 110.072 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.439 ' CD1' ' HD2' ' A' ' 114' ' ' PRO . 2.4 mm? -104.3 170.98 5.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 44.1 Cg_endo -70.74 -22.71 27.2 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.696 1.366 . . . . 0.0 110.622 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.884 ' HB ' HD11 ' A' ' 130' ' ' LEU . 7.2 p -82.81 -39.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 110.082 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.415 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 89.3 m-20 -52.48 -38.79 60.21 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.75 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.5 mt -59.73 -58.45 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -50.93 -39.82 55.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.17 -46.41 75.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.21 -24.77 57.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -87.64 -81.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.922 . . . . 0.0 110.681 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.72 42.55 0.02 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 37.3 m-70 -106.03 52.4 0.73 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.983 . . . . 0.0 108.951 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 12.2 ptm180 -42.41 -40.88 2.7 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.201 0.524 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.496 ' O ' HD21 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -60.15 -41.01 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.268 -0.895 . . . . 0.0 108.918 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -85.0 -41.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.675 -0.64 . . . . 0.0 109.656 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -51.67 -45.62 63.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -0.805 . . . . 0.0 110.308 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -82.57 -43.69 16.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.434 -0.791 . . . . 0.0 110.278 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.752 ' CG ' HD11 ' A' ' 91' ' ' LEU . 53.8 t80 -65.23 -61.76 1.94 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.233 -0.917 . . . . 0.0 109.953 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.884 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -56.32 -31.05 63.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 110.064 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.522 ' HB2' HG21 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -66.24 -28.95 69.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.003 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.95 -39.84 65.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.006 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.93 -13.12 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 111.029 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -106.93 -35.2 6.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.975 -1.078 . . . . 0.0 111.098 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' A' ' 131' ' ' ARG . . . 175.31 90.64 0.08 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -113.78 40.29 2.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.501 HG22 ' HE ' ' A' ' 144' ' ' ARG . 61.8 p -91.44 127.24 36.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -1.137 . . . . 0.0 109.973 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -81.98 -52.56 6.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.449 -0.782 . . . . 0.0 110.182 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.79 133.42 47.8 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.4 p -59.95 -23.97 64.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.385 -1.068 . . . . 0.0 110.383 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -63.2 105.67 0.75 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.355 -0.84 . . . . 0.0 110.147 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.476 ' CG ' ' N ' ' A' ' 143' ' ' ALA . 1.0 OUTLIER -70.06 -142.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' N ' ' CG ' ' A' ' 142' ' ' HIS . . . 56.98 37.52 28.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.146 -0.971 . . . . 0.0 109.707 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.501 ' HE ' HG22 ' A' ' 137' ' ' THR . 0.2 OUTLIER -72.91 108.23 5.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.541 -0.725 . . . . 0.0 110.25 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.3 mt -83.73 135.73 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 109.379 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 t0 57.52 68.27 0.87 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.085 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -69.45 117.0 10.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.248 -0.908 . . . . 0.0 110.239 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 61.11 137.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.456 -0.778 . . . . 0.0 110.253 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.0 153.54 1.8 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.144 -0.972 . . . . 0.0 110.356 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -169.25 -144.84 4.39 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.55 157.37 61.05 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.672 1.354 . . . . 0.0 110.815 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.98 177.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.43 -0.794 . . . . 0.0 110.587 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -87.82 105.71 17.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.572 -0.705 . . . . 0.0 110.24 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 91.7 mt -129.93 78.84 74.28 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.227 -0.921 . . . . 0.0 110.463 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.05 134.5 14.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.852 1.449 . . . . 0.0 109.926 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.461 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.177 0.513 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.584 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.4 m0 -72.31 -11.46 60.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.484 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.784 HD11 ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -74.86 -58.5 3.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.441 -0.787 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.2 -49.43 77.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -43.89 -67.9 0.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.835 -0.541 . . . . 0.0 110.737 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -46.24 -51.21 14.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.33 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.604 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -46.59 -54.18 9.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.667 . . . . 0.0 110.334 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.14 -20.11 65.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.409 -0.807 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 26.4 mtm180 -99.38 22.2 10.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 111.364 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.517 ' CA ' ' HG3' ' A' ' 53' ' ' MET . . . 54.38 52.61 43.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 14.7 mmt180 -124.97 89.93 3.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.2 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 59' ' ' VAL . 81.2 t -74.36 -40.51 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.443 -0.786 . . . . 0.0 110.041 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -34.7 76.75 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.385 -0.822 . . . . 0.0 110.729 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 1.007 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.6 tp10 -61.07 -50.71 72.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.695 HG12 HD13 ' A' ' 62' ' ' LEU . 20.6 t -71.55 -48.54 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.903 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.893 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -41.18 -42.1 1.97 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 -179.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.72 -50.33 13.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.49 -0.756 . . . . 0.0 109.09 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.007 HD12 ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -61.56 -60.19 4.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.502 -0.749 . . . . 0.0 110.049 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.808 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -42.95 -46.27 5.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.75 -0.594 . . . . 0.0 110.83 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -75.53 -14.85 60.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 110.318 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.36 -8.39 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.843 . . . . 0.0 110.769 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.58 16.95 3.28 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.119 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.81 135.65 55.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.892 -1.357 . . . . 0.0 110.292 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.427 ' O ' HD23 ' A' ' 16' ' ' LEU . 32.0 tp -83.19 116.71 65.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.669 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HD2' HD12 ' A' ' 37' ' ' LEU . 43.6 Cg_endo -73.1 -36.72 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.488 1.257 . . . . 0.0 110.944 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -91.94 24.09 3.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.306 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.32 148.32 64.03 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.381 -0.824 . . . . 0.0 110.444 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.67 93.4 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.782 1.412 . . . . 0.0 110.258 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -65.43 158.89 25.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.65 -0.656 . . . . 0.0 110.356 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.9 3.51 55.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 110.65 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 11.6 m-85 -114.3 23.12 13.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 74' ' ' ASP . . . 47.18 31.22 6.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HD3' ' HG2' ' A' ' 50' ' ' GLN . 15.1 mtt-85 -114.18 -161.09 0.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.684 -0.892 . . . . 0.0 110.427 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.484 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.98 179.13 0.82 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.955 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.731 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 47.5 Cg_endo -71.21 -26.42 21.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.935 1.492 . . . . 0.0 110.126 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.535 HG23 ' HG2' ' A' ' 52' ' ' MET . 4.4 mt -109.31 -37.57 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.376 -0.828 . . . . 0.0 109.826 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HB3' ' H ' ' A' ' 47' ' ' ARG . 2.0 tt0 -49.4 -22.04 1.05 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.079 -1.013 . . . . 0.0 110.05 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.1 p -104.43 -10.28 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.454 -0.779 . . . . 0.0 110.585 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.73 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -65.08 161.54 18.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.159 -0.963 . . . . 0.0 110.557 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.517 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.54 105.82 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -62.62 -10.53 12.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.469 -0.769 . . . . 0.0 110.881 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -90.33 28.38 7.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -161.39 81.24 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -1.123 . . . . 0.0 110.07 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . . . -49.11 -24.45 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -52.47 -49.86 63.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 25' ' ' VAL . 2.7 t -56.66 -65.15 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.267 -0.896 . . . . 0.0 110.086 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.73 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -40.53 -42.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.606 -0.683 . . . . 0.0 110.008 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.64 -46.37 84.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.458 -0.776 . . . . 0.0 109.055 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.893 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -53.05 -55.2 25.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.784 ' CD2' HD11 ' A' ' 16' ' ' LEU . 2.5 mp -66.54 -43.89 83.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.853 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.764 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -64.24 -55.07 24.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.462 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 15.5 tp -49.18 -34.36 14.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.849 0.833 . . . . 0.0 108.912 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 2.7 m-70 -83.14 -35.02 25.9 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.4 58.62 0.18 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.644 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -78.05 -156.57 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 72' ' ' CYS . 1.8 mt-10 -114.92 64.42 1.61 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.466 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . 40.9 Cg_endo -67.19 -13.95 41.42 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.786 1.413 . . . . 0.0 110.409 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 0.4 OUTLIER -107.26 -57.6 2.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -48.32 150.27 1.32 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 110.751 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' HB2' ' CD ' ' A' ' 80' ' ' ARG . . . -136.54 -139.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.737 . . . . 0.0 109.757 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' LEU . 2.8 t0 -116.32 126.78 27.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.19 -8.89 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.143 1.076 . . . . 0.0 110.142 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.33 -46.87 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.588 HG22 ' CH2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -116.3 -0.52 12.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.1 mt 46.92 23.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.911 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.9 m -61.54 94.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.18 -0.95 . . . . 0.0 108.8 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.597 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -66.49 143.56 98.25 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.567 -0.708 . . . . 0.0 109.2 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 39.1 Cg_endo -66.56 -9.6 24.86 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.784 1.413 . . . . 0.0 110.142 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 104' ' ' LEU . 42.7 t -70.56 -25.12 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.675 ' HD2' HD12 ' A' ' 117' ' ' LEU . 5.9 m80 -72.78 -41.8 64.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.212 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.572 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 15.9 m-20 -47.47 -42.88 23.64 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.277 0.561 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.644 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -66.28 -65.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.959 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.798 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.58 -48.57 81.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -0.899 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.4 tmm_? -51.51 -35.69 41.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.987 -1.071 . . . . 0.0 109.872 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.513 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 2.3 tp10 -88.85 4.07 49.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.09 -1.006 . . . . 0.0 110.218 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 69.56 28.38 72.37 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.613 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -106.21 120.12 41.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.448 -1.031 . . . . 0.0 110.046 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.47 -41.27 9.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 0.0 110.01 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.789 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.2 m-20 -52.58 -25.35 10.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.905 . . . . 0.0 110.471 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.644 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 5.6 m -74.85 -45.95 39.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.191 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.703 ' CD2' HD21 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -57.96 -54.97 40.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.37 -50.68 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.394 -0.816 . . . . 0.0 109.379 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 92' ' ' ASP . 85.3 t -51.07 -55.99 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.748 -0.595 . . . . 0.0 110.162 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.476 ' HA ' HD11 ' A' ' 64' ' ' LEU . 7.6 mp -49.73 -53.51 24.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -61.62 -31.14 71.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.0 109.977 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -71.05 -11.96 61.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.935 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.741 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -140.63 66.32 1.38 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.185 -0.947 . . . . 0.0 111.004 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.87 97.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.445 ' HB3' ' C ' ' A' ' 97' ' ' LEU . . . -160.41 108.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -1.147 . . . . 0.0 110.445 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 4.7 ttt85 -64.75 128.46 35.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.325 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.61 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -119.21 19.72 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.388 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 44.8 t0 -124.48 58.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 110.077 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.71 HG22 ' H ' ' A' ' 107' ' ' ARG . 5.2 p -117.4 -175.39 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.345 -0.847 . . . . 0.0 109.731 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.71 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -139.02 127.96 23.64 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.56 -0.712 . . . . 0.0 110.235 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.537 ' OD1' ' NE2' ' A' ' 83' ' ' HIS . 1.7 m-20 -51.31 150.64 3.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 109.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 77' ' ' THR . . . -44.19 -35.76 2.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.463 -0.773 . . . . 0.0 111.034 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.588 ' CH2' HG22 ' A' ' 77' ' ' THR . 13.4 m-90 -59.57 -79.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.18 29.36 0.02 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.427 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -107.42 -165.04 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -1.21 . . . . 0.0 110.975 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.03 160.51 39.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 39.5 Cg_endo -67.66 -33.64 27.46 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.433 1.228 . . . . 0.0 110.645 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 5.4 p -78.33 -37.81 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.0 110.082 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.99 -43.64 91.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.51 -0.744 . . . . 0.0 109.978 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.675 HD12 ' HD2' ' A' ' 83' ' ' HIS . 2.9 mt -52.27 -39.29 60.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.738 ' HB3' ' HB2' ' A' ' 127' ' ' ALA . . . -69.12 -34.08 74.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.532 -0.73 . . . . 0.0 110.008 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.0 -20.08 64.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.427 ' OE2' ' NH2' ' A' ' 112' ' ' ARG . 29.2 tt0 -86.25 -57.98 2.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.706 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.487 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 6.7 mp -57.07 -81.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.008 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.3 40.41 0.02 OUTLIER Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.5 m-70 -115.09 43.39 2.0 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.43 -1.041 . . . . 0.0 109.759 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -45.65 -37.19 5.45 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -62.33 -37.46 85.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.62 -0.675 . . . . 0.0 109.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.751 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -80.93 -36.19 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . . . -68.34 -32.93 73.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.544 -0.722 . . . . 0.0 109.602 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -59.3 -66.27 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.406 -0.809 . . . . 0.0 109.741 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -52.13 -25.51 9.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.36 -0.838 . . . . 0.0 109.352 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 86' ' ' ALA . 8.7 mt -73.88 -58.82 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 110.427 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -24.06 0.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.84 -51.04 9.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.955 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.15 -13.19 53.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.0 110.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 110.715 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.829 0.347 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.591 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.9 m0 -79.78 -9.97 59.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.96 HD11 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -74.92 -50.75 15.73 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.164 -0.96 . . . . 0.0 109.354 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.46 -47.78 66.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.368 -0.833 . . . . 0.0 109.799 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -50.89 -49.81 58.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.456 -0.777 . . . . 0.0 110.411 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -59.89 -55.71 30.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -48.21 -44.25 32.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.315 -0.866 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -77.33 -32.09 54.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 111.034 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 1.1 ttt-85 -90.99 32.25 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.264 -0.898 . . . . 0.0 111.196 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 48.38 71.17 0.62 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -137.49 50.4 1.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.386 -1.067 . . . . 0.0 110.061 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.808 HG22 ' CG2' ' A' ' 59' ' ' VAL . 70.7 t -45.96 -37.41 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.459 -0.776 . . . . 0.0 110.282 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.83 -46.6 62.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.38 -44.89 89.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.315 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 62' ' ' LEU . 23.7 t -66.02 -46.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.886 . . . . 0.0 109.958 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.923 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -51.27 -46.04 62.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.07 -39.8 65.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.496 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.3 -56.31 11.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.498 -0.751 . . . . 0.0 110.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.885 HD23 ' HB3' ' A' ' 36' ' ' ALA . 14.3 mt -50.1 -50.38 48.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 110.16 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.22 -13.62 60.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.361 -0.837 . . . . 0.0 110.742 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 -11.53 36.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.977 -1.077 . . . . 0.0 111.006 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.55 37.0 0.7 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.885 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -66.84 162.36 21.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -1.125 . . . . 0.0 109.905 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.84 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 5.5 tp -92.18 115.23 64.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 0.0 109.663 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.39 -28.58 39.06 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.461 1.243 . . . . 0.0 110.195 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 28.6 m120 -129.74 66.49 1.47 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 109.753 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.84 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -88.33 108.52 22.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 47.5 Cg_endo -71.63 94.31 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.622 1.327 . . . . 0.0 110.061 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 34.2 p-10 -94.02 -174.81 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.812 . . . . 0.0 110.644 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.46 5.59 41.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 110.914 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.417 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -91.9 -5.56 53.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.83 22.84 12.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -115.03 134.74 54.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -1.064 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -60.37 169.16 1.86 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.813 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 39.6 Cg_endo -66.35 -23.23 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.542 1.285 . . . . 0.0 111.296 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.518 HG23 ' HG2' ' A' ' 52' ' ' MET . 6.1 mt -107.99 -36.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.973 -1.079 . . . . 0.0 109.065 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.478 ' HG3' ' OD2' ' A' ' 84' ' ' ASP . 2.7 tt0 -52.18 -19.85 2.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.734 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 7.2 p -110.37 2.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.72 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -76.91 165.16 25.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.999 -1.063 . . . . 0.0 110.147 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.412 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 3.3 tpp -61.1 96.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.218 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.598 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -55.82 -13.64 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.038 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -90.5 8.94 79.01 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.18 88.84 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.204 -1.174 . . . . 0.0 109.856 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -59.22 -24.34 63.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -52.15 -49.96 62.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.808 ' CG2' HG22 ' A' ' 25' ' ' VAL . 40.6 t -56.72 -56.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 110.109 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.72 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.7 -57.56 2.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.606 -0.684 . . . . 0.0 110.64 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.609 ' O ' HD23 ' A' ' 65' ' ' LEU . 11.0 tt0 -47.02 -48.87 21.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.37 -0.831 . . . . 0.0 110.232 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.923 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -49.62 -70.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.523 -0.735 . . . . 0.0 109.854 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.96 HD11 HD11 ' A' ' 16' ' ' LEU . 3.8 mt -59.96 -48.73 80.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.641 0.734 . . . . 0.0 110.024 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.868 ' HG ' HG12 ' A' ' 96' ' ' VAL . 3.4 tm? -50.96 -69.53 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.692 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.4 pp -53.01 -24.88 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 110.027 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.622 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -77.35 -55.36 5.46 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.481 -0.762 . . . . 0.0 109.319 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.02 44.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.563 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.813 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -76.05 -158.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.019 -1.283 . . . . 0.0 109.117 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.55 74.63 3.21 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.357 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.594 ' HB3' HD23 ' A' ' 97' ' ' LEU . 55.8 Cg_endo -78.69 10.15 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.955 1.502 . . . . 0.0 110.351 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.487 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -139.53 -60.92 0.55 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.43 152.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.624 -0.672 . . . . 0.0 110.316 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -143.14 -161.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.316 -0.865 . . . . 0.0 110.512 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.6 140.17 25.18 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 110.267 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 1.32 9.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.453 1.239 . . . . 0.0 110.564 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.0 -39.39 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 109.631 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.763 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -128.98 2.07 5.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.49 -0.756 . . . . 0.0 110.279 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 78' ' ' LEU . 3.3 mt 47.76 21.73 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.941 . . . . 0.0 111.684 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -59.08 102.81 0.14 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.926 -1.109 . . . . 0.0 109.115 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.854 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -77.89 159.1 76.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.757 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.417 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 42.2 Cg_endo -68.13 -13.92 39.36 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.154 1.607 . . . . 0.0 110.267 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 104' ' ' LEU . 94.8 t -68.2 -28.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.569 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.487 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.3 m80 -70.74 -44.07 67.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.598 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.11 -47.05 45.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.732 -0.605 . . . . 0.0 110.982 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -62.2 -66.23 0.57 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.562 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.868 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -54.32 -43.4 71.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.449 -0.782 . . . . 0.0 110.592 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -46.38 -41.95 14.33 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.514 -0.741 . . . . 0.0 110.559 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 1.2 mm-40 -96.59 -2.27 45.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.195 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.601 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 75.99 47.25 11.69 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -115.87 95.2 5.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.304 -1.115 . . . . 0.0 111.18 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.675 HD21 ' CD2' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.3 -36.33 79.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.534 179.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.95 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.7 m-20 -50.46 -58.59 5.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 0.0 109.357 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 92.4 m -52.77 -44.48 66.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.991 HD11 HD21 ' A' ' 130' ' ' LEU . 5.9 tp -54.89 -53.22 58.3 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.32 -40.16 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 92' ' ' ASP . 21.8 t -62.75 -40.41 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 94' ' ' LEU . 19.4 mt -63.38 -61.48 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.42 -17.66 3.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -39.01 66.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.382 -0.824 . . . . 0.0 110.963 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -118.98 70.83 0.83 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 111.457 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.65 90.78 0.01 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . . . -143.94 82.5 1.72 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -1.167 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.16 143.81 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.51 -0.744 . . . . 0.0 110.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.734 ' HA ' HG21 ' A' ' 82' ' ' VAL . 2.9 mp -129.74 0.53 4.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.654 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.68 56.65 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.245 -0.909 . . . . 0.0 110.296 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.854 HG11 ' HG3' ' A' ' 80' ' ' ARG . 1.7 p -114.99 -164.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -147.37 140.33 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.518 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 110' ' ' TRP . 45.2 t0 -68.73 63.75 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.763 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 57.06 -77.17 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.4 m-90 -45.94 -70.7 0.09 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.728 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.36 -34.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -43.73 144.79 0.76 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.651 -0.911 . . . . 0.0 110.855 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -114.67 167.03 10.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.371 -0.831 . . . . 0.0 110.464 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' A' ' 117' ' ' LEU . 40.9 Cg_endo -68.61 -34.76 18.64 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.884 1.465 . . . . 0.0 110.563 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.636 HG21 ' HG3' ' A' ' 131' ' ' ARG . 4.3 p -80.77 -23.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.767 . . . . 0.0 110.337 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.78 -44.69 40.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.638 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 117' ' ' LEU . 4.5 pp -63.0 -21.42 66.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.637 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 117' ' ' LEU . . . -77.39 -49.91 13.88 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -31.02 28.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.159 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -86.69 -51.29 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.77 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.524 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -178.46 39.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 39.0 m-70 -120.05 49.19 1.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.383 -1.069 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -53.91 11.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.728 -0.608 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.515 ' O ' HD11 ' A' ' 91' ' ' LEU . 3.0 m-20 -50.13 -34.98 24.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.488 -0.758 . . . . 0.0 109.722 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.802 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -83.41 -35.73 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.151 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -61.65 -45.33 94.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.513 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -55.23 20.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.383 -0.823 . . . . 0.0 109.446 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.675 ' CD2' HD21 ' A' ' 91' ' ' LEU . 20.5 t80 -55.19 -40.52 70.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.346 -0.846 . . . . 0.0 109.539 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.991 HD21 HD11 ' A' ' 94' ' ' LEU . 12.1 mt -64.52 -50.48 67.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 109.312 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.636 ' HG3' HG21 ' A' ' 115' ' ' VAL . 5.2 ttp180 -53.23 -27.64 23.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 0.0 110.328 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.3 -42.8 20.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.48 -11.01 50.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.416 -0.802 . . . . 0.0 110.729 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' A' ' 18' ' ' THR . 9.4 t70 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.914 0.387 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.559 ' O ' HD13 ' A' ' 31' ' ' LEU . 42.2 m0 -76.51 -8.27 56.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.211 -0.931 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 37' ' ' LEU . 1.2 tp -79.41 -50.89 10.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.31 -0.869 . . . . 0.0 109.036 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.49 46.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -63.96 -40.66 96.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.934 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.873 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -63.35 -45.5 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 108.894 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -62.68 -54.3 41.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.95 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -54.82 -22.03 13.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.548 -0.72 . . . . 0.0 110.979 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.94 27.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.943 . . . . 0.0 110.581 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.05 34.12 4.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 1.2 tpt180 -118.69 105.76 11.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.474 -1.015 . . . . 0.0 110.527 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 58' ' ' ARG . 71.6 t -72.46 -56.93 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.299 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -48.92 -26.89 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.533 -0.729 . . . . 0.0 110.909 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.873 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 3.0 mm-40 -71.52 -44.73 64.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 108.84 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.068 HG12 HD23 ' A' ' 62' ' ' LEU . 22.7 t -75.75 -52.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -0.807 . . . . 0.0 109.103 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.926 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -43.57 -50.43 7.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.599 -0.688 . . . . 0.0 110.406 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -73.02 -48.84 32.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.597 -0.689 . . . . 0.0 109.99 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 15' ' ' TRP . 13.5 mt -55.27 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 111.251 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.833 ' CB ' HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -45.64 -49.42 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.0 111.537 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -68.98 -9.1 50.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 110.804 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -102.03 -23.2 14.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.937 -1.102 . . . . 0.0 111.261 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 162.5 -28.62 0.26 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.635 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.759 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -41.87 141.03 0.9 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.286 -1.126 . . . . 0.0 110.464 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.916 ' O ' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -55.94 154.81 13.25 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.2 -38.9 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.818 1.431 . . . . 0.0 109.844 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.9 m120 -122.63 -65.54 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.58 -0.7 . . . . 0.0 109.817 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . 60.59 154.19 0.1 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.586 -0.696 . . . . 0.0 110.275 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.17 177.27 8.04 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.7 1.368 . . . . 0.0 110.171 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.7 155.62 47.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 110.077 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.42 16.14 18.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.5 23.18 34.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -110.14 174.5 5.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.714 ' O ' HG12 ' A' ' 51' ' ' VAL . 4.8 mmp_? -86.49 165.45 33.06 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 63' ' ' LEU . 42.0 Cg_endo -68.69 -12.6 35.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.773 1.407 . . . . 0.0 110.374 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.9 mt -109.37 -36.67 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 108.731 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.46 -21.72 38.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.871 -1.143 . . . . 0.0 108.979 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 47' ' ' ARG . 14.6 p -114.87 31.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.443 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.611 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -96.89 33.65 1.85 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 109.798 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.8 tmm? 72.5 -14.5 0.56 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.781 -0.574 . . . . 0.0 111.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.53 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 50.28 25.25 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.983 -1.073 . . . . 0.0 110.075 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -126.33 15.75 6.77 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.715 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -156.22 93.41 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 109.866 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.37 -22.74 33.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.347 -0.845 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.439 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -58.33 -39.57 79.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.458 -0.776 . . . . 0.0 110.16 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' A' ' 56' ' ' SER . 11.0 t -53.98 -65.17 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB1' HD12 ' A' ' 64' ' ' LEU . . . -52.72 -33.63 48.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 19.4 tt0 -47.23 -42.15 19.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.068 HD23 HG12 ' A' ' 28' ' ' VAL . 1.7 tp -82.7 -41.47 19.27 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -63.83 -62.87 1.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.629 -0.669 . . . . 0.0 109.739 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -48.54 -43.73 35.77 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.355 -0.841 . . . . 0.0 109.756 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.502 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.2 tp -58.95 -43.16 91.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.183 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CG ' HD22 ' A' ' 32' ' ' LEU . 3.5 m80 -81.06 0.03 37.78 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.729 -0.607 . . . . 0.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.11 60.13 1.98 Allowed Glycine 0 N--CA 1.48 1.609 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.83 -148.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.252 . . . . 0.0 109.014 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -115.17 52.75 0.76 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.867 . . . . 0.0 109.662 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 48.6 Cg_endo -70.77 -31.32 16.24 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.461 1.243 . . . . 0.0 109.628 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.403 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.6 OUTLIER -82.85 -75.46 0.31 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.563 -0.711 . . . . 0.0 109.139 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.13 164.43 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.566 -0.709 . . . . 0.0 110.534 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 80' ' ' ARG . . . -154.03 -126.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.027 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.2 m-20 -110.31 132.79 21.32 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.783 -1.198 . . . . 0.0 109.932 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.92 -9.91 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.313 1.165 . . . . 0.0 110.655 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.72 -74.63 0.42 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.377 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.998 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -100.3 9.11 43.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 110.473 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.3 mt 51.09 39.75 24.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -0.896 . . . . 0.0 110.318 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.418 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -64.19 96.21 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 110.019 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -73.19 148.58 88.83 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 110.636 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.7 Cg_endo -67.99 -14.49 41.25 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.699 1.368 . . . . 0.0 109.129 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.886 HG21 ' HA ' ' A' ' 104' ' ' LEU . 94.3 t -64.36 -31.51 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.425 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 26.1 m80 -67.74 -41.23 83.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.53 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 4.0 m-20 -52.35 -51.16 60.35 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.211 0.529 . . . . 0.0 110.58 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.607 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -53.52 -64.98 0.65 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.442 -0.787 . . . . 0.0 109.452 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.799 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.7 -27.9 65.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.654 ' HG2' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -54.11 -49.61 68.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.15 -0.969 . . . . 0.0 110.591 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.84 4.5 53.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 110.321 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.627 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 71.89 36.33 61.29 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -102.53 83.25 2.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.358 -1.083 . . . . 0.0 110.87 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.464 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.88 -39.06 80.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.684 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.2 m-20 -47.67 -37.43 12.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.502 -0.749 . . . . 0.0 110.006 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 97' ' ' LEU . 54.7 m -64.3 -46.59 82.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.731 HD13 HG13 ' A' ' 126' ' ' VAL . 1.2 mp -63.3 -45.11 92.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 110.138 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 55.6 t -48.79 -44.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 92' ' ' ASP . 10.9 t -67.02 -45.4 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.689 . . . . 0.0 109.147 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.842 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -53.09 -43.34 66.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.448 -0.782 . . . . 0.0 109.859 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -83.49 -33.48 25.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.074 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 5.6 ttt85 -66.09 -11.22 47.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.556 -0.715 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.442 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -132.1 -67.71 0.66 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.082 -1.012 . . . . 0.0 111.071 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.57 107.1 0.23 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.842 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -167.29 117.07 0.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.452 -1.028 . . . . 0.0 110.271 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.8 113.88 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.886 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.1 mp -106.41 25.68 10.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 110.225 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.6 p30 -128.79 47.71 2.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.365 -0.834 . . . . 0.0 110.59 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.638 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.6 p -112.14 -169.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.857 . . . . 0.0 109.961 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.638 ' H ' HG22 ' A' ' 106' ' ' VAL . 19.3 ptt180 -140.64 146.74 38.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.96 66.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 110.117 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 51.78 -84.9 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.611 -0.681 . . . . 0.0 110.67 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.998 ' CH2' HG23 ' A' ' 77' ' ' THR . 23.9 p90 -122.94 15.16 9.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.98 -81.0 1.35 Allowed Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.79 -164.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.228 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 106' ' ' VAL . 41.8 mt -95.79 163.42 21.27 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.75 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.6 -19.14 60.26 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.88 1.463 . . . . 0.0 110.379 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 116' ' ' ASP . 14.3 p -79.36 -36.59 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.824 . . . . 0.0 110.152 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 2.5 m-20 -66.95 -39.66 87.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.854 . . . . 0.0 110.353 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.654 HD21 ' HG2' ' A' ' 87' ' ' ARG . 1.4 tt -69.04 -35.74 76.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.951 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.705 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -56.07 -55.96 26.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.531 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -60.52 -41.97 95.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.803 . . . . 0.0 110.473 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.18 -37.89 67.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 109.984 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 87' ' ' ARG . 11.7 mt -86.47 -2.32 58.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 110.416 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.44 33.64 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.546 ' ND1' ' HA3' ' A' ' 89' ' ' GLY . 71.9 m-70 -102.77 46.18 0.93 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.89 -1.359 . . . . 0.0 109.56 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -45.82 -37.97 6.71 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.29 0.566 . . . . 0.0 110.346 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.418 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.6 m-20 -58.15 -42.95 87.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.725 . . . . 0.0 109.195 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 86' ' ' ALA . 13.6 t -76.09 -37.79 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.72 85.43 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -56.51 -61.34 2.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.905 . . . . 0.0 109.625 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -57.63 -24.92 59.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 109.454 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' A' ' 86' ' ' ALA . 11.3 mt -75.73 -52.87 9.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.79 . . . . 0.0 109.545 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -23.28 2.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.814 . . . . 0.0 110.169 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.24 -57.43 3.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.981 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.45 -1.65 34.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 111.013 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.55 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.832 0.349 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.498 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 31.1 m0 -40.19 -30.55 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.619 . . . . 0.0 111.012 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.035 HD11 ' HB1' ' A' ' 36' ' ' ALA . 9.8 mt -75.68 -54.57 6.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.512 -0.742 . . . . 0.0 109.144 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.41 69.43 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.783 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -73.9 -59.31 2.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.755 -0.591 . . . . 0.0 110.633 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . . . -49.67 -54.43 18.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -47.73 -50.22 25.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -36.8 82.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.184 -0.947 . . . . 0.0 109.952 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.84 15.1 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.81 72.05 0.6 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 93.0 mtt180 -136.74 67.95 1.44 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.517 -0.99 . . . . 0.0 109.739 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.763 HG22 ' CG2' ' A' ' 59' ' ' VAL . 50.4 t -57.27 -62.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.451 -0.78 . . . . 0.0 110.058 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 25' ' ' VAL . 9.3 mt-10 -39.73 -36.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.75 -0.594 . . . . 0.0 110.943 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -72.34 -50.11 29.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.554 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.99 HG12 HD13 ' A' ' 62' ' ' LEU . 43.6 t -62.58 -38.87 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.181 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.986 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -55.2 -38.44 68.4 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.855 -1.153 . . . . 0.0 108.434 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.88 12.11 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.93 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' ALA . 4.2 mt -56.35 -65.86 0.53 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 110.339 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.964 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 13.5 mt -43.42 -51.04 6.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.296 -0.877 . . . . 0.0 109.68 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 43.0 mt-10 -69.79 -15.25 63.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.61 -5.46 58.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.0 110.732 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.05 2.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.035 ' HB1' HD11 ' A' ' 16' ' ' LEU . . . -75.91 165.44 24.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.547 -0.972 . . . . 0.0 110.253 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -80.43 137.92 51.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 110.344 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 49.9 Cg_endo -76.14 -40.8 0.58 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.888 1.467 . . . . 0.0 110.323 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 25.6 m120 -101.71 -83.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.653 -0.654 . . . . 0.0 110.087 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . 57.41 69.66 1.56 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 45.4 Cg_endo -71.44 101.97 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.048 1.552 . . . . 0.0 111.708 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 3.9 p30 -178.75 -156.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.52 -0.737 . . . . 0.0 109.706 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 1.1 t 61.72 85.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.42 -0.8 . . . . 0.0 109.747 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.1 m-85 65.89 8.37 5.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 109.836 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.13 23.57 52.71 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.563 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 16.2 mmt-85 -99.62 35.49 1.98 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.07 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.517 ' CB ' ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 53.23 -178.34 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 47' ' ' ARG . 55.7 Cg_endo -82.58 -29.27 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.426 1.224 . . . . 0.0 111.337 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.627 HG13 ' HB1' ' A' ' 68' ' ' ALA . 6.4 mt -107.47 -35.53 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.517 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 20.4 tt0 -60.51 -11.72 7.79 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.019 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.563 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 12.9 p -105.79 3.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.873 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -73.11 166.28 23.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.967 -1.083 . . . . 0.0 109.024 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.3 ttm -63.87 -6.74 6.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.355 -0.841 . . . . 0.0 111.204 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.576 ' HE3' ' CB ' ' A' ' 84' ' ' ASP . 8.5 mmt 56.1 17.22 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.885 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.47 -0.65 24.82 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 88.74 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -1.027 . . . . 0.0 109.873 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -53.35 -24.55 12.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.314 -0.867 . . . . 0.0 110.651 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -48.23 70.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 108.84 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.763 ' CG2' HG22 ' A' ' 25' ' ' VAL . 67.3 t -52.4 -49.5 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -51.71 -53.51 38.54 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.669 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.0 tt0 -49.23 -47.11 46.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.715 -0.615 . . . . 0.0 110.04 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.99 HD13 HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -56.26 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 110.176 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 69.1 mt -53.67 -49.85 67.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.481 -0.762 . . . . 0.0 110.396 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.815 HD13 HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -50.7 -69.19 0.12 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.427 -0.796 . . . . 0.0 111.045 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.9 OUTLIER -51.26 -22.32 2.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.412 -0.805 . . . . 0.0 109.697 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.806 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -83.87 -49.11 9.34 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.646 -0.659 . . . . 0.0 109.596 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 154.51 39.07 0.02 OUTLIER Glycine 0 N--CA 1.478 1.46 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.744 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -71.09 -173.94 0.9 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.557 -1.555 . . . . 0.0 108.593 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 3.6 mt-10 -113.72 64.71 1.17 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.072 -1.017 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.578 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 46.3 Cg_endo -70.77 -10.31 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.093 1.575 . . . . 0.0 109.857 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.469 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 10.2 t-20 -107.89 -29.06 9.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -0.774 . . . . 0.0 109.688 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 158.71 16.94 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.652 -0.655 . . . . 0.0 110.099 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -137.24 -145.92 0.21 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.409 -0.807 . . . . 0.0 110.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.9 143.05 26.1 Favored Pre-proline 0 C--N 1.306 -1.304 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.31 -12.22 23.0 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.82 1.432 . . . . 0.0 110.019 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.86 -71.22 0.46 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.6 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -103.04 -2.53 27.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 111.017 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 mt 63.58 20.92 12.5 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.224 -0.923 . . . . 0.0 111.282 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.7 m -65.51 97.03 0.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.695 ' HG3' HG11 ' A' ' 106' ' ' VAL . 11.9 mmt85 -69.62 164.21 52.44 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.148 -0.97 . . . . 0.0 109.217 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.583 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -67.18 -21.46 48.39 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.879 1.463 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 114' ' ' PRO . 13.4 t -59.99 -27.26 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.567 0.699 . . . . 0.0 109.491 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.511 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.1 m80 -80.47 -32.09 37.23 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.576 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 5.0 m-20 -61.07 -43.03 99.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -60.32 -64.41 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.368 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.935 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -59.59 -35.32 74.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.516 -0.74 . . . . 0.0 110.107 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -45.41 -55.88 5.6 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.249 -0.907 . . . . 0.0 110.717 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.64 5.02 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.547 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 72.74 27.72 68.56 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 1.6 t80 -94.99 103.75 15.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.304 -1.115 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.52 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.96 -43.69 34.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.862 -0.524 . . . . 0.0 110.807 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.1 m-20 -44.39 -34.89 2.16 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.547 0.689 . . . . 0.0 109.748 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.475 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 95.2 m -66.37 -39.89 89.41 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.338 0.589 . . . . 0.0 109.901 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.828 HD13 HG13 ' A' ' 126' ' ' VAL . 1.0 OUTLIER -64.02 -58.28 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 40.0 t -38.21 -53.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.732 -0.605 . . . . 0.0 110.208 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.815 HG12 HD13 ' A' ' 64' ' ' LEU . 24.7 t -55.74 -56.34 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.783 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -44.35 -44.35 8.17 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.351 -0.843 . . . . 0.0 110.509 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -82.4 -26.87 32.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.1 ttt85 -65.05 -10.3 28.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.697 -0.627 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.459 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -133.11 -68.7 0.58 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 111.153 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 70' ' ' PRO . . . -174.12 107.85 0.25 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.43 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -152.39 -155.61 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.572 -0.958 . . . . 0.0 109.629 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' O ' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -162.63 105.92 1.1 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -98.9 68.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.585 -0.697 . . . . 0.0 110.812 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -175.34 42.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.695 HG11 ' HG3' ' A' ' 80' ' ' ARG . 1.4 p -107.16 -175.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 106' ' ' VAL . 2.5 mtp85 -125.8 133.83 51.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -67.05 64.23 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.752 -0.592 . . . . 0.0 110.197 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.6 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 57.87 -80.85 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.449 -0.782 . . . . 0.0 110.947 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.573 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.2 m-90 -45.68 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.0 110.266 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.24 73.05 0.06 OUTLIER Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 108' ' ' ASP . 3.9 mtt180 -134.34 -164.02 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.395 -1.062 . . . . 0.0 109.884 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.508 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -153.07 166.48 15.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 82' ' ' VAL . 43.6 Cg_endo -70.33 -54.9 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.875 1.46 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.16 -26.03 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.626 -0.671 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -62.38 -30.24 71.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.449 -0.782 . . . . 0.0 110.494 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -44.31 18.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 109.666 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.539 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -52.84 -47.03 68.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.506 ' HG2' ' HB1' ' A' ' 127' ' ' ALA . 64.5 mm-40 -63.98 -35.0 79.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.024 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.48 -25.07 50.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.772 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.639 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 42.6 mt -101.7 2.57 38.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.44 43.51 24.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 20.4 m-70 -106.63 55.52 0.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.086 -1.244 . . . . 0.0 110.154 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 12.4 mmt180 -41.05 -57.31 2.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.843 -0.536 . . . . 0.0 110.418 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.455 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -43.59 -43.98 5.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.935 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -86.9 -50.96 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.353 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.506 ' HB1' ' HG2' ' A' ' 119' ' ' GLU . . . -49.94 -50.69 45.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -62.24 -66.12 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.487 ' CD2' HD21 ' A' ' 91' ' ' LEU . 56.6 t80 -47.66 -40.58 20.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.717 . . . . 0.0 109.844 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.0 mt -60.24 -54.12 49.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.659 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -45.28 -36.72 4.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.565 -0.709 . . . . 0.0 110.656 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.82 62.3 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.598 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -83.56 -1.22 53.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.714 -0.616 . . . . 0.0 110.602 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 110.283 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 18' ' ' THR . 16.6 p30 . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.937 0.398 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.525 ' HB3' HD13 ' A' ' 31' ' ' LEU . 42.3 m0 -45.49 -43.6 11.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.593 -0.692 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 32' ' ' LEU . 12.4 mt -58.1 -58.61 7.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.0 109.158 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.4 -51.64 66.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.729 -0.607 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -51.51 -66.14 0.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.342 -0.849 . . . . 0.0 110.845 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.47 -52.2 66.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.98 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -50.4 -58.31 6.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.358 -0.839 . . . . 0.0 110.399 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -52.58 -24.55 8.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.798 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.2 7.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.43 47.81 61.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.6 mtt180 -118.62 73.03 0.9 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.443 -1.034 . . . . 0.0 109.896 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 59' ' ' VAL . 49.2 t -60.59 -60.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.334 -0.854 . . . . 0.0 111.125 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -47.63 -35.19 8.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 110.969 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -39.41 74.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.277 -0.889 . . . . 0.0 109.584 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.909 HG12 HD23 ' A' ' 62' ' ' LEU . 39.1 t -76.13 -49.84 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.187 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 1.013 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -42.32 -46.51 4.61 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.446 -0.784 . . . . 0.0 110.039 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -72.39 -51.86 18.58 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.852 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 15' ' ' TRP . 60.4 mt -51.99 -66.88 0.31 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.542 -0.724 . . . . 0.0 110.964 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -41.51 -59.24 1.66 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.707 -0.621 . . . . 0.0 111.282 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -13.44 61.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.822 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -85.04 -6.93 59.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.97 -1.082 . . . . 0.0 110.86 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.51 -10.29 6.45 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.535 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -50.92 143.6 9.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.274 . . . . 0.0 110.264 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.58 ' O ' HD11 ' A' ' 16' ' ' LEU . 5.8 mp -59.82 153.77 51.57 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.395 -0.816 . . . . 0.0 109.957 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.02 -56.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.679 1.357 . . . . 0.0 110.932 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 33.7 m120 -96.96 -66.97 0.87 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.11 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 39' ' ' ASN . . . 58.34 101.55 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 40.5 Cg_endo -68.17 122.41 9.47 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.579 1.305 . . . . 0.0 110.705 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -103.87 -166.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.592 -0.693 . . . . 0.0 109.739 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.1 38.5 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.287 -0.883 . . . . 0.0 110.519 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.551 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 18.9 m-85 -122.49 13.75 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.82 49.78 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.551 ' HD3' ' HB3' ' A' ' 44' ' ' TYR . 2.9 ptm180 -159.73 131.67 6.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -1.143 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.596 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.86 -173.66 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.668 -0.645 . . . . 0.0 110.169 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 38.5 Cg_endo -64.44 -173.7 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.196 1.103 . . . . 0.0 111.467 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.2 mt 62.97 -64.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.6 tt0 -48.08 -25.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.001 -1.062 . . . . 0.0 109.344 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 51' ' ' VAL . 12.5 p -120.7 34.18 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.611 -0.681 . . . . 0.0 109.556 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.795 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -94.11 38.25 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.0 110.068 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.45 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 7.5 tmm? 66.98 -10.62 0.3 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.509 -0.745 . . . . 0.0 110.751 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.495 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 48.56 27.76 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.989 -1.069 . . . . 0.0 110.127 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -133.05 13.76 4.95 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.676 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.1 m -144.13 78.13 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -1.044 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -50.63 -29.53 11.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 110.006 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.453 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -56.91 -31.53 65.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.618 -0.677 . . . . 0.0 109.464 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.795 HG11 ' HB2' ' A' ' 52' ' ' MET . 53.1 t -58.59 -65.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.082 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -50.76 -39.21 51.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 110.22 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -51.44 -36.91 46.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.189 -0.945 . . . . 0.0 110.038 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.013 HD22 ' HA ' ' A' ' 29' ' ' ARG . 6.9 tp -89.97 -43.8 10.31 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.455 -0.778 . . . . 0.0 109.158 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -63.7 -55.59 22.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -59.19 -47.36 85.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.335 -0.853 . . . . 0.0 109.7 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 1.7 tp -52.54 -28.35 20.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.213 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.548 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.1 m-70 -93.36 -41.36 9.88 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.551 -0.718 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.34 47.49 0.04 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.593 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.756 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -67.01 -149.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.008 -1.29 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 3.1 pt-20 -116.71 56.71 1.59 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.981 . . . . 0.0 110.872 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.787 ' HB3' HD11 ' A' ' 64' ' ' LEU . 40.1 Cg_endo -68.28 -15.04 41.86 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.635 1.334 . . . . 0.0 109.886 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -110.27 -77.9 0.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.528 -0.733 . . . . 0.0 110.095 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -43.0 145.04 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 110.95 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -128.72 -143.0 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 11.3 m-20 -112.58 134.44 21.64 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 109.978 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.54 -19.91 36.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.489 1.257 . . . . 0.0 110.062 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.54 -76.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 108.915 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.544 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 69.6 p -122.36 36.15 4.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.931 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 78' ' ' LEU . 8.7 mt 48.17 34.13 4.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.498 -0.751 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.0 101.67 0.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -85.36 173.18 7.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.47 -11.62 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.07 1.563 . . . . 0.0 110.14 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 104' ' ' LEU . 36.2 t -69.91 -30.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 26.6 m80 -73.1 -47.03 47.92 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 20.6 m-20 -47.28 -47.0 25.24 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.894 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -60.16 -59.98 4.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.827 . . . . 0.0 109.669 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.106 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -61.07 -51.52 68.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.399 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.569 ' HD3' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -41.88 -30.54 0.26 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.522 -0.736 . . . . 0.0 111.058 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.12 -18.89 15.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 110.391 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 88.84 23.81 34.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -97.0 85.02 3.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -1.067 . . . . 0.0 111.018 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.779 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -58.89 -38.39 78.74 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 13.8 m-20 -50.67 -36.99 38.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.3 m -62.96 -47.96 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.766 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -60.84 -43.61 98.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.488 -0.758 . . . . 0.0 109.68 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 91' ' ' LEU . 91.9 t -50.71 -47.67 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.366 -0.834 . . . . 0.0 109.183 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.568 HG12 HD13 ' A' ' 64' ' ' LEU . 45.2 t -60.02 -48.12 89.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' ALA . 1.7 mp -54.98 -40.96 70.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -82.9 -33.11 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.084 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -65.69 -12.2 51.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -0.775 . . . . 0.0 110.439 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.487 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -119.84 -82.15 0.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.715 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.71 56.04 0.13 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . . . -105.7 122.62 46.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -1.132 . . . . 0.0 110.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -54.87 162.13 1.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 109.849 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -149.59 36.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.301 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -150.64 40.63 0.75 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 111.34 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.649 HG22 ' H ' ' A' ' 107' ' ' ARG . 5.1 p -97.87 -176.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -130.2 146.93 51.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.341 -0.849 . . . . 0.0 109.681 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 110' ' ' TRP . 15.1 p-10 -74.53 50.36 0.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 109.851 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 61.66 -60.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.694 -0.628 . . . . 0.0 110.795 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.41 -54.94 14.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.62 -25.4 0.75 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.489 ' O ' HD12 ' A' ' 113' ' ' LEU . 4.0 ttp180 -60.87 -174.15 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.228 -1.16 . . . . 0.0 110.697 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -138.55 175.46 3.32 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.487 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 46.5 Cg_endo -73.48 -47.61 0.29 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.539 1.284 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' CG2' ' HD3' ' A' ' 131' ' ' ARG . 9.2 p -54.46 -33.0 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 0.0 109.1 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -37.72 69.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.639 -0.663 . . . . 0.0 109.321 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -30.78 67.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.217 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.106 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -69.38 -53.41 19.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -16.13 63.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.431 -0.793 . . . . 0.0 110.06 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -38.4 36.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.569 HD13 ' HD3' ' A' ' 87' ' ' ARG . 5.1 mt -92.23 1.46 57.2 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 110.955 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.06 12.87 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.617 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 80.3 m-70 -95.78 46.69 1.09 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.974 -1.309 . . . . 0.0 109.318 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -43.79 -38.1 3.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.747 -0.595 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.779 ' O ' HD11 ' A' ' 91' ' ' LEU . 15.9 p-10 -64.23 -40.8 96.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.371 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -82.94 -40.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -57.51 -53.89 53.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.082 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 mtt-85 -52.99 -59.75 4.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 110.264 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -59.32 -39.88 84.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.882 HD11 ' HB2' ' A' ' 86' ' ' ALA . 12.6 mt -60.06 -30.66 69.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.422 ' HD3' ' CG2' ' A' ' 115' ' ' VAL . 4.1 tpp180 -67.6 -36.74 81.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.875 . . . . 0.0 109.634 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.13 -35.88 36.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.448 -0.782 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.08 23.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.0 110.119 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 0.0 110.091 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.083 0.468 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.497 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 16.2 m0 -69.88 -5.5 26.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.852 HD21 ' CB ' ' A' ' 36' ' ' ALA . 30.7 mt -76.62 -54.33 6.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.981 -1.074 . . . . 0.0 109.689 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -66.16 -33.04 74.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.73 -0.606 . . . . 0.0 110.513 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -71.84 -59.99 2.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.86 -47.73 76.79 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.887 -1.133 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -47.95 -62.89 1.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.449 -0.782 . . . . 0.0 110.186 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.924 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -51.34 -24.25 4.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.233 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -90.27 28.86 1.34 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.521 -0.737 . . . . 0.0 111.028 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.29 43.48 9.77 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HD2' ' HB3' ' A' ' 22' ' ' ARG . 1.7 mtt180 -122.91 96.66 5.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.435 -1.038 . . . . 0.0 109.661 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.738 HG22 ' CG2' ' A' ' 59' ' ' VAL . 60.1 t -82.05 -55.48 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.07 -33.22 1.4 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.668 -0.645 . . . . 0.0 111.685 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 31' ' ' LEU . 1.3 mt-10 -67.77 -65.87 0.64 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.896 -1.127 . . . . 0.0 108.621 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.994 HG12 HD21 ' A' ' 62' ' ' LEU . 6.7 t -58.01 -44.47 87.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.82 ' HA ' HD22 ' A' ' 62' ' ' LEU . 1.5 tpt85 -47.51 -48.93 27.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.947 -1.096 . . . . 0.0 110.31 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.37 -51.28 5.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.578 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -58.28 -40.64 82.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.711 HD22 HD11 ' A' ' 62' ' ' LEU . 6.6 tt -67.92 -47.69 68.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.338 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -59.93 -15.14 19.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.0 110.407 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.33 -62.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.71 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.14 28.1 0.08 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.852 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -70.17 167.37 17.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 110.469 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 16' ' ' LEU . 4.0 mm? -98.23 134.22 22.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.846 . . . . 0.0 110.975 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 44.6 Cg_endo -71.6 -22.95 23.68 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.587 1.309 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -129.81 53.92 1.88 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.578 -0.701 . . . . 0.0 109.279 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -85.06 145.91 44.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.612 -0.68 . . . . 0.0 111.051 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.44 136.9 29.63 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.95 1.5 . . . . 0.0 109.92 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 8.7 m-80 -100.71 -161.8 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -0.889 . . . . 0.0 110.562 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.24 13.34 16.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.488 -0.757 . . . . 0.0 110.246 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -149.1 27.12 0.86 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 110.137 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.86 56.29 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.511 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -115.27 96.48 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.534 -0.98 . . . . 0.0 110.138 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' CD ' ' HD2' ' A' ' 48' ' ' PRO . 29.0 mmt-85 -52.27 171.89 0.19 Allowed Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.332 -0.855 . . . . 0.0 110.45 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HB2' HD22 ' A' ' 63' ' ' LEU . 38.9 Cg_endo -65.89 166.68 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.566 1.298 . . . . 0.0 110.215 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.59 HG13 ' HB1' ' A' ' 68' ' ' ALA . 1.2 mt 64.21 -64.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.808 -0.557 . . . . 0.0 109.625 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 48' ' ' PRO . 17.7 tt0 -45.55 -27.61 0.78 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.861 -1.149 . . . . 0.0 109.35 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.924 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.9 p -117.35 43.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.313 -0.867 . . . . 0.0 110.541 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -104.08 33.65 3.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 109.173 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 9.7 ttp 70.76 -6.62 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.883 -0.511 . . . . 0.0 110.318 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.574 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.92 25.78 0.11 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.0 110.736 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.28 19.16 4.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.02 75.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.455 -1.026 . . . . 0.0 109.697 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -45.03 -27.48 0.56 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.895 . . . . 0.0 109.756 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -49.84 20.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.654 -0.654 . . . . 0.0 109.503 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.738 ' CG2' HG22 ' A' ' 25' ' ' VAL . 62.9 t -56.61 -64.29 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -0.758 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -44.54 -52.16 8.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.432 -0.792 . . . . 0.0 109.827 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.564 ' HA ' HG11 ' A' ' 96' ' ' VAL . 7.0 tm-20 -41.75 -53.38 3.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.994 HD21 HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -59.57 -53.44 58.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.671 -0.643 . . . . 0.0 109.992 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.822 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -65.31 -50.9 63.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.588 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.748 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -48.88 -59.4 3.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.797 . . . . 0.0 110.424 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.2 pp -57.67 -23.32 50.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.077 -1.015 . . . . 0.0 108.776 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.553 ' CG ' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -86.76 -3.12 59.01 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.639 -0.663 . . . . 0.0 109.915 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 84.92 46.91 5.5 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.26 -146.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -1.164 . . . . 0.0 109.301 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 2.0 tp10 -120.72 64.36 11.58 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 49.9 Cg_endo -74.04 -35.23 4.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.916 1.482 . . . . 0.0 110.468 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 3.5 m-80 -85.28 -69.3 0.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.294 -0.879 . . . . 0.0 110.242 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.5 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.3 t -48.71 144.02 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -0.757 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.92 -152.83 0.53 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.512 -0.743 . . . . 0.0 109.815 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.65 149.51 37.53 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.205 -0.934 . . . . 0.0 109.823 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.88 -21.42 24.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.645 1.339 . . . . 0.0 109.098 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.09 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.72 -0.613 . . . . 0.0 109.593 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 27.2 p -133.48 40.98 3.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.445 -0.784 . . . . 0.0 109.079 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.512 ' HA ' HD23 ' A' ' 78' ' ' LEU . 5.8 mt 41.82 42.8 2.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.729 -0.607 . . . . 0.0 111.495 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 m -78.7 103.5 8.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.604 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -76.4 155.13 83.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 109.388 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 39.5 Cg_endo -64.57 -15.67 51.16 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.422 1.222 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' A' ' 104' ' ' LEU . 11.1 t -61.07 -33.29 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 87' ' ' ARG . 7.4 m80 -71.72 -35.36 70.16 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -54.84 -46.89 74.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -57.99 -58.09 9.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.458 -0.776 . . . . 0.0 109.384 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.035 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -69.67 -15.83 63.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.7 tpt180 -80.81 -22.73 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -112.32 -12.93 13.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 110.134 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' CE1' ' A' ' 123' ' ' HIS . . . 80.99 61.02 2.18 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.445 ' O ' HD12 ' A' ' 94' ' ' LEU . 1.2 t80 -135.97 86.08 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -1.069 . . . . 0.0 110.335 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.92 HD23 HG22 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -60.36 -40.52 91.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 111.047 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -45.7 -37.14 5.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.83 . . . . 0.0 109.851 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.445 ' O ' HD12 ' A' ' 97' ' ' LEU . 8.5 m -73.8 -42.81 60.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.784 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.498 -0.751 . . . . 0.0 109.417 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 91' ' ' LEU . 57.8 t -60.49 -45.51 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.662 0.744 . . . . 0.0 109.203 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 HD22 ' A' ' 64' ' ' LEU . 6.5 t -60.31 -50.34 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.751 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -48.26 -44.32 33.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.512 -0.743 . . . . 0.0 110.141 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -84.94 -36.91 21.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.258 -0.901 . . . . 0.0 110.58 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -59.52 -15.12 15.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -128.2 -81.64 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.662 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.33 106.15 0.27 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.751 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -159.06 120.87 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.372 -1.075 . . . . 0.0 110.378 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.539 ' HD3' ' NH1' ' A' ' 80' ' ' ARG . 41.6 ttt85 -74.71 102.08 4.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.513 -0.742 . . . . 0.0 110.073 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.751 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.2 mp -98.31 56.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.25 -0.906 . . . . 0.0 110.396 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -162.36 50.79 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.874 -1.141 . . . . 0.0 110.7 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.729 HG22 ' H ' ' A' ' 107' ' ' ARG . 2.5 p -111.61 -169.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.929 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.729 ' H ' HG22 ' A' ' 106' ' ' VAL . 20.0 mtt180 -127.95 138.25 52.56 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.529 -0.732 . . . . 0.0 109.967 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.4 m-20 -75.34 57.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 110.264 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 57.65 -69.56 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.704 -0.623 . . . . 0.0 111.376 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.566 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.03 -50.49 36.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.328 -0.858 . . . . 0.0 110.425 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.48 -21.33 0.83 Allowed Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -49.27 168.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.416 -1.049 . . . . 0.0 110.778 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 30.9 mt -131.68 167.75 20.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -69.6 -42.19 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.7 1.368 . . . . 0.0 109.699 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 127' ' ' ALA . 5.7 p -71.25 -25.73 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 110.203 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t70 -67.68 -58.19 5.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.57 -60.03 2.41 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.445 -0.784 . . . . 0.0 110.653 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.035 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -47.22 -53.1 14.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -31.25 64.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -26.91 46.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.049 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.544 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 12.4 mt -92.66 -0.72 57.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.72 23.95 40.52 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.544 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 15.6 m170 -95.33 49.34 1.19 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.268 -1.136 . . . . 0.0 109.704 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' HIS . 10.7 mmm-85 -43.16 -33.71 0.96 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.527 -0.733 . . . . 0.0 109.616 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -46.4 79.7 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.92 HG22 HD23 ' A' ' 91' ' ' LEU . 2.4 t -82.81 -34.85 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.478 -0.763 . . . . 0.0 109.544 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.639 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -65.1 -51.36 61.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 108.961 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.405 ' C ' ' HD3' ' A' ' 128' ' ' ARG . 1.2 tmt_? -64.65 -52.5 57.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.655 -0.653 . . . . 0.0 109.482 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.674 ' CD2' HD11 ' A' ' 91' ' ' LEU . 7.7 t80 -50.76 -40.08 53.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.41 -0.807 . . . . 0.0 109.136 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.739 HD11 ' HB2' ' A' ' 86' ' ' ALA . 24.0 mt -65.57 -53.51 40.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.695 -0.628 . . . . 0.0 109.587 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -21.32 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.123 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.26 -54.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 110.566 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.94 56.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.755 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 11.5 p30 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.738 0.304 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.493 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 24.6 m0 -52.05 -52.2 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.996 -1.065 . . . . 0.0 110.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.597 ' CD2' ' HB1' ' A' ' 36' ' ' ALA . 1.4 pp -51.01 -27.49 7.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.26 -0.9 . . . . 0.0 109.899 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 14' ' ' ASP . . . -82.68 -44.04 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 0.0 109.492 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -65.86 -44.55 85.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.492 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.65 -45.86 88.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.852 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -58.61 -44.54 89.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.909 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.63 -30.03 71.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.555 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -97.61 22.38 9.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.432 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.39 60.64 6.59 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 67.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -1.085 . . . . 0.0 110.464 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 59' ' ' VAL . 64.0 t -52.53 -58.92 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -43.12 -41.62 3.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.713 -0.617 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.853 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.3 tp10 -66.4 -46.55 76.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.07 HG12 HD13 ' A' ' 62' ' ' LEU . 22.1 t -70.24 -41.03 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.325 -0.86 . . . . 0.0 110.893 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.769 ' CA ' HD11 ' A' ' 62' ' ' LEU . 24.9 mmm-85 -51.0 -46.01 61.37 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.186 -0.946 . . . . 0.0 109.93 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.43 -43.45 32.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 0.0 109.956 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 27' ' ' GLU . 1.4 mt -57.78 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.89 ' CD1' HD22 ' A' ' 62' ' ' LEU . 12.4 mt -53.25 -44.49 68.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 0.0 110.048 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.19 -16.04 63.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.862 . . . . 0.0 109.917 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.21 -9.79 55.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 110.311 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 22.95 3.53 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.784 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -62.04 134.96 57.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -1.221 . . . . 0.0 109.906 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.597 HD23 ' CA ' ' A' ' 40' ' ' ALA . 3.6 tp -83.3 116.87 66.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -71.74 -41.74 2.05 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.671 1.353 . . . . 0.0 110.489 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.83 48.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.597 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . -93.02 118.57 67.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.72 94.99 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.618 1.325 . . . . 0.0 110.524 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -78.44 179.29 7.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 110.005 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -90.93 23.11 3.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -113.66 -19.05 11.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.73 37.11 93.02 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 32.6 mtt-85 -124.34 31.62 5.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -1.12 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 12.7 mmt-85 49.32 177.31 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.522 -0.736 . . . . 0.0 110.585 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 51.6 Cg_endo -79.71 -19.64 9.76 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.357 1.188 . . . . 0.0 109.92 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.624 HG13 ' HB1' ' A' ' 68' ' ' ALA . 7.0 mt -109.06 -42.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.688 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -50.73 -22.91 2.33 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.881 -1.137 . . . . 0.0 110.295 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.1 p -100.8 5.31 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.605 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.852 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -89.94 146.49 24.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.844 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 106.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.333 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.555 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 13.5 mmt -59.67 -8.46 2.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.814 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -82.0 11.56 47.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 59' ' ' VAL . 3.6 m -144.95 88.65 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.216 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.656 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -61.68 -29.68 70.24 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.16 -0.963 . . . . 0.0 109.546 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -29.75 10.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.681 -0.637 . . . . 0.0 109.821 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 25' ' ' VAL . 11.2 t -74.85 -55.3 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.144 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.612 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -50.22 -47.77 54.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.382 -0.824 . . . . 0.0 109.5 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.736 ' OE1' HG13 ' A' ' 96' ' ' VAL . 3.1 tp10 -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.07 HD13 HG12 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -51.36 -66.31 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.481 0.658 . . . . 0.0 109.943 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.82 HD23 HD21 ' A' ' 32' ' ' LEU . 45.4 mt -68.25 -49.54 59.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 110.858 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD22 HG12 ' A' ' 96' ' ' VAL . 1.8 tt -44.9 -67.37 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.439 -0.788 . . . . 0.0 110.858 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -55.97 -23.5 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.852 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.19 -43.35 24.07 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.409 -0.807 . . . . 0.0 109.534 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.96 36.05 0.06 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.63 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -68.89 -171.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.657 -1.496 . . . . 0.0 109.257 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -111.18 73.07 0.91 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 44.9 Cg_endo -70.5 -7.84 22.21 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.959 1.505 . . . . 0.0 110.64 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.34 -57.17 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.63 161.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 111.566 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.08 -143.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.512 -0.743 . . . . 0.0 109.966 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' LEU . 31.3 t0 -114.37 134.57 22.26 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 109.416 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.71 -3.06 12.84 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.29 1.153 . . . . 0.0 111.011 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.37 -41.3 9.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.0 110.256 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.571 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -131.15 5.98 4.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.09 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.8 mt 48.48 42.63 18.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -0.838 . . . . 0.0 111.008 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 m -75.65 93.32 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 110.401 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.758 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.72 168.77 17.63 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 108.777 179.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -75.62 -0.87 10.66 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.096 1.051 . . . . 0.0 110.289 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.756 HG13 HD23 ' A' ' 104' ' ' LEU . 11.4 t -76.31 -34.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -68.08 -36.34 79.67 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.251 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 1.8 m-20 -55.46 -56.12 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.695 -0.628 . . . . 0.0 110.474 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -55.12 -62.06 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.355 -0.84 . . . . 0.0 109.985 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.922 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -56.59 -49.3 75.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 111.108 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -32.35 12.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.081 -1.012 . . . . 0.0 111.045 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -94.3 -4.28 49.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.517 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 81.8 25.51 52.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -98.76 143.7 28.81 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.328 -1.101 . . . . 0.0 110.63 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.656 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -117.04 -39.36 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.867 ' O ' HG23 ' A' ' 96' ' ' VAL . 3.3 t0 -52.83 -36.66 58.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.605 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 2.5 m -60.53 -49.66 76.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.667 -0.646 . . . . 0.0 109.635 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.638 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.8 mp -57.65 -45.23 85.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 109.685 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.0 t -55.89 -43.29 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.343 -0.848 . . . . 0.0 108.922 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 92' ' ' ASP . 46.2 t -61.13 -45.27 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.42 0.629 . . . . 0.0 109.479 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.631 HD23 ' CD1' ' A' ' 64' ' ' LEU . 96.0 mt -57.43 -46.89 83.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.513 -0.742 . . . . 0.0 110.313 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -77.77 -25.94 49.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.498 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -67.04 -13.52 62.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 110.11 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -127.22 -74.24 0.59 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 70' ' ' PRO . . . -174.19 105.83 0.21 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.18 -165.0 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -1.084 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.86 102.59 3.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.489 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.756 HD23 HG13 ' A' ' 82' ' ' VAL . 1.7 mp -93.26 11.31 28.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.843 . . . . 0.0 109.444 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.34 31.06 4.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.758 HG11 ' HB2' ' A' ' 80' ' ' ARG . 4.1 p -104.01 -176.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 110.055 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.662 ' H ' HG22 ' A' ' 106' ' ' VAL . 10.7 ptt-85 -139.21 145.4 39.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.581 -0.7 . . . . 0.0 109.568 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -70.55 63.11 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.124 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 60.04 -65.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.697 -0.627 . . . . 0.0 111.007 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.1 m-90 -57.47 -74.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 110.873 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.76 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -49.69 124.26 9.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -1.12 . . . . 0.0 110.634 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 113' ' ' LEU . 42.4 mt -85.97 164.79 37.67 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.462 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -20.3 46.04 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.719 1.378 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.496 HG23 ' CB ' ' A' ' 130' ' ' LEU . 7.4 p -83.65 -37.88 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.382 -0.824 . . . . 0.0 109.832 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.444 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -70.96 -38.13 72.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.852 . . . . 0.0 109.898 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.36 -41.54 89.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.126 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.922 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -58.6 -59.42 5.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.619 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -30.9 35.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.314 -0.866 . . . . 0.0 110.433 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -24.75 56.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.563 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -90.28 -3.65 57.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 110.607 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.35 14.72 46.85 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.563 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 44.2 m-70 -98.42 48.95 0.99 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.91 -1.347 . . . . 0.0 109.478 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -30.17 2.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.687 -0.633 . . . . 0.0 110.229 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.656 ' O ' HD11 ' A' ' 91' ' ' LEU . 30.7 m-20 -65.41 -41.88 93.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 86' ' ' ALA . 4.7 t -81.6 -38.32 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.42 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.86 97.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -57.96 -67.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.429 -0.795 . . . . 0.0 109.494 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -50.59 -40.89 53.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 86' ' ' ALA . 13.8 mt -57.02 -50.3 73.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -56.23 -22.13 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.753 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.02 -66.39 0.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.083 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.97 -7.31 53.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 111.105 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.144 -0.973 . . . . 0.0 110.355 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.77 0.319 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.487 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 38.2 m0 -74.42 -24.5 59.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.257 -0.902 . . . . 0.0 109.877 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.56 -35.54 79.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 110.151 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.88 -50.56 12.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.457 -0.777 . . . . 0.0 109.184 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -51.36 -51.56 53.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.333 -0.854 . . . . 0.0 109.669 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.64 -37.93 76.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -62.16 -61.02 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.992 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -46.46 -29.1 1.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.702 -0.624 . . . . 0.0 111.105 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 21.2 mtm-85 -91.9 32.43 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.451 -0.78 . . . . 0.0 111.04 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.39 36.2 3.01 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 3.0 mpt_? -108.5 94.74 5.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -1.12 . . . . 0.0 109.609 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.638 HG12 ' HD3' ' A' ' 29' ' ' ARG . 89.8 t -74.46 -59.73 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.646 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -43.15 -30.75 0.49 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 111.668 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.756 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.5 mt-10 -68.0 -52.46 35.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 19' ' ' ALA . 6.1 t -68.49 -41.22 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.578 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.916 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.02 -50.42 27.77 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.439 -0.788 . . . . 0.0 109.616 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.82 -49.1 66.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.643 -0.661 . . . . 0.0 109.84 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.1 mt -58.78 -60.25 4.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.888 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 11.7 mt -44.41 -49.25 9.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.595 -0.691 . . . . 0.0 109.95 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.08 -14.29 61.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.471 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -94.63 -3.42 49.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.992 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.35 33.05 1.26 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.684 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.888 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -79.36 140.22 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.296 . . . . 0.0 108.761 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.0 tp -79.72 123.34 84.01 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.083 -1.01 . . . . 0.0 111.058 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.503 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 42.2 Cg_endo -70.72 -21.33 29.18 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.827 1.435 . . . . 0.0 109.84 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.78 52.65 1.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.067 -1.02 . . . . 0.0 110.03 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -86.32 154.99 57.38 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.843 . . . . 0.0 110.131 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -79.04 132.04 10.27 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.868 1.457 . . . . 0.0 109.858 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -97.95 -171.84 2.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.38 -0.825 . . . . 0.0 110.822 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 m -113.47 2.78 15.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.79 . . . . 0.0 110.271 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.503 ' CB ' ' HD3' ' A' ' 46' ' ' ARG . 72.5 m-85 -118.24 20.06 13.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.595 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.91 22.69 35.45 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' HD3' ' CB ' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -109.5 -169.64 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -1.201 . . . . 0.0 109.896 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.719 ' O ' HG12 ' A' ' 51' ' ' VAL . 23.7 mmt180 -106.02 165.9 12.21 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.379 -0.826 . . . . 0.0 109.72 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.2 Cg_endo -62.85 -12.79 30.86 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.665 1.35 . . . . 0.0 109.885 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.658 HG13 ' HB1' ' A' ' 68' ' ' ALA . 2.8 mt -110.96 -35.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.431 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 4.1 tt0 -59.17 -15.9 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.992 HG22 ' HB2' ' A' ' 21' ' ' ALA . 7.7 p -118.12 38.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.358 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.616 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.96 29.96 4.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.755 -1.216 . . . . 0.0 109.578 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 7.5 tmm? 74.21 -8.78 1.38 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.792 -0.567 . . . . 0.0 110.46 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.553 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 45.11 24.22 0.12 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.603 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -130.05 18.01 5.35 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.1 t -149.54 64.58 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.486 -1.008 . . . . 0.0 110.586 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -38.33 -32.76 0.08 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.568 -0.707 . . . . 0.0 110.087 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 56' ' ' SER . 3.9 mmt85 -49.74 -41.13 43.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.591 -0.693 . . . . 0.0 109.201 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ALA . 40.8 t -62.22 -61.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.578 -0.701 . . . . 0.0 109.492 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -35.55 -52.84 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.481 -0.762 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.655 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -50.33 -55.39 15.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.006 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.916 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -43.45 -65.8 0.45 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.641 -0.662 . . . . 0.0 110.506 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.837 HD23 HD21 ' A' ' 32' ' ' LEU . 74.2 mt -66.78 -49.88 64.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.526 -0.734 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.764 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -41.82 -72.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.629 -0.669 . . . . 0.0 110.648 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.3 pp -52.46 -23.64 6.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.883 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.04 -31.55 44.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.649 -0.657 . . . . 0.0 109.545 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.503 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 124.76 41.1 0.39 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -63.51 -156.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.07 -1.253 . . . . 0.0 109.745 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.534 ' HG2' ' HB3' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -118.87 59.08 4.05 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.426 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 51.9 Cg_endo -69.89 -22.09 31.97 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 124.149 1.605 . . . . 0.0 110.178 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.31 -52.32 3.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.731 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -60.51 133.27 55.93 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.545 0.688 . . . . 0.0 110.649 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -123.81 -177.27 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.35 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.48 138.48 36.07 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.192 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.0 -29.26 18.21 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 124.089 1.573 . . . . 0.0 110.539 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.15 -61.03 1.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 13.2 p -137.66 41.56 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.691 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 78' ' ' LEU . 1.7 mt 37.56 56.21 1.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.311 0.577 . . . . 0.0 111.401 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.629 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 58.3 m -77.54 104.4 8.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.596 -0.69 . . . . 0.0 110.048 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.998 ' NH1' HG21 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -79.37 142.92 59.05 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 70' ' ' PRO . 42.9 Cg_endo -66.92 -10.65 29.2 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.804 1.423 . . . . 0.0 109.654 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.415 HG13 HD23 ' A' ' 104' ' ' LEU . 6.0 t -70.46 -36.84 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.911 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.498 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 16.4 m80 -57.37 -40.47 78.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.553 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -50.01 -58.69 4.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.999 -0.438 . . . . 0.0 111.314 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -46.41 -55.11 7.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.617 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.074 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -67.21 -35.76 80.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 0.0 110.767 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -46.27 -39.46 10.03 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 111.286 -178.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -105.37 -3.63 22.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 110.46 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.562 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 81.43 35.45 23.05 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.603 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 1.0 OUTLIER -105.83 83.55 1.94 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.393 -1.063 . . . . 0.0 110.336 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.554 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -56.97 -46.35 82.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 111.575 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 96' ' ' VAL . 31.3 m-20 -42.93 -37.95 2.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.39 -0.819 . . . . 0.0 110.338 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.4 m -62.63 -44.32 96.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.579 -0.701 . . . . 0.0 109.327 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -61.51 -55.94 25.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 0.0 109.769 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 95' ' ' VAL . 39.1 t -38.97 -45.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.731 -0.606 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.764 ' CG1' HD22 ' A' ' 64' ' ' LEU . 11.9 t -63.42 -53.75 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.664 0.745 . . . . 0.0 109.013 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 mt -47.99 -58.95 3.75 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.456 0.646 . . . . 0.0 110.266 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.99 -28.34 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 10.2 ttt85 -72.73 -3.86 27.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.353 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -146.56 53.81 1.12 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.965 -1.084 . . . . 0.0 111.438 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . 56.84 107.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.11 86.59 0.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -1.049 . . . . 0.0 109.68 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -51.14 116.9 2.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 110.683 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.958 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.3 mp -101.22 -16.21 17.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 26.1 t0 -85.1 55.13 3.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.998 HG21 ' NH1' ' A' ' 80' ' ' ARG . 1.9 p -110.49 -170.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.161 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.628 ' H ' HG22 ' A' ' 106' ' ' VAL . 1.9 mtt180 -137.04 135.69 37.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.213 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.9 m-20 -73.82 58.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.51 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 54.27 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.376 -0.828 . . . . 0.0 110.555 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.668 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -37.32 -63.38 0.44 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.412 0.625 . . . . 0.0 110.7 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.32 -34.74 0.23 Allowed Glycine 0 N--CA 1.478 1.471 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -48.42 141.94 6.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -1.11 . . . . 0.0 109.976 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.514 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -109.89 170.49 5.29 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.408 -0.808 . . . . 0.0 109.742 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 42.4 Cg_endo -70.44 -40.25 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.856 1.45 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 127' ' ' ALA . 13.3 p -70.51 -34.15 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.588 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -70.73 -51.67 25.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.513 -0.742 . . . . 0.0 109.812 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.78 -32.33 30.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.267 -0.896 . . . . 0.0 109.746 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.074 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -73.7 -46.58 45.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.876 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.478 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -67.8 -30.29 69.68 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -67.69 -41.48 83.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.545 -0.722 . . . . 0.0 110.091 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -83.32 -4.31 58.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 111.022 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.3 25.78 17.91 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.306 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.553 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 74.7 m-70 -98.27 47.11 1.0 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.069 -1.254 . . . . 0.0 109.39 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.681 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -44.48 -38.01 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.672 -0.643 . . . . 0.0 109.739 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.52 ' OD2' HD12 ' A' ' 91' ' ' LEU . 11.2 t70 -55.19 -47.03 75.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 94' ' ' LEU . 3.2 t -79.65 -46.28 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 108.88 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.681 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -51.29 -43.72 61.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.607 -0.683 . . . . 0.0 110.369 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 131' ' ' ARG . 5.6 ttp180 -68.16 -54.81 15.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 110.058 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.547 ' CG ' HD21 ' A' ' 91' ' ' LEU . 21.9 t80 -58.8 -39.59 81.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.171 -0.956 . . . . 0.0 109.143 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.7 mt -62.21 -35.0 77.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.529 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 39.7 ttt180 -65.13 -27.28 68.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.93 28.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.958 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -89.51 -16.05 31.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.287 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 0.0 110.452 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.59 ' OD1' ' HB1' ' A' ' 40' ' ' ALA . 66.5 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.244 0.545 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.584 ' HB3' HD13 ' A' ' 31' ' ' LEU . 40.2 m0 -73.01 -31.82 64.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.058 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.808 HD23 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -53.06 -33.49 52.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 0.0 110.795 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.9 -48.49 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -51.8 37.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.693 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -65.89 -40.54 91.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -56.81 -52.36 65.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.203 -0.936 . . . . 0.0 109.62 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -57.3 -29.39 63.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.38 23.16 4.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.0 110.765 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.72 61.42 6.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -131.54 53.89 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.396 -1.061 . . . . 0.0 110.01 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 59' ' ' VAL . 98.0 t -42.36 -59.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.848 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -45.98 -38.57 7.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.773 . . . . 0.0 110.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 1.6 tp10 -70.93 -36.32 72.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.979 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.854 HG12 HD21 ' A' ' 62' ' ' LEU . 5.2 t -79.6 -41.4 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.0 mmm180 -51.59 -41.91 61.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.874 . . . . 0.0 109.363 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -56.07 4.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.673 -0.642 . . . . 0.0 109.461 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 15' ' ' TRP . 12.8 mt -45.0 -60.16 2.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.554 -0.717 . . . . 0.0 110.597 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.977 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -51.83 -51.88 53.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.5 -0.75 . . . . 0.0 110.258 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.98 -9.29 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 110.428 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.05 -13.56 30.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.07 -1.019 . . . . 0.0 110.895 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.02 -20.59 1.59 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.462 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.977 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -47.73 136.93 10.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.282 -1.128 . . . . 0.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 13.0 mt -73.13 155.75 89.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.975 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.59 -54.8 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.737 1.388 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -98.63 21.22 11.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -39.53 100.22 0.21 Allowed Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.71 -0.619 . . . . 0.0 110.689 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.63 146.8 44.35 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.875 1.46 . . . . 0.0 110.963 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -139.28 174.47 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.618 -0.676 . . . . 0.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.07 50.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.926 . . . . 0.0 110.574 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -3.47 5.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.17 23.51 25.31 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -138.64 106.15 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -1.051 . . . . 0.0 110.46 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.535 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -58.11 -177.2 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CB ' HD22 ' A' ' 63' ' ' LEU . 41.1 Cg_endo -66.52 175.68 4.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.319 1.168 . . . . 0.0 111.263 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.7 mt 61.92 -64.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.919 -0.488 . . . . 0.0 110.045 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' PRO . 50.2 tt0 -44.16 -26.91 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.3 p -123.56 36.57 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.641 -0.662 . . . . 0.0 109.891 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.82 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -94.24 38.32 1.09 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.772 -1.205 . . . . 0.0 110.653 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 6.1 tmm? 71.15 -14.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.52 -0.737 . . . . 0.0 110.672 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.55 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.43 27.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.71 13.47 5.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.47 82.91 1.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -1.013 . . . . 0.0 109.734 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -50.66 -25.24 4.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.0 110.394 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.64 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -53.56 -41.09 66.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.279 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 25' ' ' VAL . 24.1 t -55.57 -58.47 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.233 -0.917 . . . . 0.0 109.566 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.67 -52.78 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.675 . . . . 0.0 109.708 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.954 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -45.23 -42.75 9.72 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 28' ' ' VAL . 2.9 tp -73.83 -61.33 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.588 -0.695 . . . . 0.0 110.087 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.614 HD22 ' CB ' ' A' ' 48' ' ' PRO . 5.3 mt -64.7 -55.87 17.3 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 110.993 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.753 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -46.68 -61.75 1.69 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.447 -0.783 . . . . 0.0 111.118 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.954 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -57.55 -23.58 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.935 -1.103 . . . . 0.0 109.655 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CD2' ' CD2' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -81.98 -38.88 24.45 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.457 -0.777 . . . . 0.0 109.969 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.01 46.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.487 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.98 -151.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.008 -1.289 . . . . 0.0 109.583 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -117.14 53.51 1.3 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.003 . . . . 0.0 110.718 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.2 Cg_endo -66.85 -15.32 46.83 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.444 1.234 . . . . 0.0 109.877 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.473 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 4.1 m-20 -107.93 -72.56 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 171.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -147.33 -152.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.276 -0.89 . . . . 0.0 110.114 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -98.59 131.77 25.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.25 -27.55 34.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.337 1.177 . . . . 0.0 110.729 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.1 -64.43 0.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.667 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 27.5 p -130.29 36.31 3.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' A' ' 78' ' ' LEU . 4.3 mt 43.29 37.91 1.48 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.639 -0.663 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.9 OUTLIER -70.05 99.51 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.532 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -76.43 165.4 53.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 47.1 Cg_endo -69.8 -23.2 30.86 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.655 1.345 . . . . 0.0 109.536 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 114' ' ' PRO . 60.8 t -55.89 -29.29 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.676 -0.64 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 12.2 m80 -74.15 -50.16 20.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -45.24 -43.96 10.81 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -64.46 -67.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.109 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -54.14 -45.68 72.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.776 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -48.56 -33.33 9.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.277 -0.89 . . . . 0.0 110.627 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 4.2 mm-40 -99.28 -11.97 20.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.555 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 83.78 33.84 20.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -104.99 92.28 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -1.052 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 0.4 OUTLIER -67.66 -32.55 73.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 110.063 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 42.9 m-20 -52.26 -50.06 62.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.873 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 m -56.95 -36.28 70.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.86 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 mp -60.84 -44.12 97.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.503 -0.748 . . . . 0.0 109.701 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 16.5 t -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.517 HG12 HD13 ' A' ' 64' ' ' LEU . 15.6 t -55.51 -46.01 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.411 -0.806 . . . . 0.0 109.571 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -54.94 -69.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 110.057 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.12 -22.25 50.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.369 -0.832 . . . . 0.0 110.158 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -72.04 -16.54 62.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.753 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -144.25 72.68 1.35 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.338 -0.851 . . . . 0.0 110.596 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.52 101.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -161.93 79.28 0.54 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -1.087 . . . . 0.0 110.411 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.541 ' CZ ' HG23 ' A' ' 106' ' ' VAL . 1.2 ttp180 -56.89 119.64 6.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.121 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' O ' ' HB1' ' A' ' 134' ' ' ALA . 12.0 mt -99.13 15.49 25.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.059 . . . . 0.0 109.544 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.65 43.29 1.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.822 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.565 HG22 ' H ' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -103.19 -169.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.565 ' H ' HG22 ' A' ' 106' ' ' VAL . 36.0 ptt180 -142.0 140.69 32.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.652 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 110' ' ' TRP . 10.8 t0 -73.46 54.81 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.636 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 56.02 -75.59 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.616 -0.677 . . . . 0.0 111.483 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.667 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.1 OUTLIER -46.73 -39.15 11.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.294 -0.879 . . . . 0.0 110.37 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.23 -28.74 2.21 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -56.23 128.87 37.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -1.065 . . . . 0.0 110.569 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.464 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -93.09 171.64 7.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.63 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HB2' HG12 ' A' ' 82' ' ' VAL . 41.7 Cg_endo -69.46 -38.64 8.16 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.488 1.257 . . . . 0.0 110.048 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.558 HG21 ' CA ' ' A' ' 131' ' ' ARG . 9.6 p -70.55 -31.03 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.276 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.36 -26.06 66.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.548 -0.72 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.504 HD23 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -78.02 -55.05 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.39 -0.819 . . . . 0.0 110.551 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.109 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -47.97 -40.92 23.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 110.285 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -47.66 81.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.526 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -60.91 -54.13 48.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 109.627 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.504 HD23 HD23 ' A' ' 117' ' ' LEU . 1.9 mm? -55.16 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.0 110.427 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.19 41.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.517 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 49.4 m-70 -122.23 63.32 0.94 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.388 -1.066 . . . . 0.0 109.546 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -45.3 46.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -46.16 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.867 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -74.83 -42.01 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.72 84.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 109.64 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -52.93 -67.45 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 49.7 t80 -52.86 -30.4 33.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.919 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.86 ' HG ' HD21 ' A' ' 94' ' ' LEU . 5.8 mt -70.75 -53.58 15.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.596 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CA ' HG21 ' A' ' 115' ' ' VAL . 8.7 ttp180 -55.23 -29.79 58.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.86 -54.23 4.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.664 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -75.87 -9.14 58.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.327 -0.858 . . . . 0.0 110.781 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.164 -0.96 . . . . 0.0 110.693 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.026 0.441 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.484 ' HE3' HD21 ' A' ' 31' ' ' LEU . 16.3 m0 -57.03 -17.22 9.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 110.457 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -69.85 -56.03 8.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -71.81 -42.96 66.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -47.81 -62.51 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.166 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -52.0 -42.96 63.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.816 . . . . 0.0 109.936 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -57.63 -52.15 66.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.679 -0.638 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -50.38 -25.63 4.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.451 -0.781 . . . . 0.0 110.607 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . 37.6 mtt180 -103.74 28.93 6.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.656 -0.652 . . . . 0.0 109.849 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.76 41.89 10.43 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 28' ' ' VAL . 11.7 mtt180 -99.85 54.93 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -1.081 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.713 HG12 ' HD3' ' A' ' 29' ' ' ARG . 99.3 t -38.9 -53.61 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.769 -0.582 . . . . 0.0 111.07 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -49.81 -56.29 10.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.755 . . . . 0.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp10 -54.45 -39.0 67.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.383 -0.823 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.06 HG12 HD23 ' A' ' 62' ' ' LEU . 14.0 t -71.74 -56.0 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.707 -0.621 . . . . 0.0 110.279 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.874 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -39.41 -52.48 2.08 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.428 -0.795 . . . . 0.0 110.668 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -73.82 -50.75 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.76 . . . . 0.0 109.907 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.484 HD21 ' HE3' ' A' ' 15' ' ' TRP . 14.0 mt -47.37 -57.05 5.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.59 -0.694 . . . . 0.0 110.728 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.973 ' HB2' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.86 -50.36 45.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 109.491 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -70.53 -17.38 62.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.714 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -81.83 -6.35 59.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.067 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.06 16.68 6.1 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.565 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.872 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -58.15 160.87 4.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.074 -1.25 . . . . 0.0 109.975 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -101.39 113.26 65.85 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 111.269 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.41 -5.17 16.62 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.753 1.396 . . . . 0.0 110.421 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.416 ' C ' HD23 ' A' ' 37' ' ' LEU . 1.5 m-80 -131.59 40.06 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 110.075 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.758 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -84.18 133.85 44.51 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.268 -0.895 . . . . 0.0 110.546 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.3 89.65 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.726 1.382 . . . . 0.0 110.375 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.76 166.18 5.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -85.41 21.71 1.7 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -119.38 15.35 12.99 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.16 24.15 20.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.4 -170.33 1.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.447 -1.031 . . . . 0.0 110.256 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.3 mmt180 -103.45 167.51 10.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.673 . . . . 0.0 109.547 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 63' ' ' LEU . 42.6 Cg_endo -67.26 -12.0 34.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.582 1.306 . . . . 0.0 110.414 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.54 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.1 mt -107.2 -42.76 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 108.637 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.449 ' HB2' ' H ' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -49.44 -20.95 0.79 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.383 -0.823 . . . . 0.0 110.472 179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 51' ' ' VAL . 10.8 p -115.91 35.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 110.477 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.808 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.4 34.57 1.6 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 109.729 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 10.0 ttp 67.67 -6.69 0.65 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 110.821 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.563 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.66 27.19 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.235 -0.916 . . . . 0.0 110.41 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.464 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.35 11.65 7.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.656 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.8 m -148.91 93.22 2.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.482 -1.011 . . . . 0.0 109.615 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.42 -34.15 70.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.468 -0.77 . . . . 0.0 109.872 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -52.15 -42.04 63.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 110.093 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 52' ' ' MET . 91.0 t -48.15 -53.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -62.79 -43.69 98.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.565 -0.709 . . . . 0.0 109.315 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 4.0 tt0 -46.8 -31.73 3.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.248 -0.908 . . . . 0.0 110.276 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.06 HD23 HG12 ' A' ' 28' ' ' VAL . 7.5 tp -89.87 -49.66 6.49 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -56.65 -55.41 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.451 0.643 . . . . 0.0 109.387 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.916 HD22 HG12 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -61.23 -45.76 93.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.671 -0.643 . . . . 0.0 109.756 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.4 tp -53.04 -32.97 49.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -0.874 . . . . 0.0 108.719 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CG ' ' CD1' ' A' ' 32' ' ' LEU . 2.0 m80 -92.6 -1.04 57.21 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.426 0.631 . . . . 0.0 110.355 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.0 63.48 1.97 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.447 ' C ' ' HD3' ' A' ' 70' ' ' PRO . . . -72.26 -149.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -1.067 . . . . 0.0 109.228 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mt-10 -114.88 57.22 0.97 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -72.17 -0.89 9.26 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.315 1.166 . . . . 0.0 110.585 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.46 -73.72 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.055 -1.028 . . . . 0.0 109.804 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 134.7 16.61 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.578 0.704 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.424 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . -127.34 -134.16 0.24 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.03 125.73 30.92 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.786 -1.196 . . . . 0.0 109.452 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.84 5.75 5.06 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.255 1.134 . . . . 0.0 110.865 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.27 -43.77 4.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 108.925 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.897 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -121.44 2.98 10.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.619 -0.676 . . . . 0.0 109.932 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 2.8 mt 54.99 25.23 6.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.278 -0.889 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.71 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.81 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.36 165.9 40.09 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.173 -0.954 . . . . 0.0 110.104 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 44.4 Cg_endo -71.54 -9.01 24.39 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.76 1.4 . . . . 0.0 110.672 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.618 HG11 HD23 ' A' ' 104' ' ' LEU . 3.5 t -73.87 -30.53 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.103 -0.998 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.412 ' CD2' ' OD1' ' A' ' 108' ' ' ASP . 27.0 m80 -68.64 -43.97 75.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -48.81 -49.95 36.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.331 0.586 . . . . 0.0 110.251 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.692 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -57.81 -68.7 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.0 109.766 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.912 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -51.24 -39.29 56.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.362 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -44.01 -51.73 7.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.328 -0.857 . . . . 0.0 110.812 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -96.14 18.7 13.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 109.775 179.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.836 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 54.39 52.78 42.31 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.489 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -117.07 84.36 2.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -1.157 . . . . 0.0 110.611 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.581 ' HA ' HD13 ' A' ' 94' ' ' LEU . 1.2 mt -55.89 -43.81 77.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 0.0 110.75 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 47.9 m-20 -45.89 -35.66 4.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.496 -0.753 . . . . 0.0 111.048 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -71.9 -38.61 69.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -0.91 . . . . 0.0 110.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.692 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 1.6 mp -63.08 -59.55 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.8 t -46.2 -49.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.58 -0.7 . . . . 0.0 110.314 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.916 HG12 HD22 ' A' ' 64' ' ' LEU . 23.6 t -50.39 -53.04 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.571 -0.705 . . . . 0.0 109.71 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.661 ' HA ' HD21 ' A' ' 64' ' ' LEU . 64.6 mt -52.39 -66.11 0.44 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 0.0 109.837 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -55.78 -26.71 47.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.933 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.62 -13.19 61.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.977 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.798 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -147.87 78.19 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.183 -0.948 . . . . 0.0 111.001 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 52.07 101.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 97' ' ' LEU . . . -163.06 123.53 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -1.211 . . . . 0.0 110.744 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -78.41 141.63 38.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 133' ' ' ALA . 0.5 OUTLIER -126.4 8.19 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.335 -0.853 . . . . 0.0 110.287 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -115.75 49.62 1.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.062 -1.024 . . . . 0.0 111.365 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.81 HG11 ' CG ' ' A' ' 80' ' ' ARG . 7.6 p -112.45 171.64 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.85 ' HG2' HD12 ' A' ' 113' ' ' LEU . 24.1 mtm180 -131.42 143.8 50.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 109.59 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -68.51 58.04 0.08 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.241 -0.912 . . . . 0.0 110.17 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 50.9 -88.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.897 ' CH2' HG23 ' A' ' 77' ' ' THR . 5.8 p90 -112.62 -1.57 14.79 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.263 -0.898 . . . . 0.0 110.758 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -77.93 -80.61 0.68 Allowed Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 4.3 mtt180 170.98 -169.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.816 -0.814 . . . . 0.0 110.069 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.85 HD12 ' HG2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -80.37 166.96 36.56 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 110.417 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.1 Cg_endo -72.32 -35.91 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.813 1.428 . . . . 0.0 110.16 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 7.9 p -67.69 -28.45 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -50.68 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.71 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -24.71 41.95 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.272 -0.893 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.29 -62.9 1.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 111.109 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -23.77 1.16 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -37.2 23.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.285 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 1.7 mm? -86.9 7.52 26.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.31 24.03 52.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.322 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 17.0 m-70 -99.4 43.47 1.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.951 -1.323 . . . . 0.0 109.223 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -42.58 7.77 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.292 0.568 . . . . 0.0 110.158 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.09 -38.13 78.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 109.6 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.912 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.3 t -82.54 -38.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.41 -22.65 63.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -68.1 -71.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 0.0 110.389 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.614 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 2.4 t80 -53.88 -45.11 70.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 86' ' ' ALA . 12.9 mt -50.53 -55.26 16.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.522 -0.736 . . . . 0.0 109.488 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.435 ' CA ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -54.46 -23.14 14.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.169 -0.957 . . . . 0.0 109.95 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -80.31 -52.36 7.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -88.37 -7.13 57.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 111.134 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.811 0 O-C-N 120.921 -1.112 . . . . 0.0 110.508 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.891 0.377 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.598 ' HB3' HD11 ' A' ' 31' ' ' LEU . 21.2 m0 -48.04 -33.96 8.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.313 -0.867 . . . . 0.0 109.7 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.825 HD22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -43.86 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.375 0.607 . . . . 0.0 110.849 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 42' ' ' ASN . . . -43.89 -54.02 5.63 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.69 -0.631 . . . . 0.0 111.299 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -59.58 3.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 110.702 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.17 -47.93 74.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.326 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -57.06 -48.9 77.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.455 -0.778 . . . . 0.0 110.319 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.98 -25.63 67.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 110.105 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -85.78 5.45 32.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.308 -0.87 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 63.97 44.81 95.43 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -122.1 72.7 1.05 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.953 . . . . 0.0 109.611 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.831 HG22 HG23 ' A' ' 59' ' ' VAL . 39.1 t -53.38 -45.41 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.414 -0.804 . . . . 0.0 110.274 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.33 -33.99 66.14 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 0.0 110.508 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' O ' HD12 ' A' ' 31' ' ' LEU . 5.7 tt0 -68.19 -41.8 80.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.871 . . . . 0.0 109.772 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.82 HG12 HD12 ' A' ' 32' ' ' LEU . 21.4 t -77.59 -45.38 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.958 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.699 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.22 -47.77 35.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -29.83 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 15' ' ' TRP . 7.9 mt -68.34 -70.43 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.206 -0.934 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.842 HD22 ' CG ' ' A' ' 66' ' ' HIS . 1.3 mt -46.88 -49.41 20.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.373 -0.829 . . . . 0.0 111.542 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -60.9 -24.46 66.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.31 -5.79 55.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.48 29.83 3.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.46 128.35 33.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -1.099 . . . . 0.0 110.123 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.825 ' O ' HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -49.25 111.6 2.05 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.38 -0.825 . . . . 0.0 110.666 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HA ' HD21 ' A' ' 16' ' ' LEU . 43.3 Cg_endo -69.12 -33.15 19.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.678 1.357 . . . . 0.0 110.811 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.68 50.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.707 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -78.01 150.96 78.61 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.415 -0.803 . . . . 0.0 110.324 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.87 116.38 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.79 1.416 . . . . 0.0 110.188 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 12.9 m120 -94.21 170.68 9.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.961 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -89.95 33.41 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.638 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -137.06 3.63 2.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.054 -1.029 . . . . 0.0 110.725 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.14 26.87 36.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -130.78 20.8 5.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -1.15 . . . . 0.0 110.691 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 48.91 -177.51 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.707 -0.62 . . . . 0.0 111.069 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 50' ' ' GLN . 44.4 Cg_endo -72.95 -179.52 4.36 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.44 1.232 . . . . 0.0 111.165 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.62 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 56.88 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.761 -0.587 . . . . 0.0 110.322 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -47.73 -23.09 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.939 -1.101 . . . . 0.0 110.264 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.66 6.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 110.664 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -68.98 171.65 7.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.795 -1.191 . . . . 0.0 109.211 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.432 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 3.2 ttm -52.79 -19.06 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.229 -0.919 . . . . 0.0 110.37 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.606 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.48 10.14 3.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.405 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -119.02 18.28 10.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.3 78.25 1.32 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.459 -1.024 . . . . 0.0 109.449 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -44.75 -28.88 0.68 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.0 110.378 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -42.71 57.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.831 HG23 HG22 ' A' ' 25' ' ' VAL . 77.8 t -53.67 -60.84 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.488 -0.757 . . . . 0.0 109.409 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -53.53 -52.34 59.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.326 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.786 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.0 tt0 -45.74 -35.73 4.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.196 -0.94 . . . . 0.0 110.062 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.775 HD21 HG12 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -78.3 -60.89 2.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.573 -0.704 . . . . 0.0 109.248 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.0 mt -60.95 -56.07 25.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 110.521 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.738 HD13 HG12 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -48.68 -62.47 1.49 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.563 -0.711 . . . . 0.0 110.814 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -55.16 -24.96 29.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.972 -1.08 . . . . 0.0 109.385 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.842 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -82.22 -29.26 31.48 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.416 -0.802 . . . . 0.0 109.811 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.47 38.02 0.31 Allowed Glycine 0 N--CA 1.479 1.508 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.65 -148.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 0.0 109.678 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -115.65 59.04 1.45 Allowed Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.332 -0.855 . . . . 0.0 110.387 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.1 -8.64 22.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.553 1.291 . . . . 0.0 110.613 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.474 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 2.2 t30 -129.1 -65.26 0.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.314 -0.866 . . . . 0.0 109.704 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.88 144.29 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 110.532 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -136.34 -136.01 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.27 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -110.68 136.02 20.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.057 -1.027 . . . . 0.0 110.221 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.2 -5.35 16.95 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.542 1.285 . . . . 0.0 110.596 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.1 -49.67 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.619 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -120.57 9.63 10.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.377 -0.827 . . . . 0.0 110.945 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.522 ' HA ' HD23 ' A' ' 78' ' ' LEU . 7.4 mt 47.02 27.81 0.8 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.479 HG23 ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -60.59 89.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.644 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.814 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -69.14 168.78 13.99 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.864 . . . . 0.0 110.366 -179.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.595 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 54.5 Cg_endo -72.72 2.58 5.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 124.003 1.528 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 104' ' ' LEU . 19.8 t -85.09 -31.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 110.301 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 83' ' ' HIS . 9.1 m80 -67.48 -43.67 80.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.08 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.9 OUTLIER -53.52 -54.09 42.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.701 -0.624 . . . . 0.0 111.373 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.675 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -52.76 -63.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 109.934 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.813 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.05 -55.01 40.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.26 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 5.0 tpt180 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.507 -0.746 . . . . 0.0 111.299 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 54' ' ' MET . 9.9 tp10 -103.83 -4.64 23.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.025 -1.047 . . . . 0.0 111.09 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 20.83 69.14 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.613 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -102.01 96.35 6.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -1.151 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.669 HD21 ' CG ' ' A' ' 129' ' ' TYR . 1.2 tt -69.82 -38.37 76.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.724 -0.61 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 96' ' ' VAL . 42.3 m-20 -50.56 -41.62 54.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.89 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.1 m -55.89 -48.27 75.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.733 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.704 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -59.05 -43.21 91.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.833 . . . . 0.0 109.805 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -51.47 -49.17 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 HD13 ' A' ' 64' ' ' LEU . 25.4 t -59.83 -43.1 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.589 0.709 . . . . 0.0 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.52 ' HA ' HD11 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -56.96 -58.62 7.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.618 -0.677 . . . . 0.0 110.107 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -65.41 -35.74 81.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 110.125 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 2.3 ttp85 -61.57 -14.9 33.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.411 -0.806 . . . . 0.0 110.449 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -140.79 54.43 1.59 Allowed 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.988 -1.07 . . . . 0.0 111.168 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.36 106.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -156.91 97.57 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.467 -1.02 . . . . 0.0 109.876 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -51.37 115.32 1.53 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.338 -0.851 . . . . 0.0 110.404 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -105.36 4.08 30.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 110.611 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -112.63 51.46 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 110.535 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.814 HG11 ' CG ' ' A' ' 80' ' ' ARG . 4.5 p -107.55 -178.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.997 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.641 ' H ' HG22 ' A' ' 106' ' ' VAL . 42.3 mtt85 -131.26 153.01 49.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 109.564 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -80.38 54.93 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.537 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 62.86 -68.65 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.626 -0.672 . . . . 0.0 111.276 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 6.6 m0 -65.67 -37.68 87.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.818 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.79 -20.56 1.0 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.493 ' HB2' ' HB2' ' A' ' 108' ' ' ASP . 12.4 mtt180 -49.75 136.77 17.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -1.106 . . . . 0.0 110.266 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -111.06 161.17 26.17 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.358 -0.839 . . . . 0.0 110.116 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -70.24 -21.62 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.583 1.307 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.441 ' CB ' HD11 ' A' ' 130' ' ' LEU . 4.4 p -86.57 -31.74 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.053 -1.029 . . . . 0.0 110.038 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.34 -22.96 63.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.9 mt -75.67 -44.59 41.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.537 -0.727 . . . . 0.0 110.497 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -68.2 -36.22 79.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.94 -39.24 88.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -57.7 3.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 109.897 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.51 -85.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.478 -0.764 . . . . 0.0 110.257 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.03 39.31 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 22.6 m-70 -103.87 55.82 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.378 -1.072 . . . . 0.0 108.822 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.51 -40.81 13.15 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.45 0.643 . . . . 0.0 109.909 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.16 -42.17 90.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.646 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.3 t -82.18 -44.88 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.987 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -54.8 -37.61 66.3 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -77.14 -48.26 18.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.73 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.669 ' CG ' HD21 ' A' ' 91' ' ' LEU . 27.2 t80 -70.73 -57.16 4.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.119 -0.988 . . . . 0.0 110.503 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.623 ' C ' HD12 ' A' ' 130' ' ' LEU . 0.7 OUTLIER -54.55 -32.75 58.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.114 -0.992 . . . . 0.0 110.612 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 127' ' ' ALA . 23.7 ttt180 -66.55 -38.13 86.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -0.847 . . . . 0.0 110.083 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.378 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.81 -19.41 23.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.733 -0.605 . . . . 0.0 110.295 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.332 -0.855 . . . . 0.0 110.721 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.83 0.347 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 3.0 m0 -85.13 -26.78 26.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 17' ' ' ALA . 3.8 pp -61.99 -32.48 72.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 109.457 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.545 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -80.34 -48.2 13.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.4 -0.813 . . . . 0.0 109.89 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -63.06 -41.07 99.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -55.51 -52.44 63.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.408 -0.808 . . . . 0.0 109.775 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -58.62 -31.89 68.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.358 -0.838 . . . . 0.0 110.192 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . -59.79 -35.47 74.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -94.18 23.46 5.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.28 42.85 89.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -105.12 67.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.877 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.563 HG12 ' HD3' ' A' ' 29' ' ' ARG . 85.3 t -51.75 -30.01 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.469 -0.769 . . . . 0.0 110.325 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -73.27 -39.06 65.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.325 -0.859 . . . . 0.0 110.728 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.637 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.5 tp10 -66.74 -31.99 73.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.257 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.853 HG12 HD12 ' A' ' 32' ' ' LEU . 6.5 t -83.09 -46.49 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.563 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.368 -0.833 . . . . 0.0 110.123 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.75 -35.98 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 109.728 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 27' ' ' GLU . 3.4 mt -59.09 -65.1 0.72 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.853 HD12 HG12 ' A' ' 28' ' ' VAL . 2.5 mt -51.39 -34.82 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 110.259 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -20.09 62.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.954 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.75 -9.23 47.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.09 28.01 2.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -57.71 151.49 17.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -1.168 . . . . 0.0 109.74 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' O ' HD22 ' A' ' 16' ' ' LEU . 2.3 mp -73.35 135.43 79.15 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 109.729 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.11 -31.41 19.02 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.546 1.287 . . . . 0.0 110.128 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -139.69 61.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.558 -0.714 . . . . 0.0 110.032 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.4 160.01 83.83 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.283 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.5 124.03 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.827 1.435 . . . . 0.0 110.487 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -108.79 158.58 17.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -95.44 27.96 3.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 110.537 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -136.48 13.33 3.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 109.953 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.96 26.9 35.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.9 tpp180 -130.66 107.04 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 110.217 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.574 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mpt_? -55.09 -175.08 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.595 -0.691 . . . . 0.0 110.259 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.759 ' HB2' HD13 ' A' ' 63' ' ' LEU . 38.2 Cg_endo -64.34 163.66 25.76 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.267 1.14 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 66.68 -59.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' PRO . 5.1 tt0 -53.22 -20.93 4.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 46' ' ' ARG . 12.0 p -114.82 -7.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.622 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -56.52 165.17 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.986 -1.071 . . . . 0.0 109.796 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.418 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 0.9 OUTLIER -54.73 -17.07 3.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.229 -0.92 . . . . 0.0 110.397 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.58 ' HE1' ' HE2' ' A' ' 52' ' ' MET . 0.0 OUTLIER 61.96 11.46 4.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.41 18.42 20.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -155.47 96.08 1.75 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.674 -0.898 . . . . 0.0 109.634 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.91 -21.04 56.99 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.344 -0.848 . . . . 0.0 109.759 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -56.43 -30.49 62.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.567 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.546 HG11 ' HB1' ' A' ' 20' ' ' ALA . 41.2 t -64.68 -44.88 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.591 -0.693 . . . . 0.0 109.947 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.841 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.2 tt0 -45.73 -29.18 1.21 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.156 -0.965 . . . . 0.0 110.775 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.692 ' CD1' HD13 ' A' ' 32' ' ' LEU . 2.7 tp -83.82 -56.8 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 110.019 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 8.2 mt -67.68 -35.06 78.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.729 HD11 ' CB ' ' A' ' 100' ' ' ALA . 2.7 tm? -61.74 -65.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.81 -0.556 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.7 pp -54.53 -24.15 19.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.813 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.842 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.0 m80 -81.6 -49.95 9.92 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.526 -0.734 . . . . 0.0 110.134 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.24 46.02 0.03 OUTLIER Glycine 0 N--CA 1.482 1.731 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.029 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -75.57 -155.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.786 -1.42 . . . . 0.0 109.192 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 47' ' ' ARG . 6.7 tp10 -122.99 68.4 35.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 110.267 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HG3' HD23 ' A' ' 64' ' ' LEU . 52.5 Cg_endo -73.23 -9.13 22.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.896 1.471 . . . . 0.0 110.384 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 3.7 t30 -117.82 -70.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.711 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 152.7 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.105 -0.997 . . . . 0.0 111.082 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -137.62 -137.42 0.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 2.2 t70 -122.13 132.11 24.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.67 -7.78 21.85 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.639 1.336 . . . . 0.0 110.88 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.35 -55.74 4.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.212 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.531 HG22 ' CH2' ' A' ' 110' ' ' TRP . 61.2 p -117.26 7.34 12.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.2 mt 49.33 30.35 3.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.269 -0.894 . . . . 0.0 111.005 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -69.0 91.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.136 -0.977 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.87 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.87 159.22 83.51 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.623 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HB2' HD21 ' A' ' 97' ' ' LEU . 44.0 Cg_endo -70.08 -6.13 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.654 1.344 . . . . 0.0 110.626 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 t -77.29 -31.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 110.021 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 35.9 m80 -69.74 -42.8 73.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -0.828 . . . . 0.0 109.301 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.47 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.7 m-20 -48.47 -49.01 37.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.708 -0.62 . . . . 0.0 110.527 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.489 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -60.79 -68.9 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.819 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -50.64 -55.96 14.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.453 -0.78 . . . . 0.0 111.16 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 6.7 ttm180 -44.74 -27.79 0.55 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.173 -0.954 . . . . 0.0 111.683 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.476 ' CG ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -102.11 -5.03 24.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.689 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 79.84 36.06 26.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -116.41 101.66 8.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 110.724 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 125' ' ' ASP . 1.0 OUTLIER -83.1 -35.14 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 96' ' ' VAL . 3.1 m-20 -48.48 -43.06 34.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.383 -0.823 . . . . 0.0 109.784 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 m -65.07 -39.3 93.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 109.0 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.919 HD21 ' HB2' ' A' ' 130' ' ' LEU . 1.5 tp -51.81 -48.93 63.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.613 -0.68 . . . . 0.0 109.838 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 45.2 t -56.51 -51.35 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 109.68 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.5 HG12 ' HG ' ' A' ' 64' ' ' LEU . 26.3 t -49.25 -53.32 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.449 -0.782 . . . . 0.0 110.296 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.464 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -50.65 -67.76 0.23 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.468 -0.77 . . . . 0.0 110.683 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -61.86 -30.18 70.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.297 -0.877 . . . . 0.0 110.585 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -61.72 -16.6 50.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.348 -0.845 . . . . 0.0 110.764 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.729 ' CB ' HD11 ' A' ' 64' ' ' LEU . . . -129.74 -44.82 1.19 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.751 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.69 108.6 0.22 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -167.59 112.57 0.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -1.088 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.407 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -66.04 95.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.477 -0.765 . . . . 0.0 109.844 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 59.75 5.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.285 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -170.49 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -0.954 . . . . 0.0 110.062 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.87 HG11 ' CG ' ' A' ' 80' ' ' ARG . 1.5 p -102.54 -169.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.622 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.28 112.11 6.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.217 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.02 147.45 9.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.356 -0.84 . . . . 0.0 110.663 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -57.46 -27.24 62.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.531 ' CH2' HG22 ' A' ' 77' ' ' THR . 7.0 m95 -63.41 -14.35 49.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.72 46.02 5.86 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.41 104.29 2.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -1.043 . . . . 0.0 110.156 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.448 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -54.31 167.49 0.55 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.9 . . . . 0.0 109.941 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.553 ' O ' HD21 ' A' ' 130' ' ' LEU . 43.8 Cg_endo -69.93 -34.93 13.06 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.614 1.323 . . . . 0.0 109.931 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 131' ' ' ARG . 5.9 p -74.01 -27.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.398 -0.814 . . . . 0.0 110.192 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -37.94 63.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 109.69 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 87' ' ' ARG . 2.0 tt -69.39 -41.93 75.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.116 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -56.39 -48.49 76.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.267 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -65.51 -22.18 66.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.973 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.39 -65.62 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -83.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.182 -0.948 . . . . 0.0 110.539 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 35.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 24.0 m-70 -105.66 36.81 2.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -1.055 . . . . 0.0 108.659 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -46.87 -45.15 20.17 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.405 0.621 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.723 ' O ' HD12 ' A' ' 91' ' ' LEU . 14.8 p30 -56.64 -39.82 74.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.376 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 86' ' ' ALA . 10.6 t -74.14 -52.44 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 109.841 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.674 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -48.99 -28.54 3.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.628 -0.67 . . . . 0.0 111.227 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -50.02 -70.58 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.03 -1.044 . . . . 0.0 110.626 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -73.11 -28.36 62.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.919 ' HB2' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -72.1 -14.53 61.87 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 109.634 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.477 ' HA ' HG21 ' A' ' 115' ' ' VAL . 10.6 ttt180 -88.21 -42.97 11.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.143 -0.973 . . . . 0.0 110.064 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.14 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.7 -23.89 20.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 110.547 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' OG1' ' A' ' 18' ' ' THR . 9.0 p-10 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.214 0.53 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.647 ' O ' HD13 ' A' ' 31' ' ' LEU . 30.6 m0 -67.7 -28.15 67.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.449 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.051 HD13 HD21 ' A' ' 63' ' ' LEU . 3.9 pp -63.13 -38.93 93.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 110.063 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.789 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -77.25 -42.12 38.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 110.056 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -60.54 -40.95 93.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 110.318 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -70.79 -35.92 72.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.773 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB1' ' HB2' ' A' ' 52' ' ' MET . . . -67.08 -45.15 78.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 109.748 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.77 -29.33 68.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.617 -0.677 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -88.23 14.98 8.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 0.0 110.107 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.26 50.22 56.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -123.83 77.43 1.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -1.055 . . . . 0.0 110.315 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 59' ' ' VAL . 59.4 t -51.55 -46.35 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.386 -0.822 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.63 -60.7 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.594 -0.691 . . . . 0.0 110.311 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 -38.18 65.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.459 -0.776 . . . . 0.0 109.73 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.081 HG12 HD23 ' A' ' 62' ' ' LEU . 21.6 t -69.97 -56.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.956 ' HA ' HD22 ' A' ' 62' ' ' LEU . 9.8 mmm-85 -46.1 -45.17 16.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.73 . . . . 0.0 110.243 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.62 -36.93 57.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.483 -0.761 . . . . 0.0 109.567 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 15' ' ' TRP . 11.6 mt -62.15 -67.28 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.934 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -44.62 -43.56 8.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.665 -0.647 . . . . 0.0 110.164 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 2.6 tt0 -79.77 -17.43 53.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.643 -0.66 . . . . 0.0 110.798 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -80.74 -8.05 59.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 111.012 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.46 0.19 4.13 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.876 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.934 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -52.2 157.59 1.34 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.996 -1.297 . . . . 0.0 110.0 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.958 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 18.3 mt -86.14 153.77 57.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.114 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 48.5 Cg_endo -77.38 -54.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.644 1.339 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -107.44 40.05 1.77 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.839 . . . . 0.0 109.571 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.958 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -61.54 126.73 87.33 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.592 -0.693 . . . . 0.0 110.423 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.89 151.44 50.85 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.668 1.352 . . . . 0.0 110.099 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -122.52 171.68 8.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.865 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -4.44 59.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.325 -0.859 . . . . 0.0 110.07 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' HD2' HG21 ' A' ' 51' ' ' VAL . 3.3 m-30 -100.78 -3.04 30.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.93 29.02 54.47 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -119.83 39.41 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -1.065 . . . . 0.0 111.064 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 10.5 mmt180 49.59 172.68 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.424 -0.797 . . . . 0.0 111.741 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 53.4 Cg_endo -77.0 -18.63 14.43 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.638 1.336 . . . . 0.0 110.51 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.796 HG23 ' SD ' ' A' ' 52' ' ' MET . 15.3 mt -104.94 -47.2 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -48.4 -25.03 1.43 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG21 ' HD2' ' A' ' 44' ' ' TYR . 11.5 p -100.05 -1.03 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.957 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.7 ptt? -75.55 141.14 43.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ttp -54.25 123.6 13.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.976 . . . . 0.0 108.528 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.564 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -82.02 44.12 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.967 -1.083 . . . . 0.0 110.823 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.25 2.28 11.48 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.639 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -137.14 88.87 2.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.714 -0.874 . . . . 0.0 109.96 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -61.54 -11.67 12.03 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.115 -0.991 . . . . 0.0 109.951 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.1 -47.43 58.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.994 HG13 HG11 ' A' ' 28' ' ' VAL . 42.2 t -45.52 -62.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.41 -0.806 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -49.13 -40.76 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.094 -1.004 . . . . 0.0 109.648 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 7.4 tm-20 -50.07 -27.49 5.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.77 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.081 HD23 HG12 ' A' ' 28' ' ' VAL . 8.3 tp -90.05 -54.46 4.03 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.051 HD21 HD13 ' A' ' 16' ' ' LEU . 11.4 mt -55.11 -46.28 75.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -69.59 -41.04 76.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 5.4 tp -54.08 -33.67 58.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.542 ' CG ' HD11 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -90.78 -47.02 7.88 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.767 -0.583 . . . . 0.0 109.555 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.25 63.84 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 C-N-CA 120.151 -1.024 . . . . 0.0 110.758 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.759 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -77.04 -153.85 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.948 -1.324 . . . . 0.0 109.283 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.59 55.76 2.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.111 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.572 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 45.9 Cg_endo -70.81 -14.84 33.06 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.576 1.303 . . . . 0.0 110.323 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 -64.12 1.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.47 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.2 150.73 8.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 111.03 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' NE ' ' A' ' 80' ' ' ARG . . . -128.83 -153.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.584 -0.698 . . . . 0.0 109.134 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -102.13 136.7 19.41 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 0.0 109.701 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.41 -3.2 13.56 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.396 1.208 . . . . 0.0 110.699 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.66 -30.72 18.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 0.0 109.471 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.627 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -151.11 22.07 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 109.854 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.8 OUTLIER 37.28 33.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.862 -0.524 . . . . 0.0 111.515 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -69.34 100.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.872 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.51 166.92 25.93 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.273 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 43.9 Cg_endo -72.79 -21.08 21.91 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.578 1.304 . . . . 0.0 109.581 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.953 HG21 ' HA ' ' A' ' 104' ' ' LEU . 45.8 t -54.16 -30.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 32.8 m80 -71.65 -42.85 67.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 10.7 t0 -49.1 -47.46 45.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.779 -0.575 . . . . 0.0 109.926 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.464 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -59.72 -69.42 0.21 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.456 -0.777 . . . . 0.0 110.548 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.75 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.58 -41.6 86.08 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.003 . . . . 0.0 111.446 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.48 ' NH1' HD11 ' A' ' 121' ' ' LEU . 12.1 tpt85 -45.84 -41.54 11.27 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 110.886 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.5 5.34 49.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.97 34.26 27.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -103.29 97.81 7.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -1.119 . . . . 0.0 110.999 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 91' ' ' LEU . 3.0 tt -82.67 -40.21 21.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 109.64 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.511 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.3 m-20 -46.42 -56.11 6.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.582 -0.699 . . . . 0.0 109.846 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 m -54.08 -43.38 70.28 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD23 ' CD1' ' A' ' 129' ' ' TYR . 0.7 OUTLIER -50.59 -34.26 25.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 25.1 t -72.92 -45.2 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.582 -0.699 . . . . 0.0 109.118 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 46.6 t -61.12 -46.71 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -0.785 . . . . 0.0 109.808 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' HA ' HD11 ' A' ' 64' ' ' LEU . 3.7 mm? -52.58 -46.0 66.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.451 -0.78 . . . . 0.0 110.217 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -84.35 -12.84 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 96' ' ' VAL . 2.5 mtt180 -80.06 -12.02 59.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.328 -0.858 . . . . 0.0 111.013 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.57 -66.25 0.77 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.52 108.41 0.29 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 97' ' ' LEU . . . -168.66 128.36 1.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -1.062 . . . . 0.0 110.578 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 112.26 23.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.965 HD12 ' HB2' ' A' ' 134' ' ' ALA . 0.4 OUTLIER -104.06 5.19 35.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 110.644 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 134' ' ' ALA . 5.0 m-20 -100.31 41.14 1.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.63 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.872 HG11 ' CD ' ' A' ' 80' ' ' ARG . 7.2 p -108.75 178.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.822 . . . . 0.0 110.925 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.587 ' H ' HG22 ' A' ' 106' ' ' VAL . 11.4 ptt180 -131.17 143.69 50.81 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -68.06 69.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.387 -0.82 . . . . 0.0 110.803 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 60.92 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.627 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.7 m-90 -60.08 -75.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.755 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.98 32.28 0.07 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.503 ' CB ' ' HB2' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -89.42 107.96 19.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -1.129 . . . . 0.0 109.824 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.652 HD13 ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -82.55 159.11 64.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.434 -0.791 . . . . 0.0 110.159 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.652 ' HD2' HD13 ' A' ' 113' ' ' LEU . 42.3 Cg_endo -71.59 -24.68 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.797 1.419 . . . . 0.0 110.398 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 127' ' ' ALA . 11.6 p -79.42 -40.16 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.127 -0.983 . . . . 0.0 110.087 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.497 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -69.23 -30.01 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.483 -0.76 . . . . 0.0 109.884 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.465 HD21 ' HD3' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -78.4 -32.0 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.023 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.718 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.51 -44.7 50.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 109.672 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -36.42 78.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 110.02 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -59.5 4.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -0.813 . . . . 0.0 109.96 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.48 HD11 ' NH1' ' A' ' 87' ' ' ARG . 3.3 mm? -54.83 -82.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.28 37.24 0.03 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.481 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 31.1 m-70 -113.87 52.38 0.82 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.336 -1.096 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -33.83 9.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 110.27 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.426 ' C ' HD12 ' A' ' 91' ' ' LEU . 2.0 m-20 -63.81 -39.23 93.75 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.364 -0.835 . . . . 0.0 108.938 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -83.91 -43.18 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 109.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -63.27 -34.02 76.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -52.25 43.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.41 -0.807 . . . . 0.0 109.48 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.617 ' CD1' HD23 ' A' ' 94' ' ' LEU . 4.8 t80 -60.86 -30.34 70.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.747 . . . . 0.0 109.168 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.748 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 36.6 mt -65.13 -60.13 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.039 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' A' ' 115' ' ' VAL . 5.9 ttp180 -53.24 -20.82 4.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 110.411 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.7 -60.19 2.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.48 -12.52 59.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.372 -0.83 . . . . 0.0 110.389 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.965 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 120.962 0.41 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.562 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.3 OUTLIER -66.39 -4.73 8.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.404 -0.81 . . . . 0.0 111.146 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 38' ' ' PRO . 1.3 tp -80.55 -45.21 17.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.883 -1.135 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.7 53.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 110.171 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -61.32 -54.72 40.32 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -51.85 -49.44 62.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.366 -0.834 . . . . 0.0 109.784 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.12 -48.03 68.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 109.317 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -62.06 -28.93 69.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.579 -0.701 . . . . 0.0 109.345 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.93 20.65 3.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.655 -0.653 . . . . 0.0 110.286 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.46 52.92 22.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.627 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -128.72 96.03 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.109 . . . . 0.0 110.526 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 ' CG2' ' A' ' 59' ' ' VAL . 98.5 t -73.11 -54.6 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -44.08 -40.98 5.24 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.56 -0.712 . . . . 0.0 111.549 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.565 ' OE2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.02 -46.5 71.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.997 -1.064 . . . . 0.0 109.902 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.889 HG12 HD12 ' A' ' 32' ' ' LEU . 17.8 t -68.25 -41.29 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.819 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.929 ' HA ' HD11 ' A' ' 62' ' ' LEU . 13.6 mmm180 -50.43 -47.46 56.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.0 110.123 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.58 -45.1 47.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.79 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 ' OE2' ' A' ' 27' ' ' GLU . 10.6 mt -56.97 -60.45 3.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 110.198 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.901 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 mt -51.1 -32.57 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.313 -0.867 . . . . 0.0 109.574 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.58 -25.34 45.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.588 -0.695 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.67 -5.22 52.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.325 -0.859 . . . . 0.0 110.201 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.2 22.02 5.37 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -65.06 141.05 58.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.173 -1.192 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD1' ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -104.72 117.45 58.86 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.471 -0.768 . . . . 0.0 109.53 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HA ' HD21 ' A' ' 16' ' ' LEU . 43.0 Cg_endo -69.66 -29.53 24.23 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.46 1.242 . . . . 0.0 110.802 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.36 44.75 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 0.0 109.73 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . . . -88.3 155.57 51.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.581 -0.7 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.05 89.18 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.669 1.352 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 47' ' ' ARG . 41.3 m-80 -59.55 151.22 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.541 -0.725 . . . . 0.0 110.381 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.85 26.65 2.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.438 -0.789 . . . . 0.0 110.772 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -160.64 26.1 0.15 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.33 -0.856 . . . . 0.0 110.207 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.02 35.1 53.34 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -120.21 89.6 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.7 -0.883 . . . . 0.0 110.165 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -54.84 179.24 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.557 -0.714 . . . . 0.0 109.994 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.774 ' CB ' HD23 ' A' ' 63' ' ' LEU . 41.8 Cg_endo -66.96 156.77 64.83 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.387 1.204 . . . . 0.0 109.376 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 6.7 mt 67.2 -59.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 48' ' ' PRO . 36.4 tt0 -49.59 -21.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.919 -1.113 . . . . 0.0 109.688 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.5 p -124.49 37.06 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.812 . . . . 0.0 110.017 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.756 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -101.84 37.67 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.293 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.2 ttp 64.91 -9.22 0.2 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.535 -0.728 . . . . 0.0 111.693 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.554 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.4 28.57 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.035 -1.04 . . . . 0.0 110.339 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.27 11.46 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -144.54 73.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -1.021 . . . . 0.0 109.549 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -47.23 -27.92 1.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.605 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -59.24 -31.88 69.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.935 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.796 ' CG2' HG22 ' A' ' 25' ' ' VAL . 48.4 t -71.8 -50.41 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.756 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -43.0 -46.84 5.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.71 -55.15 38.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 109.702 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -44.38 -56.21 4.39 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.652 -0.655 . . . . 0.0 110.708 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.774 HD23 ' CB ' ' A' ' 48' ' ' PRO . 6.2 mp -68.84 -58.84 3.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 110.541 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -48.24 -52.91 19.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.175 -0.953 . . . . 0.0 110.301 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -55.04 -33.84 63.03 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.397 -0.814 . . . . 0.0 109.319 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.792 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.5 m-70 -81.88 -48.78 11.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.302 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.39 43.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.577 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' HA ' ' CG ' ' A' ' 48' ' ' PRO . . . -69.02 -172.53 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.703 -1.469 . . . . 0.0 109.722 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 47' ' ' ARG . 3.7 mm-40 -121.02 65.14 13.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.378 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.486 ' HG3' HD21 ' A' ' 64' ' ' LEU . 42.8 Cg_endo -68.84 -26.16 32.4 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.07 1.563 . . . . 0.0 110.378 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -92.7 -63.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 173.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -164.07 -170.74 2.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.85 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.52 132.96 43.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.604 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 -15.92 39.51 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.556 1.293 . . . . 0.0 110.708 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.76 -84.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 109.991 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 66.6 p -110.1 32.99 4.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.286 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 5.5 mt 49.27 32.54 4.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.472 -0.767 . . . . 0.0 110.529 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.61 97.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.503 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -72.24 147.78 90.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.457 -0.777 . . . . 0.0 109.859 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 40.8 Cg_endo -66.56 -20.59 53.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.521 1.274 . . . . 0.0 109.515 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.977 HG13 HD23 ' A' ' 104' ' ' LEU . 27.6 t -58.46 -25.7 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -0.801 . . . . 0.0 109.8 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.493 ' CE1' ' HB3' ' A' ' 80' ' ' ARG . 23.9 m80 -73.27 -41.29 63.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.554 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.55 -43.85 46.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.694 -0.629 . . . . 0.0 110.23 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.708 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -63.35 -64.54 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.388 -0.82 . . . . 0.0 109.736 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.757 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -59.46 -52.41 65.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -41.27 -34.85 0.54 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.33 -8.99 28.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.16 -0.962 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . 82.92 23.81 54.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.646 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -98.95 84.01 3.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 110.445 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -57.9 -39.62 78.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 110.46 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.588 ' O ' HG23 ' A' ' 96' ' ' VAL . 46.2 t0 -50.01 -40.96 46.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.032 -1.042 . . . . 0.0 109.959 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 85' ' ' ALA . 50.7 m -60.03 -32.38 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.71 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.708 HD12 ' HB1' ' A' ' 85' ' ' ALA . 1.1 mp -72.15 -51.23 22.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.419 -0.801 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.3 t -50.17 -45.02 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.538 -0.726 . . . . 0.0 109.579 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 92' ' ' ASP . 39.1 t -61.72 -49.04 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.578 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.593 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.75 -71.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.139 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -48.77 -34.42 12.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.685 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -62.03 -20.72 64.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.54 86.15 1.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.212 -0.93 . . . . 0.0 111.124 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 49.13 97.8 0.01 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -168.19 97.5 0.43 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -1.131 . . . . 0.0 110.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.764 ' O ' HG21 ' A' ' 82' ' ' VAL . 10.7 ttm180 -71.93 137.08 47.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.49 -0.756 . . . . 0.0 109.567 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.977 HD23 HG13 ' A' ' 82' ' ' VAL . 1.1 mp -121.32 21.37 11.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 103' ' ' ARG . 4.8 p-10 -124.32 40.43 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.067 -1.02 . . . . 0.0 110.584 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.64 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.7 p -101.44 -171.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.64 ' H ' HG22 ' A' ' 106' ' ' VAL . 38.7 mtp180 -135.33 142.8 45.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 110' ' ' TRP . 94.0 m-20 -78.42 60.66 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 110.046 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.2 -71.18 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.756 -0.59 . . . . 0.0 111.082 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.597 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -40.57 -58.38 1.61 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.435 -0.791 . . . . 0.0 110.829 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -23.5 0.73 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -56.02 160.56 2.75 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.323 -1.104 . . . . 0.0 109.896 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 106' ' ' VAL . 36.6 mt -120.02 166.9 13.71 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 0.0 110.679 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.79 -34.92 29.44 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.806 1.424 . . . . 0.0 110.392 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 130' ' ' LEU . 9.8 p -82.78 -33.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.57 -38.37 90.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -60.15 -24.56 64.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.785 . . . . 0.0 110.14 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -83.19 -27.7 29.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.26 -40.58 70.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.7 -47.28 32.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 117' ' ' LEU . 5.2 mp -69.85 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.32 38.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 16.6 m-70 -99.3 48.99 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.277 -1.131 . . . . 0.0 109.275 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -44.31 -38.02 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.757 -0.589 . . . . 0.0 110.646 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.53 -44.67 95.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.757 HG11 ' CB ' ' A' ' 86' ' ' ALA . 22.7 t -78.67 -42.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.426 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -50.98 -41.41 59.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -63.94 1.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.52 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.7 t80 -54.0 -41.38 67.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.498 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 86' ' ' ALA . 15.5 mt -58.1 -65.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.84 -26.04 0.89 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.076 -1.015 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.06 -58.58 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.05 -3.59 36.72 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.522 -0.736 . . . . 0.0 110.977 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 109.833 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.366 0.603 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.508 ' CD1' ' N ' ' A' ' 15' ' ' TRP . 35.6 m0 -68.19 -4.4 13.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.657 -0.652 . . . . 0.0 111.536 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.747 HD11 ' HB1' ' A' ' 36' ' ' ALA . 25.1 mt -79.66 -52.26 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 108.825 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.42 83.92 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.029 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -75.25 -60.95 2.07 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.21 -0.931 . . . . 0.0 111.074 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -45.74 -57.68 4.07 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.159 -0.963 . . . . 0.0 110.821 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -53.53 -41.43 66.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -64.7 -33.1 75.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.712 . . . . 0.0 110.198 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 24.5 2.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.824 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.22 61.05 6.13 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.98 68.25 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.964 . . . . 0.0 109.72 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 59' ' ' VAL . 18.1 t -52.7 -54.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.539 -0.726 . . . . 0.0 110.308 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -42.74 -38.07 1.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.0 110.747 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -66.3 -51.49 56.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.719 HG12 HD13 ' A' ' 62' ' ' LEU . 5.2 t -68.62 -42.89 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.561 -0.712 . . . . 0.0 110.215 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.932 ' HA ' HD11 ' A' ' 62' ' ' LEU . 14.4 mmm180 -46.41 -48.02 18.82 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.375 -0.828 . . . . 0.0 110.277 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.24 -37.65 52.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.465 -0.772 . . . . 0.0 109.918 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 14.4 mt -59.2 -66.94 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.874 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 23.7 mt -46.93 -48.52 21.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.581 -0.699 . . . . 0.0 110.427 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.08 -18.67 65.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.608 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.53 -6.68 57.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 111.012 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.21 31.79 1.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.874 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -74.09 157.93 35.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -1.057 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.96 115.26 61.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.442 -0.786 . . . . 0.0 109.911 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' HD13 ' A' ' 37' ' ' LEU . 43.8 Cg_endo -69.45 -36.53 11.46 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.497 1.262 . . . . 0.0 110.094 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 24.2 m120 -108.05 61.05 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 110.221 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -104.06 99.19 15.76 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.37 -0.831 . . . . 0.0 110.364 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.24 121.02 7.41 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.546 1.288 . . . . 0.0 110.343 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -98.61 178.28 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.928 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -69.55 -6.13 28.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 110.816 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 1.95 22.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 0.0 110.695 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.23 30.76 8.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -124.5 133.83 53.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.805 -0.82 . . . . 0.0 109.906 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -50.65 168.98 0.22 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.498 -0.751 . . . . 0.0 110.745 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 69' ' ' GLU . 44.2 Cg_endo -72.32 -19.95 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.03 1.542 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.475 HG13 ' HB1' ' A' ' 68' ' ' ALA . 4.9 mt -107.03 -39.28 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.191 -0.943 . . . . 0.0 109.798 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 8.5 mt-30 -50.16 -22.11 1.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.585 HG22 ' HB2' ' A' ' 21' ' ' ALA . 13.4 p -113.21 34.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.033 . . . . 0.0 110.584 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.722 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -96.19 35.28 1.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.724 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.9 tmm? 72.39 -10.45 0.92 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.656 -0.652 . . . . 0.0 110.614 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.567 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 44.61 28.47 0.33 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.982 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -137.0 16.91 3.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.544 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.6 m -150.04 75.38 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -1.087 . . . . 0.0 109.579 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -43.85 -34.3 1.57 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 0.0 110.673 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -48.91 -40.22 29.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.49 -0.756 . . . . 0.0 109.812 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 25' ' ' VAL . 19.4 t -62.4 -55.69 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.722 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.56 -54.55 3.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.626 -0.671 . . . . 0.0 109.92 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.558 ' O ' HD23 ' A' ' 65' ' ' LEU . 1.9 tt0 -49.75 -43.86 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.673 -0.642 . . . . 0.0 110.136 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.932 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -53.66 -73.36 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.125 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.978 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 34.2 mt -58.84 -49.26 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.698 . . . . 0.0 109.533 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.831 HD22 HG12 ' A' ' 96' ' ' VAL . 3.0 tt -48.42 -67.45 0.27 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.509 -0.745 . . . . 0.0 110.705 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -56.83 -19.51 17.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.347 -0.846 . . . . 0.0 110.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -85.06 -44.35 13.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.404 -0.81 . . . . 0.0 109.777 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 139.93 37.7 0.11 Allowed Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.978 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.8 -147.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.867 -1.372 . . . . 0.0 109.141 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 2.3 mt-10 -121.07 67.07 15.6 Favored Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 121.625 -0.672 . . . . 0.0 109.392 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CB ' HD23 ' A' ' 97' ' ' LEU . 45.2 Cg_endo -70.44 -7.9 22.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.971 1.511 . . . . 0.0 110.259 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -118.81 -72.85 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.376 -0.828 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.2 t -42.27 149.11 0.17 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.375 -0.828 . . . . 0.0 110.541 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . . . -132.36 -144.86 0.25 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.811 . . . . 0.0 110.405 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -103.72 139.07 19.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.578 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.63 2.23 7.63 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.444 1.234 . . . . 0.0 110.486 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.46 -56.02 3.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 109.148 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.617 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -129.26 19.05 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.751 -0.593 . . . . 0.0 109.576 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER 44.08 43.58 5.67 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.627 -0.671 . . . . 0.0 111.559 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.418 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 81.0 m -69.96 104.45 2.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 109.857 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.745 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -69.45 148.79 97.19 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.914 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.633 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.2 Cg_endo -64.66 -14.89 47.19 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.519 1.273 . . . . 0.0 108.919 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.402 HG13 HD23 ' A' ' 104' ' ' LEU . 72.2 t -67.04 -35.4 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.578 0.704 . . . . 0.0 109.221 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.426 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 24.0 m80 -65.38 -38.14 89.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.468 0.651 . . . . 0.0 109.501 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.567 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -55.13 -50.42 69.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.746 -0.596 . . . . 0.0 110.951 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -56.73 -64.38 0.89 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.978 -1.076 . . . . 0.0 108.725 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.825 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -53.33 -38.34 63.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.45 -0.781 . . . . 0.0 110.259 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.7 OUTLIER -49.55 -38.77 32.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.614 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.79 8.79 39.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 110.437 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 65.15 30.04 76.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -95.01 82.05 3.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.522 -0.987 . . . . 0.0 110.654 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.47 -42.39 74.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.832 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 96' ' ' VAL . 73.4 m-20 -47.33 -50.81 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 85' ' ' ALA . 3.1 m -53.82 -45.8 70.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.407 -0.808 . . . . 0.0 109.855 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.687 HD12 ' HB1' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -58.81 -44.89 90.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.742 . . . . 0.0 110.007 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 91' ' ' LEU . 21.4 t -56.7 -44.61 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.831 HG12 HD22 ' A' ' 64' ' ' LEU . 6.3 t -57.2 -54.49 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.589 ' HA ' HD11 ' A' ' 64' ' ' LEU . 13.3 mt -49.4 -51.0 37.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.679 -0.638 . . . . 0.0 110.16 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.66 -30.36 65.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.4 mtp180 -61.38 -14.02 24.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -123.33 -86.33 0.64 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.03 94.5 0.12 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.19 107.37 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 110.591 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -69.62 143.11 53.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.713 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.548 HD13 ' HB1' ' A' ' 133' ' ' ALA . 2.1 mp -123.18 37.07 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.417 -0.802 . . . . 0.0 109.763 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.02 34.22 4.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.365 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.745 HG11 ' CG ' ' A' ' 80' ' ' ARG . 13.0 p -102.6 173.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.946 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.548 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -124.91 148.15 48.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -69.4 66.22 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 0.0 109.883 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 65.51 -61.72 0.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.509 -0.744 . . . . 0.0 109.964 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.617 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.8 m-90 -70.2 -83.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 107' ' ' ARG . . . -170.06 21.62 0.08 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.442 ' C ' HD22 ' A' ' 113' ' ' LEU . 9.9 mtm180 -84.29 136.8 33.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.06 -1.259 . . . . 0.0 109.931 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 106' ' ' VAL . 4.0 mm? -104.98 165.9 12.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.635 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.433 ' C ' HD13 ' A' ' 130' ' ' LEU . 46.2 Cg_endo -71.73 -38.86 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.841 1.443 . . . . 0.0 109.838 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 127' ' ' ALA . 9.8 p -64.98 -35.91 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 0.0 111.225 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.407 ' N ' HG13 ' A' ' 115' ' ' VAL . 14.6 t0 -61.09 -47.71 85.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 111.268 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.598 HD23 ' CD1' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -52.46 -49.57 64.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.196 -0.94 . . . . 0.0 110.939 -179.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.771 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -53.26 -50.25 65.2 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.235 -0.916 . . . . 0.0 110.736 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -56.86 -51.83 67.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.996 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -61.54 -57.94 10.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.466 -0.771 . . . . 0.0 110.193 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.598 ' CD1' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -59.35 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.368 -0.832 . . . . 0.0 110.419 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.59 34.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.2 m-70 -107.33 53.39 0.69 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.434 -1.039 . . . . 0.0 109.288 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -47.62 -36.7 11.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.533 -0.729 . . . . 0.0 110.069 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.413 ' C ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -58.23 -44.98 88.5 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.95 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.825 HG11 ' CB ' ' A' ' 86' ' ' ALA . 20.2 t -80.27 -42.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.771 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -52.25 -44.81 65.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 109.676 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -65.27 -64.57 0.83 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.278 -0.888 . . . . 0.0 109.323 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -47.51 -40.66 19.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.655 . . . . 0.0 110.06 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.591 ' CD1' HG12 ' A' ' 126' ' ' VAL . 14.2 mt -63.28 -55.03 28.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.544 -0.723 . . . . 0.0 110.083 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.32 -27.08 0.61 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.512 -0.742 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.19 -62.94 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.036 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.548 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -68.9 -6.09 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.317 -0.864 . . . . 0.0 111.026 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.101 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.835 0.35 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.51 ' CE3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -43.03 -36.26 1.53 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.523 -0.736 . . . . 0.0 110.468 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.733 ' CD1' ' HB1' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -49.88 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' H ' ' HB3' ' A' ' 16' ' ' LEU . . . -47.41 -52.67 16.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.625 -0.672 . . . . 0.0 111.394 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 4.8 p -40.57 -61.01 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.34 -0.85 . . . . 0.0 111.137 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.657 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.19 -53.59 54.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -54.37 -44.28 72.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.65 -17.65 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.647 -0.658 . . . . 0.0 110.276 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -100.67 19.9 16.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.366 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.4 53.67 39.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.595 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -127.64 96.24 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' CZ ' ' A' ' 29' ' ' ARG . 24.4 t -74.56 -44.49 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.292 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.19 -45.63 90.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 110.729 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.836 ' O ' HD12 ' A' ' 31' ' ' LEU . 2.2 mt-10 -53.05 -44.76 67.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.357 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.931 HG12 HD12 ' A' ' 32' ' ' LEU . 4.7 t -75.97 -46.61 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.724 . . . . 0.0 109.936 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HD2' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.93 -44.89 40.88 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.305 -0.872 . . . . 0.0 110.204 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.51 61.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.571 -0.705 . . . . 0.0 110.232 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.1 mt -65.44 -67.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.931 HD12 HG12 ' A' ' 28' ' ' VAL . 2.7 mt -47.43 -33.64 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -30.4 68.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.94 -6.68 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.845 . . . . 0.0 110.193 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.27 30.88 3.22 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.1 162.42 1.96 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.289 -1.124 . . . . 0.0 109.929 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' A' ' 37' ' ' LEU . 13.1 tp -80.28 127.33 76.73 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.393 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.36 -29.58 13.69 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.765 1.403 . . . . 0.0 110.407 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -132.91 81.08 1.92 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HA ' HD23 ' A' ' 37' ' ' LEU . . . -97.66 129.43 31.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 110.221 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.63 93.41 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.562 1.296 . . . . 0.0 110.259 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.8 -167.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.244 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.64 2.77 41.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.895 . . . . 0.0 110.544 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -105.26 23.1 14.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.121 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.45 23.57 19.95 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -124.02 -164.52 1.25 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.48 -1.012 . . . . 0.0 110.087 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.557 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -139.88 -174.39 0.41 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 108.997 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HB2' HD13 ' A' ' 63' ' ' LEU . 38.9 Cg_endo -66.2 160.82 43.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.127 1.067 . . . . 0.0 109.965 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt 68.43 -59.61 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.613 -0.679 . . . . 0.0 110.008 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -51.78 -21.16 2.58 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.82 -1.175 . . . . 0.0 110.015 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 51' ' ' VAL . 14.4 p -125.2 9.81 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.383 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.514 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 2.6 ptt? -69.59 159.74 32.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.993 -1.067 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -46.65 -24.74 0.59 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.569 -0.707 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.508 ' HE3' ' HE3' ' A' ' 52' ' ' MET . 0.0 OUTLIER 64.54 14.44 8.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.914 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.44 14.63 27.65 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.637 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -149.24 87.22 1.51 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.59 -0.947 . . . . 0.0 109.818 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -53.55 -23.09 9.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.85 . . . . 0.0 110.03 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -60.29 -35.35 75.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 110.001 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 56' ' ' SER . 57.4 t -59.56 -49.09 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.61 -55.44 25.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.792 . . . . 0.0 110.043 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.55 ' O ' HD23 ' A' ' 65' ' ' LEU . 2.2 tm-20 -49.76 -41.53 44.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.094 -1.004 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.672 ' CD1' HD13 ' A' ' 32' ' ' LEU . 2.6 tp -69.03 -57.18 5.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.302 -0.874 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 6.8 mt -65.71 -41.02 92.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.919 HD13 HG12 ' A' ' 96' ' ' VAL . 2.9 tt -59.46 -65.4 0.68 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 110.938 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.75 HD12 ' C ' ' A' ' 65' ' ' LEU . 3.5 pp -52.9 -24.56 9.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 109.697 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.838 ' CB ' HD22 ' A' ' 32' ' ' LEU . 1.3 m80 -80.79 -41.99 22.46 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.541 -0.724 . . . . 0.0 109.941 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.56 41.11 0.1 OUTLIER Glycine 0 N--CA 1.482 1.76 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.787 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -68.2 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.986 -1.302 . . . . 0.0 109.737 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 4.3 tp10 -120.96 57.12 5.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.331 -0.856 . . . . 0.0 110.217 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 48.9 Cg_endo -72.14 -25.42 19.13 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.885 1.466 . . . . 0.0 110.341 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 103' ' ' ARG . 2.3 m-20 -100.06 -76.81 0.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 0.0 110.137 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 162.91 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.568 -0.707 . . . . 0.0 110.41 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -140.53 -132.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -0.842 . . . . 0.0 110.196 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 78' ' ' LEU . 41.6 t0 -121.18 129.8 25.11 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 -7.95 22.46 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.369 1.194 . . . . 0.0 110.592 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.45 -49.58 11.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.01 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.606 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -134.72 24.5 3.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.55 -0.719 . . . . 0.0 110.072 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 78' ' ' LEU . 7.7 mt 41.86 31.63 0.23 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.697 -0.627 . . . . 0.0 110.749 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.6 m -67.61 86.56 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.818 . . . . 0.0 110.236 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.845 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.56 167.78 20.78 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 109.787 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 51.1 Cg_endo -73.46 -2.68 12.49 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.433 1.228 . . . . 0.0 110.913 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.004 HG13 HD23 ' A' ' 104' ' ' LEU . 36.1 t -78.25 -27.45 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 110.092 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 19.9 m80 -74.19 -39.32 63.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.885 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD2' ' HA ' ' A' ' 81' ' ' PRO . 50.2 m-20 -55.02 -56.0 24.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.645 -0.659 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.35 -63.01 1.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.747 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.814 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -52.65 -54.25 35.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.873 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -47.66 -39.52 17.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.394 -0.816 . . . . 0.0 110.803 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.62 12.6 20.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.97 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 55.59 56.16 25.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -129.63 90.6 3.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.468 -1.019 . . . . 0.0 111.223 -178.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.697 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -73.41 -35.0 65.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.792 . . . . 0.0 109.665 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -47.58 -47.98 28.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.673 -0.642 . . . . 0.0 109.779 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 m -64.11 -41.64 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.718 HD21 ' CB ' ' A' ' 130' ' ' LEU . 1.6 tp -52.86 -55.09 25.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.6 -0.687 . . . . 0.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 87.2 t -48.92 -46.26 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.72 -0.613 . . . . 0.0 109.433 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.919 HG12 HD13 ' A' ' 64' ' ' LEU . 49.9 t -58.52 -53.31 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.512 0.672 . . . . 0.0 109.402 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.922 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -48.72 -52.74 22.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.551 -0.718 . . . . 0.0 110.071 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -74.05 -21.84 59.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 109.817 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.9 ttp180 -64.24 -16.73 62.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.495 -0.753 . . . . 0.0 110.474 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.592 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -134.1 -76.85 0.47 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.0 100.52 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.922 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -152.01 94.94 2.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -1.046 . . . . 0.0 110.526 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -55.66 108.2 0.41 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.249 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.004 HD23 HG13 ' A' ' 82' ' ' VAL . 2.0 mt -98.9 32.38 2.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.04 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.47 44.64 2.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 0.0 110.373 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.845 HG11 ' HB2' ' A' ' 80' ' ' ARG . 9.5 p -111.21 -178.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.635 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.9 mtp85 -122.83 -176.67 3.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 44.4 p-10 -104.46 36.28 2.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.901 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 66.35 3.7 2.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 110.945 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.606 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 3.6 m-90 -123.65 -57.96 1.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.981 -1.074 . . . . 0.0 109.959 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.83 -30.4 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.44 165.4 4.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -1.036 . . . . 0.0 110.831 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 117' ' ' LEU . 42.3 mt -128.82 169.62 12.57 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.644 -0.66 . . . . 0.0 109.278 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.96 -13.87 37.5 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.454 1.239 . . . . 0.0 109.806 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 130' ' ' LEU . 4.6 p -90.56 -40.09 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 110.657 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -57.01 -43.18 81.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.354 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -56.54 -53.19 60.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.861 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.573 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -53.36 -53.89 44.59 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -49.46 -30.45 8.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.0 109.94 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 28.2 mm-40 -85.15 -59.12 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.565 -0.71 . . . . 0.0 109.544 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 110.053 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.68 28.34 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 12.0 m-70 -97.98 47.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.028 -1.278 . . . . 0.0 109.159 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.91 -40.92 6.73 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.606 0.717 . . . . 0.0 109.547 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.545 ' OD2' HG23 ' A' ' 126' ' ' VAL . 5.3 p-10 -61.74 -46.79 88.13 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.039 -0.665 . . . . 0.0 109.635 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.814 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -76.17 -40.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 109.777 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.573 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -52.81 -62.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.348 -0.845 . . . . 0.0 110.341 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -47.02 -61.27 1.95 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.504 -0.748 . . . . 0.0 111.303 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.697 ' CG ' HD21 ' A' ' 91' ' ' LEU . 14.8 t80 -56.64 -63.55 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.896 . . . . 0.0 110.62 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.718 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.29 -19.92 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 110.514 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.511 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -75.4 -40.62 57.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.036 -1.04 . . . . 0.0 110.148 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.55 77.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.61 -15.94 31.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.716 -0.615 . . . . 0.0 109.819 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.331 -0.855 . . . . 0.0 110.397 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 20.2 p-10 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.002 0.43 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.596 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.8 m0 -54.42 -21.03 8.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.803 HD11 HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -75.62 -42.33 51.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.452 -0.78 . . . . 0.0 109.403 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.93 -45.12 28.92 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.823 . . . . 0.0 109.895 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -47.23 -56.26 7.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.571 -0.705 . . . . 0.0 110.434 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.83 91.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 110.163 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.96 -53.81 47.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -58.5 -29.31 66.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.422 -0.799 . . . . 0.0 110.436 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.85 23.86 2.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.587 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 49.82 44.62 39.99 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -109.09 93.55 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -1.11 . . . . 0.0 110.017 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 58' ' ' ARG . 5.1 t -75.1 -46.46 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 110.192 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -32.92 70.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 1.6 tp10 -74.03 -46.45 43.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 0.0 109.766 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.537 HG21 HG13 ' A' ' 59' ' ' VAL . 51.4 t -64.94 -46.89 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 1.077 ' HA ' HD12 ' A' ' 62' ' ' LEU . 46.3 mmm-85 -55.21 -46.76 75.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.053 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.34 56.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 0.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 13.0 mt -61.15 -63.01 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.945 . . . . 0.0 110.49 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.92 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 1.4 mt -49.18 -43.27 42.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.392 -0.817 . . . . 0.0 110.476 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -71.09 -13.36 61.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.88 -10.17 37.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.194 -0.941 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.01 -2.83 5.57 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.333 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.92 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -53.69 103.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.03 -1.276 . . . . 0.0 109.896 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 17.3 tp -50.5 123.4 17.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.494 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 40.8 Cg_endo -67.84 -43.44 5.2 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.598 1.315 . . . . 0.0 110.489 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -91.07 54.13 2.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.12 -0.988 . . . . 0.0 109.817 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -104.8 93.95 6.84 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.771 . . . . 0.0 110.612 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.17 97.11 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.588 1.309 . . . . 0.0 110.034 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -63.7 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.315 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.12 36.42 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -0.887 . . . . 0.0 110.319 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -7.76 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 111.073 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 24.48 19.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.44 32.45 5.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.541 -0.976 . . . . 0.0 109.369 -179.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mmt180 49.77 179.76 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 49.7 Cg_endo -86.44 -13.69 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.155 1.082 . . . . 0.0 111.065 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 63' ' ' LEU . 5.2 mt -107.69 -43.05 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.95 -1.094 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 1.5 tt0 -46.24 -28.91 1.4 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 21' ' ' ALA . 7.1 p -109.32 40.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.599 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -99.48 30.38 3.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 109.669 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.587 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 7.3 tmm? 64.65 -4.7 0.43 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.724 -0.61 . . . . 0.0 111.292 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.599 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 13.0 mmt 42.39 28.64 0.12 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.41 6.89 8.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.662 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -145.75 87.34 1.77 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 110.115 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -54.01 -30.84 49.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.805 . . . . 0.0 109.545 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.606 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -54.12 -37.47 64.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.574 -0.704 . . . . 0.0 109.273 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.682 ' O ' HD12 ' A' ' 63' ' ' LEU . 99.0 t -59.84 -61.17 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -54.75 -25.61 28.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.545 -0.722 . . . . 0.0 109.104 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 58' ' ' ARG . 5.2 tm-20 -53.54 -72.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.302 -0.874 . . . . 0.0 110.045 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.077 HD12 ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.56 -36.57 71.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.778 -1.201 . . . . 0.0 109.393 179.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 16' ' ' LEU . 1.1 mt -58.09 -63.41 1.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.447 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.728 HD13 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.38 -31.37 71.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.421 -0.799 . . . . 0.0 109.248 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 26.0 tp -68.78 -48.34 63.9 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.517 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.91 -16.08 58.5 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.423 -0.798 . . . . 0.0 109.951 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.5 63.63 0.58 Allowed Glycine 0 N--CA 1.483 1.825 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.618 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -79.71 -146.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.945 -1.327 . . . . 0.0 109.145 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mm-40 -117.14 55.07 1.53 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.285 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 49.2 Cg_endo -70.72 -14.07 32.75 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.497 1.262 . . . . 0.0 110.95 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -103.65 -76.44 0.59 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.127 -0.983 . . . . 0.0 110.262 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.61 144.17 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . . . -119.01 -156.28 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.924 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -102.7 144.18 28.1 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.951 . . . . 0.0 110.441 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.94 -17.08 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.614 1.323 . . . . 0.0 110.327 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.66 -78.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.714 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.687 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 34.8 p -115.06 27.36 9.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.143 -0.973 . . . . 0.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.1 mt 46.64 31.06 1.27 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 111.117 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -67.09 100.37 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.581 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -75.86 165.48 52.88 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.315 -0.866 . . . . 0.0 109.513 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HD2' ' HG2' ' A' ' 80' ' ' ARG . 47.4 Cg_endo -71.54 -11.51 28.27 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.637 1.335 . . . . 0.0 109.625 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 114' ' ' PRO . 77.2 t -69.5 -46.39 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.436 -0.79 . . . . 0.0 109.93 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 39.9 m80 -52.03 -49.63 63.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.424 -0.797 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 7.0 m-20 -42.54 -54.67 3.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 122.02 -0.425 . . . . 0.0 111.437 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.508 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -53.29 -62.69 1.49 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.914 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -63.18 -26.15 68.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.564 -0.71 . . . . 0.0 110.686 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -62.35 -28.44 69.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.018 -1.051 . . . . 0.0 109.947 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.433 ' C ' ' CE1' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -109.05 -20.82 12.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.404 -0.81 . . . . 0.0 110.089 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.735 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 94.39 32.6 7.27 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.906 -1.677 . . . . 0.0 108.906 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.556 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -99.46 88.05 3.77 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 110.406 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.612 HD11 ' CD2' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -60.6 -39.08 86.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 110.432 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 31.8 m-20 -46.85 -46.15 20.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 110.081 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.5 m -61.47 -46.42 90.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.564 -0.71 . . . . 0.0 110.055 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.624 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -51.31 -57.91 7.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.38 -0.825 . . . . 0.0 110.481 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.34 -50.67 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.284 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.728 HG12 HD13 ' A' ' 64' ' ' LEU . 57.7 t -55.37 -51.07 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.532 -0.73 . . . . 0.0 110.358 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 1.1 mp -51.46 -55.66 17.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -71.7 -42.41 67.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.369 -0.832 . . . . 0.0 110.882 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -7.35 6.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -132.77 -59.16 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.931 -1.106 . . . . 0.0 110.74 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.85 108.78 0.28 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -173.03 133.62 0.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -1.167 . . . . 0.0 110.915 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -97.23 80.79 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.611 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.4 mp -69.91 67.88 0.28 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.0 110.011 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -168.02 33.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.314 -0.866 . . . . 0.0 110.43 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.2 p -105.9 -170.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.925 -1.11 . . . . 0.0 109.996 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 106' ' ' VAL . 30.5 mtt180 -131.29 147.52 52.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 35.7 t0 -79.1 54.89 1.71 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.687 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 58.6 -69.06 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.74 -0.6 . . . . 0.0 110.635 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.686 ' CH2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -41.22 -48.65 3.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.71 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.38 -33.88 1.54 Allowed Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.452 ' HD2' ' HB2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -56.58 156.35 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -1.064 . . . . 0.0 110.35 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 117' ' ' LEU . 29.9 mt -105.9 168.03 8.82 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.489 -0.757 . . . . 0.0 110.412 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 82' ' ' VAL . 38.8 Cg_endo -65.81 -27.96 51.47 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.773 1.407 . . . . 0.0 110.046 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 127' ' ' ALA . 3.4 p -77.83 -31.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.506 -0.747 . . . . 0.0 109.731 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -60.12 -49.2 78.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.448 -0.782 . . . . 0.0 110.189 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.658 ' C ' HD12 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -57.58 -57.25 13.5 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.317 -0.865 . . . . 0.0 110.356 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.914 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -51.22 -54.95 20.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.446 ' N ' ' HB2' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -49.31 -41.25 37.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.351 -0.843 . . . . 0.0 110.578 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -80.09 -26.42 39.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 0.0 110.421 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 117' ' ' LEU . 8.3 mt -81.0 2.64 26.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.275 -0.891 . . . . 0.0 110.383 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.86 17.28 73.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 22.2 m170 -94.67 53.44 1.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -1.158 . . . . 0.0 108.949 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -39.97 -59.21 1.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.222 0.535 . . . . 0.0 111.802 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.528 ' O ' HD21 ' A' ' 91' ' ' LEU . 54.8 m-20 -48.6 -39.44 23.9 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.492 -0.755 . . . . 0.0 110.393 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -80.89 -38.74 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.511 -0.743 . . . . 0.0 110.012 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -64.79 -38.99 92.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 109.553 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -73.99 -42.62 60.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.257 -0.902 . . . . 0.0 109.841 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.612 ' CD2' HD11 ' A' ' 91' ' ' LEU . 9.5 t80 -59.79 -40.63 88.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.624 ' HG ' HD21 ' A' ' 94' ' ' LEU . 19.4 mt -68.28 -42.96 78.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.509 -0.744 . . . . 0.0 109.591 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.445 ' HG3' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -58.53 -20.95 50.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.72 -47.6 11.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.881 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.71 -14.57 42.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.397 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' A' ' 18' ' ' THR . 12.1 t70 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.644 0.259 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -3.98 17.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.933 -1.105 . . . . 0.0 111.169 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.911 HD21 ' CB ' ' A' ' 36' ' ' ALA . 28.0 mt -81.14 -49.63 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.128 -0.983 . . . . 0.0 109.57 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.88 -46.73 67.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.675 -0.64 . . . . 0.0 110.077 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.79 -63.67 1.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.673 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -51.97 -46.02 64.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -57.63 -49.22 77.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.77 -24.86 67.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.454 -0.778 . . . . 0.0 110.694 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -90.13 26.35 1.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.784 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.91 31.11 4.0 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.619 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -104.46 94.16 5.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.617 -0.931 . . . . 0.0 110.174 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 59' ' ' VAL . 46.2 t -71.43 -54.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.592 -0.692 . . . . 0.0 110.025 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -47.82 -41.23 23.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.493 -0.755 . . . . 0.0 110.671 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 5.2 mm-40 -59.13 -54.62 44.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 24' ' ' ARG . 2.6 t -64.79 -49.67 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.619 -0.676 . . . . 0.0 109.238 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HA ' HD11 ' A' ' 62' ' ' LEU . 3.4 mmt180 -36.95 -51.61 0.92 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.347 0.594 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -78.7 -52.51 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.3 mt -48.39 -74.23 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.317 -0.864 . . . . 0.0 111.382 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.019 HD23 HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -50.1 -43.25 51.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 110.804 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.44 -10.09 59.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 0.0 110.386 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -87.33 -13.47 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.005 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.49 23.61 1.35 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.494 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.911 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -69.6 -172.95 0.53 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.259 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.53 ' H ' HD11 ' A' ' 16' ' ' LEU . 3.1 mm? -94.96 126.38 47.09 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 110.829 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 43.1 Cg_endo -71.34 -16.45 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.284 1.15 . . . . 0.0 110.225 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -137.79 48.08 2.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . . . -73.79 137.98 76.76 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.42 169.35 22.61 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.751 1.395 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -133.39 -172.13 2.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.3 m -109.14 13.04 24.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.892 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 15.7 m-85 -117.96 8.25 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.248 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.37 31.96 79.19 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -119.1 -169.58 1.76 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.459 -1.024 . . . . 0.0 110.127 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -105.95 164.72 14.4 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.8 Cg_endo -65.85 -15.73 50.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.561 1.295 . . . . 0.0 111.266 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.6 mt -109.12 -38.25 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.92 . . . . 0.0 108.799 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 2.8 mt-30 -49.96 -23.55 2.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.328 -0.858 . . . . 0.0 110.41 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 21' ' ' ALA . 11.1 p -110.98 36.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.456 -0.777 . . . . 0.0 110.537 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.545 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 0.1 OUTLIER -96.8 32.25 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.955 -1.09 . . . . 0.0 110.198 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.443 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 6.7 tmm? 64.98 -3.26 0.61 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.654 -0.654 . . . . 0.0 110.568 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.549 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 39.88 32.71 0.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.429 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -122.15 -3.23 9.82 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -145.6 85.95 1.72 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 110.212 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.6 -25.74 11.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -49.81 -43.38 48.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.725 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 25' ' ' VAL . 5.9 t -60.21 -54.79 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -48.63 -35.63 14.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.641 -0.662 . . . . 0.0 109.333 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -49.53 76.02 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.019 HD22 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -55.06 -57.03 13.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.657 0.742 . . . . 0.0 109.157 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.81 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.4 mm? -59.93 -27.96 67.21 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.96 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.821 ' HG ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -73.42 -56.31 5.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.199 -0.938 . . . . 0.0 110.342 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -51.47 -27.08 9.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.838 0.828 . . . . 0.0 109.253 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.637 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.0 -28.58 21.33 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.627 0.727 . . . . 0.0 109.112 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.29 63.34 0.73 Allowed Glycine 0 N--CA 1.477 1.432 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.81 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -71.3 -154.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.079 -1.248 . . . . 0.0 108.664 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 47' ' ' ARG . 13.2 mt-10 -113.9 66.7 1.42 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.286 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.472 ' HB3' HD23 ' A' ' 97' ' ' LEU . 45.3 Cg_endo -69.69 -17.7 37.76 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.766 1.403 . . . . 0.0 110.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.432 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.4 t30 -98.02 -58.61 1.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -0.826 . . . . 0.0 110.501 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 30.7 t -47.0 147.95 1.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.9 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.92 -144.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.797 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.8 140.87 24.51 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.241 -0.912 . . . . 0.0 109.96 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -20.03 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.257 1.135 . . . . 0.0 109.919 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.22 -57.8 4.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 110.237 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.857 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -131.72 29.01 4.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 78' ' ' LEU . 6.1 mt 41.29 38.76 0.84 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.539 -0.726 . . . . 0.0 111.201 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.2 m -72.8 98.28 2.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.949 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.786 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -78.0 163.2 64.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.927 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.4 Cg_endo -69.07 -3.99 12.67 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.414 1.218 . . . . 0.0 110.393 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 104' ' ' LEU . 31.2 t -74.99 -29.48 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 2.2 m80 -74.67 -33.21 62.44 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -55.15 -59.67 4.45 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.341 0.591 . . . . 0.0 110.033 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.668 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -53.99 -61.56 2.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.388 -0.82 . . . . 0.0 109.76 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.799 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -54.99 -58.8 6.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 3.3 ttt180 -46.5 -28.16 1.32 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.279 -0.888 . . . . 0.0 110.894 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.482 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 1.8 tm-20 -103.3 1.99 33.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 111.044 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.476 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 64.38 58.93 9.09 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.47 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -134.23 86.75 2.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 110.339 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -58.21 -44.38 88.14 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.566 -0.709 . . . . 0.0 110.077 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 96' ' ' VAL . 22.5 t0 -43.8 -46.64 7.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.541 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 52.4 m -60.21 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 97' ' ' LEU . 1.8 tp -56.8 -45.67 82.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.178 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 91' ' ' LEU . 60.5 t -55.63 -50.67 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.608 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.821 HG12 ' HG ' ' A' ' 64' ' ' LEU . 52.7 t -53.54 -53.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.345 -0.847 . . . . 0.0 110.401 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 94' ' ' LEU . 6.2 mt -50.08 -66.92 0.31 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -56.72 -32.61 65.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 0.0 109.853 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.7 ttp85 -67.44 -8.97 37.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.602 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.498 ' CB ' HD12 ' A' ' 64' ' ' LEU . . . -149.35 58.21 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.969 -1.082 . . . . 0.0 111.19 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.4 109.01 0.01 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -166.41 125.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.4 -1.059 . . . . 0.0 110.757 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.449 ' O ' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -69.88 114.1 7.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.424 -0.797 . . . . 0.0 109.191 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.523 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -111.06 25.01 12.21 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 110.661 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 2.0 p30 -145.19 59.8 1.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.104 -0.997 . . . . 0.0 110.355 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.786 HG11 ' HB2' ' A' ' 80' ' ' ARG . 9.2 p -108.77 -177.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.696 ' H ' HG22 ' A' ' 106' ' ' VAL . 12.9 mtt180 -132.6 132.37 42.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -72.48 60.95 0.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.445 -0.785 . . . . 0.0 110.07 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.27 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.36 -0.838 . . . . 0.0 110.451 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CH2' HG23 ' A' ' 77' ' ' THR . 0.8 OUTLIER -124.09 25.28 7.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 0.0 109.902 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -93.61 -75.99 1.32 Allowed Glycine 0 N--CA 1.48 1.605 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 2.1 mtt180 171.93 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.939 . . . . 0.0 110.072 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.439 ' CD1' ' HD2' ' A' ' 114' ' ' PRO . 2.4 mm? -104.3 170.98 5.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 44.1 Cg_endo -70.74 -22.71 27.2 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.696 1.366 . . . . 0.0 110.622 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.884 ' HB ' HD11 ' A' ' 130' ' ' LEU . 7.2 p -82.81 -39.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 110.082 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.415 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 89.3 m-20 -52.48 -38.79 60.21 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.75 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.5 mt -59.73 -58.45 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -50.93 -39.82 55.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.17 -46.41 75.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.21 -24.77 57.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -87.64 -81.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.922 . . . . 0.0 110.681 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.72 42.55 0.02 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 37.3 m-70 -106.03 52.4 0.73 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.983 . . . . 0.0 108.951 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 12.2 ptm180 -42.41 -40.88 2.7 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.201 0.524 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.496 ' O ' HD21 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -60.15 -41.01 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.268 -0.895 . . . . 0.0 108.918 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -85.0 -41.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.675 -0.64 . . . . 0.0 109.656 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -51.67 -45.62 63.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -0.805 . . . . 0.0 110.308 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -82.57 -43.69 16.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.434 -0.791 . . . . 0.0 110.278 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.752 ' CG ' HD11 ' A' ' 91' ' ' LEU . 53.8 t80 -65.23 -61.76 1.94 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.233 -0.917 . . . . 0.0 109.953 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.884 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -56.32 -31.05 63.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 110.064 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.522 ' HB2' HG21 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -66.24 -28.95 69.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.003 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.95 -39.84 65.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.006 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.93 -13.12 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 111.029 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.812 0 O-C-N 120.975 -1.078 . . . . 0.0 111.098 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.131 0.491 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.0 106.83 57.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.049 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.15 152.85 62.44 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.497 1.261 . . . . 0.0 109.927 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.29 167.99 9.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 110.037 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.73 108.94 13.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.313 -0.867 . . . . 0.0 109.786 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' SER . . . 112.77 -148.8 18.48 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' GLY . 14.9 m 60.87 59.78 2.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.258 -1.143 . . . . 0.0 110.241 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.7 p -154.7 135.7 13.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 110.34 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -96.75 86.05 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.41 -0.806 . . . . 0.0 110.652 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.52 72.77 0.74 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.12 -0.987 . . . . 0.0 110.921 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.67 63.72 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.782 1.412 . . . . 0.0 111.131 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.94 112.04 24.12 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.301 -0.874 . . . . 0.0 109.574 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.75 -62.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 110.575 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -88.83 3.05 52.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.222 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.584 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.4 m0 -72.31 -11.46 60.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.484 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.784 HD11 ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -74.86 -58.5 3.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.441 -0.787 . . . . 0.0 109.459 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.2 -49.43 77.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -43.89 -67.9 0.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.835 -0.541 . . . . 0.0 110.737 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -46.24 -51.21 14.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.424 -0.797 . . . . 0.0 110.33 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.604 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -46.59 -54.18 9.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.667 . . . . 0.0 110.334 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.14 -20.11 65.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.409 -0.807 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 26.4 mtm180 -99.38 22.2 10.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 111.364 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.517 ' CA ' ' HG3' ' A' ' 53' ' ' MET . . . 54.38 52.61 43.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 14.7 mmt180 -124.97 89.93 3.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.2 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 59' ' ' VAL . 81.2 t -74.36 -40.51 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.443 -0.786 . . . . 0.0 110.041 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -34.7 76.75 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.385 -0.822 . . . . 0.0 110.729 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 1.007 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.6 tp10 -61.07 -50.71 72.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG12 HD13 ' A' ' 62' ' ' LEU . 20.6 t -71.55 -48.54 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.903 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.893 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -41.18 -42.1 1.97 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 -179.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.72 -50.33 13.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.49 -0.756 . . . . 0.0 109.09 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.007 HD12 ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -61.56 -60.19 4.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.502 -0.749 . . . . 0.0 110.049 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.808 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -42.95 -46.27 5.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.75 -0.594 . . . . 0.0 110.83 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -75.53 -14.85 60.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 110.318 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.36 -8.39 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.843 . . . . 0.0 110.769 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.58 16.95 3.28 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.119 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.81 135.65 55.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.892 -1.357 . . . . 0.0 110.292 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.427 ' O ' HD23 ' A' ' 16' ' ' LEU . 32.0 tp -83.19 116.71 65.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.669 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HD2' HD12 ' A' ' 37' ' ' LEU . 43.6 Cg_endo -73.1 -36.72 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.488 1.257 . . . . 0.0 110.944 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -91.94 24.09 3.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.306 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.32 148.32 64.03 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.381 -0.824 . . . . 0.0 110.444 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.67 93.4 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.782 1.412 . . . . 0.0 110.258 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -65.43 158.89 25.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.65 -0.656 . . . . 0.0 110.356 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.9 3.51 55.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 110.65 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 11.6 m-85 -114.3 23.12 13.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 74' ' ' ASP . . . 47.18 31.22 6.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HD3' ' HG2' ' A' ' 50' ' ' GLN . 15.1 mtt-85 -114.18 -161.09 0.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.684 -0.892 . . . . 0.0 110.427 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.484 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.98 179.13 0.82 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.955 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.731 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 47.5 Cg_endo -71.21 -26.42 21.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.935 1.492 . . . . 0.0 110.126 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.535 HG23 ' HG2' ' A' ' 52' ' ' MET . 4.4 mt -109.31 -37.57 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.376 -0.828 . . . . 0.0 109.826 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HB3' ' H ' ' A' ' 47' ' ' ARG . 2.0 tt0 -49.4 -22.04 1.05 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.079 -1.013 . . . . 0.0 110.05 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.1 p -104.43 -10.28 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.454 -0.779 . . . . 0.0 110.585 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.73 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -65.08 161.54 18.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.159 -0.963 . . . . 0.0 110.557 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.517 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.54 105.82 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -62.62 -10.53 12.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.469 -0.769 . . . . 0.0 110.881 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -90.33 28.38 7.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -161.39 81.24 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -1.123 . . . . 0.0 110.07 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . . . -49.11 -24.45 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -52.47 -49.86 63.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 25' ' ' VAL . 2.7 t -56.66 -65.15 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.267 -0.896 . . . . 0.0 110.086 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.73 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -40.53 -42.8 1.73 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.606 -0.683 . . . . 0.0 110.008 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.64 -46.37 84.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.458 -0.776 . . . . 0.0 109.055 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.893 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -53.05 -55.2 25.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.784 ' CD2' HD11 ' A' ' 16' ' ' LEU . 2.5 mp -66.54 -43.89 83.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.853 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.764 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -64.24 -55.07 24.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.462 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 15.5 tp -49.18 -34.36 14.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.849 0.833 . . . . 0.0 108.912 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 2.7 m-70 -83.14 -35.02 25.9 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.4 58.62 0.18 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.644 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -78.05 -156.57 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 72' ' ' CYS . 1.8 mt-10 -114.92 64.42 1.61 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.466 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . 40.9 Cg_endo -67.19 -13.95 41.42 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.786 1.413 . . . . 0.0 110.409 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 0.4 OUTLIER -107.26 -57.6 2.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -48.32 150.27 1.32 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 110.751 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' HB2' ' CD ' ' A' ' 80' ' ' ARG . . . -136.54 -139.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.737 . . . . 0.0 109.757 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' LEU . 2.8 t0 -116.32 126.78 27.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.19 -8.89 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.143 1.076 . . . . 0.0 110.142 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.33 -46.87 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.588 HG22 ' CH2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -116.3 -0.52 12.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.1 mt 46.92 23.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.911 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.9 m -61.54 94.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.18 -0.95 . . . . 0.0 108.8 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.597 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -66.49 143.56 98.25 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.567 -0.708 . . . . 0.0 109.2 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 39.1 Cg_endo -66.56 -9.6 24.86 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.784 1.413 . . . . 0.0 110.142 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 104' ' ' LEU . 42.7 t -70.56 -25.12 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.675 ' HD2' HD12 ' A' ' 117' ' ' LEU . 5.9 m80 -72.78 -41.8 64.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 109.212 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.572 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 15.9 m-20 -47.47 -42.88 23.64 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.277 0.561 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.644 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -66.28 -65.46 0.68 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.959 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.798 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.58 -48.57 81.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -0.899 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.4 tmm_? -51.51 -35.69 41.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.987 -1.071 . . . . 0.0 109.872 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.513 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 2.3 tp10 -88.85 4.07 49.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.09 -1.006 . . . . 0.0 110.218 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 69.56 28.38 72.37 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.613 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -106.21 120.12 41.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.448 -1.031 . . . . 0.0 110.046 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.47 -41.27 9.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 0.0 110.01 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.789 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.2 m-20 -52.58 -25.35 10.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.905 . . . . 0.0 110.471 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.644 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 5.6 m -74.85 -45.95 39.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.191 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.703 ' CD2' HD21 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -57.96 -54.97 40.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.37 -50.68 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.394 -0.816 . . . . 0.0 109.379 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 92' ' ' ASP . 85.3 t -51.07 -55.99 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.748 -0.595 . . . . 0.0 110.162 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.476 ' HA ' HD11 ' A' ' 64' ' ' LEU . 7.6 mp -49.73 -53.51 24.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -61.62 -31.14 71.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.0 109.977 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -71.05 -11.96 61.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.935 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.741 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -140.63 66.32 1.38 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.185 -0.947 . . . . 0.0 111.004 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.87 97.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.445 ' HB3' ' C ' ' A' ' 97' ' ' LEU . . . -160.41 108.86 1.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -1.147 . . . . 0.0 110.445 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 4.7 ttt85 -64.75 128.46 35.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.325 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.61 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -119.21 19.72 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.388 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 44.8 t0 -124.48 58.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 110.077 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.71 HG22 ' H ' ' A' ' 107' ' ' ARG . 5.2 p -117.4 -175.39 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.345 -0.847 . . . . 0.0 109.731 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.71 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -139.02 127.96 23.64 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.56 -0.712 . . . . 0.0 110.235 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.537 ' OD1' ' NE2' ' A' ' 83' ' ' HIS . 1.7 m-20 -51.31 150.64 3.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 109.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 77' ' ' THR . . . -44.19 -35.76 2.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.463 -0.773 . . . . 0.0 111.034 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.588 ' CH2' HG22 ' A' ' 77' ' ' THR . 13.4 m-90 -59.57 -79.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.18 29.36 0.02 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.427 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -107.42 -165.04 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -1.21 . . . . 0.0 110.975 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.03 160.51 39.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.559 -0.713 . . . . 0.0 109.61 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 39.5 Cg_endo -67.66 -33.64 27.46 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.433 1.228 . . . . 0.0 110.645 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 5.4 p -78.33 -37.81 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.0 110.082 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.99 -43.64 91.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.51 -0.744 . . . . 0.0 109.978 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.675 HD12 ' HD2' ' A' ' 83' ' ' HIS . 2.9 mt -52.27 -39.29 60.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.738 ' HB3' ' HB2' ' A' ' 127' ' ' ALA . . . -69.12 -34.08 74.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.532 -0.73 . . . . 0.0 110.008 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.0 -20.08 64.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.427 ' OE2' ' NH2' ' A' ' 112' ' ' ARG . 29.2 tt0 -86.25 -57.98 2.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.706 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.487 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 6.7 mp -57.07 -81.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.008 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.3 40.41 0.02 OUTLIER Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.5 m-70 -115.09 43.39 2.0 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.43 -1.041 . . . . 0.0 109.759 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -45.65 -37.19 5.45 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -62.33 -37.46 85.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.62 -0.675 . . . . 0.0 109.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.751 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -80.93 -36.19 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.738 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . . . -68.34 -32.93 73.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.544 -0.722 . . . . 0.0 109.602 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -59.3 -66.27 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.406 -0.809 . . . . 0.0 109.741 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -52.13 -25.51 9.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.36 -0.838 . . . . 0.0 109.352 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 86' ' ' ALA . 8.7 mt -73.88 -58.82 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 110.427 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -24.06 0.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.84 -51.04 9.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.298 -0.876 . . . . 0.0 109.955 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.15 -13.19 53.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.0 110.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . . . -97.42 54.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 110.715 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.43 133.93 4.59 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.52 -43.93 66.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 t -50.01 138.13 16.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.577 -0.955 . . . . 0.0 110.494 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -151.77 63.55 0.86 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.828 . . . . 0.0 110.278 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -104.88 123.93 7.82 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -53.79 6.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.209 -1.171 . . . . 0.0 110.478 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -102.07 39.05 1.53 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 109.854 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.7 OUTLIER -117.37 -161.71 0.83 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.502 -0.749 . . . . 0.0 110.142 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' HIS . . . -176.88 115.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.692 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -56.05 -175.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.823 . . . . 0.0 109.689 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 tp -68.81 142.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.902 . . . . 0.0 109.733 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -44.98 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.486 -0.759 . . . . 0.0 111.055 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.82 63.55 1.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.007 . . . . 0.0 110.75 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.58 119.11 2.86 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.18 -0.95 . . . . 0.0 109.799 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -101.78 106.19 17.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.886 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 170.99 -137.43 4.41 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.93 146.61 37.68 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.786 1.414 . . . . 0.0 110.607 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 153' ' ' ASP . 9.7 p -60.63 167.78 2.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 152' ' ' SER . 1.9 t0 65.29 137.31 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.381 -0.824 . . . . 0.0 110.421 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 154' ' ' ILE . 2.4 mp -127.85 84.71 62.56 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 0.0 109.532 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.88 115.57 4.37 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 124.029 1.541 . . . . 0.0 110.849 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.104 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tpp . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.13 0.49 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -110.95 81.31 2.57 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.46 179.24 4.76 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.827 1.435 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.35 92.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.445 -0.785 . . . . 0.0 110.606 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -166.7 138.74 3.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 110.245 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.9 -51.33 0.72 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 p -55.47 175.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.394 -1.062 . . . . 0.0 110.067 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 9' ' ' MET . 0.4 OUTLIER -109.44 -44.58 3.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.941 . . . . 0.0 110.723 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.402 ' CB ' ' O ' ' A' ' 8' ' ' SER . 1.7 ttm 65.72 174.86 0.22 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.377 -0.827 . . . . 0.0 110.213 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.78 72.28 0.86 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.345 -0.847 . . . . 0.0 110.241 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.42 164.3 35.7 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.671 1.353 . . . . 0.0 110.629 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -66.43 124.75 23.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.087 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . -179.97 -37.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.269 -0.895 . . . . 0.0 110.525 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.74 -17.13 51.99 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 0.0 110.885 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.591 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 45.9 m0 -79.78 -9.97 59.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.96 HD11 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -74.92 -50.75 15.73 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.164 -0.96 . . . . 0.0 109.354 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.46 -47.78 66.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.368 -0.833 . . . . 0.0 109.799 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -50.89 -49.81 58.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.456 -0.777 . . . . 0.0 110.411 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -59.89 -55.71 30.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -48.21 -44.25 32.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.315 -0.866 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -77.33 -32.09 54.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 111.034 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 1.1 ttt-85 -90.99 32.25 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.264 -0.898 . . . . 0.0 111.196 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 48.38 71.17 0.62 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -137.49 50.4 1.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.386 -1.067 . . . . 0.0 110.061 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.808 HG22 ' CG2' ' A' ' 59' ' ' VAL . 70.7 t -45.96 -37.41 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.459 -0.776 . . . . 0.0 110.282 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.83 -46.6 62.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.38 -44.89 89.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.315 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 62' ' ' LEU . 23.7 t -66.02 -46.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.886 . . . . 0.0 109.958 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.923 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -51.27 -46.04 62.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.07 -39.8 65.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.496 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.3 -56.31 11.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.498 -0.751 . . . . 0.0 110.434 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.885 HD23 ' HB3' ' A' ' 36' ' ' ALA . 14.3 mt -50.1 -50.38 48.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 110.16 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.22 -13.62 60.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.361 -0.837 . . . . 0.0 110.742 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 -11.53 36.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.977 -1.077 . . . . 0.0 111.006 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.55 37.0 0.7 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.885 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -66.84 162.36 21.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -1.125 . . . . 0.0 109.905 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.84 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 5.5 tp -92.18 115.23 64.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 0.0 109.663 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.39 -28.58 39.06 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.461 1.243 . . . . 0.0 110.195 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 28.6 m120 -129.74 66.49 1.47 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 109.753 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.84 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -88.33 108.52 22.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 47.5 Cg_endo -71.63 94.31 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.622 1.327 . . . . 0.0 110.061 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 34.2 p-10 -94.02 -174.81 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.812 . . . . 0.0 110.644 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.46 5.59 41.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.365 -0.834 . . . . 0.0 110.914 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.417 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -91.9 -5.56 53.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.83 22.84 12.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -115.03 134.74 54.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -1.064 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -60.37 169.16 1.86 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 109.942 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.813 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 39.6 Cg_endo -66.35 -23.23 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.542 1.285 . . . . 0.0 111.296 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.518 HG23 ' HG2' ' A' ' 52' ' ' MET . 6.1 mt -107.99 -36.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.973 -1.079 . . . . 0.0 109.065 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.478 ' HG3' ' OD2' ' A' ' 84' ' ' ASP . 2.7 tt0 -52.18 -19.85 2.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.734 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 7.2 p -110.37 2.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.464 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.72 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -76.91 165.16 25.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.999 -1.063 . . . . 0.0 110.147 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.412 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 3.3 tpp -61.1 96.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.218 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.598 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -55.82 -13.64 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.038 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -90.5 8.94 79.01 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.18 88.84 2.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.204 -1.174 . . . . 0.0 109.856 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -59.22 -24.34 63.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -52.15 -49.96 62.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.808 ' CG2' HG22 ' A' ' 25' ' ' VAL . 40.6 t -56.72 -56.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 110.109 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.72 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.7 -57.56 2.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.606 -0.684 . . . . 0.0 110.64 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.609 ' O ' HD23 ' A' ' 65' ' ' LEU . 11.0 tt0 -47.02 -48.87 21.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.37 -0.831 . . . . 0.0 110.232 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.923 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -49.62 -70.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.523 -0.735 . . . . 0.0 109.854 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.96 HD11 HD11 ' A' ' 16' ' ' LEU . 3.8 mt -59.96 -48.73 80.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.641 0.734 . . . . 0.0 110.024 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.868 ' HG ' HG12 ' A' ' 96' ' ' VAL . 3.4 tm? -50.96 -69.53 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.692 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.4 pp -53.01 -24.88 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 110.027 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.622 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -77.35 -55.36 5.46 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.481 -0.762 . . . . 0.0 109.319 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.02 44.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.563 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.813 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -76.05 -158.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.019 -1.283 . . . . 0.0 109.117 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.55 74.63 3.21 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.357 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.594 ' HB3' HD23 ' A' ' 97' ' ' LEU . 55.8 Cg_endo -78.69 10.15 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.955 1.502 . . . . 0.0 110.351 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.487 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -139.53 -60.92 0.55 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.43 152.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.624 -0.672 . . . . 0.0 110.316 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -143.14 -161.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.316 -0.865 . . . . 0.0 110.512 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.6 140.17 25.18 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 110.267 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 1.32 9.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.453 1.239 . . . . 0.0 110.564 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.0 -39.39 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 109.631 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.763 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -128.98 2.07 5.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.49 -0.756 . . . . 0.0 110.279 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 78' ' ' LEU . 3.3 mt 47.76 21.73 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.941 . . . . 0.0 111.684 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -59.08 102.81 0.14 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.926 -1.109 . . . . 0.0 109.115 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.854 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -77.89 159.1 76.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.757 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.417 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 42.2 Cg_endo -68.13 -13.92 39.36 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.154 1.607 . . . . 0.0 110.267 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 104' ' ' LEU . 94.8 t -68.2 -28.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.569 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.487 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.3 m80 -70.74 -44.07 67.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.598 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.11 -47.05 45.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.732 -0.605 . . . . 0.0 110.982 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -62.2 -66.23 0.57 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.562 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.868 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -54.32 -43.4 71.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.449 -0.782 . . . . 0.0 110.592 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -46.38 -41.95 14.33 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.514 -0.741 . . . . 0.0 110.559 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 1.2 mm-40 -96.59 -2.27 45.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.195 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.601 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 75.99 47.25 11.69 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -115.87 95.2 5.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.304 -1.115 . . . . 0.0 111.18 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.675 HD21 ' CD2' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.3 -36.33 79.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.534 179.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.95 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.7 m-20 -50.46 -58.59 5.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 0.0 109.357 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 92.4 m -52.77 -44.48 66.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.752 . . . . 0.0 109.144 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.991 HD11 HD21 ' A' ' 130' ' ' LEU . 5.9 tp -54.89 -53.22 58.3 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.32 -40.16 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 92' ' ' ASP . 21.8 t -62.75 -40.41 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 94' ' ' LEU . 19.4 mt -63.38 -61.48 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.42 -17.66 3.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -39.01 66.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.382 -0.824 . . . . 0.0 110.963 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -118.98 70.83 0.83 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 111.457 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.65 90.78 0.01 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . . . -143.94 82.5 1.72 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -1.167 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.16 143.81 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.51 -0.744 . . . . 0.0 110.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.734 ' HA ' HG21 ' A' ' 82' ' ' VAL . 2.9 mp -129.74 0.53 4.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.654 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.68 56.65 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.245 -0.909 . . . . 0.0 110.296 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.854 HG11 ' HG3' ' A' ' 80' ' ' ARG . 1.7 p -114.99 -164.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -147.37 140.33 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.518 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 110' ' ' TRP . 45.2 t0 -68.73 63.75 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.763 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 57.06 -77.17 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.4 m-90 -45.94 -70.7 0.09 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.728 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.36 -34.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -43.73 144.79 0.76 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.651 -0.911 . . . . 0.0 110.855 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -114.67 167.03 10.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.371 -0.831 . . . . 0.0 110.464 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' A' ' 117' ' ' LEU . 40.9 Cg_endo -68.61 -34.76 18.64 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.884 1.465 . . . . 0.0 110.563 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.636 HG21 ' HG3' ' A' ' 131' ' ' ARG . 4.3 p -80.77 -23.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.767 . . . . 0.0 110.337 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.78 -44.69 40.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.638 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 117' ' ' LEU . 4.5 pp -63.0 -21.42 66.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.637 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 117' ' ' LEU . . . -77.39 -49.91 13.88 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -31.02 28.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.159 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -86.69 -51.29 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.77 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.524 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -178.46 39.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 39.0 m-70 -120.05 49.19 1.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.383 -1.069 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -53.91 11.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.728 -0.608 . . . . 0.0 110.5 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.515 ' O ' HD11 ' A' ' 91' ' ' LEU . 3.0 m-20 -50.13 -34.98 24.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.488 -0.758 . . . . 0.0 109.722 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.802 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -83.41 -35.73 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.151 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -61.65 -45.33 94.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.513 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -55.23 20.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.383 -0.823 . . . . 0.0 109.446 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.675 ' CD2' HD21 ' A' ' 91' ' ' LEU . 20.5 t80 -55.19 -40.52 70.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.346 -0.846 . . . . 0.0 109.539 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.991 HD21 HD11 ' A' ' 94' ' ' LEU . 12.1 mt -64.52 -50.48 67.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 109.312 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.636 ' HG3' HG21 ' A' ' 115' ' ' VAL . 5.2 ttp180 -53.23 -27.64 23.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 0.0 110.328 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.3 -42.8 20.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.48 -11.01 50.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.416 -0.802 . . . . 0.0 110.729 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -116.89 -25.68 7.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.35 109.27 2.81 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -100.32 70.19 0.47 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.2 t -53.36 135.64 38.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.339 -1.095 . . . . 0.0 110.007 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.15 170.18 16.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 110.525 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -151.21 -107.28 0.36 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.41 39.13 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.399 -1.06 . . . . 0.0 110.763 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.56 166.64 5.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.279 -0.888 . . . . 0.0 110.686 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.85 74.72 0.92 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.454 -0.779 . . . . 0.0 109.732 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 145' ' ' ILE . . . -135.86 -43.96 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.494 -0.754 . . . . 0.0 110.125 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.07 142.89 34.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.819 . . . . 0.0 110.574 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 143' ' ' ALA . 1.0 OUTLIER -177.52 67.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.16 115.56 1.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.697 -0.627 . . . . 0.0 110.768 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 55.08 93.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 0.0 110.303 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.53 123.14 13.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.459 -0.776 . . . . 0.0 110.392 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -81.67 165.23 21.2 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 109.99 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 135.53 159.76 8.69 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -82.27 105.43 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.877 1.462 . . . . 0.0 110.329 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.24 -157.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.454 -0.779 . . . . 0.0 109.789 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -73.51 151.48 40.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 110.029 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.7 tt -178.9 93.83 0.21 Allowed Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.307 -0.87 . . . . 0.0 109.677 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.27 129.46 17.09 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.787 1.414 . . . . 0.0 110.777 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.07 179.838 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 tpt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.163 0.506 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.482 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -62.75 -55.0 42.44 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.344 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 47.6 Cg_endo -74.18 102.14 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.518 1.273 . . . . 0.0 110.435 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.7 48.66 2.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.106 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.73 72.4 0.26 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.594 -0.692 . . . . 0.0 110.529 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.88 -93.44 0.65 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t -134.78 -163.56 1.39 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.501 -0.999 . . . . 0.0 110.095 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.59 17.92 8.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.3 ttp -76.29 106.06 7.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.761 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.03 174.98 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.267 -0.896 . . . . 0.0 110.185 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.83 145.15 35.9 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.724 1.381 . . . . 0.0 110.237 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.441 ' HB3' ' CE2' ' A' ' 15' ' ' TRP . 24.5 t -85.63 118.94 25.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -0.836 . . . . 0.0 109.857 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.13 -12.97 61.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 110.828 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' A' ' 18' ' ' THR . 9.4 t70 -74.27 -5.56 42.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.252 -0.905 . . . . 0.0 110.524 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.559 ' O ' HD13 ' A' ' 31' ' ' LEU . 42.2 m0 -76.51 -8.27 56.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.211 -0.931 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 37' ' ' LEU . 1.2 tp -79.41 -50.89 10.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.31 -0.869 . . . . 0.0 109.036 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.49 46.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -63.96 -40.66 96.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.934 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.873 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -63.35 -45.5 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 108.894 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -62.68 -54.3 41.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.95 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -54.82 -22.03 13.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.548 -0.72 . . . . 0.0 110.979 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.94 27.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.943 . . . . 0.0 110.581 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.05 34.12 4.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 1.2 tpt180 -118.69 105.76 11.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.474 -1.015 . . . . 0.0 110.527 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 58' ' ' ARG . 71.6 t -72.46 -56.93 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.299 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -48.92 -26.89 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.533 -0.729 . . . . 0.0 110.909 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.873 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 3.0 mm-40 -71.52 -44.73 64.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 108.84 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.068 HG12 HD23 ' A' ' 62' ' ' LEU . 22.7 t -75.75 -52.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -0.807 . . . . 0.0 109.103 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.926 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -43.57 -50.43 7.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.599 -0.688 . . . . 0.0 110.406 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -73.02 -48.84 32.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.597 -0.689 . . . . 0.0 109.99 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 15' ' ' TRP . 13.5 mt -55.27 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 111.251 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.833 ' CB ' HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -45.64 -49.42 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.0 111.537 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -68.98 -9.1 50.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 110.804 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -102.03 -23.2 14.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.937 -1.102 . . . . 0.0 111.261 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 162.5 -28.62 0.26 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.635 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.759 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -41.87 141.03 0.9 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.286 -1.126 . . . . 0.0 110.464 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.916 ' O ' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -55.94 154.81 13.25 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.2 -38.9 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.818 1.431 . . . . 0.0 109.844 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.9 m120 -122.63 -65.54 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.58 -0.7 . . . . 0.0 109.817 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . 60.59 154.19 0.1 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.586 -0.696 . . . . 0.0 110.275 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.17 177.27 8.04 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.7 1.368 . . . . 0.0 110.171 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.7 155.62 47.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 110.16 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 110.077 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.42 16.14 18.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.5 23.18 34.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -110.14 174.5 5.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.714 ' O ' HG12 ' A' ' 51' ' ' VAL . 4.8 mmp_? -86.49 165.45 33.06 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 63' ' ' LEU . 42.0 Cg_endo -68.69 -12.6 35.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.773 1.407 . . . . 0.0 110.374 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.9 mt -109.37 -36.67 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 108.731 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.46 -21.72 38.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.871 -1.143 . . . . 0.0 108.979 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 47' ' ' ARG . 14.6 p -114.87 31.63 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.443 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.611 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -96.89 33.65 1.85 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 109.798 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.8 tmm? 72.5 -14.5 0.56 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.781 -0.574 . . . . 0.0 111.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.53 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 50.28 25.25 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.983 -1.073 . . . . 0.0 110.075 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -126.33 15.75 6.77 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.715 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -156.22 93.41 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 109.866 179.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.37 -22.74 33.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.347 -0.845 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.439 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -58.33 -39.57 79.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.458 -0.776 . . . . 0.0 110.16 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' A' ' 56' ' ' SER . 11.0 t -53.98 -65.17 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB1' HD12 ' A' ' 64' ' ' LEU . . . -52.72 -33.63 48.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 19.4 tt0 -47.23 -42.15 19.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.068 HD23 HG12 ' A' ' 28' ' ' VAL . 1.7 tp -82.7 -41.47 19.27 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -63.83 -62.87 1.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.629 -0.669 . . . . 0.0 109.739 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -48.54 -43.73 35.77 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.355 -0.841 . . . . 0.0 109.756 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.502 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.2 tp -58.95 -43.16 91.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.183 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CG ' HD22 ' A' ' 32' ' ' LEU . 3.5 m80 -81.06 0.03 37.78 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.729 -0.607 . . . . 0.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.11 60.13 1.98 Allowed Glycine 0 N--CA 1.48 1.609 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.83 -148.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.252 . . . . 0.0 109.014 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -115.17 52.75 0.76 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.867 . . . . 0.0 109.662 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 48.6 Cg_endo -70.77 -31.32 16.24 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.461 1.243 . . . . 0.0 109.628 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 0.6 OUTLIER -82.85 -75.46 0.31 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.563 -0.711 . . . . 0.0 109.139 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.13 164.43 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.566 -0.709 . . . . 0.0 110.534 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 80' ' ' ARG . . . -154.03 -126.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.027 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.2 m-20 -110.31 132.79 21.32 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.783 -1.198 . . . . 0.0 109.932 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.92 -9.91 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.313 1.165 . . . . 0.0 110.655 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.72 -74.63 0.42 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.377 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.998 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -100.3 9.11 43.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 110.473 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.3 mt 51.09 39.75 24.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -0.896 . . . . 0.0 110.318 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.418 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -64.19 96.21 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 110.019 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -73.19 148.58 88.83 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 110.636 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.7 Cg_endo -67.99 -14.49 41.25 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.699 1.368 . . . . 0.0 109.129 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.886 HG21 ' HA ' ' A' ' 104' ' ' LEU . 94.3 t -64.36 -31.51 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.425 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 26.1 m80 -67.74 -41.23 83.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.53 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 4.0 m-20 -52.35 -51.16 60.35 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.211 0.529 . . . . 0.0 110.58 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.607 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -53.52 -64.98 0.65 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.442 -0.787 . . . . 0.0 109.452 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.799 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.7 -27.9 65.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.654 ' HG2' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -54.11 -49.61 68.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.15 -0.969 . . . . 0.0 110.591 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.84 4.5 53.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 110.321 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.627 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 71.89 36.33 61.29 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -102.53 83.25 2.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.358 -1.083 . . . . 0.0 110.87 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.464 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.88 -39.06 80.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.684 ' O ' HG23 ' A' ' 96' ' ' VAL . 1.2 m-20 -47.67 -37.43 12.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.502 -0.749 . . . . 0.0 110.006 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 97' ' ' LEU . 54.7 m -64.3 -46.59 82.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.731 HD13 HG13 ' A' ' 126' ' ' VAL . 1.2 mp -63.3 -45.11 92.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 110.138 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 55.6 t -48.79 -44.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 92' ' ' ASP . 10.9 t -67.02 -45.4 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.597 -0.689 . . . . 0.0 109.147 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.842 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -53.09 -43.34 66.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.448 -0.782 . . . . 0.0 109.859 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -83.49 -33.48 25.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.074 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 5.6 ttt85 -66.09 -11.22 47.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.556 -0.715 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.442 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -132.1 -67.71 0.66 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.082 -1.012 . . . . 0.0 111.071 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.57 107.1 0.23 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.842 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -167.29 117.07 0.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.452 -1.028 . . . . 0.0 110.271 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.8 113.88 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.886 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.1 mp -106.41 25.68 10.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 110.225 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.6 p30 -128.79 47.71 2.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.365 -0.834 . . . . 0.0 110.59 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.638 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.6 p -112.14 -169.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.857 . . . . 0.0 109.961 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.638 ' H ' HG22 ' A' ' 106' ' ' VAL . 19.3 ptt180 -140.64 146.74 38.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.96 66.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 110.117 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 51.78 -84.9 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.611 -0.681 . . . . 0.0 110.67 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.998 ' CH2' HG23 ' A' ' 77' ' ' THR . 23.9 p90 -122.94 15.16 9.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.98 -81.0 1.35 Allowed Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.79 -164.41 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.228 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 106' ' ' VAL . 41.8 mt -95.79 163.42 21.27 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.75 . . . . 0.0 110.199 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.6 -19.14 60.26 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.88 1.463 . . . . 0.0 110.379 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 116' ' ' ASP . 14.3 p -79.36 -36.59 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.824 . . . . 0.0 110.152 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 2.5 m-20 -66.95 -39.66 87.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.854 . . . . 0.0 110.353 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.654 HD21 ' HG2' ' A' ' 87' ' ' ARG . 1.4 tt -69.04 -35.74 76.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.951 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.705 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -56.07 -55.96 26.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.531 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -60.52 -41.97 95.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.803 . . . . 0.0 110.473 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.18 -37.89 67.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 109.984 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 87' ' ' ARG . 11.7 mt -86.47 -2.32 58.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 110.416 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.44 33.64 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.546 ' ND1' ' HA3' ' A' ' 89' ' ' GLY . 71.9 m-70 -102.77 46.18 0.93 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.89 -1.359 . . . . 0.0 109.56 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -45.82 -37.97 6.71 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.29 0.566 . . . . 0.0 110.346 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.418 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.6 m-20 -58.15 -42.95 87.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.725 . . . . 0.0 109.195 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 86' ' ' ALA . 13.6 t -76.09 -37.79 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.72 85.43 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -56.51 -61.34 2.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.905 . . . . 0.0 109.625 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -57.63 -24.92 59.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 109.454 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' A' ' 86' ' ' ALA . 11.3 mt -75.73 -52.87 9.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.79 . . . . 0.0 109.545 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -23.28 2.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.814 . . . . 0.0 110.169 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.24 -57.43 3.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.981 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.45 -1.65 34.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 111.013 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . -106.97 -41.87 5.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.55 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.29 -103.18 2.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.08 95.85 0.64 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.5 p -89.01 17.31 5.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -1.078 . . . . 0.0 110.703 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -103.29 147.85 26.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.123 -0.985 . . . . 0.0 110.006 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 157.46 -99.33 0.18 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.3 p -171.46 172.87 4.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -1.01 . . . . 0.0 110.234 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 52.31 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.403 -0.811 . . . . 0.0 110.765 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -54.74 -90.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.358 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 48.41 26.17 1.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.091 -1.006 . . . . 0.0 110.476 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -80.48 146.66 31.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.909 . . . . 0.0 110.275 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 1.1 tt -74.3 146.68 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.891 . . . . 0.0 110.916 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 0.2 OUTLIER 173.34 53.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.366 -0.834 . . . . 0.0 109.929 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -173.67 86.85 0.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.371 -0.831 . . . . 0.0 109.949 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.41 114.83 1.34 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.253 -0.904 . . . . 0.0 110.454 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -81.76 148.35 28.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.772 . . . . 0.0 110.077 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 67.03 102.19 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.26 147.39 53.25 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.72 1.379 . . . . 0.0 110.592 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.7 m -96.19 114.44 26.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.382 -0.824 . . . . 0.0 110.243 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -65.11 156.54 31.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.355 -0.841 . . . . 0.0 110.457 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.1 mm -124.55 97.84 38.66 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 110.492 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.62 117.86 5.36 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.577 1.303 . . . . 0.0 110.08 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.893 -1.051 . . . . 0.0 110.317 -179.752 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -51.59 -55.84 26.11 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.366 -0.833 . . . . 0.0 109.924 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 43.6 Cg_endo -72.13 72.68 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.647 1.341 . . . . 0.0 110.188 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -47.71 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.642 -0.661 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 3' ' ' PRO . . . 47.86 75.52 0.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.776 . . . . 0.0 110.329 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.12 -115.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -62.39 -71.75 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.491 -1.005 . . . . 0.0 110.843 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.9 m -101.32 146.75 27.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.302 -0.874 . . . . 0.0 110.684 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.5 tpp -46.25 -61.98 1.55 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.622 -0.673 . . . . 0.0 110.059 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 178.78 92.01 0.16 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.766 -0.583 . . . . 0.0 109.684 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.76 153.35 64.4 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.717 1.377 . . . . 0.0 110.409 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.24 137.14 35.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.338 -0.851 . . . . 0.0 110.141 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -71.8 142.54 49.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 20.5 t70 -177.44 -50.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.385 -0.822 . . . . 0.0 110.133 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.498 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 31.1 m0 -40.19 -30.55 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.619 . . . . 0.0 111.012 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.035 HD11 ' HB1' ' A' ' 36' ' ' ALA . 9.8 mt -75.68 -54.57 6.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.512 -0.742 . . . . 0.0 109.144 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.41 69.43 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.783 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -73.9 -59.31 2.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.755 -0.591 . . . . 0.0 110.633 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . . . -49.67 -54.43 18.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -47.73 -50.22 25.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.655 -0.653 . . . . 0.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -36.8 82.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.184 -0.947 . . . . 0.0 109.952 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.84 15.1 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.81 72.05 0.6 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 93.0 mtt180 -136.74 67.95 1.44 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.517 -0.99 . . . . 0.0 109.739 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.763 HG22 ' CG2' ' A' ' 59' ' ' VAL . 50.4 t -57.27 -62.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.451 -0.78 . . . . 0.0 110.058 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 25' ' ' VAL . 9.3 mt-10 -39.73 -36.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.75 -0.594 . . . . 0.0 110.943 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -72.34 -50.11 29.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.554 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.99 HG12 HD13 ' A' ' 62' ' ' LEU . 43.6 t -62.58 -38.87 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.181 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.986 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -55.2 -38.44 68.4 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.855 -1.153 . . . . 0.0 108.434 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.88 12.11 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.93 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' ALA . 4.2 mt -56.35 -65.86 0.53 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 110.339 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.964 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 13.5 mt -43.42 -51.04 6.75 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.296 -0.877 . . . . 0.0 109.68 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 43.0 mt-10 -69.79 -15.25 63.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -88.61 -5.46 58.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.0 110.732 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.05 2.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.035 ' HB1' HD11 ' A' ' 16' ' ' LEU . . . -75.91 165.44 24.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.547 -0.972 . . . . 0.0 110.253 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.672 HD13 ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -80.43 137.92 51.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 110.344 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 49.9 Cg_endo -76.14 -40.8 0.58 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.888 1.467 . . . . 0.0 110.323 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 25.6 m120 -101.71 -83.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.653 -0.654 . . . . 0.0 110.087 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . 57.41 69.66 1.56 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 45.4 Cg_endo -71.44 101.97 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.048 1.552 . . . . 0.0 111.708 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 3.9 p30 -178.75 -156.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.52 -0.737 . . . . 0.0 109.706 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 1.1 t 61.72 85.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.42 -0.8 . . . . 0.0 109.747 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.1 m-85 65.89 8.37 5.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.498 -0.751 . . . . 0.0 109.836 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.13 23.57 52.71 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.563 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 16.2 mmt-85 -99.62 35.49 1.98 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.07 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.517 ' CB ' ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 53.23 -178.34 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 47' ' ' ARG . 55.7 Cg_endo -82.58 -29.27 1.46 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.426 1.224 . . . . 0.0 111.337 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.627 HG13 ' HB1' ' A' ' 68' ' ' ALA . 6.4 mt -107.47 -35.53 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.517 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 20.4 tt0 -60.51 -11.72 7.79 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.019 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.563 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 12.9 p -105.79 3.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.873 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -73.11 166.28 23.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.967 -1.083 . . . . 0.0 109.024 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.3 ttm -63.87 -6.74 6.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.355 -0.841 . . . . 0.0 111.204 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.576 ' HE3' ' CB ' ' A' ' 84' ' ' ASP . 8.5 mmt 56.1 17.22 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.885 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.47 -0.65 24.82 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 88.74 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -1.027 . . . . 0.0 109.873 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -53.35 -24.55 12.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.314 -0.867 . . . . 0.0 110.651 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -48.23 70.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 108.84 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.763 ' CG2' HG22 ' A' ' 25' ' ' VAL . 67.3 t -52.4 -49.5 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -51.71 -53.51 38.54 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.669 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.0 tt0 -49.23 -47.11 46.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.715 -0.615 . . . . 0.0 110.04 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.99 HD13 HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -56.26 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 110.176 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 69.1 mt -53.67 -49.85 67.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.481 -0.762 . . . . 0.0 110.396 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.815 HD13 HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -50.7 -69.19 0.12 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.427 -0.796 . . . . 0.0 111.045 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.9 OUTLIER -51.26 -22.32 2.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.412 -0.805 . . . . 0.0 109.697 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.806 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -83.87 -49.11 9.34 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.646 -0.659 . . . . 0.0 109.596 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 154.51 39.07 0.02 OUTLIER Glycine 0 N--CA 1.478 1.46 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.744 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -71.09 -173.94 0.9 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.557 -1.555 . . . . 0.0 108.593 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 3.6 mt-10 -113.72 64.71 1.17 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.072 -1.017 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.578 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 46.3 Cg_endo -70.77 -10.31 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.093 1.575 . . . . 0.0 109.857 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.469 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 10.2 t-20 -107.89 -29.06 9.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -0.774 . . . . 0.0 109.688 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 158.71 16.94 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.652 -0.655 . . . . 0.0 110.099 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -137.24 -145.92 0.21 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.409 -0.807 . . . . 0.0 110.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.9 143.05 26.1 Favored Pre-proline 0 C--N 1.306 -1.304 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.31 -12.22 23.0 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.82 1.432 . . . . 0.0 110.019 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.86 -71.22 0.46 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.6 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -103.04 -2.53 27.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 111.017 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 mt 63.58 20.92 12.5 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.224 -0.923 . . . . 0.0 111.282 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.7 m -65.51 97.03 0.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.695 ' HG3' HG11 ' A' ' 106' ' ' VAL . 11.9 mmt85 -69.62 164.21 52.44 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.148 -0.97 . . . . 0.0 109.217 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.583 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -67.18 -21.46 48.39 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.879 1.463 . . . . 0.0 109.71 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 114' ' ' PRO . 13.4 t -59.99 -27.26 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.567 0.699 . . . . 0.0 109.491 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.511 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.1 m80 -80.47 -32.09 37.23 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.576 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 5.0 m-20 -61.07 -43.03 99.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -60.32 -64.41 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.368 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.935 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -59.59 -35.32 74.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.516 -0.74 . . . . 0.0 110.107 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -45.41 -55.88 5.6 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.249 -0.907 . . . . 0.0 110.717 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.64 5.02 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.547 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 72.74 27.72 68.56 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 1.6 t80 -94.99 103.75 15.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.304 -1.115 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.52 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.96 -43.69 34.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.862 -0.524 . . . . 0.0 110.807 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.1 m-20 -44.39 -34.89 2.16 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.547 0.689 . . . . 0.0 109.748 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.475 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 95.2 m -66.37 -39.89 89.41 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.338 0.589 . . . . 0.0 109.901 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.828 HD13 HG13 ' A' ' 126' ' ' VAL . 1.0 OUTLIER -64.02 -58.28 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 40.0 t -38.21 -53.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.732 -0.605 . . . . 0.0 110.208 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.815 HG12 HD13 ' A' ' 64' ' ' LEU . 24.7 t -55.74 -56.34 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.783 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -44.35 -44.35 8.17 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.351 -0.843 . . . . 0.0 110.509 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -82.4 -26.87 32.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.1 ttt85 -65.05 -10.3 28.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.697 -0.627 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.459 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -133.11 -68.7 0.58 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 111.153 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 70' ' ' PRO . . . -174.12 107.85 0.25 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -152.39 -155.61 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.572 -0.958 . . . . 0.0 109.629 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' O ' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -162.63 105.92 1.1 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -98.9 68.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.585 -0.697 . . . . 0.0 110.812 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -175.34 42.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.695 HG11 ' HG3' ' A' ' 80' ' ' ARG . 1.4 p -107.16 -175.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 106' ' ' VAL . 2.5 mtp85 -125.8 133.83 51.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -67.05 64.23 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.752 -0.592 . . . . 0.0 110.197 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.6 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 57.87 -80.85 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.449 -0.782 . . . . 0.0 110.947 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.573 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.2 m-90 -45.68 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.0 110.266 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.24 73.05 0.06 OUTLIER Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 108' ' ' ASP . 3.9 mtt180 -134.34 -164.02 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.395 -1.062 . . . . 0.0 109.884 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.508 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -153.07 166.48 15.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 82' ' ' VAL . 43.6 Cg_endo -70.33 -54.9 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.875 1.46 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.16 -26.03 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.626 -0.671 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -62.38 -30.24 71.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.449 -0.782 . . . . 0.0 110.494 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -44.31 18.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 109.666 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.539 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -52.84 -47.03 68.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.506 ' HG2' ' HB1' ' A' ' 127' ' ' ALA . 64.5 mm-40 -63.98 -35.0 79.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.024 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.48 -25.07 50.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.772 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.639 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 42.6 mt -101.7 2.57 38.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.44 43.51 24.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 20.4 m-70 -106.63 55.52 0.66 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.086 -1.244 . . . . 0.0 110.154 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 12.4 mmt180 -41.05 -57.31 2.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.843 -0.536 . . . . 0.0 110.418 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.455 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -43.59 -43.98 5.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.935 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -86.9 -50.96 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.353 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.506 ' HB1' ' HG2' ' A' ' 119' ' ' GLU . . . -49.94 -50.69 45.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -62.24 -66.12 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.487 ' CD2' HD21 ' A' ' 91' ' ' LEU . 56.6 t80 -47.66 -40.58 20.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.717 . . . . 0.0 109.844 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.0 mt -60.24 -54.12 49.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.659 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -45.28 -36.72 4.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.565 -0.709 . . . . 0.0 110.656 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.74 -46.82 62.3 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.598 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -83.56 -1.22 53.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.714 -0.616 . . . . 0.0 110.602 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -112.11 -19.35 12.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 110.283 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.8 -121.96 0.58 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.496 ' O ' HG23 ' A' ' 137' ' ' THR . . . 110.45 -10.76 30.75 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 136' ' ' GLY . 13.7 p -153.46 -63.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -1.202 . . . . 0.0 110.126 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.18 155.3 34.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.101 -0.999 . . . . 0.0 110.023 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.07 86.37 0.11 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.68 -62.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -1.173 . . . . 0.0 110.959 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -138.27 -64.34 0.53 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.087 -1.008 . . . . 0.0 110.948 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -89.07 66.91 7.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.783 . . . . 0.0 110.003 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.27 144.43 2.82 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.402 -0.811 . . . . 0.0 110.211 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.419 ' HG2' HG22 ' A' ' 145' ' ' ILE . 25.0 ttt180 -59.05 161.84 4.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.274 -0.891 . . . . 0.0 110.126 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.419 HG22 ' HG2' ' A' ' 144' ' ' ARG . 1.3 tt -42.34 150.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.66 -0.65 . . . . 0.0 111.156 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.9 OUTLIER 174.14 85.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.708 -0.62 . . . . 0.0 109.88 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . 57.26 -169.12 0.11 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.168 -0.957 . . . . 0.0 110.184 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 58.02 -168.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.192 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -58.6 -153.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.603 -0.686 . . . . 0.0 109.993 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.18 152.12 8.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.74 135.89 24.53 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.558 1.294 . . . . 0.0 109.894 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.415 ' O ' HG13 ' A' ' 154' ' ' ILE . 2.0 t -177.08 84.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.454 -0.779 . . . . 0.0 110.395 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.49 148.58 3.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.281 -0.887 . . . . 0.0 109.707 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 152' ' ' SER . 4.0 mt -127.71 77.32 76.34 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.048 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.3 119.96 5.47 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 124.225 1.645 . . . . 0.0 110.613 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 t70 . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.692 179.54 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.181 0.515 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.19 148.18 39.52 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.64 -175.58 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.754 1.397 . . . . 0.0 110.299 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.78 86.21 1.98 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.423 -0.798 . . . . 0.0 110.211 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.03 -167.02 0.78 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.426 -0.797 . . . . 0.0 110.301 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.25 -173.7 16.1 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t 52.42 74.22 0.29 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.319 -1.106 . . . . 0.0 110.352 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.91 -34.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.34 -0.85 . . . . 0.0 110.368 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 71.3 mmm -85.75 -16.3 39.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.968 . . . . 0.0 110.308 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -172.9 112.71 0.36 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.391 -0.818 . . . . 0.0 109.508 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.61 80.74 1.1 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.436 1.23 . . . . 0.0 110.683 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.96 12.16 36.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.924 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.627 ' HB3' HD22 ' A' ' 37' ' ' LEU . . . -71.07 64.2 0.34 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.938 . . . . 0.0 109.918 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 18' ' ' THR . 16.6 p30 -91.59 17.51 8.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.429 -0.794 . . . . 0.0 110.175 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.525 ' HB3' HD13 ' A' ' 31' ' ' LEU . 42.3 m0 -45.49 -43.6 11.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.593 -0.692 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 32' ' ' LEU . 12.4 mt -58.1 -58.61 7.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.0 109.158 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.4 -51.64 66.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.729 -0.607 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -51.51 -66.14 0.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.342 -0.849 . . . . 0.0 110.845 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.47 -52.2 66.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.98 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -50.4 -58.31 6.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.358 -0.839 . . . . 0.0 110.399 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -52.58 -24.55 8.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.798 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.2 7.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.43 47.81 61.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.6 mtt180 -118.62 73.03 0.9 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.443 -1.034 . . . . 0.0 109.896 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 59' ' ' VAL . 49.2 t -60.59 -60.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.334 -0.854 . . . . 0.0 111.125 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -47.63 -35.19 8.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 110.969 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -39.41 74.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.277 -0.889 . . . . 0.0 109.584 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.909 HG12 HD23 ' A' ' 62' ' ' LEU . 39.1 t -76.13 -49.84 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.187 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 1.013 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -42.32 -46.51 4.61 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.446 -0.784 . . . . 0.0 110.039 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -72.39 -51.86 18.58 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.852 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 15' ' ' TRP . 60.4 mt -51.99 -66.88 0.31 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.542 -0.724 . . . . 0.0 110.964 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -41.51 -59.24 1.66 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.707 -0.621 . . . . 0.0 111.282 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -13.44 61.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.822 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -85.04 -6.93 59.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.97 -1.082 . . . . 0.0 110.86 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.51 -10.29 6.45 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.535 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -50.92 143.6 9.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.274 . . . . 0.0 110.264 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD22 ' HB3' ' A' ' 13' ' ' ALA . 5.8 mp -59.82 153.77 51.57 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.395 -0.816 . . . . 0.0 109.957 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.02 -56.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.679 1.357 . . . . 0.0 110.932 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 33.7 m120 -96.96 -66.97 0.87 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.11 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 39' ' ' ASN . . . 58.34 101.55 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 40.5 Cg_endo -68.17 122.41 9.47 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.579 1.305 . . . . 0.0 110.705 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -103.87 -166.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.592 -0.693 . . . . 0.0 109.739 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.1 38.5 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.287 -0.883 . . . . 0.0 110.519 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 18.9 m-85 -122.49 13.75 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.82 49.78 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.551 ' HD3' ' HB3' ' A' ' 44' ' ' TYR . 2.9 ptm180 -159.73 131.67 6.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -1.143 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.596 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.86 -173.66 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.668 -0.645 . . . . 0.0 110.169 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 38.5 Cg_endo -64.44 -173.7 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.196 1.103 . . . . 0.0 111.467 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.2 mt 62.97 -64.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.6 tt0 -48.08 -25.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.001 -1.062 . . . . 0.0 109.344 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 51' ' ' VAL . 12.5 p -120.7 34.18 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.611 -0.681 . . . . 0.0 109.556 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.795 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -94.11 38.25 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.0 110.068 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.45 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 7.5 tmm? 66.98 -10.62 0.3 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.509 -0.745 . . . . 0.0 110.751 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.495 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 48.56 27.76 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.989 -1.069 . . . . 0.0 110.127 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -133.05 13.76 4.95 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.676 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.1 m -144.13 78.13 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -1.044 . . . . 0.0 109.941 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -50.63 -29.53 11.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 110.006 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.453 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -56.91 -31.53 65.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.618 -0.677 . . . . 0.0 109.464 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.795 HG11 ' HB2' ' A' ' 52' ' ' MET . 53.1 t -58.59 -65.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.082 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -50.76 -39.21 51.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 110.22 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -51.44 -36.91 46.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.189 -0.945 . . . . 0.0 110.038 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.013 HD22 ' HA ' ' A' ' 29' ' ' ARG . 6.9 tp -89.97 -43.8 10.31 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.455 -0.778 . . . . 0.0 109.158 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -63.7 -55.59 22.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -59.19 -47.36 85.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.335 -0.853 . . . . 0.0 109.7 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 1.7 tp -52.54 -28.35 20.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.213 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.548 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.1 m-70 -93.36 -41.36 9.88 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.551 -0.718 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.34 47.49 0.04 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.593 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.756 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -67.01 -149.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.008 -1.29 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 3.1 pt-20 -116.71 56.71 1.59 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.981 . . . . 0.0 110.872 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.787 ' HB3' HD11 ' A' ' 64' ' ' LEU . 40.1 Cg_endo -68.28 -15.04 41.86 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.635 1.334 . . . . 0.0 109.886 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -110.27 -77.9 0.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.528 -0.733 . . . . 0.0 110.095 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -43.0 145.04 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 110.95 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -128.72 -143.0 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 11.3 m-20 -112.58 134.44 21.64 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 109.978 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.54 -19.91 36.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.489 1.257 . . . . 0.0 110.062 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.54 -76.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 108.915 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.544 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 69.6 p -122.36 36.15 4.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.931 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 78' ' ' LEU . 8.7 mt 48.17 34.13 4.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.498 -0.751 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.0 101.67 0.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -85.36 173.18 7.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.47 -11.62 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.07 1.563 . . . . 0.0 110.14 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 104' ' ' LEU . 36.2 t -69.91 -30.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 26.6 m80 -73.1 -47.03 47.92 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 20.6 m-20 -47.28 -47.0 25.24 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.894 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -60.16 -59.98 4.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.827 . . . . 0.0 109.669 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.106 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -61.07 -51.52 68.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.399 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.569 ' HD3' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -41.88 -30.54 0.26 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.522 -0.736 . . . . 0.0 111.058 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.12 -18.89 15.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 110.391 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 88.84 23.81 34.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -97.0 85.02 3.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -1.067 . . . . 0.0 111.018 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.779 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -58.89 -38.39 78.74 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 13.8 m-20 -50.67 -36.99 38.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.3 m -62.96 -47.96 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.766 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -60.84 -43.61 98.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.488 -0.758 . . . . 0.0 109.68 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 91' ' ' LEU . 91.9 t -50.71 -47.67 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.366 -0.834 . . . . 0.0 109.183 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.568 HG12 HD13 ' A' ' 64' ' ' LEU . 45.2 t -60.02 -48.12 89.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' ALA . 1.7 mp -54.98 -40.96 70.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -82.9 -33.11 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.084 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -65.69 -12.2 51.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -0.775 . . . . 0.0 110.439 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.487 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -119.84 -82.15 0.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.715 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.71 56.04 0.13 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . . . -105.7 122.62 46.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -1.132 . . . . 0.0 110.436 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -54.87 162.13 1.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 109.849 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -149.59 36.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.301 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -150.64 40.63 0.75 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 111.34 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.649 HG22 ' H ' ' A' ' 107' ' ' ARG . 5.1 p -97.87 -176.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -130.2 146.93 51.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.341 -0.849 . . . . 0.0 109.681 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 110' ' ' TRP . 15.1 p-10 -74.53 50.36 0.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 109.851 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 61.66 -60.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.694 -0.628 . . . . 0.0 110.795 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.41 -54.94 14.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.62 -25.4 0.75 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.489 ' O ' HD12 ' A' ' 113' ' ' LEU . 4.0 ttp180 -60.87 -174.15 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.228 -1.16 . . . . 0.0 110.697 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -138.55 175.46 3.32 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.298 -0.876 . . . . 0.0 110.241 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.487 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 46.5 Cg_endo -73.48 -47.61 0.29 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.539 1.284 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' CG2' ' HD3' ' A' ' 131' ' ' ARG . 9.2 p -54.46 -33.0 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 0.0 109.1 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.26 -37.72 69.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.639 -0.663 . . . . 0.0 109.321 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -30.78 67.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.217 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.106 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -69.38 -53.41 19.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -16.13 63.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.431 -0.793 . . . . 0.0 110.06 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -38.4 36.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.569 HD13 ' HD3' ' A' ' 87' ' ' ARG . 5.1 mt -92.23 1.46 57.2 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 110.955 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.06 12.87 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.617 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 80.3 m-70 -95.78 46.69 1.09 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.974 -1.309 . . . . 0.0 109.318 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -43.79 -38.1 3.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.747 -0.595 . . . . 0.0 110.689 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.779 ' O ' HD11 ' A' ' 91' ' ' LEU . 15.9 p-10 -64.23 -40.8 96.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.371 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -82.94 -40.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -57.51 -53.89 53.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.082 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 mtt-85 -52.99 -59.75 4.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.566 -0.709 . . . . 0.0 110.264 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -59.32 -39.88 84.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.882 HD11 ' HB2' ' A' ' 86' ' ' ALA . 12.6 mt -60.06 -30.66 69.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.422 ' HD3' ' CG2' ' A' ' 115' ' ' VAL . 4.1 tpp180 -67.6 -36.74 81.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.875 . . . . 0.0 109.634 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.13 -35.88 36.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.448 -0.782 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.7 -32.08 23.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.0 110.119 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -102.17 18.9 19.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 0.0 110.091 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.01 128.87 9.44 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.77 23.56 0.92 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.08 118.36 6.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.23 -1.159 . . . . 0.0 110.312 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 75.09 2.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.462 -0.774 . . . . 0.0 109.949 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 59.6 -145.33 45.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.7 p -147.75 95.42 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -1.13 . . . . 0.0 110.113 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.23 -62.77 1.48 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 110.376 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.56 -57.65 1.27 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.213 -0.929 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.09 109.09 4.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.821 . . . . 0.0 110.249 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.5 ttp85 -48.34 125.81 10.17 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.691 -0.631 . . . . 0.0 110.319 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 146' ' ' ASP . 60.0 mt 57.14 164.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.517 -0.74 . . . . 0.0 110.048 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.419 ' N ' HG22 ' A' ' 145' ' ' ILE . 0.6 OUTLIER 175.5 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.68 99.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.266 -0.896 . . . . 0.0 110.374 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.35 130.21 45.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.422 -0.799 . . . . 0.0 110.185 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.49 148.97 22.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.38 144.67 1.22 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.4 134.99 25.7 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.632 1.333 . . . . 0.0 110.541 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.1 m -111.22 -20.86 12.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.502 -0.749 . . . . 0.0 110.711 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -51.1 157.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.387 -0.821 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mt -110.32 88.94 7.91 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.335 -0.853 . . . . 0.0 109.977 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 113.69 3.83 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.774 1.407 . . . . 0.0 110.637 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.243 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.052 0.453 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -176.75 124.02 0.29 Allowed Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.194 -0.941 . . . . 0.0 110.122 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.66 128.86 9.68 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.477 1.251 . . . . 0.0 110.508 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.2 68.18 0.48 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.441 -0.787 . . . . 0.0 110.309 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.69 83.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.428 -0.795 . . . . 0.0 110.032 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.47 -177.28 41.43 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.0 m -118.46 169.05 10.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.936 . . . . 0.0 109.56 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.4 m 51.18 51.26 17.34 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.64 9.47 5.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.771 -0.581 . . . . 0.0 110.305 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.38 67.12 4.81 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.318 -0.864 . . . . 0.0 110.457 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.9 -179.65 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.774 1.408 . . . . 0.0 110.105 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.441 ' HA ' ' CD1' ' A' ' 15' ' ' TRP . 3.5 m -112.46 -22.52 10.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.174 -0.954 . . . . 0.0 110.635 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.76 -26.81 15.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.109 -0.994 . . . . 0.0 110.436 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -80.12 10.44 4.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.452 -0.78 . . . . 0.0 110.427 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.497 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 16.2 m0 -69.88 -5.5 26.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.852 HD21 ' CB ' ' A' ' 36' ' ' ALA . 30.7 mt -76.62 -54.33 6.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.981 -1.074 . . . . 0.0 109.689 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -66.16 -33.04 74.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.73 -0.606 . . . . 0.0 110.513 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -71.84 -59.99 2.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.86 -47.73 76.79 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.887 -1.133 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -47.95 -62.89 1.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.449 -0.782 . . . . 0.0 110.186 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.924 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -51.34 -24.25 4.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.233 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -90.27 28.86 1.34 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.521 -0.737 . . . . 0.0 111.028 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.29 43.48 9.77 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HD2' ' HB3' ' A' ' 22' ' ' ARG . 1.7 mtt180 -122.91 96.66 5.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.435 -1.038 . . . . 0.0 109.661 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.738 HG22 ' CG2' ' A' ' 59' ' ' VAL . 60.1 t -82.05 -55.48 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.07 -33.22 1.4 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.668 -0.645 . . . . 0.0 111.685 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 31' ' ' LEU . 1.3 mt-10 -67.77 -65.87 0.64 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.896 -1.127 . . . . 0.0 108.621 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.994 HG12 HD21 ' A' ' 62' ' ' LEU . 6.7 t -58.01 -44.47 87.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.82 ' HA ' HD22 ' A' ' 62' ' ' LEU . 1.5 tpt85 -47.51 -48.93 27.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.947 -1.096 . . . . 0.0 110.31 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.37 -51.28 5.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.578 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -58.28 -40.64 82.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.711 HD22 HD11 ' A' ' 62' ' ' LEU . 6.6 tt -67.92 -47.69 68.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.338 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -59.93 -15.14 19.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.0 110.407 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.33 -62.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.71 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.14 28.1 0.08 OUTLIER Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.852 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -70.17 167.37 17.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 110.469 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 16' ' ' LEU . 4.0 mm? -98.23 134.22 22.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.846 . . . . 0.0 110.975 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 44.6 Cg_endo -71.6 -22.95 23.68 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.587 1.309 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -129.81 53.92 1.88 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.578 -0.701 . . . . 0.0 109.279 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -85.06 145.91 44.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.612 -0.68 . . . . 0.0 111.051 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.44 136.9 29.63 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.95 1.5 . . . . 0.0 109.92 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 8.7 m-80 -100.71 -161.8 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -0.889 . . . . 0.0 110.562 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.24 13.34 16.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.488 -0.757 . . . . 0.0 110.246 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -149.1 27.12 0.86 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 110.137 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.86 56.29 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.511 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -115.27 96.48 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.534 -0.98 . . . . 0.0 110.138 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' CD ' ' HD2' ' A' ' 48' ' ' PRO . 29.0 mmt-85 -52.27 171.89 0.19 Allowed Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.332 -0.855 . . . . 0.0 110.45 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HB2' HD22 ' A' ' 63' ' ' LEU . 38.9 Cg_endo -65.89 166.68 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.566 1.298 . . . . 0.0 110.215 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.59 HG13 ' HB1' ' A' ' 68' ' ' ALA . 1.2 mt 64.21 -64.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.808 -0.557 . . . . 0.0 109.625 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 48' ' ' PRO . 17.7 tt0 -45.55 -27.61 0.78 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.861 -1.149 . . . . 0.0 109.35 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.924 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.9 p -117.35 43.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.313 -0.867 . . . . 0.0 110.541 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -104.08 33.65 3.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 109.173 179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 9.7 ttp 70.76 -6.62 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.883 -0.511 . . . . 0.0 110.318 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.574 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.92 25.78 0.11 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.0 110.736 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.28 19.16 4.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.02 75.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.455 -1.026 . . . . 0.0 109.697 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -45.03 -27.48 0.56 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.895 . . . . 0.0 109.756 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -49.84 20.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.654 -0.654 . . . . 0.0 109.503 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.738 ' CG2' HG22 ' A' ' 25' ' ' VAL . 62.9 t -56.61 -64.29 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -0.758 . . . . 0.0 109.931 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -44.54 -52.16 8.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.432 -0.792 . . . . 0.0 109.827 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.564 ' HA ' HG11 ' A' ' 96' ' ' VAL . 7.0 tm-20 -41.75 -53.38 3.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.994 HD21 HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -59.57 -53.44 58.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.671 -0.643 . . . . 0.0 109.992 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.822 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -65.31 -50.9 63.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.588 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.748 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -48.88 -59.4 3.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.797 . . . . 0.0 110.424 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.2 pp -57.67 -23.32 50.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.077 -1.015 . . . . 0.0 108.776 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.553 ' CG ' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -86.76 -3.12 59.01 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.639 -0.663 . . . . 0.0 109.915 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 84.92 46.91 5.5 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.26 -146.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -1.164 . . . . 0.0 109.301 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 2.0 tp10 -120.72 64.36 11.58 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 49.9 Cg_endo -74.04 -35.23 4.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.916 1.482 . . . . 0.0 110.468 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 3.5 m-80 -85.28 -69.3 0.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.294 -0.879 . . . . 0.0 110.242 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.5 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.3 t -48.71 144.02 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -0.757 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.92 -152.83 0.53 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.512 -0.743 . . . . 0.0 109.815 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.65 149.51 37.53 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.205 -0.934 . . . . 0.0 109.823 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.88 -21.42 24.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.645 1.339 . . . . 0.0 109.098 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.09 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.72 -0.613 . . . . 0.0 109.593 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 27.2 p -133.48 40.98 3.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.445 -0.784 . . . . 0.0 109.079 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.512 ' HA ' HD23 ' A' ' 78' ' ' LEU . 5.8 mt 41.82 42.8 2.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.729 -0.607 . . . . 0.0 111.495 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 m -78.7 103.5 8.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.604 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -76.4 155.13 83.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 109.388 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 39.5 Cg_endo -64.57 -15.67 51.16 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.422 1.222 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' A' ' 104' ' ' LEU . 11.1 t -61.07 -33.29 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 87' ' ' ARG . 7.4 m80 -71.72 -35.36 70.16 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -54.84 -46.89 74.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.446 -0.784 . . . . 0.0 110.133 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -57.99 -58.09 9.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.458 -0.776 . . . . 0.0 109.384 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.035 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -69.67 -15.83 63.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 83' ' ' HIS . 5.7 tpt180 -80.81 -22.73 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -112.32 -12.93 13.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 110.134 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' CE1' ' A' ' 123' ' ' HIS . . . 80.99 61.02 2.18 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.445 ' O ' HD12 ' A' ' 94' ' ' LEU . 1.2 t80 -135.97 86.08 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -1.069 . . . . 0.0 110.335 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.92 HD23 HG22 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -60.36 -40.52 91.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 111.047 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -45.7 -37.14 5.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.83 . . . . 0.0 109.851 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.445 ' O ' HD12 ' A' ' 97' ' ' LEU . 8.5 m -73.8 -42.81 60.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.784 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.498 -0.751 . . . . 0.0 109.417 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 91' ' ' LEU . 57.8 t -60.49 -45.51 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.662 0.744 . . . . 0.0 109.203 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 HD22 ' A' ' 64' ' ' LEU . 6.5 t -60.31 -50.34 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.751 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -48.26 -44.32 33.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.512 -0.743 . . . . 0.0 110.141 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -84.94 -36.91 21.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.258 -0.901 . . . . 0.0 110.58 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -59.52 -15.12 15.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -128.2 -81.64 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.662 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.33 106.15 0.27 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.751 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -159.06 120.87 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.372 -1.075 . . . . 0.0 110.378 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.539 ' HD3' ' NH1' ' A' ' 80' ' ' ARG . 41.6 ttt85 -74.71 102.08 4.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.513 -0.742 . . . . 0.0 110.073 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.751 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.2 mp -98.31 56.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.25 -0.906 . . . . 0.0 110.396 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -162.36 50.79 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.874 -1.141 . . . . 0.0 110.7 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG22 ' H ' ' A' ' 107' ' ' ARG . 2.5 p -111.61 -169.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.929 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.729 ' H ' HG22 ' A' ' 106' ' ' VAL . 20.0 mtt180 -127.95 138.25 52.56 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.529 -0.732 . . . . 0.0 109.967 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.4 m-20 -75.34 57.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 110.264 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 57.65 -69.56 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.704 -0.623 . . . . 0.0 111.376 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.566 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.03 -50.49 36.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.328 -0.858 . . . . 0.0 110.425 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.48 -21.33 0.83 Allowed Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -49.27 168.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.416 -1.049 . . . . 0.0 110.778 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 30.9 mt -131.68 167.75 20.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.1 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -69.6 -42.19 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.7 1.368 . . . . 0.0 109.699 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 127' ' ' ALA . 5.7 p -71.25 -25.73 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 110.203 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t70 -67.68 -58.19 5.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.57 -60.03 2.41 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.445 -0.784 . . . . 0.0 110.653 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.035 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -47.22 -53.1 14.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -31.25 64.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -26.91 46.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.664 -0.647 . . . . 0.0 110.049 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.544 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 12.4 mt -92.66 -0.72 57.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.72 23.95 40.52 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.544 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 15.6 m170 -95.33 49.34 1.19 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.268 -1.136 . . . . 0.0 109.704 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' HIS . 10.7 mmm-85 -43.16 -33.71 0.96 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.527 -0.733 . . . . 0.0 109.616 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -46.4 79.7 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.92 HG22 HD23 ' A' ' 91' ' ' LEU . 2.4 t -82.81 -34.85 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.478 -0.763 . . . . 0.0 109.544 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.639 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -65.1 -51.36 61.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 108.961 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.405 ' C ' ' HD3' ' A' ' 128' ' ' ARG . 1.2 tmt_? -64.65 -52.5 57.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.655 -0.653 . . . . 0.0 109.482 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.674 ' CD2' HD11 ' A' ' 91' ' ' LEU . 7.7 t80 -50.76 -40.08 53.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.41 -0.807 . . . . 0.0 109.136 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.739 HD11 ' HB2' ' A' ' 86' ' ' ALA . 24.0 mt -65.57 -53.51 40.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.695 -0.628 . . . . 0.0 109.587 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -21.32 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.123 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.26 -54.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 110.566 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.94 56.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -98.96 -24.18 15.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.755 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.54 143.93 43.14 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.96 -7.89 76.88 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 55.1 p -113.22 62.49 0.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -1.235 . . . . 0.0 110.532 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.463 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -69.99 105.23 2.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.352 -0.842 . . . . 0.0 109.947 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.84 87.18 1.75 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.97 75.6 0.91 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.359 -1.083 . . . . 0.0 110.003 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -176.95 51.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 0.0 109.876 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.57 -177.05 6.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.385 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.93 110.21 22.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.632 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -171.79 73.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.862 . . . . 0.0 109.881 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.447 ' H ' HG23 ' A' ' 145' ' ' ILE . 1.7 pp -60.47 150.0 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.321 -0.862 . . . . 0.0 110.206 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.06 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.387 -0.821 . . . . 0.0 109.971 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -164.53 78.87 0.36 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 110.422 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 53.61 178.69 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.375 -0.828 . . . . 0.0 110.341 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -121.62 -14.69 8.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 134.47 -115.16 1.4 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.15 144.21 33.26 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.578 1.304 . . . . 0.0 109.975 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.7 m -72.08 133.88 45.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 0.0 110.99 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.63 96.44 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.197 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 154' ' ' ILE . 12.4 tt -112.49 79.27 2.99 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 110.293 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.65 152.37 53.42 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 124.113 1.586 . . . . 0.0 110.575 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.221 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.264 0.554 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.11 149.16 39.31 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.432 -0.793 . . . . 0.0 109.936 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.44 87.22 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.758 1.399 . . . . 0.0 110.765 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.4 62.44 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.125 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.22 66.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.467 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.4 135.38 5.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 p -123.31 21.02 9.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.42 -1.047 . . . . 0.0 110.274 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.4 134.18 8.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.323 -0.86 . . . . 0.0 109.991 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -67.59 135.17 52.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.342 -0.849 . . . . 0.0 109.844 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.88 139.02 93.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.799 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.6 89.57 0.72 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.579 1.305 . . . . 0.0 109.992 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 t -49.9 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.524 -0.735 . . . . 0.0 110.028 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . . . -50.92 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.801 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 11.5 p30 -136.49 -16.84 1.55 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.593 -0.692 . . . . 0.0 110.795 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.493 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 24.6 m0 -52.05 -52.2 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.996 -1.065 . . . . 0.0 110.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.597 ' CD2' ' HB1' ' A' ' 36' ' ' ALA . 1.4 pp -51.01 -27.49 7.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.26 -0.9 . . . . 0.0 109.899 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 14' ' ' ASP . . . -82.68 -44.04 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 0.0 109.492 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -65.86 -44.55 85.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.492 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.65 -45.86 88.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.852 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -58.61 -44.54 89.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.909 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.63 -30.03 71.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.555 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -97.61 22.38 9.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 110.432 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.39 60.64 6.59 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 67.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -1.085 . . . . 0.0 110.464 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 59' ' ' VAL . 64.0 t -52.53 -58.92 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -43.12 -41.62 3.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.713 -0.617 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.853 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.3 tp10 -66.4 -46.55 76.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.07 HG12 HD13 ' A' ' 62' ' ' LEU . 22.1 t -70.24 -41.03 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.325 -0.86 . . . . 0.0 110.893 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.769 ' CA ' HD11 ' A' ' 62' ' ' LEU . 24.9 mmm-85 -51.0 -46.01 61.37 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.186 -0.946 . . . . 0.0 109.93 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.43 -43.45 32.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 0.0 109.956 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 27' ' ' GLU . 1.4 mt -57.78 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.89 ' CD1' HD22 ' A' ' 62' ' ' LEU . 12.4 mt -53.25 -44.49 68.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 0.0 110.048 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.19 -16.04 63.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.862 . . . . 0.0 109.917 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.21 -9.79 55.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 110.311 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 22.95 3.53 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.784 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -62.04 134.96 57.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -1.221 . . . . 0.0 109.906 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.597 HD23 ' CA ' ' A' ' 40' ' ' ALA . 3.6 tp -83.3 116.87 66.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -71.74 -41.74 2.05 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.671 1.353 . . . . 0.0 110.489 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.83 48.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.597 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . -93.02 118.57 67.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.72 94.99 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.618 1.325 . . . . 0.0 110.524 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -78.44 179.29 7.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 110.005 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -90.93 23.11 3.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -113.66 -19.05 11.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.73 37.11 93.02 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 32.6 mtt-85 -124.34 31.62 5.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -1.12 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 12.7 mmt-85 49.32 177.31 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.522 -0.736 . . . . 0.0 110.585 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 51.6 Cg_endo -79.71 -19.64 9.76 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.357 1.188 . . . . 0.0 109.92 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.624 HG13 ' HB1' ' A' ' 68' ' ' ALA . 7.0 mt -109.06 -42.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.688 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -50.73 -22.91 2.33 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.881 -1.137 . . . . 0.0 110.295 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.1 p -100.8 5.31 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.605 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.852 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -89.94 146.49 24.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.844 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 106.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.333 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.555 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 13.5 mmt -59.67 -8.46 2.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.814 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -82.0 11.56 47.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 59' ' ' VAL . 3.6 m -144.95 88.65 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.216 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.656 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -61.68 -29.68 70.24 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.16 -0.963 . . . . 0.0 109.546 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -29.75 10.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.681 -0.637 . . . . 0.0 109.821 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 25' ' ' VAL . 11.2 t -74.85 -55.3 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.144 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.612 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -50.22 -47.77 54.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.382 -0.824 . . . . 0.0 109.5 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.736 ' OE1' HG13 ' A' ' 96' ' ' VAL . 3.1 tp10 -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.07 HD13 HG12 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -51.36 -66.31 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.481 0.658 . . . . 0.0 109.943 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.82 HD23 HD21 ' A' ' 32' ' ' LEU . 45.4 mt -68.25 -49.54 59.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 110.858 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD22 HG12 ' A' ' 96' ' ' VAL . 1.8 tt -44.9 -67.37 0.29 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.439 -0.788 . . . . 0.0 110.858 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -55.97 -23.5 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.744 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.852 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.19 -43.35 24.07 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.409 -0.807 . . . . 0.0 109.534 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.96 36.05 0.06 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.63 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -68.89 -171.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.657 -1.496 . . . . 0.0 109.257 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -111.18 73.07 0.91 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 44.9 Cg_endo -70.5 -7.84 22.21 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.959 1.505 . . . . 0.0 110.64 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.34 -57.17 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.63 161.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 111.566 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.08 -143.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.512 -0.743 . . . . 0.0 109.966 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' LEU . 31.3 t0 -114.37 134.57 22.26 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 109.416 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.71 -3.06 12.84 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.29 1.153 . . . . 0.0 111.011 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.37 -41.3 9.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.0 110.256 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.571 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -131.15 5.98 4.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.09 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.8 mt 48.48 42.63 18.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -0.838 . . . . 0.0 111.008 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 m -75.65 93.32 3.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 110.401 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.758 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.72 168.77 17.63 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 108.777 179.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 43.5 Cg_endo -75.62 -0.87 10.66 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.096 1.051 . . . . 0.0 110.289 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.756 HG13 HD23 ' A' ' 104' ' ' LEU . 11.4 t -76.31 -34.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -68.08 -36.34 79.67 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.251 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 1.8 m-20 -55.46 -56.12 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.695 -0.628 . . . . 0.0 110.474 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -55.12 -62.06 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.355 -0.84 . . . . 0.0 109.985 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.922 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -56.59 -49.3 75.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 111.108 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -32.35 12.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.081 -1.012 . . . . 0.0 111.045 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -94.3 -4.28 49.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.517 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 81.8 25.51 52.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -98.76 143.7 28.81 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.328 -1.101 . . . . 0.0 110.63 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.656 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -117.04 -39.36 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.867 ' O ' HG23 ' A' ' 96' ' ' VAL . 3.3 t0 -52.83 -36.66 58.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.605 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 2.5 m -60.53 -49.66 76.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.667 -0.646 . . . . 0.0 109.635 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.638 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.8 mp -57.65 -45.23 85.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 109.685 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.0 t -55.89 -43.29 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.343 -0.848 . . . . 0.0 108.922 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 92' ' ' ASP . 46.2 t -61.13 -45.27 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.42 0.629 . . . . 0.0 109.479 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.631 HD23 ' CD1' ' A' ' 64' ' ' LEU . 96.0 mt -57.43 -46.89 83.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.513 -0.742 . . . . 0.0 110.313 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -77.77 -25.94 49.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.498 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -67.04 -13.52 62.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 110.11 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.474 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -127.22 -74.24 0.59 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 70' ' ' PRO . . . -174.19 105.83 0.21 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.18 -165.0 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -1.084 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.86 102.59 3.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.489 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.756 HD23 HG13 ' A' ' 82' ' ' VAL . 1.7 mp -93.26 11.31 28.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.843 . . . . 0.0 109.444 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.34 31.06 4.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.758 HG11 ' HB2' ' A' ' 80' ' ' ARG . 4.1 p -104.01 -176.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 110.055 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.662 ' H ' HG22 ' A' ' 106' ' ' VAL . 10.7 ptt-85 -139.21 145.4 39.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.581 -0.7 . . . . 0.0 109.568 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -70.55 63.11 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.124 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 60.04 -65.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.697 -0.627 . . . . 0.0 111.007 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 108' ' ' ASP . 5.1 m-90 -57.47 -74.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 110.873 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.76 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -49.69 124.26 9.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -1.12 . . . . 0.0 110.634 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 113' ' ' LEU . 42.4 mt -85.97 164.79 37.67 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.462 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -20.3 46.04 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.719 1.378 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.496 HG23 ' CB ' ' A' ' 130' ' ' LEU . 7.4 p -83.65 -37.88 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.382 -0.824 . . . . 0.0 109.832 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.444 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -70.96 -38.13 72.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.852 . . . . 0.0 109.898 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.36 -41.54 89.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.126 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.922 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -58.6 -59.42 5.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.619 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -30.9 35.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.314 -0.866 . . . . 0.0 110.433 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -24.75 56.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.563 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -90.28 -3.65 57.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 110.607 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.35 14.72 46.85 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.563 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 44.2 m-70 -98.42 48.95 0.99 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.91 -1.347 . . . . 0.0 109.478 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -30.17 2.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.687 -0.633 . . . . 0.0 110.229 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.656 ' O ' HD11 ' A' ' 91' ' ' LEU . 30.7 m-20 -65.41 -41.88 93.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 86' ' ' ALA . 4.7 t -81.6 -38.32 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.42 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.86 97.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -57.96 -67.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.429 -0.795 . . . . 0.0 109.494 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -50.59 -40.89 53.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 86' ' ' ALA . 13.8 mt -57.02 -50.3 73.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.41 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 4.7 ttp180 -56.23 -22.13 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.753 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.02 -66.39 0.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.083 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.97 -7.31 53.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 111.105 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -128.4 -42.74 1.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.144 -0.973 . . . . 0.0 110.355 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 131' ' ' ARG . . . -72.82 64.68 1.51 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.85 120.43 20.11 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 82.6 p -85.14 104.13 14.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -1.097 . . . . 0.0 110.213 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.79 131.93 31.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 145.22 92.05 0.13 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.21 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.385 -1.068 . . . . 0.0 110.053 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -65.71 -79.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.676 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.06 -177.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.09 -1.006 . . . . 0.0 110.293 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -122.19 97.49 5.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.989 . . . . 0.0 110.048 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.11 131.31 19.38 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.404 -0.81 . . . . 0.0 110.079 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 32.3 mm 51.26 69.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.878 . . . . 0.0 109.076 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -44.16 168.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.465 0.65 . . . . 0.0 111.507 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -43.93 106.59 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 110.411 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 63.54 154.3 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.587 -0.696 . . . . 0.0 110.264 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.19 160.27 32.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.481 -0.762 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 71.23 152.63 1.11 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.29 113.77 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.74 1.389 . . . . 0.0 110.69 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.0 t -118.27 7.88 12.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.392 -0.818 . . . . 0.0 110.388 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 162.31 28.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.236 -0.915 . . . . 0.0 110.294 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 154' ' ' ILE . 3.2 mp -124.67 83.44 58.64 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.963 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.74 130.94 15.25 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.838 1.441 . . . . 0.0 110.802 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 42.4 t0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.796 179.807 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.148 0.499 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -53.5 -52.8 63.48 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.227 -0.921 . . . . 0.0 110.479 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 43.0 Cg_endo -74.79 151.99 41.33 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.619 1.326 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . -58.58 141.62 51.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.376 -0.828 . . . . 0.0 110.187 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -176.79 131.5 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.374 -0.829 . . . . 0.0 109.853 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.18 -73.02 0.44 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.54 -153.03 0.38 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.257 -1.143 . . . . 0.0 109.875 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 t -155.78 143.14 19.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.95 . . . . 0.0 110.376 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.6 ttp -162.1 -55.35 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.433 -0.792 . . . . 0.0 109.718 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 52.61 81.65 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.321 -0.862 . . . . 0.0 110.254 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.74 71.9 2.58 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.821 1.432 . . . . 0.0 110.179 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.1 m 62.04 12.98 5.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.674 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 59.39 36.84 23.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.911 -1.118 . . . . 0.0 109.954 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -86.29 19.9 2.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -0.854 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.487 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 38.2 m0 -74.42 -24.5 59.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.257 -0.902 . . . . 0.0 109.877 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.56 -35.54 79.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 110.151 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.88 -50.56 12.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.457 -0.777 . . . . 0.0 109.184 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -51.36 -51.56 53.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.333 -0.854 . . . . 0.0 109.669 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -58.64 -37.93 76.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -62.16 -61.02 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.992 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -46.46 -29.1 1.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.702 -0.624 . . . . 0.0 111.105 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 21.2 mtm-85 -91.9 32.43 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.451 -0.78 . . . . 0.0 111.04 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.39 36.2 3.01 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 3.0 mpt_? -108.5 94.74 5.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -1.12 . . . . 0.0 109.609 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.638 HG12 ' HD3' ' A' ' 29' ' ' ARG . 89.8 t -74.46 -59.73 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.646 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -43.15 -30.75 0.49 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 111.668 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.756 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.5 mt-10 -68.0 -52.46 35.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 19' ' ' ALA . 6.1 t -68.49 -41.22 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.578 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.916 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.02 -50.42 27.77 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.439 -0.788 . . . . 0.0 109.616 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.82 -49.1 66.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.643 -0.661 . . . . 0.0 109.84 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.1 mt -58.78 -60.25 4.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.888 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 11.7 mt -44.41 -49.25 9.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.595 -0.691 . . . . 0.0 109.95 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.08 -14.29 61.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.471 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -94.63 -3.42 49.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.992 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.35 33.05 1.26 Allowed Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.684 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.888 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -79.36 140.22 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.296 . . . . 0.0 108.761 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.0 tp -79.72 123.34 84.01 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.083 -1.01 . . . . 0.0 111.058 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.503 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 42.2 Cg_endo -70.72 -21.33 29.18 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.827 1.435 . . . . 0.0 109.84 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.78 52.65 1.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.067 -1.02 . . . . 0.0 110.03 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -86.32 154.99 57.38 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.843 . . . . 0.0 110.131 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -79.04 132.04 10.27 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.868 1.457 . . . . 0.0 109.858 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -97.95 -171.84 2.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.38 -0.825 . . . . 0.0 110.822 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 m -113.47 2.78 15.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.79 . . . . 0.0 110.271 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.503 ' CB ' ' HD3' ' A' ' 46' ' ' ARG . 72.5 m-85 -118.24 20.06 13.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.595 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.91 22.69 35.45 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' HD3' ' CB ' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -109.5 -169.64 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -1.201 . . . . 0.0 109.896 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.719 ' O ' HG12 ' A' ' 51' ' ' VAL . 23.7 mmt180 -106.02 165.9 12.21 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.379 -0.826 . . . . 0.0 109.72 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.2 Cg_endo -62.85 -12.79 30.86 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.665 1.35 . . . . 0.0 109.885 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.658 HG13 ' HB1' ' A' ' 68' ' ' ALA . 2.8 mt -110.96 -35.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.431 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 4.1 tt0 -59.17 -15.9 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.992 HG22 ' HB2' ' A' ' 21' ' ' ALA . 7.7 p -118.12 38.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.358 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.616 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.96 29.96 4.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.755 -1.216 . . . . 0.0 109.578 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 7.5 tmm? 74.21 -8.78 1.38 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.792 -0.567 . . . . 0.0 110.46 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.553 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 45.11 24.22 0.12 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.603 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -130.05 18.01 5.35 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.1 t -149.54 64.58 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.486 -1.008 . . . . 0.0 110.586 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -38.33 -32.76 0.08 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.568 -0.707 . . . . 0.0 110.087 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 56' ' ' SER . 3.9 mmt85 -49.74 -41.13 43.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.591 -0.693 . . . . 0.0 109.201 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ALA . 40.8 t -62.22 -61.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.578 -0.701 . . . . 0.0 109.492 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -35.55 -52.84 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.481 -0.762 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.655 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -50.33 -55.39 15.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.006 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.916 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -43.45 -65.8 0.45 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.641 -0.662 . . . . 0.0 110.506 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.837 HD23 HD21 ' A' ' 32' ' ' LEU . 74.2 mt -66.78 -49.88 64.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.526 -0.734 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.764 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -41.82 -72.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.629 -0.669 . . . . 0.0 110.648 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.3 pp -52.46 -23.64 6.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.883 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.04 -31.55 44.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.649 -0.657 . . . . 0.0 109.545 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.503 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 124.76 41.1 0.39 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -63.51 -156.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.07 -1.253 . . . . 0.0 109.745 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.534 ' HG2' ' HB3' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -118.87 59.08 4.05 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.426 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 51.9 Cg_endo -69.89 -22.09 31.97 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 124.149 1.605 . . . . 0.0 110.178 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.31 -52.32 3.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.731 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -60.51 133.27 55.93 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.545 0.688 . . . . 0.0 110.649 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -123.81 -177.27 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.35 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.48 138.48 36.07 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.192 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.0 -29.26 18.21 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 124.089 1.573 . . . . 0.0 110.539 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -45.15 -61.03 1.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 13.2 p -137.66 41.56 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.691 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 78' ' ' LEU . 1.7 mt 37.56 56.21 1.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.311 0.577 . . . . 0.0 111.401 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.629 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 58.3 m -77.54 104.4 8.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.596 -0.69 . . . . 0.0 110.048 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.998 ' NH1' HG21 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -79.37 142.92 59.05 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 70' ' ' PRO . 42.9 Cg_endo -66.92 -10.65 29.2 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.804 1.423 . . . . 0.0 109.654 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.415 HG13 HD23 ' A' ' 104' ' ' LEU . 6.0 t -70.46 -36.84 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.911 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.498 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 16.4 m80 -57.37 -40.47 78.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.553 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -50.01 -58.69 4.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.999 -0.438 . . . . 0.0 111.314 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -46.41 -55.11 7.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 109.617 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.074 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -67.21 -35.76 80.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.505 -0.747 . . . . 0.0 110.767 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -46.27 -39.46 10.03 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 111.286 -178.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -105.37 -3.63 22.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 110.46 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.562 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 81.43 35.45 23.05 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.603 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 1.0 OUTLIER -105.83 83.55 1.94 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.393 -1.063 . . . . 0.0 110.336 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.554 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -56.97 -46.35 82.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 111.575 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 96' ' ' VAL . 31.3 m-20 -42.93 -37.95 2.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.39 -0.819 . . . . 0.0 110.338 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.4 m -62.63 -44.32 96.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.579 -0.701 . . . . 0.0 109.327 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -61.51 -55.94 25.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 0.0 109.769 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 95' ' ' VAL . 39.1 t -38.97 -45.69 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.731 -0.606 . . . . 0.0 110.485 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.764 ' CG1' HD22 ' A' ' 64' ' ' LEU . 11.9 t -63.42 -53.75 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.664 0.745 . . . . 0.0 109.013 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 mt -47.99 -58.95 3.75 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.456 0.646 . . . . 0.0 110.266 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.99 -28.34 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 10.2 ttt85 -72.73 -3.86 27.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.353 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -146.56 53.81 1.12 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.965 -1.084 . . . . 0.0 111.438 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . 56.84 107.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.11 86.59 0.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -1.049 . . . . 0.0 109.68 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -51.14 116.9 2.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 110.683 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.958 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.3 mp -101.22 -16.21 17.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.772 . . . . 0.0 110.381 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 26.1 t0 -85.1 55.13 3.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.393 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.998 HG21 ' NH1' ' A' ' 80' ' ' ARG . 1.9 p -110.49 -170.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.161 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.628 ' H ' HG22 ' A' ' 106' ' ' VAL . 1.9 mtt180 -137.04 135.69 37.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.213 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 110' ' ' TRP . 2.9 m-20 -73.82 58.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.51 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 54.27 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.376 -0.828 . . . . 0.0 110.555 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.668 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -37.32 -63.38 0.44 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.412 0.625 . . . . 0.0 110.7 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.32 -34.74 0.23 Allowed Glycine 0 N--CA 1.478 1.471 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -48.42 141.94 6.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -1.11 . . . . 0.0 109.976 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.514 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -109.89 170.49 5.29 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.408 -0.808 . . . . 0.0 109.742 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 42.4 Cg_endo -70.44 -40.25 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.856 1.45 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 127' ' ' ALA . 13.3 p -70.51 -34.15 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.432 -0.792 . . . . 0.0 109.588 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -70.73 -51.67 25.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.513 -0.742 . . . . 0.0 109.812 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.78 -32.33 30.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.267 -0.896 . . . . 0.0 109.746 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.074 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -73.7 -46.58 45.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.876 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.478 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -67.8 -30.29 69.68 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -67.69 -41.48 83.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.545 -0.722 . . . . 0.0 110.091 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -83.32 -4.31 58.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 111.022 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.3 25.78 17.91 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.306 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.553 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 74.7 m-70 -98.27 47.11 1.0 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.069 -1.254 . . . . 0.0 109.39 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.681 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -44.48 -38.01 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.672 -0.643 . . . . 0.0 109.739 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.52 ' OD2' HD12 ' A' ' 91' ' ' LEU . 11.2 t70 -55.19 -47.03 75.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 94' ' ' LEU . 3.2 t -79.65 -46.28 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 108.88 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.681 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -51.29 -43.72 61.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.607 -0.683 . . . . 0.0 110.369 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 131' ' ' ARG . 5.6 ttp180 -68.16 -54.81 15.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 110.058 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.547 ' CG ' HD21 ' A' ' 91' ' ' LEU . 21.9 t80 -58.8 -39.59 81.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.171 -0.956 . . . . 0.0 109.143 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.7 mt -62.21 -35.0 77.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.529 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.417 ' HA ' ' H ' ' A' ' 135' ' ' GLY . 39.7 ttt180 -65.13 -27.28 68.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.93 28.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.958 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -89.51 -16.05 31.61 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.287 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -129.13 -50.21 1.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.449 -0.782 . . . . 0.0 110.452 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 131' ' ' ARG . . . 52.22 -112.53 2.05 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 146.04 45.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.529 ' OG1' ' HB1' ' A' ' 143' ' ' ALA . 10.1 t -70.85 139.93 50.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.459 -1.024 . . . . 0.0 110.764 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -164.92 28.11 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.503 -0.748 . . . . 0.0 109.808 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.34 -156.96 8.4 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 m -137.16 67.02 1.45 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.309 -1.112 . . . . 0.0 110.104 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -140.19 -60.53 0.53 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 110.626 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -120.6 36.03 4.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 110.536 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.529 ' HB1' ' OG1' ' A' ' 137' ' ' THR . . . -145.89 165.08 29.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 109.735 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 53.11 176.19 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.21 -0.931 . . . . 0.0 110.449 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 145' ' ' ILE . 1.2 tt -124.19 44.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 109.888 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.89 52.14 2.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.455 -0.778 . . . . 0.0 109.591 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -50.42 139.31 15.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.462 -0.774 . . . . 0.0 110.332 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 63.17 -177.84 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.415 -0.803 . . . . 0.0 109.963 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -99.86 20.84 13.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.454 -0.779 . . . . 0.0 109.467 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 55.16 177.91 0.19 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -72.23 -85.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.765 1.402 . . . . 0.0 110.144 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.04 13.02 7.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.194 -0.941 . . . . 0.0 110.684 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 51.3 85.25 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.334 -0.854 . . . . 0.0 110.497 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 154' ' ' ILE . 1.5 tt -131.81 65.85 76.58 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.513 -0.742 . . . . 0.0 109.846 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.62 127.56 5.02 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.91 1.479 . . . . 0.0 109.958 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 117.864 -1.065 . . . . 0.0 109.861 179.788 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 mtt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 66.7 mt-10 -79.49 163.26 59.92 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.418 -0.801 . . . . 0.0 110.607 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 45.3 Cg_endo -70.41 113.06 3.36 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.815 1.429 . . . . 0.0 110.623 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.64 -177.16 0.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 110.071 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.27 -43.22 24.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.41 -158.65 17.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.55 -172.06 0.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.241 -1.152 . . . . 0.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.09 121.42 0.9 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.402 -0.811 . . . . 0.0 109.85 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.4 mtt -46.59 -29.34 1.77 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -0.766 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.67 144.37 17.71 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.92 83.91 1.88 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.709 1.373 . . . . 0.0 110.358 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.55 -69.41 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.959 . . . . 0.0 110.377 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HB3' HD12 ' A' ' 37' ' ' LEU . . . 51.31 28.46 4.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -0.826 . . . . 0.0 110.685 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.59 ' OD1' ' HB1' ' A' ' 40' ' ' ALA . 66.5 m-20 -99.56 22.31 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.255 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.584 ' HB3' HD13 ' A' ' 31' ' ' LEU . 40.2 m0 -73.01 -31.82 64.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.058 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.808 HD23 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -53.06 -33.49 52.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 0.0 110.795 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.9 -48.49 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -51.8 37.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.693 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -65.89 -40.54 91.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -56.81 -52.36 65.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.203 -0.936 . . . . 0.0 109.62 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -57.3 -29.39 63.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.38 23.16 4.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.0 110.765 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.72 61.42 6.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -131.54 53.89 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.396 -1.061 . . . . 0.0 110.01 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 59' ' ' VAL . 98.0 t -42.36 -59.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.848 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -45.98 -38.57 7.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.773 . . . . 0.0 110.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 1.6 tp10 -70.93 -36.32 72.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.979 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.854 HG12 HD21 ' A' ' 62' ' ' LEU . 5.2 t -79.6 -41.4 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.0 mmm180 -51.59 -41.91 61.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.874 . . . . 0.0 109.363 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -56.07 4.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.673 -0.642 . . . . 0.0 109.461 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 15' ' ' TRP . 12.8 mt -45.0 -60.16 2.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.554 -0.717 . . . . 0.0 110.597 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.977 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -51.83 -51.88 53.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.5 -0.75 . . . . 0.0 110.258 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.98 -9.29 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.52 -0.737 . . . . 0.0 110.428 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.05 -13.56 30.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.07 -1.019 . . . . 0.0 110.895 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.02 -20.59 1.59 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.462 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.977 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -47.73 136.93 10.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.282 -1.128 . . . . 0.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 13.0 mt -73.13 155.75 89.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.975 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.59 -54.8 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.737 1.388 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -98.63 21.22 11.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -39.53 100.22 0.21 Allowed Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.71 -0.619 . . . . 0.0 110.689 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.63 146.8 44.35 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.875 1.46 . . . . 0.0 110.963 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -139.28 174.47 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.618 -0.676 . . . . 0.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.07 50.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.926 . . . . 0.0 110.574 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -3.47 5.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.17 23.51 25.31 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -138.64 106.15 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -1.051 . . . . 0.0 110.46 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.535 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -58.11 -177.2 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.614 ' CB ' HD22 ' A' ' 63' ' ' LEU . 41.1 Cg_endo -66.52 175.68 4.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.319 1.168 . . . . 0.0 111.263 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.7 mt 61.92 -64.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.919 -0.488 . . . . 0.0 110.045 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' PRO . 50.2 tt0 -44.16 -26.91 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.3 p -123.56 36.57 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.641 -0.662 . . . . 0.0 109.891 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.82 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -94.24 38.32 1.09 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.772 -1.205 . . . . 0.0 110.653 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 21' ' ' ALA . 6.1 tmm? 71.15 -14.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.52 -0.737 . . . . 0.0 110.672 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.55 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.43 27.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.0 110.253 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.71 13.47 5.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.47 82.91 1.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -1.013 . . . . 0.0 109.734 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -50.66 -25.24 4.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.0 110.394 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.64 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -53.56 -41.09 66.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.279 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 25' ' ' VAL . 24.1 t -55.57 -58.47 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.233 -0.917 . . . . 0.0 109.566 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.67 -52.78 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.675 . . . . 0.0 109.708 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.954 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -45.23 -42.75 9.72 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 28' ' ' VAL . 2.9 tp -73.83 -61.33 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.588 -0.695 . . . . 0.0 110.087 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.614 HD22 ' CB ' ' A' ' 48' ' ' PRO . 5.3 mt -64.7 -55.87 17.3 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 110.993 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.753 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -46.68 -61.75 1.69 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.447 -0.783 . . . . 0.0 111.118 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.954 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -57.55 -23.58 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.935 -1.103 . . . . 0.0 109.655 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CD2' ' CD2' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -81.98 -38.88 24.45 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.457 -0.777 . . . . 0.0 109.969 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.01 46.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.487 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.98 -151.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.008 -1.289 . . . . 0.0 109.583 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -117.14 53.51 1.3 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.003 . . . . 0.0 110.718 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.2 Cg_endo -66.85 -15.32 46.83 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.444 1.234 . . . . 0.0 109.877 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.473 ' O ' ' CZ ' ' A' ' 80' ' ' ARG . 4.1 m-20 -107.93 -72.56 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 171.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -147.33 -152.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.276 -0.89 . . . . 0.0 110.114 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -98.59 131.77 25.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.25 -27.55 34.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.337 1.177 . . . . 0.0 110.729 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.1 -64.43 0.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.667 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 27.5 p -130.29 36.31 3.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' A' ' 78' ' ' LEU . 4.3 mt 43.29 37.91 1.48 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.639 -0.663 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.9 OUTLIER -70.05 99.51 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.532 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -76.43 165.4 53.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 47.1 Cg_endo -69.8 -23.2 30.86 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.655 1.345 . . . . 0.0 109.536 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 114' ' ' PRO . 60.8 t -55.89 -29.29 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.676 -0.64 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 12.2 m80 -74.15 -50.16 20.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -45.24 -43.96 10.81 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -64.46 -67.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.429 -0.794 . . . . 0.0 110.005 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.109 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -54.14 -45.68 72.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.776 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -48.56 -33.33 9.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.277 -0.89 . . . . 0.0 110.627 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 4.2 mm-40 -99.28 -11.97 20.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.555 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 83.78 33.84 20.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -104.99 92.28 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -1.052 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 0.4 OUTLIER -67.66 -32.55 73.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 110.063 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 42.9 m-20 -52.26 -50.06 62.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.873 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 m -56.95 -36.28 70.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.86 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 mp -60.84 -44.12 97.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.503 -0.748 . . . . 0.0 109.701 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 16.5 t -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.477 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.517 HG12 HD13 ' A' ' 64' ' ' LEU . 15.6 t -55.51 -46.01 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.411 -0.806 . . . . 0.0 109.571 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -54.94 -69.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 110.057 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.12 -22.25 50.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.369 -0.832 . . . . 0.0 110.158 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -72.04 -16.54 62.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.753 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -144.25 72.68 1.35 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.338 -0.851 . . . . 0.0 110.596 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.52 101.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -161.93 79.28 0.54 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -1.087 . . . . 0.0 110.411 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.541 ' CZ ' HG23 ' A' ' 106' ' ' VAL . 1.2 ttp180 -56.89 119.64 6.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.121 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' O ' ' HB1' ' A' ' 134' ' ' ALA . 12.0 mt -99.13 15.49 25.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.059 . . . . 0.0 109.544 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.65 43.29 1.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.822 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.565 HG22 ' H ' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -103.19 -169.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.565 ' H ' HG22 ' A' ' 106' ' ' VAL . 36.0 ptt180 -142.0 140.69 32.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.652 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 110' ' ' TRP . 10.8 t0 -73.46 54.81 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.117 -0.989 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.636 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 56.02 -75.59 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.616 -0.677 . . . . 0.0 111.483 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.667 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.1 OUTLIER -46.73 -39.15 11.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.294 -0.879 . . . . 0.0 110.37 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.23 -28.74 2.21 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -56.23 128.87 37.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -1.065 . . . . 0.0 110.569 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.464 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -93.09 171.64 7.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.63 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HB2' HG12 ' A' ' 82' ' ' VAL . 41.7 Cg_endo -69.46 -38.64 8.16 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.488 1.257 . . . . 0.0 110.048 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.558 HG21 ' CA ' ' A' ' 131' ' ' ARG . 9.6 p -70.55 -31.03 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.276 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.36 -26.06 66.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.548 -0.72 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.504 HD23 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -78.02 -55.05 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.39 -0.819 . . . . 0.0 110.551 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.109 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -47.97 -40.92 23.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 110.285 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -47.66 81.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.526 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -60.91 -54.13 48.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 109.627 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.504 HD23 HD23 ' A' ' 117' ' ' LEU . 1.9 mm? -55.16 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.0 110.427 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.19 41.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.517 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 49.4 m-70 -122.23 63.32 0.94 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.388 -1.066 . . . . 0.0 109.546 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -45.3 46.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -46.16 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.867 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.7 t -74.83 -42.01 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.72 84.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 109.64 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -52.93 -67.45 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 49.7 t80 -52.86 -30.4 33.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.919 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.86 ' HG ' HD21 ' A' ' 94' ' ' LEU . 5.8 mt -70.75 -53.58 15.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.596 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CA ' HG21 ' A' ' 115' ' ' VAL . 8.7 ttp180 -55.23 -29.79 58.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.86 -54.23 4.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.664 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -75.87 -9.14 58.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.327 -0.858 . . . . 0.0 110.781 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -122.84 -44.92 2.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.164 -0.96 . . . . 0.0 110.693 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -49.77 120.28 7.69 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.61 8.02 73.99 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 44.9 p -59.54 109.81 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -1.204 . . . . 0.0 110.299 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -123.44 -76.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 109.763 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.54 48.92 0.36 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.8 m -62.91 -18.16 62.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -1.064 . . . . 0.0 109.887 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -108.09 -37.33 6.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -144.71 -162.71 1.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.332 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.74 133.59 55.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 110.269 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.705 ' CZ ' HD12 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -71.48 112.8 7.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.192 -0.943 . . . . 0.0 109.834 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.705 HD12 ' CZ ' ' A' ' 144' ' ' ARG . 48.9 mt 51.79 86.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.293 -0.879 . . . . 0.0 109.69 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -48.07 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.426 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -48.75 103.63 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.535 -0.728 . . . . 0.0 110.392 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.45 124.57 8.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.542 -0.724 . . . . 0.0 110.37 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -46.69 119.92 2.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.538 -0.726 . . . . 0.0 110.284 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -83.32 150.75 27.56 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.29 -85.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.907 1.477 . . . . 0.0 110.299 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.7 m -165.91 105.34 0.69 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.215 -0.928 . . . . 0.0 110.345 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -59.06 173.95 0.41 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 mt -125.18 85.68 57.85 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.357 -0.84 . . . . 0.0 110.023 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.59 120.01 6.45 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.848 1.446 . . . . 0.0 110.389 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.293 -179.884 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.138 0.494 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -68.54 -56.77 9.46 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 109.85 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 48.0 Cg_endo -72.98 147.13 42.92 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.484 1.254 . . . . 0.0 110.478 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . -174.9 161.18 2.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.462 -0.774 . . . . 0.0 109.85 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . 176.12 91.31 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.32 -0.862 . . . . 0.0 110.114 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.84 -78.44 0.05 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.61 55.33 3.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.194 -1.18 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.93 24.44 0.56 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.841 . . . . 0.0 110.524 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.7 ttp -96.19 54.93 1.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.167 -0.958 . . . . 0.0 110.773 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.14 79.24 5.67 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.029 -1.044 . . . . 0.0 110.563 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -79.15 86.03 1.76 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.875 1.46 . . . . 0.0 110.358 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 m -61.89 143.53 56.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.262 -0.899 . . . . 0.0 110.351 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.77 -51.3 0.1 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.45 -6.15 41.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.283 -0.886 . . . . 0.0 110.573 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.484 ' HE3' HD21 ' A' ' 31' ' ' LEU . 16.3 m0 -57.03 -17.22 9.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 110.457 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -69.85 -56.03 8.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -71.81 -42.96 66.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -47.81 -62.51 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.166 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -52.0 -42.96 63.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.816 . . . . 0.0 109.936 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -57.63 -52.15 66.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.679 -0.638 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -50.38 -25.63 4.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.451 -0.781 . . . . 0.0 110.607 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . 37.6 mtt180 -103.74 28.93 6.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.656 -0.652 . . . . 0.0 109.849 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.76 41.89 10.43 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 28' ' ' VAL . 11.7 mtt180 -99.85 54.93 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -1.081 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.713 HG12 ' HD3' ' A' ' 29' ' ' ARG . 99.3 t -38.9 -53.61 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.769 -0.582 . . . . 0.0 111.07 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -49.81 -56.29 10.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.755 . . . . 0.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp10 -54.45 -39.0 67.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.383 -0.823 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.06 HG12 HD23 ' A' ' 62' ' ' LEU . 14.0 t -71.74 -56.0 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.707 -0.621 . . . . 0.0 110.279 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.874 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -39.41 -52.48 2.08 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.428 -0.795 . . . . 0.0 110.668 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -73.82 -50.75 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.76 . . . . 0.0 109.907 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.484 HD21 ' HE3' ' A' ' 15' ' ' TRP . 14.0 mt -47.37 -57.05 5.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.59 -0.694 . . . . 0.0 110.728 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.973 ' HB2' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.86 -50.36 45.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 109.491 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -70.53 -17.38 62.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.714 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -81.83 -6.35 59.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 110.067 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.06 16.68 6.1 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.565 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.872 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -58.15 160.87 4.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.074 -1.25 . . . . 0.0 109.975 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -101.39 113.26 65.85 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 111.269 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.41 -5.17 16.62 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.753 1.396 . . . . 0.0 110.421 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.416 ' C ' HD23 ' A' ' 37' ' ' LEU . 1.5 m-80 -131.59 40.06 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 110.075 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.758 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -84.18 133.85 44.51 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.268 -0.895 . . . . 0.0 110.546 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.3 89.65 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.726 1.382 . . . . 0.0 110.375 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.76 166.18 5.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -85.41 21.71 1.7 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.34 -0.85 . . . . 0.0 110.861 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -119.38 15.35 12.99 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.16 24.15 20.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.4 -170.33 1.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.447 -1.031 . . . . 0.0 110.256 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.3 mmt180 -103.45 167.51 10.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.673 . . . . 0.0 109.547 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 63' ' ' LEU . 42.6 Cg_endo -67.26 -12.0 34.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.582 1.306 . . . . 0.0 110.414 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.54 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.1 mt -107.2 -42.76 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 108.637 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.449 ' HB2' ' H ' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -49.44 -20.95 0.79 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.383 -0.823 . . . . 0.0 110.472 179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 51' ' ' VAL . 10.8 p -115.91 35.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 110.477 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.808 ' HB2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.4 34.57 1.6 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 109.729 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 10.0 ttp 67.67 -6.69 0.65 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 110.821 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.563 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 43.66 27.19 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.235 -0.916 . . . . 0.0 110.41 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.35 11.65 7.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.656 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.8 m -148.91 93.22 2.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.482 -1.011 . . . . 0.0 109.615 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.42 -34.15 70.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.468 -0.77 . . . . 0.0 109.872 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -52.15 -42.04 63.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 110.093 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 52' ' ' MET . 91.0 t -48.15 -53.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -62.79 -43.69 98.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.565 -0.709 . . . . 0.0 109.315 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 4.0 tt0 -46.8 -31.73 3.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.248 -0.908 . . . . 0.0 110.276 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.06 HD23 HG12 ' A' ' 28' ' ' VAL . 7.5 tp -89.87 -49.66 6.49 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -56.65 -55.41 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.451 0.643 . . . . 0.0 109.387 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.916 HD22 HG12 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -61.23 -45.76 93.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.671 -0.643 . . . . 0.0 109.756 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.4 tp -53.04 -32.97 49.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -0.874 . . . . 0.0 108.719 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CG ' ' CD1' ' A' ' 32' ' ' LEU . 2.0 m80 -92.6 -1.04 57.21 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.426 0.631 . . . . 0.0 110.355 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.0 63.48 1.97 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.447 ' C ' ' HD3' ' A' ' 70' ' ' PRO . . . -72.26 -149.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -1.067 . . . . 0.0 109.228 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mt-10 -114.88 57.22 0.97 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.432 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -72.17 -0.89 9.26 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.315 1.166 . . . . 0.0 110.585 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.46 -73.72 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.055 -1.028 . . . . 0.0 109.804 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 134.7 16.61 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.578 0.704 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.424 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . -127.34 -134.16 0.24 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.03 125.73 30.92 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.786 -1.196 . . . . 0.0 109.452 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.84 5.75 5.06 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.255 1.134 . . . . 0.0 110.865 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.27 -43.77 4.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 108.925 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.897 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -121.44 2.98 10.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.619 -0.676 . . . . 0.0 109.932 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 2.8 mt 54.99 25.23 6.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.278 -0.889 . . . . 0.0 111.322 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.71 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.81 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.36 165.9 40.09 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.173 -0.954 . . . . 0.0 110.104 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 44.4 Cg_endo -71.54 -9.01 24.39 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.76 1.4 . . . . 0.0 110.672 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.618 HG11 HD23 ' A' ' 104' ' ' LEU . 3.5 t -73.87 -30.53 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.103 -0.998 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.412 ' CD2' ' OD1' ' A' ' 108' ' ' ASP . 27.0 m80 -68.64 -43.97 75.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -48.81 -49.95 36.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.331 0.586 . . . . 0.0 110.251 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.692 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -57.81 -68.7 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.0 109.766 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.912 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -51.24 -39.29 56.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.362 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -44.01 -51.73 7.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.328 -0.857 . . . . 0.0 110.812 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -96.14 18.7 13.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 109.775 179.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.836 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 54.39 52.78 42.31 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.489 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -117.07 84.36 2.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -1.157 . . . . 0.0 110.611 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.581 ' HA ' HD13 ' A' ' 94' ' ' LEU . 1.2 mt -55.89 -43.81 77.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 0.0 110.75 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 47.9 m-20 -45.89 -35.66 4.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.496 -0.753 . . . . 0.0 111.048 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -71.9 -38.61 69.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -0.91 . . . . 0.0 110.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.692 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 1.6 mp -63.08 -59.55 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.8 t -46.2 -49.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.58 -0.7 . . . . 0.0 110.314 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.916 HG12 HD22 ' A' ' 64' ' ' LEU . 23.6 t -50.39 -53.04 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.571 -0.705 . . . . 0.0 109.71 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.661 ' HA ' HD21 ' A' ' 64' ' ' LEU . 64.6 mt -52.39 -66.11 0.44 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 0.0 109.837 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -55.78 -26.71 47.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.933 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.62 -13.19 61.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.977 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.798 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -147.87 78.19 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.183 -0.948 . . . . 0.0 111.001 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 52.07 101.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 97' ' ' LEU . . . -163.06 123.53 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -1.211 . . . . 0.0 110.744 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -78.41 141.63 38.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 133' ' ' ALA . 0.5 OUTLIER -126.4 8.19 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.335 -0.853 . . . . 0.0 110.287 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -115.75 49.62 1.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.062 -1.024 . . . . 0.0 111.365 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.81 HG11 ' CG ' ' A' ' 80' ' ' ARG . 7.6 p -112.45 171.64 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.85 ' HG2' HD12 ' A' ' 113' ' ' LEU . 24.1 mtm180 -131.42 143.8 50.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 109.59 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -68.51 58.04 0.08 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.241 -0.912 . . . . 0.0 110.17 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 50.9 -88.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.897 ' CH2' HG23 ' A' ' 77' ' ' THR . 5.8 p90 -112.62 -1.57 14.79 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.263 -0.898 . . . . 0.0 110.758 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -77.93 -80.61 0.68 Allowed Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 4.3 mtt180 170.98 -169.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.816 -0.814 . . . . 0.0 110.069 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.85 HD12 ' HG2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -80.37 166.96 36.56 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 110.417 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.1 Cg_endo -72.32 -35.91 6.05 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.813 1.428 . . . . 0.0 110.16 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 7.9 p -67.69 -28.45 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -50.68 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.71 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -24.71 41.95 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.272 -0.893 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.29 -62.9 1.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 111.109 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -23.77 1.16 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.18 -37.2 23.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.285 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 1.7 mm? -86.9 7.52 26.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.31 24.03 52.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.322 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 17.0 m-70 -99.4 43.47 1.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.951 -1.323 . . . . 0.0 109.223 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -42.58 7.77 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.292 0.568 . . . . 0.0 110.158 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -59.09 -38.13 78.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 109.6 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.912 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.3 t -82.54 -38.29 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.41 -22.65 63.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -68.1 -71.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 0.0 110.389 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.614 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 2.4 t80 -53.88 -45.11 70.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 86' ' ' ALA . 12.9 mt -50.53 -55.26 16.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.522 -0.736 . . . . 0.0 109.488 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.435 ' CA ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -54.46 -23.14 14.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.169 -0.957 . . . . 0.0 109.95 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -80.31 -52.36 7.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -88.37 -7.13 57.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 111.134 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -107.68 -31.59 8.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.921 -1.112 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.5 98.77 0.95 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.05 83.83 0.34 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.412 HG21 ' CD ' ' A' ' 144' ' ' ARG . 0.1 OUTLIER -60.08 107.13 0.59 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.529 -0.983 . . . . 0.0 109.856 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.25 74.88 1.46 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.362 -0.836 . . . . 0.0 110.182 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -177.84 -133.35 1.85 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.54 51.71 1.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -1.178 . . . . 0.0 110.295 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 48.84 43.34 21.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.589 -0.695 . . . . 0.0 111.037 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' A' ' 142' ' ' HIS . 55.0 p-80 -57.59 112.56 1.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.0 109.396 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 54.14 -155.35 0.24 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.036 -1.04 . . . . 0.0 109.83 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.437 ' O ' ' HB ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER 58.04 60.06 2.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.129 -0.982 . . . . 0.0 110.354 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 37.7 mm 60.27 157.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.385 -0.822 . . . . 0.0 110.377 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.4 76.11 0.38 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.128 -0.982 . . . . 0.0 110.67 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.0 129.51 37.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.305 -0.872 . . . . 0.0 109.446 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -45.14 120.15 2.31 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.429 -0.795 . . . . 0.0 110.86 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.61 167.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -0.893 . . . . 0.0 110.152 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.0 113.85 0.22 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.33 129.38 16.9 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.501 1.264 . . . . 0.0 110.681 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.0 t -138.44 -0.91 1.94 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.512 -0.742 . . . . 0.0 110.757 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' A' ' 155' ' ' PRO . 28.9 p-10 -96.15 63.91 2.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.984 -1.072 . . . . 0.0 110.578 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 31.3 mm -112.38 75.56 1.75 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.104 -0.998 . . . . 0.0 110.019 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 153' ' ' ASP . 51.9 Cg_endo -77.8 117.59 4.27 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.793 1.417 . . . . 0.0 110.266 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.0 t0 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.469 179.638 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.345 0.593 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 60.08 72.13 0.79 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.386 -0.821 . . . . 0.0 110.846 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.79 74.12 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.63 1.331 . . . . 0.0 109.876 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.05 128.84 14.35 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.538 -0.726 . . . . 0.0 110.979 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.05 175.49 5.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.434 -0.791 . . . . 0.0 110.394 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.08 -113.4 2.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.4 p -75.17 148.16 39.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 109.804 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.98 120.94 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.311 -0.868 . . . . 0.0 110.246 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -98.71 -42.95 6.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.38 -0.825 . . . . 0.0 110.507 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.44 157.29 51.93 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.431 -0.793 . . . . 0.0 110.637 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.91 170.12 20.4 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.895 1.471 . . . . 0.0 110.411 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -58.55 122.75 14.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.323 -0.86 . . . . 0.0 110.091 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.24 -18.37 52.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.512 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -54.86 -20.46 8.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.144 -0.972 . . . . 0.0 110.292 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.598 ' HB3' HD11 ' A' ' 31' ' ' LEU . 21.2 m0 -48.04 -33.96 8.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.313 -0.867 . . . . 0.0 109.7 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.825 HD22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -43.86 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.375 0.607 . . . . 0.0 110.849 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 42' ' ' ASN . . . -43.89 -54.02 5.63 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.69 -0.631 . . . . 0.0 111.299 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -59.58 3.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 110.702 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.17 -47.93 74.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.326 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -57.06 -48.9 77.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.455 -0.778 . . . . 0.0 110.319 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.98 -25.63 67.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 110.105 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -85.78 5.45 32.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.308 -0.87 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 63.97 44.81 95.43 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -122.1 72.7 1.05 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.953 . . . . 0.0 109.611 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.831 HG22 HG23 ' A' ' 59' ' ' VAL . 39.1 t -53.38 -45.41 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.414 -0.804 . . . . 0.0 110.274 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.33 -33.99 66.14 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 0.0 110.508 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' O ' HD12 ' A' ' 31' ' ' LEU . 5.7 tt0 -68.19 -41.8 80.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.871 . . . . 0.0 109.772 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.82 HG12 HD12 ' A' ' 32' ' ' LEU . 21.4 t -77.59 -45.38 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.958 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.699 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.22 -47.77 35.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -29.83 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 15' ' ' TRP . 7.9 mt -68.34 -70.43 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.206 -0.934 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.842 HD22 ' CG ' ' A' ' 66' ' ' HIS . 1.3 mt -46.88 -49.41 20.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.373 -0.829 . . . . 0.0 111.542 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -60.9 -24.46 66.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.31 -5.79 55.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.48 29.83 3.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.46 128.35 33.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -1.099 . . . . 0.0 110.123 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.825 ' O ' HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -49.25 111.6 2.05 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.38 -0.825 . . . . 0.0 110.666 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HA ' HD21 ' A' ' 16' ' ' LEU . 43.3 Cg_endo -69.12 -33.15 19.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.678 1.357 . . . . 0.0 110.811 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.68 50.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.707 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -78.01 150.96 78.61 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.415 -0.803 . . . . 0.0 110.324 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.87 116.38 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.79 1.416 . . . . 0.0 110.188 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 12.9 m120 -94.21 170.68 9.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.961 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -89.95 33.41 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.638 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -137.06 3.63 2.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.054 -1.029 . . . . 0.0 110.725 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.14 26.87 36.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -130.78 20.8 5.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -1.15 . . . . 0.0 110.691 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 48.91 -177.51 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.707 -0.62 . . . . 0.0 111.069 178.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 50' ' ' GLN . 44.4 Cg_endo -72.95 -179.52 4.36 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.44 1.232 . . . . 0.0 111.165 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.62 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 56.88 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.761 -0.587 . . . . 0.0 110.322 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -47.73 -23.09 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.939 -1.101 . . . . 0.0 110.264 179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.66 6.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 110.664 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -68.98 171.65 7.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.795 -1.191 . . . . 0.0 109.211 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.432 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 3.2 ttm -52.79 -19.06 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.229 -0.919 . . . . 0.0 110.37 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.606 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.48 10.14 3.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.405 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -119.02 18.28 10.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.3 78.25 1.32 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.459 -1.024 . . . . 0.0 109.449 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -44.75 -28.88 0.68 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.0 110.378 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -42.71 57.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.831 HG23 HG22 ' A' ' 25' ' ' VAL . 77.8 t -53.67 -60.84 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.488 -0.757 . . . . 0.0 109.409 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -53.53 -52.34 59.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.326 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.786 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.0 tt0 -45.74 -35.73 4.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.196 -0.94 . . . . 0.0 110.062 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.775 HD21 HG12 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -78.3 -60.89 2.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.573 -0.704 . . . . 0.0 109.248 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.0 mt -60.95 -56.07 25.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 110.521 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.738 HD13 HG12 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -48.68 -62.47 1.49 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.563 -0.711 . . . . 0.0 110.814 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -55.16 -24.96 29.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.972 -1.08 . . . . 0.0 109.385 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.842 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -82.22 -29.26 31.48 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.416 -0.802 . . . . 0.0 109.811 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.47 38.02 0.31 Allowed Glycine 0 N--CA 1.479 1.508 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.65 -148.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 0.0 109.678 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -115.65 59.04 1.45 Allowed Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.332 -0.855 . . . . 0.0 110.387 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.1 -8.64 22.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.553 1.291 . . . . 0.0 110.613 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 2.2 t30 -129.1 -65.26 0.87 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.314 -0.866 . . . . 0.0 109.704 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.88 144.29 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 110.532 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -136.34 -136.01 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.27 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -110.68 136.02 20.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.057 -1.027 . . . . 0.0 110.221 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.2 -5.35 16.95 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.542 1.285 . . . . 0.0 110.596 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.1 -49.67 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.619 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -120.57 9.63 10.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.377 -0.827 . . . . 0.0 110.945 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.522 ' HA ' HD23 ' A' ' 78' ' ' LEU . 7.4 mt 47.02 27.81 0.8 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.479 HG23 ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -60.59 89.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.644 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.814 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -69.14 168.78 13.99 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.864 . . . . 0.0 110.366 -179.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.595 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 54.5 Cg_endo -72.72 2.58 5.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 124.003 1.528 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 104' ' ' LEU . 19.8 t -85.09 -31.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 110.301 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 83' ' ' HIS . 9.1 m80 -67.48 -43.67 80.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.08 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.9 OUTLIER -53.52 -54.09 42.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.701 -0.624 . . . . 0.0 111.373 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.675 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -52.76 -63.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 109.934 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.813 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.05 -55.01 40.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.26 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 5.0 tpt180 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.507 -0.746 . . . . 0.0 111.299 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 54' ' ' MET . 9.9 tp10 -103.83 -4.64 23.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.025 -1.047 . . . . 0.0 111.09 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 20.83 69.14 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.613 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -102.01 96.35 6.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -1.151 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.669 HD21 ' CG ' ' A' ' 129' ' ' TYR . 1.2 tt -69.82 -38.37 76.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.724 -0.61 . . . . 0.0 110.528 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 96' ' ' VAL . 42.3 m-20 -50.56 -41.62 54.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.89 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.1 m -55.89 -48.27 75.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.733 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.704 HD13 HG13 ' A' ' 126' ' ' VAL . 1.4 mp -59.05 -43.21 91.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.833 . . . . 0.0 109.805 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -51.47 -49.17 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 HD13 ' A' ' 64' ' ' LEU . 25.4 t -59.83 -43.1 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.589 0.709 . . . . 0.0 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.52 ' HA ' HD11 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -56.96 -58.62 7.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.618 -0.677 . . . . 0.0 110.107 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -65.41 -35.74 81.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 110.125 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 2.3 ttp85 -61.57 -14.9 33.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.411 -0.806 . . . . 0.0 110.449 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -140.79 54.43 1.59 Allowed 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.988 -1.07 . . . . 0.0 111.168 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.36 106.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -156.91 97.57 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.467 -1.02 . . . . 0.0 109.876 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -51.37 115.32 1.53 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.338 -0.851 . . . . 0.0 110.404 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -105.36 4.08 30.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 110.611 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -112.63 51.46 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 110.535 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.814 HG11 ' CG ' ' A' ' 80' ' ' ARG . 4.5 p -107.55 -178.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.997 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.641 ' H ' HG22 ' A' ' 106' ' ' VAL . 42.3 mtt85 -131.26 153.01 49.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 109.564 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -80.38 54.93 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.537 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 62.86 -68.65 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.626 -0.672 . . . . 0.0 111.276 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 6.6 m0 -65.67 -37.68 87.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.818 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.79 -20.56 1.0 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.493 ' HB2' ' HB2' ' A' ' 108' ' ' ASP . 12.4 mtt180 -49.75 136.77 17.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -1.106 . . . . 0.0 110.266 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -111.06 161.17 26.17 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.358 -0.839 . . . . 0.0 110.116 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.1 Cg_endo -70.24 -21.62 31.0 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.583 1.307 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' CB ' HD11 ' A' ' 130' ' ' LEU . 4.4 p -86.57 -31.74 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.053 -1.029 . . . . 0.0 110.038 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.34 -22.96 63.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.9 mt -75.67 -44.59 41.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.537 -0.727 . . . . 0.0 110.497 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -68.2 -36.22 79.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.94 -39.24 88.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -57.7 3.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 109.897 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.51 -85.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.478 -0.764 . . . . 0.0 110.257 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.03 39.31 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 22.6 m-70 -103.87 55.82 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.378 -1.072 . . . . 0.0 108.822 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.51 -40.81 13.15 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.45 0.643 . . . . 0.0 109.909 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.16 -42.17 90.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.646 . . . . 0.0 109.794 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.3 t -82.18 -44.88 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.987 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -54.8 -37.61 66.3 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.278 -0.889 . . . . 0.0 110.793 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -77.14 -48.26 18.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.73 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.669 ' CG ' HD21 ' A' ' 91' ' ' LEU . 27.2 t80 -70.73 -57.16 4.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.119 -0.988 . . . . 0.0 110.503 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.623 ' C ' HD12 ' A' ' 130' ' ' LEU . 0.7 OUTLIER -54.55 -32.75 58.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.114 -0.992 . . . . 0.0 110.612 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 127' ' ' ALA . 23.7 ttt180 -66.55 -38.13 86.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -0.847 . . . . 0.0 110.083 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.378 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.81 -19.41 23.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.733 -0.605 . . . . 0.0 110.295 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 104' ' ' LEU . . . -94.3 -13.35 26.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.332 -0.855 . . . . 0.0 110.721 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 173.6 -80.49 0.08 OUTLIER Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 55.76 40.46 80.22 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 t -50.47 133.2 25.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -1.024 . . . . 0.0 110.137 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.94 114.19 28.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 110.163 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 154.39 -175.57 32.51 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.91 -31.29 8.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.296 -1.12 . . . . 0.0 110.167 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -161.87 28.88 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.846 . . . . 0.0 110.755 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -78.08 -47.69 17.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 109.073 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 144' ' ' ARG . . . -87.9 -179.32 6.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.588 -0.695 . . . . 0.0 109.257 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 143' ' ' ALA . 0.0 OUTLIER 60.45 147.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.134 -0.979 . . . . 0.0 109.776 -179.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 tt -80.38 158.8 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.042 -1.036 . . . . 0.0 110.39 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -49.34 162.15 0.15 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.426 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -166.61 64.88 0.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.273 -0.892 . . . . 0.0 110.434 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 144.8 54.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.775 . . . . 0.0 109.968 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.71 137.47 37.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.03 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.68 121.09 5.87 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -79.63 5.72 5.68 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.577 1.304 . . . . 0.0 110.761 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.57 -13.51 12.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.14 -0.975 . . . . 0.0 110.394 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -48.0 149.55 1.36 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.32 -0.862 . . . . 0.0 110.365 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.74 110.51 42.14 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.162 -0.961 . . . . 0.0 110.795 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.86 111.8 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.751 1.395 . . . . 0.0 110.277 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.228 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.152 0.501 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.68 162.02 21.02 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 49.1 Cg_endo -74.63 77.44 2.98 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.789 1.415 . . . . 0.0 110.421 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 3' ' ' PRO . . . 59.6 111.44 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.387 -0.821 . . . . 0.0 110.516 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.67 -18.44 61.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.886 . . . . 0.0 110.336 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.19 136.86 47.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.3 p -100.51 38.8 1.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -1.081 . . . . 0.0 110.11 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 p -161.39 165.74 28.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.845 . . . . 0.0 110.317 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.63 103.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.486 -0.758 . . . . 0.0 110.227 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -103.07 163.33 17.73 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.376 -0.827 . . . . 0.0 110.182 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.17 123.24 7.1 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.727 1.383 . . . . 0.0 110.292 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 t -171.99 -52.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.273 -0.892 . . . . 0.0 110.338 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -66.88 -16.12 64.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 110.355 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -89.64 12.25 17.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.884 . . . . 0.0 110.634 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 3.0 m0 -85.13 -26.78 26.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 17' ' ' ALA . 3.8 pp -61.99 -32.48 72.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 109.457 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.545 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -80.34 -48.2 13.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.4 -0.813 . . . . 0.0 109.89 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -63.06 -41.07 99.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -55.51 -52.44 63.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.408 -0.808 . . . . 0.0 109.775 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -58.62 -31.89 68.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.358 -0.838 . . . . 0.0 110.192 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . -59.79 -35.47 74.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -94.18 23.46 5.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.28 42.85 89.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -105.12 67.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.877 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.563 HG12 ' HD3' ' A' ' 29' ' ' ARG . 85.3 t -51.75 -30.01 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.469 -0.769 . . . . 0.0 110.325 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -73.27 -39.06 65.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.325 -0.859 . . . . 0.0 110.728 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.637 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.5 tp10 -66.74 -31.99 73.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.257 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.853 HG12 HD12 ' A' ' 32' ' ' LEU . 6.5 t -83.09 -46.49 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.563 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.368 -0.833 . . . . 0.0 110.123 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.75 -35.98 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 109.728 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 27' ' ' GLU . 3.4 mt -59.09 -65.1 0.72 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.853 HD12 HG12 ' A' ' 28' ' ' VAL . 2.5 mt -51.39 -34.82 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 110.259 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -20.09 62.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.954 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.75 -9.23 47.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.09 28.01 2.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -57.71 151.49 17.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -1.168 . . . . 0.0 109.74 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 2.3 mp -73.35 135.43 79.15 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 109.729 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.11 -31.41 19.02 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.546 1.287 . . . . 0.0 110.128 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -139.69 61.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.558 -0.714 . . . . 0.0 110.032 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.4 160.01 83.83 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.283 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.5 124.03 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.827 1.435 . . . . 0.0 110.487 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -108.79 158.58 17.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -95.44 27.96 3.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 110.537 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -136.48 13.33 3.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 109.953 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.96 26.9 35.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.9 tpp180 -130.66 107.04 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 110.217 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.574 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mpt_? -55.09 -175.08 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.595 -0.691 . . . . 0.0 110.259 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.759 ' HB2' HD13 ' A' ' 63' ' ' LEU . 38.2 Cg_endo -64.34 163.66 25.76 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.267 1.14 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 52' ' ' MET . 5.7 mt 66.68 -59.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' PRO . 5.1 tt0 -53.22 -20.93 4.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 46' ' ' ARG . 12.0 p -114.82 -7.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.622 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -56.52 165.17 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.986 -1.071 . . . . 0.0 109.796 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.418 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 0.9 OUTLIER -54.73 -17.07 3.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.229 -0.92 . . . . 0.0 110.397 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.58 ' HE1' ' HE2' ' A' ' 52' ' ' MET . 0.0 OUTLIER 61.96 11.46 4.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -113.41 18.42 20.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -155.47 96.08 1.75 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.674 -0.898 . . . . 0.0 109.634 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.91 -21.04 56.99 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.344 -0.848 . . . . 0.0 109.759 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -56.43 -30.49 62.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.567 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.546 HG11 ' HB1' ' A' ' 20' ' ' ALA . 41.2 t -64.68 -44.88 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -59.92 -60.2 4.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.591 -0.693 . . . . 0.0 109.947 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.841 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.2 tt0 -45.73 -29.18 1.21 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.156 -0.965 . . . . 0.0 110.775 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.692 ' CD1' HD13 ' A' ' 32' ' ' LEU . 2.7 tp -83.82 -56.8 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 110.019 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 8.2 mt -67.68 -35.06 78.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.729 HD11 ' CB ' ' A' ' 100' ' ' ALA . 2.7 tm? -61.74 -65.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.81 -0.556 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.7 pp -54.53 -24.15 19.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.813 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.842 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.0 m80 -81.6 -49.95 9.92 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.526 -0.734 . . . . 0.0 110.134 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.24 46.02 0.03 OUTLIER Glycine 0 N--CA 1.482 1.731 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.029 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -75.57 -155.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.786 -1.42 . . . . 0.0 109.192 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 47' ' ' ARG . 6.7 tp10 -122.99 68.4 35.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 110.267 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HG3' HD23 ' A' ' 64' ' ' LEU . 52.5 Cg_endo -73.23 -9.13 22.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.896 1.471 . . . . 0.0 110.384 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 3.7 t30 -117.82 -70.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.711 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 152.7 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.105 -0.997 . . . . 0.0 111.082 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -137.62 -137.42 0.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 2.2 t70 -122.13 132.11 24.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.67 -7.78 21.85 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.639 1.336 . . . . 0.0 110.88 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.35 -55.74 4.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.212 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.531 HG22 ' CH2' ' A' ' 110' ' ' TRP . 61.2 p -117.26 7.34 12.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.2 mt 49.33 30.35 3.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.269 -0.894 . . . . 0.0 111.005 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -69.0 91.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.136 -0.977 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.87 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.87 159.22 83.51 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.623 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HB2' HD21 ' A' ' 97' ' ' LEU . 44.0 Cg_endo -70.08 -6.13 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.654 1.344 . . . . 0.0 110.626 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 t -77.29 -31.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 110.021 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 35.9 m80 -69.74 -42.8 73.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -0.828 . . . . 0.0 109.301 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.47 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.7 m-20 -48.47 -49.01 37.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.708 -0.62 . . . . 0.0 110.527 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.489 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -60.79 -68.9 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.819 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -50.64 -55.96 14.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.453 -0.78 . . . . 0.0 111.16 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 6.7 ttm180 -44.74 -27.79 0.55 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.173 -0.954 . . . . 0.0 111.683 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.476 ' CG ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -102.11 -5.03 24.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.689 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 79.84 36.06 26.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -116.41 101.66 8.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 110.724 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 125' ' ' ASP . 1.0 OUTLIER -83.1 -35.14 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 96' ' ' VAL . 3.1 m-20 -48.48 -43.06 34.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.383 -0.823 . . . . 0.0 109.784 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 m -65.07 -39.3 93.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 109.0 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.919 HD21 ' HB2' ' A' ' 130' ' ' LEU . 1.5 tp -51.81 -48.93 63.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.613 -0.68 . . . . 0.0 109.838 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 45.2 t -56.51 -51.35 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 109.68 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.5 HG12 ' HG ' ' A' ' 64' ' ' LEU . 26.3 t -49.25 -53.32 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.449 -0.782 . . . . 0.0 110.296 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.464 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -50.65 -67.76 0.23 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.468 -0.77 . . . . 0.0 110.683 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -61.86 -30.18 70.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.297 -0.877 . . . . 0.0 110.585 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -61.72 -16.6 50.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.348 -0.845 . . . . 0.0 110.764 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.729 ' CB ' HD11 ' A' ' 64' ' ' LEU . . . -129.74 -44.82 1.19 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.751 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.69 108.6 0.22 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -167.59 112.57 0.7 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -1.088 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.407 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -66.04 95.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.477 -0.765 . . . . 0.0 109.844 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 59.75 5.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.285 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -170.49 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -0.954 . . . . 0.0 110.062 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.87 HG11 ' CG ' ' A' ' 80' ' ' ARG . 1.5 p -102.54 -169.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.622 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.28 112.11 6.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.217 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.02 147.45 9.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.356 -0.84 . . . . 0.0 110.663 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -57.46 -27.24 62.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.531 ' CH2' HG22 ' A' ' 77' ' ' THR . 7.0 m95 -63.41 -14.35 49.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.72 46.02 5.86 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.41 104.29 2.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -1.043 . . . . 0.0 110.156 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.448 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -54.31 167.49 0.55 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.9 . . . . 0.0 109.941 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.553 ' O ' HD21 ' A' ' 130' ' ' LEU . 43.8 Cg_endo -69.93 -34.93 13.06 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.614 1.323 . . . . 0.0 109.931 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 131' ' ' ARG . 5.9 p -74.01 -27.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.398 -0.814 . . . . 0.0 110.192 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -37.94 63.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 109.69 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 87' ' ' ARG . 2.0 tt -69.39 -41.93 75.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.116 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -56.39 -48.49 76.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.267 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -65.51 -22.18 66.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 0.0 109.973 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.39 -65.62 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -83.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.182 -0.948 . . . . 0.0 110.539 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 35.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 24.0 m-70 -105.66 36.81 2.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -1.055 . . . . 0.0 108.659 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -46.87 -45.15 20.17 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.405 0.621 . . . . 0.0 109.601 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.723 ' O ' HD12 ' A' ' 91' ' ' LEU . 14.8 p30 -56.64 -39.82 74.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.376 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 86' ' ' ALA . 10.6 t -74.14 -52.44 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 109.841 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.674 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -48.99 -28.54 3.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.628 -0.67 . . . . 0.0 111.227 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -50.02 -70.58 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.03 -1.044 . . . . 0.0 110.626 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -73.11 -28.36 62.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.961 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.919 ' HB2' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -72.1 -14.53 61.87 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 109.634 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.477 ' HA ' HG21 ' A' ' 115' ' ' VAL . 10.6 ttt180 -88.21 -42.97 11.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.143 -0.973 . . . . 0.0 110.064 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.14 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.7 -23.89 20.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 110.547 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -120.29 60.91 0.87 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.61 99.96 0.17 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.17 -7.97 27.95 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.9 p -72.97 103.11 3.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 110.291 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.95 105.24 17.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.323 -0.861 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.79 -90.82 1.33 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.7 m -64.08 146.57 53.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -1.086 . . . . 0.0 109.829 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.94 1.17 32.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.0 110.704 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.94 -177.05 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.083 -1.011 . . . . 0.0 110.399 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.87 130.32 48.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -0.809 . . . . 0.0 110.111 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.54 85.77 0.78 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.401 -0.812 . . . . 0.0 110.245 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 145' ' ' ILE . 1.0 OUTLIER -165.38 94.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 109.978 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -50.52 98.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.402 -0.811 . . . . 0.0 110.537 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.82 124.2 9.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.424 -0.797 . . . . 0.0 110.28 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 55.05 -171.75 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.368 -0.833 . . . . 0.0 110.14 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -76.12 154.9 35.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.867 . . . . 0.0 110.14 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.38 114.43 0.08 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.7 143.6 42.24 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.542 1.285 . . . . 0.0 110.09 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.5 m 55.55 19.83 3.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.412 -0.805 . . . . 0.0 110.774 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 51.57 -170.5 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.154 -0.966 . . . . 0.0 110.671 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 154' ' ' ILE . 1.1 tt -121.06 88.95 45.68 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.425 -0.797 . . . . 0.0 109.821 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.34 126.29 12.77 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.792 1.417 . . . . 0.0 110.702 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.284 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.231 0.539 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.98 62.14 3.61 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.286 -0.884 . . . . 0.0 110.348 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.46 173.2 14.91 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.722 1.38 . . . . 0.0 110.679 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.31 152.0 38.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.379 -0.826 . . . . 0.0 110.069 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.21 39.7 1.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.0 110.372 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.94 -86.33 0.52 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 p -74.81 55.2 0.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -1.088 . . . . 0.0 110.261 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 t -112.7 -16.29 12.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.322 -0.861 . . . . 0.0 110.219 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.54 -9.62 21.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.496 -0.753 . . . . 0.0 110.787 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -102.26 129.95 25.17 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.072 -1.018 . . . . 0.0 110.621 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HB3' ' HG2' ' A' ' 41' ' ' PRO . 49.0 Cg_endo -72.2 68.5 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.705 1.371 . . . . 0.0 110.329 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -59.69 -173.81 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 110.32 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 63.31 13.85 7.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.445 -0.785 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' OG1' ' A' ' 18' ' ' THR . 9.0 p-10 -89.83 24.73 2.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.059 -1.025 . . . . 0.0 109.944 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.647 ' O ' HD13 ' A' ' 31' ' ' LEU . 30.6 m0 -67.7 -28.15 67.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.449 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.051 HD13 HD21 ' A' ' 63' ' ' LEU . 3.9 pp -63.13 -38.93 93.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 110.063 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.789 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -77.25 -42.12 38.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 110.056 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -60.54 -40.95 93.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 110.318 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -70.79 -35.92 72.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.773 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB1' ' HB2' ' A' ' 52' ' ' MET . . . -67.08 -45.15 78.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 109.748 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.77 -29.33 68.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.617 -0.677 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -88.23 14.98 8.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.406 -0.809 . . . . 0.0 110.107 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.26 50.22 56.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -123.83 77.43 1.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.407 -1.055 . . . . 0.0 110.315 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 59' ' ' VAL . 59.4 t -51.55 -46.35 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.386 -0.822 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.63 -60.7 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.594 -0.691 . . . . 0.0 110.311 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 -38.18 65.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.459 -0.776 . . . . 0.0 109.73 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.081 HG12 HD23 ' A' ' 62' ' ' LEU . 21.6 t -69.97 -56.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.956 ' HA ' HD22 ' A' ' 62' ' ' LEU . 9.8 mmm-85 -46.1 -45.17 16.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.73 . . . . 0.0 110.243 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.62 -36.93 57.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.483 -0.761 . . . . 0.0 109.567 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 15' ' ' TRP . 11.6 mt -62.15 -67.28 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.934 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -44.62 -43.56 8.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.665 -0.647 . . . . 0.0 110.164 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 2.6 tt0 -79.77 -17.43 53.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.643 -0.66 . . . . 0.0 110.798 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -80.74 -8.05 59.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 111.012 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.46 0.19 4.13 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.876 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.934 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -52.2 157.59 1.34 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.996 -1.297 . . . . 0.0 110.0 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.958 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 18.3 mt -86.14 153.77 57.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.114 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 48.5 Cg_endo -77.38 -54.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.644 1.339 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -107.44 40.05 1.77 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.839 . . . . 0.0 109.571 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.958 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -61.54 126.73 87.33 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.592 -0.693 . . . . 0.0 110.423 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HG2' ' HB3' ' A' ' 11' ' ' PRO . 45.7 Cg_endo -72.89 151.44 50.85 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.668 1.352 . . . . 0.0 110.099 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -122.52 171.68 8.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 109.865 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -4.44 59.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.325 -0.859 . . . . 0.0 110.07 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' HD2' HG21 ' A' ' 51' ' ' VAL . 3.3 m-30 -100.78 -3.04 30.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.93 29.02 54.47 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -119.83 39.41 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -1.065 . . . . 0.0 111.064 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 10.5 mmt180 49.59 172.68 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.424 -0.797 . . . . 0.0 111.741 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HG2' ' HB1' ' A' ' 68' ' ' ALA . 53.4 Cg_endo -77.0 -18.63 14.43 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.638 1.336 . . . . 0.0 110.51 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.796 HG23 ' SD ' ' A' ' 52' ' ' MET . 15.3 mt -104.94 -47.2 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -48.4 -25.03 1.43 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG21 ' HD2' ' A' ' 44' ' ' TYR . 11.5 p -100.05 -1.03 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.957 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.7 ptt? -75.55 141.14 43.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ttp -54.25 123.6 13.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.976 . . . . 0.0 108.528 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.564 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -82.02 44.12 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.967 -1.083 . . . . 0.0 110.823 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.25 2.28 11.48 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.639 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -137.14 88.87 2.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.714 -0.874 . . . . 0.0 109.96 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -61.54 -11.67 12.03 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.115 -0.991 . . . . 0.0 109.951 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.1 -47.43 58.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.994 HG13 HG11 ' A' ' 28' ' ' VAL . 42.2 t -45.52 -62.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.41 -0.806 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -49.13 -40.76 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.094 -1.004 . . . . 0.0 109.648 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 7.4 tm-20 -50.07 -27.49 5.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.77 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.081 HD23 HG12 ' A' ' 28' ' ' VAL . 8.3 tp -90.05 -54.46 4.03 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.051 HD21 HD13 ' A' ' 16' ' ' LEU . 11.4 mt -55.11 -46.28 75.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -69.59 -41.04 76.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 5.4 tp -54.08 -33.67 58.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.542 ' CG ' HD11 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -90.78 -47.02 7.88 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.767 -0.583 . . . . 0.0 109.555 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.25 63.84 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 C-N-CA 120.151 -1.024 . . . . 0.0 110.758 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.759 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -77.04 -153.85 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.948 -1.324 . . . . 0.0 109.283 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.59 55.76 2.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.111 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.572 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 45.9 Cg_endo -70.81 -14.84 33.06 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.576 1.303 . . . . 0.0 110.323 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 -64.12 1.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.47 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.2 150.73 8.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 111.03 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' NE ' ' A' ' 80' ' ' ARG . . . -128.83 -153.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.584 -0.698 . . . . 0.0 109.134 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -102.13 136.7 19.41 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 0.0 109.701 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.41 -3.2 13.56 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.396 1.208 . . . . 0.0 110.699 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.66 -30.72 18.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 0.0 109.471 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.627 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -151.11 22.07 0.76 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 109.854 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.8 OUTLIER 37.28 33.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.862 -0.524 . . . . 0.0 111.515 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -69.34 100.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.872 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.51 166.92 25.93 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.273 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 43.9 Cg_endo -72.79 -21.08 21.91 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.578 1.304 . . . . 0.0 109.581 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.953 HG21 ' HA ' ' A' ' 104' ' ' LEU . 45.8 t -54.16 -30.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 32.8 m80 -71.65 -42.85 67.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 10.7 t0 -49.1 -47.46 45.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.779 -0.575 . . . . 0.0 109.926 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.464 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -59.72 -69.42 0.21 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.456 -0.777 . . . . 0.0 110.548 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.75 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.58 -41.6 86.08 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.003 . . . . 0.0 111.446 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.48 ' NH1' HD11 ' A' ' 121' ' ' LEU . 12.1 tpt85 -45.84 -41.54 11.27 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 110.886 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.5 5.34 49.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.97 34.26 27.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -103.29 97.81 7.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -1.119 . . . . 0.0 110.999 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 91' ' ' LEU . 3.0 tt -82.67 -40.21 21.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 109.64 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.511 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.3 m-20 -46.42 -56.11 6.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.582 -0.699 . . . . 0.0 109.846 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 m -54.08 -43.38 70.28 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD23 ' CD1' ' A' ' 129' ' ' TYR . 0.7 OUTLIER -50.59 -34.26 25.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 25.1 t -72.92 -45.2 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.582 -0.699 . . . . 0.0 109.118 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 46.6 t -61.12 -46.71 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -0.785 . . . . 0.0 109.808 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' HA ' HD11 ' A' ' 64' ' ' LEU . 3.7 mm? -52.58 -46.0 66.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.451 -0.78 . . . . 0.0 110.217 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -84.35 -12.84 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 96' ' ' VAL . 2.5 mtt180 -80.06 -12.02 59.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.328 -0.858 . . . . 0.0 111.013 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.57 -66.25 0.77 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.52 108.41 0.29 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 97' ' ' LEU . . . -168.66 128.36 1.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -1.062 . . . . 0.0 110.578 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 112.26 23.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.965 HD12 ' HB2' ' A' ' 134' ' ' ALA . 0.4 OUTLIER -104.06 5.19 35.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 110.644 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 134' ' ' ALA . 5.0 m-20 -100.31 41.14 1.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.63 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.872 HG11 ' CD ' ' A' ' 80' ' ' ARG . 7.2 p -108.75 178.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.822 . . . . 0.0 110.925 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.587 ' H ' HG22 ' A' ' 106' ' ' VAL . 11.4 ptt180 -131.17 143.69 50.81 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -68.06 69.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.387 -0.82 . . . . 0.0 110.803 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 60.92 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.627 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.7 m-90 -60.08 -75.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.755 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.98 32.28 0.07 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.503 ' CB ' ' HB2' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -89.42 107.96 19.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -1.129 . . . . 0.0 109.824 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.652 HD13 ' HD2' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -82.55 159.11 64.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.434 -0.791 . . . . 0.0 110.159 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.652 ' HD2' HD13 ' A' ' 113' ' ' LEU . 42.3 Cg_endo -71.59 -24.68 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.797 1.419 . . . . 0.0 110.398 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 127' ' ' ALA . 11.6 p -79.42 -40.16 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.127 -0.983 . . . . 0.0 110.087 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.497 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -69.23 -30.01 68.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.483 -0.76 . . . . 0.0 109.884 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.465 HD21 ' HD3' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -78.4 -32.0 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.023 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.718 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.51 -44.7 50.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 109.672 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -36.42 78.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 110.02 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -59.5 4.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -0.813 . . . . 0.0 109.96 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.48 HD11 ' NH1' ' A' ' 87' ' ' ARG . 3.3 mm? -54.83 -82.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.28 37.24 0.03 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.481 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 31.1 m-70 -113.87 52.38 0.82 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.336 -1.096 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -33.83 9.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 110.27 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.426 ' C ' HD12 ' A' ' 91' ' ' LEU . 2.0 m-20 -63.81 -39.23 93.75 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.364 -0.835 . . . . 0.0 108.938 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -83.91 -43.18 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 109.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -63.27 -34.02 76.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -52.25 43.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.41 -0.807 . . . . 0.0 109.48 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.617 ' CD1' HD23 ' A' ' 94' ' ' LEU . 4.8 t80 -60.86 -30.34 70.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.505 -0.747 . . . . 0.0 109.168 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.748 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 36.6 mt -65.13 -60.13 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.039 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' A' ' 115' ' ' VAL . 5.9 ttp180 -53.24 -20.82 4.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 110.411 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.7 -60.19 2.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.48 -12.52 59.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.372 -0.83 . . . . 0.0 110.389 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.965 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -108.95 41.04 1.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 110.002 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.82 108.72 0.64 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 131' ' ' ARG . . . -99.7 124.86 8.37 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.5 p -90.03 149.55 22.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.57 -0.959 . . . . 0.0 110.275 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.04 32.84 0.59 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.403 -0.81 . . . . 0.0 110.547 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -93.48 -9.53 60.13 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.05 116.44 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.294 -1.121 . . . . 0.0 110.946 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.8 m120 47.15 47.41 16.31 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.541 -0.724 . . . . 0.0 110.52 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.26 -171.16 3.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.441 -0.787 . . . . 0.0 109.722 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -170.6 53.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.206 -0.934 . . . . 0.0 110.676 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.9 -174.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.45 -0.781 . . . . 0.0 111.398 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 145' ' ' ILE . 9.6 tp -153.48 68.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 110.776 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 145' ' ' ILE . 1.8 m-20 -39.62 124.29 1.64 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.221 -0.924 . . . . 0.0 110.431 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.95 130.47 15.22 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.293 -0.88 . . . . 0.0 110.284 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.35 134.79 45.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.365 -0.835 . . . . 0.0 110.793 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.56 161.81 30.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.504 -0.747 . . . . 0.0 110.021 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 58.18 -174.96 2.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.57 128.35 15.17 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.839 1.441 . . . . 0.0 111.133 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.93 12.95 22.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.563 -0.711 . . . . 0.0 109.542 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.44 160.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.566 -0.709 . . . . 0.0 111.226 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.409 ' O ' HD12 ' A' ' 154' ' ' ILE . 1.1 pp -119.39 82.76 24.83 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.0 109.978 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.69 111.05 2.48 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.55 1.289 . . . . 0.0 110.855 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.896 179.476 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.095 0.474 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -125.15 115.15 25.99 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 109.842 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.518 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 50.0 Cg_endo -73.69 157.49 48.17 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.692 1.364 . . . . 0.0 110.663 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . 177.75 61.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.357 -0.839 . . . . 0.0 109.904 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.81 -87.7 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.337 -0.852 . . . . 0.0 110.226 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 4' ' ' ALA . . . 51.5 32.85 31.85 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.6 p -147.54 -50.93 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.361 -1.082 . . . . 0.0 110.13 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -88.07 42.69 1.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 110.231 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -72.36 175.12 6.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.231 -0.918 . . . . 0.0 109.888 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.19 110.35 1.29 Allowed Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.417 -0.802 . . . . 0.0 110.566 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.06 111.86 3.37 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.611 1.321 . . . . 0.0 110.734 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.81 -37.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.472 -0.768 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.66 -51.58 7.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 110.05 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -65.33 -13.55 58.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 110.4 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.562 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.3 OUTLIER -66.39 -4.73 8.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.404 -0.81 . . . . 0.0 111.146 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 38' ' ' PRO . 1.3 tp -80.55 -45.21 17.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.883 -1.135 . . . . 0.0 109.075 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.7 53.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.486 -0.759 . . . . 0.0 110.171 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -61.32 -54.72 40.32 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -51.85 -49.44 62.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.366 -0.834 . . . . 0.0 109.784 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.12 -48.03 68.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 109.317 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -62.06 -28.93 69.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.579 -0.701 . . . . 0.0 109.345 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.93 20.65 3.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.655 -0.653 . . . . 0.0 110.286 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.46 52.92 22.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.627 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -128.72 96.03 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.109 . . . . 0.0 110.526 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 ' CG2' ' A' ' 59' ' ' VAL . 98.5 t -73.11 -54.6 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -44.08 -40.98 5.24 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.56 -0.712 . . . . 0.0 111.549 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.565 ' OE2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.02 -46.5 71.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.997 -1.064 . . . . 0.0 109.902 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.889 HG12 HD12 ' A' ' 32' ' ' LEU . 17.8 t -68.25 -41.29 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.819 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.929 ' HA ' HD11 ' A' ' 62' ' ' LEU . 13.6 mmm180 -50.43 -47.46 56.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.0 110.123 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.58 -45.1 47.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.79 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 ' OE2' ' A' ' 27' ' ' GLU . 10.6 mt -56.97 -60.45 3.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 110.198 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.901 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 mt -51.1 -32.57 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.313 -0.867 . . . . 0.0 109.574 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.58 -25.34 45.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.588 -0.695 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.67 -5.22 52.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.325 -0.859 . . . . 0.0 110.201 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.2 22.02 5.37 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -65.06 141.05 58.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.173 -1.192 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD1' ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -104.72 117.45 58.86 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.471 -0.768 . . . . 0.0 109.53 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HA ' HD21 ' A' ' 16' ' ' LEU . 43.0 Cg_endo -69.66 -29.53 24.23 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.46 1.242 . . . . 0.0 110.802 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.36 44.75 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 0.0 109.73 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . . . -88.3 155.57 51.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.581 -0.7 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.05 89.18 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.669 1.352 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 47' ' ' ARG . 41.3 m-80 -59.55 151.22 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.541 -0.725 . . . . 0.0 110.381 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.85 26.65 2.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.438 -0.789 . . . . 0.0 110.772 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -160.64 26.1 0.15 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.33 -0.856 . . . . 0.0 110.207 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.02 35.1 53.34 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -120.21 89.6 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.7 -0.883 . . . . 0.0 110.165 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -54.84 179.24 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.557 -0.714 . . . . 0.0 109.994 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.774 ' CB ' HD23 ' A' ' 63' ' ' LEU . 41.8 Cg_endo -66.96 156.77 64.83 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.387 1.204 . . . . 0.0 109.376 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 6.7 mt 67.2 -59.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 48' ' ' PRO . 36.4 tt0 -49.59 -21.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.919 -1.113 . . . . 0.0 109.688 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.5 p -124.49 37.06 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.812 . . . . 0.0 110.017 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.756 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -101.84 37.67 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.293 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.2 ttp 64.91 -9.22 0.2 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.535 -0.728 . . . . 0.0 111.693 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.554 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.4 28.57 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.035 -1.04 . . . . 0.0 110.339 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -132.27 11.46 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -144.54 73.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -1.021 . . . . 0.0 109.549 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -47.23 -27.92 1.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.605 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -59.24 -31.88 69.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.935 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.796 ' CG2' HG22 ' A' ' 25' ' ' VAL . 48.4 t -71.8 -50.41 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.756 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -43.0 -46.84 5.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -57.71 -55.15 38.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 109.702 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -44.38 -56.21 4.39 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.652 -0.655 . . . . 0.0 110.708 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.774 HD23 ' CB ' ' A' ' 48' ' ' PRO . 6.2 mp -68.84 -58.84 3.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 110.541 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -48.24 -52.91 19.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.175 -0.953 . . . . 0.0 110.301 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -55.04 -33.84 63.03 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.397 -0.814 . . . . 0.0 109.319 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.792 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.5 m-70 -81.88 -48.78 11.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.302 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.39 43.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.577 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.785 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' HA ' ' CG ' ' A' ' 48' ' ' PRO . . . -69.02 -172.53 0.41 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.703 -1.469 . . . . 0.0 109.722 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 47' ' ' ARG . 3.7 mm-40 -121.02 65.14 13.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.378 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.486 ' HG3' HD21 ' A' ' 64' ' ' LEU . 42.8 Cg_endo -68.84 -26.16 32.4 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.07 1.563 . . . . 0.0 110.378 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -92.7 -63.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 173.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -164.07 -170.74 2.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.85 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.52 132.96 43.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.604 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 -15.92 39.51 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.556 1.293 . . . . 0.0 110.708 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.76 -84.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 109.991 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 66.6 p -110.1 32.99 4.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.286 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 5.5 mt 49.27 32.54 4.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.472 -0.767 . . . . 0.0 110.529 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.61 97.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.503 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -72.24 147.78 90.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.457 -0.777 . . . . 0.0 109.859 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 40.8 Cg_endo -66.56 -20.59 53.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.521 1.274 . . . . 0.0 109.515 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.977 HG13 HD23 ' A' ' 104' ' ' LEU . 27.6 t -58.46 -25.7 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -0.801 . . . . 0.0 109.8 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.493 ' CE1' ' HB3' ' A' ' 80' ' ' ARG . 23.9 m80 -73.27 -41.29 63.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.214 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.554 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.4 OUTLIER -49.55 -43.85 46.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.694 -0.629 . . . . 0.0 110.23 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.708 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -63.35 -64.54 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.388 -0.82 . . . . 0.0 109.736 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.757 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -59.46 -52.41 65.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -41.27 -34.85 0.54 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.33 -8.99 28.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.16 -0.962 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . 82.92 23.81 54.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.646 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -98.95 84.01 3.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 110.445 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -57.9 -39.62 78.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 110.46 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.588 ' O ' HG23 ' A' ' 96' ' ' VAL . 46.2 t0 -50.01 -40.96 46.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.032 -1.042 . . . . 0.0 109.959 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 85' ' ' ALA . 50.7 m -60.03 -32.38 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.71 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.708 HD12 ' HB1' ' A' ' 85' ' ' ALA . 1.1 mp -72.15 -51.23 22.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.419 -0.801 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.3 t -50.17 -45.02 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.538 -0.726 . . . . 0.0 109.579 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 92' ' ' ASP . 39.1 t -61.72 -49.04 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.578 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.593 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.75 -71.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.139 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -48.77 -34.42 12.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.685 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -62.03 -20.72 64.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.54 86.15 1.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.212 -0.93 . . . . 0.0 111.124 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 49.13 97.8 0.01 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -168.19 97.5 0.43 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -1.131 . . . . 0.0 110.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.764 ' O ' HG21 ' A' ' 82' ' ' VAL . 10.7 ttm180 -71.93 137.08 47.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.49 -0.756 . . . . 0.0 109.567 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.977 HD23 HG13 ' A' ' 82' ' ' VAL . 1.1 mp -121.32 21.37 11.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 103' ' ' ARG . 4.8 p-10 -124.32 40.43 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.067 -1.02 . . . . 0.0 110.584 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.64 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.7 p -101.44 -171.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.64 ' H ' HG22 ' A' ' 106' ' ' VAL . 38.7 mtp180 -135.33 142.8 45.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 110' ' ' TRP . 94.0 m-20 -78.42 60.66 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 110.046 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.2 -71.18 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.756 -0.59 . . . . 0.0 111.082 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.597 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -40.57 -58.38 1.61 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.435 -0.791 . . . . 0.0 110.829 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -23.5 0.73 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -56.02 160.56 2.75 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.323 -1.104 . . . . 0.0 109.896 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 106' ' ' VAL . 36.6 mt -120.02 166.9 13.71 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 0.0 110.679 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.79 -34.92 29.44 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.806 1.424 . . . . 0.0 110.392 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 130' ' ' LEU . 9.8 p -82.78 -33.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.335 -0.853 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.57 -38.37 90.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -60.15 -24.56 64.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.785 . . . . 0.0 110.14 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -83.19 -27.7 29.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.26 -40.58 70.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.7 -47.28 32.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 117' ' ' LEU . 5.2 mp -69.85 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.32 38.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 16.6 m-70 -99.3 48.99 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.277 -1.131 . . . . 0.0 109.275 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -44.31 -38.02 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.757 -0.589 . . . . 0.0 110.646 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.53 -44.67 95.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.757 HG11 ' CB ' ' A' ' 86' ' ' ALA . 22.7 t -78.67 -42.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.426 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -50.98 -41.41 59.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -63.94 1.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.52 ' CB ' HD21 ' A' ' 91' ' ' LEU . 12.7 t80 -54.0 -41.38 67.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.498 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 86' ' ' ALA . 15.5 mt -58.1 -65.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.412 ' HG2' ' HA3' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -46.84 -26.04 0.89 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.076 -1.015 . . . . 0.0 110.499 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.06 -58.58 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.05 -3.59 36.72 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.522 -0.736 . . . . 0.0 110.977 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -108.06 -39.58 5.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 109.833 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.4 -69.84 0.51 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.412 ' HA3' ' HG2' ' A' ' 131' ' ' ARG . . . 79.59 -68.34 3.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 137' ' ' THR . 9.5 t -53.96 130.86 39.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.316 -1.108 . . . . 0.0 110.489 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -85.03 -156.98 0.27 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.0 110.412 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 67.69 -91.88 0.22 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.08 -172.87 3.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.42 -1.047 . . . . 0.0 110.498 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -141.76 136.23 30.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.512 -0.742 . . . . 0.0 109.751 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.86 50.38 8.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.375 -0.828 . . . . 0.0 110.088 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -128.32 -6.06 5.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.333 -0.855 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.03 102.91 12.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.89 135.87 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.313 -0.867 . . . . 0.0 109.924 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -86.12 111.77 20.66 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.224 -0.922 . . . . 0.0 111.147 -178.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 146' ' ' ASP . . . 174.69 69.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.315 -0.866 . . . . 0.0 110.582 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 60.21 119.98 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.406 -0.809 . . . . 0.0 110.883 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.47 118.88 37.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.0 109.772 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.55 134.89 12.2 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.71 -83.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.777 1.409 . . . . 0.0 110.928 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.55 22.36 10.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.176 -0.952 . . . . 0.0 110.765 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -50.37 162.94 0.19 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.331 -0.855 . . . . 0.0 110.001 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.74 81.11 3.2 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.237 -0.915 . . . . 0.0 109.832 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.97 100.77 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.911 1.48 . . . . 0.0 110.956 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.063 179.871 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.242 0.544 . . . . 0.0 110.066 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -56.39 -63.67 3.18 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.342 -0.849 . . . . 0.0 110.94 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.526 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 47.7 Cg_endo -72.55 153.94 54.99 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.239 1.126 . . . . 0.0 110.638 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 3' ' ' PRO . . . 62.22 118.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.674 -0.641 . . . . 0.0 110.514 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.4 147.15 49.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.442 -0.786 . . . . 0.0 110.116 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.77 148.42 4.79 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.3 p -100.86 143.98 30.36 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.378 -1.072 . . . . 0.0 109.88 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.6 129.58 31.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.184 -0.947 . . . . 0.0 110.648 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.9 mtp -140.81 141.85 34.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.421 -0.799 . . . . 0.0 109.912 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.469 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -174.66 165.0 2.41 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 10' ' ' GLU . 43.3 Cg_endo -70.8 -171.07 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.759 1.399 . . . . 0.0 109.901 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.7 t -136.33 -13.9 1.77 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.257 -0.902 . . . . 0.0 110.975 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -64.46 117.45 7.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.022 -1.049 . . . . 0.0 109.698 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.8 OUTLIER -175.16 -49.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 110.75 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.508 ' CD1' ' N ' ' A' ' 15' ' ' TRP . 35.6 m0 -68.19 -4.4 13.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.657 -0.652 . . . . 0.0 111.536 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.747 HD11 ' HB1' ' A' ' 36' ' ' ALA . 25.1 mt -79.66 -52.26 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 108.825 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.42 83.92 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.029 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -75.25 -60.95 2.07 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.21 -0.931 . . . . 0.0 111.074 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -45.74 -57.68 4.07 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.159 -0.963 . . . . 0.0 110.821 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -53.53 -41.43 66.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -64.7 -33.1 75.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.712 . . . . 0.0 110.198 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 24.5 2.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.824 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.22 61.05 6.13 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.98 68.25 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.964 . . . . 0.0 109.72 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 59' ' ' VAL . 18.1 t -52.7 -54.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.539 -0.726 . . . . 0.0 110.308 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -42.74 -38.07 1.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.0 110.747 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -66.3 -51.49 56.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.719 HG12 HD13 ' A' ' 62' ' ' LEU . 5.2 t -68.62 -42.89 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.561 -0.712 . . . . 0.0 110.215 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.932 ' HA ' HD11 ' A' ' 62' ' ' LEU . 14.4 mmm180 -46.41 -48.02 18.82 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.375 -0.828 . . . . 0.0 110.277 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.24 -37.65 52.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.465 -0.772 . . . . 0.0 109.918 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 14.4 mt -59.2 -66.94 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.874 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 23.7 mt -46.93 -48.52 21.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.581 -0.699 . . . . 0.0 110.427 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.08 -18.67 65.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.608 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.53 -6.68 57.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 111.012 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.21 31.79 1.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.874 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -74.09 157.93 35.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -1.057 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.96 115.26 61.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.442 -0.786 . . . . 0.0 109.911 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' HD13 ' A' ' 37' ' ' LEU . 43.8 Cg_endo -69.45 -36.53 11.46 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.497 1.262 . . . . 0.0 110.094 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 24.2 m120 -108.05 61.05 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.786 . . . . 0.0 110.221 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -104.06 99.19 15.76 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.37 -0.831 . . . . 0.0 110.364 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.24 121.02 7.41 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.546 1.288 . . . . 0.0 110.343 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -98.61 178.28 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.928 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -69.55 -6.13 28.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.39 -0.819 . . . . 0.0 110.816 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.21 1.95 22.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 0.0 110.695 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.23 30.76 8.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -124.5 133.83 53.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.805 -0.82 . . . . 0.0 109.906 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -50.65 168.98 0.22 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.498 -0.751 . . . . 0.0 110.745 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 69' ' ' GLU . 44.2 Cg_endo -72.32 -19.95 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 124.03 1.542 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.475 HG13 ' HB1' ' A' ' 68' ' ' ALA . 4.9 mt -107.03 -39.28 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.191 -0.943 . . . . 0.0 109.798 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 8.5 mt-30 -50.16 -22.11 1.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.585 HG22 ' HB2' ' A' ' 21' ' ' ALA . 13.4 p -113.21 34.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.046 -1.033 . . . . 0.0 110.584 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.722 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -96.19 35.28 1.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.724 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 52' ' ' MET . 1.9 tmm? 72.39 -10.45 0.92 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.656 -0.652 . . . . 0.0 110.614 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.567 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 44.61 28.47 0.33 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.982 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -137.0 16.91 3.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.544 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.6 m -150.04 75.38 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -1.087 . . . . 0.0 109.579 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -43.85 -34.3 1.57 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 0.0 110.673 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -48.91 -40.22 29.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.49 -0.756 . . . . 0.0 109.812 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 25' ' ' VAL . 19.4 t -62.4 -55.69 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.722 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.56 -54.55 3.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.626 -0.671 . . . . 0.0 109.92 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.558 ' O ' HD23 ' A' ' 65' ' ' LEU . 1.9 tt0 -49.75 -43.86 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.673 -0.642 . . . . 0.0 110.136 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.932 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -53.66 -73.36 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.125 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.978 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 34.2 mt -58.84 -49.26 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.698 . . . . 0.0 109.533 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.831 HD22 HG12 ' A' ' 96' ' ' VAL . 3.0 tt -48.42 -67.45 0.27 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.509 -0.745 . . . . 0.0 110.705 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -56.83 -19.51 17.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.347 -0.846 . . . . 0.0 110.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -85.06 -44.35 13.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.404 -0.81 . . . . 0.0 109.777 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 139.93 37.7 0.11 Allowed Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.978 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.8 -147.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.867 -1.372 . . . . 0.0 109.141 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 2.3 mt-10 -121.07 67.07 15.6 Favored Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 121.625 -0.672 . . . . 0.0 109.392 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CB ' HD23 ' A' ' 97' ' ' LEU . 45.2 Cg_endo -70.44 -7.9 22.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.971 1.511 . . . . 0.0 110.259 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -118.81 -72.85 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.376 -0.828 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.2 t -42.27 149.11 0.17 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.375 -0.828 . . . . 0.0 110.541 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . . . -132.36 -144.86 0.25 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.811 . . . . 0.0 110.405 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -103.72 139.07 19.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.578 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.63 2.23 7.63 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.444 1.234 . . . . 0.0 110.486 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.46 -56.02 3.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 109.148 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.617 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -129.26 19.05 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.751 -0.593 . . . . 0.0 109.576 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER 44.08 43.58 5.67 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.627 -0.671 . . . . 0.0 111.559 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.418 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 81.0 m -69.96 104.45 2.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 109.857 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.745 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -69.45 148.79 97.19 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.914 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.633 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 38.2 Cg_endo -64.66 -14.89 47.19 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.519 1.273 . . . . 0.0 108.919 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.402 HG13 HD23 ' A' ' 104' ' ' LEU . 72.2 t -67.04 -35.4 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.578 0.704 . . . . 0.0 109.221 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.426 ' ND1' ' HB3' ' A' ' 80' ' ' ARG . 24.0 m80 -65.38 -38.14 89.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.468 0.651 . . . . 0.0 109.501 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.567 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -55.13 -50.42 69.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.746 -0.596 . . . . 0.0 110.951 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -56.73 -64.38 0.89 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.978 -1.076 . . . . 0.0 108.725 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.825 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -53.33 -38.34 63.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.45 -0.781 . . . . 0.0 110.259 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.7 OUTLIER -49.55 -38.77 32.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.614 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.79 8.79 39.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 110.437 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 65.15 30.04 76.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -95.01 82.05 3.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.522 -0.987 . . . . 0.0 110.654 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.47 -42.39 74.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.832 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 96' ' ' VAL . 73.4 m-20 -47.33 -50.81 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 85' ' ' ALA . 3.1 m -53.82 -45.8 70.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.407 -0.808 . . . . 0.0 109.855 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.687 HD12 ' HB1' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -58.81 -44.89 90.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.742 . . . . 0.0 110.007 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 91' ' ' LEU . 21.4 t -56.7 -44.61 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.831 HG12 HD22 ' A' ' 64' ' ' LEU . 6.3 t -57.2 -54.49 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.589 ' HA ' HD11 ' A' ' 64' ' ' LEU . 13.3 mt -49.4 -51.0 37.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.679 -0.638 . . . . 0.0 110.16 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.66 -30.36 65.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 3.4 mtp180 -61.38 -14.02 24.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -123.33 -86.33 0.64 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.03 94.5 0.12 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -148.19 107.37 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 110.591 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -69.62 143.11 53.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.713 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.548 HD13 ' HB1' ' A' ' 133' ' ' ALA . 2.1 mp -123.18 37.07 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.417 -0.802 . . . . 0.0 109.763 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.02 34.22 4.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.365 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.745 HG11 ' CG ' ' A' ' 80' ' ' ARG . 13.0 p -102.6 173.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.946 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.548 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -124.91 148.15 48.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -69.4 66.22 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 0.0 109.883 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 65.51 -61.72 0.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.509 -0.744 . . . . 0.0 109.964 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.617 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.8 m-90 -70.2 -83.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 107' ' ' ARG . . . -170.06 21.62 0.08 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.442 ' C ' HD22 ' A' ' 113' ' ' LEU . 9.9 mtm180 -84.29 136.8 33.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.06 -1.259 . . . . 0.0 109.931 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 106' ' ' VAL . 4.0 mm? -104.98 165.9 12.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.635 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.433 ' C ' HD13 ' A' ' 130' ' ' LEU . 46.2 Cg_endo -71.73 -38.86 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.841 1.443 . . . . 0.0 109.838 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 127' ' ' ALA . 9.8 p -64.98 -35.91 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 0.0 111.225 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.407 ' N ' HG13 ' A' ' 115' ' ' VAL . 14.6 t0 -61.09 -47.71 85.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 111.268 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.598 HD23 ' CD1' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -52.46 -49.57 64.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.196 -0.94 . . . . 0.0 110.939 -179.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.771 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -53.26 -50.25 65.2 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.235 -0.916 . . . . 0.0 110.736 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -56.86 -51.83 67.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.996 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -61.54 -57.94 10.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.466 -0.771 . . . . 0.0 110.193 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.598 ' CD1' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -59.35 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.368 -0.832 . . . . 0.0 110.419 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.59 34.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.2 m-70 -107.33 53.39 0.69 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.434 -1.039 . . . . 0.0 109.288 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -47.62 -36.7 11.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.533 -0.729 . . . . 0.0 110.069 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.413 ' C ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -58.23 -44.98 88.5 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.95 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.825 HG11 ' CB ' ' A' ' 86' ' ' ALA . 20.2 t -80.27 -42.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.771 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -52.25 -44.81 65.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 109.676 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -65.27 -64.57 0.83 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.278 -0.888 . . . . 0.0 109.323 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -47.51 -40.66 19.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.655 . . . . 0.0 110.06 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.591 ' CD1' HG12 ' A' ' 126' ' ' VAL . 14.2 mt -63.28 -55.03 28.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.544 -0.723 . . . . 0.0 110.083 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.32 -27.08 0.61 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.512 -0.742 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.19 -62.94 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.036 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.548 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -68.9 -6.09 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.317 -0.864 . . . . 0.0 111.026 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -108.37 0.8 21.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.101 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.78 71.81 0.05 OUTLIER Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -88.92 27.45 7.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.8 p -90.46 -2.73 57.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.251 . . . . 0.0 110.323 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.5 mtp-105 60.9 -153.64 0.37 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.363 -0.836 . . . . 0.0 110.378 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.02 -96.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.4 p -96.07 -140.05 0.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.316 -1.108 . . . . 0.0 110.05 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.16 117.09 26.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.001 . . . . 0.0 109.925 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.19 -72.96 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.871 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 144' ' ' ARG . . . -64.54 -157.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.44 -0.787 . . . . 0.0 109.629 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 143' ' ' ALA . 3.7 ttt180 61.18 142.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.377 -0.827 . . . . 0.0 110.375 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 145' ' ' ILE . 3.6 tp -98.42 112.36 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.284 -0.885 . . . . 0.0 109.968 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -50.66 93.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 145' ' ' ILE . . . -44.59 119.13 1.78 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.503 -0.748 . . . . 0.0 110.85 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.4 132.52 20.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.56 -0.712 . . . . 0.0 110.185 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.59 -1.29 15.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 110.574 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.79 125.36 4.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.37 109.69 2.67 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.46 1.242 . . . . 0.0 110.37 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.18 2.43 2.78 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.43 -0.794 . . . . 0.0 111.518 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.461 ' C ' HD12 ' A' ' 154' ' ' ILE . 0.7 OUTLIER 50.18 -177.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.054 -1.029 . . . . 0.0 110.697 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 154' ' ' ILE . 5.4 mp -135.59 94.15 15.42 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.32 126.99 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.663 1.349 . . . . 0.0 110.624 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.145 179.764 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.185 0.517 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.87 131.23 23.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.394 -0.817 . . . . 0.0 109.931 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.92 117.71 4.56 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.702 1.369 . . . . 0.0 110.547 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.05 156.03 21.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 0.0 110.093 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.85 -160.21 1.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.411 -0.806 . . . . 0.0 110.177 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.43 65.19 3.42 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 p 50.13 -173.32 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.617 -0.931 . . . . 0.0 110.385 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.2 p -83.12 -178.51 7.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 109.927 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.7 mtm -58.11 -171.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.22 -0.925 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -47.72 123.19 9.37 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.316 -0.865 . . . . 0.0 110.557 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -74.29 -179.47 4.78 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.516 1.272 . . . . 0.0 110.894 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 13' ' ' ALA . 1.6 t -65.09 -177.47 0.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.693 . . . . 0.0 110.016 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . -93.31 55.09 2.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.367 -0.833 . . . . 0.0 110.381 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.12 -36.08 78.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.353 -0.842 . . . . 0.0 110.285 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.51 ' CE3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -43.03 -36.26 1.53 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.523 -0.736 . . . . 0.0 110.468 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.733 ' CD1' ' HB1' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -49.88 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 110.465 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' H ' ' HB3' ' A' ' 16' ' ' LEU . . . -47.41 -52.67 16.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.625 -0.672 . . . . 0.0 111.394 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 4.8 p -40.57 -61.01 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.34 -0.85 . . . . 0.0 111.137 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.657 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -55.19 -53.59 54.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -54.37 -44.28 72.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.65 -17.65 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.647 -0.658 . . . . 0.0 110.276 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -100.67 19.9 16.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.366 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.4 53.67 39.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.595 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -127.64 96.24 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' CZ ' ' A' ' 29' ' ' ARG . 24.4 t -74.56 -44.49 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.292 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.19 -45.63 90.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 110.729 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.836 ' O ' HD12 ' A' ' 31' ' ' LEU . 2.2 mt-10 -53.05 -44.76 67.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.357 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.931 HG12 HD12 ' A' ' 32' ' ' LEU . 4.7 t -75.97 -46.61 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.724 . . . . 0.0 109.936 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HD2' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.93 -44.89 40.88 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.305 -0.872 . . . . 0.0 110.204 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.51 61.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.571 -0.705 . . . . 0.0 110.232 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.1 mt -65.44 -67.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.931 HD12 HG12 ' A' ' 28' ' ' VAL . 2.7 mt -47.43 -33.64 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -30.4 68.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.94 -6.68 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.845 . . . . 0.0 110.193 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.27 30.88 3.22 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.1 162.42 1.96 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.289 -1.124 . . . . 0.0 109.929 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' A' ' 37' ' ' LEU . 13.1 tp -80.28 127.33 76.73 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.393 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.36 -29.58 13.69 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.765 1.403 . . . . 0.0 110.407 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -132.91 81.08 1.92 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HA ' HD23 ' A' ' 37' ' ' LEU . . . -97.66 129.43 31.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 110.221 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.63 93.41 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.562 1.296 . . . . 0.0 110.259 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.8 -167.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.244 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.64 2.77 41.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.895 . . . . 0.0 110.544 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -105.26 23.1 14.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.121 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.45 23.57 19.95 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -124.02 -164.52 1.25 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.48 -1.012 . . . . 0.0 110.087 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.557 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -139.88 -174.39 0.41 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 108.997 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HB2' HD13 ' A' ' 63' ' ' LEU . 38.9 Cg_endo -66.2 160.82 43.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.127 1.067 . . . . 0.0 109.965 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt 68.43 -59.61 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.613 -0.679 . . . . 0.0 110.008 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -51.78 -21.16 2.58 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.82 -1.175 . . . . 0.0 110.015 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 51' ' ' VAL . 14.4 p -125.2 9.81 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.383 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.514 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 2.6 ptt? -69.59 159.74 32.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.993 -1.067 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -46.65 -24.74 0.59 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.569 -0.707 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.508 ' HE3' ' HE3' ' A' ' 52' ' ' MET . 0.0 OUTLIER 64.54 14.44 8.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.914 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.44 14.63 27.65 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.637 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -149.24 87.22 1.51 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.59 -0.947 . . . . 0.0 109.818 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -53.55 -23.09 9.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.85 . . . . 0.0 110.03 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -60.29 -35.35 75.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 110.001 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 56' ' ' SER . 57.4 t -59.56 -49.09 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.61 -55.44 25.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.792 . . . . 0.0 110.043 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.55 ' O ' HD23 ' A' ' 65' ' ' LEU . 2.2 tm-20 -49.76 -41.53 44.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.094 -1.004 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.672 ' CD1' HD13 ' A' ' 32' ' ' LEU . 2.6 tp -69.03 -57.18 5.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.302 -0.874 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 6.8 mt -65.71 -41.02 92.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.919 HD13 HG12 ' A' ' 96' ' ' VAL . 2.9 tt -59.46 -65.4 0.68 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 110.938 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.75 HD12 ' C ' ' A' ' 65' ' ' LEU . 3.5 pp -52.9 -24.56 9.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 109.697 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.838 ' CB ' HD22 ' A' ' 32' ' ' LEU . 1.3 m80 -80.79 -41.99 22.46 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.541 -0.724 . . . . 0.0 109.941 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.56 41.11 0.1 OUTLIER Glycine 0 N--CA 1.482 1.76 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.787 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -68.2 -148.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.986 -1.302 . . . . 0.0 109.737 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 4.3 tp10 -120.96 57.12 5.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.331 -0.856 . . . . 0.0 110.217 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 48.9 Cg_endo -72.14 -25.42 19.13 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.885 1.466 . . . . 0.0 110.341 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 103' ' ' ARG . 2.3 m-20 -100.06 -76.81 0.54 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 0.0 110.137 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 162.91 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.568 -0.707 . . . . 0.0 110.41 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -140.53 -132.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -0.842 . . . . 0.0 110.196 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 78' ' ' LEU . 41.6 t0 -121.18 129.8 25.11 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 -7.95 22.46 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.369 1.194 . . . . 0.0 110.592 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.45 -49.58 11.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.01 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.606 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -134.72 24.5 3.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.55 -0.719 . . . . 0.0 110.072 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 78' ' ' LEU . 7.7 mt 41.86 31.63 0.23 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.697 -0.627 . . . . 0.0 110.749 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.6 m -67.61 86.56 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.818 . . . . 0.0 110.236 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.845 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.56 167.78 20.78 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 109.787 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 51.1 Cg_endo -73.46 -2.68 12.49 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.433 1.228 . . . . 0.0 110.913 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.004 HG13 HD23 ' A' ' 104' ' ' LEU . 36.1 t -78.25 -27.45 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 110.092 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 19.9 m80 -74.19 -39.32 63.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.885 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD2' ' HA ' ' A' ' 81' ' ' PRO . 50.2 m-20 -55.02 -56.0 24.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.645 -0.659 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.35 -63.01 1.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.747 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.814 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -52.65 -54.25 35.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.873 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -47.66 -39.52 17.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.394 -0.816 . . . . 0.0 110.803 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.62 12.6 20.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.97 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 55.59 56.16 25.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -129.63 90.6 3.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.468 -1.019 . . . . 0.0 111.223 -178.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.697 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -73.41 -35.0 65.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.792 . . . . 0.0 109.665 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -47.58 -47.98 28.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.673 -0.642 . . . . 0.0 109.779 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 m -64.11 -41.64 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.718 HD21 ' CB ' ' A' ' 130' ' ' LEU . 1.6 tp -52.86 -55.09 25.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.6 -0.687 . . . . 0.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 87.2 t -48.92 -46.26 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.72 -0.613 . . . . 0.0 109.433 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.919 HG12 HD13 ' A' ' 64' ' ' LEU . 49.9 t -58.52 -53.31 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.512 0.672 . . . . 0.0 109.402 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.922 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -48.72 -52.74 22.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.551 -0.718 . . . . 0.0 110.071 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -74.05 -21.84 59.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 109.817 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.9 ttp180 -64.24 -16.73 62.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.495 -0.753 . . . . 0.0 110.474 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.592 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -134.1 -76.85 0.47 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.0 100.52 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.922 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -152.01 94.94 2.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -1.046 . . . . 0.0 110.526 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -55.66 108.2 0.41 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.249 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.004 HD23 HG13 ' A' ' 82' ' ' VAL . 2.0 mt -98.9 32.38 2.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.04 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.47 44.64 2.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 0.0 110.373 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.845 HG11 ' HB2' ' A' ' 80' ' ' ARG . 9.5 p -111.21 -178.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.376 -0.828 . . . . 0.0 110.191 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.635 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.9 mtp85 -122.83 -176.67 3.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 44.4 p-10 -104.46 36.28 2.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.901 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 66.35 3.7 2.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 110.945 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.606 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 3.6 m-90 -123.65 -57.96 1.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.981 -1.074 . . . . 0.0 109.959 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.83 -30.4 0.15 Allowed Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.44 165.4 4.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -1.036 . . . . 0.0 110.831 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 117' ' ' LEU . 42.3 mt -128.82 169.62 12.57 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.644 -0.66 . . . . 0.0 109.278 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.96 -13.87 37.5 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.454 1.239 . . . . 0.0 109.806 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 130' ' ' LEU . 4.6 p -90.56 -40.09 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 110.657 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -57.01 -43.18 81.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.354 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -56.54 -53.19 60.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.861 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.573 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -53.36 -53.89 44.59 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -49.46 -30.45 8.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.0 109.94 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 28.2 mm-40 -85.15 -59.12 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.565 -0.71 . . . . 0.0 109.544 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.42 -0.8 . . . . 0.0 110.053 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.68 28.34 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 12.0 m-70 -97.98 47.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.028 -1.278 . . . . 0.0 109.159 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.91 -40.92 6.73 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.606 0.717 . . . . 0.0 109.547 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.545 ' OD2' HG23 ' A' ' 126' ' ' VAL . 5.3 p-10 -61.74 -46.79 88.13 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.039 -0.665 . . . . 0.0 109.635 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.814 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -76.17 -40.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 109.777 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.573 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -52.81 -62.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.348 -0.845 . . . . 0.0 110.341 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -47.02 -61.27 1.95 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.504 -0.748 . . . . 0.0 111.303 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.697 ' CG ' HD21 ' A' ' 91' ' ' LEU . 14.8 t80 -56.64 -63.55 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.896 . . . . 0.0 110.62 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.718 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.29 -19.92 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 110.514 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.511 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -75.4 -40.62 57.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.036 -1.04 . . . . 0.0 110.148 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.55 77.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.61 -15.94 31.64 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.716 -0.615 . . . . 0.0 109.819 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -111.78 27.9 9.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.331 -0.855 . . . . 0.0 110.397 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.45 -103.9 0.19 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.17 -67.56 1.44 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.4 p -59.82 112.68 1.93 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.277 -1.131 . . . . 0.0 110.021 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.27 73.24 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 110.158 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 77.14 -142.55 27.51 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.57 -179.13 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.378 -1.072 . . . . 0.0 110.343 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -131.5 -43.03 1.03 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -138.27 -170.46 2.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.41 -0.806 . . . . 0.0 110.06 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 44.95 62.17 2.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.503 -0.748 . . . . 0.0 110.642 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -58.07 171.41 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 110.125 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.5 tp -77.96 137.76 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.459 -0.776 . . . . 0.0 109.906 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -43.49 110.81 0.22 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 110.704 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.4 133.39 24.53 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.787 . . . . 0.0 110.321 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.99 116.56 2.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.443 -0.786 . . . . 0.0 110.476 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -91.42 117.45 29.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 64.52 156.03 0.17 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.23 134.55 10.36 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.722 1.38 . . . . 0.0 110.421 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.08 116.18 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.331 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.01 54.64 0.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 79.0 mt -113.86 95.97 39.54 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.409 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.57 126.17 15.04 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.571 1.3 . . . . 0.0 110.065 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.2 t0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.55 -179.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.077 0.465 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -119.45 105.5 43.87 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.222 -0.924 . . . . 0.0 110.412 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.593 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 46.4 Cg_endo -71.47 138.07 31.86 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.64 1.337 . . . . 0.0 111.087 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . 172.78 111.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.427 -0.795 . . . . 0.0 109.793 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.88 56.59 0.43 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 110.252 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.15 163.42 20.97 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.3 p -94.05 -1.2 54.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.375 -1.073 . . . . 0.0 110.611 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 10' ' ' GLU . 27.8 p -82.3 104.43 12.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.93 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.1 ttp -54.32 91.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.46 -0.775 . . . . 0.0 110.7 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 8' ' ' SER . 2.0 mp0 49.42 91.34 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.471 -0.768 . . . . 0.0 110.554 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.8 83.05 1.63 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.697 1.367 . . . . 0.0 109.901 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.69 -67.48 0.98 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 111.021 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.51 22.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.392 -0.817 . . . . 0.0 110.118 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 20.2 p-10 -100.17 3.74 43.96 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.408 -0.808 . . . . 0.0 110.579 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.596 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.8 m0 -54.42 -21.03 8.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.803 HD11 HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -75.62 -42.33 51.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.452 -0.78 . . . . 0.0 109.403 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.93 -45.12 28.92 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.823 . . . . 0.0 109.895 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -47.23 -56.26 7.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.571 -0.705 . . . . 0.0 110.434 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.83 91.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 110.163 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -53.96 -53.81 47.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -58.5 -29.31 66.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.422 -0.799 . . . . 0.0 110.436 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.85 23.86 2.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.587 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 49.82 44.62 39.99 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -109.09 93.55 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -1.11 . . . . 0.0 110.017 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 58' ' ' ARG . 5.1 t -75.1 -46.46 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 110.192 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -32.92 70.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 1.6 tp10 -74.03 -46.45 43.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 0.0 109.766 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.537 HG21 HG13 ' A' ' 59' ' ' VAL . 51.4 t -64.94 -46.89 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 1.077 ' HA ' HD12 ' A' ' 62' ' ' LEU . 46.3 mmm-85 -55.21 -46.76 75.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.053 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.34 56.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 0.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 13.0 mt -61.15 -63.01 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.945 . . . . 0.0 110.49 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.92 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 1.4 mt -49.18 -43.27 42.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.392 -0.817 . . . . 0.0 110.476 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -71.09 -13.36 61.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.88 -10.17 37.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.194 -0.941 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.01 -2.83 5.57 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.333 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.92 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -53.69 103.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.03 -1.276 . . . . 0.0 109.896 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 17.3 tp -50.5 123.4 17.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.494 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 40.8 Cg_endo -67.84 -43.44 5.2 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.598 1.315 . . . . 0.0 110.489 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -91.07 54.13 2.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.12 -0.988 . . . . 0.0 109.817 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -104.8 93.95 6.84 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.771 . . . . 0.0 110.612 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.17 97.11 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.588 1.309 . . . . 0.0 110.034 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -63.7 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.315 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.12 36.42 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.28 -0.887 . . . . 0.0 110.319 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -7.76 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 111.073 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 24.48 19.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.44 32.45 5.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.541 -0.976 . . . . 0.0 109.369 -179.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mmt180 49.77 179.76 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 49.7 Cg_endo -86.44 -13.69 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.155 1.082 . . . . 0.0 111.065 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 63' ' ' LEU . 5.2 mt -107.69 -43.05 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.95 -1.094 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 1.5 tt0 -46.24 -28.91 1.4 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 21' ' ' ALA . 7.1 p -109.32 40.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.599 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -99.48 30.38 3.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 109.669 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.587 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 7.3 tmm? 64.65 -4.7 0.43 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.724 -0.61 . . . . 0.0 111.292 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.599 ' HE2' ' CG ' ' A' ' 52' ' ' MET . 13.0 mmt 42.39 28.64 0.12 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.41 6.89 8.03 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.662 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -145.75 87.34 1.77 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 110.115 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -54.01 -30.84 49.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.805 . . . . 0.0 109.545 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.606 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -54.12 -37.47 64.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.574 -0.704 . . . . 0.0 109.273 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.682 ' O ' HD12 ' A' ' 63' ' ' LEU . 99.0 t -59.84 -61.17 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . . . -54.75 -25.61 28.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.545 -0.722 . . . . 0.0 109.104 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 58' ' ' ARG . 5.2 tm-20 -53.54 -72.13 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.302 -0.874 . . . . 0.0 110.045 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.077 HD12 ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.56 -36.57 71.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.778 -1.201 . . . . 0.0 109.393 179.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 16' ' ' LEU . 1.1 mt -58.09 -63.41 1.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.447 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.728 HD13 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.38 -31.37 71.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.421 -0.799 . . . . 0.0 109.248 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 26.0 tp -68.78 -48.34 63.9 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.593 -0.692 . . . . 0.0 109.559 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.517 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.91 -16.08 58.5 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.423 -0.798 . . . . 0.0 109.951 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.5 63.63 0.58 Allowed Glycine 0 N--CA 1.483 1.825 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.618 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 48' ' ' PRO . . . -79.71 -146.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.945 -1.327 . . . . 0.0 109.145 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mm-40 -117.14 55.07 1.53 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.285 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 49.2 Cg_endo -70.72 -14.07 32.75 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.497 1.262 . . . . 0.0 110.95 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -103.65 -76.44 0.59 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.127 -0.983 . . . . 0.0 110.262 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.61 144.17 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . . . -119.01 -156.28 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.924 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -102.7 144.18 28.1 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.951 . . . . 0.0 110.441 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.94 -17.08 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.614 1.323 . . . . 0.0 110.327 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.66 -78.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.714 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.687 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 34.8 p -115.06 27.36 9.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.143 -0.973 . . . . 0.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.1 mt 46.64 31.06 1.27 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 111.117 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -67.09 100.37 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.581 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -75.86 165.48 52.88 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.315 -0.866 . . . . 0.0 109.513 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HD2' ' HG2' ' A' ' 80' ' ' ARG . 47.4 Cg_endo -71.54 -11.51 28.27 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.637 1.335 . . . . 0.0 109.625 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 114' ' ' PRO . 77.2 t -69.5 -46.39 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.436 -0.79 . . . . 0.0 109.93 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 39.9 m80 -52.03 -49.63 63.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.424 -0.797 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 7.0 m-20 -42.54 -54.67 3.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 122.02 -0.425 . . . . 0.0 111.437 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.508 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -53.29 -62.69 1.49 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.914 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -63.18 -26.15 68.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.564 -0.71 . . . . 0.0 110.686 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -62.35 -28.44 69.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.018 -1.051 . . . . 0.0 109.947 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.433 ' C ' ' CE1' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -109.05 -20.82 12.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.404 -0.81 . . . . 0.0 110.089 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.735 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 94.39 32.6 7.27 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.906 -1.677 . . . . 0.0 108.906 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.556 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -99.46 88.05 3.77 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 110.406 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.612 HD11 ' CD2' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -60.6 -39.08 86.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 110.432 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 31.8 m-20 -46.85 -46.15 20.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.527 -0.733 . . . . 0.0 110.081 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.5 m -61.47 -46.42 90.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.564 -0.71 . . . . 0.0 110.055 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.624 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -51.31 -57.91 7.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.38 -0.825 . . . . 0.0 110.481 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.34 -50.67 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.284 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.728 HG12 HD13 ' A' ' 64' ' ' LEU . 57.7 t -55.37 -51.07 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.532 -0.73 . . . . 0.0 110.358 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 1.1 mp -51.46 -55.66 17.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -71.7 -42.41 67.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.369 -0.832 . . . . 0.0 110.882 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -7.35 6.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -132.77 -59.16 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.931 -1.106 . . . . 0.0 110.74 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.85 108.78 0.28 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -173.03 133.62 0.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -1.167 . . . . 0.0 110.915 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -97.23 80.79 2.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.611 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.4 mp -69.91 67.88 0.28 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.0 110.011 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -168.02 33.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.314 -0.866 . . . . 0.0 110.43 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.2 p -105.9 -170.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.925 -1.11 . . . . 0.0 109.996 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 106' ' ' VAL . 30.5 mtt180 -131.29 147.52 52.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 110' ' ' TRP . 35.7 t0 -79.1 54.89 1.71 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.687 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 58.6 -69.06 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.74 -0.6 . . . . 0.0 110.635 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.686 ' CH2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -41.22 -48.65 3.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.71 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.38 -33.88 1.54 Allowed Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.452 ' HD2' ' HB2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -56.58 156.35 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -1.064 . . . . 0.0 110.35 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 117' ' ' LEU . 29.9 mt -105.9 168.03 8.82 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.489 -0.757 . . . . 0.0 110.412 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 82' ' ' VAL . 38.8 Cg_endo -65.81 -27.96 51.47 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.773 1.407 . . . . 0.0 110.046 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 127' ' ' ALA . 3.4 p -77.83 -31.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.506 -0.747 . . . . 0.0 109.731 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -60.12 -49.2 78.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.448 -0.782 . . . . 0.0 110.189 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.658 ' C ' HD12 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -57.58 -57.25 13.5 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.317 -0.865 . . . . 0.0 110.356 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.914 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -51.22 -54.95 20.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.446 ' N ' ' HB2' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -49.31 -41.25 37.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.351 -0.843 . . . . 0.0 110.578 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -80.09 -26.42 39.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.378 -0.826 . . . . 0.0 110.421 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 117' ' ' LEU . 8.3 mt -81.0 2.64 26.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.275 -0.891 . . . . 0.0 110.383 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.86 17.28 73.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 22.2 m170 -94.67 53.44 1.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -1.158 . . . . 0.0 108.949 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -39.97 -59.21 1.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.222 0.535 . . . . 0.0 111.802 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.528 ' O ' HD21 ' A' ' 91' ' ' LEU . 54.8 m-20 -48.6 -39.44 23.9 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.492 -0.755 . . . . 0.0 110.393 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -80.89 -38.74 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.511 -0.743 . . . . 0.0 110.012 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -64.79 -38.99 92.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 109.553 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -73.99 -42.62 60.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.257 -0.902 . . . . 0.0 109.841 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.612 ' CD2' HD11 ' A' ' 91' ' ' LEU . 9.5 t80 -59.79 -40.63 88.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.624 ' HG ' HD21 ' A' ' 94' ' ' LEU . 19.4 mt -68.28 -42.96 78.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.509 -0.744 . . . . 0.0 109.591 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.445 ' HG3' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -58.53 -20.95 50.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.72 -47.6 11.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.881 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.71 -14.57 42.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -102.5 -64.02 1.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.397 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.8 -158.06 53.03 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -175.34 91.92 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.9 p -88.12 20.53 3.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.29 -1.124 . . . . 0.0 110.731 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.01 69.3 0.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.006 . . . . 0.0 109.735 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 162.7 172.82 30.65 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.1 m 57.18 168.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.403 -1.057 . . . . 0.0 110.537 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -89.39 50.3 1.9 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.168 -0.958 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.3 OUTLIER -138.39 -166.12 1.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.361 -0.837 . . . . 0.0 110.045 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' HIS . . . -178.65 126.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.422 -0.799 . . . . 0.0 109.992 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 57.9 77.61 0.28 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.481 -0.762 . . . . 0.0 111.029 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.9 pt -76.79 157.63 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.147 -0.97 . . . . 0.0 109.784 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.9 OUTLIER 58.87 168.4 0.06 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -0.995 . . . . 0.0 109.999 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . 62.84 142.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.407 -0.808 . . . . 0.0 110.25 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.79 124.08 7.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.537 -0.727 . . . . 0.0 111.264 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.2 71.53 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.892 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.33 -145.73 16.1 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -79.98 140.64 14.41 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.58 1.305 . . . . 0.0 110.329 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.4 m -86.45 103.56 15.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.525 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.56 93.51 0.16 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.349 -0.844 . . . . 0.0 109.706 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 154' ' ' ILE . 0.8 OUTLIER -123.05 92.8 48.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.503 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.62 113.24 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.596 1.314 . . . . 0.0 110.362 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.058 -179.657 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mmm . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.237 0.541 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.508 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 2.2 mt-10 -78.72 -61.19 0.54 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.499 -0.75 . . . . 0.0 111.007 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 47.8 Cg_endo -70.28 149.06 63.02 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.284 1.149 . . . . 0.0 110.653 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 3' ' ' PRO . . . 59.57 76.31 0.36 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.341 -0.849 . . . . 0.0 110.377 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.98 100.54 4.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.461 -0.774 . . . . 0.0 110.369 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.94 125.76 7.24 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -145.44 36.76 1.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -1.178 . . . . 0.0 110.104 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 t 46.39 83.88 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.566 -0.709 . . . . 0.0 110.565 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.7 ptp -119.22 -11.01 9.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 0.0 110.71 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 1.7 mp0 -61.23 130.68 91.77 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 0.0 109.732 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.28 80.68 2.44 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.454 1.239 . . . . 0.0 109.837 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.3 11.02 6.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.529 -0.732 . . . . 0.0 110.336 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . . . -82.17 -33.1 29.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 110.485 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' A' ' 18' ' ' THR . 12.1 t70 -81.91 -5.86 58.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.422 -0.799 . . . . 0.0 110.988 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -3.98 17.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.933 -1.105 . . . . 0.0 111.169 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.911 HD21 ' CB ' ' A' ' 36' ' ' ALA . 28.0 mt -81.14 -49.63 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.128 -0.983 . . . . 0.0 109.57 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.88 -46.73 67.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.675 -0.64 . . . . 0.0 110.077 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.79 -63.67 1.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.673 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -51.97 -46.02 64.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.348 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -57.63 -49.22 77.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -63.77 -24.86 67.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.454 -0.778 . . . . 0.0 110.694 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -90.13 26.35 1.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.784 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.91 31.11 4.0 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.619 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -104.46 94.16 5.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.617 -0.931 . . . . 0.0 110.174 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 59' ' ' VAL . 46.2 t -71.43 -54.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.592 -0.692 . . . . 0.0 110.025 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -47.82 -41.23 23.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.493 -0.755 . . . . 0.0 110.671 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 5.2 mm-40 -59.13 -54.62 44.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 24' ' ' ARG . 2.6 t -64.79 -49.67 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.619 -0.676 . . . . 0.0 109.238 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HA ' HD11 ' A' ' 62' ' ' LEU . 3.4 mmt180 -36.95 -51.61 0.92 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.347 0.594 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' ALA . . . -78.7 -52.51 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.3 mt -48.39 -74.23 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.317 -0.864 . . . . 0.0 111.382 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.019 HD23 HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -50.1 -43.25 51.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 110.804 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.44 -10.09 59.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 0.0 110.386 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' ALA . . . -87.33 -13.47 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.005 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.49 23.61 1.35 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.494 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.911 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -69.6 -172.95 0.53 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.259 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.53 ' H ' HD11 ' A' ' 16' ' ' LEU . 3.1 mm? -94.96 126.38 47.09 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 110.829 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 43.1 Cg_endo -71.34 -16.45 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.284 1.15 . . . . 0.0 110.225 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -137.79 48.08 2.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.217 -0.927 . . . . 0.0 109.981 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . . . -73.79 137.98 76.76 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.42 169.35 22.61 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.751 1.395 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -133.39 -172.13 2.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.3 m -109.14 13.04 24.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.892 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 15.7 m-85 -117.96 8.25 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.248 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.37 31.96 79.19 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -119.1 -169.58 1.76 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.459 -1.024 . . . . 0.0 110.127 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -105.95 164.72 14.4 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 38.8 Cg_endo -65.85 -15.73 50.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.561 1.295 . . . . 0.0 111.266 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.6 mt -109.12 -38.25 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.92 . . . . 0.0 108.799 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 2.8 mt-30 -49.96 -23.55 2.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.328 -0.858 . . . . 0.0 110.41 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 21' ' ' ALA . 11.1 p -110.98 36.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.456 -0.777 . . . . 0.0 110.537 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.545 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 0.1 OUTLIER -96.8 32.25 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.955 -1.09 . . . . 0.0 110.198 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.443 ' HE3' ' HB3' ' A' ' 53' ' ' MET . 6.7 tmm? 64.98 -3.26 0.61 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.654 -0.654 . . . . 0.0 110.568 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.549 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 39.88 32.71 0.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.429 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -122.15 -3.23 9.82 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -145.6 85.95 1.72 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 110.212 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.6 -25.74 11.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -49.81 -43.38 48.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.725 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 25' ' ' VAL . 5.9 t -60.21 -54.79 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -48.63 -35.63 14.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.641 -0.662 . . . . 0.0 109.333 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -49.53 76.02 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.019 HD22 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -55.06 -57.03 13.38 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.657 0.742 . . . . 0.0 109.157 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.81 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.4 mm? -59.93 -27.96 67.21 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.96 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.821 ' HG ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -73.42 -56.31 5.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.199 -0.938 . . . . 0.0 110.342 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -51.47 -27.08 9.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.838 0.828 . . . . 0.0 109.253 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.637 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.0 -28.58 21.33 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.627 0.727 . . . . 0.0 109.112 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.29 63.34 0.73 Allowed Glycine 0 N--CA 1.477 1.432 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.81 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -71.3 -154.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.079 -1.248 . . . . 0.0 108.664 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 47' ' ' ARG . 13.2 mt-10 -113.9 66.7 1.42 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.286 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.472 ' HB3' HD23 ' A' ' 97' ' ' LEU . 45.3 Cg_endo -69.69 -17.7 37.76 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.766 1.403 . . . . 0.0 110.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.432 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.4 t30 -98.02 -58.61 1.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -0.826 . . . . 0.0 110.501 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 30.7 t -47.0 147.95 1.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.9 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.92 -144.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.797 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.8 140.87 24.51 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.241 -0.912 . . . . 0.0 109.96 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -20.03 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.257 1.135 . . . . 0.0 109.919 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.22 -57.8 4.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 110.237 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.857 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -131.72 29.01 4.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 78' ' ' LEU . 6.1 mt 41.29 38.76 0.84 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.539 -0.726 . . . . 0.0 111.201 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.2 m -72.8 98.28 2.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.949 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.786 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -78.0 163.2 64.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.927 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.4 Cg_endo -69.07 -3.99 12.67 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.414 1.218 . . . . 0.0 110.393 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 104' ' ' LEU . 31.2 t -74.99 -29.48 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 2.2 m80 -74.67 -33.21 62.44 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -55.15 -59.67 4.45 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.341 0.591 . . . . 0.0 110.033 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.668 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -53.99 -61.56 2.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.388 -0.82 . . . . 0.0 109.76 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.799 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -54.99 -58.8 6.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 3.3 ttt180 -46.5 -28.16 1.32 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.279 -0.888 . . . . 0.0 110.894 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.482 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 1.8 tm-20 -103.3 1.99 33.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 111.044 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.476 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 64.38 58.93 9.09 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.47 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -134.23 86.75 2.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 110.339 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -58.21 -44.38 88.14 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.566 -0.709 . . . . 0.0 110.077 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 96' ' ' VAL . 22.5 t0 -43.8 -46.64 7.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.541 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 52.4 m -60.21 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 97' ' ' LEU . 1.8 tp -56.8 -45.67 82.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.178 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 91' ' ' LEU . 60.5 t -55.63 -50.67 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.608 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.821 HG12 ' HG ' ' A' ' 64' ' ' LEU . 52.7 t -53.54 -53.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.345 -0.847 . . . . 0.0 110.401 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 94' ' ' LEU . 6.2 mt -50.08 -66.92 0.31 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -56.72 -32.61 65.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 0.0 109.853 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.7 ttp85 -67.44 -8.97 37.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.602 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.498 ' CB ' HD12 ' A' ' 64' ' ' LEU . . . -149.35 58.21 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.969 -1.082 . . . . 0.0 111.19 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.4 109.01 0.01 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -166.41 125.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.4 -1.059 . . . . 0.0 110.757 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.449 ' O ' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -69.88 114.1 7.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.424 -0.797 . . . . 0.0 109.191 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.523 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -111.06 25.01 12.21 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 110.661 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 2.0 p30 -145.19 59.8 1.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.104 -0.997 . . . . 0.0 110.355 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.786 HG11 ' HB2' ' A' ' 80' ' ' ARG . 9.2 p -108.77 -177.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.696 ' H ' HG22 ' A' ' 106' ' ' VAL . 12.9 mtt180 -132.6 132.37 42.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -72.48 60.95 0.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.445 -0.785 . . . . 0.0 110.07 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.27 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.36 -0.838 . . . . 0.0 110.451 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CH2' HG23 ' A' ' 77' ' ' THR . 0.8 OUTLIER -124.09 25.28 7.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 0.0 109.902 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -93.61 -75.99 1.32 Allowed Glycine 0 N--CA 1.48 1.605 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 2.1 mtt180 171.93 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.939 . . . . 0.0 110.072 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.439 ' CD1' ' HD2' ' A' ' 114' ' ' PRO . 2.4 mm? -104.3 170.98 5.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HB3' ' ND1' ' A' ' 83' ' ' HIS . 44.1 Cg_endo -70.74 -22.71 27.2 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.696 1.366 . . . . 0.0 110.622 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.884 ' HB ' HD11 ' A' ' 130' ' ' LEU . 7.2 p -82.81 -39.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 110.082 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.415 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 89.3 m-20 -52.48 -38.79 60.21 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.75 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.5 mt -59.73 -58.45 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -50.93 -39.82 55.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.17 -46.41 75.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.21 -24.77 57.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -87.64 -81.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.922 . . . . 0.0 110.681 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.72 42.55 0.02 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 37.3 m-70 -106.03 52.4 0.73 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.528 -0.983 . . . . 0.0 108.951 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 12.2 ptm180 -42.41 -40.88 2.7 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.201 0.524 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.496 ' O ' HD21 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -60.15 -41.01 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.268 -0.895 . . . . 0.0 108.918 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.4 t -85.0 -41.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.675 -0.64 . . . . 0.0 109.656 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -51.67 -45.62 63.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -0.805 . . . . 0.0 110.308 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -82.57 -43.69 16.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.434 -0.791 . . . . 0.0 110.278 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.752 ' CG ' HD11 ' A' ' 91' ' ' LEU . 53.8 t80 -65.23 -61.76 1.94 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.233 -0.917 . . . . 0.0 109.953 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.884 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -56.32 -31.05 63.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 110.064 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.522 ' HB2' HG21 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -66.24 -28.95 69.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.003 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.95 -39.84 65.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.006 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.93 -13.12 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 111.029 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -106.93 -35.2 6.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.975 -1.078 . . . . 0.0 111.098 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' A' ' 131' ' ' ARG . . . 175.31 90.64 0.08 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -113.78 40.29 2.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.501 HG22 ' HE ' ' A' ' 144' ' ' ARG . 61.8 p -91.44 127.24 36.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -1.137 . . . . 0.0 109.973 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -81.98 -52.56 6.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.449 -0.782 . . . . 0.0 110.182 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.79 133.42 47.8 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.4 p -59.95 -23.97 64.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.385 -1.068 . . . . 0.0 110.383 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -63.2 105.67 0.75 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.355 -0.84 . . . . 0.0 110.147 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.476 ' CG ' ' N ' ' A' ' 143' ' ' ALA . 1.0 OUTLIER -70.06 -142.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' N ' ' CG ' ' A' ' 142' ' ' HIS . . . 56.98 37.52 28.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.146 -0.971 . . . . 0.0 109.707 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.501 ' HE ' HG22 ' A' ' 137' ' ' THR . 0.2 OUTLIER -72.91 108.23 5.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.541 -0.725 . . . . 0.0 110.25 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.3 mt -83.73 135.73 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 109.379 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 t0 57.52 68.27 0.87 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.085 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -69.45 117.0 10.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.248 -0.908 . . . . 0.0 110.239 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 61.11 137.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.456 -0.778 . . . . 0.0 110.253 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.0 153.54 1.8 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.144 -0.972 . . . . 0.0 110.356 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -169.25 -144.84 4.39 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.55 157.37 61.05 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.672 1.354 . . . . 0.0 110.815 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.98 177.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.43 -0.794 . . . . 0.0 110.587 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -87.82 105.71 17.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.572 -0.705 . . . . 0.0 110.24 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 91.7 mt -129.93 78.84 74.28 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.227 -0.921 . . . . 0.0 110.463 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.05 134.5 14.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.852 1.449 . . . . 0.0 109.926 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.461 -179.915 . . . . . . . . 0 0 . 1 stop_ save_